RXCUI_IN,DRUG_DESC,ICD9,INDICATION_DESCRIPTION,POSSIBLE_LABEL_USE
44,Mesna,459.0,Hemorrhage NOS,0
44,Mesna,595,Cystitis,1
44,Mesna,595.9,Cystitis NOS,1
44,Mesna,977.9,Poisoning by unspecified drug or medicinal substance,0
74,4-Aminobenzoic Acid,692.70,Unspecified dermatitis due to sun,0
74,4-Aminobenzoic Acid,692.71,Sunburn,0
74,4-Aminobenzoic Acid,694.4,Pemphigus,0
74,4-Aminobenzoic Acid,710.1,Systemic sclerosis,0
74,4-Aminobenzoic Acid,710.3,Dermatomyositis,0
99,6-Aminocaproic Acid,185,Malignant neoplasm of prostate,1
99,6-Aminocaproic Acid,459.0,Hemorrhage NOS,1
99,6-Aminocaproic Acid,641.2,Premature separation of placenta,1
99,6-Aminocaproic Acid,641.20,Premature separation of placenta; unspecified as to episode of care,1
103,mercaptopurine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
103,mercaptopurine,204.0,Lymphoid leukemia; acute,1
103,mercaptopurine,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
103,mercaptopurine,204.1,Lymphoid leukemia; chronic,1
103,mercaptopurine,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
103,mercaptopurine,208,Leukemia of unspecified cell type,1
103,mercaptopurine,208.9,Unspecified leukemia,1
103,mercaptopurine,208.90,Unspecified leukemia without mention of having achieved remission,1
103,mercaptopurine,555.9,Regional enteritis of unspecified site,0
103,mercaptopurine,556,Ulcerative colitis,0
103,mercaptopurine,556.8,Other ulcerative colitis,0
103,mercaptopurine,556.9,Ulcerative colitis; unspecified,0
110,Oxyquinoline,686.9,Unspecified local infection of skin and subcutaneous tissue,0
149,Acebutolol,401-405.99,,1
149,Acebutolol,401.9,Hypertension NOS,1
149,Acebutolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
149,Acebutolol,413,Angina pectoris,1
149,Acebutolol,413.9,Other and unspecified angina pectoris,1
149,Acebutolol,427,Cardiac dysrhythmias,1
149,Acebutolol,427.1,Paroxysmal ventricular tachycardia,0
149,Acebutolol,427.41,Ventricular fibrillation,0
149,Acebutolol,427.89,Other specified cardiac dysrhythmias,1
149,Acebutolol,427.9,Cardiac dysrhythmia NOS,1
149,Acebutolol,429.9,Heart disease NOS,1
149,Acebutolol,786.50,Unspecified chest pain,1
149,Acebutolol,997.91,Hypertension,1
161,Acetaminophen,338-338.99,,1
161,Acetaminophen,346,Migraine,0
161,Acetaminophen,346.9,Migraine; unspecified,0
161,Acetaminophen,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
161,Acetaminophen,460,Acute nasopharyngitis (common cold),1
161,Acetaminophen,462,Acute pharyngitis,1
161,Acetaminophen,487,Influenza,1
161,Acetaminophen,487.1,Influenza with other respiratory manifestations,1
161,Acetaminophen,525.9,Dental disorder NOS,1
161,Acetaminophen,536.8,Dyspepsia and other specified disorders of function of stomach,0
161,Acetaminophen,625.3,Dysmenorrhea,1
161,Acetaminophen,715.00,Osteoarthrosis; generalized; involving unspecified site,0
161,Acetaminophen,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
161,Acetaminophen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
161,Acetaminophen,716.90,Arthropathy; unspecified; site unspecified,1
161,Acetaminophen,724.1,Pain in thoracic spine,1
161,Acetaminophen,724.5,Backache unspecified,1
161,Acetaminophen,729.1,Myalgia and myositis unspecified,1
161,Acetaminophen,780.60,Fever; unspecified,1
161,Acetaminophen,780.96,Generalized pain,1
161,Acetaminophen,780.99,Other general symptoms,0
161,Acetaminophen,781.99,Other symptoms involving nervous and musculoskeletal systems,0
161,Acetaminophen,784.0,Headache,1
161,Acetaminophen,786.2,Cough,0
161,Acetaminophen,787.02,Nausea alone,0
161,Acetaminophen,787.1,Heartburn,0
161,Acetaminophen,995.3,Allergy unspecified not elsewhere classified,0
167,Acetazolamide,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
167,Acetazolamide,345.9,Epilepsy; unspecified,1
167,Acetazolamide,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
167,Acetazolamide,365,Glaucoma,1
167,Acetazolamide,365.9,Glaucoma NOS,1
167,Acetazolamide,428.0,Congestive heart failure (CHF) NOS,1
167,Acetazolamide,780.39,Other convulsions,1
167,Acetazolamide,782.3,Edema,1
167,Acetazolamide,799.89,Other ill-defined conditions,1
167,Acetazolamide,993.2,Other and unspecified effects of high altitude,1
168,Acetic Acid,380.10,Infective otitis externa; unspecified,0
168,Acetic Acid,596.9,Unspecified disorder of bladder,0
168,Acetic Acid,616.10|041.9,,0
197,Acetylcysteine,277.0,Cystic fibrosis,1
197,Acetylcysteine,277.00,Cystic fibrosis without mention of meconium ileus,1
197,Acetylcysteine,277.3,Amyloidosis,1
197,Acetylcysteine,277.30,Amyloidosis NOS,1
197,Acetylcysteine,486,Pneumonia; organism unspecified,1
197,Acetylcysteine,490,Bronchitis NOS,1
197,Acetylcysteine,492,Emphysema,1
197,Acetylcysteine,492.8,Other emphysema,1
197,Acetylcysteine,494,Bronchiectasis,1
197,Acetylcysteine,494.0,Bronchiectasis without acute exacerbation,1
197,Acetylcysteine,514,Pulmonary congestion and hypostasis,0
197,Acetylcysteine,518.52,Other pulmonary insufficiency; not elsewhere classified; following trauma and surgery,0
197,Acetylcysteine,518.89,Other diseases of lung; not elsewhere classified,0
197,Acetylcysteine,584.5,Acute renal failure with lesion of tubular necrosis,0
197,Acetylcysteine,977.9,Poisoning by unspecified drug or medicinal substance,0
197,Acetylcysteine,998.9,Unspecified complication of procedure; not elsewhere classified,0
270,Spectinomycin,098,Gonococcal infections,1
270,Spectinomycin,098.89,Gonococcal infection of other specified sites,1
272,Activated Charcoal,586,Renal failure unspecified,0
272,Activated Charcoal,787.03,Vomiting alone,1
272,Activated Charcoal,787.3,Flatulence; eructation; and gas pain,0
272,Activated Charcoal,787.7,Abnormal feces,0
272,Activated Charcoal,787.91,Diarrhea,0
272,Activated Charcoal,977.9,Poisoning by unspecified drug or medicinal substance,0
272,Activated Charcoal,V62.81,Interpersonal problems; not elsewhere classified,0
281,Acyclovir,042,Human immunodeficiency virus [HIV] disease,0
281,Acyclovir,042-042.99,,0
281,Acyclovir,052,Chickenpox,1
281,Acyclovir,052.9,Varicella uncomplicated,1
281,Acyclovir,053,Herpes zoster,1
281,Acyclovir,053.2,Herpes zoster with ophthalmic complications,0
281,Acyclovir,053.20,Herpes zoster dermatitis of eyelid,0
281,Acyclovir,053.29,Herpes zoster with other ophthalmic complications,0
281,Acyclovir,053.9,Herpes zoster without mention of complication,1
281,Acyclovir,054,Herpes simplex,1
281,Acyclovir,054.1,Genital herpes,1
281,Acyclovir,054.10,Genital herpes NOS,1
281,Acyclovir,054.40,Herpes simplex with unspecified ophthalmic complication,0
281,Acyclovir,054.43,Herpes simplex disciform keratitis,0
281,Acyclovir,054.9,Herpes simplex without mention of complication,1
281,Acyclovir,058.29,Other human herpesvirus encephalitis,1
281,Acyclovir,075,Infectious mononucleosis,0
281,Acyclovir,078.5,Cytomegaloviral disease,0
281,Acyclovir,136.9,Unspecified infectious and parasitic diseases,1
281,Acyclovir,338-338.99,,1
281,Acyclovir,780.79,Other malaise and fatigue,0
281,Acyclovir,780.96,Generalized pain,1
296,Adenosine,426.7,Anomalous atrioventricular excitation,0
296,Adenosine,427.0,Paroxysmal supraventricular tachycardia,1
296,Adenosine,427.1,Paroxysmal ventricular tachycardia,1
296,Adenosine,427.2,Paroxysmal tachycardia; unspecified,0
296,Adenosine,427.31,Atrial fibrillation,1
296,Adenosine,427.32,Atrial flutter,1
296,Adenosine,427.89,Other specified cardiac dysrhythmias,1
296,Adenosine,427.9,Cardiac dysrhythmia NOS,1
309,Adenosine Monophosphate,426.7,Anomalous atrioventricular excitation,0
309,Adenosine Monophosphate,427.0,Paroxysmal supraventricular tachycardia,0
309,Adenosine Monophosphate,427.2,Paroxysmal tachycardia; unspecified,0
318,Adenosine Triphosphate,426.7,Anomalous atrioventricular excitation,0
318,Adenosine Triphosphate,427.0,Paroxysmal supraventricular tachycardia,0
318,Adenosine Triphosphate,427.2,Paroxysmal tachycardia; unspecified,0
376,Corticotropin,255.9,Unspecified disorder of adrenal glands,0
376,Corticotropin,345.6,Infantile spasms,1
376,Corticotropin,345.60,Infantile spasms; without mention of intractable epilepsy,1
388,Polymyxin B Sulfate,041.49,Other and unspecified Escherichia coli [E. coli],0
388,Polymyxin B Sulfate,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
388,Polymyxin B Sulfate,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
388,Polymyxin B Sulfate,136.9,Unspecified infectious and parasitic diseases,0
388,Polymyxin B Sulfate,320,Bacterial meningitis,0
388,Polymyxin B Sulfate,320.9,Bacterial meningitis NOS,0
388,Polymyxin B Sulfate,379.99|041.9,,0
388,Polymyxin B Sulfate,380.10,Infective otitis externa; unspecified,0
388,Polymyxin B Sulfate,569.9,Unspecified disorder of intestine,0
388,Polymyxin B Sulfate,596.9,Unspecified disorder of bladder,0
388,Polymyxin B Sulfate,709.9,Unspecified disorder of skin and subcutaneous tissue,0
430,Albendazole,007.1,Giardiasis,0
430,Albendazole,120-129.99,,0
430,Albendazole,121.0,Opisthorchiasis,0
430,Albendazole,121.1,Clonorchiasis,0
430,Albendazole,122,Echinococcosis,1
430,Albendazole,122.9,Echinococcosis; other and unspecified,1
430,Albendazole,123.1,Cysticercosis,1
430,Albendazole,123.6,Hymenolepiasis,0
430,Albendazole,126.9,Ancylostomiasis NOS,0
430,Albendazole,127.3,Trichuriasis,0
430,Albendazole,127.4,Enterobiasis,0
430,Albendazole,127.9,Intestinal helminthiasis; unspecified,0
430,Albendazole,128.0,Toxocariasis,0
430,Albendazole,128.9,Helminthiasis NOS,0
430,Albendazole,136.9,Unspecified infectious and parasitic diseases,1
435,Albuterol,491,Chronic bronchitis,1
435,Albuterol,491.9,Chronic bronchitis NOS,1
435,Albuterol,493,Asthma,1
435,Albuterol,493.81,Exercise induced bronchospasm,1
435,Albuterol,493.9,Asthma; unspecified,1
435,Albuterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
435,Albuterol,496,Chronic airway obstruction; not elsewhere classified,0
435,Albuterol,519.11,Acute bronchospasm,1
435,Albuterol,796.4,Other abnormal clinical findings,0
448,Ethanol,276.51,Dehydration,1
448,Ethanol,337.20,Reflex sympathetic dystrophy; unspecified,0
448,Ethanol,350.1,Trigeminal neuralgia,1
448,Ethanol,459.9,Unspecified circulatory system disorder,1
480,Alfentanil,338-338.99,,0
480,Alfentanil,780.96,Generalized pain,0
519,Allopurinol,274,Gout,1
519,Allopurinol,274.9,Gout NOS,1
519,Allopurinol,277.88,Tumor lysis syndrome,0
519,Allopurinol,277.89,Other specified disorders of metabolism,0
519,Allopurinol,592.0,Calculus of kidney,1
519,Allopurinol,593.9,Unspecified disorder of kidney and ureter,1
519,Allopurinol,790.6,Other abnormal blood chemistry,1
569,Eflornithine,086.5,African trypanosoma NOS,0
569,Eflornithine,704.1,Hirsutism,0
594,Alphaprodine,338-338.99,,0
594,Alphaprodine,780.96,Generalized pain,0
596,Alprazolam,300.00,Anxiety state unspecified,1
596,Alprazolam,300.01,Panic disorder without agoraphobia,1
596,Alprazolam,300.02,Generalized anxiety disorder,1
596,Alprazolam,300.21,Agoraphobia with panic disorder,1
596,Alprazolam,300.22,Agoraphobia without mention of panic attacks,1
596,Alprazolam,300.23,Social phobia,1
596,Alprazolam,300.9,Unspecified nonpsychotic mental disorder,1
596,Alprazolam,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
596,Alprazolam,308.2,Predominant psychomotor disturbance,1
596,Alprazolam,311,Depressive disorder NEC,0
596,Alprazolam,780.79,Other malaise and fatigue,1
596,Alprazolam,787.02,Nausea alone,1
596,Alprazolam,799.21,Nervousness (ADDED),1
598,Alprostadil,302.72,Psychosexual dysfunction with inhibited sexual excitement,1
598,Alprostadil,416.0,Primary pulmonary hypertension,0
598,Alprostadil,446.7,Takayasu's disease,0
598,Alprostadil,607.84,Impotence of organic origin,1
598,Alprostadil,745.2,Tetralogy of Fallot,1
598,Alprostadil,746.02,Stenosis of pulmonary valve; congenital,0
598,Alprostadil,746.1,Tricuspid atresia and stenosis; congenital,1
598,Alprostadil,746.7,Hypoplastic left heart syndrome,0
598,Alprostadil,746.89,Other specified congenital anomalies of heart,1
598,Alprostadil,747.0,Patent ductus arteriosus,1
598,Alprostadil,747.1,Coarctation of aorta,1
598,Alprostadil,747.10,Coarctation of aorta (preductal) (postductal),1
599,Alseroxylon,401-405.99,,0
599,Alseroxylon,401.9,Hypertension NOS,0
599,Alseroxylon,997.91,Hypertension,0
612,Aluminum Hydroxide,338-338.99,,0
612,Aluminum Hydroxide,530.11,Reflux esophagitis,0
612,Aluminum Hydroxide,530.81,Esophageal reflux,0
612,Aluminum Hydroxide,531,Gastric ulcer,0
612,Aluminum Hydroxide,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
612,Aluminum Hydroxide,532,Duodenal ulcer,0
612,Aluminum Hydroxide,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
612,Aluminum Hydroxide,536.8,Dyspepsia and other specified disorders of function of stomach,0
612,Aluminum Hydroxide,564.0,Constipation,0
612,Aluminum Hydroxide,564.00,Constipation NOS,0
612,Aluminum Hydroxide,578,Gastrointestinal hemorrhage,0
612,Aluminum Hydroxide,578.9,Hemorrhage of gastrointestinal tract NOS,0
612,Aluminum Hydroxide,780-789.99,,0
612,Aluminum Hydroxide,780.96,Generalized pain,0
612,Aluminum Hydroxide,787.1,Heartburn,0
620,Amantadine,136.9,Unspecified infectious and parasitic diseases,1
620,Amantadine,332,Parkinson's disease,1
620,Amantadine,332.0,Paralysis agitans,1
620,Amantadine,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
620,Amantadine,487,Influenza,1
620,Amantadine,487.1,Influenza with other respiratory manifestations,1
632,Mitomycin,151.9,Malignant neoplasm of stomach; unspecified,1
632,Mitomycin,188,Malignant neoplasm of bladder,0
632,Mitomycin,188.9,Malignant neoplasm of bladder; part unspecified,0
632,Mitomycin,199.1,Other malignant neoplasm of unspecified site,1
632,Mitomycin,239.0,Neoplasm of unspecified nature of digestive system,0
632,Mitomycin,239.4,Neoplasm of unspecified nature of bladder,0
632,Mitomycin,365,Glaucoma,0
632,Mitomycin,365.9,Glaucoma NOS,0
641,Amikacin,031.9,Unspecified diseases due to mycobacteria,0
641,Amikacin,038,Septicemia,1
641,Amikacin,038.9,Septicemia NOS,1
641,Amikacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
641,Amikacin,136.9,Unspecified infectious and parasitic diseases,1
641,Amikacin,424.90,Endocarditis valve unspecified cause,0
641,Amikacin,519.8,Other diseases of respiratory system; not elsewhere classified,0
641,Amikacin,599.0,Urinary tract infection; site not specified,1
643,Amikacin Sulfate,031.9,Unspecified diseases due to mycobacteria,0
643,Amikacin Sulfate,038,Septicemia,0
643,Amikacin Sulfate,038.9,Septicemia NOS,0
643,Amikacin Sulfate,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
643,Amikacin Sulfate,136.9,Unspecified infectious and parasitic diseases,0
643,Amikacin Sulfate,424.90,Endocarditis valve unspecified cause,0
643,Amikacin Sulfate,519.8,Other diseases of respiratory system; not elsewhere classified,0
644,Amiloride,276.2,Acidosis,1
644,Amiloride,276.7,Hyperpotassemia,1
644,Amiloride,276.8,Hypopotassemia,1
644,Amiloride,277.0,Cystic fibrosis,0
644,Amiloride,277.00,Cystic fibrosis without mention of meconium ileus,0
644,Amiloride,401-405.99,,1
644,Amiloride,401.9,Hypertension NOS,1
644,Amiloride,427.9,Cardiac dysrhythmia NOS,1
644,Amiloride,428,Heart failure,1
644,Amiloride,428.0,Congestive heart failure (CHF) NOS,1
644,Amiloride,428.9,Heart failure unspecified,1
644,Amiloride,782.3,Edema,0
644,Amiloride,788.42,Polyuria,0
644,Amiloride,789.5,Ascites,0
644,Amiloride,789.59,Other ascites,0
644,Amiloride,997.91,Hypertension,1
677,Aminoglutethimide,239.3,Neoplasm of unspecified nature of breast,0
677,Aminoglutethimide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
677,Aminoglutethimide,255.0,Cushing's syndrome,0
689,Aminophylline,427.89,Other specified cardiac dysrhythmias,0
689,Aminophylline,490,Bronchitis NOS,1
689,Aminophylline,491,Chronic bronchitis,1
689,Aminophylline,491.9,Chronic bronchitis NOS,1
689,Aminophylline,492,Emphysema,1
689,Aminophylline,492.8,Other emphysema,1
689,Aminophylline,493,Asthma,1
689,Aminophylline,493.9,Asthma; unspecified,1
689,Aminophylline,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
689,Aminophylline,518.89,Other diseases of lung; not elsewhere classified,1
689,Aminophylline,519.11,Acute bronchospasm,0
689,Aminophylline,786.03,Apnea,0
689,Aminophylline,786.09,Other dyspnea and respiratory abnormality,0
703,Amiodarone,427,Cardiac dysrhythmias,1
703,Amiodarone,427.1,Paroxysmal ventricular tachycardia,1
703,Amiodarone,427.41,Ventricular fibrillation,1
703,Amiodarone,427.89,Other specified cardiac dysrhythmias,0
703,Amiodarone,427.9,Cardiac dysrhythmia NOS,1
704,Amitriptyline,053.19,Herpes zoster with other nervous system complications,0
704,Amitriptyline,300.00,Anxiety state unspecified,0
704,Amitriptyline,307.50,Eating disorder NOS,0
704,Amitriptyline,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
704,Amitriptyline,311,Depressive disorder NEC,1
704,Amitriptyline,338-338.99,,0
704,Amitriptyline,346,Migraine,0
704,Amitriptyline,346.9,Migraine; unspecified,0
704,Amitriptyline,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
704,Amitriptyline,564.1,Irritable bowel syndrome,0
704,Amitriptyline,780.96,Generalized pain,0
712,Ammonium Chloride,338-338.99,,0
712,Ammonium Chloride,780.96,Generalized pain,0
712,Ammonium Chloride,786.2,Cough,0
719,Amobarbital,300.00,Anxiety state unspecified,0
719,Amobarbital,307.42,Persistent disorder of initiating or maintaining sleep,0
719,Amobarbital,345.3,Grand mal status; epileptic,0
719,Amobarbital,780.39,Other convulsions,0
719,Amobarbital,780.52,Insomnia; unspecified,0
722,Amoxapine,300.00,Anxiety state unspecified,1
722,Amoxapine,306.9,Unspecified psychophysiological malfunction,0
722,Amoxapine,311,Depressive disorder NEC,1
723,Amoxicillin,027.0,Listeriosis,0
723,Amoxicillin,039,Actinomycotic infections,0
723,Amoxicillin,039.9,Actinomycosis NOS,0
723,Amoxicillin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
723,Amoxicillin,041.9|421.0,,1
723,Amoxicillin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
723,Amoxicillin,088.81,Lyme disease,0
723,Amoxicillin,098,Gonococcal infections,1
723,Amoxicillin,098.89,Gonococcal infection of other specified sites,1
723,Amoxicillin,136.9,Unspecified infectious and parasitic diseases,1
723,Amoxicillin,382.9,Unspecified otitis media,0
723,Amoxicillin,461.9,Acute sinusitis NOS,0
723,Amoxicillin,462,Acute pharyngitis,1
723,Amoxicillin,486,Pneumonia; organism unspecified,1
723,Amoxicillin,532,Duodenal ulcer,1
723,Amoxicillin,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
723,Amoxicillin,599.0,Urinary tract infection; site not specified,0
723,Amoxicillin,686.8|041.9,,0
723,Amoxicillin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
723,Amoxicillin,707.9,Chronic ulcer of unspecified site,1
723,Amoxicillin,E928.3,Human bite,0
725,Amphetamine,314,Hyperkinetic syndrome of childhood,0
725,Amphetamine,314.01,Attention deficit disorder of childhood with hyperactivity,0
725,Amphetamine,314.9,Unspecified hyperkinetic syndrome of childhood,0
725,Amphetamine,347.0,Narcolepsy,0
725,Amphetamine,347.00,Narcolepsy; without cataplexy,0
732,Amphotericin B,085.0,Visceral leishmaniasis,1
732,Amphotericin B,110-118.99,,1
732,Amphotericin B,112,Candidiasis,1
732,Amphotericin B,112.3,Candidiasis of skin and nails,0
732,Amphotericin B,112.9,Candidiasis of unspecified site,1
732,Amphotericin B,114,Coccidioidomycosis,1
732,Amphotericin B,114.9,Coccidioidomycosis NOS,1
732,Amphotericin B,115,Histoplasmosis,1
732,Amphotericin B,115.9,Histoplasmosis; unspecified,1
732,Amphotericin B,115.90,Histoplasmosis; unspecified without mention of manifestation,1
732,Amphotericin B,116,Blastomycotic infection,1
732,Amphotericin B,116.0,Blastomycosis,1
732,Amphotericin B,116.1,Paracoccidioidomycosis,1
732,Amphotericin B,117.1,Sporotrichosis,1
732,Amphotericin B,117.3,Aspergillosis,1
732,Amphotericin B,117.7,Zygomycosis,1
732,Amphotericin B,117.9,Other and unspecified mycoses,1
732,Amphotericin B,136.9,Unspecified infectious and parasitic diseases,1
732,Amphotericin B,288.0,Agranulocytosis,0
732,Amphotericin B,288.00,Neutropenia NOS,0
732,Amphotericin B,321.0,Cryptococcal meningitis,1
732,Amphotericin B,567.9,Peritonitis NOS,0
732,Amphotericin B,595,Cystitis,0
732,Amphotericin B,595.9,Cystitis NOS,0
732,Amphotericin B,599.0,Urinary tract infection; site not specified,0
733,Ampicillin,003.9,Salmonella infection NOS,1
733,Ampicillin,004.9,Shigellosis NOS,0
733,Ampicillin,027.0,Listeriosis,0
733,Ampicillin,036,Meningococcal infection,0
733,Ampicillin,036.9,Meningococcal infection; unspecified,0
733,Ampicillin,039,Actinomycotic infections,0
733,Ampicillin,039.9,Actinomycosis NOS,0
733,Ampicillin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
733,Ampicillin,041.2,Pneumococcus infection in conditions classified elsewhere and of unspecified site,0
733,Ampicillin,041.49,Other and unspecified Escherichia coli [E. coli],0
733,Ampicillin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
733,Ampicillin,041.9|421.0,,0
733,Ampicillin,098,Gonococcal infections,0
733,Ampicillin,098.89,Gonococcal infection of other specified sites,0
733,Ampicillin,136.9,Unspecified infectious and parasitic diseases,1
733,Ampicillin,320,Bacterial meningitis,1
733,Ampicillin,320.9,Bacterial meningitis NOS,1
733,Ampicillin,322,Meningitis of unspecified cause,1
733,Ampicillin,322.9,Meningitis NOS,1
733,Ampicillin,486,Pneumonia; organism unspecified,1
733,Ampicillin,519.8,Other diseases of respiratory system; not elsewhere classified,1
733,Ampicillin,599.0,Urinary tract infection; site not specified,1
733,Ampicillin,686.8|041.9,,0
733,Ampicillin,998.59,Other postoperative infection,0
733,Ampicillin,E928.3,Human bite,0
738,Inamrinone,425.4,Other primary cardiomyopathies,0
738,Inamrinone,428,Heart failure,1
738,Inamrinone,428.0,Congestive heart failure (CHF) NOS,1
738,Inamrinone,428.9,Heart failure unspecified,1
738,Inamrinone,785.51,Cardiogenic shock,0
738,Inamrinone,785.9,Other symptoms involving cardiovascular system,0
742,Amyl Nitrite,413,Angina pectoris,1
742,Amyl Nitrite,413.9,Other and unspecified angina pectoris,1
742,Amyl Nitrite,786.50,Unspecified chest pain,1
865,Antazoline,372.14,Other chronic allergic conjunctivitis,0
865,Antazoline,698.9,Unspecified pruritic disorder,0
866,Antazoline Phosphate,372.14,Other chronic allergic conjunctivitis,0
866,Antazoline Phosphate,698.9,Unspecified pruritic disorder,0
873,Anthralin,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
1001,Antipyrine,338-338.99,,0
1001,Antipyrine,382.9,Unspecified otitis media,0
1001,Antipyrine,780.96,Generalized pain,0
1009,Antithrombin III,286.6,Defibrination syndrome,0
1009,Antithrombin III,286.9,Other and unspecified coagulation defects,1
1009,Antithrombin III,453.89,Acute venous embolism and thrombosis of other specified veins (ADDED),0
1009,Antithrombin III,453.9,Embolism and thrombosis of unspecified site,1
1043,Apomorphine,332,Parkinson's disease,0
1043,Apomorphine,332.0,Paralysis agitans,0
1056,Aprotinin,459.0,Hemorrhage NOS,1
1056,Aprotinin,998.11,Hemorrhage complicating a procedure,0
1091,Arginine,253.9,Unspecified disorder of the pituitary gland and its hypothalamic control,0
1091,Arginine,276.2,Acidosis,0
1091,Arginine,276.3,Alkalosis,0
1115,Trihexyphenidyl Hydrochloride,332,Parkinson's disease,0
1115,Trihexyphenidyl Hydrochloride,332.0,Paralysis agitans,1
1115,Trihexyphenidyl Hydrochloride,780-789.99,,0
1151,Ascorbic Acid,136.9,Unspecified infectious and parasitic diseases,1
1151,Ascorbic Acid,260-269.99,,0
1151,Ascorbic Acid,267,Ascorbic acid deficiency,1
1151,Ascorbic Acid,269.9,Unspecified nutritional deficiency,0
1151,Ascorbic Acid,270.2,Other disturbances of aromatic amino-acid metabolism,0
1151,Ascorbic Acid,285.9,Anemia unspecified,0
1151,Ascorbic Acid,289.7,Methemoglobinemia,0
1151,Ascorbic Acid,459.0,Hemorrhage NOS,1
1151,Ascorbic Acid,460,Acute nasopharyngitis (common cold),0
1151,Ascorbic Acid,486,Pneumonia; organism unspecified,1
1151,Ascorbic Acid,799.89,Other ill-defined conditions,1
1151,Ascorbic Acid,799.9,Other unknown and unspecified cause of morbidity or mortality,0
1151,Ascorbic Acid,879.8,Open wound(s) (multiple) of unspecified site(s); without mention of complication,0
1151,Ascorbic Acid,994.2,Effects of hunger,0
1156,ASPARAGINASE,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
1156,ASPARAGINASE,204.0,Lymphoid leukemia; acute,1
1156,ASPARAGINASE,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
1156,ASPARAGINASE,205.00,Acute myeloid leukemia without mention of having achieved remission,1
1191,Aspirin,274,Gout,0
1191,Aspirin,274.9,Gout NOS,0
1191,Aspirin,307.81,Tension headache,0
1191,Aspirin,338-338.99,,1
1191,Aspirin,339.1,Tension type headache,0
1191,Aspirin,339.10,Tension headache NOS,0
1191,Aspirin,346,Migraine,1
1191,Aspirin,346.9,Migraine; unspecified,1
1191,Aspirin,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
1191,Aspirin,379.99,Other ill-defined disorders of eye,1
1191,Aspirin,390,Rheumatic fever without mention of heart involvement,1
1191,Aspirin,390-392.99,,1
1191,Aspirin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
1191,Aspirin,413,Angina pectoris,1
1191,Aspirin,413.9,Other and unspecified angina pectoris,1
1191,Aspirin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
1191,Aspirin,435.9,Unspecified transient cerebral ischemia,1
1191,Aspirin,446.1,Acute febrile mucocutaneous lymph node syndrome [MCLS],0
1191,Aspirin,459.0,Hemorrhage NOS,1
1191,Aspirin,460,Acute nasopharyngitis (common cold),1
1191,Aspirin,487,Influenza,1
1191,Aspirin,487.1,Influenza with other respiratory manifestations,1
1191,Aspirin,525.9,Dental disorder NOS,1
1191,Aspirin,536.8,Dyspepsia and other specified disorders of function of stomach,0
1191,Aspirin,578,Gastrointestinal hemorrhage,1
1191,Aspirin,578.9,Hemorrhage of gastrointestinal tract NOS,1
1191,Aspirin,625.3,Dysmenorrhea,1
1191,Aspirin,625.4,Premenstrual tension syndromes,1
1191,Aspirin,642.40,Mild or unspecified pre-eclampsia; unspecified as to episode of care,0
1191,Aspirin,714.0,Rheumatoid arthritis,1
1191,Aspirin,715.00,Osteoarthrosis; generalized; involving unspecified site,1
1191,Aspirin,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
1191,Aspirin,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
1191,Aspirin,716.90,Arthropathy; unspecified; site unspecified,1
1191,Aspirin,729.1,Myalgia and myositis unspecified,1
1191,Aspirin,780.60,Fever; unspecified,1
1191,Aspirin,780.96,Generalized pain,1
1191,Aspirin,780.99,Other general symptoms,0
1191,Aspirin,784.0,Headache,1
1191,Aspirin,786.2,Cough,0
1191,Aspirin,786.50,Unspecified chest pain,1
1191,Aspirin,799.89,Other ill-defined conditions,0
1191,Aspirin,799.9,Other unknown and unspecified cause of morbidity or mortality,1
1191,Aspirin,999.9,Other and unspecified complications of medical care; not elsewhere classified,0
1202,Atenolol,401-405.99,,1
1202,Atenolol,401.9,Hypertension NOS,1
1202,Atenolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
1202,Atenolol,413,Angina pectoris,1
1202,Atenolol,413.9,Other and unspecified angina pectoris,1
1202,Atenolol,427.1,Paroxysmal ventricular tachycardia,0
1202,Atenolol,427.31,Atrial fibrillation,0
1202,Atenolol,427.32,Atrial flutter,0
1202,Atenolol,427.41,Ventricular fibrillation,0
1202,Atenolol,427.89,Other specified cardiac dysrhythmias,0
1202,Atenolol,428.0,Congestive heart failure (CHF) NOS,0
1202,Atenolol,429.9,Heart disease NOS,1
1202,Atenolol,786.50,Unspecified chest pain,1
1202,Atenolol,997.91,Hypertension,1
1223,Atropine,332.0,Paralysis agitans,1
1223,Atropine,338-338.99,,0
1223,Atropine,364.3,Iridocyclitis NOS,0
1223,Atropine,367.51,Paresis of accommodation,1
1223,Atropine,379.42,Miosis (persistent); not due to miotics,1
1223,Atropine,379.43,Mydriasis (persistent); not due to mydriatics,1
1223,Atropine,426.6,Other heart block,0
1223,Atropine,426.9,Conduction disorder NOS,1
1223,Atropine,427.5,Cardiac arrest,0
1223,Atropine,427.89,Other specified cardiac dysrhythmias,1
1223,Atropine,493,Asthma,0
1223,Atropine,493.9,Asthma; unspecified,0
1223,Atropine,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
1223,Atropine,527.7,Disturbance of salivary secretion,1
1223,Atropine,531,Gastric ulcer,0
1223,Atropine,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
1223,Atropine,533,Peptic ulcer; site unspecified,1
1223,Atropine,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
1223,Atropine,564.1,Irritable bowel syndrome,0
1223,Atropine,707.9,Chronic ulcer of unspecified site,1
1223,Atropine,728.85,Spasm of muscle,1
1223,Atropine,780.8,Generalized hyperhidrosis,1
1223,Atropine,780.96,Generalized pain,1
1223,Atropine,781.0,Abnormal involuntary movements,1
1223,Atropine,787.03,Vomiting alone,1
1223,Atropine,787.7,Abnormal feces,1
1223,Atropine,787.91,Diarrhea,1
1223,Atropine,789.00,Abdominal pain; unspecified site,1
1223,Atropine,789.7,Colic (ADDED),1
1223,Atropine,95.09,EYE EXAMINATION NOS,0
1223,Atropine,977.9,Poisoning by unspecified drug or medicinal substance,0
1225,Hyoscyamine Sulfate,332,Parkinson's disease,0
1225,Hyoscyamine Sulfate,332.0,Paralysis agitans,0
1225,Hyoscyamine Sulfate,472.0,Chronic rhinitis,0
1225,Hyoscyamine Sulfate,527.7,Disturbance of salivary secretion,0
1225,Hyoscyamine Sulfate,533,Peptic ulcer; site unspecified,0
1225,Hyoscyamine Sulfate,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
1225,Hyoscyamine Sulfate,564.1,Irritable bowel syndrome,0
1225,Hyoscyamine Sulfate,569.9,Unspecified disorder of intestine,0
1225,Hyoscyamine Sulfate,577.0,Acute pancreatitis,0
1225,Hyoscyamine Sulfate,595,Cystitis,0
1225,Hyoscyamine Sulfate,595.9,Cystitis NOS,0
1225,Hyoscyamine Sulfate,596.54,Neurogenic bladder NOS,0
1225,Hyoscyamine Sulfate,596.59,Other functional disorder of bladder,0
1225,Hyoscyamine Sulfate,705.21,Primary focal hyperhidrosis,0
1225,Hyoscyamine Sulfate,728.85,Spasm of muscle,0
1225,Hyoscyamine Sulfate,780-789.99,,0
1225,Hyoscyamine Sulfate,780.96,Generalized pain,0
1225,Hyoscyamine Sulfate,781.0,Abnormal involuntary movements,0
1225,Hyoscyamine Sulfate,789.00,Abdominal pain; unspecified site,0
1225,Hyoscyamine Sulfate,789.7,Colic (ADDED),0
1227,Auranofin,338-338.99,,0
1227,Auranofin,694.4,Pemphigus,0
1227,Auranofin,696.0,Psoriatic arthropathy,1
1227,Auranofin,714.0,Rheumatoid arthritis,1
1227,Auranofin,719.00,Effusion of joint; site unspecified,0
1227,Auranofin,719.40,Pain in joint site unspecified,0
1227,Auranofin,719.50,Stiffness of joint; not elsewhere classified; involving unspecified site,0
1227,Auranofin,780.96,Generalized pain,0
1251,Azacitidine,238.75,Myelodysplastic syndrome; unspecified,1
1256,Azathioprine,279.5,Graft-versus-host disease,0
1256,Azathioprine,279.50,Graft-versus-host disease; unspecified,0
1256,Azathioprine,287.31,Immune thrombocytopenic purpura,0
1256,Azathioprine,340,Multiple sclerosis,0
1256,Azathioprine,55.6,Transplant of kidney,0
1256,Azathioprine,555.9,Regional enteritis of unspecified site,0
1256,Azathioprine,556,Ulcerative colitis,0
1256,Azathioprine,556.8,Other ulcerative colitis,0
1256,Azathioprine,556.9,Ulcerative colitis; unspecified,0
1256,Azathioprine,710.0,Systemic lupus erythematosus,0
1256,Azathioprine,714.0,Rheumatoid arthritis,1
1256,Azathioprine,996.52,Mechanical complication due to other tissue graft; not elsewhere classified,0
1272,Aztreonam,038,Septicemia,1
1272,Aztreonam,038.9,Septicemia NOS,1
1272,Aztreonam,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
1272,Aztreonam,136.9,Unspecified infectious and parasitic diseases,1
1272,Aztreonam,277.0,Cystic fibrosis,1
1272,Aztreonam,277.00,Cystic fibrosis without mention of meconium ileus,1
1272,Aztreonam,486,Pneumonia; organism unspecified,1
1272,Aztreonam,519.8,Other diseases of respiratory system; not elsewhere classified,1
1272,Aztreonam,599.0,Urinary tract infection; site not specified,1
1272,Aztreonam,629.9,Unspecified disorder of female genital organs,0
1272,Aztreonam,686.9,Unspecified local infection of skin and subcutaneous tissue,0
1291,Bacitracin,008.45,Intestinal infection due to clostridium difficile,0
1291,Bacitracin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
1291,Bacitracin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
1291,Bacitracin,379.99,Other ill-defined disorders of eye,1
1291,Bacitracin,379.99|041.9,,0
1291,Bacitracin,510,Empyema,1
1291,Bacitracin,510.9,Empyema without mention of fistula,1
1291,Bacitracin,686.8|041.9,,0
1292,Baclofen,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
1292,Baclofen,323.9,Unspecified cause of encephalitis; myelitis; and encephalomyelitis,0
1292,Baclofen,333.4,Huntington's chorea,0
1292,Baclofen,336.1,Vascular myelopathies,0
1292,Baclofen,336.9,Spinal cord disease NOS,1
1292,Baclofen,338-338.99,,1
1292,Baclofen,340,Multiple sclerosis,1
1292,Baclofen,343.9,Infantile cerebral palsy NOS,1
1292,Baclofen,350.1,Trigeminal neuralgia,0
1292,Baclofen,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
1292,Baclofen,596.54,Neurogenic bladder NOS,0
1292,Baclofen,596.59,Other functional disorder of bladder,0
1292,Baclofen,728.85,Spasm of muscle,1
1292,Baclofen,756.11,Spondylolysis; congenital; lumbosacral region,0
1292,Baclofen,780.96,Generalized pain,1
1292,Baclofen,781.0,Abnormal involuntary movements,1
1292,Baclofen,786.8,Hiccough,0
1292,Baclofen,952.9,Spinal cord injury NOS,0
1347,Beclomethasone,471,Nasal polyps,1
1347,Beclomethasone,471.0,Polyp of nasal cavity,1
1347,Beclomethasone,471.9,Nasal polyp NOS,1
1347,Beclomethasone,477.9,Allergic rhinitis NOS,0
1347,Beclomethasone,493,Asthma,0
1347,Beclomethasone,493.9,Asthma; unspecified,0
1347,Beclomethasone,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
1348,Beclomethasone Dipropionate,471,Nasal polyps,0
1348,Beclomethasone Dipropionate,471.0,Polyp of nasal cavity,0
1348,Beclomethasone Dipropionate,471.9,Nasal polyp NOS,0
1348,Beclomethasone Dipropionate,477.9,Allergic rhinitis NOS,0
1348,Beclomethasone Dipropionate,493,Asthma,1
1348,Beclomethasone Dipropionate,493.9,Asthma; unspecified,1
1348,Beclomethasone Dipropionate,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
1348,Beclomethasone Dipropionate,692.9,Contact dermatitis and other eczema; unspecified cause,1
1348,Beclomethasone Dipropionate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
1348,Beclomethasone Dipropionate,698.9,Unspecified pruritic disorder,1
1359,Belladonna Alkaloids,564.1,Irritable bowel syndrome,0
1359,Belladonna Alkaloids,569.9,Unspecified disorder of intestine,0
1359,Belladonna Alkaloids,728.85,Spasm of muscle,0
1359,Belladonna Alkaloids,780.96,Generalized pain,0
1359,Belladonna Alkaloids,781.0,Abnormal involuntary movements,0
1359,Belladonna Alkaloids,784.0,Headache,0
1362,Diphenhydramine Hydrochloride,300.00,Anxiety state unspecified,0
1362,Diphenhydramine Hydrochloride,307.42,Persistent disorder of initiating or maintaining sleep,0
1362,Diphenhydramine Hydrochloride,460,Acute nasopharyngitis (common cold),0
1362,Diphenhydramine Hydrochloride,477.9,Allergic rhinitis NOS,0
1362,Diphenhydramine Hydrochloride,698.9,Unspecified pruritic disorder,0
1362,Diphenhydramine Hydrochloride,708,Urticaria,0
1362,Diphenhydramine Hydrochloride,708.9,Unspecified urticaria,0
1362,Diphenhydramine Hydrochloride,780.52,Insomnia; unspecified,0
1362,Diphenhydramine Hydrochloride,781.0,Abnormal involuntary movements,0
1362,Diphenhydramine Hydrochloride,787.02,Nausea alone,0
1362,Diphenhydramine Hydrochloride,994.6,Motion sickness,0
1362,Diphenhydramine Hydrochloride,995.3,Allergy unspecified not elsewhere classified,0
1369,Bendroflumethiazide,401-405.99,,0
1369,Bendroflumethiazide,401.9,Hypertension NOS,0
1369,Bendroflumethiazide,428.0,Congestive heart failure (CHF) NOS,0
1369,Bendroflumethiazide,581,Nephrotic syndrome,0
1369,Bendroflumethiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
1369,Bendroflumethiazide,782.3,Edema,0
1369,Bendroflumethiazide,997.91,Hypertension,0
1378,Benzalkonium,054.9,Herpes simplex without mention of complication,1
1378,Benzalkonium,136.9,Unspecified infectious and parasitic diseases,1
1388,Lindane,132.9,Pediculosis NOS,1
1388,Lindane,133.0,Scabies,1
1399,Benzocaine,054,Herpes simplex,0
1399,Benzocaine,054.9,Herpes simplex without mention of complication,0
1399,Benzocaine,338-338.99,,1
1399,Benzocaine,380.10,Infective otitis externa; unspecified,1
1399,Benzocaine,382.9,Unspecified otitis media,1
1399,Benzocaine,388.7,Otalgia,1
1399,Benzocaine,388.70,Otalgia NOS,1
1399,Benzocaine,455,Hemorrhoids,1
1399,Benzocaine,455.6,Hemorrhoids NOS,1
1399,Benzocaine,525.9,Dental disorder NOS,1
1399,Benzocaine,528.2,Oral aphthae,1
1399,Benzocaine,565.0,Anal fissure,0
1399,Benzocaine,569.41,Ulcer of anus and rectum,0
1399,Benzocaine,695.89,Other specified erythematous conditions,1
1399,Benzocaine,698.9,Unspecified pruritic disorder,1
1399,Benzocaine,780.96,Generalized pain,1
1399,Benzocaine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
1399,Benzocaine,940-949.99,,0
1399,Benzocaine,949.0,Burn of unspecified site; unspecified degree,0
1399,Benzocaine,V60.3,Person living alone,0
1418,Benzoyl Peroxide,692.9,Contact dermatitis and other eczema; unspecified cause,0
1418,Benzoyl Peroxide,695.3,Rosacea,0
1418,Benzoyl Peroxide,698.9,Unspecified pruritic disorder,0
1418,Benzoyl Peroxide,701.1,Keratoderma; acquired,0
1418,Benzoyl Peroxide,706.1,Other acne,1
1418,Benzoyl Peroxide,709.9,Unspecified disorder of skin and subcutaneous tissue,0
1418,Benzoyl Peroxide,782.1,Rash and other nonspecific skin eruption,0
1422,Benzphetamine,278.00,Obesity NOS,1
1422,Benzphetamine,783.9,Other symptoms concerning nutrition; metabolism; and development,1
1424,Benztropine,332,Parkinson's disease,0
1424,Benztropine,332.0,Paralysis agitans,1
1426,Benzyl Alcohol,132.0,Pediculus capitis [head louse],1
1426,Benzyl Alcohol,132.9,Pediculosis NOS,1
1436,Bepridil,401-405.99,,0
1436,Bepridil,401.9,Hypertension NOS,0
1436,Bepridil,413,Angina pectoris,0
1436,Bepridil,413.9,Other and unspecified angina pectoris,0
1436,Bepridil,786.50,Unspecified chest pain,0
1436,Bepridil,997.91,Hypertension,0
1512,Betaine,270.4,Disturbances of sulphur-bearing amino-acid metabolism,1
1512,Betaine,780.39,Other convulsions,1
1512,Betaine,780.79,Other malaise and fatigue,1
1514,Betamethasone,686.9,Unspecified local infection of skin and subcutaneous tissue,0
1514,Betamethasone,690.1,Seborrheic dermatitis,0
1514,Betamethasone,690.10,Seborheic dermatitis; unspecified,0
1514,Betamethasone,691.8,Other atopic dermatitis,1
1514,Betamethasone,692.9,Contact dermatitis and other eczema; unspecified cause,1
1514,Betamethasone,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
1514,Betamethasone,698.0,Pruritus ani,0
1514,Betamethasone,698.9,Unspecified pruritic disorder,0
1514,Betamethasone,706.3,Seborrhea,0
1514,Betamethasone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
1514,Betamethasone,799.89,Other ill-defined conditions,1
1516,Betamethasone acetate,690.1,Seborrheic dermatitis,0
1516,Betamethasone acetate,690.10,Seborheic dermatitis; unspecified,0
1516,Betamethasone acetate,691.8,Other atopic dermatitis,0
1516,Betamethasone acetate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
1516,Betamethasone acetate,698.0,Pruritus ani,0
1516,Betamethasone acetate,706.3,Seborrhea,0
1516,Betamethasone acetate,709.9,Unspecified disorder of skin and subcutaneous tissue,0
1520,Betaxolol,365,Glaucoma,1
1520,Betaxolol,365.00,Preglaucoma; unspecified,1
1520,Betaxolol,365.1,Open-angle glaucoma,0
1520,Betaxolol,365.10,Open-angle glaucoma NOS,0
1520,Betaxolol,365.13,Pigmentary glaucoma,0
1520,Betaxolol,365.9,Glaucoma NOS,1
1520,Betaxolol,401-405.99,,1
1520,Betaxolol,401.9,Hypertension NOS,1
1520,Betaxolol,997.91,Hypertension,1
1520,Betaxolol,V62.81,Interpersonal problems; not elsewhere classified,0
1525,Bezafibrate,272.4,Other and unspecified hyperlipidemia,1
1588,Biotin,266,Deficiency of B-complex components,0
1588,Biotin,266.9,Vitamin B deficiency NOS,0
1588,Biotin,277.9,Unspecified disorder of metabolism,0
1589,Biperiden,332,Parkinson's disease,0
1589,Biperiden,332.0,Paralysis agitans,1
1589,Biperiden,977.9,Poisoning by unspecified drug or medicinal substance,0
1596,Bisacodyl,564.0,Constipation,1
1596,Bisacodyl,564.00,Constipation NOS,1
1598,Dicumarol,415.19,Other pulmonary embolism and infarction,0
1598,Dicumarol,453.9,Embolism and thrombosis of unspecified site,0
1598,Dicumarol,459.9,Unspecified circulatory system disorder,0
1622,Bleomycin,140-239.99,,1
1622,Bleomycin,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
1622,Bleomycin,172.9,Melanoma of skin; site unspecified,1
1622,Bleomycin,186,Malignant neoplasm of testis,1
1622,Bleomycin,186.9,Malignant neoplasm of other and unspecified testis,1
1622,Bleomycin,195.0,Malignant neoplasm of head; face; and neck,1
1622,Bleomycin,201,Hodgkin's disease,0
1622,Bleomycin,201.0,Hodgkin's paragranuloma,0
1622,Bleomycin,201.1,Hodgkin's granuloma,0
1622,Bleomycin,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
1622,Bleomycin,201.2,Hodgkin's sarcoma,0
1622,Bleomycin,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
1622,Bleomycin,201.9,Hodgkin's disease; unspecified type,0
1622,Bleomycin,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
1622,Bleomycin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
1622,Bleomycin,232.9,Carcinoma in situ of skin; site unspecified,1
1622,Bleomycin,239,Neoplasms of unspecified nature,1
1622,Bleomycin,239-239.99,,1
1622,Bleomycin,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
1622,Bleomycin,511.9,Pleural effusion NOS,1
1700,boric acid,380.10,Infective otitis externa; unspecified,0
1700,boric acid,691.0,Diaper or napkin rash,0
1700,boric acid,692.71,Sunburn,0
1700,boric acid,692.9,Contact dermatitis and other eczema; unspecified cause,0
1760,Bromocriptine,140-239.99,,1
1760,Bromocriptine,239,Neoplasms of unspecified nature,1
1760,Bromocriptine,239-239.99,,1
1760,Bromocriptine,250,Diabetes mellitus,1
1760,Bromocriptine,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
1760,Bromocriptine,250.1,Diabetes with ketoacidosis,1
1760,Bromocriptine,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
1760,Bromocriptine,253.0,Acromegaly and gigantism,1
1760,Bromocriptine,253.1,Other and unspecified anterior pituitary hyperfunction,1
1760,Bromocriptine,253.4,Other anterior pituitary disorders,1
1760,Bromocriptine,332,Parkinson's disease,0
1760,Bromocriptine,332.0,Paralysis agitans,0
1760,Bromocriptine,333.92,Neuroleptic malignant syndrome,0
1760,Bromocriptine,611.6,Galactorrhea not associated with childbirth,1
1760,Bromocriptine,626.0,Absence of menstruation,1
1760,Bromocriptine,780-789.99,,0
1767,Brompheniramine,375.2,Epiphora,0
1767,Brompheniramine,375.20,Epiphora NOS,0
1767,Brompheniramine,379.99,Other ill-defined disorders of eye,0
1767,Brompheniramine,460,Acute nasopharyngitis (common cold),0
1767,Brompheniramine,477.9,Allergic rhinitis NOS,1
1808,Bumetanide,401-405.99,,0
1808,Bumetanide,401.9,Hypertension NOS,0
1808,Bumetanide,428,Heart failure,1
1808,Bumetanide,428.0,Congestive heart failure (CHF) NOS,1
1808,Bumetanide,428.9,Heart failure unspecified,1
1808,Bumetanide,514,Pulmonary congestion and hypostasis,0
1808,Bumetanide,571.5,Cirrhosis of liver without mention of alcohol,0
1808,Bumetanide,581,Nephrotic syndrome,1
1808,Bumetanide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
1808,Bumetanide,584,Acute renal failure,0
1808,Bumetanide,584.9,Acute renal failure NOS,0
1808,Bumetanide,585.6,End stage renal disease,0
1808,Bumetanide,585.9,Chronic kidney disease; unspecified,0
1808,Bumetanide,586,Renal failure unspecified,0
1808,Bumetanide,593.9,Unspecified disorder of kidney and ureter,1
1808,Bumetanide,782.3,Edema,1
1808,Bumetanide,789.5,Ascites,0
1808,Bumetanide,789.59,Other ascites,0
1808,Bumetanide,997.91,Hypertension,0
1813,Levobunolol,365,Glaucoma,1
1813,Levobunolol,365.1,Open-angle glaucoma,0
1813,Levobunolol,365.10,Open-angle glaucoma NOS,0
1813,Levobunolol,365.13,Pigmentary glaucoma,0
1813,Levobunolol,365.9,Glaucoma NOS,1
1815,Bupivacaine,338-338.99,,0
1815,Bupivacaine,780.96,Generalized pain,0
1819,Buprenorphine,304,Drug dependence,1
1819,Buprenorphine,304.0,Opioid type dependence,1
1819,Buprenorphine,304.00,Opioid type dependence unspecified use,1
1819,Buprenorphine,304.60,Other specified drug dependence; unspecified use,1
1819,Buprenorphine,304.9,Unspecified drug dependence,1
1819,Buprenorphine,304.90,Unspecified drug dependence; unspecified use,1
1819,Buprenorphine,338-338.99,,1
1819,Buprenorphine,338.2,Chronic pain,1
1819,Buprenorphine,338.29,Other chronic pain,1
1819,Buprenorphine,780.96,Generalized pain,1
1827,Buspirone,300.00,Anxiety state unspecified,1
1827,Buspirone,300.02,Generalized anxiety disorder,1
1827,Buspirone,311,Depressive disorder NEC,1
1827,Buspirone,315.9,Unspecified delay in development,0
1827,Buspirone,317-319.99,,0
1827,Buspirone,319,Unspecified mental retardation,0
1828,Busulfan,205.1,Myeloid leukemia; chronic,1
1828,Busulfan,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
1828,Busulfan,238.4,Polycythemia vera,0
1828,Busulfan,238.76,Myelofibrosis with myeloid metaplasia,0
1828,Busulfan,41.00,Bone marrow transplant; not otherwise specified,0
1841,Butorphanol,338-338.99,,1
1841,Butorphanol,780.96,Generalized pain,1
1851,butylscopolamine bromide,728.85,Spasm of muscle,1
1851,butylscopolamine bromide,780.96,Generalized pain,1
1851,butylscopolamine bromide,781.0,Abnormal involuntary movements,1
1851,butylscopolamine bromide,789.00,Abdominal pain; unspecified site,1
1886,Caffeine,338-338.99,,0
1886,Caffeine,346,Migraine,0
1886,Caffeine,346.9,Migraine; unspecified,0
1886,Caffeine,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
1886,Caffeine,765.10,Other preterm infants; unspecified [weight],1
1886,Caffeine,780.96,Generalized pain,0
1886,Caffeine,784.0,Headache,0
1886,Caffeine,786.00,Respiratory abnormality; unspecified,1
1886,Caffeine,786.03,Apnea,1
1886,Caffeine,786.09,Other dyspnea and respiratory abnormality,1
1886,Caffeine,V22.2,Pregnant state; incidental,0
1889,Calcifediol,268,Vitamin D deficiency,0
1889,Calcifediol,268.9,Vitamin d deficiency NOS,0
1889,Calcifediol,733.99,Other disorders of bone and cartilage,0
1894,Calcitriol,252.0,Hyperparathyroidism,1
1894,Calcitriol,252.00,Hyperparathyroidism NOS,1
1894,Calcitriol,252.1,Hypoparathyroidism,1
1894,Calcitriol,268,Vitamin D deficiency,0
1894,Calcitriol,268.2,Osteomalacia NOS,0
1894,Calcitriol,268.9,Vitamin d deficiency NOS,0
1894,Calcitriol,269.1,Deficiency of other vitamins,0
1894,Calcitriol,275.41,Hypocalcemia,1
1894,Calcitriol,588.0,Renal osteodystrophy,1
1894,Calcitriol,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
1894,Calcitriol,733.90,Disorder of bone and cartilage; unspecified,1
1897,Calcium Carbonate,275.41,Hypocalcemia,0
1897,Calcium Carbonate,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
1897,Calcium Carbonate,530.11,Reflux esophagitis,0
1897,Calcium Carbonate,530.81,Esophageal reflux,0
1897,Calcium Carbonate,531,Gastric ulcer,0
1897,Calcium Carbonate,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
1897,Calcium Carbonate,532,Duodenal ulcer,0
1897,Calcium Carbonate,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
1897,Calcium Carbonate,533,Peptic ulcer; site unspecified,0
1897,Calcium Carbonate,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
1897,Calcium Carbonate,536.8,Dyspepsia and other specified disorders of function of stomach,0
1897,Calcium Carbonate,564.0,Constipation,0
1897,Calcium Carbonate,564.00,Constipation NOS,0
1897,Calcium Carbonate,578,Gastrointestinal hemorrhage,0
1897,Calcium Carbonate,578.9,Hemorrhage of gastrointestinal tract NOS,0
1897,Calcium Carbonate,585.6,End stage renal disease,0
1897,Calcium Carbonate,585.9,Chronic kidney disease; unspecified,0
1897,Calcium Carbonate,586,Renal failure unspecified,0
1897,Calcium Carbonate,593.9,Unspecified disorder of kidney and ureter,0
1897,Calcium Carbonate,733.0,Osteoporosis,0
1897,Calcium Carbonate,733.00,Osteoporosis NOS,0
1897,Calcium Carbonate,733.01,Senile osteoporosis,0
1897,Calcium Carbonate,780-789.99,,0
1897,Calcium Carbonate,780.79,Other malaise and fatigue,0
1897,Calcium Carbonate,787.1,Heartburn,0
1897,Calcium Carbonate,999.9,Other and unspecified complications of medical care; not elsewhere classified,0
1897,Calcium Carbonate,V22.2,Pregnant state; incidental,0
1897,Calcium Carbonate,V62.81,Interpersonal problems; not elsewhere classified,0
1901,Calcium Chloride,276.7,Hyperpotassemia,0
1901,Calcium Chloride,427.5,Cardiac arrest,0
1901,Calcium Chloride,781.7,Tetany,0
1903,edetate calcium disodium,984,Toxic effect of lead and its compounds (including fumes),0
1903,edetate calcium disodium,984.9,Toxic effect of unspecified lead compound,0
1903,edetate calcium disodium,985.2,Toxic effect of manganese and its compounds,0
1908,Calcium Gluconate,276.7,Hyperpotassemia,0
1908,Calcium Gluconate,427.5,Cardiac arrest,0
1908,Calcium Gluconate,733.0,Osteoporosis,0
1908,Calcium Gluconate,733.00,Osteoporosis NOS,0
1908,Calcium Gluconate,733.01,Senile osteoporosis,0
1908,Calcium Gluconate,781.7,Tetany,0
1909,Calcium Glycerophosphate,275.41,Hypocalcemia,0
1909,Calcium Glycerophosphate,530.11,Reflux esophagitis,0
1909,Calcium Glycerophosphate,733.01,Senile osteoporosis,0
1918,Calcium Pantothenate,266,Deficiency of B-complex components,0
1918,Calcium Pantothenate,266.9,Vitamin B deficiency NOS,0
1918,Calcium Pantothenate,275.41,Hypocalcemia,0
1918,Calcium Pantothenate,733.0,Osteoporosis,0
1918,Calcium Pantothenate,733.00,Osteoporosis NOS,0
1918,Calcium Pantothenate,733.01,Senile osteoporosis,0
1919,calcium phosphate,275.41,Hypocalcemia,0
1919,calcium phosphate,733.0,Osteoporosis,0
1919,calcium phosphate,733.00,Osteoporosis NOS,0
1919,calcium phosphate,733.01,Senile osteoporosis,0
1952,Camphor,338-338.99,,0
1952,Camphor,525.9,Dental disorder NOS,0
1952,Camphor,780.96,Generalized pain,0
1984,Cantharidin,078.0,Molluscum contagiosum,0
1984,Cantharidin,078.1,Viral warts,0
1984,Cantharidin,078.10,Viral warts; unspecified,0
1992,Capsaicin,053,Herpes zoster,0
1992,Capsaicin,053.19,Herpes zoster with other nervous system complications,1
1992,Capsaicin,053.9,Herpes zoster without mention of complication,0
1992,Capsaicin,250.6,Diabetes with neurological manifestations,0
1992,Capsaicin,338-338.99,,1
1992,Capsaicin,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
1992,Capsaicin,780.96,Generalized pain,1
1998,Captopril,250.4,Diabetes with renal manifestations,1
1998,Captopril,255.13,Bartter's syndrome,0
1998,Captopril,401-405.99,,1
1998,Captopril,401.0,Malignant essential hypertension,0
1998,Captopril,401.9,Hypertension NOS,1
1998,Captopril,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
1998,Captopril,428,Heart failure,1
1998,Captopril,428.0,Congestive heart failure (CHF) NOS,1
1998,Captopril,428.9,Heart failure unspecified,1
1998,Captopril,429.3,Cardiomegaly,0
1998,Captopril,443.0,Raynaud's syndrome,0
1998,Captopril,714.0,Rheumatoid arthritis,0
1998,Captopril,782.3,Edema,1
1998,Captopril,997.91,Hypertension,1
1999,Carbachol,365,Glaucoma,0
1999,Carbachol,365.9,Glaucoma NOS,0
1999,Carbachol,379.42,Miosis (persistent); not due to miotics,1
2002,Carbamazepine,290-299.99,,0
2002,Carbamazepine,295,Schizophrenic disorders,0
2002,Carbamazepine,295.9,Unspecified schizophrenia,0
2002,Carbamazepine,295.90,Unspecified schizophrenia; unspecified state,0
2002,Carbamazepine,296.00,Manic disorder; single episode; unspecified degree,1
2002,Carbamazepine,296.7,Bipolar I disorder; most recent episode (or current) unspecified,1
2002,Carbamazepine,296.80,Bipolar disorder NOS,0
2002,Carbamazepine,298.9,Unspecified psychosis,0
2002,Carbamazepine,308.9,Unspecified acute reaction to stress,0
2002,Carbamazepine,309.81,Posttraumatic stress disorder,0
2002,Carbamazepine,333.94,Restless legs syndrome (RLS),0
2002,Carbamazepine,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
2002,Carbamazepine,345.40,Partial epilepsy without intractable epilepsy,0
2002,Carbamazepine,345.9,Epilepsy; unspecified,1
2002,Carbamazepine,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
2002,Carbamazepine,350.1,Trigeminal neuralgia,1
2002,Carbamazepine,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
2002,Carbamazepine,780.39,Other convulsions,1
2015,Carbenicillin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2015,Carbenicillin,599.0,Urinary tract infection; site not specified,0
2015,Carbenicillin,601,Inflammatory diseases of prostate,1
2015,Carbenicillin,601.9,Prostatitis NOS,1
2019,Carbidopa,332,Parkinson's disease,1
2019,Carbidopa,332.0,Paralysis agitans,1
2019,Carbidopa,787.02,Nausea alone,1
2019,Carbidopa,787.03,Vomiting alone,1
2051,Carboprost,595,Cystitis,0
2051,Carboprost,595.9,Cystitis NOS,0
2051,Carboprost,661.20,Other and unspecified uterine inertia; unspecified as to episode of care,1
2051,Carboprost,666,Postpartum hemorrhage,1
2051,Carboprost,666.14,Other immediate postpartum hemorrhage; postpartum,1
2101,Carisoprodol,338-338.99,,0
2101,Carisoprodol,728.85,Spasm of muscle,0
2101,Carisoprodol,728.9,Unspecified disorder of muscle; ligament; and fascia,0
2101,Carisoprodol,729.1,Myalgia and myositis unspecified,0
2101,Carisoprodol,729.82,Cramp of limb,0
2101,Carisoprodol,780.96,Generalized pain,0
2101,Carisoprodol,781.0,Abnormal involuntary movements,0
2101,Carisoprodol,781.99,Other symptoms involving nervous and musculoskeletal systems,1
2101,Carisoprodol,784.0,Headache,0
2105,Carmustine,172.9,Melanoma of skin; site unspecified,1
2105,Carmustine,191.9,Malignant neoplasm of brain; unspecified,1
2105,Carmustine,201,Hodgkin's disease,0
2105,Carmustine,201.0,Hodgkin's paragranuloma,0
2105,Carmustine,201.1,Hodgkin's granuloma,0
2105,Carmustine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
2105,Carmustine,201.2,Hodgkin's sarcoma,0
2105,Carmustine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
2105,Carmustine,201.9,Hodgkin's disease; unspecified type,0
2105,Carmustine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
2105,Carmustine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
2105,Carmustine,203.0,Multiple myeloma,1
2105,Carmustine,203.00,Multiple myeloma without mention of having achieved remission,1
2105,Carmustine,239.0,Neoplasm of unspecified nature of digestive system,0
2105,Carmustine,239.1,Neoplasm of unspecified nature of respiratory system,0
2105,Carmustine,239.6,Neoplasm of unspecified nature of brain,1
2116,Carteolol,365,Glaucoma,1
2116,Carteolol,365.1,Open-angle glaucoma,0
2116,Carteolol,365.10,Open-angle glaucoma NOS,0
2116,Carteolol,365.13,Pigmentary glaucoma,0
2116,Carteolol,365.9,Glaucoma NOS,1
2116,Carteolol,401-405.99,,1
2116,Carteolol,401.9,Hypertension NOS,1
2116,Carteolol,997.91,Hypertension,1
2129,Castor Oil,564.0,Constipation,0
2129,Castor Oil,564.00,Constipation NOS,0
2176,Cefaclor,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
2176,Cefaclor,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2176,Cefaclor,041.49,Other and unspecified Escherichia coli [E. coli],0
2176,Cefaclor,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2176,Cefaclor,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2176,Cefaclor,136.9,Unspecified infectious and parasitic diseases,1
2176,Cefaclor,382.9,Unspecified otitis media,1
2176,Cefaclor,462,Acute pharyngitis,1
2176,Cefaclor,482.9,Bacterial pneumonia NOS,0
2176,Cefaclor,486,Pneumonia; organism unspecified,1
2176,Cefaclor,490,Bronchitis NOS,1
2176,Cefaclor,599.0,Urinary tract infection; site not specified,1
2176,Cefaclor,686.8|041.9,,0
2176,Cefaclor,686.9,Unspecified local infection of skin and subcutaneous tissue,1
2177,Cefadroxil,041.49,Other and unspecified Escherichia coli [E. coli],0
2177,Cefadroxil,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2177,Cefadroxil,041.9|421.0,,0
2177,Cefadroxil,136.9,Unspecified infectious and parasitic diseases,1
2177,Cefadroxil,462,Acute pharyngitis,1
2177,Cefadroxil,599.0,Urinary tract infection; site not specified,1
2177,Cefadroxil,684,Impetigo,0
2178,Cefamandole,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2178,Cefamandole,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2178,Cefamandole,041.49,Other and unspecified Escherichia coli [E. coli],0
2178,Cefamandole,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2178,Cefamandole,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2178,Cefamandole,136.9,Unspecified infectious and parasitic diseases,0
2178,Cefamandole,482.9,Bacterial pneumonia NOS,0
2178,Cefamandole,599.0,Urinary tract infection; site not specified,0
2178,Cefamandole,686.8|041.9,,0
2178,Cefamandole,998.59,Other postoperative infection,0
2180,Cefazolin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
2180,Cefazolin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2180,Cefazolin,041.49,Other and unspecified Escherichia coli [E. coli],0
2180,Cefazolin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2180,Cefazolin,041.9|421.0,,0
2180,Cefazolin,136.9,Unspecified infectious and parasitic diseases,1
2180,Cefazolin,482.9,Bacterial pneumonia NOS,0
2180,Cefazolin,599.0,Urinary tract infection; site not specified,1
2180,Cefazolin,686.8|041.9,,0
2180,Cefazolin,728.9,Unspecified disorder of muscle; ligament; and fascia,0
2180,Cefazolin,998.59,Other postoperative infection,0
2180,Cefazolin,E928.3,Human bite,0
2184,Cefoperazone,003.9,Salmonella infection NOS,0
2184,Cefoperazone,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2184,Cefoperazone,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2184,Cefoperazone,041.49,Other and unspecified Escherichia coli [E. coli],0
2184,Cefoperazone,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2184,Cefoperazone,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
2184,Cefoperazone,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2184,Cefoperazone,136.9,Unspecified infectious and parasitic diseases,1
2184,Cefoperazone,482.9,Bacterial pneumonia NOS,0
2184,Cefoperazone,599.0,Urinary tract infection; site not specified,1
2184,Cefoperazone,629.9,Unspecified disorder of female genital organs,0
2184,Cefoperazone,686.8|041.9,,0
2186,Cefotaxime,003.9,Salmonella infection NOS,0
2186,Cefotaxime,038.9,Septicemia NOS,1
2186,Cefotaxime,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2186,Cefotaxime,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2186,Cefotaxime,041.49,Other and unspecified Escherichia coli [E. coli],0
2186,Cefotaxime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2186,Cefotaxime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2186,Cefotaxime,098,Gonococcal infections,1
2186,Cefotaxime,098.89,Gonococcal infection of other specified sites,1
2186,Cefotaxime,136.9,Unspecified infectious and parasitic diseases,1
2186,Cefotaxime,320,Bacterial meningitis,0
2186,Cefotaxime,320.9,Bacterial meningitis NOS,0
2186,Cefotaxime,322,Meningitis of unspecified cause,1
2186,Cefotaxime,322.9,Meningitis NOS,1
2186,Cefotaxime,482.9,Bacterial pneumonia NOS,0
2186,Cefotaxime,519.8,Other diseases of respiratory system; not elsewhere classified,1
2186,Cefotaxime,567.9,Peritonitis NOS,1
2186,Cefotaxime,599.0,Urinary tract infection; site not specified,1
2186,Cefotaxime,686.8|041.9,,0
2186,Cefotaxime,995.91,Sepsis,1
2187,Cefotetan,038,Septicemia,0
2187,Cefotetan,038.9,Septicemia NOS,1
2187,Cefotetan,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2187,Cefotetan,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2187,Cefotetan,041.49,Other and unspecified Escherichia coli [E. coli],0
2187,Cefotetan,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2187,Cefotetan,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
2187,Cefotetan,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2187,Cefotetan,136.9,Unspecified infectious and parasitic diseases,1
2187,Cefotetan,519.8,Other diseases of respiratory system; not elsewhere classified,1
2187,Cefotetan,567.9,Peritonitis NOS,0
2187,Cefotetan,599.0,Urinary tract infection; site not specified,1
2187,Cefotetan,629.9,Unspecified disorder of female genital organs,0
2187,Cefotetan,682.9,Cellulitis and abscess NOS,0
2187,Cefotetan,686.8|041.9,,0
2187,Cefotetan,998.59,Other postoperative infection,0
2187,Cefotetan,E928.3,Human bite,0
2189,Cefoxitin,038,Septicemia,1
2189,Cefoxitin,038.9,Septicemia NOS,1
2189,Cefoxitin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2189,Cefoxitin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2189,Cefoxitin,041.49,Other and unspecified Escherichia coli [E. coli],0
2189,Cefoxitin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2189,Cefoxitin,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
2189,Cefoxitin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2189,Cefoxitin,136.9,Unspecified infectious and parasitic diseases,1
2189,Cefoxitin,519.8,Other diseases of respiratory system; not elsewhere classified,1
2189,Cefoxitin,567.9,Peritonitis NOS,1
2189,Cefoxitin,599.0,Urinary tract infection; site not specified,1
2189,Cefoxitin,629.9,Unspecified disorder of female genital organs,0
2189,Cefoxitin,682.9,Cellulitis and abscess NOS,1
2189,Cefoxitin,686.8|041.9,,0
2189,Cefoxitin,998.59,Other postoperative infection,0
2191,Ceftazidime,038.9,Septicemia NOS,1
2191,Ceftazidime,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2191,Ceftazidime,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2191,Ceftazidime,041.49,Other and unspecified Escherichia coli [E. coli],0
2191,Ceftazidime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2191,Ceftazidime,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,1
2191,Ceftazidime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2191,Ceftazidime,136.9,Unspecified infectious and parasitic diseases,1
2191,Ceftazidime,288.0,Agranulocytosis,0
2191,Ceftazidime,288.00,Neutropenia NOS,0
2191,Ceftazidime,320,Bacterial meningitis,0
2191,Ceftazidime,320.9,Bacterial meningitis NOS,0
2191,Ceftazidime,482.9,Bacterial pneumonia NOS,0
2191,Ceftazidime,599.0,Urinary tract infection; site not specified,1
2191,Ceftazidime,686.8|041.9,,0
2191,Ceftazidime,780.60,Fever; unspecified,0
2191,Ceftazidime,995.91,Sepsis,1
2192,Ceftizoxime,038.9,Septicemia NOS,1
2192,Ceftizoxime,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2192,Ceftizoxime,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2192,Ceftizoxime,041.49,Other and unspecified Escherichia coli [E. coli],0
2192,Ceftizoxime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2192,Ceftizoxime,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
2192,Ceftizoxime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2192,Ceftizoxime,098,Gonococcal infections,1
2192,Ceftizoxime,098.89,Gonococcal infection of other specified sites,1
2192,Ceftizoxime,136.9,Unspecified infectious and parasitic diseases,1
2192,Ceftizoxime,482.9,Bacterial pneumonia NOS,0
2192,Ceftizoxime,599.0,Urinary tract infection; site not specified,1
2192,Ceftizoxime,686.8|041.9,,0
2192,Ceftizoxime,995.91,Sepsis,0
2193,Ceftriaxone,002.0,Typhoid fever,0
2193,Ceftriaxone,003.9,Salmonella infection NOS,0
2193,Ceftriaxone,038.9,Septicemia NOS,1
2193,Ceftriaxone,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
2193,Ceftriaxone,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,1
2193,Ceftriaxone,041.49,Other and unspecified Escherichia coli [E. coli],0
2193,Ceftriaxone,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2193,Ceftriaxone,088.81,Lyme disease,0
2193,Ceftriaxone,098,Gonococcal infections,1
2193,Ceftriaxone,098.89,Gonococcal infection of other specified sites,1
2193,Ceftriaxone,099.0,Chancroid,0
2193,Ceftriaxone,136.9,Unspecified infectious and parasitic diseases,1
2193,Ceftriaxone,320,Bacterial meningitis,0
2193,Ceftriaxone,320.9,Bacterial meningitis NOS,0
2193,Ceftriaxone,322,Meningitis of unspecified cause,1
2193,Ceftriaxone,322.9,Meningitis NOS,1
2193,Ceftriaxone,382.9,Unspecified otitis media,1
2193,Ceftriaxone,482.9,Bacterial pneumonia NOS,0
2193,Ceftriaxone,486,Pneumonia; organism unspecified,1
2193,Ceftriaxone,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
2193,Ceftriaxone,567.9,Peritonitis NOS,0
2193,Ceftriaxone,599.0,Urinary tract infection; site not specified,1
2193,Ceftriaxone,604.90,Orchitis and epididymitis; unspecified,0
2193,Ceftriaxone,686.8|041.9,,0
2193,Ceftriaxone,780.60,Fever; unspecified,0
2193,Ceftriaxone,995.91,Sepsis,0
2194,Cefuroxime,041.49,Other and unspecified Escherichia coli [E. coli],0
2194,Cefuroxime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2194,Cefuroxime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2194,Cefuroxime,088.81,Lyme disease,1
2194,Cefuroxime,098,Gonococcal infections,1
2194,Cefuroxime,098.89,Gonococcal infection of other specified sites,1
2194,Cefuroxime,136.9,Unspecified infectious and parasitic diseases,1
2194,Cefuroxime,461.9,Acute sinusitis NOS,1
2194,Cefuroxime,462,Acute pharyngitis,1
2194,Cefuroxime,482.9,Bacterial pneumonia NOS,0
2194,Cefuroxime,490,Bronchitis NOS,1
2194,Cefuroxime,599.0,Urinary tract infection; site not specified,1
2194,Cefuroxime,684,Impetigo,0
2194,Cefuroxime,998.59,Other postoperative infection,0
2231,Cephalexin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
2231,Cephalexin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2231,Cephalexin,041.49,Other and unspecified Escherichia coli [E. coli],0
2231,Cephalexin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2231,Cephalexin,041.9|421.0,,0
2231,Cephalexin,136.9,Unspecified infectious and parasitic diseases,1
2231,Cephalexin,382.9,Unspecified otitis media,1
2231,Cephalexin,462,Acute pharyngitis,0
2231,Cephalexin,482.9,Bacterial pneumonia NOS,0
2231,Cephalexin,486,Pneumonia; organism unspecified,1
2231,Cephalexin,599.0,Urinary tract infection; site not specified,0
2231,Cephalexin,686.8|041.9,,0
2231,Cephalexin,998.59,Other postoperative infection,0
2231,Cephalexin,E928.3,Human bite,0
2239,Cephradine,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2239,Cephradine,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2239,Cephradine,041.49,Other and unspecified Escherichia coli [E. coli],0
2239,Cephradine,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2239,Cephradine,136.9,Unspecified infectious and parasitic diseases,0
2239,Cephradine,519.8,Other diseases of respiratory system; not elsewhere classified,0
2239,Cephradine,599.0,Urinary tract infection; site not specified,0
2239,Cephradine,686.8|041.9,,0
2296,Charcoal,586,Renal failure unspecified,0
2296,Charcoal,787.3,Flatulence; eructation; and gas pain,0
2296,Charcoal,787.7,Abnormal feces,0
2296,Charcoal,787.91,Diarrhea,0
2296,Charcoal,977.9,Poisoning by unspecified drug or medicinal substance,0
2344,Chloral Hydrate,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
2344,Chloral Hydrate,308.2,Predominant psychomotor disturbance,0
2344,Chloral Hydrate,780.52,Insomnia; unspecified,0
2344,Chloral Hydrate,799.21,Nervousness (ADDED),0
2346,Chlorambucil,181,Malignant neoplasm of placenta,0
2346,Chlorambucil,201,Hodgkin's disease,0
2346,Chlorambucil,201.0,Hodgkin's paragranuloma,0
2346,Chlorambucil,201.1,Hodgkin's granuloma,0
2346,Chlorambucil,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
2346,Chlorambucil,201.2,Hodgkin's sarcoma,0
2346,Chlorambucil,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
2346,Chlorambucil,201.9,Hodgkin's disease; unspecified type,0
2346,Chlorambucil,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
2346,Chlorambucil,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
2346,Chlorambucil,204.1,Lymphoid leukemia; chronic,1
2346,Chlorambucil,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
2346,Chlorambucil,239.3,Neoplasm of unspecified nature of breast,0
2346,Chlorambucil,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
2346,Chlorambucil,273.3,Macroglobulinemia,0
2346,Chlorambucil,289.9,Blood disease NOS,0
2346,Chlorambucil,790.99,Other nonspecific findings on examination of blood,0
2348,Chloramphenicol,003.9,Salmonella infection NOS,1
2348,Chloramphenicol,036.0,Meningococcal meningitis,0
2348,Chloramphenicol,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2348,Chloramphenicol,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
2348,Chloramphenicol,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2348,Chloramphenicol,083.9,Rickettsiosis NOS,0
2348,Chloramphenicol,136.9,Unspecified infectious and parasitic diseases,1
2348,Chloramphenicol,322,Meningitis of unspecified cause,1
2348,Chloramphenicol,322.9,Meningitis NOS,1
2348,Chloramphenicol,379.99,Other ill-defined disorders of eye,1
2348,Chloramphenicol,379.99|041.9,,0
2348,Chloramphenicol,380.10,Infective otitis externa; unspecified,0
2348,Chloramphenicol,780.60,Fever; unspecified,1
2353,clorazepate,291.0,Alcohol withdrawal delirium,0
2353,clorazepate,300.00,Anxiety state unspecified,0
2353,clorazepate,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
2353,clorazepate,780.39,Other convulsions,0
2354,chlorcyclizine,477.9,Allergic rhinitis NOS,0
2354,chlorcyclizine,698.9,Unspecified pruritic disorder,0
2354,chlorcyclizine,787.03,Vomiting alone,1
2354,chlorcyclizine,994.6,Motion sickness,1
2356,Chlordiazepoxide,300.00,Anxiety state unspecified,1
2356,Chlordiazepoxide,300.9,Unspecified nonpsychotic mental disorder,1
2356,Chlordiazepoxide,303,Alcohol dependence syndrome,0
2356,Chlordiazepoxide,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
2356,Chlordiazepoxide,305.01,Alcohol abuse; continuous drinking behavior,0
2356,Chlordiazepoxide,707.9,Chronic ulcer of unspecified site,0
2358,Chlorhexidine,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2358,Chlorhexidine,112.0,Candidiasis of mouth,0
2358,Chlorhexidine,523.10,Chronic gingivitis; plaque induced,1
2358,Chlorhexidine,523.9,Unspecified gingival and periodontal disease,0
2358,Chlorhexidine,686.9,Unspecified local infection of skin and subcutaneous tissue,0
2373,Chlormezanone,300.00,Anxiety state unspecified,0
2373,Chlormezanone,781.0,Abnormal involuntary movements,0
2382,Proguanil,084.0,Falciparum malaria [malignant tertian],0
2393,Chloroquine,006,Amebiasis,1
2393,Chloroquine,006.9,Amebiasis NOS,1
2393,Chloroquine,084,Malaria,0
2393,Chloroquine,084.0,Falciparum malaria [malignant tertian],1
2393,Chloroquine,084.2,Quartan malaria,1
2393,Chloroquine,084.6,Malaria NOS,0
2393,Chloroquine,136.8,Other specified infectious and parasitic diseases,1
2393,Chloroquine,694.4,Pemphigus,0
2393,Chloroquine,695.4,Lupus erythematosus,0
2393,Chloroquine,710.1,Systemic sclerosis,0
2393,Chloroquine,714.0,Rheumatoid arthritis,0
2396,Chlorothiazide,276.6,Fluid overload,1
2396,Chlorothiazide,276.69,Other fluid overload,1
2396,Chlorothiazide,276.9,Electrolyte and fluid disorders not elsewhere classified,1
2396,Chlorothiazide,401-405.99,,1
2396,Chlorothiazide,401.9,Hypertension NOS,1
2396,Chlorothiazide,428,Heart failure,1
2396,Chlorothiazide,428.0,Congestive heart failure (CHF) NOS,1
2396,Chlorothiazide,428.9,Heart failure unspecified,1
2396,Chlorothiazide,581,Nephrotic syndrome,1
2396,Chlorothiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
2396,Chlorothiazide,782.3,Edema,1
2396,Chlorothiazide,997.91,Hypertension,1
2397,Chlorotrianisene,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
2397,Chlorotrianisene,253.4,Other anterior pituitary disorders,0
2397,Chlorotrianisene,256.31,Premature menopause,0
2399,Chlorphenesin,338-338.99,,0
2399,Chlorphenesin,728.85,Spasm of muscle,0
2399,Chlorphenesin,728.9,Unspecified disorder of muscle; ligament; and fascia,0
2399,Chlorphenesin,729.1,Myalgia and myositis unspecified,0
2399,Chlorphenesin,729.82,Cramp of limb,0
2399,Chlorphenesin,780.96,Generalized pain,0
2399,Chlorphenesin,781.0,Abnormal involuntary movements,0
2400,Chlorpheniramine,460,Acute nasopharyngitis (common cold),0
2400,Chlorpheniramine,477.9,Allergic rhinitis NOS,0
2400,Chlorpheniramine,708,Urticaria,0
2400,Chlorpheniramine,708.9,Unspecified urticaria,0
2400,Chlorpheniramine,780-789.99,,0
2400,Chlorpheniramine,786.2,Cough,0
2400,Chlorpheniramine,995.3,Allergy unspecified not elsewhere classified,0
2403,Chlorpromazine,037,Tetanus,1
2403,Chlorpromazine,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,1
2403,Chlorpromazine,136.9,Unspecified infectious and parasitic diseases,0
2403,Chlorpromazine,277.1,Disorders of porphyrin metabolism,1
2403,Chlorpromazine,290-299.99,,1
2403,Chlorpromazine,295,Schizophrenic disorders,1
2403,Chlorpromazine,295.9,Unspecified schizophrenia,1
2403,Chlorpromazine,295.90,Unspecified schizophrenia; unspecified state,1
2403,Chlorpromazine,296.00,Manic disorder; single episode; unspecified degree,1
2403,Chlorpromazine,298.8,Other and unspecified reactive psychosis,1
2403,Chlorpromazine,298.9,Unspecified psychosis,1
2403,Chlorpromazine,300.00,Anxiety state unspecified,1
2403,Chlorpromazine,300.9,Unspecified nonpsychotic mental disorder,1
2403,Chlorpromazine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
2403,Chlorpromazine,308.2,Predominant psychomotor disturbance,1
2403,Chlorpromazine,311,Depressive disorder NEC,1
2403,Chlorpromazine,780-789.99,,0
2403,Chlorpromazine,786.8,Hiccough,1
2403,Chlorpromazine,787.02,Nausea alone,1
2403,Chlorpromazine,787.03,Vomiting alone,1
2403,Chlorpromazine,799.21,Nervousness (ADDED),1
2404,Chlorpropamide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
2404,Chlorpropamide,251.2,Hypoglycemia NOS,0
2404,Chlorpropamide,790.6,Other abnormal blood chemistry,1
2406,Chlorprothixene,290-299.99,,0
2406,Chlorprothixene,295.3,Paranoid type schizophrenia,0
2406,Chlorprothixene,295.30,Paranoid type schizophrenia; unspecified state,0
2406,Chlorprothixene,298.9,Unspecified psychosis,0
2409,Chlorthalidone,276.6,Fluid overload,1
2409,Chlorthalidone,276.69,Other fluid overload,1
2409,Chlorthalidone,276.9,Electrolyte and fluid disorders not elsewhere classified,0
2409,Chlorthalidone,401-405.99,,1
2409,Chlorthalidone,401.9,Hypertension NOS,1
2409,Chlorthalidone,428,Heart failure,1
2409,Chlorthalidone,428.0,Congestive heart failure (CHF) NOS,1
2409,Chlorthalidone,428.9,Heart failure unspecified,1
2409,Chlorthalidone,458,Hypotension,0
2409,Chlorthalidone,458.9,Hypotension NOS,0
2409,Chlorthalidone,581,Nephrotic syndrome,1
2409,Chlorthalidone,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
2409,Chlorthalidone,585.6,End stage renal disease,1
2409,Chlorthalidone,585.9,Chronic kidney disease; unspecified,1
2409,Chlorthalidone,586,Renal failure unspecified,1
2409,Chlorthalidone,782.3,Edema,1
2409,Chlorthalidone,997.91,Hypertension,1
2410,Chlorzoxazone,338-338.99,,0
2410,Chlorzoxazone,728.85,Spasm of muscle,0
2410,Chlorzoxazone,728.9,Unspecified disorder of muscle; ligament; and fascia,0
2410,Chlorzoxazone,729.1,Myalgia and myositis unspecified,0
2410,Chlorzoxazone,729.82,Cramp of limb,0
2410,Chlorzoxazone,780.96,Generalized pain,0
2410,Chlorzoxazone,781.0,Abnormal involuntary movements,0
2410,Chlorzoxazone,781.99,Other symptoms involving nervous and musculoskeletal systems,1
2418,Cholecalciferol,239.1,Neoplasm of unspecified nature of respiratory system,0
2418,Cholecalciferol,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
2418,Cholecalciferol,429.2,Cardiovascular disease [ASCVD],0
2418,Cholecalciferol,555.9,Regional enteritis of unspecified site,0
2418,Cholecalciferol,585.6,End stage renal disease,0
2418,Cholecalciferol,585.9,Chronic kidney disease; unspecified,0
2418,Cholecalciferol,586,Renal failure unspecified,0
2418,Cholecalciferol,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
2418,Cholecalciferol,733.0,Osteoporosis,0
2418,Cholecalciferol,733.00,Osteoporosis NOS,0
2447,Cholestyramine Resin,008.45,Intestinal infection due to clostridium difficile,0
2447,Cholestyramine Resin,272.1,Pure hyperglyceridemia,1
2447,Cholestyramine Resin,272.4,Other and unspecified hyperlipidemia,1
2447,Cholestyramine Resin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
2447,Cholestyramine Resin,429.9,Heart disease NOS,1
2447,Cholestyramine Resin,440,Atherosclerosis,1
2447,Cholestyramine Resin,447.9,Unspecified disorders of arteries and arterioles,1
2447,Cholestyramine Resin,698.9,Unspecified pruritic disorder,1
2447,Cholestyramine Resin,787.7,Abnormal feces,1
2447,Cholestyramine Resin,787.91,Diarrhea,1
2449,Choline,266.2,Other B-complex deficiencies,0
2449,Choline,338-338.99,,0
2449,Choline,390,Rheumatic fever without mention of heart involvement,0
2449,Choline,390-392.99,,0
2449,Choline,714.0,Rheumatoid arthritis,0
2449,Choline,715.00,Osteoarthrosis; generalized; involving unspecified site,0
2449,Choline,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
2449,Choline,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
2449,Choline,780.96,Generalized pain,0
2473,Chondroitin Sulfates,338-338.99,,0
2473,Chondroitin Sulfates,715.00,Osteoarthrosis; generalized; involving unspecified site,0
2473,Chondroitin Sulfates,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
2473,Chondroitin Sulfates,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
2473,Chondroitin Sulfates,733.90,Disorder of bone and cartilage; unspecified,0
2473,Chondroitin Sulfates,780.96,Generalized pain,0
2540,Cilastatin,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
2541,Cimetidine,251.5,Abnormality of secretion of gastrin,0
2541,Cimetidine,530.11,Reflux esophagitis,0
2541,Cimetidine,530.81,Esophageal reflux,1
2541,Cimetidine,531,Gastric ulcer,1
2541,Cimetidine,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
2541,Cimetidine,532,Duodenal ulcer,1
2541,Cimetidine,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
2541,Cimetidine,536.8,Dyspepsia and other specified disorders of function of stomach,0
2541,Cimetidine,578,Gastrointestinal hemorrhage,1
2541,Cimetidine,578.9,Hemorrhage of gastrointestinal tract NOS,1
2541,Cimetidine,707.9,Chronic ulcer of unspecified site,1
2541,Cimetidine,708,Urticaria,0
2541,Cimetidine,708.9,Unspecified urticaria,0
2541,Cimetidine,787.1,Heartburn,0
2550,Cinoxacin,599.0,Urinary tract infection; site not specified,1
2551,Ciprofloxacin,002.0,Typhoid fever,1
2551,Ciprofloxacin,008.43,Intestinal infection due to campylobacter,0
2551,Ciprofloxacin,009.0,Infectious colitis; enteritis; and gastroenteritis,1
2551,Ciprofloxacin,009.2,Infectious diarrhea,1
2551,Ciprofloxacin,022,Anthrax,1
2551,Ciprofloxacin,022.1,Pulmonary anthrax,1
2551,Ciprofloxacin,022.9,Anthrax NOS,1
2551,Ciprofloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2551,Ciprofloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
2551,Ciprofloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
2551,Ciprofloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,1
2551,Ciprofloxacin,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
2551,Ciprofloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2551,Ciprofloxacin,098,Gonococcal infections,1
2551,Ciprofloxacin,098.89,Gonococcal infection of other specified sites,1
2551,Ciprofloxacin,136.9,Unspecified infectious and parasitic diseases,1
2551,Ciprofloxacin,288.0,Agranulocytosis,1
2551,Ciprofloxacin,288.00,Neutropenia NOS,1
2551,Ciprofloxacin,370.0,Corneal ulcer,1
2551,Ciprofloxacin,370.00,Corneal ulcer NOS,1
2551,Ciprofloxacin,372.03,Other mucopurulent conjunctivitis,1
2551,Ciprofloxacin,372.30,Conjunctivitis NOS,1
2551,Ciprofloxacin,380.10,Infective otitis externa; unspecified,1
2551,Ciprofloxacin,382.9,Unspecified otitis media,1
2551,Ciprofloxacin,461.9,Acute sinusitis NOS,1
2551,Ciprofloxacin,484.5,Pneumonia in anthrax,1
2551,Ciprofloxacin,490,Bronchitis NOS,1
2551,Ciprofloxacin,491,Chronic bronchitis,1
2551,Ciprofloxacin,491.9,Chronic bronchitis NOS,1
2551,Ciprofloxacin,519.8,Other diseases of respiratory system; not elsewhere classified,1
2551,Ciprofloxacin,590.80,Pyelonephritis NOS,1
2551,Ciprofloxacin,595,Cystitis,1
2551,Ciprofloxacin,595.9,Cystitis NOS,1
2551,Ciprofloxacin,599.0,Urinary tract infection; site not specified,1
2551,Ciprofloxacin,601,Inflammatory diseases of prostate,1
2551,Ciprofloxacin,601.9,Prostatitis NOS,1
2551,Ciprofloxacin,686.8|041.9,,0
2551,Ciprofloxacin,716.9,Arthropathy; unspecified,1
2551,Ciprofloxacin,716.90,Arthropathy; unspecified; site unspecified,1
2551,Ciprofloxacin,719.9,Unspecified disorder of joint,1
2551,Ciprofloxacin,719.90,Unspecified disorder of joint site unspecified,1
2551,Ciprofloxacin,730.2,Unspecified osteomyelitis,0
2551,Ciprofloxacin,730.20,Unspecified osteomyelitis; site unspecified,0
2551,Ciprofloxacin,780.60,Fever; unspecified,1
2555,Cisplatin,150.9,Malignant neoplasm of esophagus; unspecified,1
2555,Cisplatin,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
2555,Cisplatin,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
2555,Cisplatin,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
2555,Cisplatin,180.9,Malignant neoplasm of cervix uteri; unspecified,1
2555,Cisplatin,183.0,Malignant neoplasm of ovary,1
2555,Cisplatin,186,Malignant neoplasm of testis,1
2555,Cisplatin,186.9,Malignant neoplasm of other and unspecified testis,1
2555,Cisplatin,188,Malignant neoplasm of bladder,1
2555,Cisplatin,188.9,Malignant neoplasm of bladder; part unspecified,1
2555,Cisplatin,191.9,Malignant neoplasm of brain; unspecified,1
2555,Cisplatin,195.0,Malignant neoplasm of head; face; and neck,1
2555,Cisplatin,199,Malignant neoplasm without specification of site,1
2555,Cisplatin,199.1,Other malignant neoplasm of unspecified site,1
2555,Cisplatin,201,Hodgkin's disease,0
2555,Cisplatin,201.0,Hodgkin's paragranuloma,0
2555,Cisplatin,201.1,Hodgkin's granuloma,0
2555,Cisplatin,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
2555,Cisplatin,201.2,Hodgkin's sarcoma,0
2555,Cisplatin,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
2555,Cisplatin,201.9,Hodgkin's disease; unspecified type,0
2555,Cisplatin,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
2555,Cisplatin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
2555,Cisplatin,203.0,Multiple myeloma,0
2555,Cisplatin,203.00,Multiple myeloma without mention of having achieved remission,0
2555,Cisplatin,209.20,Malignant carcinoid tumor of unknown primary site,0
2555,Cisplatin,239.0,Neoplasm of unspecified nature of digestive system,0
2555,Cisplatin,239.1,Neoplasm of unspecified nature of respiratory system,0
2555,Cisplatin,239.3,Neoplasm of unspecified nature of breast,0
2555,Cisplatin,239.4,Neoplasm of unspecified nature of bladder,0
2555,Cisplatin,239.5,Neoplasm of unspecified nature of other genitourinary organs,1
2556,Citalopram,250.6,Diabetes with neurological manifestations,0
2556,Citalopram,290,Dementias,0
2556,Citalopram,294.2,,0
2556,Citalopram,294.20,Dementia; unspecified; without behavioral disturbance,0
2556,Citalopram,296.20,Major depressive disorder; single episode; unspecified degree,1
2556,Citalopram,300.00,Anxiety state unspecified,0
2556,Citalopram,300.01,Panic disorder without agoraphobia,0
2556,Citalopram,300.3,Obsessive-compulsive disorders,0
2556,Citalopram,303,Alcohol dependence syndrome,0
2556,Citalopram,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
2556,Citalopram,305.01,Alcohol abuse; continuous drinking behavior,0
2556,Citalopram,305.1,Tobacco use disorder,0
2556,Citalopram,311,Depressive disorder NEC,1
2556,Citalopram,625.4,Premenstrual tension syndromes,1
2556,Citalopram,780-789.99,,0
2556,Citalopram,797,Senility without mention of psychosis,1
2557,Prilocaine Hydrochloride,338-338.99,,0
2557,Prilocaine Hydrochloride,525.9,Dental disorder NOS,0
2557,Prilocaine Hydrochloride,780.96,Generalized pain,0
2578,Clemastine,477.9,Allergic rhinitis NOS,1
2578,Clemastine,698.9,Unspecified pruritic disorder,1
2578,Clemastine,708,Urticaria,1
2578,Clemastine,708.9,Unspecified urticaria,1
2578,Clemastine,780.60,Fever; unspecified,0
2578,Clemastine,995.3,Allergy unspecified not elsewhere classified,0
2582,Clindamycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
2582,Clindamycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2582,Clindamycin,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
2582,Clindamycin,041.9|421.0,,1
2582,Clindamycin,084,Malaria,0
2582,Clindamycin,084.2,Quartan malaria,0
2582,Clindamycin,084.6,Malaria NOS,0
2582,Clindamycin,130,Toxoplasmosis,0
2582,Clindamycin,130.9,Toxoplasmosis NOS,0
2582,Clindamycin,131,Trichomoniasis,1
2582,Clindamycin,131.9,Trichomoniasis NOS,1
2582,Clindamycin,136.3,Pneumocystosis,1
2582,Clindamycin,136.9,Unspecified infectious and parasitic diseases,1
2582,Clindamycin,424.90,Endocarditis valve unspecified cause,1
2582,Clindamycin,486,Pneumonia; organism unspecified,1
2582,Clindamycin,519.8,Other diseases of respiratory system; not elsewhere classified,1
2582,Clindamycin,567.9,Peritonitis NOS,1
2582,Clindamycin,616.10|041.9,,1
2582,Clindamycin,706.1,Other acne,1
2582,Clindamycin,730.2,Unspecified osteomyelitis,1
2582,Clindamycin,730.20,Unspecified osteomyelitis; site unspecified,1
2582,Clindamycin,E968.9,ASSAULT NOS,0
2590,Clobetasol,692.9,Contact dermatitis and other eczema; unspecified cause,1
2590,Clobetasol,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
2590,Clobetasol,709.9,Unspecified disorder of skin and subcutaneous tissue,1
2592,Clofazimine,030,Leprosy,1
2592,Clofazimine,030.0,Lepromatous leprosy,1
2592,Clofazimine,030.3,Borderline leprosy,0
2592,Clofazimine,030.9,Leprosy NOS,1
2592,Clofazimine,031.8,Other specified mycobacterial diseases,0
2592,Clofazimine,686.01,Pyoderma gangrenosum,0
2592,Clofazimine,695.2,Erythema nodosum,1
2596,Clomiphene,256.1,Other ovarian hyperfunction,1
2596,Clomiphene,256.4,Polycystic ovaries,1
2596,Clomiphene,606,Infertility; male,1
2596,Clomiphene,606.9,Male infertility NOS,1
2596,Clomiphene,628,Infertility; female,0
2596,Clomiphene,628.9,Female infertility NOS,0
2597,Clomipramine,300.01,Panic disorder without agoraphobia,0
2597,Clomipramine,300.3,Obsessive-compulsive disorders,1
2597,Clomipramine,311,Depressive disorder NEC,0
2597,Clomipramine,338-338.99,,0
2597,Clomipramine,780.96,Generalized pain,0
2598,Clonazepam,295,Schizophrenic disorders,0
2598,Clonazepam,295.9,Unspecified schizophrenia,0
2598,Clonazepam,295.90,Unspecified schizophrenia; unspecified state,0
2598,Clonazepam,296.80,Bipolar disorder NOS,0
2598,Clonazepam,300.01,Panic disorder without agoraphobia,1
2598,Clonazepam,307.2,Tics,0
2598,Clonazepam,307.20,Tic disorder NOS,0
2598,Clonazepam,333.94,Restless legs syndrome (RLS),0
2598,Clonazepam,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
2598,Clonazepam,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
2598,Clonazepam,345.9,Epilepsy; unspecified,1
2598,Clonazepam,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
2598,Clonazepam,438.13,Late effects of cerebrovascular disease; dysarthria (ADDED),0
2598,Clonazepam,729.2,Neuralgia; neuritis; and radiculitis; unspecified,0
2598,Clonazepam,780.39,Other convulsions,1
2598,Clonazepam,780.99,Other general symptoms,1
2598,Clonazepam,781.0,Abnormal involuntary movements,1
2598,Clonazepam,781.99,Other symptoms involving nervous and musculoskeletal systems,1
2598,Clonazepam,784.51,Dysarthria (ADDED),0
2599,Clonidine,292.89,Other specified drug-induced mental disorders,0
2599,Clonidine,300.9,Unspecified nonpsychotic mental disorder,1
2599,Clonidine,307.23,Tourette's disorder,0
2599,Clonidine,314,Hyperkinetic syndrome of childhood,1
2599,Clonidine,314.01,Attention deficit disorder of childhood with hyperactivity,1
2599,Clonidine,314.9,Unspecified hyperkinetic syndrome of childhood,1
2599,Clonidine,338-338.99,,1
2599,Clonidine,365,Glaucoma,0
2599,Clonidine,365.9,Glaucoma NOS,0
2599,Clonidine,401-405.99,,1
2599,Clonidine,401.9,Hypertension NOS,1
2599,Clonidine,527.7,Disturbance of salivary secretion,0
2599,Clonidine,625.3,Dysmenorrhea,0
2599,Clonidine,627.2,Symptomatic menopausal or female climacteric states,0
2599,Clonidine,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
2599,Clonidine,780.96,Generalized pain,1
2599,Clonidine,781.0,Abnormal involuntary movements,0
2599,Clonidine,782.62,Flushing,0
2599,Clonidine,785.0,Tachycardia NOS,0
2599,Clonidine,787.7,Abnormal feces,0
2599,Clonidine,787.91,Diarrhea,0
2599,Clonidine,997.91,Hypertension,1
2607,Clorazepate Dipotassium,291.0,Alcohol withdrawal delirium,0
2607,Clorazepate Dipotassium,300.00,Anxiety state unspecified,0
2607,Clorazepate Dipotassium,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
2607,Clorazepate Dipotassium,780.39,Other convulsions,0
2623,Clotrimazole,110.3,Dermatophytosis of groin and perianal area,1
2623,Clotrimazole,110.4,Dermatophytosis of foot,1
2623,Clotrimazole,110.5,Dermatophytosis of the body,1
2623,Clotrimazole,112.0,Candidiasis of mouth,0
2623,Clotrimazole,112.1,Candidiasis of vulva and vagina,0
2623,Clotrimazole,112.3,Candidiasis of skin and nails,0
2626,Clozapine,290-299.99,,0
2626,Clozapine,295,Schizophrenic disorders,1
2626,Clozapine,295.9,Unspecified schizophrenia,1
2626,Clozapine,295.90,Unspecified schizophrenia; unspecified state,1
2626,Clozapine,296.80,Bipolar disorder NOS,0
2626,Clozapine,298.9,Unspecified psychosis,0
2626,Clozapine,300.9,Unspecified nonpsychotic mental disorder,1
2635,Coal Tar,690.1,Seborrheic dermatitis,0
2635,Coal Tar,690.10,Seborheic dermatitis; unspecified,0
2635,Coal Tar,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
2635,Coal Tar,696.5,Other and unspecified pityriasis,0
2635,Coal Tar,706.3,Seborrhea,0
2653,Cocaine,338-338.99,,0
2653,Cocaine,521.0,Dental caries,1
2653,Cocaine,521.00,Dental caries NOS,1
2653,Cocaine,780.96,Generalized pain,0
2653,Cocaine,786.2,Cough,0
2669,Cod Liver Oil,252.0,Hyperparathyroidism,0
2669,Cod Liver Oil,252.00,Hyperparathyroidism NOS,0
2669,Cod Liver Oil,264,Vitamin A deficiency,0
2669,Cod Liver Oil,264.9,Vitamin A deficiency NOS,0
2669,Cod Liver Oil,268,Vitamin D deficiency,0
2669,Cod Liver Oil,268.9,Vitamin d deficiency NOS,0
2669,Cod Liver Oil,275.41,Hypocalcemia,0
2669,Cod Liver Oil,368.6,Night blindness,0
2669,Cod Liver Oil,368.60,Night blindness NOS,0
2669,Cod Liver Oil,372.53,Conjunctival xerosis,0
2669,Cod Liver Oil,579,Intestinal malabsorption,0
2669,Cod Liver Oil,579.9,Unspecified intestinal malabsorption,0
2669,Cod Liver Oil,692.9,Contact dermatitis and other eczema; unspecified cause,0
2669,Cod Liver Oil,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
2670,Codeine,338-338.99,,1
2670,Codeine,338.18,Other acute postoperative pain,0
2670,Codeine,780.96,Generalized pain,1
2670,Codeine,786.2,Cough,0
2670,Codeine,995.0,Other anaphylactic reaction,0
2672,Codeine Phosphate,338-338.99,,0
2672,Codeine Phosphate,338.18,Other acute postoperative pain,0
2672,Codeine Phosphate,780.96,Generalized pain,0
2672,Codeine Phosphate,786.2,Cough,0
2683,Colchicine,274,Gout,1
2683,Colchicine,274.9,Gout NOS,1
2683,Colchicine,277.3,Amyloidosis,0
2683,Colchicine,277.30,Amyloidosis NOS,0
2683,Colchicine,277.31,Familial Mediterranean fever,1
2683,Colchicine,338-338.99,,1
2683,Colchicine,571.6,Biliary cirrhosis,0
2683,Colchicine,780.60,Fever; unspecified,1
2683,Colchicine,780.96,Generalized pain,1
2685,Colestipol,008.45,Intestinal infection due to clostridium difficile,0
2685,Colestipol,272.1,Pure hyperglyceridemia,0
2685,Colestipol,272.4,Other and unspecified hyperlipidemia,1
2685,Colestipol,429.9,Heart disease NOS,1
2685,Colestipol,440,Atherosclerosis,1
2685,Colestipol,447.9,Unspecified disorders of arteries and arterioles,1
2685,Colestipol,787.7,Abnormal feces,0
2685,Colestipol,787.91,Diarrhea,0
2709,Colistin,041.49,Other and unspecified Escherichia coli [E. coli],0
2709,Colistin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
2709,Colistin,136.9,Unspecified infectious and parasitic diseases,1
2709,Colistin,599.0,Urinary tract infection; site not specified,0
2878,Cortisone,255.41,Glucocorticoid deficiency,1
2878,Cortisone,472.0,Chronic rhinitis,1
2878,Cortisone,493,Asthma,1
2878,Cortisone,493.9,Asthma; unspecified,1
2878,Cortisone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
2878,Cortisone,716.90,Arthropathy; unspecified; site unspecified,1
2878,Cortisone,799.89,Other ill-defined conditions,1
2878,Cortisone,995.3,Allergy unspecified not elsewhere classified,1
2890,Cosyntropin,255.41,Glucocorticoid deficiency,1
2890,Cosyntropin,255.9,Unspecified disorder of adrenal glands,0
2968,Cyclacillin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
2968,Cyclacillin,041.2,Pneumococcus infection in conditions classified elsewhere and of unspecified site,0
2968,Cyclacillin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
2968,Cyclacillin,519.8,Other diseases of respiratory system; not elsewhere classified,0
2968,Cyclacillin,599.0,Urinary tract infection; site not specified,0
2970,Cyclandelate,443.9,Peripheral vascular disease; unspecified,0
2977,Cyclizine,787.02,Nausea alone,0
2977,Cyclizine,787.03,Vomiting alone,0
2977,Cyclizine,994.6,Motion sickness,0
3001,Cyclopentolate,367.51,Paresis of accommodation,1
3001,Cyclopentolate,379.43,Mydriasis (persistent); not due to mydriatics,1
3002,Cyclophosphamide,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
3002,Cyclophosphamide,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
3002,Cyclophosphamide,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
3002,Cyclophosphamide,174.9,Malignant neoplasm of breast (female); unspecified,1
3002,Cyclophosphamide,190.5,Malignant neoplasm of retina,1
3002,Cyclophosphamide,191,Malignant neoplasm of brain,1
3002,Cyclophosphamide,191.9,Malignant neoplasm of brain; unspecified,1
3002,Cyclophosphamide,199,Malignant neoplasm without specification of site,1
3002,Cyclophosphamide,199.1,Other malignant neoplasm of unspecified site,1
3002,Cyclophosphamide,200.2,Burkitt's tumor or lymphoma,0
3002,Cyclophosphamide,200.20,Burkitt's tumor or lymphoma; unspecified site; extranodal and solid organ sites,0
3002,Cyclophosphamide,201,Hodgkin's disease,0
3002,Cyclophosphamide,201.0,Hodgkin's paragranuloma,0
3002,Cyclophosphamide,201.1,Hodgkin's granuloma,0
3002,Cyclophosphamide,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
3002,Cyclophosphamide,201.2,Hodgkin's sarcoma,0
3002,Cyclophosphamide,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
3002,Cyclophosphamide,201.9,Hodgkin's disease; unspecified type,0
3002,Cyclophosphamide,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
3002,Cyclophosphamide,202.1,Mycosis fungoides,1
3002,Cyclophosphamide,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,1
3002,Cyclophosphamide,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
3002,Cyclophosphamide,203.0,Multiple myeloma,1
3002,Cyclophosphamide,203.00,Multiple myeloma without mention of having achieved remission,1
3002,Cyclophosphamide,204.1,Lymphoid leukemia; chronic,1
3002,Cyclophosphamide,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
3002,Cyclophosphamide,205.0,Myeloid leukemia; acute,0
3002,Cyclophosphamide,205.00,Acute myeloid leukemia without mention of having achieved remission,0
3002,Cyclophosphamide,205.1,Myeloid leukemia; chronic,1
3002,Cyclophosphamide,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
3002,Cyclophosphamide,208,Leukemia of unspecified cell type,1
3002,Cyclophosphamide,208.9,Unspecified leukemia,1
3002,Cyclophosphamide,208.90,Unspecified leukemia without mention of having achieved remission,1
3002,Cyclophosphamide,209.20,Malignant carcinoid tumor of unknown primary site,1
3002,Cyclophosphamide,239.1,Neoplasm of unspecified nature of respiratory system,0
3002,Cyclophosphamide,239.3,Neoplasm of unspecified nature of breast,0
3002,Cyclophosphamide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
3002,Cyclophosphamide,273.3,Macroglobulinemia,1
3002,Cyclophosphamide,275.09,Other disorders of iron metabolism,0
3002,Cyclophosphamide,283.0,Autoimmune hemolytic anemias,0
3002,Cyclophosphamide,284.81,Red cell aplasia (acquired) (adult) (with thymoma),0
3002,Cyclophosphamide,287.31,Immune thrombocytopenic purpura,0
3002,Cyclophosphamide,340,Multiple sclerosis,0
3002,Cyclophosphamide,358.0,Myasthenia gravis,0
3002,Cyclophosphamide,358.00,Myasthenia gravis without (acute) exacerbation,0
3002,Cyclophosphamide,446.4,Wegener's granulomatosis,0
3002,Cyclophosphamide,581,Nephrotic syndrome,1
3002,Cyclophosphamide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
3002,Cyclophosphamide,710.0|581.81,,0
3002,Cyclophosphamide,729.0,Rheumatism; unspecified and fibrositis,0
3002,Cyclophosphamide,799.9,Other unknown and unspecified cause of morbidity or mortality,0
3007,Cycloserine,010-018.99,,1
3007,Cycloserine,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
3007,Cycloserine,272.7,Lipidoses,0
3008,Cyclosporine,279.5,Graft-versus-host disease,1
3008,Cyclosporine,279.50,Graft-versus-host disease; unspecified,1
3008,Cyclosporine,358.0,Myasthenia gravis,0
3008,Cyclosporine,358.00,Myasthenia gravis without (acute) exacerbation,0
3008,Cyclosporine,370.33,Keratoconjunctivitis sicca; not specified as Sjogren's,1
3008,Cyclosporine,375.15,Tear film insufficiency NOS,0
3008,Cyclosporine,50.5,Liver transplant,0
3008,Cyclosporine,582.1,Chronic glomerulonephritis with lesion of membranous glomerulonephritis,0
3008,Cyclosporine,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
3008,Cyclosporine,710.0,Systemic lupus erythematosus,0
3008,Cyclosporine,714.0,Rheumatoid arthritis,1
3008,Cyclosporine,716.90,Arthropathy; unspecified; site unspecified,1
3008,Cyclosporine,799.9,Other unknown and unspecified cause of morbidity or mortality,0
3008,Cyclosporine,996.52,Mechanical complication due to other tissue graft; not elsewhere classified,1
3013,Cyproheptadine,253.7,Iatrogenic pituitary disorders,0
3013,Cyproheptadine,295,Schizophrenic disorders,0
3013,Cyproheptadine,295.9,Unspecified schizophrenia,0
3013,Cyproheptadine,295.90,Unspecified schizophrenia; unspecified state,0
3013,Cyproheptadine,333.81,Blepharospasm,0
3013,Cyproheptadine,339.00,Cluster headache syndrome; unspecified,0
3013,Cyproheptadine,339.02,Chronic cluster headache,0
3013,Cyproheptadine,346,Migraine,0
3013,Cyproheptadine,346.9,Migraine; unspecified,0
3013,Cyproheptadine,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
3013,Cyproheptadine,477.0,Allergic rhinitis due to pollen,1
3013,Cyproheptadine,477.9,Allergic rhinitis NOS,1
3013,Cyproheptadine,698.9,Unspecified pruritic disorder,0
3013,Cyproheptadine,708,Urticaria,1
3013,Cyproheptadine,708.9,Unspecified urticaria,1
3013,Cyproheptadine,728.9,Unspecified disorder of muscle; ligament; and fascia,0
3013,Cyproheptadine,781.3,Lack of coordination,0
3013,Cyproheptadine,995.3,Allergy unspecified not elsewhere classified,1
3014,Cyproterone,185,Malignant neoplasm of prostate,1
3022,Cysteamine,270.0,Disturbances of amino-acid transport,0
3041,Cytarabine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
3041,Cytarabine,204.0,Lymphoid leukemia; acute,1
3041,Cytarabine,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
3041,Cytarabine,205.0,Myeloid leukemia; acute,1
3041,Cytarabine,205.00,Acute myeloid leukemia without mention of having achieved remission,1
3041,Cytarabine,205.1,Myeloid leukemia; chronic,1
3041,Cytarabine,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
3041,Cytarabine,208,Leukemia of unspecified cell type,1
3041,Cytarabine,208.9,Unspecified leukemia,1
3041,Cytarabine,208.90,Unspecified leukemia without mention of having achieved remission,1
3041,Cytarabine,238.75,Myelodysplastic syndrome; unspecified,1
3041,Cytarabine,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
3098,Dacarbazine,157.4,Malignant neoplasm of islets of Langerhans,1
3098,Dacarbazine,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
3098,Dacarbazine,172.9,Melanoma of skin; site unspecified,1
3098,Dacarbazine,201,Hodgkin's disease,0
3098,Dacarbazine,201.0,Hodgkin's paragranuloma,0
3098,Dacarbazine,201.1,Hodgkin's granuloma,0
3098,Dacarbazine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
3098,Dacarbazine,201.2,Hodgkin's sarcoma,0
3098,Dacarbazine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
3098,Dacarbazine,201.9,Hodgkin's disease; unspecified type,0
3098,Dacarbazine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
3098,Dacarbazine,209.20,Malignant carcinoid tumor of unknown primary site,1
3100,Dactinomycin,140-239.99,,1
3100,Dactinomycin,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
3100,Dactinomycin,172.9,Melanoma of skin; site unspecified,0
3100,Dactinomycin,176,Kaposi's sarcoma,0
3100,Dactinomycin,176.9,Kaposi's sarcoma NOS,0
3100,Dactinomycin,181,Malignant neoplasm of placenta,0
3100,Dactinomycin,186,Malignant neoplasm of testis,1
3100,Dactinomycin,186.9,Malignant neoplasm of other and unspecified testis,1
3100,Dactinomycin,189.0,Malignant neoplasm of kidney; except pelvis,0
3100,Dactinomycin,190.5,Malignant neoplasm of retina,0
3100,Dactinomycin,209.20,Malignant carcinoid tumor of unknown primary site,0
3100,Dactinomycin,239,Neoplasms of unspecified nature,1
3100,Dactinomycin,239-239.99,,1
3100,Dactinomycin,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
3100,Dactinomycin,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
3100,Dactinomycin,630,Hydatidiform mole,1
3102,Danazol,277.6,Other deficiencies of circulating enzymes,1
3102,Danazol,338-338.99,,1
3102,Danazol,610.1,Diffuse cystic mastopathy,1
3102,Danazol,617,Endometriosis,1
3102,Danazol,617.9,Endometriosis; site unspecified,1
3102,Danazol,780.96,Generalized pain,1
3102,Danazol,782.3,Edema,0
3102,Danazol,995.1,Angioneurotic edema not elsewhere classified,1
3105,Dantrolene,333.92,Neuroleptic malignant syndrome,0
3105,Dantrolene,340,Multiple sclerosis,1
3105,Dantrolene,343.9,Infantile cerebral palsy NOS,1
3105,Dantrolene,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
3105,Dantrolene,728.85,Spasm of muscle,1
3105,Dantrolene,781.0,Abnormal involuntary movements,1
3105,Dantrolene,781.99,Other symptoms involving nervous and musculoskeletal systems,1
3105,Dantrolene,952.9,Spinal cord injury NOS,0
3105,Dantrolene,995.86,Malignant hyperthermia,1
3106,Dantrolene Sodium,333.92,Neuroleptic malignant syndrome,0
3106,Dantrolene Sodium,340,Multiple sclerosis,1
3106,Dantrolene Sodium,343.9,Infantile cerebral palsy NOS,1
3106,Dantrolene Sodium,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
3106,Dantrolene Sodium,728.85,Spasm of muscle,1
3106,Dantrolene Sodium,781.0,Abnormal involuntary movements,1
3106,Dantrolene Sodium,952.9,Spinal cord injury NOS,0
3106,Dantrolene Sodium,995.86,Malignant hyperthermia,1
3108,Dapsone,030,Leprosy,1
3108,Dapsone,030.0,Lepromatous leprosy,0
3108,Dapsone,030.9,Leprosy NOS,1
3108,Dapsone,084,Malaria,0
3108,Dapsone,084.2,Quartan malaria,0
3108,Dapsone,084.6,Malaria NOS,0
3108,Dapsone,130,Toxoplasmosis,0
3108,Dapsone,130.9,Toxoplasmosis NOS,0
3108,Dapsone,694.0,Dermatitis herpetiformis,1
3108,Dapsone,706.1,Other acne,1
3108,Dapsone,733.99,Other disorders of bone and cartilage,0
3109,Daunorubicin,204.0,Lymphoid leukemia; acute,1
3109,Daunorubicin,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
3109,Daunorubicin,205.0,Myeloid leukemia; acute,1
3109,Daunorubicin,205.00,Acute myeloid leukemia without mention of having achieved remission,1
3109,Daunorubicin,208,Leukemia of unspecified cell type,1
3109,Daunorubicin,208.9,Unspecified leukemia,1
3109,Daunorubicin,208.90,Unspecified leukemia without mention of having achieved remission,1
3131,Deferoxamine,275.01,Hereditary hemochromatosis,1
3131,Deferoxamine,275.03,Other hemochromatosis,1
3131,Deferoxamine,275.09,Other disorders of iron metabolism,1
3131,Deferoxamine,282.4,Thalassemias,1
3131,Deferoxamine,282.40,Thalassemia; unspecified,1
3131,Deferoxamine,371.9,Unspecified corneal disorder,0
3131,Deferoxamine,585.6,End stage renal disease,0
3131,Deferoxamine,585.9,Chronic kidney disease; unspecified,0
3131,Deferoxamine,586,Renal failure unspecified,0
3131,Deferoxamine,733.90,Disorder of bone and cartilage; unspecified,0
3132,deferoxamine mesylate,275.01,Hereditary hemochromatosis,1
3132,deferoxamine mesylate,275.03,Other hemochromatosis,1
3132,deferoxamine mesylate,275.09,Other disorders of iron metabolism,1
3132,deferoxamine mesylate,282.4,Thalassemias,1
3132,deferoxamine mesylate,282.40,Thalassemia; unspecified,1
3132,deferoxamine mesylate,371.9,Unspecified corneal disorder,0
3132,deferoxamine mesylate,585.6,End stage renal disease,0
3132,deferoxamine mesylate,585.9,Chronic kidney disease; unspecified,0
3132,deferoxamine mesylate,586,Renal failure unspecified,1
3132,deferoxamine mesylate,733.90,Disorder of bone and cartilage; unspecified,0
3143,dehydroepiandrosterone,017.00,Tuberculosis of skin and subcutaneous cellular tissue; unspecified examination,0
3143,dehydroepiandrosterone,255.41,Glucocorticoid deficiency,0
3154,Demeclocycline,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
3154,Demeclocycline,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
3154,Demeclocycline,088.81,Lyme disease,1
3154,Demeclocycline,098,Gonococcal infections,1
3154,Demeclocycline,098.89,Gonococcal infection of other specified sites,1
3154,Demeclocycline,136.9,Unspecified infectious and parasitic diseases,1
3154,Demeclocycline,253.6,Other disorders of neurohypophysis,0
3154,Demeclocycline,486,Pneumonia; organism unspecified,1
3154,Demeclocycline,519.8,Other diseases of respiratory system; not elsewhere classified,1
3154,Demeclocycline,599.0,Urinary tract infection; site not specified,1
3154,Demeclocycline,706.1,Other acne,1
3247,Desipramine,311,Depressive disorder NEC,0
3247,Desipramine,314,Hyperkinetic syndrome of childhood,0
3247,Desipramine,314.01,Attention deficit disorder of childhood with hyperactivity,0
3247,Desipramine,314.9,Unspecified hyperkinetic syndrome of childhood,0
3247,Desipramine,338-338.99,,0
3247,Desipramine,780.96,Generalized pain,0
3248,Deslanoside,427.31,Atrial fibrillation,0
3248,Deslanoside,427.32,Atrial flutter,0
3248,Deslanoside,427.89,Other specified cardiac dysrhythmias,0
3248,Deslanoside,428.0,Congestive heart failure (CHF) NOS,0
3248,Deslanoside,785.9,Other symptoms involving cardiovascular system,0
3251,desmopressin,250,Diabetes mellitus,1
3251,desmopressin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
3251,desmopressin,253.5,Diabetes insipidus,1
3251,desmopressin,286.0,Congenital factor VIII disorder,1
3251,desmopressin,286.4,Von willebrand's disease,1
3251,desmopressin,286.7,Acquired coagulation factor deficiency,1
3251,desmopressin,287.5,Thrombocytopenia NOS,0
3251,desmopressin,307.6,Enuresis,1
3251,desmopressin,459.0,Hemorrhage NOS,1
3251,desmopressin,588.1,Nephrogenic diabetes insipidus,1
3251,desmopressin,783.5,Polydipsia,1
3251,desmopressin,788.36,Nocturnal enuresis,1
3251,desmopressin,788.43,Nocturia,1
3251,desmopressin,790.99,Other nonspecific findings on examination of blood,0
3254,Desonide,691.8,Other atopic dermatitis,1
3254,Desonide,692.9,Contact dermatitis and other eczema; unspecified cause,1
3254,Desonide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
3255,Desoximetasone,698.9,Unspecified pruritic disorder,0
3255,Desoximetasone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
3264,Dexamethasone,136.9,Unspecified infectious and parasitic diseases,1
3264,Dexamethasone,140-239.99,,1
3264,Dexamethasone,239,Neoplasms of unspecified nature,1
3264,Dexamethasone,239-239.99,,1
3264,Dexamethasone,239.6,Neoplasm of unspecified nature of brain,1
3264,Dexamethasone,255.0,Cushing's syndrome,1
3264,Dexamethasone,255.2,Adrenogenital disorders,1
3264,Dexamethasone,255.41,Glucocorticoid deficiency,1
3264,Dexamethasone,280-289.99,,1
3264,Dexamethasone,287.31,Immune thrombocytopenic purpura,1
3264,Dexamethasone,289.9,Blood disease NOS,1
3264,Dexamethasone,311,Depressive disorder NEC,0
3264,Dexamethasone,348.5,Cerebral edema,1
3264,Dexamethasone,379.99,Other ill-defined disorders of eye,1
3264,Dexamethasone,380.10,Infective otitis externa; unspecified,1
3264,Dexamethasone,382.9,Unspecified otitis media,1
3264,Dexamethasone,471,Nasal polyps,0
3264,Dexamethasone,471.0,Polyp of nasal cavity,0
3264,Dexamethasone,471.9,Nasal polyp NOS,0
3264,Dexamethasone,477.9,Allergic rhinitis NOS,1
3264,Dexamethasone,493,Asthma,1
3264,Dexamethasone,493.9,Asthma; unspecified,1
3264,Dexamethasone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
3264,Dexamethasone,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
3264,Dexamethasone,569.9,Unspecified disorder of intestine,1
3264,Dexamethasone,714.0,Rheumatoid arthritis,1
3264,Dexamethasone,716.90,Arthropathy; unspecified; site unspecified,1
3264,Dexamethasone,782.3,Edema,1
3264,Dexamethasone,784.2,Swelling; mass; or lump in head and neck,0
3264,Dexamethasone,785.52,Septic shock,0
3264,Dexamethasone,787.02,Nausea alone,1
3264,Dexamethasone,787.03,Vomiting alone,1
3264,Dexamethasone,995.3,Allergy unspecified not elsewhere classified,1
3266,Phenylpropanolamine Hydrochloride,278.00,Obesity NOS,0
3266,Phenylpropanolamine Hydrochloride,460,Acute nasopharyngitis (common cold),0
3266,Phenylpropanolamine Hydrochloride,477.9,Allergic rhinitis NOS,0
3266,Phenylpropanolamine Hydrochloride,786.2,Cough,0
3268,Dexfenfluramine,278.00,Obesity NOS,0
3272,Dextran 40,415.19,Other pulmonary embolism and infarction,0
3272,Dextran 40,453.9,Embolism and thrombosis of unspecified site,0
3272,Dextran 40,785.50,Shock NOS,0
3274,Dextran 70,415.19,Other pulmonary embolism and infarction,0
3274,Dextran 70,453.9,Embolism and thrombosis of unspecified site,0
3274,Dextran 70,785.50,Shock NOS,0
3287,Dextroamphetamine Sulfate,296.99,Other specified episodic mood disorder,1
3287,Dextroamphetamine Sulfate,300.9,Unspecified nonpsychotic mental disorder,1
3287,Dextroamphetamine Sulfate,314,Hyperkinetic syndrome of childhood,1
3287,Dextroamphetamine Sulfate,314.01,Attention deficit disorder of childhood with hyperactivity,1
3287,Dextroamphetamine Sulfate,314.9,Unspecified hyperkinetic syndrome of childhood,1
3287,Dextroamphetamine Sulfate,347.0,Narcolepsy,1
3287,Dextroamphetamine Sulfate,347.00,Narcolepsy; without cataplexy,1
3288,Dextroamphetamine,296.99,Other specified episodic mood disorder,1
3288,Dextroamphetamine,300.9,Unspecified nonpsychotic mental disorder,1
3288,Dextroamphetamine,314,Hyperkinetic syndrome of childhood,1
3288,Dextroamphetamine,314.01,Attention deficit disorder of childhood with hyperactivity,1
3288,Dextroamphetamine,314.9,Unspecified hyperkinetic syndrome of childhood,1
3288,Dextroamphetamine,347.0,Narcolepsy,1
3288,Dextroamphetamine,347.00,Narcolepsy; without cataplexy,1
3289,Dextromethorphan,335.20,Amyotrophic lateral sclerosis,0
3289,Dextromethorphan,338-338.99,,0
3289,Dextromethorphan,340,Multiple sclerosis,0
3289,Dextromethorphan,460,Acute nasopharyngitis (common cold),1
3289,Dextromethorphan,487,Influenza,0
3289,Dextromethorphan,487.1,Influenza with other respiratory manifestations,0
3289,Dextromethorphan,698.9,Unspecified pruritic disorder,0
3289,Dextromethorphan,729.1,Myalgia and myositis unspecified,0
3289,Dextromethorphan,780.09,Other alteration of consciousness,0
3289,Dextromethorphan,780.52,Insomnia; unspecified,0
3289,Dextromethorphan,780.96,Generalized pain,0
3289,Dextromethorphan,781.0,Abnormal involuntary movements,0
3289,Dextromethorphan,786.2,Cough,1
3289,Dextromethorphan,994.6,Motion sickness,0
3289,Dextromethorphan,995.0,Other anaphylactic reaction,0
3289,Dextromethorphan,995.3,Allergy unspecified not elsewhere classified,0
3292,Dextrothyroxine,272.4,Other and unspecified hyperlipidemia,0
3292,Dextrothyroxine,447.9,Unspecified disorders of arteries and arterioles,0
3322,Diazepam,037,Tetanus,1
3322,Diazepam,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,1
3322,Diazepam,291.0,Alcohol withdrawal delirium,1
3322,Diazepam,291.81,Alcohol withdrawal,1
3322,Diazepam,300.00,Anxiety state unspecified,1
3322,Diazepam,300.01,Panic disorder without agoraphobia,0
3322,Diazepam,300.9,Unspecified nonpsychotic mental disorder,1
3322,Diazepam,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
3322,Diazepam,308.2,Predominant psychomotor disturbance,1
3322,Diazepam,333.91,Stiff-man syndrome,1
3322,Diazepam,344.1,Paraplegia,1
3322,Diazepam,345.3,Grand mal status; epileptic,1
3322,Diazepam,345.9,Epilepsy; unspecified,1
3322,Diazepam,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
3322,Diazepam,728.85,Spasm of muscle,1
3322,Diazepam,780.39,Other convulsions,1
3322,Diazepam,781.0,Abnormal involuntary movements,1
3322,Diazepam,799.21,Nervousness (ADDED),1
3327,Diazoxide,251.1,Other specified hypoglycemia,1
3327,Diazoxide,251.2,Hypoglycemia NOS,1
3327,Diazoxide,401.0,Malignant essential hypertension,1
3339,Dibucaine,338-338.99,,0
3339,Dibucaine,698.9,Unspecified pruritic disorder,0
3339,Dibucaine,780.96,Generalized pain,0
3353,Dichlorphenamide,365,Glaucoma,0
3353,Dichlorphenamide,365.9,Glaucoma NOS,0
3355,Diclofenac,338-338.99,,1
3355,Diclofenac,368.13,Visual discomfort,1
3355,Diclofenac,379.99,Other ill-defined disorders of eye,1
3355,Diclofenac,625.3,Dysmenorrhea,1
3355,Diclofenac,701.1,Keratoderma; acquired,1
3355,Diclofenac,702.0,Actinic keratosis,1
3355,Diclofenac,714.0,Rheumatoid arthritis,1
3355,Diclofenac,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,0
3355,Diclofenac,715.00,Osteoarthrosis; generalized; involving unspecified site,1
3355,Diclofenac,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
3355,Diclofenac,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
3355,Diclofenac,716.90,Arthropathy; unspecified; site unspecified,1
3355,Diclofenac,720.0,Ankylosing spondylitis,1
3355,Diclofenac,780.60,Fever; unspecified,0
3355,Diclofenac,780.96,Generalized pain,1
3355,Diclofenac,780.99,Other general symptoms,1
3356,Dicloxacillin,136.9,Unspecified infectious and parasitic diseases,1
3356,Dicloxacillin,482.9,Bacterial pneumonia NOS,0
3356,Dicloxacillin,486,Pneumonia; organism unspecified,0
3356,Dicloxacillin,599.0,Urinary tract infection; site not specified,0
3356,Dicloxacillin,682.9,Cellulitis and abscess NOS,0
3356,Dicloxacillin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
3356,Dicloxacillin,730.2,Unspecified osteomyelitis,0
3356,Dicloxacillin,730.20,Unspecified osteomyelitis; site unspecified,0
3356,Dicloxacillin,958.3,Posttraumatic wound infection not elsewhere classified,0
3356,Dicloxacillin,998.9,Unspecified complication of procedure; not elsewhere classified,0
3361,Dicyclomine,564.1,Irritable bowel syndrome,1
3361,Dicyclomine,569.9,Unspecified disorder of intestine,0
3361,Dicyclomine,728.85,Spasm of muscle,0
3361,Dicyclomine,780-789.99,,0
3361,Dicyclomine,781.0,Abnormal involuntary movements,0
3363,Zalcitabine,042,Human immunodeficiency virus [HIV] disease,1
3363,Zalcitabine,042-042.99,,1
3364,Didanosine,042,Human immunodeficiency virus [HIV] disease,1
3364,Didanosine,042-042.99,,1
3364,Didanosine,136.9,Unspecified infectious and parasitic diseases,1
3389,Diethylpropion,278.00,Obesity NOS,1
3389,Diethylpropion,783.9,Other symptoms concerning nutrition; metabolism; and development,1
3390,Diethylstilbestrol,239.3,Neoplasm of unspecified nature of breast,0
3390,Diethylstilbestrol,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
3393,Diflunisal,338-338.99,,1
3393,Diflunisal,714.0,Rheumatoid arthritis,1
3393,Diflunisal,715.00,Osteoarthrosis; generalized; involving unspecified site,1
3393,Diflunisal,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
3393,Diflunisal,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
3393,Diflunisal,716.90,Arthropathy; unspecified; site unspecified,1
3393,Diflunisal,780.96,Generalized pain,1
3403,Digitoxin,427.31,Atrial fibrillation,0
3403,Digitoxin,427.32,Atrial flutter,0
3403,Digitoxin,427.89,Other specified cardiac dysrhythmias,0
3403,Digitoxin,428.0,Congestive heart failure (CHF) NOS,0
3403,Digitoxin,785.51,Cardiogenic shock,0
3403,Digitoxin,785.9,Other symptoms involving cardiovascular system,0
3407,Digoxin,427,Cardiac dysrhythmias,0
3407,Digoxin,427.31,Atrial fibrillation,1
3407,Digoxin,427.32,Atrial flutter,1
3407,Digoxin,427.89,Other specified cardiac dysrhythmias,0
3407,Digoxin,427.9,Cardiac dysrhythmia NOS,1
3407,Digoxin,428,Heart failure,1
3407,Digoxin,428.0,Congestive heart failure (CHF) NOS,1
3407,Digoxin,428.9,Heart failure unspecified,1
3407,Digoxin,593.9,Unspecified disorder of kidney and ureter,1
3407,Digoxin,785.0,Tachycardia NOS,1
3407,Digoxin,785.51,Cardiogenic shock,0
3407,Digoxin,785.9,Other symptoms involving cardiovascular system,0
3418,Dihydroergotamine,339.00,Cluster headache syndrome; unspecified,1
3418,Dihydroergotamine,339.02,Chronic cluster headache,1
3418,Dihydroergotamine,346,Migraine,1
3418,Dihydroergotamine,346.9,Migraine; unspecified,1
3418,Dihydroergotamine,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
3418,Dihydroergotamine,413.1,Prinzmetal angina,0
3418,Dihydroergotamine,458.0,Orthostatic hypotension,0
3418,Dihydroergotamine,527.7,Disturbance of salivary secretion,0
3418,Dihydroergotamine,666,Postpartum hemorrhage,0
3418,Dihydroergotamine,666.14,Other immediate postpartum hemorrhage; postpartum,0
3423,Hydromorphone,338-338.99,,1
3423,Hydromorphone,338.18,Other acute postoperative pain,1
3423,Hydromorphone,780.96,Generalized pain,1
3423,Hydromorphone,786.2,Cough,0
3423,Hydromorphone,799.89,Other ill-defined conditions,1
3429,Dihydrotachysterol,252.0,Hyperparathyroidism,0
3429,Dihydrotachysterol,252.00,Hyperparathyroidism NOS,0
3429,Dihydrotachysterol,275.41,Hypocalcemia,0
3429,Dihydrotachysterol,585.6,End stage renal disease,0
3429,Dihydrotachysterol,585.9,Chronic kidney disease; unspecified,0
3429,Dihydrotachysterol,586,Renal failure unspecified,0
3429,Dihydrotachysterol,781.7,Tetany,0
3430,Dihydroxyacetone,692.70,Unspecified dermatitis due to sun,0
3430,Dihydroxyacetone,709.00,Dyschromia; unspecified,0
3435,Iodoquinol,006.9,Amebiasis NOS,0
3435,Iodoquinol,007.8,Other specified protozoal intestinal diseases,0
3435,Iodoquinol,270.0,Disturbances of amino-acid transport,0
3443,Diltiazem,401-405.99,,1
3443,Diltiazem,401.9,Hypertension NOS,1
3443,Diltiazem,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
3443,Diltiazem,413,Angina pectoris,1
3443,Diltiazem,413.1,Prinzmetal angina,0
3443,Diltiazem,413.9,Other and unspecified angina pectoris,1
3443,Diltiazem,427,Cardiac dysrhythmias,1
3443,Diltiazem,427.0,Paroxysmal supraventricular tachycardia,1
3443,Diltiazem,427.31,Atrial fibrillation,1
3443,Diltiazem,427.32,Atrial flutter,1
3443,Diltiazem,427.89,Other specified cardiac dysrhythmias,1
3443,Diltiazem,427.9,Cardiac dysrhythmia NOS,1
3443,Diltiazem,443.9,Peripheral vascular disease; unspecified,1
3443,Diltiazem,458,Hypotension,1
3443,Diltiazem,458.9,Hypotension NOS,1
3443,Diltiazem,786.50,Unspecified chest pain,1
3443,Diltiazem,997.91,Hypertension,1
3444,Dimenhydrinate,780.4,Dizziness and giddiness,1
3444,Dimenhydrinate,787.02,Nausea alone,1
3444,Dimenhydrinate,787.03,Vomiting alone,1
3444,Dimenhydrinate,994.6,Motion sickness,1
3445,Dimercaprol,984,Toxic effect of lead and its compounds (including fumes),0
3445,Dimercaprol,984.9,Toxic effect of unspecified lead compound,0
3445,Dimercaprol,985.1,Toxic effect of arsenic and its compounds,0
3455,Dimethyl Sulfoxide,595.9,Cystitis NOS,1
3478,Dinoprostone,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
3478,Dinoprostone,250,Diabetes mellitus,1
3478,Dinoprostone,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
3478,Dinoprostone,634,Spontaneous abortion,0
3478,Dinoprostone,634.90,Spontaneous abortion; unspecified; without mention of complication,0
3498,Diphenhydramine,300.00,Anxiety state unspecified,0
3498,Diphenhydramine,307.42,Persistent disorder of initiating or maintaining sleep,0
3498,Diphenhydramine,332.0,Paralysis agitans,1
3498,Diphenhydramine,375.2,Epiphora,1
3498,Diphenhydramine,375.20,Epiphora NOS,1
3498,Diphenhydramine,379.99,Other ill-defined disorders of eye,1
3498,Diphenhydramine,460,Acute nasopharyngitis (common cold),1
3498,Diphenhydramine,477.0,Allergic rhinitis due to pollen,1
3498,Diphenhydramine,477.9,Allergic rhinitis NOS,1
3498,Diphenhydramine,478.19,Other diseases of nasal cavity and sinuses,0
3498,Diphenhydramine,698.9,Unspecified pruritic disorder,1
3498,Diphenhydramine,708,Urticaria,1
3498,Diphenhydramine,708.9,Unspecified urticaria,1
3498,Diphenhydramine,780-789.99,,0
3498,Diphenhydramine,780.52,Insomnia; unspecified,0
3498,Diphenhydramine,780.60,Fever; unspecified,1
3498,Diphenhydramine,780.99,Other general symptoms,0
3498,Diphenhydramine,781.0,Abnormal involuntary movements,0
3498,Diphenhydramine,781.99,Other symptoms involving nervous and musculoskeletal systems,0
3498,Diphenhydramine,782.1,Rash and other nonspecific skin eruption,0
3498,Diphenhydramine,784.0,Headache,0
3498,Diphenhydramine,786.2,Cough,0
3498,Diphenhydramine,787.02,Nausea alone,0
3498,Diphenhydramine,799.89,Other ill-defined conditions,1
3498,Diphenhydramine,989.5,Toxic effect of venom,0
3498,Diphenhydramine,994.6,Motion sickness,1
3498,Diphenhydramine,995.0,Other anaphylactic reaction,1
3498,Diphenhydramine,995.3,Allergy unspecified not elsewhere classified,1
3500,Diphenoxylate,787.7,Abnormal feces,0
3500,Diphenoxylate,787.91,Diarrhea,0
3521,Dipyridamole,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
3521,Dipyridamole,443.9,Peripheral vascular disease; unspecified,1
3521,Dipyridamole,459.9,Unspecified circulatory system disorder,1
3521,Dipyridamole,996.74,Other complications due to other vascular device; implant; and graft,0
3538,Cromolyn Sodium,372.30,Conjunctivitis NOS,0
3538,Cromolyn Sodium,477.9,Allergic rhinitis NOS,0
3538,Cromolyn Sodium,493,Asthma,1
3538,Cromolyn Sodium,493.81,Exercise induced bronchospasm,1
3538,Cromolyn Sodium,493.9,Asthma; unspecified,1
3538,Cromolyn Sodium,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
3538,Cromolyn Sodium,519.11,Acute bronchospasm,1
3538,Cromolyn Sodium,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
3538,Cromolyn Sodium,708.9,Unspecified urticaria,1
3538,Cromolyn Sodium,757.33,Congenital pigmentary anomalies of skin,1
3538,Cromolyn Sodium,995.3,Allergy unspecified not elsewhere classified,0
3539,Edetic Acid  Disodium Salt,275.42,Hypercalcemia,0
3539,Edetic Acid  Disodium Salt,427.41,Ventricular fibrillation,0
3539,Edetic Acid  Disodium Salt,984,Toxic effect of lead and its compounds (including fumes),0
3539,Edetic Acid  Disodium Salt,984.9,Toxic effect of unspecified lead compound,0
3539,Edetic Acid  Disodium Salt,985.2,Toxic effect of manganese and its compounds,0
3541,Disopyramide,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
3541,Disopyramide,427,Cardiac dysrhythmias,1
3541,Disopyramide,427.1,Paroxysmal ventricular tachycardia,1
3541,Disopyramide,427.31,Atrial fibrillation,0
3541,Disopyramide,427.32,Atrial flutter,0
3541,Disopyramide,427.61,Supraventricular premature beats,0
3541,Disopyramide,427.69,Other premature beats,1
3541,Disopyramide,427.89,Other specified cardiac dysrhythmias,0
3541,Disopyramide,427.9,Cardiac dysrhythmia NOS,1
3541,Disopyramide,785.0,Tachycardia NOS,1
3554,Disulfiram,298.9,Unspecified psychosis,0
3554,Disulfiram,300.00,Anxiety state unspecified,0
3554,Disulfiram,303,Alcohol dependence syndrome,0
3554,Disulfiram,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
3554,Disulfiram,305.01,Alcohol abuse; continuous drinking behavior,0
3554,Disulfiram,784.0,Headache,0
3554,Disulfiram,786.05,Shortness of breath,0
3554,Disulfiram,786.09,Other dyspnea and respiratory abnormality,0
3554,Disulfiram,787.02,Nausea alone,0
3554,Disulfiram,787.03,Vomiting alone,0
3616,Dobutamine,428,Heart failure,1
3616,Dobutamine,428.0,Congestive heart failure (CHF) NOS,1
3616,Dobutamine,428.9,Heart failure unspecified,1
3616,Dobutamine,785.9,Other symptoms involving cardiovascular system,0
3626,Domperidone,535.50,Unspecified gastritis and gastroduodenitis; without mention of hemorrhage,1
3626,Domperidone,536.3,Gastroparesis,1
3626,Domperidone,569.9,Unspecified disorder of intestine,1
3626,Domperidone,787.02,Nausea alone,1
3626,Domperidone,787.03,Vomiting alone,1
3628,Dopamine,298.9,Unspecified psychosis,1
3628,Dopamine,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
3628,Dopamine,426.9,Conduction disorder NOS,0
3628,Dopamine,427.89,Other specified cardiac dysrhythmias,0
3628,Dopamine,458,Hypotension,1
3628,Dopamine,458.9,Hypotension NOS,1
3628,Dopamine,593.9,Unspecified disorder of kidney and ureter,0
3628,Dopamine,785.50,Shock NOS,1
3628,Dopamine,785.9,Other symptoms involving cardiovascular system,1
3637,Doxapram,786.00,Respiratory abnormality; unspecified,1
3637,Doxapram,786.09,Other dyspnea and respiratory abnormality,1
3638,Doxepin,300.00,Anxiety state unspecified,1
3638,Doxepin,311,Depressive disorder NEC,1
3638,Doxepin,338-338.99,,0
3638,Doxepin,691.8,Other atopic dermatitis,1
3638,Doxepin,692.9,Contact dermatitis and other eczema; unspecified cause,1
3638,Doxepin,698.9,Unspecified pruritic disorder,1
3638,Doxepin,780.52,Insomnia; unspecified,1
3638,Doxepin,780.96,Generalized pain,0
3639,Doxorubicin,042,Human immunodeficiency virus [HIV] disease,0
3639,Doxorubicin,140-239.99,,1
3639,Doxorubicin,157.9,Malignant neoplasm of pancreas; part unspecified,1
3639,Doxorubicin,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
3639,Doxorubicin,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
3639,Doxorubicin,176,Kaposi's sarcoma,0
3639,Doxorubicin,176.9,Kaposi's sarcoma NOS,0
3639,Doxorubicin,185,Malignant neoplasm of prostate,1
3639,Doxorubicin,188.9,Malignant neoplasm of bladder; part unspecified,1
3639,Doxorubicin,199,Malignant neoplasm without specification of site,1
3639,Doxorubicin,199.1,Other malignant neoplasm of unspecified site,1
3639,Doxorubicin,201,Hodgkin's disease,0
3639,Doxorubicin,201.0,Hodgkin's paragranuloma,0
3639,Doxorubicin,201.1,Hodgkin's granuloma,0
3639,Doxorubicin,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
3639,Doxorubicin,201.2,Hodgkin's sarcoma,0
3639,Doxorubicin,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
3639,Doxorubicin,201.9,Hodgkin's disease; unspecified type,0
3639,Doxorubicin,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
3639,Doxorubicin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
3639,Doxorubicin,203.0,Multiple myeloma,1
3639,Doxorubicin,203.00,Multiple myeloma without mention of having achieved remission,1
3639,Doxorubicin,204.0,Lymphoid leukemia; acute,1
3639,Doxorubicin,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
3639,Doxorubicin,205.0,Myeloid leukemia; acute,1
3639,Doxorubicin,205.00,Acute myeloid leukemia without mention of having achieved remission,1
3639,Doxorubicin,208,Leukemia of unspecified cell type,1
3639,Doxorubicin,208.9,Unspecified leukemia,1
3639,Doxorubicin,208.90,Unspecified leukemia without mention of having achieved remission,1
3639,Doxorubicin,209.20,Malignant carcinoid tumor of unknown primary site,1
3639,Doxorubicin,239,Neoplasms of unspecified nature,1
3639,Doxorubicin,239-239.99,,1
3639,Doxorubicin,239.0,Neoplasm of unspecified nature of digestive system,0
3639,Doxorubicin,239.1,Neoplasm of unspecified nature of respiratory system,0
3639,Doxorubicin,239.3,Neoplasm of unspecified nature of breast,0
3639,Doxorubicin,239.4,Neoplasm of unspecified nature of bladder,0
3639,Doxorubicin,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
3639,Doxorubicin,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
3640,Doxycycline,022,Anthrax,1
3640,Doxycycline,022.9,Anthrax NOS,1
3640,Doxycycline,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
3640,Doxycycline,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
3640,Doxycycline,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
3640,Doxycycline,082.0,Spotted fevers,1
3640,Doxycycline,083.9,Rickettsiosis NOS,0
3640,Doxycycline,084,Malaria,0
3640,Doxycycline,084.2,Quartan malaria,0
3640,Doxycycline,084.6,Malaria NOS,0
3640,Doxycycline,088.81,Lyme disease,1
3640,Doxycycline,097.9,Syphilis NOS,1
3640,Doxycycline,136.9,Unspecified infectious and parasitic diseases,1
3640,Doxycycline,461.9,Acute sinusitis NOS,1
3640,Doxycycline,465.9,Acute upper respiratory infections of unspecified site,1
3640,Doxycycline,482.9,Bacterial pneumonia NOS,0
3640,Doxycycline,486,Pneumonia; organism unspecified,1
3640,Doxycycline,511.9,Pleural effusion NOS,0
3640,Doxycycline,519.8,Other diseases of respiratory system; not elsewhere classified,1
3640,Doxycycline,599.0,Urinary tract infection; site not specified,1
3640,Doxycycline,686.9,Unspecified local infection of skin and subcutaneous tissue,1
3640,Doxycycline,695.3,Rosacea,1
3640,Doxycycline,706.1,Other acne,1
3640,Doxycycline,709.9,Unspecified disorder of skin and subcutaneous tissue,1
3640,Doxycycline,780.60,Fever; unspecified,1
3640,Doxycycline,780.99,Other general symptoms,1
3640,Doxycycline,799.89,Other ill-defined conditions,1
3642,Doxylamine,307.42,Persistent disorder of initiating or maintaining sleep,0
3642,Doxylamine,477.9,Allergic rhinitis NOS,0
3642,Doxylamine,784.0,Headache,0
3642,Doxylamine,V22.2,Pregnant state; incidental,0
3648,Droperidol,290-299.99,,0
3648,Droperidol,298.9,Unspecified psychosis,0
3648,Droperidol,338-338.99,,0
3648,Droperidol,780.96,Generalized pain,0
3648,Droperidol,787.02,Nausea alone,1
3648,Droperidol,787.03,Vomiting alone,1
3714,Dyphylline,490,Bronchitis NOS,1
3714,Dyphylline,493,Asthma,1
3714,Dyphylline,493.9,Asthma; unspecified,1
3714,Dyphylline,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
3740,Echothiophate Iodide,365.02,Anatomical narrow angle borderline glaucoma,0
3740,Echothiophate Iodide,365.1,Open-angle glaucoma,0
3740,Echothiophate Iodide,365.10,Open-angle glaucoma NOS,0
3740,Echothiophate Iodide,365.13,Pigmentary glaucoma,0
3740,Echothiophate Iodide,365.20|365.70,,0
3740,Echothiophate Iodide,378.0,Esotropia,1
3740,Echothiophate Iodide,378.00,Esotropia NOS,1
3740,Echothiophate Iodide,378.35,Accommodative component in esotropia,1
3743,Econazole,110.3,Dermatophytosis of groin and perianal area,1
3743,Econazole,110.4,Dermatophytosis of foot,1
3743,Econazole,111.0,Pityriasis versicolor,1
3743,Econazole,112.3,Candidiasis of skin and nails,1
3743,Econazole,686.9,Unspecified local infection of skin and subcutaneous tissue,0
3752,Edrophonium,358.0,Myasthenia gravis,0
3752,Edrophonium,358.00,Myasthenia gravis without (acute) exacerbation,0
3752,Edrophonium,977.9,Poisoning by unspecified drug or medicinal substance,0
3754,Edrophonium Chloride,358.0,Myasthenia gravis,0
3754,Edrophonium Chloride,358.00,Myasthenia gravis without (acute) exacerbation,0
3754,Edrophonium Chloride,977.9,Poisoning by unspecified drug or medicinal substance,0
3755,Edetic Acid,275.42,Hypercalcemia,1
3755,Edetic Acid,427.1,Paroxysmal ventricular tachycardia,0
3755,Edetic Acid,427.41,Ventricular fibrillation,0
3755,Edetic Acid,977.9,Poisoning by unspecified drug or medicinal substance,0
3755,Edetic Acid,984,Toxic effect of lead and its compounds (including fumes),0
3755,Edetic Acid,984.9,Toxic effect of unspecified lead compound,0
3755,Edetic Acid,985.2,Toxic effect of manganese and its compounds,0
3820,Emetine,006,Amebiasis,0
3820,Emetine,006.9,Amebiasis NOS,0
3820,Emetine,121.3,Fascioliasis,0
3820,Emetine,136.8,Other specified infectious and parasitic diseases,0
3827,Enalapril,250.4,Diabetes with renal manifestations,0
3827,Enalapril,255.13,Bartter's syndrome,0
3827,Enalapril,401-405.99,,1
3827,Enalapril,401.0,Malignant essential hypertension,0
3827,Enalapril,401.9,Hypertension NOS,1
3827,Enalapril,428,Heart failure,1
3827,Enalapril,428.0,Congestive heart failure (CHF) NOS,1
3827,Enalapril,428.9,Heart failure unspecified,1
3827,Enalapril,429.3,Cardiomegaly,0
3827,Enalapril,593.9,Unspecified disorder of kidney and ureter,1
3827,Enalapril,714.0,Rheumatoid arthritis,0
3827,Enalapril,782.3,Edema,0
3827,Enalapril,997.91,Hypertension,1
3829,Enalaprilat,250.4,Diabetes with renal manifestations,0
3829,Enalaprilat,255.13,Bartter's syndrome,0
3829,Enalaprilat,401-405.99,,1
3829,Enalaprilat,401.0,Malignant essential hypertension,1
3829,Enalaprilat,401.9,Hypertension NOS,1
3829,Enalaprilat,428,Heart failure,1
3829,Enalaprilat,428.0,Congestive heart failure (CHF) NOS,0
3829,Enalaprilat,428.9,Heart failure unspecified,1
3829,Enalaprilat,429.3,Cardiomegaly,0
3829,Enalaprilat,593.9,Unspecified disorder of kidney and ureter,1
3829,Enalaprilat,714.0,Rheumatoid arthritis,0
3829,Enalaprilat,782.3,Edema,0
3829,Enalaprilat,997.91,Hypertension,1
3920,Enflurane,427.69,Other premature beats,0
3920,Enflurane,493.91,Asthma; unspecified type; with status asthmaticus,0
3925,Enoxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
3925,Enoxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
3925,Enoxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
3925,Enoxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
3925,Enoxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
3925,Enoxacin,098,Gonococcal infections,0
3925,Enoxacin,098.89,Gonococcal infection of other specified sites,0
3925,Enoxacin,599.0,Urinary tract infection; site not specified,0
3966,Ephedrine,458,Hypotension,1
3966,Ephedrine,458.0,Orthostatic hypotension,0
3966,Ephedrine,458.9,Hypotension NOS,1
3966,Ephedrine,472.0,Chronic rhinitis,0
3966,Ephedrine,493,Asthma,1
3966,Ephedrine,493.9,Asthma; unspecified,1
3966,Ephedrine,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
3966,Ephedrine,519.11,Acute bronchospasm,1
3966,Ephedrine,995.3,Allergy unspecified not elsewhere classified,1
3992,Epinephrine,365.1,Open-angle glaucoma,0
3992,Epinephrine,365.10,Open-angle glaucoma NOS,0
3992,Epinephrine,365.13,Pigmentary glaucoma,0
3992,Epinephrine,426.9,Conduction disorder NOS,1
3992,Epinephrine,427.1,Paroxysmal ventricular tachycardia,0
3992,Epinephrine,427.41,Ventricular fibrillation,1
3992,Epinephrine,427.5,Cardiac arrest,1
3992,Epinephrine,427.89,Other specified cardiac dysrhythmias,0
3992,Epinephrine,458,Hypotension,1
3992,Epinephrine,458.9,Hypotension NOS,1
3992,Epinephrine,477.0,Allergic rhinitis due to pollen,1
3992,Epinephrine,477.9,Allergic rhinitis NOS,1
3992,Epinephrine,493,Asthma,1
3992,Epinephrine,493.9,Asthma; unspecified,1
3992,Epinephrine,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
3992,Epinephrine,519.11,Acute bronchospasm,1
3992,Epinephrine,519.8,Other diseases of respiratory system; not elsewhere classified,0
3992,Epinephrine,698.9,Unspecified pruritic disorder,1
3992,Epinephrine,780.2,Syncope and collapse,1
3992,Epinephrine,781.0,Abnormal involuntary movements,1
3992,Epinephrine,785.52,Septic shock,0
3992,Epinephrine,786.05,Shortness of breath,1
3992,Epinephrine,786.09,Other dyspnea and respiratory abnormality,1
3992,Epinephrine,787.7,Abnormal feces,1
3992,Epinephrine,787.91,Diarrhea,1
3992,Epinephrine,995.0,Other anaphylactic reaction,1
3992,Epinephrine,995.3,Allergy unspecified not elsewhere classified,1
3995,Epirubicin,140-239.99,,1
3995,Epirubicin,151.9,Malignant neoplasm of stomach; unspecified,1
3995,Epirubicin,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
3995,Epirubicin,174.9,Malignant neoplasm of breast (female); unspecified,1
3995,Epirubicin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
3995,Epirubicin,239,Neoplasms of unspecified nature,1
3995,Epirubicin,239-239.99,,1
3995,Epirubicin,239.3,Neoplasm of unspecified nature of breast,0
4018,Ergocalciferol,252.1,Hypoparathyroidism,1
4018,Ergocalciferol,275.3,Disorders of phosphorus metabolism,1
4018,Ergocalciferol,733.0,Osteoporosis,0
4018,Ergocalciferol,733.00,Osteoporosis NOS,0
4021,Ergonovine,413.1,Prinzmetal angina,0
4021,Ergonovine,666,Postpartum hemorrhage,0
4021,Ergonovine,666.14,Other immediate postpartum hemorrhage; postpartum,0
4024,ergoloid mesylates  USP,339.00,Cluster headache syndrome; unspecified,0
4024,ergoloid mesylates  USP,339.02,Chronic cluster headache,0
4024,ergoloid mesylates  USP,413.1,Prinzmetal angina,0
4024,ergoloid mesylates  USP,666,Postpartum hemorrhage,0
4024,ergoloid mesylates  USP,666.14,Other immediate postpartum hemorrhage; postpartum,0
4025,Ergotamine,339.00,Cluster headache syndrome; unspecified,0
4025,Ergotamine,339.02,Chronic cluster headache,0
4025,Ergotamine,346,Migraine,0
4025,Ergotamine,346.9,Migraine; unspecified,0
4025,Ergotamine,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
4040,Erythrityl Tetranitrate,413,Angina pectoris,0
4040,Erythrityl Tetranitrate,413.9,Other and unspecified angina pectoris,0
4040,Erythrityl Tetranitrate,786.50,Unspecified chest pain,0
4053,Erythromycin,008.43,Intestinal infection due to campylobacter,0
4053,Erythromycin,032,Diphtheria,1
4053,Erythromycin,032.9,Diphtheria NOS,1
4053,Erythromycin,033.0,Whooping cough due to bordetella pertussis (b. pertussis),1
4053,Erythromycin,039.0,Cutaneous actinomycosis,1
4053,Erythromycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
4053,Erythromycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
4053,Erythromycin,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
4053,Erythromycin,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
4053,Erythromycin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
4053,Erythromycin,097.9,Syphilis NOS,1
4053,Erythromycin,098,Gonococcal infections,1
4053,Erythromycin,098.89,Gonococcal infection of other specified sites,1
4053,Erythromycin,099.0,Chancroid,0
4053,Erythromycin,099.9,Venereal disease NOS,1
4053,Erythromycin,136.9,Unspecified infectious and parasitic diseases,1
4053,Erythromycin,379.99|041.9,,0
4053,Erythromycin,390,Rheumatic fever without mention of heart involvement,1
4053,Erythromycin,390-392.99,,1
4053,Erythromycin,482.84,Legionnaires' disease,0
4053,Erythromycin,486,Pneumonia; organism unspecified,1
4053,Erythromycin,519.8,Other diseases of respiratory system; not elsewhere classified,1
4053,Erythromycin,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
4053,Erythromycin,597.80,Urethritis NOS,1
4053,Erythromycin,706.1,Other acne,1
4055,Erythromycin Estolate,008.43,Intestinal infection due to campylobacter,0
4055,Erythromycin Estolate,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
4055,Erythromycin Estolate,039.0,Cutaneous actinomycosis,0
4055,Erythromycin Estolate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
4055,Erythromycin Estolate,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
4055,Erythromycin Estolate,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,0
4055,Erythromycin Estolate,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
4055,Erythromycin Estolate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
4055,Erythromycin Estolate,097.9,Syphilis NOS,0
4055,Erythromycin Estolate,098,Gonococcal infections,0
4055,Erythromycin Estolate,098.89,Gonococcal infection of other specified sites,0
4055,Erythromycin Estolate,099.0,Chancroid,0
4055,Erythromycin Estolate,379.99|041.9,,0
4055,Erythromycin Estolate,482.84,Legionnaires' disease,0
4055,Erythromycin Estolate,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
4055,Erythromycin Estolate,597.80,Urethritis NOS,0
4055,Erythromycin Estolate,706.1,Other acne,0
4056,Erythromycin Ethylsuccinate,008.43,Intestinal infection due to campylobacter,0
4056,Erythromycin Ethylsuccinate,032,Diphtheria,1
4056,Erythromycin Ethylsuccinate,032.9,Diphtheria NOS,1
4056,Erythromycin Ethylsuccinate,033.0,Whooping cough due to bordetella pertussis (b. pertussis),1
4056,Erythromycin Ethylsuccinate,039.0,Cutaneous actinomycosis,1
4056,Erythromycin Ethylsuccinate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
4056,Erythromycin Ethylsuccinate,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
4056,Erythromycin Ethylsuccinate,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
4056,Erythromycin Ethylsuccinate,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
4056,Erythromycin Ethylsuccinate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
4056,Erythromycin Ethylsuccinate,097.9,Syphilis NOS,1
4056,Erythromycin Ethylsuccinate,098,Gonococcal infections,1
4056,Erythromycin Ethylsuccinate,098.89,Gonococcal infection of other specified sites,1
4056,Erythromycin Ethylsuccinate,099.0,Chancroid,0
4056,Erythromycin Ethylsuccinate,136.9,Unspecified infectious and parasitic diseases,1
4056,Erythromycin Ethylsuccinate,379.99|041.9,,0
4056,Erythromycin Ethylsuccinate,390,Rheumatic fever without mention of heart involvement,1
4056,Erythromycin Ethylsuccinate,390-392.99,,1
4056,Erythromycin Ethylsuccinate,482.84,Legionnaires' disease,0
4056,Erythromycin Ethylsuccinate,486,Pneumonia; organism unspecified,1
4056,Erythromycin Ethylsuccinate,519.8,Other diseases of respiratory system; not elsewhere classified,1
4056,Erythromycin Ethylsuccinate,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
4056,Erythromycin Ethylsuccinate,597.80,Urethritis NOS,1
4056,Erythromycin Ethylsuccinate,706.1,Other acne,0
4077,Estazolam,307.42,Persistent disorder of initiating or maintaining sleep,0
4077,Estazolam,780.52,Insomnia; unspecified,1
4083,Estradiol,140-239.99,,1
4083,Estradiol,174.9,Malignant neoplasm of breast (female); unspecified,1
4083,Estradiol,182.0,Malignant neoplasm of corpus uteri; except isthmus,1
4083,Estradiol,185,Malignant neoplasm of prostate,1
4083,Estradiol,239,Neoplasms of unspecified nature,1
4083,Estradiol,239-239.99,,1
4083,Estradiol,239.3,Neoplasm of unspecified nature of breast,0
4083,Estradiol,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
4083,Estradiol,253.4,Other anterior pituitary disorders,1
4083,Estradiol,256.31,Premature menopause,1
4083,Estradiol,256.39,Other ovarian failure,1
4083,Estradiol,290,Dementias,1
4083,Estradiol,294.2,,1
4083,Estradiol,294.20,Dementia; unspecified; without behavioral disturbance,1
4083,Estradiol,302.76,Dyspareunia; psychogenic,1
4083,Estradiol,338-338.99,,0
4083,Estradiol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
4083,Estradiol,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,1
4083,Estradiol,415.19,Other pulmonary embolism and infarction,1
4083,Estradiol,429.9,Heart disease NOS,1
4083,Estradiol,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
4083,Estradiol,451.9,Phlebitis and thrombophlebitis of unspecified site,1
4083,Estradiol,617,Endometriosis,0
4083,Estradiol,617.9,Endometriosis; site unspecified,0
4083,Estradiol,621.3,Endometrial hyperplasia,1
4083,Estradiol,621.30,Endometrial hyperplasia; unspecified,1
4083,Estradiol,623.8,Other specified noninflammatory disorders of vagina,1
4083,Estradiol,625.0,Dyspareunia,1
4083,Estradiol,625.8,Other specified symptoms associated with female genital organs,0
4083,Estradiol,626.2,Excessive or frequent menstruation,0
4083,Estradiol,626.4,Irregular menstrual cycle,0
4083,Estradiol,627.2,Symptomatic menopausal or female climacteric states,1
4083,Estradiol,627.3,Postmenopausal atrophic vaginitis,1
4083,Estradiol,698.1,Pruritus of genital organs,1
4083,Estradiol,698.9,Unspecified pruritic disorder,1
4083,Estradiol,733.0,Osteoporosis,1
4083,Estradiol,733.00,Osteoporosis NOS,1
4083,Estradiol,733.01,Senile osteoporosis,1
4083,Estradiol,733.90,Disorder of bone and cartilage; unspecified,1
4083,Estradiol,780-789.99,,0
4083,Estradiol,780.79,Other malaise and fatigue,0
4083,Estradiol,780.96,Generalized pain,0
4083,Estradiol,782.62,Flushing,1
4083,Estradiol,788.1,Dysuria,1
4083,Estradiol,788.63,Urgency of urination,1
4083,Estradiol,797,Senility without mention of psychosis,1
4083,Estradiol,799.9,Other unknown and unspecified cause of morbidity or mortality,1
4083,Estradiol,V22.2,Pregnant state; incidental,0
4089,Estramustine,185,Malignant neoplasm of prostate,1
4089,Estramustine,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
4099,Estrogens  Conjugated (USP),174.9,Malignant neoplasm of breast (female); unspecified,1
4099,Estrogens  Conjugated (USP),185,Malignant neoplasm of prostate,1
4099,Estrogens  Conjugated (USP),239.3,Neoplasm of unspecified nature of breast,0
4099,Estrogens  Conjugated (USP),239.5,Neoplasm of unspecified nature of other genitourinary organs,0
4099,Estrogens  Conjugated (USP),253.4,Other anterior pituitary disorders,1
4099,Estrogens  Conjugated (USP),256.31,Premature menopause,1
4099,Estrogens  Conjugated (USP),256.39,Other ovarian failure,1
4099,Estrogens  Conjugated (USP),259.9,Unspecified endocrine disorder,1
4099,Estrogens  Conjugated (USP),290,Dementias,1
4099,Estrogens  Conjugated (USP),294.2,,1
4099,Estrogens  Conjugated (USP),294.20,Dementia; unspecified; without behavioral disturbance,1
4099,Estrogens  Conjugated (USP),429.2,Cardiovascular disease [ASCVD],1
4099,Estrogens  Conjugated (USP),624.09,Other dystrophy of vulva,1
4099,Estrogens  Conjugated (USP),625.8,Other specified symptoms associated with female genital organs,0
4099,Estrogens  Conjugated (USP),626.2,Excessive or frequent menstruation,0
4099,Estrogens  Conjugated (USP),627.2,Symptomatic menopausal or female climacteric states,0
4099,Estrogens  Conjugated (USP),627.3,Postmenopausal atrophic vaginitis,1
4099,Estrogens  Conjugated (USP),698.1,Pruritus of genital organs,0
4099,Estrogens  Conjugated (USP),698.9,Unspecified pruritic disorder,1
4099,Estrogens  Conjugated (USP),701.0,Circumscribed scleroderma,1
4099,Estrogens  Conjugated (USP),733.0,Osteoporosis,1
4099,Estrogens  Conjugated (USP),733.00,Osteoporosis NOS,1
4099,Estrogens  Conjugated (USP),733.01,Senile osteoporosis,1
4099,Estrogens  Conjugated (USP),780.79,Other malaise and fatigue,0
4099,Estrogens  Conjugated (USP),780.8,Generalized hyperhidrosis,0
4099,Estrogens  Conjugated (USP),782.62,Flushing,0
4099,Estrogens  Conjugated (USP),796.4,Other abnormal clinical findings,1
4103,Estrone,239.3,Neoplasm of unspecified nature of breast,0
4103,Estrone,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
4103,Estrone,253.4,Other anterior pituitary disorders,0
4103,Estrone,256.31,Premature menopause,0
4103,Estrone,256.39,Other ovarian failure,0
4103,Estrone,626.2,Excessive or frequent menstruation,0
4103,Estrone,627.2,Symptomatic menopausal or female climacteric states,1
4103,Estrone,733.01,Senile osteoporosis,0
4103,Estrone,782.62,Flushing,0
4109,Ethacrynic Acid,401-405.99,,0
4109,Ethacrynic Acid,401.9,Hypertension NOS,0
4109,Ethacrynic Acid,428.0,Congestive heart failure (CHF) NOS,1
4109,Ethacrynic Acid,514,Pulmonary congestion and hypostasis,1
4109,Ethacrynic Acid,571.5,Cirrhosis of liver without mention of alcohol,1
4109,Ethacrynic Acid,581,Nephrotic syndrome,1
4109,Ethacrynic Acid,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
4109,Ethacrynic Acid,584,Acute renal failure,0
4109,Ethacrynic Acid,584.9,Acute renal failure NOS,0
4109,Ethacrynic Acid,585.6,End stage renal disease,0
4109,Ethacrynic Acid,585.9,Chronic kidney disease; unspecified,0
4109,Ethacrynic Acid,586,Renal failure unspecified,0
4109,Ethacrynic Acid,782.3,Edema,1
4109,Ethacrynic Acid,789.5,Ascites,1
4109,Ethacrynic Acid,789.59,Other ascites,1
4109,Ethacrynic Acid,997.91,Hypertension,0
4110,Ethambutol,010-018.99,,1
4110,Ethambutol,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
4110,Ethambutol,031.9,Unspecified diseases due to mycobacteria,0
4118,Ethchlorvynol,307.42,Persistent disorder of initiating or maintaining sleep,0
4124,Ethinyl Estradiol,239.3,Neoplasm of unspecified nature of breast,0
4124,Ethinyl Estradiol,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
4124,Ethinyl Estradiol,253.4,Other anterior pituitary disorders,0
4124,Ethinyl Estradiol,256.31,Premature menopause,0
4124,Ethinyl Estradiol,256.39,Other ovarian failure,0
4124,Ethinyl Estradiol,626.2,Excessive or frequent menstruation,0
4124,Ethinyl Estradiol,627.2,Symptomatic menopausal or female climacteric states,0
4124,Ethinyl Estradiol,733.01,Senile osteoporosis,0
4124,Ethinyl Estradiol,782.62,Flushing,0
4126,Amifostine,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
4126,Amifostine,195.0,Malignant neoplasm of head; face; and neck,1
4126,Amifostine,527.7,Disturbance of salivary secretion,1
4126,Amifostine,584,Acute renal failure,0
4126,Amifostine,584.5,Acute renal failure with lesion of tubular necrosis,1
4126,Amifostine,584.9,Acute renal failure NOS,0
4126,Amifostine,585.6,End stage renal disease,0
4126,Amifostine,585.9,Chronic kidney disease; unspecified,0
4126,Amifostine,586,Renal failure unspecified,0
4126,Amifostine,977.9,Poisoning by unspecified drug or medicinal substance,0
4127,Ethionamide,010-018.99,,1
4127,Ethionamide,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
4135,Ethosuximide,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
4135,Ethosuximide,780.39,Other convulsions,1
4136,Ethotoin,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
4136,Ethotoin,780.39,Other convulsions,1
4141,Ethyl Chloride,338-338.99,,0
4141,Ethyl Chloride,780.96,Generalized pain,0
4171,Etidocaine,338.18,Other acute postoperative pain,0
4177,Etomidate,338-338.99,,0
4177,Etomidate,345.3,Grand mal status; epileptic,0
4177,Etomidate,348.89,Other conditions of brain (ADDED),0
4177,Etomidate,780.39,Other convulsions,0
4177,Etomidate,780.96,Generalized pain,0
4179,Etoposide,136.9,Unspecified infectious and parasitic diseases,0
4179,Etoposide,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
4179,Etoposide,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
4179,Etoposide,176,Kaposi's sarcoma,0
4179,Etoposide,176.9,Kaposi's sarcoma NOS,0
4179,Etoposide,186,Malignant neoplasm of testis,1
4179,Etoposide,186.9,Malignant neoplasm of other and unspecified testis,1
4179,Etoposide,202.1,Mycosis fungoides,0
4179,Etoposide,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
4179,Etoposide,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
4179,Etoposide,204.1,Lymphoid leukemia; chronic,0
4179,Etoposide,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
4179,Etoposide,205.0,Myeloid leukemia; acute,0
4179,Etoposide,205.00,Acute myeloid leukemia without mention of having achieved remission,0
4179,Etoposide,208,Leukemia of unspecified cell type,1
4179,Etoposide,208.9,Unspecified leukemia,1
4179,Etoposide,208.90,Unspecified leukemia without mention of having achieved remission,1
4179,Etoposide,209.20,Malignant carcinoid tumor of unknown primary site,1
4179,Etoposide,239.1,Neoplasm of unspecified nature of respiratory system,0
4179,Etoposide,239.4,Neoplasm of unspecified nature of bladder,0
4179,Etoposide,239.5,Neoplasm of unspecified nature of other genitourinary organs,1
4179,Etoposide,239.6,Neoplasm of unspecified nature of brain,1
4182,Etretinate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
4249,Factor IX,286.0,Congenital factor VIII disorder,1
4249,Factor IX,286.1,Congenital factor IX disorder,1
4249,Factor IX,286.3,Congenital deficiency of other clotting factors,0
4249,Factor IX,286.7,Acquired coagulation factor deficiency,1
4249,Factor IX,459.0,Hemorrhage NOS,1
4256,Factor VIIa,286.0,Congenital factor VIII disorder,0
4256,Factor VIIa,286.1,Congenital factor IX disorder,0
4256,Factor VIIa,286.3,Congenital deficiency of other clotting factors,0
4256,Factor VIIa,286.7,Acquired coagulation factor deficiency,0
4257,Factor VIII,286.0,Congenital factor VIII disorder,1
4257,Factor VIII,286.3,Congenital deficiency of other clotting factors,0
4257,Factor VIII,286.4,Von willebrand's disease,1
4257,Factor VIII,286.7,Acquired coagulation factor deficiency,1
4257,Factor VIII,459.0,Hemorrhage NOS,1
4278,Famotidine,251.5,Abnormality of secretion of gastrin,0
4278,Famotidine,530.11,Reflux esophagitis,0
4278,Famotidine,530.81,Esophageal reflux,1
4278,Famotidine,531,Gastric ulcer,1
4278,Famotidine,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
4278,Famotidine,532,Duodenal ulcer,1
4278,Famotidine,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
4278,Famotidine,536.8,Dyspepsia and other specified disorders of function of stomach,1
4278,Famotidine,578,Gastrointestinal hemorrhage,0
4278,Famotidine,578.9,Hemorrhage of gastrointestinal tract NOS,0
4278,Famotidine,707.9,Chronic ulcer of unspecified site,1
4278,Famotidine,708,Urticaria,0
4278,Famotidine,708.9,Unspecified urticaria,0
4278,Famotidine,787.1,Heartburn,1
4316,Felodipine,401-405.99,,1
4316,Felodipine,401.9,Hypertension NOS,1
4316,Felodipine,413.1,Prinzmetal angina,0
4316,Felodipine,997.91,Hypertension,1
4328,Fenfluramine,278.00,Obesity NOS,0
4328,Fenfluramine,299.0,Autistic disorder,0
4328,Fenfluramine,299.00,Infantile autism; current or active state,0
4328,Fenfluramine,307.51,Bulimia nervosa,0
4331,Fenoprofen,338-338.99,,1
4331,Fenoprofen,714.0,Rheumatoid arthritis,1
4331,Fenoprofen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
4331,Fenoprofen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
4331,Fenoprofen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
4331,Fenoprofen,716.90,Arthropathy; unspecified; site unspecified,1
4331,Fenoprofen,780.60,Fever; unspecified,0
4331,Fenoprofen,780.96,Generalized pain,1
4337,Fentanyl,300.9,Unspecified nonpsychotic mental disorder,1
4337,Fentanyl,305.5,Opioid abuse,1
4337,Fentanyl,305.50,Opioid abuse; unspecified use,1
4337,Fentanyl,305.90,Other; mixed; or unspecified drug abuse; unspecified use,1
4337,Fentanyl,338-338.99,,1
4337,Fentanyl,338.2,Chronic pain,1
4337,Fentanyl,338.29,Other chronic pain,1
4337,Fentanyl,780.96,Generalized pain,1
4385,Fibrinogen,286.3,Congenital deficiency of other clotting factors,1
4385,Fibrinogen,286.6,Defibrination syndrome,1
4385,Fibrinogen,459.0,Hemorrhage NOS,1
4440,Flavoxate,338-338.99,,1
4440,Flavoxate,595,Cystitis,1
4440,Flavoxate,595.3,Trigonitis,1
4440,Flavoxate,595.9,Cystitis NOS,1
4440,Flavoxate,597.80,Urethritis NOS,1
4440,Flavoxate,601,Inflammatory diseases of prostate,1
4440,Flavoxate,601.9,Prostatitis NOS,1
4440,Flavoxate,780.96,Generalized pain,1
4440,Flavoxate,788.1,Dysuria,1
4440,Flavoxate,788.3,Urinary incontinence,0
4440,Flavoxate,788.30,Urinary incontinence NOS,0
4440,Flavoxate,788.43,Nocturia,1
4440,Flavoxate,789.09,Abdominal pain; other specified site; multiple sites,1
4441,Flecainide,427,Cardiac dysrhythmias,1
4441,Flecainide,427.0,Paroxysmal supraventricular tachycardia,1
4441,Flecainide,427.1,Paroxysmal ventricular tachycardia,1
4441,Flecainide,427.31,Atrial fibrillation,1
4441,Flecainide,427.32,Atrial flutter,1
4441,Flecainide,427.89,Other specified cardiac dysrhythmias,1
4441,Flecainide,427.9,Cardiac dysrhythmia NOS,1
4441,Flecainide,785.0,Tachycardia NOS,1
4441,Flecainide,799.9,Other unknown and unspecified cause of morbidity or mortality,1
4450,Fluconazole,042,Human immunodeficiency virus [HIV] disease,0
4450,Fluconazole,042-042.99,,0
4450,Fluconazole,110-118.99,,1
4450,Fluconazole,112,Candidiasis,1
4450,Fluconazole,112.0,Candidiasis of mouth,0
4450,Fluconazole,112.1,Candidiasis of vulva and vagina,1
4450,Fluconazole,112.3,Candidiasis of skin and nails,0
4450,Fluconazole,112.84,Candidal esophagitis,1
4450,Fluconazole,112.9,Candidiasis of unspecified site,1
4450,Fluconazole,114,Coccidioidomycosis,0
4450,Fluconazole,114.9,Coccidioidomycosis NOS,0
4450,Fluconazole,115,Histoplasmosis,0
4450,Fluconazole,115.9,Histoplasmosis; unspecified,0
4450,Fluconazole,115.90,Histoplasmosis; unspecified without mention of manifestation,0
4450,Fluconazole,116,Blastomycotic infection,0
4450,Fluconazole,116.0,Blastomycosis,0
4450,Fluconazole,117.9,Other and unspecified mycoses,1
4450,Fluconazole,136.9,Unspecified infectious and parasitic diseases,1
4450,Fluconazole,279.3,Unspecified immunity deficiency,1
4450,Fluconazole,321.0,Cryptococcal meningitis,1
4450,Fluconazole,322,Meningitis of unspecified cause,1
4450,Fluconazole,322.9,Meningitis NOS,1
4451,Flucytosine,112,Candidiasis,1
4451,Flucytosine,112.9,Candidiasis of unspecified site,1
4451,Flucytosine,117.2,Chromoblastomycosis,0
4451,Flucytosine,117.3,Aspergillosis,0
4451,Flucytosine,117.5,Cryptococcosis,1
4451,Flucytosine,117.9,Other and unspecified mycoses,0
4451,Flucytosine,321.0,Cryptococcal meningitis,0
4452,Fludrocortisone,255.0,Cushing's syndrome,0
4452,Fludrocortisone,255.2,Adrenogenital disorders,1
4452,Fludrocortisone,255.3,Other corticoadrenal overactivity,0
4452,Fludrocortisone,255.41,Glucocorticoid deficiency,1
4457,Flumazenil,977.9,Poisoning by unspecified drug or medicinal substance,0
4461,Fluocinolone Acetonide,691.8,Other atopic dermatitis,1
4461,Fluocinolone Acetonide,692.9,Contact dermatitis and other eczema; unspecified cause,1
4461,Fluocinolone Acetonide,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
4461,Fluocinolone Acetonide,698.9,Unspecified pruritic disorder,0
4462,Fluocinonide,698.9,Unspecified pruritic disorder,0
4462,Fluocinonide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
4462,Fluocinonide,781.99,Other symptoms involving nervous and musculoskeletal systems,0
4488,Floxuridine,199.1,Other malignant neoplasm of unspecified site,1
4488,Floxuridine,239.0,Neoplasm of unspecified nature of digestive system,0
4492,Fluorouracil,151.9,Malignant neoplasm of stomach; unspecified,1
4492,Fluorouracil,153.9,Malignant neoplasm of colon; unspecified,1
4492,Fluorouracil,157.9,Malignant neoplasm of pancreas; part unspecified,1
4492,Fluorouracil,173.91,Basal cell carcinoma of skin; site unspecified,1
4492,Fluorouracil,173.99,Other specified malignant neoplasm of skin; site unspecified,1
4492,Fluorouracil,174.9,Malignant neoplasm of breast (female); unspecified,1
4492,Fluorouracil,188,Malignant neoplasm of bladder,1
4492,Fluorouracil,188.9,Malignant neoplasm of bladder; part unspecified,1
4492,Fluorouracil,239.0,Neoplasm of unspecified nature of digestive system,0
4492,Fluorouracil,239.3,Neoplasm of unspecified nature of breast,0
4492,Fluorouracil,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),0
4492,Fluorouracil,701.1,Keratoderma; acquired,1
4492,Fluorouracil,702.0,Actinic keratosis,1
4493,Fluoxetine,278.00,Obesity NOS,0
4493,Fluoxetine,296.00,Manic disorder; single episode; unspecified degree,0
4493,Fluoxetine,296.20,Major depressive disorder; single episode; unspecified degree,1
4493,Fluoxetine,296.80,Bipolar disorder NOS,0
4493,Fluoxetine,296.99,Other specified episodic mood disorder,1
4493,Fluoxetine,300.01,Panic disorder without agoraphobia,1
4493,Fluoxetine,300.20,Phobia unspecified,1
4493,Fluoxetine,300.29,Other isolated or specific phobias,1
4493,Fluoxetine,300.3,Obsessive-compulsive disorders,1
4493,Fluoxetine,300.9,Unspecified nonpsychotic mental disorder,1
4493,Fluoxetine,303,Alcohol dependence syndrome,0
4493,Fluoxetine,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
4493,Fluoxetine,305.01,Alcohol abuse; continuous drinking behavior,0
4493,Fluoxetine,307.51,Bulimia nervosa,1
4493,Fluoxetine,307.59,Eating disorder NEC,1
4493,Fluoxetine,309.89,Other specified adjustment reactions,1
4493,Fluoxetine,311,Depressive disorder NEC,1
4493,Fluoxetine,611.79,Other signs and symptoms in breast,1
4493,Fluoxetine,625.4,Premenstrual tension syndromes,1
4493,Fluoxetine,784.0,Headache,1
4493,Fluoxetine,797,Senility without mention of psychosis,1
4493,Fluoxetine,799.22,Irritability (ADDED),1
4493,Fluoxetine,799.89,Other ill-defined conditions,1
4494,Fluoxymesterone,174.9,Malignant neoplasm of breast (female); unspecified,1
4494,Fluoxymesterone,239.3,Neoplasm of unspecified nature of breast,0
4494,Fluoxymesterone,253.4,Other anterior pituitary disorders,1
4494,Fluoxymesterone,257.2,Other testicular hypofunction,1
4494,Fluoxymesterone,259.0,Delay in sexual development and puberty NEC,1
4494,Fluoxymesterone,995.1,Angioneurotic edema not elsewhere classified,0
4496,Fluphenazine,290-299.99,,1
4496,Fluphenazine,295,Schizophrenic disorders,0
4496,Fluphenazine,295.9,Unspecified schizophrenia,0
4496,Fluphenazine,295.90,Unspecified schizophrenia; unspecified state,0
4496,Fluphenazine,298.9,Unspecified psychosis,1
4500,Flurandrenolide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
4501,Flurazepam,307.42,Persistent disorder of initiating or maintaining sleep,0
4501,Flurazepam,327.09,Other organic insomnia,1
4501,Flurazepam,780.52,Insomnia; unspecified,1
4502,Flurbiprofen,338-338.99,,1
4502,Flurbiprofen,362.53,Cystoid macular degeneration of retina,0
4502,Flurbiprofen,379.42,Miosis (persistent); not due to miotics,1
4502,Flurbiprofen,714.0,Rheumatoid arthritis,1
4502,Flurbiprofen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
4502,Flurbiprofen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
4502,Flurbiprofen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
4502,Flurbiprofen,716.90,Arthropathy; unspecified; site unspecified,1
4502,Flurbiprofen,720.0,Ankylosing spondylitis,1
4502,Flurbiprofen,780.96,Generalized pain,1
4508,Flutamide,185,Malignant neoplasm of prostate,1
4508,Flutamide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
4508,Flutamide,704.1,Hirsutism,0
4509,Flavin Mononucleotide,266.0,Ariboflavinosis,0
4511,Folic Acid,260-269.99,,0
4511,Folic Acid,266.2,Other B-complex deficiencies,0
4511,Folic Acid,269.9,Unspecified nutritional deficiency,0
4511,Folic Acid,281.9,Deficiency anemia NOS,1
4511,Folic Acid,285.9,Anemia unspecified,1
4511,Folic Acid,742.8,Other specified congenital anomalies of nervous system,0
4511,Folic Acid,799.9,Other unknown and unspecified cause of morbidity or mortality,0
4511,Folic Acid,994.2,Effects of hunger,0
4511,Folic Acid,V22.2,Pregnant state; incidental,0
4530,Formaldehyde,078.1,Viral warts,1
4530,Formaldehyde,078.10,Viral warts; unspecified,1
4550,Fosfomycin,041.49,Other and unspecified Escherichia coli [E. coli],0
4550,Fosfomycin,599.0,Urinary tract infection; site not specified,1
4601,Furazolidone,001,Cholera,0
4601,Furazolidone,001.0,Cholera due to Vibrio cholerae,0
4601,Furazolidone,001.9,Cholera NOS,0
4601,Furazolidone,004.9,Shigellosis NOS,0
4601,Furazolidone,007.1,Giardiasis,0
4601,Furazolidone,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
4601,Furazolidone,787.7,Abnormal feces,0
4601,Furazolidone,787.91,Diarrhea,0
4603,Furosemide,276.6,Fluid overload,0
4603,Furosemide,276.69,Other fluid overload,1
4603,Furosemide,401-405.99,,1
4603,Furosemide,401.9,Hypertension NOS,1
4603,Furosemide,428,Heart failure,1
4603,Furosemide,428.0,Congestive heart failure (CHF) NOS,1
4603,Furosemide,428.9,Heart failure unspecified,1
4603,Furosemide,514,Pulmonary congestion and hypostasis,1
4603,Furosemide,571.5,Cirrhosis of liver without mention of alcohol,1
4603,Furosemide,581,Nephrotic syndrome,1
4603,Furosemide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
4603,Furosemide,584,Acute renal failure,1
4603,Furosemide,584.9,Acute renal failure NOS,1
4603,Furosemide,585.6,End stage renal disease,1
4603,Furosemide,585.9,Chronic kidney disease; unspecified,1
4603,Furosemide,586,Renal failure unspecified,1
4603,Furosemide,593.9,Unspecified disorder of kidney and ureter,1
4603,Furosemide,782.3,Edema,1
4603,Furosemide,788.42,Polyuria,1
4603,Furosemide,789.5,Ascites,0
4603,Furosemide,789.59,Other ascites,0
4603,Furosemide,997.91,Hypertension,1
4637,Galantamine,331.0,Alzheimer's disease,0
4637,Galantamine,780-789.99,,0
4678,Ganciclovir,042,Human immunodeficiency virus [HIV] disease,1
4678,Ganciclovir,078.5,Cytomegaloviral disease,1
4678,Ganciclovir,136.9,Unspecified infectious and parasitic diseases,1
4678,Ganciclovir,279.3,Unspecified immunity deficiency,1
4678,Ganciclovir,363.20|078.5,,1
4719,Gemfibrozil,272.1,Pure hyperglyceridemia,1
4719,Gemfibrozil,272.4,Other and unspecified hyperlipidemia,1
4719,Gemfibrozil,429.9,Heart disease NOS,1
4719,Gemfibrozil,447.9,Unspecified disorders of arteries and arterioles,0
4778,Gentian Violet,112.1,Candidiasis of vulva and vagina,0
4778,Gentian Violet,112.3,Candidiasis of skin and nails,0
4778,Gentian Violet,686.9,Unspecified local infection of skin and subcutaneous tissue,0
4815,Glyburide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
4815,Glyburide,251.2,Hypoglycemia NOS,1
4815,Glyburide,790.6,Other abnormal blood chemistry,1
4816,Gliclazide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
4816,Gliclazide,790.6,Other abnormal blood chemistry,1
4821,Glipizide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
4821,Glipizide,790.6,Other abnormal blood chemistry,1
4832,Glucagon,211.7,Benign neoplasm of islets of Langerhans,1
4832,Glucagon,251.2,Hypoglycemia NOS,1
4832,Glucagon,427.89,Other specified cardiac dysrhythmias,0
4832,Glucagon,458,Hypotension,0
4832,Glucagon,458.9,Hypotension NOS,0
4832,Glucagon,569.9,Unspecified disorder of intestine,0
4832,Glucagon,785.51,Cardiogenic shock,0
4832,Glucagon,995.0,Other anaphylactic reaction,0
4845,Glucosamine,715.00,Osteoarthrosis; generalized; involving unspecified site,0
4845,Glucosamine,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
4845,Glucosamine,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
4850,Glucose,251.2,Hypoglycemia NOS,1
4850,Glucose,276.51,Dehydration,1
4850,Glucose,790.6,Other abnormal blood chemistry,1
4850,Glucose,998.9,Unspecified complication of procedure; not elsewhere classified,0
4888,Glutaral,998.59,Other postoperative infection,0
4903,Glutethimide,307.42,Persistent disorder of initiating or maintaining sleep,0
4910,Glycerin,564.0,Constipation,1
4910,Glycerin,564.00,Constipation NOS,1
4910,Glycerin,692.9,Contact dermatitis and other eczema; unspecified cause,0
4910,Glycerin,782.1,Rash and other nonspecific skin eruption,0
4910,Glycerin,940-949.99,,0
4910,Glycerin,949.0,Burn of unspecified site; unspecified degree,0
4917,Nitroglycerin,401-405.99,,1
4917,Nitroglycerin,401.9,Hypertension NOS,1
4917,Nitroglycerin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
4917,Nitroglycerin,413,Angina pectoris,1
4917,Nitroglycerin,413.9,Other and unspecified angina pectoris,1
4917,Nitroglycerin,416.0,Primary pulmonary hypertension,0
4917,Nitroglycerin,428,Heart failure,1
4917,Nitroglycerin,428.0,Congestive heart failure (CHF) NOS,1
4917,Nitroglycerin,428.9,Heart failure unspecified,1
4917,Nitroglycerin,458,Hypotension,1
4917,Nitroglycerin,458.9,Hypotension NOS,1
4917,Nitroglycerin,530.5,Dyskinesia of esophagus,0
4917,Nitroglycerin,565.0,Anal fissure,1
4917,Nitroglycerin,569.41,Ulcer of anus and rectum,1
4917,Nitroglycerin,642.60,Eclampsia complicating pregnancy; childbirth or the puerperium; unspecified as to episode of care,0
4917,Nitroglycerin,786.5,Chest pain,0
4917,Nitroglycerin,786.50,Unspecified chest pain,1
4917,Nitroglycerin,997.91,Hypertension,1
4919,Glycine,533,Peptic ulcer; site unspecified,0
4919,Glycine,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
4952,thyrotropin alfa (USP),239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
4952,thyrotropin alfa (USP),244.9,Hypothyroidism NOS,1
4955,Glycopyrrolate,427.89,Other specified cardiac dysrhythmias,1
4955,Glycopyrrolate,533,Peptic ulcer; site unspecified,1
4955,Glycopyrrolate,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
4955,Glycopyrrolate,707.9,Chronic ulcer of unspecified site,1
4981,Gold Sodium Thiomalate,714.0,Rheumatoid arthritis,0
4986,Chorionic Gonadotropin,253.4,Other anterior pituitary disorders,1
4986,Chorionic Gonadotropin,278.00,Obesity NOS,1
4986,Chorionic Gonadotropin,628,Infertility; female,0
4986,Chorionic Gonadotropin,628.9,Female infertility NOS,0
4986,Chorionic Gonadotropin,783.21,Loss of weight,1
4986,Chorionic Gonadotropin,783.9,Other symptoms concerning nutrition; metabolism; and development,1
5011,Gramicidin,379.99|041.9,,0
5021,Griseofulvin,110.0,Dermatophytosis of scalp and beard,1
5021,Griseofulvin,110.1,Dermatophytosis of nail,1
5021,Griseofulvin,110.3,Dermatophytosis of groin and perianal area,1
5021,Griseofulvin,110.4,Dermatophytosis of foot,1
5021,Griseofulvin,117.9,Other and unspecified mycoses,1
5032,Guaifenesin,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
5032,Guaifenesin,460,Acute nasopharyngitis (common cold),0
5032,Guaifenesin,461.9,Acute sinusitis NOS,0
5032,Guaifenesin,462,Acute pharyngitis,0
5032,Guaifenesin,464.00,Acute laryngitis without mention of obstruction,0
5032,Guaifenesin,477.9,Allergic rhinitis NOS,0
5032,Guaifenesin,490,Bronchitis NOS,1
5032,Guaifenesin,491,Chronic bronchitis,1
5032,Guaifenesin,491.9,Chronic bronchitis NOS,1
5032,Guaifenesin,493,Asthma,0
5032,Guaifenesin,493.9,Asthma; unspecified,0
5032,Guaifenesin,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
5032,Guaifenesin,786.2,Cough,1
5032,Guaifenesin,799.9,Other unknown and unspecified cause of morbidity or mortality,0
5033,Guanabenz,401-405.99,,0
5033,Guanabenz,401.9,Hypertension NOS,0
5033,Guanabenz,997.91,Hypertension,0
5036,Guanethidine,401-405.99,,0
5036,Guanethidine,401.9,Hypertension NOS,0
5036,Guanethidine,997.91,Hypertension,0
5084,Halcinonide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
5093,Haloperidol,290-299.99,,1
5093,Haloperidol,295,Schizophrenic disorders,1
5093,Haloperidol,295.9,Unspecified schizophrenia,1
5093,Haloperidol,295.90,Unspecified schizophrenia; unspecified state,1
5093,Haloperidol,298.8,Other and unspecified reactive psychosis,1
5093,Haloperidol,298.9,Unspecified psychosis,1
5093,Haloperidol,300.9,Unspecified nonpsychotic mental disorder,1
5093,Haloperidol,307.2,Tics,1
5093,Haloperidol,307.20,Tic disorder NOS,1
5093,Haloperidol,307.23,Tourette's disorder,0
5093,Haloperidol,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
5093,Haloperidol,308.2,Predominant psychomotor disturbance,0
5093,Haloperidol,312.9,Unspecified disturbance of conduct,1
5093,Haloperidol,787.03,Vomiting alone,0
5093,Haloperidol,799.21,Nervousness (ADDED),0
5093,Haloperidol,799.24,Emotional lability (ADDED),0
5095,Halothane,493.91,Asthma; unspecified type; with status asthmaticus,0
5095,Halothane,995.86,Malignant hyperthermia,0
5175,Hemin,270.2,Other disturbances of aromatic amino-acid metabolism,0
5175,Hemin,277.1,Disorders of porphyrin metabolism,1
5224,Heparin,289.9,Blood disease NOS,1
5224,Heparin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
5224,Heparin,411.1,Intermediate coronary syndrome,0
5224,Heparin,415.19,Other pulmonary embolism and infarction,1
5224,Heparin,427.31,Atrial fibrillation,1
5224,Heparin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,0
5224,Heparin,451.9,Phlebitis and thrombophlebitis of unspecified site,1
5224,Heparin,453.9,Embolism and thrombosis of unspecified site,1
5224,Heparin,459.9,Unspecified circulatory system disorder,1
5224,Heparin,782.62,Flushing,1
5224,Heparin,998.9,Unspecified complication of procedure; not elsewhere classified,0
5293,Hexachlorophene,686.9,Unspecified local infection of skin and subcutaneous tissue,0
5293,Hexachlorophene,706.1,Other acne,0
5296,Altretamine,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
5333,Histamine,995.3,Allergy unspecified not elsewhere classified,1
5463,Hyaluronic Acid,338-338.99,,0
5463,Hyaluronic Acid,780.96,Generalized pain,0
5470,Hydralazine,276.69,Other fluid overload,0
5470,Hydralazine,401-405.99,,1
5470,Hydralazine,401.0,Malignant essential hypertension,0
5470,Hydralazine,401.9,Hypertension NOS,1
5470,Hydralazine,413,Angina pectoris,0
5470,Hydralazine,413.9,Other and unspecified angina pectoris,0
5470,Hydralazine,416.0,Primary pulmonary hypertension,0
5470,Hydralazine,428.0,Congestive heart failure (CHF) NOS,0
5470,Hydralazine,458,Hypotension,1
5470,Hydralazine,458.9,Hypotension NOS,1
5470,Hydralazine,786.50,Unspecified chest pain,0
5470,Hydralazine,997.91,Hypertension,1
5487,Hydrochlorothiazide,253.5,Diabetes insipidus,0
5487,Hydrochlorothiazide,276.6,Fluid overload,1
5487,Hydrochlorothiazide,276.69,Other fluid overload,1
5487,Hydrochlorothiazide,300.9,Unspecified nonpsychotic mental disorder,1
5487,Hydrochlorothiazide,401-405.99,,1
5487,Hydrochlorothiazide,401.9,Hypertension NOS,1
5487,Hydrochlorothiazide,428,Heart failure,1
5487,Hydrochlorothiazide,428.0,Congestive heart failure (CHF) NOS,1
5487,Hydrochlorothiazide,428.9,Heart failure unspecified,1
5487,Hydrochlorothiazide,581,Nephrotic syndrome,1
5487,Hydrochlorothiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
5487,Hydrochlorothiazide,592.0,Calculus of kidney,0
5487,Hydrochlorothiazide,593.9,Unspecified disorder of kidney and ureter,1
5487,Hydrochlorothiazide,782.3,Edema,1
5487,Hydrochlorothiazide,997.91,Hypertension,1
5489,Hydrocodone,338-338.99,,0
5489,Hydrocodone,338.18,Other acute postoperative pain,0
5489,Hydrocodone,780.96,Generalized pain,0
5489,Hydrocodone,786.2,Cough,0
5489,Hydrocodone,V22.2,Pregnant state; incidental,0
5492,Hydrocortisone,136.9,Unspecified infectious and parasitic diseases,0
5492,Hydrocortisone,140-239.99,,1
5492,Hydrocortisone,239,Neoplasms of unspecified nature,1
5492,Hydrocortisone,239-239.99,,1
5492,Hydrocortisone,255.2,Adrenogenital disorders,1
5492,Hydrocortisone,255.41,Glucocorticoid deficiency,1
5492,Hydrocortisone,274.9,Gout NOS,1
5492,Hydrocortisone,338-338.99,,0
5492,Hydrocortisone,379.99,Other ill-defined disorders of eye,1
5492,Hydrocortisone,455,Hemorrhoids,1
5492,Hydrocortisone,455.6,Hemorrhoids NOS,1
5492,Hydrocortisone,477.0,Allergic rhinitis due to pollen,1
5492,Hydrocortisone,477.9,Allergic rhinitis NOS,1
5492,Hydrocortisone,486,Pneumonia; organism unspecified,1
5492,Hydrocortisone,493,Asthma,1
5492,Hydrocortisone,493.9,Asthma; unspecified,1
5492,Hydrocortisone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
5492,Hydrocortisone,493.91,Asthma; unspecified type; with status asthmaticus,0
5492,Hydrocortisone,556,Ulcerative colitis,1
5492,Hydrocortisone,556.2,Ulcerative (chronic) proctitis,1
5492,Hydrocortisone,556.8,Other ulcerative colitis,1
5492,Hydrocortisone,556.9,Ulcerative colitis; unspecified,1
5492,Hydrocortisone,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
5492,Hydrocortisone,569.49,Other specified disorders of rectum and anus,1
5492,Hydrocortisone,569.9,Unspecified disorder of intestine,1
5492,Hydrocortisone,691.8,Other atopic dermatitis,1
5492,Hydrocortisone,692.9,Contact dermatitis and other eczema; unspecified cause,1
5492,Hydrocortisone,695.4,Lupus erythematosus,1
5492,Hydrocortisone,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
5492,Hydrocortisone,698.0,Pruritus ani,1
5492,Hydrocortisone,698.9,Unspecified pruritic disorder,1
5492,Hydrocortisone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
5492,Hydrocortisone,714.0,Rheumatoid arthritis,1
5492,Hydrocortisone,716.90,Arthropathy; unspecified; site unspecified,1
5492,Hydrocortisone,729.0,Rheumatism; unspecified and fibrositis,0
5492,Hydrocortisone,780.79,Other malaise and fatigue,0
5492,Hydrocortisone,780.96,Generalized pain,0
5492,Hydrocortisone,782.1,Rash and other nonspecific skin eruption,1
5492,Hydrocortisone,785.50,Shock NOS,1
5492,Hydrocortisone,788.42,Polyuria,1
5492,Hydrocortisone,790.99,Other nonspecific findings on examination of blood,1
5492,Hydrocortisone,796.4,Other abnormal clinical findings,1
5492,Hydrocortisone,799.89,Other ill-defined conditions,1
5492,Hydrocortisone,995.3,Allergy unspecified not elsewhere classified,1
5495,Hydroflumethiazide,401-405.99,,1
5495,Hydroflumethiazide,401.9,Hypertension NOS,1
5495,Hydroflumethiazide,428,Heart failure,1
5495,Hydroflumethiazide,428.0,Congestive heart failure (CHF) NOS,1
5495,Hydroflumethiazide,428.9,Heart failure unspecified,1
5495,Hydroflumethiazide,571.5,Cirrhosis of liver without mention of alcohol,1
5495,Hydroflumethiazide,581,Nephrotic syndrome,1
5495,Hydroflumethiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
5495,Hydroflumethiazide,782.3,Edema,1
5495,Hydroflumethiazide,997.91,Hypertension,1
5499,Hydrogen Peroxide,136.9,Unspecified infectious and parasitic diseases,1
5499,Hydrogen Peroxide,998.59,Other postoperative infection,0
5509,hydroquinone,709.09,Other dyschromia,1
5514,Hydroxocobalamin,129,Intestinal parasitism; unspecified,1
5514,Hydroxocobalamin,140-239.99,,1
5514,Hydroxocobalamin,199,Malignant neoplasm without specification of site,1
5514,Hydroxocobalamin,199.1,Other malignant neoplasm of unspecified site,1
5514,Hydroxocobalamin,239,Neoplasms of unspecified nature,1
5514,Hydroxocobalamin,239-239.99,,1
5514,Hydroxocobalamin,250.6,Diabetes with neurological manifestations,0
5514,Hydroxocobalamin,259.9,Unspecified endocrine disorder,1
5514,Hydroxocobalamin,260-269.99,,1
5514,Hydroxocobalamin,266.2,Other B-complex deficiencies,1
5514,Hydroxocobalamin,269.9,Unspecified nutritional deficiency,1
5514,Hydroxocobalamin,275.09,Other disorders of iron metabolism,1
5514,Hydroxocobalamin,281.0,Pernicious anemia,1
5514,Hydroxocobalamin,340,Multiple sclerosis,1
5514,Hydroxocobalamin,357.5,Alcoholic polyneuropathy,0
5514,Hydroxocobalamin,535.1,Atrophic gastritis,1
5514,Hydroxocobalamin,535.10,Atrophic gastritis; without mention of hemorrhage,1
5514,Hydroxocobalamin,555.0,Regional enteritis of small intestine,1
5514,Hydroxocobalamin,569.9,Unspecified disorder of intestine,1
5514,Hydroxocobalamin,579,Intestinal malabsorption,1
5514,Hydroxocobalamin,579.0,Celiac disease,1
5514,Hydroxocobalamin,579.1,Tropical sprue,1
5514,Hydroxocobalamin,579.9,Unspecified intestinal malabsorption,1
5514,Hydroxocobalamin,796.4,Other abnormal clinical findings,1
5514,Hydroxocobalamin,994.2,Effects of hunger,1
5521,Hydroxychloroquine,084,Malaria,0
5521,Hydroxychloroquine,084.2,Quartan malaria,0
5521,Hydroxychloroquine,084.6,Malaria NOS,0
5521,Hydroxychloroquine,277.1,Disorders of porphyrin metabolism,0
5521,Hydroxychloroquine,692.70,Unspecified dermatitis due to sun,0
5521,Hydroxychloroquine,695.4,Lupus erythematosus,1
5521,Hydroxychloroquine,710.0,Systemic lupus erythematosus,1
5521,Hydroxychloroquine,714.0,Rheumatoid arthritis,1
5521,Hydroxychloroquine,716.90,Arthropathy; unspecified; site unspecified,1
5531,Hetastarch,785.59,Other shock without mention of trauma,0
5542,Hydroxyprogesterone,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
5542,Hydroxyprogesterone,617,Endometriosis,0
5542,Hydroxyprogesterone,617.9,Endometriosis; site unspecified,0
5542,Hydroxyprogesterone,621.4,Hematometra,0
5542,Hydroxyprogesterone,626.0,Absence of menstruation,0
5542,Hydroxyprogesterone,634,Spontaneous abortion,0
5542,Hydroxyprogesterone,634.90,Spontaneous abortion; unspecified; without mention of complication,0
5552,hydroxyurea,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
5552,hydroxyurea,172.9,Melanoma of skin; site unspecified,1
5552,hydroxyurea,183.0,Malignant neoplasm of ovary,1
5552,hydroxyurea,189.0,Malignant neoplasm of kidney; except pelvis,0
5552,hydroxyurea,205.1,Myeloid leukemia; chronic,1
5552,hydroxyurea,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
5552,hydroxyurea,238.4,Polycythemia vera,0
5552,hydroxyurea,238.71,Essential thrombocythemia,0
5552,hydroxyurea,238.79,Other lymphatic and hematopoietic tissues,1
5552,hydroxyurea,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
5552,hydroxyurea,239.6,Neoplasm of unspecified nature of brain,0
5552,hydroxyurea,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),0
5552,hydroxyurea,282.5,Sickle-cell trait,1
5552,hydroxyurea,282.6,Sickle-cell disease,1
5552,hydroxyurea,282.60,Sickle cell disease NOS,1
5552,hydroxyurea,282.61,Hb-SS disease without crisis,1
5552,hydroxyurea,288.60,Leukocytosis NOS,0
5552,hydroxyurea,288.8,Other specified disease of white blood cells,0
5552,hydroxyurea,289.9,Blood disease NOS,0
5552,hydroxyurea,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
5552,hydroxyurea,780.96,Generalized pain,0
5553,Hydroxyzine,298.9,Unspecified psychosis,1
5553,Hydroxyzine,300.00,Anxiety state unspecified,1
5553,Hydroxyzine,300.9,Unspecified nonpsychotic mental disorder,1
5553,Hydroxyzine,698.9,Unspecified pruritic disorder,1
5553,Hydroxyzine,708.8,Other specified urticaria,1
5553,Hydroxyzine,709.9,Unspecified disorder of skin and subcutaneous tissue,1
5553,Hydroxyzine,787.02,Nausea alone,1
5553,Hydroxyzine,787.03,Vomiting alone,1
5553,Hydroxyzine,995.3,Allergy unspecified not elsewhere classified,1
5640,Ibuprofen,274,Gout,0
5640,Ibuprofen,274.9,Gout NOS,0
5640,Ibuprofen,338-338.99,,1
5640,Ibuprofen,338.18,Other acute postoperative pain,0
5640,Ibuprofen,375.2,Epiphora,1
5640,Ibuprofen,375.20,Epiphora NOS,1
5640,Ibuprofen,379.99,Other ill-defined disorders of eye,1
5640,Ibuprofen,388.7,Otalgia,1
5640,Ibuprofen,388.70,Otalgia NOS,1
5640,Ibuprofen,460,Acute nasopharyngitis (common cold),1
5640,Ibuprofen,462,Acute pharyngitis,1
5640,Ibuprofen,478.19,Other diseases of nasal cavity and sinuses,1
5640,Ibuprofen,487,Influenza,1
5640,Ibuprofen,487.1,Influenza with other respiratory manifestations,1
5640,Ibuprofen,525.9,Dental disorder NOS,1
5640,Ibuprofen,625.3,Dysmenorrhea,1
5640,Ibuprofen,625.4,Premenstrual tension syndromes,1
5640,Ibuprofen,626.2,Excessive or frequent menstruation,0
5640,Ibuprofen,698.9,Unspecified pruritic disorder,1
5640,Ibuprofen,707.9,Chronic ulcer of unspecified site,1
5640,Ibuprofen,708,Urticaria,1
5640,Ibuprofen,708.9,Unspecified urticaria,1
5640,Ibuprofen,714.0,Rheumatoid arthritis,1
5640,Ibuprofen,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
5640,Ibuprofen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
5640,Ibuprofen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
5640,Ibuprofen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
5640,Ibuprofen,716.90,Arthropathy; unspecified; site unspecified,1
5640,Ibuprofen,719.4,Pain in joint,0
5640,Ibuprofen,719.40,Pain in joint site unspecified,0
5640,Ibuprofen,720.0,Ankylosing spondylitis,0
5640,Ibuprofen,724.1,Pain in thoracic spine,1
5640,Ibuprofen,724.5,Backache unspecified,1
5640,Ibuprofen,727.3,Other bursitis disorders,0
5640,Ibuprofen,729.1,Myalgia and myositis unspecified,1
5640,Ibuprofen,747.0,Patent ductus arteriosus,1
5640,Ibuprofen,780-789.99,,0
5640,Ibuprofen,780.60,Fever; unspecified,1
5640,Ibuprofen,780.96,Generalized pain,1
5640,Ibuprofen,780.99,Other general symptoms,1
5640,Ibuprofen,781.0,Abnormal involuntary movements,0
5640,Ibuprofen,784.0,Headache,1
5640,Ibuprofen,784.1,Throat pain,1
5640,Ibuprofen,784.2,Swelling; mass; or lump in head and neck,1
5640,Ibuprofen,995.3,Allergy unspecified not elsewhere classified,1
5650,Idarubicin,205.0,Myeloid leukemia; acute,1
5650,Idarubicin,205.00,Acute myeloid leukemia without mention of having achieved remission,1
5650,Idarubicin,205.1,Myeloid leukemia; chronic,0
5650,Idarubicin,205.10,Chronic myeloid leukemia without mention of having achieved remission,0
5650,Idarubicin,208,Leukemia of unspecified cell type,1
5650,Idarubicin,208.9,Unspecified leukemia,1
5650,Idarubicin,208.90,Unspecified leukemia without mention of having achieved remission,1
5650,Idarubicin,239.3,Neoplasm of unspecified nature of breast,0
5653,Idoxuridine,054.42,Dendritic keratitis,0
5657,Ifosfamide,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
5657,Ifosfamide,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
5657,Ifosfamide,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
5657,Ifosfamide,174.9,Malignant neoplasm of breast (female); unspecified,1
5657,Ifosfamide,180.9,Malignant neoplasm of cervix uteri; unspecified,1
5657,Ifosfamide,186,Malignant neoplasm of testis,1
5657,Ifosfamide,186.9,Malignant neoplasm of other and unspecified testis,1
5657,Ifosfamide,201,Hodgkin's disease,0
5657,Ifosfamide,201.0,Hodgkin's paragranuloma,0
5657,Ifosfamide,201.1,Hodgkin's granuloma,0
5657,Ifosfamide,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
5657,Ifosfamide,201.2,Hodgkin's sarcoma,0
5657,Ifosfamide,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
5657,Ifosfamide,201.9,Hodgkin's disease; unspecified type,0
5657,Ifosfamide,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
5657,Ifosfamide,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
5657,Ifosfamide,204.1,Lymphoid leukemia; chronic,1
5657,Ifosfamide,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
5657,Ifosfamide,239.0,Neoplasm of unspecified nature of digestive system,0
5657,Ifosfamide,239.1,Neoplasm of unspecified nature of respiratory system,0
5657,Ifosfamide,239.3,Neoplasm of unspecified nature of breast,0
5657,Ifosfamide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
5657,Ifosfamide,595.9,Cystitis NOS,1
5690,Imipenem,038,Septicemia,0
5690,Imipenem,038.9,Septicemia NOS,0
5690,Imipenem,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
5690,Imipenem,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
5690,Imipenem,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
5690,Imipenem,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
5690,Imipenem,041.9|421.0,,0
5690,Imipenem,519.8,Other diseases of respiratory system; not elsewhere classified,0
5690,Imipenem,599.0,Urinary tract infection; site not specified,0
5691,Imipramine,296.20,Major depressive disorder; single episode; unspecified degree,1
5691,Imipramine,300.01,Panic disorder without agoraphobia,0
5691,Imipramine,307.6,Enuresis,1
5691,Imipramine,311,Depressive disorder NEC,1
5691,Imipramine,314,Hyperkinetic syndrome of childhood,0
5691,Imipramine,314.01,Attention deficit disorder of childhood with hyperactivity,0
5691,Imipramine,314.9,Unspecified hyperkinetic syndrome of childhood,0
5691,Imipramine,338-338.99,,0
5691,Imipramine,780.96,Generalized pain,0
5764,Indapamide,276.69,Other fluid overload,1
5764,Indapamide,401-405.99,,1
5764,Indapamide,401.9,Hypertension NOS,1
5764,Indapamide,428.0,Congestive heart failure (CHF) NOS,1
5764,Indapamide,581,Nephrotic syndrome,0
5764,Indapamide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
5764,Indapamide,782.3,Edema,1
5764,Indapamide,997.91,Hypertension,1
5781,Indomethacin,274.0,Gouty arthropathy,1
5781,Indomethacin,274.00,Gouty arthropathy (ADDED),1
5781,Indomethacin,274.9,Gout NOS,1
5781,Indomethacin,338-338.99,,1
5781,Indomethacin,714.0,Rheumatoid arthritis,1
5781,Indomethacin,715.00,Osteoarthrosis; generalized; involving unspecified site,1
5781,Indomethacin,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
5781,Indomethacin,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
5781,Indomethacin,716.90,Arthropathy; unspecified; site unspecified,1
5781,Indomethacin,719.50,Stiffness of joint; not elsewhere classified; involving unspecified site,1
5781,Indomethacin,720.0,Ankylosing spondylitis,1
5781,Indomethacin,726.90,Enthesopathy of specified site,1
5781,Indomethacin,727.3,Other bursitis disorders,1
5781,Indomethacin,747.0,Patent ductus arteriosus,1
5781,Indomethacin,780.60,Fever; unspecified,0
5781,Indomethacin,780.96,Generalized pain,1
5879,Interferon Alfa-2a,070.31,Viral hepatitis B without mention of hepatic coma; acute or unspecified; with hepatitis delta,0
5879,Interferon Alfa-2a,070.54,Chronic hepatitis C without mention of hepatic coma,1
5879,Interferon Alfa-2a,078.1,Viral warts,0
5879,Interferon Alfa-2a,078.10,Viral warts; unspecified,0
5879,Interferon Alfa-2a,155.0,Malignant neoplasm of liver; primary,0
5879,Interferon Alfa-2a,172.9,Melanoma of skin; site unspecified,0
5879,Interferon Alfa-2a,176,Kaposi's sarcoma,0
5879,Interferon Alfa-2a,176.9,Kaposi's sarcoma NOS,0
5879,Interferon Alfa-2a,189.0,Malignant neoplasm of kidney; except pelvis,0
5879,Interferon Alfa-2a,202.1,Mycosis fungoides,0
5879,Interferon Alfa-2a,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
5879,Interferon Alfa-2a,202.2,Sezary's disease,0
5879,Interferon Alfa-2a,202.20,Sezary's disease; unspecified site; extranodal and solid organ sites,0
5879,Interferon Alfa-2a,202.4,Leukemic reticuloendotheliosis,1
5879,Interferon Alfa-2a,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,1
5879,Interferon Alfa-2a,203.0,Multiple myeloma,0
5879,Interferon Alfa-2a,203.00,Multiple myeloma without mention of having achieved remission,0
5879,Interferon Alfa-2a,228.0,Hemangioma; any site,0
5879,Interferon Alfa-2a,228.00,Hemangioma NOS,0
5879,Interferon Alfa-2a,238.71,Essential thrombocythemia,0
5879,Interferon Alfa-2a,239.0,Neoplasm of unspecified nature of digestive system,0
5879,Interferon Alfa-2a,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
5879,Interferon Alfa-2a,239.6,Neoplasm of unspecified nature of brain,0
5879,Interferon Alfa-2a,273.2,Other paraproteinemias,0
5879,Interferon Alfa-2a,287.5,Thrombocytopenia NOS,0
5879,Interferon Alfa-2a,362.50,Macular degeneration (senile) of retina NOS,0
5879,Interferon Alfa-2a,707.9,Chronic ulcer of unspecified site,0
5879,Interferon Alfa-2a,709.8,Other specified disorders of skin,0
5879,Interferon Alfa-2a,790.99,Other nonspecific findings on examination of blood,0
5880,Interferon Alfa-2b,054.1,Genital herpes,0
5880,Interferon Alfa-2b,054.10,Genital herpes NOS,0
5880,Interferon Alfa-2b,070.31,Viral hepatitis B without mention of hepatic coma; acute or unspecified; with hepatitis delta,0
5880,Interferon Alfa-2b,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
5880,Interferon Alfa-2b,070.54,Chronic hepatitis C without mention of hepatic coma,1
5880,Interferon Alfa-2b,078.1,Viral warts,0
5880,Interferon Alfa-2b,078.10,Viral warts; unspecified,0
5880,Interferon Alfa-2b,078.11,Condyloma acuminatum,1
5880,Interferon Alfa-2b,155.0,Malignant neoplasm of liver; primary,0
5880,Interferon Alfa-2b,172.9,Melanoma of skin; site unspecified,1
5880,Interferon Alfa-2b,176,Kaposi's sarcoma,0
5880,Interferon Alfa-2b,176.9,Kaposi's sarcoma NOS,0
5880,Interferon Alfa-2b,189.0,Malignant neoplasm of kidney; except pelvis,0
5880,Interferon Alfa-2b,200.80,Other named variants of lymphosarcoma and reticulosarcoma; unspecified site,1
5880,Interferon Alfa-2b,202.0,Nodular lymphoma,1
5880,Interferon Alfa-2b,202.00,Nodular lymphoma; unspecified site; extranodal and solid organ sites,1
5880,Interferon Alfa-2b,202.1,Mycosis fungoides,0
5880,Interferon Alfa-2b,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
5880,Interferon Alfa-2b,202.2,Sezary's disease,0
5880,Interferon Alfa-2b,202.20,Sezary's disease; unspecified site; extranodal and solid organ sites,0
5880,Interferon Alfa-2b,202.4,Leukemic reticuloendotheliosis,1
5880,Interferon Alfa-2b,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,1
5880,Interferon Alfa-2b,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
5880,Interferon Alfa-2b,203.0,Multiple myeloma,0
5880,Interferon Alfa-2b,203.00,Multiple myeloma without mention of having achieved remission,0
5880,Interferon Alfa-2b,205.1,Myeloid leukemia; chronic,0
5880,Interferon Alfa-2b,205.10,Chronic myeloid leukemia without mention of having achieved remission,0
5880,Interferon Alfa-2b,228.0,Hemangioma; any site,0
5880,Interferon Alfa-2b,228.00,Hemangioma NOS,0
5880,Interferon Alfa-2b,238.4,Polycythemia vera,0
5880,Interferon Alfa-2b,238.71,Essential thrombocythemia,0
5880,Interferon Alfa-2b,239.0,Neoplasm of unspecified nature of digestive system,0
5880,Interferon Alfa-2b,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
5880,Interferon Alfa-2b,239.6,Neoplasm of unspecified nature of brain,0
5880,Interferon Alfa-2b,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
5880,Interferon Alfa-2b,259.2,Carcinoid syndrome,0
5880,Interferon Alfa-2b,273.2,Other paraproteinemias,0
5880,Interferon Alfa-2b,287.30,Primary thrombocytopenia; unspecified,0
5880,Interferon Alfa-2b,287.5,Thrombocytopenia NOS,0
5880,Interferon Alfa-2b,362.50,Macular degeneration (senile) of retina NOS,0
5880,Interferon Alfa-2b,447.6,Arteritis NOS,0
5880,Interferon Alfa-2b,707.9,Chronic ulcer of unspecified site,0
5880,Interferon Alfa-2b,709.8,Other specified disorders of skin,0
5880,Interferon Alfa-2b,790.99,Other nonspecific findings on examination of blood,0
5882,Interferon gamma-1b,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
5882,Interferon gamma-1b,070.31,Viral hepatitis B without mention of hepatic coma; acute or unspecified; with hepatitis delta,0
5882,Interferon gamma-1b,070.54,Chronic hepatitis C without mention of hepatic coma,0
5882,Interferon gamma-1b,078.1,Viral warts,0
5882,Interferon gamma-1b,078.10,Viral warts; unspecified,0
5882,Interferon gamma-1b,136.9,Unspecified infectious and parasitic diseases,1
5882,Interferon gamma-1b,155.0,Malignant neoplasm of liver; primary,0
5882,Interferon gamma-1b,172.9,Melanoma of skin; site unspecified,0
5882,Interferon gamma-1b,176,Kaposi's sarcoma,0
5882,Interferon gamma-1b,176.9,Kaposi's sarcoma NOS,0
5882,Interferon gamma-1b,189.0,Malignant neoplasm of kidney; except pelvis,0
5882,Interferon gamma-1b,202.1,Mycosis fungoides,0
5882,Interferon gamma-1b,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
5882,Interferon gamma-1b,202.2,Sezary's disease,0
5882,Interferon gamma-1b,202.20,Sezary's disease; unspecified site; extranodal and solid organ sites,0
5882,Interferon gamma-1b,202.4,Leukemic reticuloendotheliosis,0
5882,Interferon gamma-1b,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,0
5882,Interferon gamma-1b,203.0,Multiple myeloma,0
5882,Interferon gamma-1b,203.00,Multiple myeloma without mention of having achieved remission,0
5882,Interferon gamma-1b,228.0,Hemangioma; any site,0
5882,Interferon gamma-1b,228.00,Hemangioma NOS,0
5882,Interferon gamma-1b,238.71,Essential thrombocythemia,0
5882,Interferon gamma-1b,239.0,Neoplasm of unspecified nature of digestive system,0
5882,Interferon gamma-1b,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
5882,Interferon gamma-1b,239.6,Neoplasm of unspecified nature of brain,0
5882,Interferon gamma-1b,273.2,Other paraproteinemias,0
5882,Interferon gamma-1b,287.5,Thrombocytopenia NOS,0
5882,Interferon gamma-1b,288.1,Functional disorders of polymorphonuclear neutrophils,1
5882,Interferon gamma-1b,312.89,Other conduct disorder,0
5882,Interferon gamma-1b,362.50,Macular degeneration (senile) of retina NOS,0
5882,Interferon gamma-1b,686.1,Pyogenic granuloma of skin and subcutaneous tissue,1
5882,Interferon gamma-1b,707.9,Chronic ulcer of unspecified site,0
5882,Interferon gamma-1b,709.8,Other specified disorders of skin,0
5882,Interferon gamma-1b,756.52,Osteopetrosis,1
5882,Interferon gamma-1b,790.99,Other nonspecific findings on examination of blood,0
5924,Inulin,593.9,Unspecified disorder of kidney and ureter,0
5933,Iodine,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
5933,Iodine,707.10,Ulcer of lower limb; unspecified,0
5933,Iodine,940-949.99,,0
5933,Iodine,949.0,Burn of unspecified site; unspecified degree,0
5933,Iodine,990|E926.3,,0
5933,Iodine,998.59,Other postoperative infection,0
5942,Clioquinol,110.4,Dermatophytosis of foot,0
5967,Iopanoic Acid,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,0
5967,Iopanoic Acid,575.9,Unspecified disorder of gallbladder,0
5975,Ipecac,977.9,Poisoning by unspecified drug or medicinal substance,0
5992,Iron-Dextran Complex,280,Iron deficiency anemias,0
5992,Iron-Dextran Complex,280.9,Iron deficiency anemia; unspecified,0
6011,Isocarboxazid,300.01,Panic disorder without agoraphobia,1
6011,Isocarboxazid,311,Depressive disorder NEC,1
6023,Isoetharine,493,Asthma,0
6023,Isoetharine,493.9,Asthma; unspecified,0
6023,Isoetharine,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
6023,Isoetharine,519.11,Acute bronchospasm,0
6023,Isoetharine,786.05,Shortness of breath,0
6023,Isoetharine,786.09,Other dyspnea and respiratory abnormality,0
6026,Isoflurane,311,Depressive disorder NEC,0
6026,Isoflurane,493.91,Asthma; unspecified type; with status asthmaticus,0
6027,Isoflurophate,365,Glaucoma,0
6027,Isoflurophate,365.9,Glaucoma NOS,0
6027,Isoflurophate,378.30,Heterotropia NOS,0
6027,Isoflurophate,378.4,Heterophoria,0
6027,Isoflurophate,378.40,Heterophoria NOS,0
6027,Isoflurophate,378.9,Unspecified disorder of eye movements,0
6038,isoniazid,010-018.99,,1
6038,isoniazid,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
6038,isoniazid,136.9,Unspecified infectious and parasitic diseases,1
6038,isoniazid,269.9,Unspecified nutritional deficiency,1
6054,Isoproterenol,426.9,Conduction disorder NOS,1
6054,Isoproterenol,427.1,Paroxysmal ventricular tachycardia,1
6054,Isoproterenol,427.41,Ventricular fibrillation,0
6054,Isoproterenol,427.89,Other specified cardiac dysrhythmias,0
6054,Isoproterenol,427.9,Cardiac dysrhythmia NOS,1
6054,Isoproterenol,493,Asthma,0
6054,Isoproterenol,493.9,Asthma; unspecified,0
6054,Isoproterenol,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
6054,Isoproterenol,780.2,Syncope and collapse,0
6054,Isoproterenol,785.0,Tachycardia NOS,1
6057,Isosorbide,365,Glaucoma,1
6057,Isosorbide,365.9,Glaucoma NOS,1
6057,Isosorbide,413,Angina pectoris,1
6057,Isosorbide,413.9,Other and unspecified angina pectoris,1
6057,Isosorbide,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,0
6057,Isosorbide,428.0,Congestive heart failure (CHF) NOS,0
6057,Isosorbide,530.5,Dyskinesia of esophagus,0
6057,Isosorbide,530.81,Esophageal reflux,0
6057,Isosorbide,782.5,Cyanosis,0
6057,Isosorbide,786.50,Unspecified chest pain,1
6057,Isosorbide,977.9,Poisoning by unspecified drug or medicinal substance,0
6058,Isosorbide Dinitrate,413,Angina pectoris,1
6058,Isosorbide Dinitrate,413.9,Other and unspecified angina pectoris,1
6058,Isosorbide Dinitrate,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,0
6058,Isosorbide Dinitrate,428.0,Congestive heart failure (CHF) NOS,0
6058,Isosorbide Dinitrate,530.5,Dyskinesia of esophagus,0
6058,Isosorbide Dinitrate,530.81,Esophageal reflux,0
6058,Isosorbide Dinitrate,782.5,Cyanosis,0
6058,Isosorbide Dinitrate,786.50,Unspecified chest pain,1
6058,Isosorbide Dinitrate,977.9,Poisoning by unspecified drug or medicinal substance,0
6064,Isotretinoin,208,Leukemia of unspecified cell type,0
6064,Isotretinoin,208.9,Unspecified leukemia,0
6064,Isotretinoin,208.90,Unspecified leukemia without mention of having achieved remission,0
6064,Isotretinoin,209.20,Malignant carcinoid tumor of unknown primary site,0
6064,Isotretinoin,629.89,Other specified disorders of female genital organs,1
6064,Isotretinoin,706.1,Other acne,1
6066,Isoxsuprine,440.9,Atherosclerosis NOS,1
6066,Isoxsuprine,443.0,Raynaud's syndrome,1
6066,Isoxsuprine,443.1,Thromboangiitis obliterans [Buerger's disease],1
6066,Isoxsuprine,443.9,Peripheral vascular disease; unspecified,1
6066,Isoxsuprine,459.9,Unspecified circulatory system disorder,1
6069,Ivermectin,120-129.99,,0
6069,Ivermectin,125.3,Onchocerciasis,1
6069,Ivermectin,125.5,Mansonella ozzardi infection,0
6069,Ivermectin,125.9,Filariasis NOS,0
6069,Ivermectin,127.0,Ascariasis,0
6069,Ivermectin,127.2,Strongyloidiasis,1
6069,Ivermectin,127.3,Trichuriasis,0
6069,Ivermectin,127.4,Enterobiasis,0
6069,Ivermectin,128.9,Helminthiasis NOS,0
6069,Ivermectin,133.0,Scabies,0
6069,Ivermectin,134.9,Infestation NOS,0
6069,Ivermectin,136.9,Unspecified infectious and parasitic diseases,1
6099,Kanamycin,031.9,Unspecified diseases due to mycobacteria,0
6099,Kanamycin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
6099,Kanamycin,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
6099,Kanamycin,519.8,Other diseases of respiratory system; not elsewhere classified,0
6099,Kanamycin,572.2,Hepatic encephalopathy,0
6130,Ketamine,338-338.99,,1
6130,Ketamine,780.96,Generalized pain,1
6135,Ketoconazole,039.9,Actinomycosis NOS,0
6135,Ketoconazole,085,Leishmaniasis,0
6135,Ketoconazole,085.9,Leishmaniasis NOS,0
6135,Ketoconazole,110-118.99,,1
6135,Ketoconazole,110.3,Dermatophytosis of groin and perianal area,1
6135,Ketoconazole,110.4,Dermatophytosis of foot,1
6135,Ketoconazole,110.5,Dermatophytosis of the body,1
6135,Ketoconazole,111,Dermatomycosis; other and unspecified,0
6135,Ketoconazole,111.0,Pityriasis versicolor,1
6135,Ketoconazole,111.9,Dermatomycosis NOS,0
6135,Ketoconazole,112,Candidiasis,1
6135,Ketoconazole,112.0,Candidiasis of mouth,1
6135,Ketoconazole,112.1,Candidiasis of vulva and vagina,0
6135,Ketoconazole,112.3,Candidiasis of skin and nails,1
6135,Ketoconazole,112.9,Candidiasis of unspecified site,1
6135,Ketoconazole,114,Coccidioidomycosis,1
6135,Ketoconazole,114.9,Coccidioidomycosis NOS,1
6135,Ketoconazole,115,Histoplasmosis,1
6135,Ketoconazole,115.9,Histoplasmosis; unspecified,1
6135,Ketoconazole,115.90,Histoplasmosis; unspecified without mention of manifestation,1
6135,Ketoconazole,116,Blastomycotic infection,1
6135,Ketoconazole,116.0,Blastomycosis,1
6135,Ketoconazole,116.1,Paracoccidioidomycosis,1
6135,Ketoconazole,117.9,Other and unspecified mycoses,1
6135,Ketoconazole,136.9,Unspecified infectious and parasitic diseases,1
6135,Ketoconazole,185,Malignant neoplasm of prostate,0
6135,Ketoconazole,255.0,Cushing's syndrome,0
6135,Ketoconazole,370.8,Other forms of keratitis,0
6135,Ketoconazole,690.1,Seborrheic dermatitis,1
6135,Ketoconazole,690.10,Seborheic dermatitis; unspecified,1
6135,Ketoconazole,690.18,Other seborrheic dermatitis,0
6135,Ketoconazole,692.9,Contact dermatitis and other eczema; unspecified cause,1
6135,Ketoconazole,706.3,Seborrhea,1
6142,Ketoprofen,338-338.99,,1
6142,Ketoprofen,525.9,Dental disorder NOS,0
6142,Ketoprofen,625.3,Dysmenorrhea,1
6142,Ketoprofen,714.0,Rheumatoid arthritis,1
6142,Ketoprofen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
6142,Ketoprofen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
6142,Ketoprofen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
6142,Ketoprofen,716.90,Arthropathy; unspecified; site unspecified,1
6142,Ketoprofen,780.60,Fever; unspecified,0
6142,Ketoprofen,780.96,Generalized pain,1
6142,Ketoprofen,780.99,Other general symptoms,1
6146,Ketotifen,372.14,Other chronic allergic conjunctivitis,1
6146,Ketotifen,379.99,Other ill-defined disorders of eye,1
6146,Ketotifen,477.9,Allergic rhinitis NOS,0
6146,Ketotifen,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
6146,Ketotifen,698.9,Unspecified pruritic disorder,1
6146,Ketotifen,995.3,Allergy unspecified not elsewhere classified,1
6185,Labetalol,401-405.99,,1
6185,Labetalol,401.0,Malignant essential hypertension,0
6185,Labetalol,401.9,Hypertension NOS,1
6185,Labetalol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
6185,Labetalol,413,Angina pectoris,0
6185,Labetalol,413.9,Other and unspecified angina pectoris,0
6185,Labetalol,428.0,Congestive heart failure (CHF) NOS,0
6185,Labetalol,786.50,Unspecified chest pain,0
6185,Labetalol,997.91,Hypertension,1
6218,Lactulose,564.0,Constipation,1
6218,Lactulose,564.00,Constipation NOS,1
6218,Lactulose,564.09,Other constipation,1
6218,Lactulose,572.2,Hepatic encephalopathy,0
6218,Lactulose,573.9,Unspecified disorder of liver,0
6313,Leucovorin,266.2,Other B-complex deficiencies,1
6313,Leucovorin,281.9,Deficiency anemia NOS,1
6313,Leucovorin,285.9,Anemia unspecified,1
6313,Leucovorin,977.9,Poisoning by unspecified drug or medicinal substance,0
6371,Levamisole,239.0,Neoplasm of unspecified nature of digestive system,0
6373,Levonorgestrel,338-338.99,,0
6373,Levonorgestrel,617,Endometriosis,0
6373,Levonorgestrel,617.9,Endometriosis; site unspecified,0
6373,Levonorgestrel,626.2,Excessive or frequent menstruation,0
6373,Levonorgestrel,780.96,Generalized pain,0
6373,Levonorgestrel,V22.2,Pregnant state; incidental,1
6375,Levodopa,332,Parkinson's disease,0
6375,Levodopa,332.0,Paralysis agitans,0
6378,Levorphanol,338-338.99,,1
6378,Levorphanol,780.96,Generalized pain,1
6384,Gonadorelin,259.0,Delay in sexual development and puberty NEC,0
6384,Gonadorelin,259.1,Precocious sexual development and puberty NEC,0
6384,Gonadorelin,626.0,Absence of menstruation,0
6387,Lidocaine,053.19,Herpes zoster with other nervous system complications,0
6387,Lidocaine,338-338.99,,1
6387,Lidocaine,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
6387,Lidocaine,427.1,Paroxysmal ventricular tachycardia,1
6387,Lidocaine,427.2,Paroxysmal tachycardia; unspecified,0
6387,Lidocaine,427.41,Ventricular fibrillation,0
6387,Lidocaine,427.69,Other premature beats,1
6387,Lidocaine,427.9,Cardiac dysrhythmia NOS,1
6387,Lidocaine,455,Hemorrhoids,1
6387,Lidocaine,455.6,Hemorrhoids NOS,1
6387,Lidocaine,528.9,Other and unspecified diseases of the oral soft tissues,0
6387,Lidocaine,530,Diseases of esophagus,0
6387,Lidocaine,530.9,Unspecified disorder of esophagus,0
6387,Lidocaine,692.9,Contact dermatitis and other eczema; unspecified cause,1
6387,Lidocaine,698.9,Unspecified pruritic disorder,1
6387,Lidocaine,780-789.99,,0
6387,Lidocaine,780.96,Generalized pain,1
6387,Lidocaine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
6387,Lidocaine,786.2,Cough,0
6387,Lidocaine,940-949.99,,0
6387,Lidocaine,949.0,Burn of unspecified site; unspecified degree,0
6387,Lidocaine,977.9,Poisoning by unspecified drug or medicinal substance,0
6398,Lincomycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
6398,Lincomycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,1
6406,Lipase,799.9,Other unknown and unspecified cause of morbidity or mortality,0
6448,Lithium,296.80,Bipolar disorder NOS,1
6448,Lithium,308.9,Unspecified acute reaction to stress,0
6448,Lithium,309.81,Posttraumatic stress disorder,0
6448,Lithium,311,Depressive disorder NEC,1
6448,Lithium,312.9,Unspecified disturbance of conduct,0
6448,Lithium,799.24,Emotional lability (ADDED),1
6466,Lomustine,172.9,Melanoma of skin; site unspecified,0
6466,Lomustine,201,Hodgkin's disease,0
6466,Lomustine,201.0,Hodgkin's paragranuloma,0
6466,Lomustine,201.1,Hodgkin's granuloma,0
6466,Lomustine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
6466,Lomustine,201.2,Hodgkin's sarcoma,0
6466,Lomustine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
6466,Lomustine,201.9,Hodgkin's disease; unspecified type,0
6466,Lomustine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
6466,Lomustine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
6466,Lomustine,239.0,Neoplasm of unspecified nature of digestive system,0
6466,Lomustine,239.1,Neoplasm of unspecified nature of respiratory system,0
6466,Lomustine,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6466,Lomustine,239.6,Neoplasm of unspecified nature of brain,1
6468,Loperamide,004.9,Shigellosis NOS,0
6468,Loperamide,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
6468,Loperamide,780-789.99,,0
6468,Loperamide,787.7,Abnormal feces,1
6468,Loperamide,787.91,Diarrhea,1
6470,Lorazepam,290-299.99,,0
6470,Lorazepam,291.81,Alcohol withdrawal,0
6470,Lorazepam,295.20,Catatonic type schizophrenia; unspecified state,0
6470,Lorazepam,298.9,Unspecified psychosis,0
6470,Lorazepam,300.00,Anxiety state unspecified,1
6470,Lorazepam,307.42,Persistent disorder of initiating or maintaining sleep,0
6470,Lorazepam,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
6470,Lorazepam,311,Depressive disorder NEC,1
6470,Lorazepam,345.3,Grand mal status; epileptic,1
6470,Lorazepam,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
6470,Lorazepam,780.09,Other alteration of consciousness,1
6470,Lorazepam,780.52,Insomnia; unspecified,0
6470,Lorazepam,787.02,Nausea alone,0
6470,Lorazepam,787.03,Vomiting alone,0
6472,Lovastatin,272.1,Pure hyperglyceridemia,1
6472,Lovastatin,272.4,Other and unspecified hyperlipidemia,1
6472,Lovastatin,272.8,Other disorders of lipoid metabolism,1
6472,Lovastatin,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,1
6472,Lovastatin,429.2,Cardiovascular disease [ASCVD],1
6472,Lovastatin,440,Atherosclerosis,1
6472,Lovastatin,447.9,Unspecified disorders of arteries and arterioles,1
6472,Lovastatin,783.21,Loss of weight,0
6472,Lovastatin,783.9,Other symptoms concerning nutrition; metabolism; and development,0
6472,Lovastatin,786.50,Unspecified chest pain,1
6472,Lovastatin,799.9,Other unknown and unspecified cause of morbidity or mortality,1
6475,Loxapine,290-299.99,,0
6475,Loxapine,295,Schizophrenic disorders,1
6475,Loxapine,295.9,Unspecified schizophrenia,1
6475,Loxapine,295.90,Unspecified schizophrenia; unspecified state,1
6475,Loxapine,298.9,Unspecified psychosis,0
6572,Mafenide,038,Septicemia,0
6572,Mafenide,038.9,Septicemia NOS,0
6572,Mafenide,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
6572,Mafenide,958.3,Posttraumatic wound infection not elsewhere classified,0
6579,Magnesium Chloride,275.2,Disorders of magnesium metabolism,0
6581,Magnesium Hydroxide,275.2,Disorders of magnesium metabolism,0
6581,Magnesium Hydroxide,277.9,Unspecified disorder of metabolism,0
6581,Magnesium Hydroxide,530.11,Reflux esophagitis,0
6581,Magnesium Hydroxide,530.81,Esophageal reflux,0
6581,Magnesium Hydroxide,531,Gastric ulcer,0
6581,Magnesium Hydroxide,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
6581,Magnesium Hydroxide,532,Duodenal ulcer,0
6581,Magnesium Hydroxide,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
6581,Magnesium Hydroxide,536.8,Dyspepsia and other specified disorders of function of stomach,0
6581,Magnesium Hydroxide,564.0,Constipation,1
6581,Magnesium Hydroxide,564.00,Constipation NOS,1
6581,Magnesium Hydroxide,578,Gastrointestinal hemorrhage,0
6581,Magnesium Hydroxide,578.9,Hemorrhage of gastrointestinal tract NOS,0
6581,Magnesium Hydroxide,585.6,End stage renal disease,0
6581,Magnesium Hydroxide,585.9,Chronic kidney disease; unspecified,0
6581,Magnesium Hydroxide,586,Renal failure unspecified,0
6581,Magnesium Hydroxide,780-789.99,,0
6581,Magnesium Hydroxide,787.1,Heartburn,0
6582,Magnesium Oxide,275.2,Disorders of magnesium metabolism,0
6582,Magnesium Oxide,536.8,Dyspepsia and other specified disorders of function of stomach,0
6582,Magnesium Oxide,787.1,Heartburn,0
6585,Magnesium Sulfate,275.2,Disorders of magnesium metabolism,1
6585,Magnesium Sulfate,427.1,Paroxysmal ventricular tachycardia,0
6585,Magnesium Sulfate,427.41,Ventricular fibrillation,0
6585,Magnesium Sulfate,564.0,Constipation,0
6585,Magnesium Sulfate,564.00,Constipation NOS,0
6585,Magnesium Sulfate,583.9,Nephritis and nephropathy; not specified as acute or chronic; with unspecified pathological lesion in kidney,0
6585,Magnesium Sulfate,642.40,Mild or unspecified pre-eclampsia; unspecified as to episode of care,1
6585,Magnesium Sulfate,642.60,Eclampsia complicating pregnancy; childbirth or the puerperium; unspecified as to episode of care,1
6585,Magnesium Sulfate,780.39,Other convulsions,1
6606,Malathion,132.0,Pediculus capitis [head louse],1
6606,Malathion,132.9,Pediculosis NOS,0
6628,Mannitol,348.5,Cerebral edema,1
6628,Mannitol,365.04,Ocular hypertension,0
6628,Mannitol,413,Angina pectoris,0
6628,Mannitol,413.9,Other and unspecified angina pectoris,0
6628,Mannitol,428.0,Congestive heart failure (CHF) NOS,0
6628,Mannitol,514,Pulmonary congestion and hypostasis,0
6628,Mannitol,584,Acute renal failure,1
6628,Mannitol,584.9,Acute renal failure NOS,1
6628,Mannitol,586,Renal failure unspecified,1
6628,Mannitol,602.9,Disorder of prostate NOS,0
6628,Mannitol,784.2,Swelling; mass; or lump in head and neck,0
6628,Mannitol,786.50,Unspecified chest pain,0
6628,Mannitol,788.5,Oliguria and anuria,0
6628,Mannitol,789.5,Ascites,0
6628,Mannitol,789.59,Other ascites,0
6628,Mannitol,790.6,Other abnormal blood chemistry,0
6628,Mannitol,959.01,Head injury NOS,0
6628,Mannitol,977.9,Poisoning by unspecified drug or medicinal substance,0
6628,Mannitol,998.9,Unspecified complication of procedure; not elsewhere classified,0
6646,Maprotiline,292.89,Other specified drug-induced mental disorders,0
6646,Maprotiline,300.00,Anxiety state unspecified,0
6646,Maprotiline,300.01,Panic disorder without agoraphobia,0
6646,Maprotiline,307.51,Bulimia nervosa,0
6646,Maprotiline,307.6,Enuresis,0
6646,Maprotiline,311,Depressive disorder NEC,0
6646,Maprotiline,338-338.99,,0
6646,Maprotiline,532,Duodenal ulcer,0
6646,Maprotiline,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
6646,Maprotiline,780.96,Generalized pain,0
6664,Mazindol,278.00,Obesity NOS,0
6669,Measles Vaccine,055,Measles,0
6669,Measles Vaccine,055.9,Measles without mention of complication,0
6672,Mebendazole,120-129.99,,0
6672,Mebendazole,126.9,Ancylostomiasis NOS,0
6672,Mebendazole,127.0,Ascariasis,0
6672,Mebendazole,127.3,Trichuriasis,0
6672,Mebendazole,127.4,Enterobiasis,0
6672,Mebendazole,127.9,Intestinal helminthiasis; unspecified,0
6672,Mebendazole,128.9,Helminthiasis NOS,0
6673,Mecamylamine,307.23,Tourette's disorder,0
6673,Mecamylamine,401.0,Malignant essential hypertension,1
6674,Mechlorethamine,200.1,Lymphosarcoma,1
6674,Mechlorethamine,200.10,Lymphosarcoma; unspecified site; extranodal and solid organ sites,1
6674,Mechlorethamine,201,Hodgkin's disease,0
6674,Mechlorethamine,201.0,Hodgkin's paragranuloma,0
6674,Mechlorethamine,201.1,Hodgkin's granuloma,0
6674,Mechlorethamine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
6674,Mechlorethamine,201.2,Hodgkin's sarcoma,0
6674,Mechlorethamine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
6674,Mechlorethamine,201.9,Hodgkin's disease; unspecified type,0
6674,Mechlorethamine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
6674,Mechlorethamine,202.1,Mycosis fungoides,1
6674,Mechlorethamine,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,1
6674,Mechlorethamine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
6674,Mechlorethamine,204.1,Lymphoid leukemia; chronic,1
6674,Mechlorethamine,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
6674,Mechlorethamine,208,Leukemia of unspecified cell type,1
6674,Mechlorethamine,208.9,Unspecified leukemia,1
6674,Mechlorethamine,208.90,Unspecified leukemia without mention of having achieved remission,1
6674,Mechlorethamine,238.4,Polycythemia vera,1
6674,Mechlorethamine,511.81,Malignant pleural effusion,0
6676,Meclizine,780-789.99,,0
6676,Meclizine,780.4,Dizziness and giddiness,1
6676,Meclizine,787.02,Nausea alone,1
6676,Meclizine,787.03,Vomiting alone,1
6676,Meclizine,994.6,Motion sickness,1
6691,Medroxyprogesterone,179,Malignant neoplasm of uterus; part unspecified,1
6691,Medroxyprogesterone,189.0,Malignant neoplasm of kidney; except pelvis,0
6691,Medroxyprogesterone,199.1,Other malignant neoplasm of unspecified site,1
6691,Medroxyprogesterone,239.3,Neoplasm of unspecified nature of breast,0
6691,Medroxyprogesterone,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6691,Medroxyprogesterone,338-338.99,,1
6691,Medroxyprogesterone,459.0,Hemorrhage NOS,1
6691,Medroxyprogesterone,617,Endometriosis,1
6691,Medroxyprogesterone,617.9,Endometriosis; site unspecified,1
6691,Medroxyprogesterone,621.3,Endometrial hyperplasia,1
6691,Medroxyprogesterone,621.30,Endometrial hyperplasia; unspecified,1
6691,Medroxyprogesterone,621.4,Hematometra,1
6691,Medroxyprogesterone,625.3,Dysmenorrhea,1
6691,Medroxyprogesterone,626.0,Absence of menstruation,1
6691,Medroxyprogesterone,626.4,Irregular menstrual cycle,0
6691,Medroxyprogesterone,627.2,Symptomatic menopausal or female climacteric states,1
6691,Medroxyprogesterone,780.96,Generalized pain,1
6691,Medroxyprogesterone,782.62,Flushing,1
6691,Medroxyprogesterone,786.09,Other dyspnea and respiratory abnormality,0
6691,Medroxyprogesterone,799.9,Other unknown and unspecified cause of morbidity or mortality,0
6691,Medroxyprogesterone,V22.2,Pregnant state; incidental,1
6693,Mefenamic Acid,338-338.99,,1
6693,Mefenamic Acid,625.3,Dysmenorrhea,1
6693,Mefenamic Acid,625.4,Premenstrual tension syndromes,0
6693,Mefenamic Acid,626.2,Excessive or frequent menstruation,0
6693,Mefenamic Acid,780.60,Fever; unspecified,0
6693,Mefenamic Acid,780.96,Generalized pain,1
6694,Mefloquine,084,Malaria,0
6694,Mefloquine,084.0,Falciparum malaria [malignant tertian],0
6694,Mefloquine,084.1,Vivax malaria [benign tertian],1
6694,Mefloquine,084.2,Quartan malaria,0
6694,Mefloquine,084.6,Malaria NOS,0
6694,Mefloquine,136.9,Unspecified infectious and parasitic diseases,1
6703,Megestrol,042,Human immunodeficiency virus [HIV] disease,1
6703,Megestrol,174.9,Malignant neoplasm of breast (female); unspecified,1
6703,Megestrol,185,Malignant neoplasm of prostate,1
6703,Megestrol,239.3,Neoplasm of unspecified nature of breast,0
6703,Megestrol,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6703,Megestrol,783.0,Anorexia,1
6703,Megestrol,783.9,Other symptoms concerning nutrition; metabolism; and development,1
6703,Megestrol,799.4,Cachexia,1
6711,Melatonin,327.35,Circadian rhythm sleep disorder; jet lag type,0
6718,Melphalan,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
6718,Melphalan,172.9,Melanoma of skin; site unspecified,1
6718,Melphalan,203.0,Multiple myeloma,1
6718,Melphalan,203.00,Multiple myeloma without mention of having achieved remission,1
6718,Melphalan,209.20,Malignant carcinoid tumor of unknown primary site,1
6718,Melphalan,239.3,Neoplasm of unspecified nature of breast,0
6718,Melphalan,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6719,Memantine,331.0,Alzheimer's disease,0
6750,Menthol,338-338.99,,1
6750,Menthol,462,Acute pharyngitis,1
6750,Menthol,698.9,Unspecified pruritic disorder,0
6750,Menthol,709.9,Unspecified disorder of skin and subcutaneous tissue,0
6750,Menthol,716.90,Arthropathy; unspecified; site unspecified,1
6750,Menthol,780.79,Other malaise and fatigue,1
6750,Menthol,780.96,Generalized pain,1
6750,Menthol,784.1,Throat pain,1
6750,Menthol,786.2,Cough,1
6754,Meperidine,338-338.99,,1
6754,Meperidine,780.60,Fever; unspecified,0
6754,Meperidine,780.96,Generalized pain,1
6754,Meperidine,784.0,Headache,0
6757,Mephenytoin,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
6757,Mephenytoin,345.40,Partial epilepsy without intractable epilepsy,1
6757,Mephenytoin,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,0
6757,Mephenytoin,780.39,Other convulsions,1
6758,Mephobarbital,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
6758,Mephobarbital,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
6758,Mephobarbital,780.39,Other convulsions,1
6759,Mepivacaine,338-338.99,,0
6759,Mepivacaine,780.96,Generalized pain,0
6760,Meprobamate,300.00,Anxiety state unspecified,1
6760,Meprobamate,338-338.99,,0
6760,Meprobamate,728.85,Spasm of muscle,0
6760,Meprobamate,780.79,Other malaise and fatigue,0
6760,Meprobamate,780.96,Generalized pain,0
6760,Meprobamate,781.0,Abnormal involuntary movements,0
6760,Meprobamate,784.0,Headache,0
6779,Mesoridazine,290-299.99,,0
6779,Mesoridazine,295,Schizophrenic disorders,0
6779,Mesoridazine,295.9,Unspecified schizophrenia,0
6779,Mesoridazine,295.90,Unspecified schizophrenia; unspecified state,0
6779,Mesoridazine,298.9,Unspecified psychosis,0
6782,Mestranol,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6782,Mestranol,V22.2,Pregnant state; incidental,0
6804,Metaproterenol Sulfate,493,Asthma,0
6804,Metaproterenol Sulfate,493.81,Exercise induced bronchospasm,0
6804,Metaproterenol Sulfate,493.9,Asthma; unspecified,0
6804,Metaproterenol Sulfate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
6804,Metaproterenol Sulfate,519.11,Acute bronchospasm,0
6809,Metformin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
6809,Metformin,250.1,Diabetes with ketoacidosis,1
6809,Metformin,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
6809,Metformin,790.6,Other abnormal blood chemistry,1
6813,Methadone,292.89,Other specified drug-induced mental disorders,0
6813,Methadone,304.0,Opioid type dependence,1
6813,Methadone,304.00,Opioid type dependence unspecified use,1
6813,Methadone,304.90,Unspecified drug dependence; unspecified use,1
6813,Methadone,305.90,Other; mixed; or unspecified drug abuse; unspecified use,1
6813,Methadone,309.83,Adjustment reaction with withdrawal,0
6813,Methadone,338-338.99,,1
6813,Methadone,780.96,Generalized pain,1
6816,Methamphetamine,278.00,Obesity NOS,1
6816,Methamphetamine,296.99,Other specified episodic mood disorder,1
6816,Methamphetamine,314,Hyperkinetic syndrome of childhood,1
6816,Methamphetamine,314.01,Attention deficit disorder of childhood with hyperactivity,1
6816,Methamphetamine,314.9,Unspecified hyperkinetic syndrome of childhood,1
6816,Methamphetamine,347.0,Narcolepsy,0
6816,Methamphetamine,347.00,Narcolepsy; without cataplexy,0
6822,Methapyrilene,477.9,Allergic rhinitis NOS,0
6826,Methazolamide,365.02,Anatomical narrow angle borderline glaucoma,0
6826,Methazolamide,365.1,Open-angle glaucoma,0
6826,Methazolamide,365.10,Open-angle glaucoma NOS,0
6826,Methazolamide,365.13,Pigmentary glaucoma,0
6826,Methazolamide,365.20|365.70,,0
6832,Methenamine,136.9,Unspecified infectious and parasitic diseases,1
6832,Methenamine,595,Cystitis,1
6832,Methenamine,595.9,Cystitis NOS,1
6832,Methenamine,599.0,Urinary tract infection; site not specified,1
6832,Methenamine,791.9,Other nonspecific findings on examination of urine,1
6835,Methimazole,240.9,Goiter NOS,0
6835,Methimazole,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
6835,Methimazole,242.91,Thyrotoxicosis without mention of goiter or other cause; with mention of thyrotoxic crisis or storm,0
6845,Methocarbamol,037,Tetanus,0
6845,Methocarbamol,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
6845,Methocarbamol,338-338.99,,0
6845,Methocarbamol,728.85,Spasm of muscle,0
6845,Methocarbamol,728.9,Unspecified disorder of muscle; ligament; and fascia,0
6845,Methocarbamol,729.1,Myalgia and myositis unspecified,0
6845,Methocarbamol,729.82,Cramp of limb,0
6845,Methocarbamol,780.60,Fever; unspecified,0
6845,Methocarbamol,780.96,Generalized pain,0
6845,Methocarbamol,781.0,Abnormal involuntary movements,0
6845,Methocarbamol,781.99,Other symptoms involving nervous and musculoskeletal systems,1
6845,Methocarbamol,V22.2,Pregnant state; incidental,0
6851,Methotrexate,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
6851,Methotrexate,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
6851,Methotrexate,174.9,Malignant neoplasm of breast (female); unspecified,1
6851,Methotrexate,202.1,Mycosis fungoides,1
6851,Methotrexate,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,1
6851,Methotrexate,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
6851,Methotrexate,208,Leukemia of unspecified cell type,1
6851,Methotrexate,208.9,Unspecified leukemia,1
6851,Methotrexate,208.90,Unspecified leukemia without mention of having achieved remission,1
6851,Methotrexate,239.0,Neoplasm of unspecified nature of digestive system,0
6851,Methotrexate,239.1,Neoplasm of unspecified nature of respiratory system,0
6851,Methotrexate,239.3,Neoplasm of unspecified nature of breast,0
6851,Methotrexate,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6851,Methotrexate,338-338.99,,0
6851,Methotrexate,340,Multiple sclerosis,0
6851,Methotrexate,555.9,Regional enteritis of unspecified site,0
6851,Methotrexate,696.0,Psoriatic arthropathy,1
6851,Methotrexate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
6851,Methotrexate,714.0,Rheumatoid arthritis,1
6851,Methotrexate,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
6851,Methotrexate,780.96,Generalized pain,0
6852,Methotrimeprazine,300.00,Anxiety state unspecified,0
6852,Methotrimeprazine,338-338.99,,0
6852,Methotrimeprazine,780.96,Generalized pain,0
6854,Methoxsalen,202.1,Mycosis fungoides,0
6854,Methoxsalen,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
6854,Methoxsalen,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
6854,Methoxsalen,709.01,Vitiligo,1
6860,Methyclothiazide,401-405.99,,0
6860,Methyclothiazide,401.9,Hypertension NOS,0
6860,Methyclothiazide,428.0,Congestive heart failure (CHF) NOS,0
6860,Methyclothiazide,581,Nephrotic syndrome,0
6860,Methyclothiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
6860,Methyclothiazide,782.3,Edema,0
6860,Methyclothiazide,997.91,Hypertension,0
6873,Methylcellulose,564.0,Constipation,0
6873,Methylcellulose,564.00,Constipation NOS,0
6873,Methylcellulose,787.7,Abnormal feces,0
6873,Methylcellulose,787.91,Diarrhea,0
6876,Methyldopa,401-405.99,,1
6876,Methyldopa,401.9,Hypertension NOS,1
6876,Methyldopa,997.91,Hypertension,1
6877,Methyldopate,401-405.99,,1
6877,Methyldopate,401.9,Hypertension NOS,1
6877,Methyldopate,997.91,Hypertension,1
6878,Methylene blue,054,Herpes simplex,0
6878,Methylene blue,054.9,Herpes simplex without mention of complication,0
6878,Methylene blue,289.7,Methemoglobinemia,1
6878,Methylene blue,599.0,Urinary tract infection; site not specified,0
6878,Methylene blue,782.5,Cyanosis,0
6878,Methylene blue,977.9,Poisoning by unspecified drug or medicinal substance,0
6883,Methylergonovine,634,Spontaneous abortion,0
6883,Methylergonovine,634.90,Spontaneous abortion; unspecified; without mention of complication,0
6883,Methylergonovine,666,Postpartum hemorrhage,0
6883,Methylergonovine,666.14,Other immediate postpartum hemorrhage; postpartum,0
6901,Methylphenidate,311,Depressive disorder NEC,0
6901,Methylphenidate,314,Hyperkinetic syndrome of childhood,1
6901,Methylphenidate,314.01,Attention deficit disorder of childhood with hyperactivity,1
6901,Methylphenidate,314.9,Unspecified hyperkinetic syndrome of childhood,1
6901,Methylphenidate,347.0,Narcolepsy,1
6901,Methylphenidate,347.00,Narcolepsy; without cataplexy,1
6901,Methylphenidate,780-789.99,,0
6901,Methylphenidate,780.50,Unspecified sleep disturbance,0
6902,Methylprednisolone,140-239.99,,1
6902,Methylprednisolone,239,Neoplasms of unspecified nature,1
6902,Methylprednisolone,239-239.99,,1
6902,Methylprednisolone,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
6902,Methylprednisolone,279.5,Graft-versus-host disease,0
6902,Methylprednisolone,279.50,Graft-versus-host disease; unspecified,0
6902,Methylprednisolone,280-289.99,,1
6902,Methylprednisolone,289.9,Blood disease NOS,1
6902,Methylprednisolone,338-338.99,,1
6902,Methylprednisolone,340,Multiple sclerosis,1
6902,Methylprednisolone,460-519.99,,1
6902,Methylprednisolone,493,Asthma,1
6902,Methylprednisolone,493.9,Asthma; unspecified,1
6902,Methylprednisolone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
6902,Methylprednisolone,514,Pulmonary congestion and hypostasis,0
6902,Methylprednisolone,518.52,Other pulmonary insufficiency; not elsewhere classified; following trauma and surgery,0
6902,Methylprednisolone,519.9,Unspecified disease of respiratory system,1
6902,Methylprednisolone,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
6902,Methylprednisolone,569.9,Unspecified disorder of intestine,1
6902,Methylprednisolone,710.0,Systemic lupus erythematosus,1
6902,Methylprednisolone,716.90,Arthropathy; unspecified; site unspecified,1
6902,Methylprednisolone,780.96,Generalized pain,1
6902,Methylprednisolone,995.3,Allergy unspecified not elsewhere classified,1
6902,Methylprednisolone,V12.60,Unspecified disease of respiratory system,1
6904,Methyltestosterone,174.9,Malignant neoplasm of breast (female); unspecified,1
6904,Methyltestosterone,239.3,Neoplasm of unspecified nature of breast,0
6904,Methyltestosterone,253.4,Other anterior pituitary disorders,1
6904,Methyltestosterone,257.2,Other testicular hypofunction,1
6904,Methyltestosterone,259.0,Delay in sexual development and puberty NEC,1
6904,Methyltestosterone,302.72,Psychosexual dysfunction with inhibited sexual excitement,0
6904,Methyltestosterone,607.84,Impotence of organic origin,0
6904,Methyltestosterone,625.8,Other specified symptoms associated with female genital organs,0
6904,Methyltestosterone,733.0,Osteoporosis,0
6904,Methyltestosterone,733.00,Osteoporosis NOS,0
6904,Methyltestosterone,780-789.99,,0
6904,Methyltestosterone,780.79,Other malaise and fatigue,0
6904,Methyltestosterone,V21.1,Puberty,1
6910,Methyprylon,307.42,Persistent disorder of initiating or maintaining sleep,0
6911,Methysergide,346.11,Migraine without aura; with intractable migraine; so stated; without mention of status migrainosus,1
6911,Methysergide,784.0,Headache,1
6915,Metoclopramide,199,Malignant neoplasm without specification of site,1
6915,Metoclopramide,199.1,Other malignant neoplasm of unspecified site,1
6915,Metoclopramide,338-338.99,,0
6915,Metoclopramide,346,Migraine,0
6915,Metoclopramide,346.9,Migraine; unspecified,0
6915,Metoclopramide,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
6915,Metoclopramide,530.81,Esophageal reflux,1
6915,Metoclopramide,536.3,Gastroparesis,1
6915,Metoclopramide,780.96,Generalized pain,0
6915,Metoclopramide,783.0,Anorexia,1
6915,Metoclopramide,787.01,Nausea with vomiting,1
6915,Metoclopramide,787.02,Nausea alone,1
6915,Metoclopramide,787.03,Vomiting alone,1
6915,Metoclopramide,787.1,Heartburn,1
6915,Metoclopramide,862.22,Injury to esophagus without mention of open wound into cavity,1
6916,Metolazone,276.6,Fluid overload,1
6916,Metolazone,276.69,Other fluid overload,1
6916,Metolazone,276.9,Electrolyte and fluid disorders not elsewhere classified,0
6916,Metolazone,401-405.99,,1
6916,Metolazone,401.9,Hypertension NOS,1
6916,Metolazone,428,Heart failure,1
6916,Metolazone,428.0,Congestive heart failure (CHF) NOS,1
6916,Metolazone,428.9,Heart failure unspecified,1
6916,Metolazone,581,Nephrotic syndrome,1
6916,Metolazone,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
6916,Metolazone,593.9,Unspecified disorder of kidney and ureter,1
6916,Metolazone,782.3,Edema,1
6916,Metolazone,788.42,Polyuria,1
6916,Metolazone,997.91,Hypertension,1
6918,Metoprolol,346,Migraine,0
6918,Metoprolol,346.9,Migraine; unspecified,0
6918,Metoprolol,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
6918,Metoprolol,401-405.99,,1
6918,Metoprolol,401.9,Hypertension NOS,1
6918,Metoprolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
6918,Metoprolol,413,Angina pectoris,1
6918,Metoprolol,413.9,Other and unspecified angina pectoris,1
6918,Metoprolol,427.1,Paroxysmal ventricular tachycardia,0
6918,Metoprolol,427.31,Atrial fibrillation,0
6918,Metoprolol,427.32,Atrial flutter,0
6918,Metoprolol,427.41,Ventricular fibrillation,0
6918,Metoprolol,427.89,Other specified cardiac dysrhythmias,0
6918,Metoprolol,428,Heart failure,1
6918,Metoprolol,428.0,Congestive heart failure (CHF) NOS,0
6918,Metoprolol,428.9,Heart failure unspecified,1
6918,Metoprolol,786.50,Unspecified chest pain,1
6918,Metoprolol,997.91,Hypertension,1
6922,Metronidazole,006,Amebiasis,1
6922,Metronidazole,006.9,Amebiasis NOS,1
6922,Metronidazole,007.1,Giardiasis,1
6922,Metronidazole,008.45,Intestinal infection due to clostridium difficile,0
6922,Metronidazole,038,Septicemia,1
6922,Metronidazole,038.9,Septicemia NOS,1
6922,Metronidazole,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
6922,Metronidazole,131,Trichomoniasis,1
6922,Metronidazole,131.01,Trichomonal vulvovaginitis,0
6922,Metronidazole,131.9,Trichomoniasis NOS,1
6922,Metronidazole,136.8,Other specified infectious and parasitic diseases,1
6922,Metronidazole,136.9,Unspecified infectious and parasitic diseases,1
6922,Metronidazole,322,Meningitis of unspecified cause,1
6922,Metronidazole,322.9,Meningitis NOS,1
6922,Metronidazole,324.0,Intracranial abscess,1
6922,Metronidazole,424.90,Endocarditis valve unspecified cause,1
6922,Metronidazole,486,Pneumonia; organism unspecified,1
6922,Metronidazole,510,Empyema,1
6922,Metronidazole,510.9,Empyema without mention of fistula,1
6922,Metronidazole,513.0,Abscess of lung,1
6922,Metronidazole,567.9,Peritonitis NOS,1
6922,Metronidazole,615.9,Unspecified inflammatory disease of uterus,1
6922,Metronidazole,616.10,Vaginitis and vulvovaginitis NOS,1
6922,Metronidazole,616.10|041.9,,1
6922,Metronidazole,682.2,Cellulitis and abscess of trunk,1
6922,Metronidazole,682.9,Cellulitis and abscess NOS,1
6922,Metronidazole,686.9,Unspecified local infection of skin and subcutaneous tissue,1
6922,Metronidazole,695.3,Rosacea,1
6922,Metronidazole,706.1,Other acne,0
6922,Metronidazole,709.9,Unspecified disorder of skin and subcutaneous tissue,1
6922,Metronidazole,998.59,Other postoperative infection,1
6923,Metyrapone,255.0,Cushing's syndrome,0
6926,Mexiletine,250.6,Diabetes with neurological manifestations,0
6926,Mexiletine,427,Cardiac dysrhythmias,1
6926,Mexiletine,427.41,Ventricular fibrillation,0
6926,Mexiletine,427.69,Other premature beats,1
6926,Mexiletine,427.9,Cardiac dysrhythmia NOS,1
6927,Mezlocillin,038,Septicemia,0
6927,Mezlocillin,038.9,Septicemia NOS,0
6927,Mezlocillin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
6927,Mezlocillin,136.9,Unspecified infectious and parasitic diseases,0
6927,Mezlocillin,519.8,Other diseases of respiratory system; not elsewhere classified,0
6927,Mezlocillin,599.0,Urinary tract infection; site not specified,0
6927,Mezlocillin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
6932,Miconazole,110.3,Dermatophytosis of groin and perianal area,1
6932,Miconazole,110.4,Dermatophytosis of foot,1
6932,Miconazole,112,Candidiasis,1
6932,Miconazole,112.1,Candidiasis of vulva and vagina,1
6932,Miconazole,112.3,Candidiasis of skin and nails,0
6932,Miconazole,112.9,Candidiasis of unspecified site,1
6932,Miconazole,117.3,Aspergillosis,0
6932,Miconazole,136.9,Unspecified infectious and parasitic diseases,1
6932,Miconazole,686.9,Unspecified local infection of skin and subcutaneous tissue,1
6932,Miconazole,698.9,Unspecified pruritic disorder,1
6932,Miconazole,781.99,Other symptoms involving nervous and musculoskeletal systems,1
6960,Midazolam,300.00,Anxiety state unspecified,0
6960,Midazolam,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
6960,Midazolam,308.2,Predominant psychomotor disturbance,0
6960,Midazolam,345.3,Grand mal status; epileptic,0
6960,Midazolam,780.09,Other alteration of consciousness,0
6960,Midazolam,799.21,Nervousness (ADDED),0
6963,Midodrine,458,Hypotension,1
6963,Midodrine,458.0,Orthostatic hypotension,1
6963,Midodrine,458.9,Hypotension NOS,1
6963,Midodrine,788.3,Urinary incontinence,0
6963,Midodrine,788.30,Urinary incontinence NOS,0
6964,Mifepristone,140-239.99,,0
6964,Mifepristone,239,Neoplasms of unspecified nature,0
6964,Mifepristone,239-239.99,,0
6964,Mifepristone,239.6,Neoplasm of unspecified nature of brain,0
6964,Mifepristone,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
6964,Mifepristone,633,Ectopic pregnancy,0
6964,Mifepristone,633.9,Unspecified ectopic pregnancy,0
6964,Mifepristone,633.90,Unspecified ectopic pregnancy without intrauterine pregnancy,0
6964,Mifepristone,V22.2,Pregnant state; incidental,0
6972,Mineral Oil,560.9,Unspecified intestinal obstruction,0
6972,Mineral Oil,564.0,Constipation,1
6972,Mineral Oil,564.00,Constipation NOS,1
6980,Minocycline,001,Cholera,1
6980,Minocycline,001.0,Cholera due to Vibrio cholerae,1
6980,Minocycline,001.9,Cholera NOS,1
6980,Minocycline,006.9,Amebiasis NOS,1
6980,Minocycline,022,Anthrax,1
6980,Minocycline,022.9,Anthrax NOS,1
6980,Minocycline,036,Meningococcal infection,1
6980,Minocycline,036.9,Meningococcal infection; unspecified,1
6980,Minocycline,082.0,Spotted fevers,1
6980,Minocycline,088.81,Lyme disease,1
6980,Minocycline,097.9,Syphilis NOS,1
6980,Minocycline,098,Gonococcal infections,1
6980,Minocycline,098.89,Gonococcal infection of other specified sites,1
6980,Minocycline,322,Meningitis of unspecified cause,1
6980,Minocycline,322.9,Meningitis NOS,1
6980,Minocycline,486,Pneumonia; organism unspecified,1
6980,Minocycline,519.8,Other diseases of respiratory system; not elsewhere classified,1
6980,Minocycline,523.9,Unspecified gingival and periodontal disease,1
6980,Minocycline,599.0,Urinary tract infection; site not specified,1
6980,Minocycline,686.9,Unspecified local infection of skin and subcutaneous tissue,0
6980,Minocycline,706.1,Other acne,1
6980,Minocycline,780.60,Fever; unspecified,1
6984,Minoxidil,401-405.99,,1
6984,Minoxidil,401.0,Malignant essential hypertension,0
6984,Minoxidil,401.9,Hypertension NOS,1
6984,Minoxidil,704.0,Alopecia,1
6984,Minoxidil,704.00,Alopecia NOS,1
6984,Minoxidil,704.09,Other alopecia,1
6984,Minoxidil,997.91,Hypertension,1
6995,Plicamycin,205.1,Myeloid leukemia; chronic,0
6995,Plicamycin,205.10,Chronic myeloid leukemia without mention of having achieved remission,0
6995,Plicamycin,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
6995,Plicamycin,275.42,Hypercalcemia,0
7004,Mitotane,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
7004,Mitotane,255.0,Cushing's syndrome,0
7005,Mitoxantrone,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
7005,Mitoxantrone,185,Malignant neoplasm of prostate,1
7005,Mitoxantrone,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
7005,Mitoxantrone,205.0,Myeloid leukemia; acute,1
7005,Mitoxantrone,205.00,Acute myeloid leukemia without mention of having achieved remission,1
7005,Mitoxantrone,208,Leukemia of unspecified cell type,1
7005,Mitoxantrone,208.9,Unspecified leukemia,1
7005,Mitoxantrone,208.90,Unspecified leukemia without mention of having achieved remission,1
7005,Mitoxantrone,239.3,Neoplasm of unspecified nature of breast,0
7005,Mitoxantrone,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
7005,Mitoxantrone,338-338.99,,1
7005,Mitoxantrone,340,Multiple sclerosis,1
7005,Mitoxantrone,780.96,Generalized pain,1
7008,Sotalol Hydrochloride,401-405.99,,1
7008,Sotalol Hydrochloride,401.9,Hypertension NOS,1
7008,Sotalol Hydrochloride,427,Cardiac dysrhythmias,1
7008,Sotalol Hydrochloride,427.1,Paroxysmal ventricular tachycardia,1
7008,Sotalol Hydrochloride,427.31,Atrial fibrillation,1
7008,Sotalol Hydrochloride,427.32,Atrial flutter,1
7008,Sotalol Hydrochloride,427.41,Ventricular fibrillation,0
7008,Sotalol Hydrochloride,427.89,Other specified cardiac dysrhythmias,0
7008,Sotalol Hydrochloride,427.9,Cardiac dysrhythmia NOS,1
7008,Sotalol Hydrochloride,785.0,Tachycardia NOS,1
7008,Sotalol Hydrochloride,997.91,Hypertension,1
7019,Molindone,290-299.99,,0
7019,Molindone,295,Schizophrenic disorders,1
7019,Molindone,295.9,Unspecified schizophrenia,1
7019,Molindone,295.90,Unspecified schizophrenia; unspecified state,1
7019,Molindone,298.9,Unspecified psychosis,0
7052,Morphine,338-338.99,,1
7052,Morphine,338.2,Chronic pain,1
7052,Morphine,338.29,Other chronic pain,1
7052,Morphine,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
7052,Morphine,518.4,Acute edema of lung; unspecified,1
7052,Morphine,780.96,Generalized pain,1
7052,Morphine,786.05,Shortness of breath,1
7052,Morphine,786.09,Other dyspnea and respiratory abnormality,1
7145,Mycophenolic Acid,279.5,Graft-versus-host disease,0
7145,Mycophenolic Acid,279.50,Graft-versus-host disease; unspecified,0
7145,Mycophenolic Acid,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
7145,Mycophenolic Acid,996.80,Complications of transplanted organ; unspecified site,0
7145,Mycophenolic Acid,996.81,Complications of transplanted kidney,0
7213,Ipratropium,477.9,Allergic rhinitis NOS,1
7213,Ipratropium,490,Bronchitis NOS,1
7213,Ipratropium,491,Chronic bronchitis,1
7213,Ipratropium,491.9,Chronic bronchitis NOS,1
7213,Ipratropium,492,Emphysema,1
7213,Ipratropium,492.8,Other emphysema,1
7213,Ipratropium,493,Asthma,0
7213,Ipratropium,493.9,Asthma; unspecified,0
7213,Ipratropium,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
7213,Ipratropium,496,Chronic airway obstruction; not elsewhere classified,1
7213,Ipratropium,519.11,Acute bronchospasm,1
7213,Ipratropium,796.4,Other abnormal clinical findings,1
7226,Nadolol,346,Migraine,0
7226,Nadolol,346.9,Migraine; unspecified,0
7226,Nadolol,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
7226,Nadolol,401-405.99,,1
7226,Nadolol,401.9,Hypertension NOS,1
7226,Nadolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
7226,Nadolol,413,Angina pectoris,1
7226,Nadolol,413.9,Other and unspecified angina pectoris,1
7226,Nadolol,427.89,Other specified cardiac dysrhythmias,0
7226,Nadolol,428.0,Congestive heart failure (CHF) NOS,0
7226,Nadolol,458,Hypotension,0
7226,Nadolol,458.9,Hypotension NOS,0
7226,Nadolol,786.5,Chest pain,0
7226,Nadolol,786.50,Unspecified chest pain,1
7226,Nadolol,997.91,Hypertension,1
7233,Nafcillin,038,Septicemia,0
7233,Nafcillin,038.9,Septicemia NOS,0
7233,Nafcillin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,1
7233,Nafcillin,041.9|421.0,,0
7233,Nafcillin,136.9,Unspecified infectious and parasitic diseases,1
7233,Nafcillin,320,Bacterial meningitis,0
7233,Nafcillin,320.9,Bacterial meningitis NOS,0
7233,Nafcillin,519.8,Other diseases of respiratory system; not elsewhere classified,0
7233,Nafcillin,599.0,Urinary tract infection; site not specified,0
7233,Nafcillin,682.9,Cellulitis and abscess NOS,0
7233,Nafcillin,686.8|041.9,,0
7233,Nafcillin,730.2,Unspecified osteomyelitis,0
7233,Nafcillin,730.20,Unspecified osteomyelitis; site unspecified,0
7233,Nafcillin,958.3,Posttraumatic wound infection not elsewhere classified,0
7233,Nafcillin,998.9,Unspecified complication of procedure; not elsewhere classified,0
7238,Nalbuphine,338-338.99,,1
7238,Nalbuphine,338.18,Other acute postoperative pain,0
7238,Nalbuphine,780.96,Generalized pain,1
7240,Nalidixic Acid,003.9,Salmonella infection NOS,0
7240,Nalidixic Acid,041.49,Other and unspecified Escherichia coli [E. coli],0
7240,Nalidixic Acid,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
7240,Nalidixic Acid,136.9,Unspecified infectious and parasitic diseases,1
7240,Nalidixic Acid,599.0,Urinary tract infection; site not specified,1
7242,Naloxone,292.89,Other specified drug-induced mental disorders,0
7242,Naloxone,309.83,Adjustment reaction with withdrawal,0
7242,Naloxone,338-338.99,,0
7242,Naloxone,460-519.99,,0
7242,Naloxone,519.9,Unspecified disease of respiratory system,0
7242,Naloxone,780.96,Generalized pain,0
7242,Naloxone,785.52,Septic shock,1
7242,Naloxone,V12.60,Unspecified disease of respiratory system,0
7243,Naltrexone,292.89,Other specified drug-induced mental disorders,0
7243,Naltrexone,303,Alcohol dependence syndrome,1
7243,Naltrexone,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,1
7243,Naltrexone,304.0,Opioid type dependence,1
7243,Naltrexone,304.00,Opioid type dependence unspecified use,1
7243,Naltrexone,304.90,Unspecified drug dependence; unspecified use,1
7243,Naltrexone,305.01,Alcohol abuse; continuous drinking behavior,1
7244,Nandrolone,239.3,Neoplasm of unspecified nature of breast,0
7244,Nandrolone,285.9,Anemia unspecified,1
7247,Naphazoline,461.9,Acute sinusitis NOS,0
7247,Naphazoline,472.0,Chronic rhinitis,0
7247,Naphazoline,695.9,Unspecified erythematous condition,0
7258,Naproxen,274,Gout,1
7258,Naproxen,274.0,Gouty arthropathy,1
7258,Naproxen,274.00,Gouty arthropathy (ADDED),1
7258,Naproxen,274.9,Gout NOS,1
7258,Naproxen,338-338.99,,1
7258,Naproxen,460,Acute nasopharyngitis (common cold),1
7258,Naproxen,525.9,Dental disorder NOS,1
7258,Naproxen,625.3,Dysmenorrhea,1
7258,Naproxen,714.0,Rheumatoid arthritis,1
7258,Naproxen,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
7258,Naproxen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
7258,Naproxen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
7258,Naproxen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
7258,Naproxen,716.90,Arthropathy; unspecified; site unspecified,1
7258,Naproxen,719.50,Stiffness of joint; not elsewhere classified; involving unspecified site,0
7258,Naproxen,720.0,Ankylosing spondylitis,1
7258,Naproxen,724.1,Pain in thoracic spine,1
7258,Naproxen,724.5,Backache unspecified,1
7258,Naproxen,726.90,Enthesopathy of specified site,1
7258,Naproxen,727.3,Other bursitis disorders,1
7258,Naproxen,729.1,Myalgia and myositis unspecified,1
7258,Naproxen,780.60,Fever; unspecified,1
7258,Naproxen,780.96,Generalized pain,1
7258,Naproxen,784.0,Headache,1
7268,Natamycin,007.8,Other specified protozoal intestinal diseases,0
7268,Natamycin,112,Candidiasis,0
7268,Natamycin,112.9,Candidiasis of unspecified site,0
7268,Natamycin,114,Coccidioidomycosis,0
7268,Natamycin,114.9,Coccidioidomycosis NOS,0
7268,Natamycin,115,Histoplasmosis,0
7268,Natamycin,115.9,Histoplasmosis; unspecified,0
7268,Natamycin,115.90,Histoplasmosis; unspecified without mention of manifestation,0
7268,Natamycin,116,Blastomycotic infection,0
7268,Natamycin,116.0,Blastomycosis,0
7268,Natamycin,117.1,Sporotrichosis,0
7268,Natamycin,117.3,Aspergillosis,0
7268,Natamycin,117.5,Cryptococcosis,0
7268,Natamycin,117.9,Other and unspecified mycoses,0
7268,Natamycin,131.01,Trichomonal vulvovaginitis,0
7268,Natamycin,136.8,Other specified infectious and parasitic diseases,0
7268,Natamycin,370,Keratitis,1
7268,Natamycin,370.8,Other forms of keratitis,1
7268,Natamycin,370.9,Keratitis NOS,1
7268,Natamycin,372.30,Conjunctivitis NOS,1
7268,Natamycin,373.0,Blepharitis,1
7268,Natamycin,373.00,Blepharitis NOS,1
7268,Natamycin,373.9,Inflammation eyelid NOS,1
7299,Neomycin,041.49,Other and unspecified Escherichia coli [E. coli],0
7299,Neomycin,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
7299,Neomycin,136.9,Unspecified infectious and parasitic diseases,1
7299,Neomycin,572.2,Hepatic encephalopathy,1
7299,Neomycin,686.8|041.9,,0
7300,Neomycin Sulfate,041.49,Other and unspecified Escherichia coli [E. coli],0
7300,Neomycin Sulfate,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
7300,Neomycin Sulfate,572.2,Hepatic encephalopathy,0
7300,Neomycin Sulfate,686.8|041.9,,0
7315,Neostigmine,358.0,Myasthenia gravis,1
7315,Neostigmine,358.00,Myasthenia gravis without (acute) exacerbation,1
7315,Neostigmine,596.9,Unspecified disorder of bladder,0
7315,Neostigmine,788.2,Retention of urine,1
7315,Neostigmine,788.20,Retention of urine NOS,1
7337,Netilmicin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
7337,Netilmicin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
7393,Niacin,250,Diabetes mellitus,1
7393,Niacin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
7393,Niacin,265.2,Pellagra,0
7393,Niacin,272.4,Other and unspecified hyperlipidemia,1
7393,Niacin,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
7393,Niacin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
7393,Niacin,440,Atherosclerosis,1
7393,Niacin,440.9,Atherosclerosis NOS,0
7393,Niacin,443.9,Peripheral vascular disease; unspecified,0
7393,Niacin,459.9,Unspecified circulatory system disorder,1
7393,Niacin,573.9,Unspecified disorder of liver,1
7393,Niacin,783.9,Other symptoms concerning nutrition; metabolism; and development,0
7393,Niacin,799.9,Other unknown and unspecified cause of morbidity or mortality,0
7396,Nicardipine,401-405.99,,1
7396,Nicardipine,401.9,Hypertension NOS,1
7396,Nicardipine,413,Angina pectoris,1
7396,Nicardipine,413.1,Prinzmetal angina,0
7396,Nicardipine,413.9,Other and unspecified angina pectoris,1
7396,Nicardipine,428.0,Congestive heart failure (CHF) NOS,0
7396,Nicardipine,786.50,Unspecified chest pain,1
7396,Nicardipine,997.91,Hypertension,1
7402,Niclosamide,120-129.99,,0
7402,Niclosamide,128.9,Helminthiasis NOS,0
7405,Niacinamide,265.2,Pellagra,0
7405,Niacinamide,272.4,Other and unspecified hyperlipidemia,0
7405,Niacinamide,440.9,Atherosclerosis NOS,0
7405,Niacinamide,443.9,Peripheral vascular disease; unspecified,0
7407,Nicotine,305.1,Tobacco use disorder,1
7407,Nicotine,309.83,Adjustment reaction with withdrawal,0
7407,Nicotine,556,Ulcerative colitis,0
7407,Nicotine,556.8,Other ulcerative colitis,0
7407,Nicotine,556.9,Ulcerative colitis; unspecified,0
7417,Nifedipine,338-338.99,,1
7417,Nifedipine,401-405.99,,1
7417,Nifedipine,401.9,Hypertension NOS,1
7417,Nifedipine,413,Angina pectoris,1
7417,Nifedipine,413.1,Prinzmetal angina,1
7417,Nifedipine,413.9,Other and unspecified angina pectoris,1
7417,Nifedipine,427.9,Cardiac dysrhythmia NOS,1
7417,Nifedipine,443.0,Raynaud's syndrome,0
7417,Nifedipine,443.9,Peripheral vascular disease; unspecified,1
7417,Nifedipine,458,Hypotension,1
7417,Nifedipine,458.9,Hypotension NOS,1
7417,Nifedipine,644.20,Early onset of delivery; unspecified as to episode of care,0
7417,Nifedipine,728.85,Spasm of muscle,1
7417,Nifedipine,780.96,Generalized pain,1
7417,Nifedipine,781.0,Abnormal involuntary movements,1
7417,Nifedipine,786.50,Unspecified chest pain,1
7417,Nifedipine,997.91,Hypertension,1
7426,Nimodipine,430,Subarachnoid hemorrhage,1
7426,Nimodipine,431,Intracerebral hemorrhage,0
7426,Nimodipine,459.0,Hemorrhage NOS,1
7435,Nisoldipine,401-405.99,,1
7435,Nisoldipine,401.9,Hypertension NOS,1
7435,Nisoldipine,413.1,Prinzmetal angina,0
7435,Nisoldipine,997.91,Hypertension,1
7442,Nitric Oxide,401-405.99,,1
7442,Nitric Oxide,401.9,Hypertension NOS,1
7442,Nitric Oxide,416.0,Primary pulmonary hypertension,1
7442,Nitric Oxide,769,Respiratory distress syndrome in newborn,0
7442,Nitric Oxide,997.91,Hypertension,1
7454,Nitrofurantoin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
7454,Nitrofurantoin,136.9,Unspecified infectious and parasitic diseases,1
7454,Nitrofurantoin,590.80,Pyelonephritis NOS,1
7454,Nitrofurantoin,599.0,Urinary tract infection; site not specified,1
7455,Nitrofurazone,038,Septicemia,0
7455,Nitrofurazone,038.9,Septicemia NOS,0
7455,Nitrofurazone,040.89,Other specified bacterial diseases,0
7455,Nitrofurazone,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
7455,Nitrofurazone,041.49,Other and unspecified Escherichia coli [E. coli],0
7455,Nitrofurazone,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
7455,Nitrofurazone,686.9,Unspecified local infection of skin and subcutaneous tissue,0
7455,Nitrofurazone,940-949.99,,0
7455,Nitrofurazone,949.0,Burn of unspecified site; unspecified degree,0
7455,Nitrofurazone,958.3,Posttraumatic wound infection not elsewhere classified,0
7456,Nitrogen,078.1,Viral warts,0
7456,Nitrogen,078.10,Viral warts; unspecified,0
7476,Nitroprusside,401.0,Malignant essential hypertension,0
7476,Nitroprusside,428.0,Congestive heart failure (CHF) NOS,0
7512,Norepinephrine,458,Hypotension,1
7512,Norepinephrine,458.9,Hypotension NOS,1
7512,Norepinephrine,785.50,Shock NOS,0
7514,Norethindrone,253.4,Other anterior pituitary disorders,0
7514,Norethindrone,617,Endometriosis,1
7514,Norethindrone,617.9,Endometriosis; site unspecified,1
7514,Norethindrone,621.3,Endometrial hyperplasia,0
7514,Norethindrone,621.30,Endometrial hyperplasia; unspecified,0
7514,Norethindrone,621.4,Hematometra,1
7514,Norethindrone,625.4,Premenstrual tension syndromes,0
7514,Norethindrone,626.2,Excessive or frequent menstruation,0
7514,Norethindrone,626.4,Irregular menstrual cycle,0
7514,Norethindrone,706.1,Other acne,0
7514,Norethindrone,733.0,Osteoporosis,0
7514,Norethindrone,733.00,Osteoporosis NOS,0
7514,Norethindrone,V22.2,Pregnant state; incidental,1
7515,Norethynodrel,621.3,Endometrial hyperplasia,0
7515,Norethynodrel,621.30,Endometrial hyperplasia; unspecified,0
7515,Norethynodrel,621.4,Hematometra,0
7515,Norethynodrel,626.0,Absence of menstruation,0
7515,Norethynodrel,628,Infertility; female,0
7515,Norethynodrel,628.9,Female infertility NOS,0
7515,Norethynodrel,V22.2,Pregnant state; incidental,0
7517,Norfloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
7517,Norfloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
7517,Norfloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
7517,Norfloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
7517,Norfloxacin,098,Gonococcal infections,1
7517,Norfloxacin,098.89,Gonococcal infection of other specified sites,1
7517,Norfloxacin,136.9,Unspecified infectious and parasitic diseases,1
7517,Norfloxacin,372.03,Other mucopurulent conjunctivitis,0
7517,Norfloxacin,372.30,Conjunctivitis NOS,0
7517,Norfloxacin,595,Cystitis,1
7517,Norfloxacin,595.9,Cystitis NOS,1
7517,Norfloxacin,599.0,Urinary tract infection; site not specified,1
7517,Norfloxacin,601,Inflammatory diseases of prostate,1
7517,Norfloxacin,601.9,Prostatitis NOS,1
7518,Norgestrel,338-338.99,,0
7518,Norgestrel,617,Endometriosis,0
7518,Norgestrel,617.9,Endometriosis; site unspecified,0
7518,Norgestrel,706.1,Other acne,0
7518,Norgestrel,780.96,Generalized pain,0
7518,Norgestrel,V22.2,Pregnant state; incidental,0
7531,Nortriptyline,296.20,Major depressive disorder; single episode; unspecified degree,1
7531,Nortriptyline,300.00,Anxiety state unspecified,0
7531,Nortriptyline,300.01,Panic disorder without agoraphobia,0
7531,Nortriptyline,307.6,Enuresis,0
7531,Nortriptyline,311,Depressive disorder NEC,1
7531,Nortriptyline,314,Hyperkinetic syndrome of childhood,0
7531,Nortriptyline,314.01,Attention deficit disorder of childhood with hyperactivity,0
7531,Nortriptyline,314.9,Unspecified hyperkinetic syndrome of childhood,0
7531,Nortriptyline,338-338.99,,0
7531,Nortriptyline,780-789.99,,0
7531,Nortriptyline,780.96,Generalized pain,0
7597,Nystatin,112,Candidiasis,1
7597,Nystatin,112.0,Candidiasis of mouth,0
7597,Nystatin,112.1,Candidiasis of vulva and vagina,0
7597,Nystatin,112.3,Candidiasis of skin and nails,0
7597,Nystatin,112.9,Candidiasis of unspecified site,1
7597,Nystatin,136.9,Unspecified infectious and parasitic diseases,1
7617,Octreotide,140-239.99,,1
7617,Octreotide,229.9,Benign neoplasm NOS,1
7617,Octreotide,239,Neoplasms of unspecified nature,1
7617,Octreotide,239-239.99,,1
7617,Octreotide,239.0,Neoplasm of unspecified nature of digestive system,0
7617,Octreotide,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
7617,Octreotide,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),1
7617,Octreotide,253.0,Acromegaly and gigantism,1
7617,Octreotide,259.2,Carcinoid syndrome,1
7617,Octreotide,459.0,Hemorrhage NOS,1
7617,Octreotide,560.9,Unspecified intestinal obstruction,1
7617,Octreotide,577.0,Acute pancreatitis,1
7617,Octreotide,719.4,Pain in joint,1
7617,Octreotide,719.40,Pain in joint site unspecified,1
7617,Octreotide,782.62,Flushing,1
7617,Octreotide,787.7,Abnormal feces,1
7617,Octreotide,787.91,Diarrhea,1
7623,Ofloxacin,003.9,Salmonella infection NOS,0
7623,Ofloxacin,011,Pulmonary tuberculosis,0
7623,Ofloxacin,011.9,Unspecified pulmonary tuberculosis,0
7623,Ofloxacin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
7623,Ofloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
7623,Ofloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
7623,Ofloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
7623,Ofloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
7623,Ofloxacin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
7623,Ofloxacin,098,Gonococcal infections,1
7623,Ofloxacin,098.89,Gonococcal infection of other specified sites,1
7623,Ofloxacin,099.40,Unspecified other nongonococcal urethritis [NGU],1
7623,Ofloxacin,136.9,Unspecified infectious and parasitic diseases,1
7623,Ofloxacin,370.0,Corneal ulcer,1
7623,Ofloxacin,370.00,Corneal ulcer NOS,1
7623,Ofloxacin,372.03,Other mucopurulent conjunctivitis,0
7623,Ofloxacin,372.30,Conjunctivitis NOS,1
7623,Ofloxacin,380.10,Infective otitis externa; unspecified,1
7623,Ofloxacin,382,Suppurative and unspecified otitis media,1
7623,Ofloxacin,382.4,Suppurative otitis media NOS,1
7623,Ofloxacin,382.9,Unspecified otitis media,1
7623,Ofloxacin,486,Pneumonia; organism unspecified,1
7623,Ofloxacin,490,Bronchitis NOS,1
7623,Ofloxacin,491,Chronic bronchitis,1
7623,Ofloxacin,491.9,Chronic bronchitis NOS,1
7623,Ofloxacin,595,Cystitis,1
7623,Ofloxacin,595.9,Cystitis NOS,1
7623,Ofloxacin,599.0,Urinary tract infection; site not specified,1
7623,Ofloxacin,601,Inflammatory diseases of prostate,1
7623,Ofloxacin,601.9,Prostatitis NOS,1
7623,Ofloxacin,604.90,Orchitis and epididymitis; unspecified,0
7623,Ofloxacin,616.9,Unspecified inflammatory disease of cervix; vagina; and vulva,1
7623,Ofloxacin,686.8|041.9,,0
7623,Ofloxacin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
7623,Ofloxacin,707.9,Chronic ulcer of unspecified site,1
7646,Omeprazole,251.5,Abnormality of secretion of gastrin,0
7646,Omeprazole,530.1,Esophagitis,1
7646,Omeprazole,530.10,Esophagitis; unspecified,1
7646,Omeprazole,530.81,Esophageal reflux,1
7646,Omeprazole,531,Gastric ulcer,1
7646,Omeprazole,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
7646,Omeprazole,532,Duodenal ulcer,1
7646,Omeprazole,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
7646,Omeprazole,533,Peptic ulcer; site unspecified,1
7646,Omeprazole,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
7646,Omeprazole,535.50,Unspecified gastritis and gastroduodenitis; without mention of hemorrhage,1
7646,Omeprazole,536.8,Dyspepsia and other specified disorders of function of stomach,1
7646,Omeprazole,707.9,Chronic ulcer of unspecified site,1
7646,Omeprazole,787.1,Heartburn,1
7676,Opium,338-338.99,,0
7676,Opium,555.9,Regional enteritis of unspecified site,0
7676,Opium,780.96,Generalized pain,0
7676,Opium,787.7,Abnormal feces,0
7676,Opium,787.91,Diarrhea,0
7688,metaproterenol,492,Emphysema,1
7688,metaproterenol,492.8,Other emphysema,1
7688,metaproterenol,493,Asthma,1
7688,metaproterenol,493.81,Exercise induced bronchospasm,0
7688,metaproterenol,493.9,Asthma; unspecified,1
7688,metaproterenol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
7688,metaproterenol,519.11,Acute bronchospasm,1
7715,Orphenadrine,037,Tetanus,0
7715,Orphenadrine,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
7715,Orphenadrine,338-338.99,,0
7715,Orphenadrine,728.85,Spasm of muscle,0
7715,Orphenadrine,728.9,Unspecified disorder of muscle; ligament; and fascia,0
7715,Orphenadrine,729.1,Myalgia and myositis unspecified,0
7715,Orphenadrine,729.82,Cramp of limb,0
7715,Orphenadrine,780.96,Generalized pain,0
7715,Orphenadrine,781.0,Abnormal involuntary movements,0
7715,Orphenadrine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
7715,Orphenadrine,784.0,Headache,0
7715,Orphenadrine,959.9,Other and unspecified injury to unspecified site,0
7716,Orphenadrine Citrate,037,Tetanus,0
7716,Orphenadrine Citrate,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
7716,Orphenadrine Citrate,338-338.99,,0
7716,Orphenadrine Citrate,728.85,Spasm of muscle,0
7716,Orphenadrine Citrate,728.9,Unspecified disorder of muscle; ligament; and fascia,0
7716,Orphenadrine Citrate,729.1,Myalgia and myositis unspecified,0
7716,Orphenadrine Citrate,729.82,Cramp of limb,0
7716,Orphenadrine Citrate,780.96,Generalized pain,0
7716,Orphenadrine Citrate,781.0,Abnormal involuntary movements,0
7716,Orphenadrine Citrate,781.99,Other symptoms involving nervous and musculoskeletal systems,1
7716,Orphenadrine Citrate,959.9,Other and unspecified injury to unspecified site,0
7773,Oxacillin,038,Septicemia,0
7773,Oxacillin,038.9,Septicemia NOS,0
7773,Oxacillin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,1
7773,Oxacillin,041.9|421.0,,0
7773,Oxacillin,136.9,Unspecified infectious and parasitic diseases,1
7773,Oxacillin,320,Bacterial meningitis,0
7773,Oxacillin,320.9,Bacterial meningitis NOS,0
7773,Oxacillin,519.8,Other diseases of respiratory system; not elsewhere classified,0
7773,Oxacillin,599.0,Urinary tract infection; site not specified,0
7773,Oxacillin,682.9,Cellulitis and abscess NOS,0
7773,Oxacillin,730.2,Unspecified osteomyelitis,0
7773,Oxacillin,730.20,Unspecified osteomyelitis; site unspecified,0
7773,Oxacillin,958.3,Posttraumatic wound infection not elsewhere classified,0
7773,Oxacillin,998.9,Unspecified complication of procedure; not elsewhere classified,0
7778,Oxamniquine,120.1,Schistosoma mansoni,0
7779,Oxandrolone,136.9,Unspecified infectious and parasitic diseases,1
7779,Oxandrolone,261,Nutritional marasmus,0
7779,Oxandrolone,608.3,Atrophy of testis,1
7779,Oxandrolone,733.0,Osteoporosis,1
7779,Oxandrolone,733.00,Osteoporosis NOS,1
7779,Oxandrolone,733.90,Disorder of bone and cartilage; unspecified,1
7779,Oxandrolone,783.21,Loss of weight,1
7779,Oxandrolone,783.9,Other symptoms concerning nutrition; metabolism; and development,1
7781,Oxazepam,291.0,Alcohol withdrawal delirium,0
7781,Oxazepam,291.81,Alcohol withdrawal,1
7781,Oxazepam,300.00,Anxiety state unspecified,1
7781,Oxazepam,300.9,Unspecified nonpsychotic mental disorder,1
7781,Oxazepam,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
7781,Oxazepam,308.2,Predominant psychomotor disturbance,1
7781,Oxazepam,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
7781,Oxazepam,799.21,Nervousness (ADDED),1
7781,Oxazepam,799.22,Irritability (ADDED),1
7781,Oxazepam,799.89,Other ill-defined conditions,1
7804,Oxycodone,338-338.99,,1
7804,Oxycodone,338.18,Other acute postoperative pain,1
7804,Oxycodone,338.2,Chronic pain,1
7804,Oxycodone,338.29,Other chronic pain,1
7804,Oxycodone,780.96,Generalized pain,1
7804,Oxycodone,786.00,Respiratory abnormality; unspecified,1
7806,Oxygen,339.00,Cluster headache syndrome; unspecified,0
7806,Oxygen,339.02,Chronic cluster headache,0
7806,Oxygen,348.1,Anoxic brain damage,0
7806,Oxygen,486,Pneumonia; organism unspecified,0
7806,Oxygen,514,Pulmonary congestion and hypostasis,0
7806,Oxygen,515,Postinflammatory pulmonary fibrosis,0
7806,Oxygen,785.4,Gangrene,0
7806,Oxygen,786.09,Other dyspnea and respiratory abnormality,0
7806,Oxygen,958.0,Air embolism as an early complication of trauma,0
7806,Oxygen,958.3,Posttraumatic wound infection not elsewhere classified,0
7806,Oxygen,986,Toxic effect of carbon monoxide,0
7806,Oxygen,993.3,Caisson disease,0
7812,Oxymetazoline,372.30,Conjunctivitis NOS,0
7812,Oxymetazoline,460,Acute nasopharyngitis (common cold),1
7812,Oxymetazoline,472.0,Chronic rhinitis,0
7812,Oxymetazoline,477.0,Allergic rhinitis due to pollen,1
7812,Oxymetazoline,477.9,Allergic rhinitis NOS,1
7812,Oxymetazoline,478.19,Other diseases of nasal cavity and sinuses,1
7812,Oxymetazoline,995.3,Allergy unspecified not elsewhere classified,1
7813,Oxymetholone,285.9,Anemia unspecified,1
7814,Oxymorphone,300.00,Anxiety state unspecified,1
7814,Oxymorphone,338-338.99,,1
7814,Oxymorphone,514,Pulmonary congestion and hypostasis,1
7814,Oxymorphone,780.96,Generalized pain,1
7814,Oxymorphone,786.00,Respiratory abnormality; unspecified,1
7814,Oxymorphone,786.05,Shortness of breath,1
7814,Oxymorphone,786.09,Other dyspnea and respiratory abnormality,1
7821,Oxytetracycline,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
7821,Oxytetracycline,073,Ornithosis,1
7821,Oxytetracycline,073.9,Ornithosis NOS,1
7821,Oxytetracycline,076,Trachoma,1
7821,Oxytetracycline,076.9,Trachoma NOS,1
7821,Oxytetracycline,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
7821,Oxytetracycline,081.9,Typhus NOS,1
7821,Oxytetracycline,083.0,Q fever,1
7821,Oxytetracycline,083.9,Rickettsiosis NOS,0
7821,Oxytetracycline,087,Relapsing fever,1
7821,Oxytetracycline,087.9,Relapsing fever NOS,1
7821,Oxytetracycline,088.81,Lyme disease,1
7821,Oxytetracycline,097.9,Syphilis NOS,1
7821,Oxytetracycline,098,Gonococcal infections,0
7821,Oxytetracycline,098.89,Gonococcal infection of other specified sites,0
7821,Oxytetracycline,099.1,Lymphogranuloma venereum,1
7821,Oxytetracycline,136.9,Unspecified infectious and parasitic diseases,1
7821,Oxytetracycline,486,Pneumonia; organism unspecified,1
7821,Oxytetracycline,519.8,Other diseases of respiratory system; not elsewhere classified,1
7821,Oxytetracycline,599.0,Urinary tract infection; site not specified,0
7821,Oxytetracycline,706.1,Other acne,1
7824,Oxytocin,459.0,Hemorrhage NOS,1
7824,Oxytocin,666,Postpartum hemorrhage,1
7824,Oxytocin,666.14,Other immediate postpartum hemorrhage; postpartum,1
7833,aminosalicylic acid,010-018.99,,1
7833,aminosalicylic acid,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
7833,aminosalicylic acid,555.9,Regional enteritis of unspecified site,0
7891,Pantothenic Acid,266,Deficiency of B-complex components,0
7891,Pantothenic Acid,266.9,Vitamin B deficiency NOS,0
7895,Papaverine,302.72,Psychosexual dysfunction with inhibited sexual excitement,0
7895,Papaverine,348.89,Other conditions of brain (ADDED),0
7895,Papaverine,413,Angina pectoris,1
7895,Papaverine,413.9,Other and unspecified angina pectoris,1
7895,Papaverine,415.19,Other pulmonary embolism and infarction,1
7895,Papaverine,427,Cardiac dysrhythmias,0
7895,Papaverine,427.9,Cardiac dysrhythmia NOS,0
7895,Papaverine,443.0,Raynaud's syndrome,0
7895,Papaverine,443.9,Peripheral vascular disease; unspecified,1
7895,Papaverine,444.9,Embolism and thrombosis of unspecified artery,1
7895,Papaverine,453.9,Embolism and thrombosis of unspecified site,0
7895,Papaverine,459.9,Unspecified circulatory system disorder,1
7895,Papaverine,607.84,Impotence of organic origin,0
7895,Papaverine,728.85,Spasm of muscle,1
7895,Papaverine,780.96,Generalized pain,1
7895,Papaverine,781.0,Abnormal involuntary movements,1
7895,Papaverine,786.50,Unspecified chest pain,1
7895,Papaverine,789.00,Abdominal pain; unspecified site,1
7895,Papaverine,789.7,Colic (ADDED),1
7909,Paraldehyde,293.0,Delirium due to conditions classified elsewhere,0
7909,Paraldehyde,780.09,Other alteration of consciousness,0
7909,Paraldehyde,780.39,Other convulsions,0
7930,Pargyline,401-405.99,,0
7930,Pargyline,401.9,Hypertension NOS,0
7930,Pargyline,997.91,Hypertension,0
7934,Paromomycin,006,Amebiasis,1
7934,Paromomycin,006.9,Amebiasis NOS,1
7934,Paromomycin,007.4,Cryptosporidiosis,0
7934,Paromomycin,136.8,Other specified infectious and parasitic diseases,1
7966,Pemoline,314,Hyperkinetic syndrome of childhood,1
7966,Pemoline,314.01,Attention deficit disorder of childhood with hyperactivity,1
7966,Pemoline,314.9,Unspecified hyperkinetic syndrome of childhood,1
7966,Pemoline,347.0,Narcolepsy,0
7966,Pemoline,347.00,Narcolepsy; without cataplexy,0
7973,Penbutolol,401-405.99,,0
7973,Penbutolol,401.9,Hypertension NOS,0
7973,Penbutolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
7973,Penbutolol,413,Angina pectoris,0
7973,Penbutolol,413.9,Other and unspecified angina pectoris,0
7973,Penbutolol,427.89,Other specified cardiac dysrhythmias,0
7973,Penbutolol,458,Hypotension,0
7973,Penbutolol,458.9,Hypotension NOS,0
7973,Penbutolol,786.50,Unspecified chest pain,0
7973,Penbutolol,997.91,Hypertension,0
7975,Penicillamine,270.0,Disturbances of amino-acid transport,1
7975,Penicillamine,275.1,Disorders of copper metabolism,1
7975,Penicillamine,348.89,Other conditions of brain (ADDED),1
7975,Penicillamine,571.6,Biliary cirrhosis,0
7975,Penicillamine,714.0,Rheumatoid arthritis,1
7975,Penicillamine,984,Toxic effect of lead and its compounds (including fumes),0
7975,Penicillamine,984.9,Toxic effect of unspecified lead compound,0
7975,Penicillamine,985.0,Toxic effect of mercury and its compounds,0
7980,Penicillin G,022,Anthrax,1
7980,Penicillin G,022.9,Anthrax NOS,1
7980,Penicillin G,032,Diphtheria,1
7980,Penicillin G,032.9,Diphtheria NOS,1
7980,Penicillin G,036,Meningococcal infection,0
7980,Penicillin G,036.9,Meningococcal infection; unspecified,0
7980,Penicillin G,038,Septicemia,1
7980,Penicillin G,038.9,Septicemia NOS,1
7980,Penicillin G,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
7980,Penicillin G,041.9|421.0,,1
7980,Penicillin G,097.9,Syphilis NOS,1
7980,Penicillin G,098,Gonococcal infections,1
7980,Penicillin G,098.89,Gonococcal infection of other specified sites,1
7980,Penicillin G,136.9,Unspecified infectious and parasitic diseases,1
7980,Penicillin G,322,Meningitis of unspecified cause,1
7980,Penicillin G,322.9,Meningitis NOS,1
7980,Penicillin G,390,Rheumatic fever without mention of heart involvement,1
7980,Penicillin G,390-392.99,,1
7980,Penicillin G,421.0,Acute and subacute bacterial endocarditis,0
7980,Penicillin G,486,Pneumonia; organism unspecified,1
7980,Penicillin G,785.4,Gangrene,1
7982,penicillin G benzathine,097.9,Syphilis NOS,1
7982,penicillin G benzathine,136.9,Unspecified infectious and parasitic diseases,1
7982,penicillin G benzathine,390,Rheumatic fever without mention of heart involvement,1
7982,penicillin G benzathine,390-392.99,,1
7983,penicillin G procaine,022,Anthrax,0
7983,penicillin G procaine,022.9,Anthrax NOS,0
7983,penicillin G procaine,097.9,Syphilis NOS,0
7983,penicillin G procaine,421.0,Acute and subacute bacterial endocarditis,0
7984,Penicillin V,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
7984,Penicillin V,041.2,Pneumococcus infection in conditions classified elsewhere and of unspecified site,1
7984,Penicillin V,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
7984,Penicillin V,104.9,Spirochetal infection; unspecified,0
7984,Penicillin V,136.9,Unspecified infectious and parasitic diseases,1
7984,Penicillin V,333.5,Other choreas,1
7984,Penicillin V,382.9,Unspecified otitis media,0
7984,Penicillin V,390,Rheumatic fever without mention of heart involvement,1
7984,Penicillin V,390-392.99,,1
7984,Penicillin V,461.9,Acute sinusitis NOS,0
7984,Penicillin V,462,Acute pharyngitis,1
7984,Penicillin V,486,Pneumonia; organism unspecified,1
7984,Penicillin V,523.10,Chronic gingivitis; plaque induced,1
7984,Penicillin V,599.0,Urinary tract infection; site not specified,0
7984,Penicillin V,686.9,Unspecified local infection of skin and subcutaneous tissue,0
7992,Pentaerythritol Tetranitrate,413,Angina pectoris,0
7992,Pentaerythritol Tetranitrate,413.9,Other and unspecified angina pectoris,0
7992,Pentaerythritol Tetranitrate,786.50,Unspecified chest pain,0
7993,Pentagastrin,537.9,Unspecified disorder of stomach and duodenum,0
7994,Pentamidine,042,Human immunodeficiency virus [HIV] disease,1
7994,Pentamidine,042-042.99,,1
7994,Pentamidine,085.0,Visceral leishmaniasis,0
7994,Pentamidine,086,Trypanosomiasis,0
7994,Pentamidine,086.9,Trypanosomiasis NOS,0
7994,Pentamidine,136.3,Pneumocystosis,1
7994,Pentamidine,136.9,Unspecified infectious and parasitic diseases,1
7994,Pentamidine,486,Pneumonia; organism unspecified,1
7995,Pentamidine Isethionate,085.0,Visceral leishmaniasis,0
7995,Pentamidine Isethionate,086,Trypanosomiasis,0
7995,Pentamidine Isethionate,086.9,Trypanosomiasis NOS,0
7995,Pentamidine Isethionate,136.3,Pneumocystosis,0
7995,Pentamidine Isethionate,136.9,Unspecified infectious and parasitic diseases,0
7995,Pentamidine Isethionate,486,Pneumonia; organism unspecified,0
8001,Pentazocine,338-338.99,,1
8001,Pentazocine,780.96,Generalized pain,1
8004,Pentobarbital,345.3,Grand mal status; epileptic,1
8004,Pentobarbital,780.52,Insomnia; unspecified,1
8011,Pentostatin,202.4,Leukemic reticuloendotheliosis,1
8011,Pentostatin,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,1
8011,Pentostatin,204.1,Lymphoid leukemia; chronic,0
8011,Pentostatin,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
8013,Pentoxifylline,084.9,Other pernicious complications of malaria,0
8013,Pentoxifylline,250.6,Diabetes with neurological manifestations,0
8013,Pentoxifylline,282.5,Sickle-cell trait,0
8013,Pentoxifylline,282.6,Sickle-cell disease,0
8013,Pentoxifylline,282.60,Sickle cell disease NOS,0
8013,Pentoxifylline,282.61,Hb-SS disease without crisis,0
8013,Pentoxifylline,348.89,Other conditions of brain (ADDED),0
8013,Pentoxifylline,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,0
8013,Pentoxifylline,443.9,Peripheral vascular disease; unspecified,1
8013,Pentoxifylline,447.6,Arteritis NOS,0
8013,Pentoxifylline,453.9,Embolism and thrombosis of unspecified site,0
8013,Pentoxifylline,459.9,Unspecified circulatory system disorder,1
8013,Pentoxifylline,785.4,Gangrene,0
8047,Pergolide,307.23,Tourette's disorder,0
8047,Pergolide,332,Parkinson's disease,0
8047,Pergolide,332.0,Paralysis agitans,0
8076,Perphenazine,290-299.99,,0
8076,Perphenazine,295,Schizophrenic disorders,1
8076,Perphenazine,295.9,Unspecified schizophrenia,1
8076,Perphenazine,295.90,Unspecified schizophrenia; unspecified state,1
8076,Perphenazine,298.9,Unspecified psychosis,0
8076,Perphenazine,300.9,Unspecified nonpsychotic mental disorder,0
8076,Perphenazine,307.23,Tourette's disorder,0
8076,Perphenazine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
8076,Perphenazine,308.2,Predominant psychomotor disturbance,0
8076,Perphenazine,331.81,Reye's syndrome,0
8076,Perphenazine,333.4,Huntington's chorea,0
8076,Perphenazine,723.5,Torticollis NOS,0
8076,Perphenazine,787.02,Nausea alone,1
8076,Perphenazine,787.03,Vomiting alone,1
8076,Perphenazine,799.21,Nervousness (ADDED),0
8091,Petrolatum,691.0,Diaper or napkin rash,1
8091,Petrolatum,692.9,Contact dermatitis and other eczema; unspecified cause,1
8091,Petrolatum,782.1,Rash and other nonspecific skin eruption,1
8120,Phenazopyridine,136.9,Unspecified infectious and parasitic diseases,1
8120,Phenazopyridine,338-338.99,,1
8120,Phenazopyridine,595.9,Cystitis NOS,0
8120,Phenazopyridine,599.0,Urinary tract infection; site not specified,1
8120,Phenazopyridine,780.96,Generalized pain,1
8120,Phenazopyridine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
8123,Phenelzine,300.00,Anxiety state unspecified,1
8123,Phenelzine,311,Depressive disorder NEC,0
8132,Pheniramine,477.0,Allergic rhinitis due to pollen,0
8132,Pheniramine,477.9,Allergic rhinitis NOS,0
8132,Pheniramine,708,Urticaria,0
8132,Pheniramine,708.9,Unspecified urticaria,0
8133,Phenmetrazine,278.00,Obesity NOS,0
8134,Phenobarbital,277.4,Disorders of bilirubin excretion,0
8134,Phenobarbital,300.00,Anxiety state unspecified,1
8134,Phenobarbital,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
8134,Phenobarbital,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,0
8134,Phenobarbital,345.3,Grand mal status; epileptic,1
8134,Phenobarbital,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
8134,Phenobarbital,779.0,Convulsions in newborn,0
8134,Phenobarbital,780.31,Febrile convulsions,0
8134,Phenobarbital,780.39,Other convulsions,1
8149,Phenoxybenzamine,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
8149,Phenoxybenzamine,239.9,Neoplasm of unspecified nature; site unspecified,1
8149,Phenoxybenzamine,401-405.99,,1
8149,Phenoxybenzamine,401.0,Malignant essential hypertension,0
8149,Phenoxybenzamine,401.9,Hypertension NOS,1
8149,Phenoxybenzamine,596.0,Bladder neck obstruction,0
8149,Phenoxybenzamine,788.3,Urinary incontinence,0
8149,Phenoxybenzamine,788.30,Urinary incontinence NOS,0
8149,Phenoxybenzamine,997.91,Hypertension,1
8150,Phenprocoumon,415.19,Other pulmonary embolism and infarction,0
8150,Phenprocoumon,453.9,Embolism and thrombosis of unspecified site,0
8150,Phenprocoumon,459.9,Unspecified circulatory system disorder,0
8152,Phentermine,278.00,Obesity NOS,1
8152,Phentermine,783.21,Loss of weight,1
8152,Phentermine,783.9,Other symptoms concerning nutrition; metabolism; and development,1
8153,Phentolamine,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
8153,Phentolamine,239.9,Neoplasm of unspecified nature; site unspecified,1
8153,Phentolamine,401.0,Malignant essential hypertension,0
8153,Phentolamine,401.9,Hypertension NOS,1
8163,Phenylephrine,338-338.99,,0
8163,Phenylephrine,365,Glaucoma,1
8163,Phenylephrine,365.1,Open-angle glaucoma,1
8163,Phenylephrine,365.10,Open-angle glaucoma NOS,1
8163,Phenylephrine,365.13,Pigmentary glaucoma,1
8163,Phenylephrine,365.9,Glaucoma NOS,1
8163,Phenylephrine,427.89,Other specified cardiac dysrhythmias,1
8163,Phenylephrine,455,Hemorrhoids,0
8163,Phenylephrine,455.6,Hemorrhoids NOS,0
8163,Phenylephrine,458,Hypotension,1
8163,Phenylephrine,458.9,Hypotension NOS,1
8163,Phenylephrine,477.9,Allergic rhinitis NOS,0
8163,Phenylephrine,565.0,Anal fissure,0
8163,Phenylephrine,569.41,Ulcer of anus and rectum,0
8163,Phenylephrine,698.0,Pruritus ani,0
8163,Phenylephrine,780.96,Generalized pain,0
8163,Phenylephrine,782.3,Edema,0
8163,Phenylephrine,785.52,Septic shock,0
8163,Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
8164,Phenylephrine Hydrochloride,338-338.99,,0
8164,Phenylephrine Hydrochloride,365.1,Open-angle glaucoma,0
8164,Phenylephrine Hydrochloride,365.10,Open-angle glaucoma NOS,0
8164,Phenylephrine Hydrochloride,365.13,Pigmentary glaucoma,0
8164,Phenylephrine Hydrochloride,427.89,Other specified cardiac dysrhythmias,0
8164,Phenylephrine Hydrochloride,455,Hemorrhoids,0
8164,Phenylephrine Hydrochloride,455.6,Hemorrhoids NOS,0
8164,Phenylephrine Hydrochloride,458,Hypotension,0
8164,Phenylephrine Hydrochloride,458.9,Hypotension NOS,0
8164,Phenylephrine Hydrochloride,477.9,Allergic rhinitis NOS,0
8164,Phenylephrine Hydrochloride,565.0,Anal fissure,0
8164,Phenylephrine Hydrochloride,569.41,Ulcer of anus and rectum,0
8164,Phenylephrine Hydrochloride,698.0,Pruritus ani,0
8164,Phenylephrine Hydrochloride,780.96,Generalized pain,0
8164,Phenylephrine Hydrochloride,785.52,Septic shock,0
8175,Phenylpropanolamine,278.00,Obesity NOS,0
8175,Phenylpropanolamine,460,Acute nasopharyngitis (common cold),0
8175,Phenylpropanolamine,472.0,Chronic rhinitis,0
8175,Phenylpropanolamine,477.9,Allergic rhinitis NOS,0
8175,Phenylpropanolamine,780.96,Generalized pain,0
8175,Phenylpropanolamine,786.2,Cough,0
8183,Phenytoin,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
8183,Phenytoin,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
8183,Phenytoin,345.40,Partial epilepsy without intractable epilepsy,0
8183,Phenytoin,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,0
8183,Phenytoin,757.39,Other specified congenital anomalies of skin,0
8183,Phenytoin,780.39,Other convulsions,1
8263,Phosphorus,275.3,Disorders of phosphorus metabolism,1
8299,Physostigmine,365,Glaucoma,0
8299,Physostigmine,365.9,Glaucoma NOS,0
8299,Physostigmine,977.9,Poisoning by unspecified drug or medicinal substance,0
8308,Vitamin K 1,286,Coagulation defects,1
8308,Vitamin K 1,286.3,Congenital deficiency of other clotting factors,1
8308,Vitamin K 1,286.9,Other and unspecified coagulation defects,1
8308,Vitamin K 1,289.9,Blood disease NOS,1
8328,Pilocarpine,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),0
8328,Pilocarpine,365,Glaucoma,1
8328,Pilocarpine,365.02,Anatomical narrow angle borderline glaucoma,0
8328,Pilocarpine,365.20|365.70,,0
8328,Pilocarpine,365.9,Glaucoma NOS,1
8328,Pilocarpine,379.42,Miosis (persistent); not due to miotics,1
8328,Pilocarpine,379.43,Mydriasis (persistent); not due to mydriatics,0
8328,Pilocarpine,527.7,Disturbance of salivary secretion,1
8331,Pimozide,290-299.99,,0
8331,Pimozide,295,Schizophrenic disorders,1
8331,Pimozide,295.9,Unspecified schizophrenia,1
8331,Pimozide,295.90,Unspecified schizophrenia; unspecified state,1
8331,Pimozide,298.9,Unspecified psychosis,0
8331,Pimozide,307.20,Tic disorder NOS,1
8331,Pimozide,307.23,Tourette's disorder,0
8331,Pimozide,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
8331,Pimozide,308.2,Predominant psychomotor disturbance,1
8331,Pimozide,333.4,Huntington's chorea,0
8331,Pimozide,799.21,Nervousness (ADDED),1
8332,Pindolol,401-405.99,,1
8332,Pindolol,401.9,Hypertension NOS,1
8332,Pindolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
8332,Pindolol,413,Angina pectoris,0
8332,Pindolol,413.9,Other and unspecified angina pectoris,0
8332,Pindolol,786.50,Unspecified chest pain,0
8332,Pindolol,997.91,Hypertension,1
8338,piperacetazine,295,Schizophrenic disorders,0
8338,piperacetazine,295.9,Unspecified schizophrenia,0
8338,piperacetazine,295.90,Unspecified schizophrenia; unspecified state,0
8339,Piperacillin,038,Septicemia,1
8339,Piperacillin,038.9,Septicemia NOS,1
8339,Piperacillin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
8339,Piperacillin,041.49,Other and unspecified Escherichia coli [E. coli],0
8339,Piperacillin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
8339,Piperacillin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
8339,Piperacillin,136.9,Unspecified infectious and parasitic diseases,1
8339,Piperacillin,486,Pneumonia; organism unspecified,1
8339,Piperacillin,519.8,Other diseases of respiratory system; not elsewhere classified,1
8339,Piperacillin,599.0,Urinary tract infection; site not specified,1
8339,Piperacillin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
8345,Piperonyl Butoxide,132.9,Pediculosis NOS,0
8345,Piperonyl Butoxide,133.0,Scabies,0
8356,Piroxicam,625.3,Dysmenorrhea,0
8356,Piroxicam,692.71,Sunburn,0
8356,Piroxicam,714.0,Rheumatoid arthritis,1
8356,Piroxicam,715.00,Osteoarthrosis; generalized; involving unspecified site,1
8356,Piroxicam,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
8356,Piroxicam,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
8356,Piroxicam,716.90,Arthropathy; unspecified; site unspecified,1
8356,Piroxicam,720.0,Ankylosing spondylitis,0
8410,Alteplase,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
8410,Alteplase,415.19,Other pulmonary embolism and infarction,0
8410,Alteplase,444.9,Embolism and thrombosis of unspecified artery,0
8462,podophyllin,078.11,Condyloma acuminatum,0
8463,podofilox,078.1,Viral warts,1
8463,podofilox,078.10,Viral warts; unspecified,1
8463,podofilox,078.11,Condyloma acuminatum,1
8513,Polyethylene Glycol 300,564.0,Constipation,0
8513,Polyethylene Glycol 300,564.00,Constipation NOS,0
8514,Polyethylene Glycol 400,564.0,Constipation,0
8514,Polyethylene Glycol 400,564.00,Constipation NOS,0
8516,Polyethylene Glycols,564.0,Constipation,0
8516,Polyethylene Glycols,564.00,Constipation NOS,0
8536,Polymyxin B,041.49,Other and unspecified Escherichia coli [E. coli],0
8536,Polymyxin B,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
8536,Polymyxin B,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
8536,Polymyxin B,136.9,Unspecified infectious and parasitic diseases,1
8536,Polymyxin B,320,Bacterial meningitis,0
8536,Polymyxin B,320.9,Bacterial meningitis NOS,0
8536,Polymyxin B,379.99|041.9,,0
8536,Polymyxin B,380.10,Infective otitis externa; unspecified,0
8536,Polymyxin B,569.9,Unspecified disorder of intestine,0
8536,Polymyxin B,596.9,Unspecified disorder of bladder,0
8536,Polymyxin B,709.9,Unspecified disorder of skin and subcutaneous tissue,0
8565,Polythiazide,401-405.99,,1
8565,Polythiazide,401.9,Hypertension NOS,1
8565,Polythiazide,428.0,Congestive heart failure (CHF) NOS,1
8565,Polythiazide,581,Nephrotic syndrome,1
8565,Polythiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
8565,Polythiazide,782.3,Edema,1
8565,Polythiazide,997.91,Hypertension,1
8588,Potassium,276.3,Alkalosis,1
8588,Potassium,276.8,Hypopotassemia,1
8588,Potassium,401-405.99,,1
8588,Potassium,401.9,Hypertension NOS,1
8588,Potassium,427,Cardiac dysrhythmias,1
8588,Potassium,427.9,Cardiac dysrhythmia NOS,1
8588,Potassium,593.9,Unspecified disorder of kidney and ureter,0
8588,Potassium,787.03,Vomiting alone,0
8588,Potassium,787.7,Abnormal feces,0
8588,Potassium,787.91,Diarrhea,0
8588,Potassium,799.9,Other unknown and unspecified cause of morbidity or mortality,0
8588,Potassium,997.91,Hypertension,1
8591,Potassium Chloride,276.8,Hypopotassemia,1
8591,Potassium Chloride,89.7,General physical examination,0
8597,Potassium Iodide,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
8597,Potassium Iodide,117.1,Sporotrichosis,0
8597,Potassium Iodide,242,Thyrotoxicosis with or without goiter,0
8597,Potassium Iodide,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,0
8597,Potassium Iodide,707.10,Ulcer of lower limb; unspecified,0
8597,Potassium Iodide,780.2,Syncope and collapse,0
8597,Potassium Iodide,786.2,Cough,0
8597,Potassium Iodide,940-949.99,,0
8597,Potassium Iodide,949.0,Burn of unspecified site; unspecified degree,0
8597,Potassium Iodide,977.9,Poisoning by unspecified drug or medicinal substance,0
8597,Potassium Iodide,990|E926.3,,0
8597,Potassium Iodide,998.59,Other postoperative infection,0
8604,Potassium Permanganate,686.8|041.9,,0
8610,Povidone,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
8610,Povidone,079.99|360.00,,0
8610,Povidone,111,Dermatomycosis; other and unspecified,0
8610,Povidone,111.9,Dermatomycosis NOS,0
8610,Povidone,134.9,Infestation NOS,0
8610,Povidone,379.99|041.9,,0
8610,Povidone,616.10|041.9,,0
8610,Povidone,686.8,Other specified local infections of skin and subcutaneous tissue,0
8610,Povidone,686.8|041.9,,0
8610,Povidone,707.10,Ulcer of lower limb; unspecified,0
8610,Povidone,709.9,Unspecified disorder of skin and subcutaneous tissue,0
8610,Povidone,940-949.99,,0
8610,Povidone,949.0,Burn of unspecified site; unspecified degree,0
8610,Povidone,990|E926.3,,0
8610,Povidone,998.59,Other postoperative infection,0
8611,Povidone-Iodine,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
8611,Povidone-Iodine,136.9,Unspecified infectious and parasitic diseases,1
8611,Povidone-Iodine,707.10,Ulcer of lower limb; unspecified,0
8611,Povidone-Iodine,709.9,Unspecified disorder of skin and subcutaneous tissue,0
8611,Povidone-Iodine,940-949.99,,0
8611,Povidone-Iodine,949.0,Burn of unspecified site; unspecified degree,0
8611,Povidone-Iodine,990|E926.3,,0
8611,Povidone-Iodine,998.59,Other postoperative infection,0
8627,Prazepam,291.0,Alcohol withdrawal delirium,0
8627,Prazepam,300.00,Anxiety state unspecified,0
8627,Prazepam,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
8627,Prazepam,532,Duodenal ulcer,0
8627,Prazepam,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
8627,Prazepam,781.0,Abnormal involuntary movements,0
8628,Praziquantel,120,Schistosomiasis [bilharziasis],0
8628,Praziquantel,120-129.99,,0
8628,Praziquantel,120.9,Schistosomiasis NOS,0
8628,Praziquantel,121.0,Opisthorchiasis,0
8628,Praziquantel,121.1,Clonorchiasis,0
8628,Praziquantel,121.9,Trematode infection NOS,0
8628,Praziquantel,123.1,Cysticercosis,0
8628,Praziquantel,123.8,Other specified cestode infection,0
8628,Praziquantel,123.9,Cestode infection NOS,0
8628,Praziquantel,127.9,Intestinal helminthiasis; unspecified,0
8628,Praziquantel,128.9,Helminthiasis NOS,0
8628,Praziquantel,129,Intestinal parasitism; unspecified,0
8628,Praziquantel,136.9,Unspecified infectious and parasitic diseases,1
8629,Prazosin,300.00,Anxiety state unspecified,0
8629,Prazosin,308.9,Unspecified acute reaction to stress,0
8629,Prazosin,309.81,Posttraumatic stress disorder,0
8629,Prazosin,401-405.99,,1
8629,Prazosin,401.9,Hypertension NOS,1
8629,Prazosin,443.0,Raynaud's syndrome,0
8629,Prazosin,600,Hyperplasia of prostate,0
8629,Prazosin,600.9,Hyperplasia of prostate; unspecified,0
8629,Prazosin,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),0
8629,Prazosin,788.2,Retention of urine,0
8629,Prazosin,788.20,Retention of urine NOS,0
8629,Prazosin,997.91,Hypertension,1
8638,prednisolone,010-018.99,,1
8638,prednisolone,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
8638,prednisolone,135,Sarcoidosis,1
8638,prednisolone,136.9,Unspecified infectious and parasitic diseases,1
8638,prednisolone,140-239.99,,1
8638,prednisolone,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
8638,prednisolone,239,Neoplasms of unspecified nature,1
8638,prednisolone,239-239.99,,1
8638,prednisolone,245,Thyroiditis,1
8638,prednisolone,245.9,Thyroiditis NOS,1
8638,prednisolone,255.2,Adrenogenital disorders,1
8638,prednisolone,255.41,Glucocorticoid deficiency,1
8638,prednisolone,274.9,Gout NOS,1
8638,prednisolone,275.42,Hypercalcemia,1
8638,prednisolone,280-289.99,,1
8638,prednisolone,289.9,Blood disease NOS,1
8638,prednisolone,340,Multiple sclerosis,1
8638,prednisolone,364.3,Iridocyclitis NOS,1
8638,prednisolone,372.30,Conjunctivitis NOS,1
8638,prednisolone,379.99,Other ill-defined disorders of eye,1
8638,prednisolone,446.5,Giant cell arteritis,1
8638,prednisolone,447.6,Arteritis NOS,1
8638,prednisolone,493,Asthma,1
8638,prednisolone,493.9,Asthma; unspecified,1
8638,prednisolone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
8638,prednisolone,496,Chronic airway obstruction; not elsewhere classified,1
8638,prednisolone,555.9,Regional enteritis of unspecified site,1
8638,prednisolone,556,Ulcerative colitis,1
8638,prednisolone,556.8,Other ulcerative colitis,1
8638,prednisolone,556.9,Ulcerative colitis; unspecified,1
8638,prednisolone,569.9,Unspecified disorder of intestine,1
8638,prednisolone,581,Nephrotic syndrome,1
8638,prednisolone,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
8638,prednisolone,586,Renal failure unspecified,1
8638,prednisolone,692.9,Contact dermatitis and other eczema; unspecified cause,1
8638,prednisolone,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
8638,prednisolone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
8638,prednisolone,710.0,Systemic lupus erythematosus,1
8638,prednisolone,710.3,Dermatomyositis,1
8638,prednisolone,710.9,Unspecified diffuse connective tissue disease,1
8638,prednisolone,714.0,Rheumatoid arthritis,1
8638,prednisolone,729.0,Rheumatism; unspecified and fibrositis,0
8638,prednisolone,782.3,Edema,1
8638,prednisolone,788.42,Polyuria,1
8638,prednisolone,790.99,Other nonspecific findings on examination of blood,1
8638,prednisolone,796.4,Other abnormal clinical findings,1
8638,prednisolone,995.3,Allergy unspecified not elsewhere classified,1
8640,Prednisone,010-018.99,,1
8640,Prednisone,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
8640,Prednisone,135,Sarcoidosis,1
8640,Prednisone,140-239.99,,0
8640,Prednisone,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
8640,Prednisone,239,Neoplasms of unspecified nature,0
8640,Prednisone,239-239.99,,0
8640,Prednisone,245,Thyroiditis,1
8640,Prednisone,245.9,Thyroiditis NOS,1
8640,Prednisone,255.2,Adrenogenital disorders,1
8640,Prednisone,255.41,Glucocorticoid deficiency,1
8640,Prednisone,275.42,Hypercalcemia,1
8640,Prednisone,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
8640,Prednisone,279.5,Graft-versus-host disease,0
8640,Prednisone,279.50,Graft-versus-host disease; unspecified,0
8640,Prednisone,280-289.99,,1
8640,Prednisone,289.9,Blood disease NOS,1
8640,Prednisone,340,Multiple sclerosis,1
8640,Prednisone,360,Disorders of the globe,0
8640,Prednisone,360.9,Disorder of globe NOS,0
8640,Prednisone,364.3,Iridocyclitis NOS,1
8640,Prednisone,379.90,Eye disorder NOS,0
8640,Prednisone,486,Pneumonia; organism unspecified,1
8640,Prednisone,493,Asthma,1
8640,Prednisone,493.9,Asthma; unspecified,1
8640,Prednisone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
8640,Prednisone,556,Ulcerative colitis,1
8640,Prednisone,556.8,Other ulcerative colitis,1
8640,Prednisone,556.9,Ulcerative colitis; unspecified,1
8640,Prednisone,569.9,Unspecified disorder of intestine,1
8640,Prednisone,581,Nephrotic syndrome,1
8640,Prednisone,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,1
8640,Prednisone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
8640,Prednisone,710.0,Systemic lupus erythematosus,1
8640,Prednisone,710.9,Unspecified diffuse connective tissue disease,1
8640,Prednisone,716.90,Arthropathy; unspecified; site unspecified,1
8640,Prednisone,729.0,Rheumatism; unspecified and fibrositis,0
8640,Prednisone,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
8640,Prednisone,780-789.99,,0
8640,Prednisone,796.4,Other abnormal clinical findings,1
8640,Prednisone,799.9,Other unknown and unspecified cause of morbidity or mortality,0
8640,Prednisone,995.3,Allergy unspecified not elsewhere classified,1
8686,Prilocaine,338-338.99,,0
8686,Prilocaine,525.9,Dental disorder NOS,0
8686,Prilocaine,780.96,Generalized pain,0
8687,Primaquine,084.0,Falciparum malaria [malignant tertian],0
8687,Primaquine,084.1,Vivax malaria [benign tertian],1
8689,Primaquine Phosphate,084.0,Falciparum malaria [malignant tertian],0
8689,Primaquine Phosphate,084.1,Vivax malaria [benign tertian],1
8691,Primidone,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
8691,Primidone,345.9,Epilepsy; unspecified,1
8691,Primidone,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
8691,Primidone,780.39,Other convulsions,1
8691,Primidone,781.0,Abnormal involuntary movements,0
8698,Probenecid,094,Neurosyphilis,0
8698,Probenecid,094.9,Neurosyphilis NOS,0
8698,Probenecid,098,Gonococcal infections,0
8698,Probenecid,098.89,Gonococcal infection of other specified sites,0
8698,Probenecid,136.9,Unspecified infectious and parasitic diseases,0
8698,Probenecid,274,Gout,1
8698,Probenecid,274.0,Gouty arthropathy,1
8698,Probenecid,274.00,Gouty arthropathy (ADDED),1
8698,Probenecid,274.9,Gout NOS,1
8698,Probenecid,790.6,Other abnormal blood chemistry,1
8699,Probucol,272.4,Other and unspecified hyperlipidemia,0
8699,Probucol,447.9,Unspecified disorders of arteries and arterioles,0
8700,Procainamide,427,Cardiac dysrhythmias,1
8700,Procainamide,427.1,Paroxysmal ventricular tachycardia,1
8700,Procainamide,427.31,Atrial fibrillation,1
8700,Procainamide,427.32,Atrial flutter,0
8700,Procainamide,427.69,Other premature beats,1
8700,Procainamide,427.89,Other specified cardiac dysrhythmias,1
8700,Procainamide,427.9,Cardiac dysrhythmia NOS,1
8701,Procaine,338-338.99,,0
8701,Procaine,780.96,Generalized pain,0
8702,Procarbazine,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
8702,Procarbazine,172.9,Melanoma of skin; site unspecified,1
8702,Procarbazine,201,Hodgkin's disease,0
8702,Procarbazine,201.0,Hodgkin's paragranuloma,0
8702,Procarbazine,201.1,Hodgkin's granuloma,0
8702,Procarbazine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
8702,Procarbazine,201.2,Hodgkin's sarcoma,0
8702,Procarbazine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
8702,Procarbazine,201.9,Hodgkin's disease; unspecified type,0
8702,Procarbazine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
8702,Procarbazine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
8702,Procarbazine,203.0,Multiple myeloma,1
8702,Procarbazine,203.00,Multiple myeloma without mention of having achieved remission,1
8702,Procarbazine,239.1,Neoplasm of unspecified nature of respiratory system,0
8702,Procarbazine,239.6,Neoplasm of unspecified nature of brain,1
8703,Fenofibrate,272.1,Pure hyperglyceridemia,1
8703,Fenofibrate,272.4,Other and unspecified hyperlipidemia,1
8703,Fenofibrate,272.8,Other disorders of lipoid metabolism,1
8703,Fenofibrate,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,1
8703,Fenofibrate,429.9,Heart disease NOS,1
8703,Fenofibrate,447.9,Unspecified disorders of arteries and arterioles,1
8704,Prochlorperazine,290,Dementias,0
8704,Prochlorperazine,290-299.99,,0
8704,Prochlorperazine,294.2,,0
8704,Prochlorperazine,294.20,Dementia; unspecified; without behavioral disturbance,0
8704,Prochlorperazine,295,Schizophrenic disorders,1
8704,Prochlorperazine,295.9,Unspecified schizophrenia,1
8704,Prochlorperazine,295.90,Unspecified schizophrenia; unspecified state,1
8704,Prochlorperazine,298.9,Unspecified psychosis,0
8704,Prochlorperazine,300.00,Anxiety state unspecified,1
8704,Prochlorperazine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
8704,Prochlorperazine,308.2,Predominant psychomotor disturbance,1
8704,Prochlorperazine,780-789.99,,0
8704,Prochlorperazine,787.02,Nausea alone,1
8704,Prochlorperazine,787.03,Vomiting alone,1
8704,Prochlorperazine,799.21,Nervousness (ADDED),1
8718,Procyclidine,332.0,Paralysis agitans,0
8727,Progesterone,179,Malignant neoplasm of uterus; part unspecified,1
8727,Progesterone,459.0,Hemorrhage NOS,1
8727,Progesterone,621.3,Endometrial hyperplasia,1
8727,Progesterone,621.30,Endometrial hyperplasia; unspecified,1
8727,Progesterone,621.4,Hematometra,1
8727,Progesterone,626.0,Absence of menstruation,1
8727,Progesterone,628,Infertility; female,0
8727,Progesterone,628.9,Female infertility NOS,0
8727,Progesterone,796.4,Other abnormal clinical findings,1
8727,Progesterone,V22.2,Pregnant state; incidental,0
8742,Promazine,290-299.99,,0
8742,Promazine,298.9,Unspecified psychosis,0
8742,Promazine,787.02,Nausea alone,0
8742,Promazine,787.03,Vomiting alone,0
8745,Promethazine,338-338.99,,1
8745,Promethazine,372.14,Other chronic allergic conjunctivitis,1
8745,Promethazine,477.0,Allergic rhinitis due to pollen,1
8745,Promethazine,477.9,Allergic rhinitis NOS,1
8745,Promethazine,780.2,Syncope and collapse,0
8745,Promethazine,780.96,Generalized pain,1
8745,Promethazine,786.2,Cough,0
8745,Promethazine,787.02,Nausea alone,1
8745,Promethazine,787.03,Vomiting alone,1
8745,Promethazine,799.89,Other ill-defined conditions,1
8745,Promethazine,994.6,Motion sickness,1
8745,Promethazine,995.0,Other anaphylactic reaction,1
8745,Promethazine,995.3,Allergy unspecified not elsewhere classified,1
8745,Promethazine,998.9,Unspecified complication of procedure; not elsewhere classified,0
8754,Propafenone,427,Cardiac dysrhythmias,1
8754,Propafenone,427.31,Atrial fibrillation,1
8754,Propafenone,427.89,Other specified cardiac dysrhythmias,1
8754,Propafenone,427.9,Cardiac dysrhythmia NOS,1
8754,Propafenone,429.9,Heart disease NOS,1
8754,Propafenone,785.0,Tachycardia NOS,1
8761,Propantheline,533,Peptic ulcer; site unspecified,1
8761,Propantheline,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
8761,Propantheline,564.1,Irritable bowel syndrome,0
8761,Propantheline,577.0,Acute pancreatitis,0
8761,Propantheline,596.9,Unspecified disorder of bladder,0
8761,Propantheline,599.9,Unspecified disorder of urethra and urinary tract,0
8761,Propantheline,707.9,Chronic ulcer of unspecified site,1
8761,Propantheline,728.85,Spasm of muscle,0
8761,Propantheline,781.0,Abnormal involuntary movements,0
8770,propiomazine,307.42,Persistent disorder of initiating or maintaining sleep,0
8782,Propofol,293.0,Delirium due to conditions classified elsewhere,0
8782,Propofol,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
8782,Propofol,308.2,Predominant psychomotor disturbance,0
8782,Propofol,338-338.99,,0
8782,Propofol,345.3,Grand mal status; epileptic,0
8782,Propofol,780.09,Other alteration of consciousness,0
8782,Propofol,780.96,Generalized pain,0
8782,Propofol,787.01,Nausea with vomiting,0
8782,Propofol,799.21,Nervousness (ADDED),0
8785,Propoxyphene,338-338.99,,1
8785,Propoxyphene,780-789.99,,0
8785,Propoxyphene,780.96,Generalized pain,1
8786,propoxyphene napsylate,338-338.99,,0
8786,propoxyphene napsylate,780.96,Generalized pain,0
8787,Propranolol,140-239.99,,1
8787,Propranolol,239,Neoplasms of unspecified nature,1
8787,Propranolol,239-239.99,,1
8787,Propranolol,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
8787,Propranolol,239.9,Neoplasm of unspecified nature; site unspecified,1
8787,Propranolol,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
8787,Propranolol,300.01,Panic disorder without agoraphobia,0
8787,Propranolol,333.1,Essential and other specified forms of tremor,1
8787,Propranolol,346,Migraine,1
8787,Propranolol,346.9,Migraine; unspecified,1
8787,Propranolol,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
8787,Propranolol,401-405.99,,1
8787,Propranolol,401.9,Hypertension NOS,1
8787,Propranolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
8787,Propranolol,413,Angina pectoris,1
8787,Propranolol,413.9,Other and unspecified angina pectoris,1
8787,Propranolol,427,Cardiac dysrhythmias,1
8787,Propranolol,427.1,Paroxysmal ventricular tachycardia,1
8787,Propranolol,427.41,Ventricular fibrillation,0
8787,Propranolol,427.89,Other specified cardiac dysrhythmias,1
8787,Propranolol,427.9,Cardiac dysrhythmia NOS,1
8787,Propranolol,428.0,Congestive heart failure (CHF) NOS,0
8787,Propranolol,429.9,Heart disease NOS,1
8787,Propranolol,781.0,Abnormal involuntary movements,1
8787,Propranolol,784.0,Headache,1
8787,Propranolol,785.0,Tachycardia NOS,1
8787,Propranolol,786.50,Unspecified chest pain,1
8787,Propranolol,997.91,Hypertension,1
8794,Propylthiouracil,240.9,Goiter NOS,1
8794,Propylthiouracil,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
8794,Propylthiouracil,242.91,Thyrotoxicosis without mention of goiter or other cause; with mention of thyrotoxic crisis or storm,0
8814,Epoprostenol,287.2,Other nonthrombocytopenic purpuras,0
8814,Epoprostenol,416.0,Primary pulmonary hypertension,1
8814,Epoprostenol,440.9,Atherosclerosis NOS,0
8814,Epoprostenol,443.9,Peripheral vascular disease; unspecified,0
8814,Epoprostenol,514,Pulmonary congestion and hypostasis,0
8814,Epoprostenol,518.52,Other pulmonary insufficiency; not elsewhere classified; following trauma and surgery,0
8814,Epoprostenol,710.1,Systemic sclerosis,0
8814,Epoprostenol,782.7,Spontaneous ecchymoses,0
8825,Protamine Sulfate (USP),459.0,Hemorrhage NOS,0
8825,Protamine Sulfate (USP),998.9,Unspecified complication of procedure; not elsewhere classified,0
8886,Protriptyline,311,Depressive disorder NEC,0
8896,Pseudoephedrine,338-338.99,,0
8896,Pseudoephedrine,460,Acute nasopharyngitis (common cold),1
8896,Pseudoephedrine,461.9,Acute sinusitis NOS,1
8896,Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
8896,Pseudoephedrine,477.9,Allergic rhinitis NOS,1
8896,Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
8896,Pseudoephedrine,493,Asthma,0
8896,Pseudoephedrine,493.9,Asthma; unspecified,0
8896,Pseudoephedrine,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
8896,Pseudoephedrine,780-789.99,,0
8896,Pseudoephedrine,780.60,Fever; unspecified,1
8896,Pseudoephedrine,780.96,Generalized pain,0
8896,Pseudoephedrine,780.99,Other general symptoms,0
8896,Pseudoephedrine,782.3,Edema,0
8896,Pseudoephedrine,786.2,Cough,0
8896,Pseudoephedrine,799.89,Other ill-defined conditions,0
8896,Pseudoephedrine,995.3,Allergy unspecified not elsewhere classified,1
8928,Psyllium,272.4,Other and unspecified hyperlipidemia,0
8928,Psyllium,455,Hemorrhoids,0
8928,Psyllium,455.6,Hemorrhoids NOS,0
8928,Psyllium,556,Ulcerative colitis,0
8928,Psyllium,556.8,Other ulcerative colitis,0
8928,Psyllium,556.9,Ulcerative colitis; unspecified,0
8928,Psyllium,564.0,Constipation,0
8928,Psyllium,564.00,Constipation NOS,0
8928,Psyllium,564.1,Irritable bowel syndrome,0
8928,Psyllium,787.7,Abnormal feces,0
8928,Psyllium,787.91,Diarrhea,0
8948,Purified Protein Derivative of Tuberculin,010-018.99,,1
8948,Purified Protein Derivative of Tuberculin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
8984,Pyrantel,120-129.99,,0
8984,Pyrantel,123.9,Cestode infection NOS,0
8984,Pyrantel,126.9,Ancylostomiasis NOS,0
8984,Pyrantel,127.0,Ascariasis,0
8984,Pyrantel,127.3,Trichuriasis,0
8984,Pyrantel,127.4,Enterobiasis,0
8984,Pyrantel,127.9,Intestinal helminthiasis; unspecified,0
8984,Pyrantel,128.9,Helminthiasis NOS,0
8987,Pyrazinamide,010-018.99,,1
8987,Pyrazinamide,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
8987,Pyrazinamide,136.9,Unspecified infectious and parasitic diseases,1
8991,Pyrethrins,132.9,Pediculosis NOS,0
8991,Pyrethrins,133.0,Scabies,0
9000,Pyridostigmine,358.0,Myasthenia gravis,1
9000,Pyridostigmine,358.00,Myasthenia gravis without (acute) exacerbation,1
9000,Pyridostigmine,728.87,Muscle weakness (generalized),0
9001,Pyridostigmine Bromide,358.0,Myasthenia gravis,0
9001,Pyridostigmine Bromide,358.00,Myasthenia gravis without (acute) exacerbation,0
9001,Pyridostigmine Bromide,728.87,Muscle weakness (generalized),0
9004,Pyridoxal Phosphate,780.39,Other convulsions,0
9004,Pyridoxal Phosphate,977.9,Poisoning by unspecified drug or medicinal substance,0
9009,Pyrilamine,372.14,Other chronic allergic conjunctivitis,0
9009,Pyrilamine,460,Acute nasopharyngitis (common cold),0
9009,Pyrilamine,477.9,Allergic rhinitis NOS,0
9009,Pyrilamine,780-789.99,,0
9010,Pyrimethamine,084.0,Falciparum malaria [malignant tertian],0
9010,Pyrimethamine,130,Toxoplasmosis,1
9010,Pyrimethamine,130.9,Toxoplasmosis NOS,1
9068,Quinidine,084.0,Falciparum malaria [malignant tertian],1
9068,Quinidine,427,Cardiac dysrhythmias,1
9068,Quinidine,427.1,Paroxysmal ventricular tachycardia,1
9068,Quinidine,427.31,Atrial fibrillation,1
9068,Quinidine,427.32,Atrial flutter,0
9068,Quinidine,427.89,Other specified cardiac dysrhythmias,0
9068,Quinidine,427.9,Cardiac dysrhythmia NOS,1
9068,Quinidine,799.9,Other unknown and unspecified cause of morbidity or mortality,1
9069,Quinidine Sulfate,084.0,Falciparum malaria [malignant tertian],0
9069,Quinidine Sulfate,427,Cardiac dysrhythmias,0
9069,Quinidine Sulfate,427.1,Paroxysmal ventricular tachycardia,0
9069,Quinidine Sulfate,427.31,Atrial fibrillation,0
9069,Quinidine Sulfate,427.32,Atrial flutter,0
9069,Quinidine Sulfate,427.89,Other specified cardiac dysrhythmias,0
9069,Quinidine Sulfate,427.9,Cardiac dysrhythmia NOS,0
9071,Quinine,084,Malaria,0
9071,Quinine,084.0,Falciparum malaria [malignant tertian],1
9071,Quinine,084.2,Quartan malaria,0
9071,Quinine,084.6,Malaria NOS,0
9071,Quinine,088.82,Babesiosis,0
9071,Quinine,729.82,Cramp of limb,1
9075,Quinine Sulfate,084,Malaria,0
9075,Quinine Sulfate,084.0,Falciparum malaria [malignant tertian],1
9075,Quinine Sulfate,084.2,Quartan malaria,0
9075,Quinine Sulfate,084.6,Malaria NOS,0
9075,Quinine Sulfate,088.82,Babesiosis,0
9075,Quinine Sulfate,729.82,Cramp of limb,1
9100,Racemethionine,692.9,Contact dermatitis and other eczema; unspecified cause,0
9100,Racemethionine,977.9,Poisoning by unspecified drug or medicinal substance,0
9143,Ranitidine,530.81,Esophageal reflux,1
9143,Ranitidine,531,Gastric ulcer,1
9143,Ranitidine,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
9143,Ranitidine,532,Duodenal ulcer,1
9143,Ranitidine,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
9143,Ranitidine,533,Peptic ulcer; site unspecified,1
9143,Ranitidine,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
9143,Ranitidine,537.9,Unspecified disorder of stomach and duodenum,1
9143,Ranitidine,578,Gastrointestinal hemorrhage,1
9143,Ranitidine,578.9,Hemorrhage of gastrointestinal tract NOS,1
9143,Ranitidine,707.9,Chronic ulcer of unspecified site,1
9143,Ranitidine,787.1,Heartburn,1
9259,rescinnamine,401-405.99,,0
9259,rescinnamine,401.9,Hypertension NOS,0
9259,rescinnamine,997.91,Hypertension,0
9260,Reserpine,295,Schizophrenic disorders,1
9260,Reserpine,295.9,Unspecified schizophrenia,1
9260,Reserpine,295.90,Unspecified schizophrenia; unspecified state,1
9260,Reserpine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
9260,Reserpine,308.2,Predominant psychomotor disturbance,1
9260,Reserpine,401-405.99,,1
9260,Reserpine,401.9,Hypertension NOS,1
9260,Reserpine,781.3,Lack of coordination,0
9260,Reserpine,799.21,Nervousness (ADDED),1
9260,Reserpine,997.91,Hypertension,1
9344,Ribavirin,065.9,Arthropod-borne hemorrhagic fever; unspecified,0
9344,Ribavirin,066.4,West Nile fever,0
9344,Ribavirin,066.40,West Nile fever NOS,0
9344,Ribavirin,070.54,Chronic hepatitis C without mention of hepatic coma,1
9344,Ribavirin,070.7,Unspecified viral hepatitis C,1
9344,Ribavirin,070.70,Unspecified viral hepatitis C without hepatic coma,1
9344,Ribavirin,070.9,Unspecified viral hepatitis without mention of hepatic coma,1
9344,Ribavirin,079.6,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,1
9344,Ribavirin,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,1
9344,Ribavirin,136.9,Unspecified infectious and parasitic diseases,1
9344,Ribavirin,486,Pneumonia; organism unspecified,1
9344,Ribavirin,487,Influenza,1
9344,Ribavirin,487.1,Influenza with other respiratory manifestations,1
9344,Ribavirin,573.9,Unspecified disorder of liver,1
9346,Riboflavin,266.0,Ariboflavinosis,0
9384,Rifampin,010-018.99,,1
9384,Rifampin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
9384,Rifampin,023,Brucellosis,0
9384,Rifampin,023.9,Brucellosis NOS,0
9384,Rifampin,030,Leprosy,0
9384,Rifampin,030.9,Leprosy NOS,0
9384,Rifampin,036,Meningococcal infection,1
9384,Rifampin,036.0,Meningococcal meningitis,0
9384,Rifampin,036.9,Meningococcal infection; unspecified,1
9384,Rifampin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
9384,Rifampin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
9384,Rifampin,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
9384,Rifampin,136.9,Unspecified infectious and parasitic diseases,1
9384,Rifampin,320,Bacterial meningitis,1
9384,Rifampin,320.9,Bacterial meningitis NOS,1
9384,Rifampin,322,Meningitis of unspecified cause,1
9384,Rifampin,322.9,Meningitis NOS,1
9384,Rifampin,482.84,Legionnaires' disease,0
9386,Rimantadine,136.9,Unspecified infectious and parasitic diseases,1
9386,Rimantadine,487,Influenza,1
9386,Rimantadine,487.1,Influenza with other respiratory manifestations,1
9471,Rose Bengal,360,Disorders of the globe,0
9471,Rose Bengal,360.9,Disorder of globe NOS,0
9471,Rose Bengal,379.90,Eye disorder NOS,0
9518,salicylamide,338-338.99,,0
9518,salicylamide,780.60,Fever; unspecified,0
9518,salicylamide,780.96,Generalized pain,0
9524,Sulfasalazine,555.9,Regional enteritis of unspecified site,0
9524,Sulfasalazine,556,Ulcerative colitis,1
9524,Sulfasalazine,556.8,Other ulcerative colitis,1
9524,Sulfasalazine,556.9,Ulcerative colitis; unspecified,1
9524,Sulfasalazine,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
9524,Sulfasalazine,714.0,Rheumatoid arthritis,1
9524,Sulfasalazine,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
9524,Sulfasalazine,716.90,Arthropathy; unspecified; site unspecified,1
9524,Sulfasalazine,799.9,Other unknown and unspecified cause of morbidity or mortality,0
9525,Salicylic Acid,078.1,Viral warts,1
9525,Salicylic Acid,078.10,Viral warts; unspecified,1
9525,Salicylic Acid,338-338.99,,1
9525,Salicylic Acid,690.1,Seborrheic dermatitis,1
9525,Salicylic Acid,690.10,Seborheic dermatitis; unspecified,1
9525,Salicylic Acid,690.18,Other seborrheic dermatitis,0
9525,Salicylic Acid,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
9525,Salicylic Acid,701.1,Keratoderma; acquired,1
9525,Salicylic Acid,706.1,Other acne,1
9525,Salicylic Acid,706.3,Seborrhea,1
9525,Salicylic Acid,709.9,Unspecified disorder of skin and subcutaneous tissue,1
9525,Salicylic Acid,780.96,Generalized pain,1
9525,Salicylic Acid,787.7,Abnormal feces,1
9525,Salicylic Acid,787.91,Diarrhea,1
9601,Scopolamine,009.0,Infectious colitis; enteritis; and gastroenteritis,0
9601,Scopolamine,009.2,Infectious diarrhea,0
9601,Scopolamine,332.1,Secondary Parkinsonism,0
9601,Scopolamine,351.9,Facial nerve disorder; unspecified,0
9601,Scopolamine,364.3,Iridocyclitis NOS,0
9601,Scopolamine,477.9,Allergic rhinitis NOS,0
9601,Scopolamine,569.9,Unspecified disorder of intestine,0
9601,Scopolamine,787.02,Nausea alone,1
9601,Scopolamine,787.03,Vomiting alone,1
9601,Scopolamine,994.6,Motion sickness,1
9603,Scopolamine Hydrobromide,009.0,Infectious colitis; enteritis; and gastroenteritis,0
9603,Scopolamine Hydrobromide,009.2,Infectious diarrhea,0
9603,Scopolamine Hydrobromide,332.1,Secondary Parkinsonism,0
9603,Scopolamine Hydrobromide,351.9,Facial nerve disorder; unspecified,0
9603,Scopolamine Hydrobromide,364.3,Iridocyclitis NOS,0
9603,Scopolamine Hydrobromide,477.9,Allergic rhinitis NOS,0
9603,Scopolamine Hydrobromide,569.9,Unspecified disorder of intestine,0
9603,Scopolamine Hydrobromide,787.02,Nausea alone,0
9603,Scopolamine Hydrobromide,787.03,Vomiting alone,0
9603,Scopolamine Hydrobromide,994.6,Motion sickness,0
9624,Secobarbital,307.42,Persistent disorder of initiating or maintaining sleep,0
9624,Secobarbital,780.52,Insomnia; unspecified,1
9639,Selegiline,295,Schizophrenic disorders,0
9639,Selegiline,295.9,Unspecified schizophrenia,0
9639,Selegiline,295.90,Unspecified schizophrenia; unspecified state,0
9639,Selegiline,296.20,Major depressive disorder; single episode; unspecified degree,1
9639,Selegiline,311,Depressive disorder NEC,1
9639,Selegiline,314,Hyperkinetic syndrome of childhood,0
9639,Selegiline,314.01,Attention deficit disorder of childhood with hyperactivity,0
9639,Selegiline,314.9,Unspecified hyperkinetic syndrome of childhood,0
9639,Selegiline,331.0,Alzheimer's disease,0
9639,Selegiline,332,Parkinson's disease,0
9639,Selegiline,332.0,Paralysis agitans,0
9639,Selegiline,780-789.99,,0
9639,Selegiline,780.97,Altered mental status,1
9789,Silver Nitrate,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
9789,Silver Nitrate,098.40,Gonococcal conjunctivitis (neonatorum),0
9789,Silver Nitrate,459.0,Hemorrhage NOS,0
9789,Silver Nitrate,771.6,Neonatal conjunctivitis and dacryocystitis,0
9789,Silver Nitrate,940-949.99,,0
9789,Silver Nitrate,949.0,Burn of unspecified site; unspecified degree,0
9793,Silver Sulfadiazine,136.9,Unspecified infectious and parasitic diseases,1
9793,Silver Sulfadiazine,686.8|041.9,,0
9793,Silver Sulfadiazine,940-949.99,,0
9793,Silver Sulfadiazine,949.0,Burn of unspecified site; unspecified degree,0
9796,Simethicone,338-338.99,,0
9796,Simethicone,780.96,Generalized pain,0
9796,Simethicone,787.3,Flatulence; eructation; and gas pain,0
9796,Simethicone,V62.81,Interpersonal problems; not elsewhere classified,0
9800,Sincalide,575.9,Unspecified disorder of gallbladder,0
9863,Sodium Chloride,276.1,Hyposmolality and/or hyponatremia,0
9863,Sodium Chloride,276.51,Dehydration,0
9863,Sodium Chloride,371.2,Corneal edema,0
9863,Sodium Chloride,371.20,Corneal edema NOS,0
9863,Sodium Chloride,375.15,Tear film insufficiency NOS,0
9863,Sodium Chloride,782.62,Flushing,1
9863,Sodium Chloride,785.59,Other shock without mention of trauma,0
9872,Etidronate Disodium,275.42,Hypercalcemia,1
9872,Etidronate Disodium,731.0,Osteitis deformans without mention of bone tumor,1
9872,Etidronate Disodium,733.0,Osteoporosis,1
9872,Etidronate Disodium,733.00,Osteoporosis NOS,1
9872,Etidronate Disodium,733.99,Other disorders of bone and cartilage,0
9873,Sodium Fluoride,521.0,Dental caries,0
9873,Sodium Fluoride,521.00,Dental caries NOS,0
9873,Sodium Fluoride,523.6,Accretions on teeth,0
9873,Sodium Fluoride,525.10,Acquired absence of teeth; unspecified,0
9873,Sodium Fluoride,525.19,Other loss of teeth,0
9873,Sodium Fluoride,733.0,Osteoporosis,0
9873,Sodium Fluoride,733.00,Osteoporosis NOS,0
9873,Sodium Fluoride,V60.3,Person living alone,0
9877,Heparin sodium,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
9877,Heparin sodium,411.1,Intermediate coronary syndrome,0
9877,Heparin sodium,415.19,Other pulmonary embolism and infarction,1
9877,Heparin sodium,427.31,Atrial fibrillation,1
9877,Heparin sodium,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,0
9877,Heparin sodium,451.9,Phlebitis and thrombophlebitis of unspecified site,1
9877,Heparin sodium,453.9,Embolism and thrombosis of unspecified site,1
9877,Heparin sodium,459.9,Unspecified circulatory system disorder,1
9877,Heparin sodium,998.9,Unspecified complication of procedure; not elsewhere classified,0
9881,Sodium Hypochlorite,110.4,Dermatophytosis of foot,0
9881,Sodium Hypochlorite,958.3,Posttraumatic wound infection not elsewhere classified,0
9884,Sodium Iodide,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
9884,Sodium Iodide,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,0
9884,Sodium Iodide,707.10,Ulcer of lower limb; unspecified,0
9884,Sodium Iodide,879.8,Open wound(s) (multiple) of unspecified site(s); without mention of complication,0
9884,Sodium Iodide,940-949.99,,0
9884,Sodium Iodide,949.0,Burn of unspecified site; unspecified degree,0
9884,Sodium Iodide,959.9,Other and unspecified injury to unspecified site,0
9884,Sodium Iodide,990|E926.3,,0
9884,Sodium Iodide,998.59,Other postoperative infection,0
9892,Sodium Morrhuate,454.9,Asymptomatic varicose veins,0
9899,Sodium Oxybate,347.0,Narcolepsy,1
9899,Sodium Oxybate,347.00,Narcolepsy; without cataplexy,1
9899,Sodium Oxybate,780.09,Other alteration of consciousness,0
9899,Sodium Oxybate,780.50,Unspecified sleep disturbance,0
9900,Penicillin G Sodium,036,Meningococcal infection,0
9900,Penicillin G Sodium,036.9,Meningococcal infection; unspecified,0
9900,Penicillin G Sodium,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
9900,Penicillin G Sodium,097.9,Syphilis NOS,0
9900,Penicillin G Sodium,098,Gonococcal infections,0
9900,Penicillin G Sodium,098.89,Gonococcal infection of other specified sites,0
9913,Sodium Tetradecyl Sulfate,454.9,Asymptomatic varicose veins,0
9945,Sorbitol,564.0,Constipation,0
9945,Sorbitol,564.00,Constipation NOS,0
9945,Sorbitol,977.9,Poisoning by unspecified drug or medicinal substance,0
9947,Sotalol,427,Cardiac dysrhythmias,1
9947,Sotalol,427.1,Paroxysmal ventricular tachycardia,1
9947,Sotalol,427.31,Atrial fibrillation,1
9947,Sotalol,427.32,Atrial flutter,1
9947,Sotalol,427.41,Ventricular fibrillation,0
9947,Sotalol,427.69,Other premature beats,1
9947,Sotalol,427.89,Other specified cardiac dysrhythmias,0
9947,Sotalol,427.9,Cardiac dysrhythmia NOS,1
9947,Sotalol,785.0,Tachycardia NOS,1
9997,Spironolactone,255.1,Hyperaldosteronism,1
9997,Spironolactone,255.10,Primary aldosteronism,1
9997,Spironolactone,255.12,Conn's syndrome,1
9997,Spironolactone,276.69,Other fluid overload,1
9997,Spironolactone,276.8,Hypopotassemia,1
9997,Spironolactone,401-405.99,,1
9997,Spironolactone,401.9,Hypertension NOS,1
9997,Spironolactone,428,Heart failure,1
9997,Spironolactone,428.0,Congestive heart failure (CHF) NOS,1
9997,Spironolactone,428.9,Heart failure unspecified,1
9997,Spironolactone,571.5,Cirrhosis of liver without mention of alcohol,1
9997,Spironolactone,573.9,Unspecified disorder of liver,0
9997,Spironolactone,704.1,Hirsutism,0
9997,Spironolactone,782.3,Edema,1
9997,Spironolactone,789.5,Ascites,1
9997,Spironolactone,789.59,Other ascites,1
9997,Spironolactone,997.91,Hypertension,1
10030,Stannous Fluoride,521.0,Dental caries,0
10030,Stannous Fluoride,521.00,Dental caries NOS,0
10030,Stannous Fluoride,523.6,Accretions on teeth,0
10030,Stannous Fluoride,523.9,Unspecified gingival and periodontal disease,0
10030,Stannous Fluoride,525.10,Acquired absence of teeth; unspecified,0
10030,Stannous Fluoride,525.19,Other loss of teeth,0
10106,Streptokinase,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
10106,Streptokinase,415.19,Other pulmonary embolism and infarction,1
10106,Streptokinase,444.9,Embolism and thrombosis of unspecified artery,1
10106,Streptokinase,453.9,Embolism and thrombosis of unspecified site,1
10109,Streptomycin,010-018.99,,1
10109,Streptomycin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
10109,Streptomycin,020,Plague,1
10109,Streptomycin,020.9,Plague NOS,1
10109,Streptomycin,021,Tularemia,1
10109,Streptomycin,021.9,Tularemia NOS,1
10109,Streptomycin,023,Brucellosis,0
10109,Streptomycin,023.9,Brucellosis NOS,0
10109,Streptomycin,031.9,Unspecified diseases due to mycobacteria,0
10109,Streptomycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
10109,Streptomycin,041.9|421.0,,0
10109,Streptomycin,136.9,Unspecified infectious and parasitic diseases,1
10114,Streptozocin,157.4,Malignant neoplasm of islets of Langerhans,1
10114,Streptozocin,201,Hodgkin's disease,0
10114,Streptozocin,201.0,Hodgkin's paragranuloma,0
10114,Streptozocin,201.1,Hodgkin's granuloma,0
10114,Streptozocin,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
10114,Streptozocin,201.2,Hodgkin's sarcoma,0
10114,Streptozocin,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
10114,Streptozocin,201.9,Hodgkin's disease; unspecified type,0
10114,Streptozocin,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
10114,Streptozocin,209.60,Benign carcinoid tumor of unknown primary site,1
10114,Streptozocin,239.0,Neoplasm of unspecified nature of digestive system,0
10122,Strontium,198.5,Secondary malignant neoplasm of bone and bone marrow,1
10122,Strontium,733.90,Disorder of bone and cartilage; unspecified,1
10156,Sucralfate,486,Pneumonia; organism unspecified,0
10156,Sucralfate,528.00,Stomatitis and mucositis; unspecified,0
10156,Sucralfate,528.2,Oral aphthae,0
10156,Sucralfate,530.1,Esophagitis,0
10156,Sucralfate,530.10,Esophagitis; unspecified,0
10156,Sucralfate,531,Gastric ulcer,0
10156,Sucralfate,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
10156,Sucralfate,532,Duodenal ulcer,1
10156,Sucralfate,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
10156,Sucralfate,535.50,Unspecified gastritis and gastroduodenitis; without mention of hemorrhage,0
10156,Sucralfate,707.9,Chronic ulcer of unspecified site,1
10169,Sulfacetamide,076,Trachoma,1
10169,Sulfacetamide,076.9,Trachoma NOS,1
10169,Sulfacetamide,136.9,Unspecified infectious and parasitic diseases,1
10169,Sulfacetamide,370.0,Corneal ulcer,0
10169,Sulfacetamide,370.00,Corneal ulcer NOS,0
10169,Sulfacetamide,372.30,Conjunctivitis NOS,1
10169,Sulfacetamide,379.99,Other ill-defined disorders of eye,1
10169,Sulfacetamide,388.9,Unspecified disorder of ear,0
10169,Sulfacetamide,686.8|041.9,,0
10169,Sulfacetamide,690.1,Seborrheic dermatitis,1
10169,Sulfacetamide,690.10,Seborheic dermatitis; unspecified,1
10169,Sulfacetamide,695.3,Rosacea,1
10169,Sulfacetamide,706.1,Other acne,1
10169,Sulfacetamide,706.3,Seborrhea,1
10169,Sulfacetamide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
10171,Sulfadiazine,039.9,Actinomycosis NOS,1
10171,Sulfadiazine,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
10171,Sulfadiazine,084,Malaria,0
10171,Sulfadiazine,084.2,Quartan malaria,0
10171,Sulfadiazine,084.6,Malaria NOS,0
10171,Sulfadiazine,130,Toxoplasmosis,1
10171,Sulfadiazine,130.9,Toxoplasmosis NOS,1
10171,Sulfadiazine,136.9,Unspecified infectious and parasitic diseases,1
10171,Sulfadiazine,390,Rheumatic fever without mention of heart involvement,1
10171,Sulfadiazine,390-392.99,,1
10171,Sulfadiazine,599.0,Urinary tract infection; site not specified,1
10173,Sulfadoxine,084.0,Falciparum malaria [malignant tertian],0
10173,Sulfadoxine,136.3,Pneumocystosis,0
10179,Sulfamethizole,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
10179,Sulfamethizole,599.0,Urinary tract infection; site not specified,0
10180,Sulfamethoxazole,039.9,Actinomycosis NOS,0
10180,Sulfamethoxazole,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
10180,Sulfamethoxazole,130,Toxoplasmosis,0
10180,Sulfamethoxazole,130.9,Toxoplasmosis NOS,0
10180,Sulfamethoxazole,382.9,Unspecified otitis media,0
10180,Sulfamethoxazole,490,Bronchitis NOS,0
10180,Sulfamethoxazole,599.0,Urinary tract infection; site not specified,0
10184,Sulfanilamide,112.1,Candidiasis of vulva and vagina,0
10188,Sulfapyridine,686.01,Pyoderma gangrenosum,0
10188,Sulfapyridine,694.0,Dermatitis herpetiformis,0
10188,Sulfapyridine,694.5,Pemphigoid,0
10193,sulfathiazole,616.10,Vaginitis and vulvovaginitis NOS,0
10205,Sulfinpyrazone,274,Gout,0
10205,Sulfinpyrazone,274.9,Gout NOS,0
10205,Sulfinpyrazone,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
10205,Sulfinpyrazone,413,Angina pectoris,0
10205,Sulfinpyrazone,413.9,Other and unspecified angina pectoris,0
10205,Sulfinpyrazone,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,0
10205,Sulfinpyrazone,453.9,Embolism and thrombosis of unspecified site,0
10205,Sulfinpyrazone,786.50,Unspecified chest pain,0
10207,Sulfisoxazole,039.9,Actinomycosis NOS,1
10207,Sulfisoxazole,076,Trachoma,1
10207,Sulfisoxazole,076.9,Trachoma NOS,1
10207,Sulfisoxazole,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
10207,Sulfisoxazole,370.0,Corneal ulcer,0
10207,Sulfisoxazole,370.00,Corneal ulcer NOS,0
10207,Sulfisoxazole,382.9,Unspecified otitis media,1
10207,Sulfisoxazole,599.0,Urinary tract infection; site not specified,1
10223,Sulfur,690.1,Seborrheic dermatitis,1
10223,Sulfur,690.10,Seborheic dermatitis; unspecified,1
10223,Sulfur,692.9,Contact dermatitis and other eczema; unspecified cause,1
10223,Sulfur,695.3,Rosacea,1
10223,Sulfur,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
10223,Sulfur,706.1,Other acne,1
10223,Sulfur,706.3,Seborrhea,1
10237,Sulindac,211.3,Benign neoplasm of colon,0
10237,Sulindac,274.0,Gouty arthropathy,1
10237,Sulindac,274.00,Gouty arthropathy (ADDED),1
10237,Sulindac,274.9,Gout NOS,1
10237,Sulindac,714.0,Rheumatoid arthritis,1
10237,Sulindac,715.00,Osteoarthrosis; generalized; involving unspecified site,1
10237,Sulindac,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
10237,Sulindac,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
10237,Sulindac,716.90,Arthropathy; unspecified; site unspecified,1
10237,Sulindac,719.41,Pain in joint involving shoulder region,0
10237,Sulindac,720.0,Ankylosing spondylitis,1
10237,Sulindac,726.90,Enthesopathy of specified site,1
10237,Sulindac,727.3,Other bursitis disorders,1
10255,Suprofen,379.42,Miosis (persistent); not due to miotics,1
10318,Tacrine,331.0,Alzheimer's disease,0
10323,Talc,511.81,Malignant pleural effusion,1
10323,Talc,511.9,Pleural effusion NOS,1
10323,Talc,512.89,Other pneumothorax,0
10323,Talc,799.89,Other ill-defined conditions,0
10324,Tamoxifen,174.9,Malignant neoplasm of breast (female); unspecified,1
10324,Tamoxifen,233.0,Carcinoma in situ of breast,1
10324,Tamoxifen,239.0,Neoplasm of unspecified nature of digestive system,0
10324,Tamoxifen,239.3,Neoplasm of unspecified nature of breast,0
10324,Tamoxifen,259.1,Precocious sexual development and puberty NEC,1
10324,Tamoxifen,611.1,Hypertrophy of breast,0
10324,Tamoxifen,799.9,Other unknown and unspecified cause of morbidity or mortality,0
10355,Temazepam,300.01,Panic disorder without agoraphobia,0
10355,Temazepam,307.42,Persistent disorder of initiating or maintaining sleep,0
10355,Temazepam,311,Depressive disorder NEC,0
10355,Temazepam,780.50,Unspecified sleep disturbance,1
10355,Temazepam,780.52,Insomnia; unspecified,1
10362,Teniposide,204,Lymphoid leukemia,1
10362,Teniposide,204.0,Lymphoid leukemia; acute,1
10362,Teniposide,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
10362,Teniposide,204.9,Unspecified lymphoid leukemia,1
10362,Teniposide,204.90,Unspecified lymphoid leukemia without mention of having achieved remission,1
10362,Teniposide,239.1,Neoplasm of unspecified nature of respiratory system,0
10368,Terbutaline,492,Emphysema,1
10368,Terbutaline,492.8,Other emphysema,1
10368,Terbutaline,493,Asthma,1
10368,Terbutaline,493.9,Asthma; unspecified,1
10368,Terbutaline,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
10368,Terbutaline,644.20,Early onset of delivery; unspecified as to episode of care,0
10369,Terbutaline Sulfate,493,Asthma,0
10369,Terbutaline Sulfate,493.9,Asthma; unspecified,0
10369,Terbutaline Sulfate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
10369,Terbutaline Sulfate,644.20,Early onset of delivery; unspecified as to episode of care,0
10378,Testolactone,174.9,Malignant neoplasm of breast (female); unspecified,1
10378,Testolactone,239.3,Neoplasm of unspecified nature of breast,0
10379,Testosterone,174.9,Malignant neoplasm of breast (female); unspecified,1
10379,Testosterone,239.3,Neoplasm of unspecified nature of breast,0
10379,Testosterone,253.4,Other anterior pituitary disorders,1
10379,Testosterone,257.2,Other testicular hypofunction,1
10379,Testosterone,259.0,Delay in sexual development and puberty NEC,1
10379,Testosterone,608.89,Male genital disorder NEC,1
10379,Testosterone,780-789.99,,0
10379,Testosterone,780.79,Other malaise and fatigue,0
10379,Testosterone,797,Senility without mention of psychosis,1
10379,Testosterone,799.81,Decreased libido,0
10379,Testosterone,V21.1,Puberty,1
10382,Testosterone Propionate,239.3,Neoplasm of unspecified nature of breast,0
10382,Testosterone Propionate,253.4,Other anterior pituitary disorders,1
10382,Testosterone Propionate,259.0,Delay in sexual development and puberty NEC,0
10382,Testosterone Propionate,797,Senility without mention of psychosis,1
10390,Tetrabenazine,333.5,Other choreas,1
10391,Tetracaine,338-338.99,,0
10391,Tetracaine,780.96,Generalized pain,0
10395,Tetracycline,001,Cholera,1
10395,Tetracycline,001.0,Cholera due to Vibrio cholerae,1
10395,Tetracycline,001.9,Cholera NOS,1
10395,Tetracycline,021,Tularemia,1
10395,Tetracycline,021.9,Tularemia NOS,1
10395,Tetracycline,022,Anthrax,1
10395,Tetracycline,022.9,Anthrax NOS,1
10395,Tetracycline,023,Brucellosis,1
10395,Tetracycline,023.9,Brucellosis NOS,1
10395,Tetracycline,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
10395,Tetracycline,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
10395,Tetracycline,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
10395,Tetracycline,083.9,Rickettsiosis NOS,0
10395,Tetracycline,088.81,Lyme disease,1
10395,Tetracycline,097.9,Syphilis NOS,1
10395,Tetracycline,098,Gonococcal infections,0
10395,Tetracycline,098.89,Gonococcal infection of other specified sites,0
10395,Tetracycline,136.9,Unspecified infectious and parasitic diseases,1
10395,Tetracycline,379.99|041.9,,0
10395,Tetracycline,486,Pneumonia; organism unspecified,1
10395,Tetracycline,490,Bronchitis NOS,0
10395,Tetracycline,519.8,Other diseases of respiratory system; not elsewhere classified,1
10395,Tetracycline,706.1,Other acne,1
10402,Tetrahydrocannabinol,783.0,Anorexia,1
10402,Tetrahydrocannabinol,783.21,Loss of weight,1
10402,Tetrahydrocannabinol,783.9,Other symptoms concerning nutrition; metabolism; and development,1
10402,Tetrahydrocannabinol,787.02,Nausea alone,1
10402,Tetrahydrocannabinol,787.03,Vomiting alone,1
10432,Thalidomide,030,Leprosy,0
10432,Thalidomide,030.9,Leprosy NOS,0
10432,Thalidomide,042,Human immunodeficiency virus [HIV] disease,0
10432,Thalidomide,136.1,Behcet's syndrome,0
10432,Thalidomide,140-239.99,,0
10432,Thalidomide,185,Malignant neoplasm of prostate,1
10432,Thalidomide,189.0,Malignant neoplasm of kidney; except pelvis,1
10432,Thalidomide,203.0,Multiple myeloma,1
10432,Thalidomide,203.00,Multiple myeloma without mention of having achieved remission,1
10432,Thalidomide,239,Neoplasms of unspecified nature,0
10432,Thalidomide,239-239.99,,0
10432,Thalidomide,273.3,Macroglobulinemia,0
10432,Thalidomide,277.89,Other specified disorders of metabolism,0
10432,Thalidomide,279.5,Graft-versus-host disease,1
10432,Thalidomide,279.50,Graft-versus-host disease; unspecified,1
10432,Thalidomide,338-338.99,,1
10432,Thalidomide,528.2,Oral aphthae,0
10432,Thalidomide,555.9,Regional enteritis of unspecified site,0
10432,Thalidomide,629.89,Other specified disorders of female genital organs,1
10432,Thalidomide,695.1,Erythema multiforme,0
10432,Thalidomide,695.10,Erythema multiforme; unspecified,0
10432,Thalidomide,695.2,Erythema nodosum,1
10432,Thalidomide,695.4,Lupus erythematosus,0
10432,Thalidomide,714.0,Rheumatoid arthritis,0
10432,Thalidomide,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
10432,Thalidomide,740-759.99,,1
10432,Thalidomide,759.9,Congenital anomaly unspecified,1
10432,Thalidomide,780.96,Generalized pain,1
10432,Thalidomide,780.99,Other general symptoms,1
10432,Thalidomide,782.0,Disturbance of skin sensation,1
10432,Thalidomide,783.9,Other symptoms concerning nutrition; metabolism; and development,0
10432,Thalidomide,799.9,Other unknown and unspecified cause of morbidity or mortality,0
10432,Thalidomide,999.9,Other and unspecified complications of medical care; not elsewhere classified,0
10438,Theophylline,427.89,Other specified cardiac dysrhythmias,0
10438,Theophylline,490,Bronchitis NOS,1
10438,Theophylline,491,Chronic bronchitis,1
10438,Theophylline,491.9,Chronic bronchitis NOS,1
10438,Theophylline,492,Emphysema,1
10438,Theophylline,492.8,Other emphysema,1
10438,Theophylline,493,Asthma,1
10438,Theophylline,493.9,Asthma; unspecified,1
10438,Theophylline,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
10438,Theophylline,518.89,Other diseases of lung; not elsewhere classified,1
10438,Theophylline,519.11,Acute bronchospasm,0
10438,Theophylline,786.03,Apnea,0
10438,Theophylline,786.09,Other dyspnea and respiratory abnormality,0
10438,Theophylline,V20.2,Routine infant or child health check,0
10450,Thiabendazole,124,Trichinosis,1
10450,Thiabendazole,125.7,Dracontiasis,0
10450,Thiabendazole,127.2,Strongyloidiasis,1
10450,Thiabendazole,127.9,Intestinal helminthiasis; unspecified,1
10454,Thiamine,265.0,Beriberi,1
10454,Thiamine,265.1,Other and unspecified manifestations of thiamine deficiency,1
10454,Thiamine,265.2,Pellagra,0
10454,Thiamine,348.3,Encephalopathy; not elsewhere classified,1
10454,Thiamine,348.30,Encephalopathy NOS,1
10454,Thiamine,357.5,Alcoholic polyneuropathy,0
10454,Thiamine,429.2,Cardiovascular disease [ASCVD],1
10454,Thiamine,783.0,Anorexia,1
10454,Thiamine,787.03,Vomiting alone,1
10456,Thiamine Mononitrate,265.0,Beriberi,0
10456,Thiamine Mononitrate,265.1,Other and unspecified manifestations of thiamine deficiency,0
10456,Thiamine Mononitrate,265.2,Pellagra,0
10456,Thiamine Mononitrate,357.5,Alcoholic polyneuropathy,0
10471,Thiethylperazine,780.4,Dizziness and giddiness,0
10471,Thiethylperazine,787.02,Nausea alone,0
10471,Thiethylperazine,787.03,Vomiting alone,0
10472,Thimerosal,110-118.99,,0
10472,Thimerosal,117.9,Other and unspecified mycoses,0
10473,Thiotepa,140-239.99,,1
10473,Thiotepa,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,0
10473,Thiotepa,174.9,Malignant neoplasm of breast (female); unspecified,1
10473,Thiotepa,188,Malignant neoplasm of bladder,1
10473,Thiotepa,188.9,Malignant neoplasm of bladder; part unspecified,1
10473,Thiotepa,199.1,Other malignant neoplasm of unspecified site,1
10473,Thiotepa,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
10473,Thiotepa,239,Neoplasms of unspecified nature,1
10473,Thiotepa,239-239.99,,1
10473,Thiotepa,239.4,Neoplasm of unspecified nature of bladder,0
10473,Thiotepa,799.89,Other ill-defined conditions,0
10485,Thioguanine,205.0,Myeloid leukemia; acute,1
10485,Thioguanine,205.00,Acute myeloid leukemia without mention of having achieved remission,1
10485,Thioguanine,205.1,Myeloid leukemia; chronic,1
10485,Thioguanine,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
10485,Thioguanine,208,Leukemia of unspecified cell type,1
10485,Thioguanine,208.9,Unspecified leukemia,1
10485,Thioguanine,208.90,Unspecified leukemia without mention of having achieved remission,1
10485,Thioguanine,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
10493,Thiopental,781.99,Other symptoms involving nervous and musculoskeletal systems,0
10502,Thioridazine,290-299.99,,0
10502,Thioridazine,295,Schizophrenic disorders,0
10502,Thioridazine,295.9,Unspecified schizophrenia,0
10502,Thioridazine,295.90,Unspecified schizophrenia; unspecified state,0
10502,Thioridazine,298.9,Unspecified psychosis,0
10502,Thioridazine,300.9,Unspecified nonpsychotic mental disorder,0
10502,Thioridazine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
10510,Thiothixene,290-299.99,,0
10510,Thiothixene,295,Schizophrenic disorders,1
10510,Thiothixene,295.9,Unspecified schizophrenia,1
10510,Thiothixene,295.90,Unspecified schizophrenia; unspecified state,1
10510,Thiothixene,298.9,Unspecified psychosis,0
10528,Thrombin,459.0,Hemorrhage NOS,1
10565,Thyroglobulin,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
10565,Thyroglobulin,240.9,Goiter NOS,0
10565,Thyroglobulin,242,Thyrotoxicosis with or without goiter,0
10565,Thyroglobulin,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,0
10565,Thyroglobulin,244.9,Hypothyroidism NOS,0
10565,Thyroglobulin,245.2,Chronic lymphocytic thyroiditis,0
10572,thyroid (USP),239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
10572,thyroid (USP),240.9,Goiter NOS,0
10572,thyroid (USP),242,Thyrotoxicosis with or without goiter,0
10572,thyroid (USP),242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,0
10572,thyroid (USP),244.9,Hypothyroidism NOS,0
10572,thyroid (USP),245.2,Chronic lymphocytic thyroiditis,0
10572,thyroid (USP),704.0,Alopecia,0
10572,thyroid (USP),704.00,Alopecia NOS,0
10572,thyroid (USP),780-789.99,,0
10572,thyroid (USP),780.79,Other malaise and fatigue,0
10572,thyroid (USP),780.99,Other general symptoms,0
10572,thyroid (USP),783.9,Other symptoms concerning nutrition; metabolism; and development,0
10582,Thyroxine,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
10582,Thyroxine,240-246.99,,1
10582,Thyroxine,240.9,Goiter NOS,1
10582,Thyroxine,242,Thyrotoxicosis with or without goiter,1
10582,Thyroxine,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
10582,Thyroxine,243,Congenital hypothyroidism,1
10582,Thyroxine,244.9,Hypothyroidism NOS,1
10582,Thyroxine,245.2,Chronic lymphocytic thyroiditis,1
10582,Thyroxine,246.9,Unspecified disorder of thyroid,1
10582,Thyroxine,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
10582,Thyroxine,644.2,Early onset of delivery,1
10582,Thyroxine,644.20,Early onset of delivery; unspecified as to episode of care,1
10582,Thyroxine,644.21,Early onset of delivery; delivered; with or without mention of antepartum condition,1
10582,Thyroxine,V22.2,Pregnant state; incidental,1
10591,Ticarcillin,038,Septicemia,0
10591,Ticarcillin,038.9,Septicemia NOS,0
10591,Ticarcillin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
10591,Ticarcillin,136.9,Unspecified infectious and parasitic diseases,0
10591,Ticarcillin,519.8,Other diseases of respiratory system; not elsewhere classified,0
10591,Ticarcillin,599.0,Urinary tract infection; site not specified,0
10591,Ticarcillin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
10594,Ticlopidine,288.0,Agranulocytosis,1
10594,Ticlopidine,288.00,Neutropenia NOS,1
10594,Ticlopidine,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
10594,Ticlopidine,446.6,Thrombotic microangiopathy,1
10594,Ticlopidine,453.9,Embolism and thrombosis of unspecified site,1
10594,Ticlopidine,459.9,Unspecified circulatory system disorder,0
10600,Timolol,346,Migraine,1
10600,Timolol,346.9,Migraine; unspecified,1
10600,Timolol,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
10600,Timolol,365,Glaucoma,1
10600,Timolol,365.04,Ocular hypertension,1
10600,Timolol,365.1,Open-angle glaucoma,0
10600,Timolol,365.10,Open-angle glaucoma NOS,0
10600,Timolol,365.13,Pigmentary glaucoma,0
10600,Timolol,365.9,Glaucoma NOS,1
10600,Timolol,401-405.99,,1
10600,Timolol,401.9,Hypertension NOS,1
10600,Timolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
10600,Timolol,413,Angina pectoris,0
10600,Timolol,413.9,Other and unspecified angina pectoris,0
10600,Timolol,428.0,Congestive heart failure (CHF) NOS,0
10600,Timolol,429.9,Heart disease NOS,0
10600,Timolol,786.50,Unspecified chest pain,0
10600,Timolol,997.91,Hypertension,1
10612,Tinidazole,006,Amebiasis,1
10612,Tinidazole,006.9,Amebiasis NOS,1
10612,Tinidazole,007.1,Giardiasis,1
10612,Tinidazole,131,Trichomoniasis,1
10612,Tinidazole,131.9,Trichomoniasis NOS,1
10612,Tinidazole,136.8,Other specified infectious and parasitic diseases,1
10612,Tinidazole,136.9,Unspecified infectious and parasitic diseases,1
10627,Tobramycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,1
10627,Tobramycin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
10627,Tobramycin,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
10627,Tobramycin,136.9,Unspecified infectious and parasitic diseases,1
10627,Tobramycin,322,Meningitis of unspecified cause,1
10627,Tobramycin,322.9,Meningitis NOS,1
10627,Tobramycin,379.99|041.9,,0
10627,Tobramycin,519.8,Other diseases of respiratory system; not elsewhere classified,1
10627,Tobramycin,599.0,Urinary tract infection; site not specified,1
10633,Tolazamide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
10633,Tolazamide,790.6,Other abnormal blood chemistry,1
10634,Tolazoline,337.20,Reflex sympathetic dystrophy; unspecified,0
10634,Tolazoline,440.9,Atherosclerosis NOS,0
10634,Tolazoline,443.0,Raynaud's syndrome,0
10634,Tolazoline,443.1,Thromboangiitis obliterans [Buerger's disease],0
10634,Tolazoline,443.9,Peripheral vascular disease; unspecified,0
10634,Tolazoline,451.9,Phlebitis and thrombophlebitis of unspecified site,0
10634,Tolazoline,710.1,Systemic sclerosis,0
10634,Tolazoline,728.85,Spasm of muscle,0
10634,Tolazoline,746.9,Unspecified congenital anomaly of heart,0
10634,Tolazoline,747.83,Persistent fetal circulation,0
10634,Tolazoline,781.0,Abnormal involuntary movements,0
10635,Tolbutamide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
10635,Tolbutamide,251.2,Hypoglycemia NOS,0
10635,Tolbutamide,790.6,Other abnormal blood chemistry,0
10636,Tolmetin,338-338.99,,0
10636,Tolmetin,714.0,Rheumatoid arthritis,1
10636,Tolmetin,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
10636,Tolmetin,715.00,Osteoarthrosis; generalized; involving unspecified site,1
10636,Tolmetin,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
10636,Tolmetin,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
10636,Tolmetin,716.90,Arthropathy; unspecified; site unspecified,1
10636,Tolmetin,719.50,Stiffness of joint; not elsewhere classified; involving unspecified site,0
10636,Tolmetin,720.0,Ankylosing spondylitis,0
10636,Tolmetin,780.96,Generalized pain,0
10637,Tolnaftate,110.3,Dermatophytosis of groin and perianal area,1
10637,Tolnaftate,110.4,Dermatophytosis of foot,1
10637,Tolnaftate,111.0,Pityriasis versicolor,0
10637,Tolnaftate,686.9,Unspecified local infection of skin and subcutaneous tissue,1
10689,Tramadol,338-338.99,,1
10689,Tramadol,780.96,Generalized pain,1
10691,Tranexamic Acid,286,Coagulation defects,1
10691,Tranexamic Acid,286.9,Other and unspecified coagulation defects,1
10691,Tranexamic Acid,289.9,Blood disease NOS,1
10691,Tranexamic Acid,430,Subarachnoid hemorrhage,0
10691,Tranexamic Acid,459.0,Hemorrhage NOS,1
10691,Tranexamic Acid,528.9,Other and unspecified diseases of the oral soft tissues,0
10691,Tranexamic Acid,626.2,Excessive or frequent menstruation,1
10734,Tranylcypromine,308.9,Unspecified acute reaction to stress,0
10734,Tranylcypromine,309.81,Posttraumatic stress disorder,0
10734,Tranylcypromine,311,Depressive disorder NEC,0
10737,Trazodone,295,Schizophrenic disorders,0
10737,Trazodone,295.9,Unspecified schizophrenia,0
10737,Trazodone,295.90,Unspecified schizophrenia; unspecified state,0
10737,Trazodone,296.20,Major depressive disorder; single episode; unspecified degree,1
10737,Trazodone,300.00,Anxiety state unspecified,1
10737,Trazodone,300.9,Unspecified nonpsychotic mental disorder,1
10737,Trazodone,307.42,Persistent disorder of initiating or maintaining sleep,0
10737,Trazodone,309.89,Other specified adjustment reactions,1
10737,Trazodone,311,Depressive disorder NEC,1
10737,Trazodone,780.79,Other malaise and fatigue,1
10737,Trazodone,V62.84,Suicidal ideation,1
10753,Tretinoin,205.00,Acute myeloid leukemia without mention of having achieved remission,0
10753,Tretinoin,208,Leukemia of unspecified cell type,1
10753,Tretinoin,208.9,Unspecified leukemia,1
10753,Tretinoin,208.90,Unspecified leukemia without mention of having achieved remission,1
10753,Tretinoin,701.1,Keratoderma; acquired,1
10753,Tretinoin,701.8,Other specified hypertrophic and atrophic conditions of skin,1
10753,Tretinoin,706.1,Other acne,1
10759,Triamcinolone,111,Dermatomycosis; other and unspecified,0
10759,Triamcinolone,111.9,Dermatomycosis NOS,0
10759,Triamcinolone,255.41,Glucocorticoid deficiency,1
10759,Triamcinolone,360.11,Sympathetic uveitis,1
10759,Triamcinolone,364.3,Iridocyclitis NOS,1
10759,Triamcinolone,477.9,Allergic rhinitis NOS,1
10759,Triamcinolone,493,Asthma,1
10759,Triamcinolone,493.9,Asthma; unspecified,1
10759,Triamcinolone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
10759,Triamcinolone,519.11,Acute bronchospasm,1
10759,Triamcinolone,528.2,Oral aphthae,0
10759,Triamcinolone,556,Ulcerative colitis,1
10759,Triamcinolone,556.8,Other ulcerative colitis,1
10759,Triamcinolone,556.9,Ulcerative colitis; unspecified,1
10759,Triamcinolone,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
10759,Triamcinolone,569.9,Unspecified disorder of intestine,1
10759,Triamcinolone,692.9,Contact dermatitis and other eczema; unspecified cause,1
10759,Triamcinolone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
10759,Triamcinolone,710.0,Systemic lupus erythematosus,1
10759,Triamcinolone,716.90,Arthropathy; unspecified; site unspecified,1
10759,Triamcinolone,729.0,Rheumatism; unspecified and fibrositis,0
10759,Triamcinolone,781.99,Other symptoms involving nervous and musculoskeletal systems,0
10759,Triamcinolone,995.3,Allergy unspecified not elsewhere classified,1
10761,Triamcinolone Acetonide,255.41,Glucocorticoid deficiency,1
10761,Triamcinolone Acetonide,477.9,Allergic rhinitis NOS,1
10761,Triamcinolone Acetonide,493,Asthma,1
10761,Triamcinolone Acetonide,493.9,Asthma; unspecified,1
10761,Triamcinolone Acetonide,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
10761,Triamcinolone Acetonide,519.11,Acute bronchospasm,0
10761,Triamcinolone Acetonide,528.2,Oral aphthae,0
10761,Triamcinolone Acetonide,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
10761,Triamcinolone Acetonide,569.9,Unspecified disorder of intestine,1
10761,Triamcinolone Acetonide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
10761,Triamcinolone Acetonide,710.0,Systemic lupus erythematosus,1
10761,Triamcinolone Acetonide,716.90,Arthropathy; unspecified; site unspecified,1
10761,Triamcinolone Acetonide,729.0,Rheumatism; unspecified and fibrositis,0
10761,Triamcinolone Acetonide,781.99,Other symptoms involving nervous and musculoskeletal systems,0
10762,triamcinolone diacetate,255.41,Glucocorticoid deficiency,0
10762,triamcinolone diacetate,477.9,Allergic rhinitis NOS,0
10762,triamcinolone diacetate,493,Asthma,0
10762,triamcinolone diacetate,493.9,Asthma; unspecified,0
10762,triamcinolone diacetate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
10762,triamcinolone diacetate,519.11,Acute bronchospasm,0
10762,triamcinolone diacetate,709.9,Unspecified disorder of skin and subcutaneous tissue,0
10762,triamcinolone diacetate,710.0,Systemic lupus erythematosus,0
10762,triamcinolone diacetate,716.90,Arthropathy; unspecified; site unspecified,0
10762,triamcinolone diacetate,729.0,Rheumatism; unspecified and fibrositis,0
10763,Triamterene,276.6,Fluid overload,1
10763,Triamterene,276.69,Other fluid overload,1
10763,Triamterene,276.8,Hypopotassemia,0
10763,Triamterene,401-405.99,,0
10763,Triamterene,401.9,Hypertension NOS,0
10763,Triamterene,782.3,Edema,1
10763,Triamterene,997.91,Hypertension,0
10767,Triazolam,307.42,Persistent disorder of initiating or maintaining sleep,0
10767,Triazolam,780.52,Insomnia; unspecified,1
10772,Trichlormethiazide,401-405.99,,0
10772,Trichlormethiazide,401.9,Hypertension NOS,0
10772,Trichlormethiazide,428.0,Congestive heart failure (CHF) NOS,0
10772,Trichlormethiazide,581,Nephrotic syndrome,0
10772,Trichlormethiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
10772,Trichlormethiazide,782.3,Edema,0
10772,Trichlormethiazide,997.91,Hypertension,0
10798,Trientine,275.1,Disorders of copper metabolism,0
10798,Trientine,348.89,Other conditions of brain (ADDED),0
10800,Trifluoperazine,290-299.99,,0
10800,Trifluoperazine,295,Schizophrenic disorders,1
10800,Trifluoperazine,295.9,Unspecified schizophrenia,1
10800,Trifluoperazine,295.90,Unspecified schizophrenia; unspecified state,1
10800,Trifluoperazine,298.9,Unspecified psychosis,0
10800,Trifluoperazine,300.00,Anxiety state unspecified,1
10800,Trifluoperazine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
10800,Trifluoperazine,308.2,Predominant psychomotor disturbance,1
10800,Trifluoperazine,780-789.99,,0
10800,Trifluoperazine,799.21,Nervousness (ADDED),1
10803,Trifluridine,054.40,Herpes simplex with unspecified ophthalmic complication,0
10803,Trifluridine,054.43,Herpes simplex disciform keratitis,0
10805,Triflupromazine,290-299.99,,0
10805,Triflupromazine,298.9,Unspecified psychosis,0
10805,Triflupromazine,338-338.99,,0
10805,Triflupromazine,780.96,Generalized pain,0
10805,Triflupromazine,786.8,Hiccough,0
10805,Triflupromazine,787.02,Nausea alone,0
10805,Triflupromazine,787.03,Vomiting alone,0
10811,Trihexyphenidyl,332,Parkinson's disease,0
10811,Trihexyphenidyl,332.0,Paralysis agitans,1
10811,Trihexyphenidyl,780-789.99,,0
10814,Triiodothyronine,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
10814,Triiodothyronine,240-246.99,,0
10814,Triiodothyronine,240.9,Goiter NOS,1
10814,Triiodothyronine,242,Thyrotoxicosis with or without goiter,0
10814,Triiodothyronine,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
10814,Triiodothyronine,244.9,Hypothyroidism NOS,1
10814,Triiodothyronine,245.2,Chronic lymphocytic thyroiditis,1
10814,Triiodothyronine,246.9,Unspecified disorder of thyroid,0
10824,Metipranolol,365,Glaucoma,1
10824,Metipranolol,365.1,Open-angle glaucoma,1
10824,Metipranolol,365.10,Open-angle glaucoma NOS,1
10824,Metipranolol,365.13,Pigmentary glaucoma,1
10824,Metipranolol,365.9,Glaucoma NOS,1
10825,Trimeprazine,477.9,Allergic rhinitis NOS,0
10825,Trimeprazine,691.8,Other atopic dermatitis,0
10825,Trimeprazine,692.9,Contact dermatitis and other eczema; unspecified cause,0
10825,Trimeprazine,708,Urticaria,0
10825,Trimeprazine,708.9,Unspecified urticaria,0
10827,Trimethadione,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,0
10827,Trimethadione,780.39,Other convulsions,0
10828,Trimethaphan,401.0,Malignant essential hypertension,0
10828,Trimethaphan,441.9,Aortic aneurysm NOS,0
10829,Trimethoprim,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
10829,Trimethoprim,041.49,Other and unspecified Escherichia coli [E. coli],0
10829,Trimethoprim,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
10829,Trimethoprim,130,Toxoplasmosis,0
10829,Trimethoprim,130.9,Toxoplasmosis NOS,0
10829,Trimethoprim,136.3,Pneumocystosis,0
10829,Trimethoprim,136.9,Unspecified infectious and parasitic diseases,1
10829,Trimethoprim,379.99|041.9,,0
10829,Trimethoprim,486,Pneumonia; organism unspecified,1
10829,Trimethoprim,490,Bronchitis NOS,0
10829,Trimethoprim,599.0,Urinary tract infection; site not specified,1
10831,Sulfamethoxazole / Trimethoprim,009.0,Infectious colitis; enteritis; and gastroenteritis,0
10831,Sulfamethoxazole / Trimethoprim,039.9,Actinomycosis NOS,1
10831,Sulfamethoxazole / Trimethoprim,136.3,Pneumocystosis,1
10831,Sulfamethoxazole / Trimethoprim,136.9,Unspecified infectious and parasitic diseases,1
10831,Sulfamethoxazole / Trimethoprim,382.9,Unspecified otitis media,1
10831,Sulfamethoxazole / Trimethoprim,486,Pneumonia; organism unspecified,1
10831,Sulfamethoxazole / Trimethoprim,491,Chronic bronchitis,1
10831,Sulfamethoxazole / Trimethoprim,491.9,Chronic bronchitis NOS,1
10831,Sulfamethoxazole / Trimethoprim,519.8,Other diseases of respiratory system; not elsewhere classified,1
10831,Sulfamethoxazole / Trimethoprim,599.0,Urinary tract infection; site not specified,1
10831,Sulfamethoxazole / Trimethoprim,787.7,Abnormal feces,1
10831,Sulfamethoxazole / Trimethoprim,787.91,Diarrhea,1
10834,Trimipramine,296.20,Major depressive disorder; single episode; unspecified degree,1
10834,Trimipramine,311,Depressive disorder NEC,1
10844,Trioxsalen,270.2,Other disturbances of aromatic amino-acid metabolism,0
10844,Trioxsalen,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
10844,Trioxsalen,709.01,Vitiligo,0
10847,Tripelennamine,477.9,Allergic rhinitis NOS,0
10847,Tripelennamine,708,Urticaria,0
10847,Tripelennamine,708.9,Unspecified urticaria,0
10849,Triprolidine,372.14,Other chronic allergic conjunctivitis,0
10849,Triprolidine,691.8,Other atopic dermatitis,0
10864,Troleandomycin,008.43,Intestinal infection due to campylobacter,0
10864,Troleandomycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
10864,Troleandomycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
10864,Troleandomycin,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,0
10864,Troleandomycin,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
10864,Troleandomycin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
10864,Troleandomycin,097.9,Syphilis NOS,0
10864,Troleandomycin,098,Gonococcal infections,0
10864,Troleandomycin,098.89,Gonococcal infection of other specified sites,0
10864,Troleandomycin,482.84,Legionnaires' disease,0
10864,Troleandomycin,493,Asthma,0
10864,Troleandomycin,493.9,Asthma; unspecified,0
10864,Troleandomycin,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
10865,Tromethamine,276.2,Acidosis,1
10869,Tropicamide,364.3,Iridocyclitis NOS,0
10869,Tropicamide,367.51,Paresis of accommodation,1
10869,Tropicamide,370,Keratitis,0
10869,Tropicamide,370.9,Keratitis NOS,0
10869,Tropicamide,379.43,Mydriasis (persistent); not due to mydriatics,1
10890,TRYPSIN,454.0,Varicose veins of lower extremities with ulcer,1
10890,TRYPSIN,692.71,Sunburn,0
10890,TRYPSIN,958.3,Posttraumatic wound infection not elsewhere classified,0
10890,TRYPSIN,998.30,Disruption of wound; unspecified,0
10890,TRYPSIN,998.32,Disruption of external operation (surgical) wound,0
10898,Tryptophan,311,Depressive disorder NEC,1
10989,Undecylenic Acid,110.3,Dermatophytosis of groin and perianal area,0
10989,Undecylenic Acid,110.4,Dermatophytosis of foot,0
10989,Undecylenic Acid,686.9,Unspecified local infection of skin and subcutaneous tissue,0
11002,Urea,136.9,Unspecified infectious and parasitic diseases,1
11002,Urea,365.04,Ocular hypertension,0
11002,Urea,692.9,Contact dermatitis and other eczema; unspecified cause,1
11002,Urea,695.89,Other specified erythematous conditions,1
11002,Urea,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
11002,Urea,698.9,Unspecified pruritic disorder,0
11002,Urea,700,Corns and callosities,1
11002,Urea,701.1,Keratoderma; acquired,1
11002,Urea,709.8,Other specified disorders of skin,1
11002,Urea,757.1,Ichthyosis congenita,0
11002,Urea,781.99,Other symptoms involving nervous and musculoskeletal systems,0
11055,Urokinase,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
11055,Urokinase,415.19,Other pulmonary embolism and infarction,0
11055,Urokinase,453.9,Embolism and thrombosis of unspecified site,0
11055,Urokinase,996.74,Other complications due to other vascular device; implant; and graft,0
11065,Ursodiol,571.5,Cirrhosis of liver without mention of alcohol,1
11065,Ursodiol,571.6,Biliary cirrhosis,1
11065,Ursodiol,574,Cholelithiasis,0
11065,Ursodiol,574.20,Calculus of gallbladder without mention of cholecystitis; without mention of obstruction,1
11065,Ursodiol,783.21,Loss of weight,1
11065,Ursodiol,783.9,Other symptoms concerning nutrition; metabolism; and development,1
11118,Valproic Acid,296.00,Manic disorder; single episode; unspecified degree,1
11118,Valproic Acid,296.20,Major depressive disorder; single episode; unspecified degree,1
11118,Valproic Acid,296.80,Bipolar disorder NOS,1
11118,Valproic Acid,331.0,Alzheimer's disease,0
11118,Valproic Acid,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
11118,Valproic Acid,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
11118,Valproic Acid,345.40,Partial epilepsy without intractable epilepsy,0
11118,Valproic Acid,345.9,Epilepsy; unspecified,1
11118,Valproic Acid,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
11118,Valproic Acid,346,Migraine,1
11118,Valproic Acid,346.9,Migraine; unspecified,1
11118,Valproic Acid,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
11118,Valproic Acid,780.39,Other convulsions,1
11118,Valproic Acid,799.24,Emotional lability (ADDED),1
11118,Valproic Acid,799.89,Other ill-defined conditions,1
11118,Valproic Acid,799.9,Other unknown and unspecified cause of morbidity or mortality,0
11124,Vancomycin,008.45,Intestinal infection due to clostridium difficile,0
11124,Vancomycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,1
11124,Vancomycin,041.9|421.0,,1
11124,Vancomycin,136.9,Unspecified infectious and parasitic diseases,1
11124,Vancomycin,288.0,Agranulocytosis,0
11124,Vancomycin,288.00,Neutropenia NOS,0
11124,Vancomycin,320.1,Pneumococcal meningitis,0
11124,Vancomycin,424.90,Endocarditis valve unspecified cause,1
11124,Vancomycin,486,Pneumonia; organism unspecified,1
11124,Vancomycin,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
11124,Vancomycin,995.3,Allergy unspecified not elsewhere classified,1
11124,Vancomycin,998.9,Unspecified complication of procedure; not elsewhere classified,0
11149,Vasopressin (USP),253.5,Diabetes insipidus,0
11149,Vasopressin (USP),427.1,Paroxysmal ventricular tachycardia,0
11149,Vasopressin (USP),427.41,Ventricular fibrillation,0
11149,Vasopressin (USP),578,Gastrointestinal hemorrhage,0
11149,Vasopressin (USP),578.9,Hemorrhage of gastrointestinal tract NOS,0
11149,Vasopressin (USP),998.9,Unspecified complication of procedure; not elsewhere classified,0
11170,Verapamil,401-405.99,,1
11170,Verapamil,401.9,Hypertension NOS,1
11170,Verapamil,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
11170,Verapamil,413,Angina pectoris,1
11170,Verapamil,413.1,Prinzmetal angina,0
11170,Verapamil,413.9,Other and unspecified angina pectoris,1
11170,Verapamil,427,Cardiac dysrhythmias,1
11170,Verapamil,427.31,Atrial fibrillation,1
11170,Verapamil,427.32,Atrial flutter,1
11170,Verapamil,427.89,Other specified cardiac dysrhythmias,1
11170,Verapamil,427.9,Cardiac dysrhythmia NOS,1
11170,Verapamil,785.0,Tachycardia NOS,1
11170,Verapamil,786.50,Unspecified chest pain,1
11170,Verapamil,997.91,Hypertension,1
11194,Vidarabine,054.40,Herpes simplex with unspecified ophthalmic complication,0
11194,Vidarabine,054.43,Herpes simplex disciform keratitis,0
11198,Vinblastine,162.9,Malignant neoplasm of bronchus and lung; unspecified,0
11198,Vinblastine,176,Kaposi's sarcoma,0
11198,Vinblastine,176.9,Kaposi's sarcoma NOS,0
11198,Vinblastine,181,Malignant neoplasm of placenta,0
11198,Vinblastine,186,Malignant neoplasm of testis,0
11198,Vinblastine,186.9,Malignant neoplasm of other and unspecified testis,0
11198,Vinblastine,195.0,Malignant neoplasm of head; face; and neck,0
11198,Vinblastine,201,Hodgkin's disease,0
11198,Vinblastine,201.0,Hodgkin's paragranuloma,0
11198,Vinblastine,201.1,Hodgkin's granuloma,0
11198,Vinblastine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
11198,Vinblastine,201.2,Hodgkin's sarcoma,0
11198,Vinblastine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
11198,Vinblastine,201.9,Hodgkin's disease; unspecified type,0
11198,Vinblastine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
11198,Vinblastine,202.1,Mycosis fungoides,0
11198,Vinblastine,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
11198,Vinblastine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
11198,Vinblastine,239.1,Neoplasm of unspecified nature of respiratory system,0
11198,Vinblastine,239.3,Neoplasm of unspecified nature of breast,0
11198,Vinblastine,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
11198,Vinblastine,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),0
11198,Vinblastine,287.31,Immune thrombocytopenic purpura,0
11202,Vincristine,140-239.99,,1
11202,Vincristine,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
11202,Vincristine,189.0,Malignant neoplasm of kidney; except pelvis,0
11202,Vincristine,201,Hodgkin's disease,0
11202,Vincristine,201.0,Hodgkin's paragranuloma,0
11202,Vincristine,201.1,Hodgkin's granuloma,0
11202,Vincristine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
11202,Vincristine,201.2,Hodgkin's sarcoma,0
11202,Vincristine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
11202,Vincristine,201.9,Hodgkin's disease; unspecified type,0
11202,Vincristine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
11202,Vincristine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
11202,Vincristine,208,Leukemia of unspecified cell type,1
11202,Vincristine,208.9,Unspecified leukemia,1
11202,Vincristine,208.90,Unspecified leukemia without mention of having achieved remission,1
11202,Vincristine,209.20,Malignant carcinoid tumor of unknown primary site,1
11202,Vincristine,239,Neoplasms of unspecified nature,1
11202,Vincristine,239-239.99,,1
11203,Vincristine Sulfate,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,0
11203,Vincristine Sulfate,189.0,Malignant neoplasm of kidney; except pelvis,0
11203,Vincristine Sulfate,201,Hodgkin's disease,0
11203,Vincristine Sulfate,201.0,Hodgkin's paragranuloma,0
11203,Vincristine Sulfate,201.1,Hodgkin's granuloma,0
11203,Vincristine Sulfate,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
11203,Vincristine Sulfate,201.2,Hodgkin's sarcoma,0
11203,Vincristine Sulfate,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
11203,Vincristine Sulfate,201.9,Hodgkin's disease; unspecified type,0
11203,Vincristine Sulfate,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
11203,Vincristine Sulfate,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
11203,Vincristine Sulfate,208,Leukemia of unspecified cell type,0
11203,Vincristine Sulfate,208.9,Unspecified leukemia,0
11203,Vincristine Sulfate,208.90,Unspecified leukemia without mention of having achieved remission,0
11203,Vincristine Sulfate,209.20,Malignant carcinoid tumor of unknown primary site,0
11246,Vitamin A,264,Vitamin A deficiency,0
11246,Vitamin A,264.9,Vitamin A deficiency NOS,0
11246,Vitamin A,368.6,Night blindness,0
11246,Vitamin A,368.60,Night blindness NOS,0
11246,Vitamin A,372.53,Conjunctival xerosis,0
11246,Vitamin A,579,Intestinal malabsorption,0
11246,Vitamin A,579.9,Unspecified intestinal malabsorption,0
11246,Vitamin A,692.70,Unspecified dermatitis due to sun,0
11246,Vitamin A,692.9,Contact dermatitis and other eczema; unspecified cause,0
11248,Vitamin B 12,136.9,Unspecified infectious and parasitic diseases,1
11248,Vitamin B 12,199,Malignant neoplasm without specification of site,1
11248,Vitamin B 12,199.1,Other malignant neoplasm of unspecified site,1
11248,Vitamin B 12,242,Thyrotoxicosis with or without goiter,1
11248,Vitamin B 12,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
11248,Vitamin B 12,250.6,Diabetes with neurological manifestations,0
11248,Vitamin B 12,260-269.99,,1
11248,Vitamin B 12,266.2,Other B-complex deficiencies,1
11248,Vitamin B 12,269.9,Unspecified nutritional deficiency,1
11248,Vitamin B 12,281.0,Pernicious anemia,1
11248,Vitamin B 12,285.9,Anemia unspecified,1
11248,Vitamin B 12,340,Multiple sclerosis,1
11248,Vitamin B 12,357.5,Alcoholic polyneuropathy,0
11248,Vitamin B 12,459.0,Hemorrhage NOS,1
11248,Vitamin B 12,537.9,Unspecified disorder of stomach and duodenum,1
11248,Vitamin B 12,593.9,Unspecified disorder of kidney and ureter,1
11248,Vitamin B 12,780-789.99,,0
11248,Vitamin B 12,799.9,Other unknown and unspecified cause of morbidity or mortality,0
11248,Vitamin B 12,994.2,Effects of hunger,1
11248,Vitamin B 12,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
11256,Vitamin E,269.1,Deficiency of other vitamins,0
11256,Vitamin E,283.9,Acquired hemolytic anemia; unspecified,0
11256,Vitamin E,331.0,Alzheimer's disease,0
11256,Vitamin E,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
11256,Vitamin E,770.7,Chronic respiratory disease arising in the perinatal period,0
11258,Vitamin K,286.3,Congenital deficiency of other clotting factors,0
11258,Vitamin K,459.0,Hemorrhage NOS,0
11289,Warfarin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
11289,Warfarin,415.19,Other pulmonary embolism and infarction,1
11289,Warfarin,427.31,Atrial fibrillation,1
11289,Warfarin,427.9,Cardiac dysrhythmia NOS,1
11289,Warfarin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
11289,Warfarin,435.9,Unspecified transient cerebral ischemia,0
11289,Warfarin,444.9,Embolism and thrombosis of unspecified artery,1
11289,Warfarin,451.9,Phlebitis and thrombophlebitis of unspecified site,0
11289,Warfarin,453.9,Embolism and thrombosis of unspecified site,1
11289,Warfarin,459.9,Unspecified circulatory system disorder,0
11289,Warfarin,799.9,Other unknown and unspecified cause of morbidity or mortality,1
11289,Warfarin,998.9,Unspecified complication of procedure; not elsewhere classified,0
11413,Zidovudine,042,Human immunodeficiency virus [HIV] disease,1
11413,Zidovudine,042-042.99,,1
11413,Zidovudine,136.9,Unspecified infectious and parasitic diseases,1
11413,Zidovudine,799.89,Other ill-defined conditions,1
11413,Zidovudine,V22.2,Pregnant state; incidental,1
11417,bacitracin zinc,008.45,Intestinal infection due to clostridium difficile,0
11417,bacitracin zinc,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
11417,bacitracin zinc,136.9,Unspecified infectious and parasitic diseases,0
11417,bacitracin zinc,372.03,Other mucopurulent conjunctivitis,0
11417,bacitracin zinc,372.30,Conjunctivitis NOS,0
11417,bacitracin zinc,686.8|041.9,,0
11417,bacitracin zinc,686.9,Unspecified local infection of skin and subcutaneous tissue,0
11417,bacitracin zinc,958.3,Posttraumatic wound infection not elsewhere classified,0
11423,Zinc Oxide,691.0,Diaper or napkin rash,0
11423,Zinc Oxide,692.71,Sunburn,0
11423,Zinc Oxide,692.9,Contact dermatitis and other eczema; unspecified cause,0
11454,glucomannan,271.3,Intestinal disaccharidase deficiencies and disaccharide malabsorption,0
11454,glucomannan,272.4,Other and unspecified hyperlipidemia,0
11454,glucomannan,562.11,Diverticulitis of colon without mention of hemorrhage,0
11454,glucomannan,564.0,Constipation,0
11454,glucomannan,564.00,Constipation NOS,0
11454,glucomannan,787.7,Abnormal feces,0
11454,glucomannan,787.91,Diarrhea,0
11454,glucomannan,790.22,Impaired glucose tolerance test (oral),0
11473,pamidronate,174.9,Malignant neoplasm of breast (female); unspecified,1
11473,pamidronate,199,Malignant neoplasm without specification of site,1
11473,pamidronate,199.1,Other malignant neoplasm of unspecified site,1
11473,pamidronate,203.0,Multiple myeloma,1
11473,pamidronate,203.00,Multiple myeloma without mention of having achieved remission,1
11473,pamidronate,275.42,Hypercalcemia,1
11473,pamidronate,338-338.99,,1
11473,pamidronate,731.0,Osteitis deformans without mention of bone tumor,1
11473,pamidronate,733.01,Senile osteoporosis,0
11473,pamidronate,733.90,Disorder of bone and cartilage; unspecified,1
11473,pamidronate,733.99,Other disorders of bone and cartilage,1
11473,pamidronate,780.96,Generalized pain,1
11476,tiludronic acid,731.0,Osteitis deformans without mention of bone tumor,1
11516,Doxercalciferol,252.0,Hyperparathyroidism,1
11516,Doxercalciferol,252.00,Hyperparathyroidism NOS,1
11516,Doxercalciferol,588.81,Secondary hyperparathyroidism (of renal origin),1
11636,drospirenone,625.4,Premenstrual tension syndromes,0
11636,drospirenone,706.1,Other acne,0
11636,drospirenone,V22.2,Pregnant state; incidental,0
11645,deferiprone,275.09,Other disorders of iron metabolism,1
11645,deferiprone,282.4,Thalassemias,1
11645,deferiprone,282.40,Thalassemia; unspecified,1
11645,deferiprone,285.9,Anemia unspecified,1
12488,hydroxyprogesterone caproate (USP),239.5,Neoplasm of unspecified nature of other genitourinary organs,0
12488,hydroxyprogesterone caproate (USP),617,Endometriosis,0
12488,hydroxyprogesterone caproate (USP),617.9,Endometriosis; site unspecified,0
12488,hydroxyprogesterone caproate (USP),621.4,Hematometra,0
12488,hydroxyprogesterone caproate (USP),626.0,Absence of menstruation,0
12488,hydroxyprogesterone caproate (USP),634,Spontaneous abortion,0
12488,hydroxyprogesterone caproate (USP),634.90,Spontaneous abortion; unspecified; without mention of complication,0
12488,hydroxyprogesterone caproate (USP),644.2,Early onset of delivery,1
12488,hydroxyprogesterone caproate (USP),644.20,Early onset of delivery; unspecified as to episode of care,1
12488,hydroxyprogesterone caproate (USP),644.21,Early onset of delivery; delivered; with or without mention of antepartum condition,1
12574,gemcitabine,157.9,Malignant neoplasm of pancreas; part unspecified,1
12574,gemcitabine,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
12574,gemcitabine,174.9,Malignant neoplasm of breast (female); unspecified,1
12574,gemcitabine,188,Malignant neoplasm of bladder,1
12574,gemcitabine,188.9,Malignant neoplasm of bladder; part unspecified,1
12574,gemcitabine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
14584,Etonogestrel,V22.2,Pregnant state; incidental,1
14845,apraclonidine,365,Glaucoma,0
14845,apraclonidine,365.04,Ocular hypertension,0
14845,apraclonidine,365.9,Glaucoma NOS,0
14851,Vigabatrin,345.6,Infantile spasms,1
14851,Vigabatrin,345.60,Infantile spasms; without mention of intractable epilepsy,1
14851,Vigabatrin,345.9,Epilepsy; unspecified,1
14851,Vigabatrin,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
14851,Vigabatrin,780.39,Other convulsions,1
15202,argatroban,287.5,Thrombocytopenia NOS,1
15202,argatroban,289.84,Heparin-induced thrombocytopenia (HIT),1
15202,argatroban,453.9,Embolism and thrombosis of unspecified site,1
15202,argatroban,459.9,Unspecified circulatory system disorder,0
15202,argatroban,790.99,Other nonspecific findings on examination of blood,1
15226,fomepizole,276.2,Acidosis,0
15226,fomepizole,368.9,Unspecified visual disturbance,0
15226,fomepizole,586,Renal failure unspecified,0
15226,fomepizole,977.9,Poisoning by unspecified drug or medicinal substance,0
15657,decitabine,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
15657,decitabine,238.72,Low grade myelodysplastic syndrome lesions,1
15657,decitabine,238.75,Myelodysplastic syndrome; unspecified,1
15657,decitabine,285.9,Anemia unspecified,1
15996,Mirtazapine,296.20,Major depressive disorder; single episode; unspecified degree,1
15996,Mirtazapine,300.3,Obsessive-compulsive disorders,1
15996,Mirtazapine,300.9,Unspecified nonpsychotic mental disorder,1
15996,Mirtazapine,311,Depressive disorder NEC,1
15996,Mirtazapine,780.52,Insomnia; unspecified,1
16521,adefovir,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
16521,adefovir,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
16521,adefovir,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,1
16521,adefovir,799.9,Other unknown and unspecified cause of morbidity or mortality,0
16681,Acarbose,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
16681,Acarbose,790.6,Other abnormal blood chemistry,1
16735,acetophenazine,290-299.99,,0
16735,acetophenazine,295,Schizophrenic disorders,0
16735,acetophenazine,295.9,Unspecified schizophrenia,0
16735,acetophenazine,295.90,Unspecified schizophrenia; unspecified state,0
16735,acetophenazine,298.9,Unspecified psychosis,0
16818,Acitretin,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
17128,lansoprazole,251.5,Abnormality of secretion of gastrin,0
17128,lansoprazole,530.1,Esophagitis,1
17128,lansoprazole,530.10,Esophagitis; unspecified,1
17128,lansoprazole,530.81,Esophageal reflux,1
17128,lansoprazole,531,Gastric ulcer,1
17128,lansoprazole,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
17128,lansoprazole,532,Duodenal ulcer,1
17128,lansoprazole,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
17128,lansoprazole,707.9,Chronic ulcer of unspecified site,1
17128,lansoprazole,787.1,Heartburn,1
17145,monobenzone,709.00,Dyschromia; unspecified,1
17145,monobenzone,709.01,Vitiligo,1
17268,alclometasone dipropionate,692.9,Contact dermatitis and other eczema; unspecified cause,0
17268,alclometasone dipropionate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
17300,alfuzosin,600.0,Hypertrophy (benign) of prostate,0
17652,amcinonide,692.9,Contact dermatitis and other eczema; unspecified cause,0
17652,amcinonide,709.9,Unspecified disorder of skin and subcutaneous tissue,1
17767,Amlodipine,401-405.99,,1
17767,Amlodipine,401.9,Hypertension NOS,1
17767,Amlodipine,413,Angina pectoris,1
17767,Amlodipine,413.1,Prinzmetal angina,1
17767,Amlodipine,413.9,Other and unspecified angina pectoris,1
17767,Amlodipine,786.50,Unspecified chest pain,1
17767,Amlodipine,997.91,Hypertension,1
17941,anisindione,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
17941,anisindione,415.19,Other pulmonary embolism and infarction,0
17941,anisindione,427.31,Atrial fibrillation,0
17941,anisindione,444.9,Embolism and thrombosis of unspecified artery,0
17941,anisindione,453.9,Embolism and thrombosis of unspecified site,0
17941,anisindione,459.9,Unspecified circulatory system disorder,0
18330,arsenic trioxide,205.0,Myeloid leukemia; acute,1
18330,arsenic trioxide,205.00,Acute myeloid leukemia without mention of having achieved remission,1
18330,arsenic trioxide,208,Leukemia of unspecified cell type,1
18330,arsenic trioxide,208.9,Unspecified leukemia,1
18330,arsenic trioxide,208.90,Unspecified leukemia without mention of having achieved remission,1
18343,artemether,084,Malaria,0
18343,artemether,084.2,Quartan malaria,0
18343,artemether,084.6,Malaria NOS,0
18343,artemether,136.9,Unspecified infectious and parasitic diseases,0
18469,sparfloxacin,003.9,Salmonella infection NOS,0
18469,sparfloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
18469,sparfloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
18469,sparfloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
18469,sparfloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
18469,sparfloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
18469,sparfloxacin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
18469,sparfloxacin,486,Pneumonia; organism unspecified,0
18516,attapulgite,536.8,Dyspepsia and other specified disorders of function of stomach,0
18516,attapulgite,787.1,Heartburn,0
18516,attapulgite,787.7,Abnormal feces,0
18516,attapulgite,787.91,Diarrhea,0
18600,azatadine,477.9,Allergic rhinitis NOS,0
18600,azatadine,708,Urticaria,0
18600,azatadine,708.9,Unspecified urticaria,0
18602,azelaic acid,695.3,Rosacea,1
18602,azelaic acid,706.1,Other acne,1
18602,azelaic acid,709.9,Unspecified disorder of skin and subcutaneous tissue,1
18603,azelastine,372.14,Other chronic allergic conjunctivitis,1
18603,azelastine,472.0,Chronic rhinitis,1
18603,azelastine,477.0,Allergic rhinitis due to pollen,1
18603,azelastine,477.9,Allergic rhinitis NOS,1
18603,azelastine,478.19,Other diseases of nasal cavity and sinuses,1
18603,azelastine,698.9,Unspecified pruritic disorder,1
18603,azelastine,784.91,Postnasal drip,1
18603,azelastine,784.99,Other symptoms involving head and neck,1
18631,Azithromycin,031.8,Other specified mycobacterial diseases,1
18631,Azithromycin,031.9,Unspecified diseases due to mycobacteria,1
18631,Azithromycin,034.0,Streptococcal sore throat,1
18631,Azithromycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
18631,Azithromycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
18631,Azithromycin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
18631,Azithromycin,041.9|421.0,,0
18631,Azithromycin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
18631,Azithromycin,088.81,Lyme disease,0
18631,Azithromycin,099.0,Chancroid,1
18631,Azithromycin,099.9,Venereal disease NOS,1
18631,Azithromycin,136.9,Unspecified infectious and parasitic diseases,1
18631,Azithromycin,382.9,Unspecified otitis media,1
18631,Azithromycin,461.9,Acute sinusitis NOS,1
18631,Azithromycin,462,Acute pharyngitis,1
18631,Azithromycin,463,Acute tonsillitis,1
18631,Azithromycin,483.0,Pneumonia due to Mycoplasma pneumoniae,0
18631,Azithromycin,486,Pneumonia; organism unspecified,1
18631,Azithromycin,518.89,Other diseases of lung; not elsewhere classified,1
18631,Azithromycin,597.80,Urethritis NOS,1
18631,Azithromycin,614-616.99,,1
18631,Azithromycin,614.9,Unspecified inflammatory disease of female pelvic organs and tissues,1
18631,Azithromycin,616.9,Unspecified inflammatory disease of cervix; vagina; and vulva,1
18631,Azithromycin,682.9,Cellulitis and abscess NOS,1
18631,Azithromycin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
18631,Azithromycin,799.89,Other ill-defined conditions,1
18687,bacampicillin,027.0,Listeriosis,0
18687,bacampicillin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
18687,bacampicillin,041.49,Other and unspecified Escherichia coli [E. coli],0
18687,bacampicillin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
18687,bacampicillin,098,Gonococcal infections,0
18687,bacampicillin,098.89,Gonococcal infection of other specified sites,0
18687,bacampicillin,519.8,Other diseases of respiratory system; not elsewhere classified,0
18687,bacampicillin,599.0,Urinary tract infection; site not specified,0
18747,balsalazide,556,Ulcerative colitis,1
18747,balsalazide,556.8,Other ulcerative colitis,1
18747,balsalazide,556.9,Ulcerative colitis; unspecified,1
18747,balsalazide,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
18789,basic aluminum carbonate gel,530.11,Reflux esophagitis,0
18789,basic aluminum carbonate gel,530.81,Esophageal reflux,0
18789,basic aluminum carbonate gel,531,Gastric ulcer,0
18789,basic aluminum carbonate gel,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
18789,basic aluminum carbonate gel,532,Duodenal ulcer,0
18789,basic aluminum carbonate gel,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
18789,basic aluminum carbonate gel,536.8,Dyspepsia and other specified disorders of function of stomach,0
18789,basic aluminum carbonate gel,578,Gastrointestinal hemorrhage,0
18789,basic aluminum carbonate gel,578.9,Hemorrhage of gastrointestinal tract NOS,0
18789,basic aluminum carbonate gel,585.6,End stage renal disease,0
18789,basic aluminum carbonate gel,585.9,Chronic kidney disease; unspecified,0
18789,basic aluminum carbonate gel,586,Renal failure unspecified,0
18789,basic aluminum carbonate gel,787.1,Heartburn,0
18867,benazepril,250.4,Diabetes with renal manifestations,0
18867,benazepril,401-405.99,,1
18867,benazepril,401.9,Hypertension NOS,1
18867,benazepril,428.0,Congestive heart failure (CHF) NOS,0
18867,benazepril,429.3,Cardiomegaly,0
18867,benazepril,997.91,Hypertension,1
18896,bentiromide,577,Diseases of pancreas,0
18896,bentiromide,577.9,Pancreatic disease NOS,0
18927,benztropine mesylate,332,Parkinson's disease,0
18927,benztropine mesylate,332.0,Paralysis agitans,0
18993,benzonatate,786.2,Cough,1
18993,benzonatate,786.8,Hiccough,0
19008,benzthiazide,401-405.99,,0
19008,benzthiazide,401.9,Hypertension NOS,0
19008,benzthiazide,428.0,Congestive heart failure (CHF) NOS,0
19008,benzthiazide,581,Nephrotic syndrome,0
19008,benzthiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
19008,benzthiazide,782.3,Edema,0
19008,benzthiazide,997.91,Hypertension,0
19257,Bethanechol,530.81,Esophageal reflux,0
19257,Bethanechol,596.54,Neurogenic bladder NOS,0
19257,Bethanechol,596.59,Other functional disorder of bladder,0
19257,Bethanechol,788.2,Retention of urine,1
19257,Bethanechol,788.20,Retention of urine NOS,1
19476,bismuth subgallate,004.9,Shigellosis NOS,0
19476,bismuth subgallate,041.49,Other and unspecified Escherichia coli [E. coli],0
19476,bismuth subgallate,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,0
19478,bismuth subsalicylate,004.9,Shigellosis NOS,0
19478,bismuth subsalicylate,041.49,Other and unspecified Escherichia coli [E. coli],0
19478,bismuth subsalicylate,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,0
19478,bismuth subsalicylate,536.8,Dyspepsia and other specified disorders of function of stomach,1
19478,bismuth subsalicylate,787.02,Nausea alone,1
19478,bismuth subsalicylate,787.1,Heartburn,1
19478,bismuth subsalicylate,787.7,Abnormal feces,1
19478,bismuth subsalicylate,787.91,Diarrhea,1
19484,Bisoprolol,401-405.99,,1
19484,Bisoprolol,401.9,Hypertension NOS,1
19484,Bisoprolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
19484,Bisoprolol,413,Angina pectoris,0
19484,Bisoprolol,413.9,Other and unspecified angina pectoris,0
19484,Bisoprolol,427.89,Other specified cardiac dysrhythmias,0
19484,Bisoprolol,428.0,Congestive heart failure (CHF) NOS,0
19484,Bisoprolol,786.50,Unspecified chest pain,0
19484,Bisoprolol,997.91,Hypertension,1
19499,bitolterol,493,Asthma,0
19499,bitolterol,493.9,Asthma; unspecified,0
19499,bitolterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
19499,bitolterol,519.11,Acute bronchospasm,0
19551,pemirolast,372.14,Other chronic allergic conjunctivitis,1
19552,cefprozil,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
19552,cefprozil,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
19552,cefprozil,041.49,Other and unspecified Escherichia coli [E. coli],0
19552,cefprozil,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
19552,cefprozil,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
19552,cefprozil,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
19552,cefprozil,136.9,Unspecified infectious and parasitic diseases,1
19552,cefprozil,380.10,Infective otitis externa; unspecified,0
19552,cefprozil,382.9,Unspecified otitis media,1
19552,cefprozil,461.9,Acute sinusitis NOS,1
19552,cefprozil,462,Acute pharyngitis,1
19552,cefprozil,490,Bronchitis NOS,1
19552,cefprozil,686.8|041.9,,0
19552,cefprozil,686.9,Unspecified local infection of skin and subcutaneous tissue,0
19666,Nesiritide,428,Heart failure,1
19666,Nesiritide,428.0,Congestive heart failure (CHF) NOS,1
19666,Nesiritide,428.9,Heart failure unspecified,1
19666,Nesiritide,786.09,Other dyspnea and respiratory abnormality,1
19666,Nesiritide,797,Senility without mention of psychosis,1
19685,bretylium,427.1,Paroxysmal ventricular tachycardia,0
19685,bretylium,427.41,Ventricular fibrillation,0
19737,bromfenac,338-338.99,,1
19737,bromfenac,338.18,Other acute postoperative pain,0
19737,bromfenac,366,Cataract,1
19737,bromfenac,366.9,Cataract NOS,1
19737,bromfenac,379.91,Pain in or around eye,1
19737,bromfenac,780.96,Generalized pain,1
19831,Budesonide,471,Nasal polyps,1
19831,Budesonide,471.0,Polyp of nasal cavity,1
19831,Budesonide,471.9,Nasal polyp NOS,1
19831,Budesonide,472.0,Chronic rhinitis,1
19831,Budesonide,477.9,Allergic rhinitis NOS,1
19831,Budesonide,493,Asthma,1
19831,Budesonide,493.9,Asthma; unspecified,1
19831,Budesonide,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
19831,Budesonide,519.11,Acute bronchospasm,1
19831,Budesonide,555.9,Regional enteritis of unspecified site,0
19831,Budesonide,995.3,Allergy unspecified not elsewhere classified,0
19860,butalbital,307.81,Tension headache,0
19860,butalbital,339.1,Tension type headache,0
19860,butalbital,339.10,Tension headache NOS,0
19860,butalbital,784.0,Headache,0
19884,butoconazole,112.1,Candidiasis of vulva and vagina,1
19959,acrivastine,477.0,Allergic rhinitis due to pollen,0
19959,acrivastine,477.9,Allergic rhinitis NOS,0
19959,acrivastine,708,Urticaria,0
19959,acrivastine,708.9,Unspecified urticaria,0
19959,acrivastine,995.3,Allergy unspecified not elsewhere classified,0
20033,caffeine citrate,765.10,Other preterm infants; unspecified [weight],1
20033,caffeine citrate,786.03,Apnea,1
20033,caffeine citrate,786.09,Other dyspnea and respiratory abnormality,1
20063,calcium polycarbophil,562.11,Diverticulitis of colon without mention of hemorrhage,0
20063,calcium polycarbophil,564.0,Constipation,0
20063,calcium polycarbophil,564.00,Constipation NOS,0
20063,calcium polycarbophil,564.1,Irritable bowel syndrome,0
20063,calcium polycarbophil,787.7,Abnormal feces,0
20063,calcium polycarbophil,787.91,Diarrhea,0
20217,carbetapentane,460,Acute nasopharyngitis (common cold),0
20217,carbetapentane,786.2,Cough,0
20220,carbinoxamine,372.14,Other chronic allergic conjunctivitis,1
20220,carbinoxamine,477.0,Allergic rhinitis due to pollen,0
20220,carbinoxamine,477.9,Allergic rhinitis NOS,1
20220,carbinoxamine,708,Urticaria,1
20220,carbinoxamine,708.3,Dermatographic urticaria,1
20220,carbinoxamine,708.9,Unspecified urticaria,1
20220,carbinoxamine,995.1,Angioneurotic edema not elsewhere classified,1
20220,carbinoxamine,995.3,Allergy unspecified not elsewhere classified,1
20352,carvedilol,401-405.99,,1
20352,carvedilol,401.9,Hypertension NOS,1
20352,carvedilol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
20352,carvedilol,413,Angina pectoris,0
20352,carvedilol,413.9,Other and unspecified angina pectoris,0
20352,carvedilol,428,Heart failure,1
20352,carvedilol,428.0,Congestive heart failure (CHF) NOS,1
20352,carvedilol,428.9,Heart failure unspecified,1
20352,carvedilol,786.50,Unspecified chest pain,0
20352,carvedilol,997.91,Hypertension,1
20481,cefepime,038.9,Septicemia NOS,1
20481,cefepime,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
20481,cefepime,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
20481,cefepime,041.49,Other and unspecified Escherichia coli [E. coli],0
20481,cefepime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
20481,cefepime,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,1
20481,cefepime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
20481,cefepime,136.9,Unspecified infectious and parasitic diseases,1
20481,cefepime,288.0,Agranulocytosis,1
20481,cefepime,288.00,Neutropenia NOS,1
20481,cefepime,482.9,Bacterial pneumonia NOS,0
20481,cefepime,486,Pneumonia; organism unspecified,1
20481,cefepime,590.80,Pyelonephritis NOS,1
20481,cefepime,599.0,Urinary tract infection; site not specified,1
20481,cefepime,686.8|041.9,,0
20481,cefepime,780.60,Fever; unspecified,0
20481,cefepime,995.91,Sepsis,0
20489,cefpodoxime,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
20489,cefpodoxime,041.49,Other and unspecified Escherichia coli [E. coli],0
20489,cefpodoxime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
20489,cefpodoxime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
20489,cefpodoxime,098,Gonococcal infections,1
20489,cefpodoxime,098.89,Gonococcal infection of other specified sites,1
20489,cefpodoxime,136.9,Unspecified infectious and parasitic diseases,1
20489,cefpodoxime,382.9,Unspecified otitis media,1
20489,cefpodoxime,461.9,Acute sinusitis NOS,1
20489,cefpodoxime,462,Acute pharyngitis,1
20489,cefpodoxime,463,Acute tonsillitis,1
20489,cefpodoxime,482.9,Bacterial pneumonia NOS,0
20489,cefpodoxime,486,Pneumonia; organism unspecified,1
20489,cefpodoxime,490,Bronchitis NOS,1
20489,cefpodoxime,599.0,Urinary tract infection; site not specified,1
20489,cefpodoxime,686.8|041.9,,0
20492,ceftibuten,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
20492,ceftibuten,041.49,Other and unspecified Escherichia coli [E. coli],0
20492,ceftibuten,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
20492,ceftibuten,136.9,Unspecified infectious and parasitic diseases,1
20492,ceftibuten,382.9,Unspecified otitis media,1
20492,ceftibuten,462,Acute pharyngitis,1
20492,ceftibuten,463,Acute tonsillitis,1
20492,ceftibuten,486,Pneumonia; organism unspecified,1
20492,ceftibuten,490,Bronchitis NOS,1
20492,ceftibuten,491,Chronic bronchitis,1
20492,ceftibuten,491.9,Chronic bronchitis NOS,1
20610,Cetirizine,375.2,Epiphora,1
20610,Cetirizine,375.20,Epiphora NOS,1
20610,Cetirizine,379.99,Other ill-defined disorders of eye,1
20610,Cetirizine,477.0,Allergic rhinitis due to pollen,1
20610,Cetirizine,477.9,Allergic rhinitis NOS,1
20610,Cetirizine,478.19,Other diseases of nasal cavity and sinuses,1
20610,Cetirizine,698.9,Unspecified pruritic disorder,1
20610,Cetirizine,708,Urticaria,1
20610,Cetirizine,708.9,Unspecified urticaria,1
20610,Cetirizine,780-789.99,,0
20610,Cetirizine,995.3,Allergy unspecified not elsewhere classified,1
20791,chlorhexidine gluconate,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
20791,chlorhexidine gluconate,112.0,Candidiasis of mouth,0
20791,chlorhexidine gluconate,523.10,Chronic gingivitis; plaque induced,1
20791,chlorhexidine gluconate,523.9,Unspecified gingival and periodontal disease,0
20791,chlorhexidine gluconate,686.9,Unspecified local infection of skin and subcutaneous tissue,0
20859,chloroprocaine,338-338.99,,0
20859,chloroprocaine,780.96,Generalized pain,0
20863,chloroquine phosphate,006,Amebiasis,1
20863,chloroquine phosphate,006.9,Amebiasis NOS,1
20863,chloroquine phosphate,084,Malaria,0
20863,chloroquine phosphate,084.0,Falciparum malaria [malignant tertian],1
20863,chloroquine phosphate,084.2,Quartan malaria,1
20863,chloroquine phosphate,084.6,Malaria NOS,0
20863,chloroquine phosphate,136.8,Other specified infectious and parasitic diseases,1
20863,chloroquine phosphate,694.4,Pemphigus,0
20863,chloroquine phosphate,695.4,Lupus erythematosus,0
20863,chloroquine phosphate,710.1,Systemic sclerosis,0
20863,chloroquine phosphate,714.0,Rheumatoid arthritis,0
20875,chloroxine,690.1,Seborrheic dermatitis,1
20875,chloroxine,690.10,Seborheic dermatitis; unspecified,1
20875,chloroxine,692.9,Contact dermatitis and other eczema; unspecified cause,1
20875,chloroxine,706.3,Seborrhea,1
20875,chloroxine,709.9,Unspecified disorder of skin and subcutaneous tissue,0
20877,chloroxylenol,686.9,Unspecified local infection of skin and subcutaneous tissue,0
20974,choline salicylate,338-338.99,,0
20974,choline salicylate,390,Rheumatic fever without mention of heart involvement,0
20974,choline salicylate,390-392.99,,0
20974,choline salicylate,714.0,Rheumatoid arthritis,0
20974,choline salicylate,715.00,Osteoarthrosis; generalized; involving unspecified site,0
20974,choline salicylate,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
20974,choline salicylate,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
20974,choline salicylate,780.96,Generalized pain,0
20976,oxtriphylline,427.89,Other specified cardiac dysrhythmias,0
20976,oxtriphylline,490,Bronchitis NOS,1
20976,oxtriphylline,492,Emphysema,1
20976,oxtriphylline,492.8,Other emphysema,1
20976,oxtriphylline,493,Asthma,1
20976,oxtriphylline,493.9,Asthma; unspecified,1
20976,oxtriphylline,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
20976,oxtriphylline,519.11,Acute bronchospasm,0
20976,oxtriphylline,786.03,Apnea,0
20976,oxtriphylline,786.09,Other dyspnea and respiratory abnormality,0
21090,ciclopirox,110.1,Dermatophytosis of nail,1
21090,ciclopirox,110.4,Dermatophytosis of foot,1
21090,ciclopirox,111,Dermatomycosis; other and unspecified,1
21090,ciclopirox,111.0,Pityriasis versicolor,0
21090,ciclopirox,111.9,Dermatomycosis NOS,1
21090,ciclopirox,112.3,Candidiasis of skin and nails,1
21090,ciclopirox,136.9,Unspecified infectious and parasitic diseases,1
21090,ciclopirox,690.1,Seborrheic dermatitis,1
21090,ciclopirox,690.10,Seborheic dermatitis; unspecified,1
21090,ciclopirox,706.3,Seborrhea,1
21102,Cilazapril,428.0,Congestive heart failure (CHF) NOS,1
21107,cilostazol,443.9,Peripheral vascular disease; unspecified,1
21107,cilostazol,996.74,Other complications due to other vascular device; implant; and graft,0
21183,Citric Acid,588.89,Other specified disorders resulting from impaired renal function,0
21212,Clarithromycin,031.8,Other specified mycobacterial diseases,1
21212,Clarithromycin,031.9,Unspecified diseases due to mycobacteria,1
21212,Clarithromycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
21212,Clarithromycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
21212,Clarithromycin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
21212,Clarithromycin,041.9|421.0,,0
21212,Clarithromycin,042,Human immunodeficiency virus [HIV] disease,1
21212,Clarithromycin,042-042.99,,1
21212,Clarithromycin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
21212,Clarithromycin,088.81,Lyme disease,0
21212,Clarithromycin,136.9,Unspecified infectious and parasitic diseases,1
21212,Clarithromycin,382.9,Unspecified otitis media,1
21212,Clarithromycin,461.0,Acute maxillary sinusitis,1
21212,Clarithromycin,461.9,Acute sinusitis NOS,1
21212,Clarithromycin,462,Acute pharyngitis,1
21212,Clarithromycin,463,Acute tonsillitis,1
21212,Clarithromycin,483.0,Pneumonia due to Mycoplasma pneumoniae,1
21212,Clarithromycin,486,Pneumonia; organism unspecified,1
21212,Clarithromycin,490,Bronchitis NOS,1
21212,Clarithromycin,491,Chronic bronchitis,1
21212,Clarithromycin,491.9,Chronic bronchitis NOS,1
21212,Clarithromycin,532,Duodenal ulcer,1
21212,Clarithromycin,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
21212,Clarithromycin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
21212,Clarithromycin,707.9,Chronic ulcer of unspecified site,1
21212,Clarithromycin,799.9,Other unknown and unspecified cause of morbidity or mortality,0
21232,clidinium,533,Peptic ulcer; site unspecified,0
21232,clidinium,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
21232,clidinium,536.8,Dyspepsia and other specified disorders of function of stomach,0
21232,clidinium,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
21232,clidinium,564.1,Irritable bowel syndrome,0
21241,clobazam,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
21241,clobazam,780.39,Other convulsions,1
21245,Clobetasol Propionate,692.9,Contact dermatitis and other eczema; unspecified cause,0
21245,Clobetasol Propionate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
21245,Clobetasol Propionate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
21249,clocortolone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
21389,cocoa butter,692.9,Contact dermatitis and other eczema; unspecified cause,0
21406,coenzyme Q10,272.4,Other and unspecified hyperlipidemia,0
21406,coenzyme Q10,333.4,Huntington's chorea,0
21406,coenzyme Q10,401-405.99,,0
21406,coenzyme Q10,401.9,Hypertension NOS,0
21406,coenzyme Q10,413,Angina pectoris,0
21406,coenzyme Q10,413.9,Other and unspecified angina pectoris,0
21406,coenzyme Q10,428.0,Congestive heart failure (CHF) NOS,0
21406,coenzyme Q10,780.71,Chronic fatigue syndrome,0
21406,coenzyme Q10,780.79,Other malaise and fatigue,0
21406,coenzyme Q10,786.50,Unspecified chest pain,0
21406,coenzyme Q10,977.9,Poisoning by unspecified drug or medicinal substance,0
21406,coenzyme Q10,997.91,Hypertension,0
21655,cortisone acetate,255.41,Glucocorticoid deficiency,0
21766,crotamiton,133.0,Scabies,1
21766,crotamiton,698.9,Unspecified pruritic disorder,0
21949,cyclobenzaprine,037,Tetanus,0
21949,cyclobenzaprine,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
21949,cyclobenzaprine,338-338.99,,1
21949,cyclobenzaprine,728.85,Spasm of muscle,1
21949,cyclobenzaprine,728.9,Unspecified disorder of muscle; ligament; and fascia,0
21949,cyclobenzaprine,729.1,Myalgia and myositis unspecified,0
21949,cyclobenzaprine,729.82,Cramp of limb,0
21949,cyclobenzaprine,780.96,Generalized pain,1
21949,cyclobenzaprine,781.0,Abnormal involuntary movements,1
21949,cyclobenzaprine,781.99,Other symptoms involving nervous and musculoskeletal systems,0
21949,cyclobenzaprine,959.9,Other and unspecified injury to unspecified site,0
22033,cyclothiazide,401-405.99,,0
22033,cyclothiazide,401.9,Hypertension NOS,0
22033,cyclothiazide,428.0,Congestive heart failure (CHF) NOS,0
22033,cyclothiazide,581,Nephrotic syndrome,0
22033,cyclothiazide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
22033,cyclothiazide,782.3,Edema,0
22033,cyclothiazide,997.91,Hypertension,0
22178,cytomegalovirus immune globulin,078.5,Cytomegaloviral disease,0
22178,cytomegalovirus immune globulin,136.9,Unspecified infectious and parasitic diseases,0
22178,cytomegalovirus immune globulin,279.3,Unspecified immunity deficiency,0
22298,dapiprazole,379.43,Mydriasis (persistent); not due to mydriatics,0
22298,dapiprazole,95.09,EYE EXAMINATION NOS,0
22299,Daptomycin,136.9,Unspecified infectious and parasitic diseases,1
22299,Daptomycin,424.90,Endocarditis valve unspecified cause,1
22299,Daptomycin,486,Pneumonia; organism unspecified,1
22299,Daptomycin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
22299,Daptomycin,790.7,Bacteremia,1
22656,Desogestrel,617,Endometriosis,0
22656,Desogestrel,617.9,Endometriosis; site unspecified,0
22656,Desogestrel,626.9,Unspecified disorders of menstruation and other abnormal bleeding from female genital tract,0
22656,Desogestrel,706.1,Other acne,0
22656,Desogestrel,V22.2,Pregnant state; incidental,0
22696,dexbrompheniramine,461.9,Acute sinusitis NOS,0
22696,dexbrompheniramine,477.0,Allergic rhinitis due to pollen,0
22696,dexbrompheniramine,477.9,Allergic rhinitis NOS,0
22697,dexchlorpheniramine,477.0,Allergic rhinitis due to pollen,0
22697,dexchlorpheniramine,477.9,Allergic rhinitis NOS,0
22697,dexchlorpheniramine,708,Urticaria,0
22697,dexchlorpheniramine,708.9,Unspecified urticaria,0
22701,dexpanthenol,266,Deficiency of B-complex components,0
22701,dexpanthenol,266.9,Vitamin B deficiency NOS,0
22713,dezocine,338-338.99,,0
22713,dezocine,780.96,Generalized pain,0
22892,dichloralphenazone,346,Migraine,0
22892,dichloralphenazone,346.9,Migraine; unspecified,0
22892,dichloralphenazone,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
22968,dienogest,617,Endometriosis,0
22968,dienogest,617.9,Endometriosis; site unspecified,0
23024,difenoxin,787.7,Abnormal feces,0
23024,difenoxin,787.91,Diarrhea,0
23033,diflorasone diacetate,698.9,Unspecified pruritic disorder,0
23033,diflorasone diacetate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
23043,difluprednate,338-338.99,,1
23043,difluprednate,780.96,Generalized pain,1
23066,Dihematoporphyrin Ether,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
23066,Dihematoporphyrin Ether,239.0,Neoplasm of unspecified nature of digestive system,0
23066,Dihematoporphyrin Ether,239.1,Neoplasm of unspecified nature of respiratory system,0
23088,dihydrocodeine,338-338.99,,0
23088,dihydrocodeine,338.18,Other acute postoperative pain,0
23088,dihydrocodeine,514,Pulmonary congestion and hypostasis,0
23088,dihydrocodeine,780.96,Generalized pain,0
23088,dihydrocodeine,786.2,Cough,0
23370,diphenidol,780.4,Dizziness and giddiness,0
23370,diphenidol,787.02,Nausea alone,0
23370,diphenidol,787.03,Vomiting alone,0
23410,Dipivefrin,365,Glaucoma,1
23410,Dipivefrin,365.1,Open-angle glaucoma,0
23410,Dipivefrin,365.10,Open-angle glaucoma NOS,0
23410,Dipivefrin,365.13,Pigmentary glaucoma,0
23410,Dipivefrin,365.9,Glaucoma NOS,1
23437,dirithromycin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
23437,dirithromycin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
23437,dirithromycin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
23437,dirithromycin,463,Acute tonsillitis,0
23437,dirithromycin,482.9,Bacterial pneumonia NOS,0
23437,dirithromycin,490,Bronchitis NOS,0
23663,doxycycline hyclate,022,Anthrax,1
23663,doxycycline hyclate,022.9,Anthrax NOS,1
23663,doxycycline hyclate,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
23663,doxycycline hyclate,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
23663,doxycycline hyclate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
23663,doxycycline hyclate,082.0,Spotted fevers,1
23663,doxycycline hyclate,083.9,Rickettsiosis NOS,0
23663,doxycycline hyclate,084,Malaria,0
23663,doxycycline hyclate,084.2,Quartan malaria,0
23663,doxycycline hyclate,084.6,Malaria NOS,0
23663,doxycycline hyclate,088.81,Lyme disease,1
23663,doxycycline hyclate,097.9,Syphilis NOS,1
23663,doxycycline hyclate,136.9,Unspecified infectious and parasitic diseases,1
23663,doxycycline hyclate,465.9,Acute upper respiratory infections of unspecified site,1
23663,doxycycline hyclate,482.9,Bacterial pneumonia NOS,0
23663,doxycycline hyclate,486,Pneumonia; organism unspecified,1
23663,doxycycline hyclate,511.9,Pleural effusion NOS,0
23663,doxycycline hyclate,519.8,Other diseases of respiratory system; not elsewhere classified,1
23663,doxycycline hyclate,599.0,Urinary tract infection; site not specified,1
23663,doxycycline hyclate,706.1,Other acne,1
23663,doxycycline hyclate,780.60,Fever; unspecified,1
23663,doxycycline hyclate,780.99,Other general symptoms,1
23663,doxycycline hyclate,799.89,Other ill-defined conditions,1
23665,doxylamine succinate,307.42,Persistent disorder of initiating or maintaining sleep,0
23665,doxylamine succinate,477.9,Allergic rhinitis NOS,0
23665,doxylamine succinate,784.0,Headache,0
23665,doxylamine succinate,V22.2,Pregnant state; incidental,0
23744,dyclonine,338-338.99,,1
23744,dyclonine,780.96,Generalized pain,1
23744,dyclonine,784.0,Headache,0
24346,Erythromycin Gluceptate,008.43,Intestinal infection due to campylobacter,0
24346,Erythromycin Gluceptate,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
24346,Erythromycin Gluceptate,039.0,Cutaneous actinomycosis,0
24346,Erythromycin Gluceptate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
24346,Erythromycin Gluceptate,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
24346,Erythromycin Gluceptate,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,0
24346,Erythromycin Gluceptate,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
24346,Erythromycin Gluceptate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
24346,Erythromycin Gluceptate,097.9,Syphilis NOS,0
24346,Erythromycin Gluceptate,098,Gonococcal infections,0
24346,Erythromycin Gluceptate,098.89,Gonococcal infection of other specified sites,0
24346,Erythromycin Gluceptate,099.0,Chancroid,0
24346,Erythromycin Gluceptate,379.99|041.9,,0
24346,Erythromycin Gluceptate,482.84,Legionnaires' disease,0
24346,Erythromycin Gluceptate,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
24346,Erythromycin Gluceptate,597.80,Urethritis NOS,0
24346,Erythromycin Gluceptate,706.1,Other acne,0
24347,erythromycin lactobionate,008.43,Intestinal infection due to campylobacter,0
24347,erythromycin lactobionate,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
24347,erythromycin lactobionate,039.0,Cutaneous actinomycosis,1
24347,erythromycin lactobionate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,1
24347,erythromycin lactobionate,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
24347,erythromycin lactobionate,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
24347,erythromycin lactobionate,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
24347,erythromycin lactobionate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
24347,erythromycin lactobionate,097.9,Syphilis NOS,1
24347,erythromycin lactobionate,098,Gonococcal infections,1
24347,erythromycin lactobionate,098.89,Gonococcal infection of other specified sites,1
24347,erythromycin lactobionate,099.0,Chancroid,0
24347,erythromycin lactobionate,379.99|041.9,,0
24347,erythromycin lactobionate,482.84,Legionnaires' disease,0
24347,erythromycin lactobionate,519.8,Other diseases of respiratory system; not elsewhere classified,1
24347,erythromycin lactobionate,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
24347,erythromycin lactobionate,597.80,Urethritis NOS,0
24347,erythromycin lactobionate,706.1,Other acne,0
24351,erythromycin stearate,008.43,Intestinal infection due to campylobacter,0
24351,erythromycin stearate,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
24351,erythromycin stearate,039.0,Cutaneous actinomycosis,0
24351,erythromycin stearate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
24351,erythromycin stearate,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
24351,erythromycin stearate,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,0
24351,erythromycin stearate,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
24351,erythromycin stearate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
24351,erythromycin stearate,097.9,Syphilis NOS,0
24351,erythromycin stearate,098,Gonococcal infections,0
24351,erythromycin stearate,098.89,Gonococcal infection of other specified sites,0
24351,erythromycin stearate,099.0,Chancroid,0
24351,erythromycin stearate,379.99|041.9,,0
24351,erythromycin stearate,482.84,Legionnaires' disease,0
24351,erythromycin stearate,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
24351,erythromycin stearate,597.80,Urethritis NOS,0
24351,erythromycin stearate,706.1,Other acne,0
24395,estradiol valerate,239.3,Neoplasm of unspecified nature of breast,0
24395,estradiol valerate,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
24395,estradiol valerate,253.4,Other anterior pituitary disorders,1
24395,estradiol valerate,256.31,Premature menopause,0
24395,estradiol valerate,256.39,Other ovarian failure,1
24395,estradiol valerate,626.2,Excessive or frequent menstruation,0
24395,estradiol valerate,627.2,Symptomatic menopausal or female climacteric states,0
24395,estradiol valerate,733.01,Senile osteoporosis,0
24395,estradiol valerate,782.62,Flushing,0
24474,ethinamate,307.42,Persistent disorder of initiating or maintaining sleep,0
24605,Etodolac,338-338.99,,1
24605,Etodolac,714.0,Rheumatoid arthritis,1
24605,Etodolac,715.00,Osteoarthrosis; generalized; involving unspecified site,1
24605,Etodolac,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
24605,Etodolac,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
24605,Etodolac,716.90,Arthropathy; unspecified; site unspecified,1
24605,Etodolac,780.60,Fever; unspecified,0
24605,Etodolac,780.96,Generalized pain,1
24698,fludarabine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
24698,fludarabine,204.1,Lymphoid leukemia; chronic,1
24698,fludarabine,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
24812,felbamate,284.9,Aplastic anemia unspecified,1
24812,felbamate,289.9,Blood disease NOS,1
24812,felbamate,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
24812,felbamate,345.40,Partial epilepsy without intractable epilepsy,0
24812,felbamate,345.9,Epilepsy; unspecified,1
24812,felbamate,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
24812,felbamate,572.8,Other sequelae of chronic liver disease,1
24812,felbamate,780.39,Other convulsions,1
24853,Fenoldopam,401.0,Malignant essential hypertension,1
24853,Fenoldopam,405.91,Unspecified renovascular hypertension,0
24853,Fenoldopam,428.0,Congestive heart failure (CHF) NOS,0
24909,ferric oxide  saccharated,275.09,Other disorders of iron metabolism,1
24909,ferric oxide  saccharated,280,Iron deficiency anemias,1
24909,ferric oxide  saccharated,280.9,Iron deficiency anemia; unspecified,1
24909,ferric oxide  saccharated,285.9,Anemia unspecified,1
24909,ferric oxide  saccharated,585.6,End stage renal disease,1
24909,ferric oxide  saccharated,585.9,Chronic kidney disease; unspecified,1
24909,ferric oxide  saccharated,586,Renal failure unspecified,1
24912,ferric subsulfate solution,940-949.99,,0
24912,ferric subsulfate solution,949.0,Burn of unspecified site; unspecified degree,0
24913,ferric sulfate,985.1,Toxic effect of arsenic and its compounds,0
24941,Ferrous fumarate,280,Iron deficiency anemias,0
24941,Ferrous fumarate,280.9,Iron deficiency anemia; unspecified,0
24941,Ferrous fumarate,799.9,Other unknown and unspecified cause of morbidity or mortality,0
24942,ferrous gluconate,280,Iron deficiency anemias,0
24942,ferrous gluconate,280.9,Iron deficiency anemia; unspecified,0
24947,ferrous sulfate,269.9,Unspecified nutritional deficiency,0
24947,ferrous sulfate,280,Iron deficiency anemias,0
24947,ferrous sulfate,280.9,Iron deficiency anemia; unspecified,0
24947,ferrous sulfate,285.9,Anemia unspecified,0
24947,ferrous sulfate,799.9,Other unknown and unspecified cause of morbidity or mortality,0
25025,Finasteride,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
25025,Finasteride,600,Hyperplasia of prostate,1
25025,Finasteride,600.0,Hypertrophy (benign) of prostate,0
25025,Finasteride,600.9,Hyperplasia of prostate; unspecified,1
25025,Finasteride,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),1
25025,Finasteride,704.0,Alopecia,1
25025,Finasteride,704.00,Alopecia NOS,1
25025,Finasteride,704.09,Other alopecia,1
25025,Finasteride,704.1,Hirsutism,0
25025,Finasteride,788.1,Dysuria,0
25025,Finasteride,788.20,Retention of urine NOS,1
25025,Finasteride,788.42,Polyuria,1
25033,Cefixime,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
25033,Cefixime,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
25033,Cefixime,041.49,Other and unspecified Escherichia coli [E. coli],0
25033,Cefixime,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
25033,Cefixime,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
25033,Cefixime,098,Gonococcal infections,1
25033,Cefixime,098.89,Gonococcal infection of other specified sites,1
25033,Cefixime,136.9,Unspecified infectious and parasitic diseases,1
25033,Cefixime,382.9,Unspecified otitis media,1
25033,Cefixime,461.9,Acute sinusitis NOS,1
25033,Cefixime,462,Acute pharyngitis,1
25033,Cefixime,463,Acute tonsillitis,1
25033,Cefixime,482.9,Bacterial pneumonia NOS,0
25033,Cefixime,486,Pneumonia; organism unspecified,1
25033,Cefixime,490,Bronchitis NOS,1
25033,Cefixime,599.0,Urinary tract infection; site not specified,1
25033,Cefixime,686.8|041.9,,0
25037,cefdinir,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
25037,cefdinir,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
25037,cefdinir,041.49,Other and unspecified Escherichia coli [E. coli],0
25037,cefdinir,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
25037,cefdinir,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
25037,cefdinir,136.9,Unspecified infectious and parasitic diseases,1
25037,cefdinir,382.9,Unspecified otitis media,1
25037,cefdinir,461.9,Acute sinusitis NOS,1
25037,cefdinir,462,Acute pharyngitis,1
25037,cefdinir,463,Acute tonsillitis,1
25037,cefdinir,482.9,Bacterial pneumonia NOS,0
25037,cefdinir,486,Pneumonia; organism unspecified,1
25037,cefdinir,490,Bronchitis NOS,1
25037,cefdinir,686.8|041.9,,0
25102,Fludarabine phosphate,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
25102,Fludarabine phosphate,204.1,Lymphoid leukemia; chronic,1
25102,Fludarabine phosphate,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
25120,flunisolide,471,Nasal polyps,0
25120,flunisolide,471.0,Polyp of nasal cavity,0
25120,flunisolide,471.9,Nasal polyp NOS,0
25120,flunisolide,477.9,Allergic rhinitis NOS,1
25120,flunisolide,493,Asthma,1
25120,flunisolide,493.9,Asthma; unspecified,1
25120,flunisolide,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
25126,fluocinolone,691.8,Other atopic dermatitis,0
25126,fluocinolone,692.9,Contact dermatitis and other eczema; unspecified cause,0
25126,fluocinolone,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
25126,fluocinolone,698.9,Unspecified pruritic disorder,0
25138,Fluorescein,362.10,Background retinopathy; unspecified,1
25138,Fluorescein,362.9,Retinal disorder NOS,1
25138,Fluorescein,371.9,Unspecified corneal disorder,0
25190,fluphenazine decanoate,290-299.99,,0
25190,fluphenazine decanoate,295,Schizophrenic disorders,1
25190,fluphenazine decanoate,295.9,Unspecified schizophrenia,1
25190,fluphenazine decanoate,295.90,Unspecified schizophrenia; unspecified state,1
25190,fluphenazine decanoate,298.9,Unspecified psychosis,0
25255,formoterol,491,Chronic bronchitis,1
25255,formoterol,491.9,Chronic bronchitis NOS,1
25255,formoterol,493,Asthma,1
25255,formoterol,493.81,Exercise induced bronchospasm,0
25255,formoterol,493.9,Asthma; unspecified,1
25255,formoterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
25255,formoterol,496,Chronic airway obstruction; not elsewhere classified,1
25255,formoterol,518.89,Other diseases of lung; not elsewhere classified,1
25255,formoterol,519.11,Acute bronchospasm,1
25255,formoterol,796.4,Other abnormal clinical findings,1
25480,gabapentin,053.19,Herpes zoster with other nervous system complications,1
25480,gabapentin,296.80,Bipolar disorder NOS,0
25480,gabapentin,300.2,Phobic disorders,0
25480,gabapentin,300.20,Phobia unspecified,0
25480,gabapentin,338-338.99,,1
25480,gabapentin,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
25480,gabapentin,345.9,Epilepsy; unspecified,1
25480,gabapentin,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
25480,gabapentin,627.2,Symptomatic menopausal or female climacteric states,0
25480,gabapentin,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
25480,gabapentin,780.39,Other convulsions,1
25480,gabapentin,780.96,Generalized pain,1
25480,gabapentin,782.62,Flushing,0
25544,gallium nitrate,275.42,Hypercalcemia,0
25789,glimepiride,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
25789,glimepiride,251.2,Hypoglycemia NOS,1
25789,glimepiride,790.6,Other abnormal blood chemistry,1
25806,glubionate calcium,275.41,Hypocalcemia,0
25806,glubionate calcium,733.0,Osteoporosis,0
25806,glubionate calcium,733.00,Osteoporosis NOS,0
25806,glubionate calcium,733.01,Senile osteoporosis,0
26225,Ondansetron,303,Alcohol dependence syndrome,0
26225,Ondansetron,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
26225,Ondansetron,305.01,Alcohol abuse; continuous drinking behavior,0
26225,Ondansetron,787.01,Nausea with vomiting,1
26225,Ondansetron,787.02,Nausea alone,1
26225,Ondansetron,787.03,Vomiting alone,1
26237,Granisetron,787.02,Nausea alone,1
26237,Granisetron,787.03,Vomiting alone,1
26296,guanadrel,401-405.99,,0
26296,guanadrel,401.9,Hypertension NOS,0
26296,guanadrel,997.91,Hypertension,0
26412,halazepam,300.00,Anxiety state unspecified,0
26420,haloperidol decanoate,290-299.99,,0
26420,haloperidol decanoate,295,Schizophrenic disorders,0
26420,haloperidol decanoate,295.9,Unspecified schizophrenia,0
26420,haloperidol decanoate,295.90,Unspecified schizophrenia; unspecified state,0
26420,haloperidol decanoate,298.9,Unspecified psychosis,0
26420,haloperidol decanoate,307.20,Tic disorder NOS,0
26420,haloperidol decanoate,307.23,Tourette's disorder,0
26420,haloperidol decanoate,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
26420,haloperidol decanoate,308.2,Predominant psychomotor disturbance,0
26420,haloperidol decanoate,312.9,Unspecified disturbance of conduct,0
26420,haloperidol decanoate,787.03,Vomiting alone,0
26420,haloperidol decanoate,799.21,Nervousness (ADDED),0
26420,haloperidol decanoate,799.24,Emotional lability (ADDED),0
26422,haloprogin,110.4,Dermatophytosis of foot,0
26744,hepatitis B immune globulin,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,0
26746,Hepatitis B Vaccine,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,0
27084,homatropine,338-338.99,,0
27084,homatropine,780.96,Generalized pain,0
27169,leflunomide,714.0,Rheumatoid arthritis,1
27169,leflunomide,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
27197,hydrocortisone acetate,255.2,Adrenogenital disorders,0
27197,hydrocortisone acetate,255.41,Glucocorticoid deficiency,0
27197,hydrocortisone acetate,338-338.99,,0
27197,hydrocortisone acetate,455,Hemorrhoids,0
27197,hydrocortisone acetate,455.6,Hemorrhoids NOS,0
27197,hydrocortisone acetate,493.91,Asthma; unspecified type; with status asthmaticus,0
27197,hydrocortisone acetate,556,Ulcerative colitis,0
27197,hydrocortisone acetate,556.8,Other ulcerative colitis,0
27197,hydrocortisone acetate,556.9,Ulcerative colitis; unspecified,0
27197,hydrocortisone acetate,692.9,Contact dermatitis and other eczema; unspecified cause,0
27197,hydrocortisone acetate,698.0,Pruritus ani,0
27197,hydrocortisone acetate,709.9,Unspecified disorder of skin and subcutaneous tissue,0
27197,hydrocortisone acetate,729.0,Rheumatism; unspecified and fibrositis,0
27197,hydrocortisone acetate,780.96,Generalized pain,0
27197,hydrocortisone acetate,782.1,Rash and other nonspecific skin eruption,0
27197,hydrocortisone acetate,785.50,Shock NOS,0
27291,hydroxypropylcellulose,370.00,Corneal ulcer NOS,1
27291,hydroxypropylcellulose,370.33,Keratoconjunctivitis sicca; not specified as Sjogren's,1
27291,hydroxypropylcellulose,371.42,Recurrent erosion of cornea,1
27340,desflurane,338-338.99,,0
27340,desflurane,780.96,Generalized pain,0
27793,ioxilan,430-438.99,,0
27793,ioxilan,437.9,Unspecified cerebrovascular disease,0
27793,ioxilan,593.9,Unspecified disorder of kidney and ureter,0
27946,isometheptene,307.81,Tension headache,0
27946,isometheptene,339.1,Tension type headache,0
27946,isometheptene,339.10,Tension headache NOS,0
27946,isometheptene,346,Migraine,0
27946,isometheptene,346.9,Migraine; unspecified,0
27946,isometheptene,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
28004,Isosorbide Mononitrate,413,Angina pectoris,1
28004,Isosorbide Mononitrate,413.9,Other and unspecified angina pectoris,1
28004,Isosorbide Mononitrate,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,0
28004,Isosorbide Mononitrate,428.0,Congestive heart failure (CHF) NOS,0
28004,Isosorbide Mononitrate,530.5,Dyskinesia of esophagus,0
28004,Isosorbide Mononitrate,530.81,Esophageal reflux,0
28004,Isosorbide Mononitrate,782.5,Cyanosis,0
28004,Isosorbide Mononitrate,786.50,Unspecified chest pain,1
28004,Isosorbide Mononitrate,977.9,Poisoning by unspecified drug or medicinal substance,0
28031,Itraconazole,085,Leishmaniasis,0
28031,Itraconazole,085.9,Leishmaniasis NOS,0
28031,Itraconazole,110-118.99,,1
28031,Itraconazole,110.1,Dermatophytosis of nail,1
28031,Itraconazole,112,Candidiasis,1
28031,Itraconazole,112.0,Candidiasis of mouth,0
28031,Itraconazole,112.1,Candidiasis of vulva and vagina,0
28031,Itraconazole,112.3,Candidiasis of skin and nails,0
28031,Itraconazole,112.9,Candidiasis of unspecified site,1
28031,Itraconazole,114,Coccidioidomycosis,0
28031,Itraconazole,114.9,Coccidioidomycosis NOS,0
28031,Itraconazole,115,Histoplasmosis,1
28031,Itraconazole,115.9,Histoplasmosis; unspecified,1
28031,Itraconazole,115.90,Histoplasmosis; unspecified without mention of manifestation,1
28031,Itraconazole,116,Blastomycotic infection,1
28031,Itraconazole,116.0,Blastomycosis,1
28031,Itraconazole,116.1,Paracoccidioidomycosis,0
28031,Itraconazole,117.1,Sporotrichosis,0
28031,Itraconazole,117.3,Aspergillosis,1
28031,Itraconazole,117.5,Cryptococcosis,0
28031,Itraconazole,117.7,Zygomycosis,0
28031,Itraconazole,117.9,Other and unspecified mycoses,1
28031,Itraconazole,136.9,Unspecified infectious and parasitic diseases,1
28031,Itraconazole,288.0,Agranulocytosis,0
28031,Itraconazole,288.00,Neutropenia NOS,0
28031,Itraconazole,780.60,Fever; unspecified,1
28031,Itraconazole,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
28144,emedastine,077.4,Epidemic hemorrhagic conjunctivitis,0
28144,emedastine,372.14,Other chronic allergic conjunctivitis,1
28200,Ketorolac Tromethamine,338-338.99,,1
28200,Ketorolac Tromethamine,368.13,Visual discomfort,1
28200,Ketorolac Tromethamine,372.14,Other chronic allergic conjunctivitis,1
28200,Ketorolac Tromethamine,379.91,Pain in or around eye,1
28200,Ketorolac Tromethamine,379.99,Other ill-defined disorders of eye,1
28200,Ketorolac Tromethamine,698.9,Unspecified pruritic disorder,1
28200,Ketorolac Tromethamine,780.96,Generalized pain,1
28393,Lactic acid,692.9,Contact dermatitis and other eczema; unspecified cause,0
28393,Lactic acid,698.9,Unspecified pruritic disorder,1
28439,lamotrigine,296.00,Manic disorder; single episode; unspecified degree,1
28439,lamotrigine,296.7,Bipolar I disorder; most recent episode (or current) unspecified,1
28439,lamotrigine,296.80,Bipolar disorder NOS,1
28439,lamotrigine,311,Depressive disorder NEC,0
28439,lamotrigine,315.9,Unspecified delay in development,0
28439,lamotrigine,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
28439,lamotrigine,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
28439,lamotrigine,345.9,Epilepsy; unspecified,1
28439,lamotrigine,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
28439,lamotrigine,780.39,Other convulsions,1
28439,lamotrigine,782.1,Rash and other nonspecific skin eruption,1
28439,lamotrigine,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
28627,levocabastine,372.14,Other chronic allergic conjunctivitis,1
28656,Nafarelin,259.1,Precocious sexual development and puberty NEC,1
28656,Nafarelin,617,Endometriosis,1
28656,Nafarelin,617.9,Endometriosis; site unspecified,1
28872,lomefloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
28872,lomefloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
28872,lomefloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
28872,lomefloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
28872,lomefloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
28872,lomefloxacin,136.9,Unspecified infectious and parasitic diseases,1
28872,lomefloxacin,490,Bronchitis NOS,1
28872,lomefloxacin,599.0,Urinary tract infection; site not specified,1
28889,Loratadine,379.99,Other ill-defined disorders of eye,1
28889,Loratadine,477.0,Allergic rhinitis due to pollen,1
28889,Loratadine,477.9,Allergic rhinitis NOS,1
28889,Loratadine,478.19,Other diseases of nasal cavity and sinuses,1
28889,Loratadine,698.9,Unspecified pruritic disorder,1
28889,Loratadine,708,Urticaria,1
28889,Loratadine,708.9,Unspecified urticaria,1
28889,Loratadine,784.99,Other symptoms involving head and neck,1
28889,Loratadine,995.3,Allergy unspecified not elsewhere classified,1
28981,loracarbef,382.9,Unspecified otitis media,0
28981,loracarbef,461.9,Acute sinusitis NOS,0
28981,loracarbef,629.9,Unspecified disorder of female genital organs,0
28981,loracarbef,686.9,Unspecified local infection of skin and subcutaneous tissue,0
28981,loracarbef,716.9,Arthropathy; unspecified,0
28981,loracarbef,716.90,Arthropathy; unspecified; site unspecified,0
28981,loracarbef,719.9,Unspecified disorder of joint,0
28981,loracarbef,719.90,Unspecified disorder of joint site unspecified,0
28981,loracarbef,788.2,Retention of urine,0
28981,loracarbef,788.20,Retention of urine NOS,0
29046,Lisinopril,250.4,Diabetes with renal manifestations,0
29046,Lisinopril,401-405.99,,1
29046,Lisinopril,401.9,Hypertension NOS,1
29046,Lisinopril,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
29046,Lisinopril,428,Heart failure,1
29046,Lisinopril,428.0,Congestive heart failure (CHF) NOS,1
29046,Lisinopril,428.9,Heart failure unspecified,1
29046,Lisinopril,429.3,Cardiomegaly,0
29046,Lisinopril,997.91,Hypertension,1
29151,magaldrate,530.81,Esophageal reflux,0
29151,magaldrate,531,Gastric ulcer,0
29151,magaldrate,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
29151,magaldrate,532,Duodenal ulcer,0
29151,magaldrate,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
29151,magaldrate,536.8,Dyspepsia and other specified disorders of function of stomach,0
29151,magaldrate,553.3,Diaphragmatic hernia without mention of obstruction or gangrene,0
29151,magaldrate,578,Gastrointestinal hemorrhage,0
29151,magaldrate,578.9,Hemorrhage of gastrointestinal tract NOS,0
29151,magaldrate,585.6,End stage renal disease,0
29151,magaldrate,585.9,Chronic kidney disease; unspecified,0
29151,magaldrate,586,Renal failure unspecified,0
29151,magaldrate,787.1,Heartburn,0
29155,magnesium carbonate,275.2,Disorders of magnesium metabolism,0
29155,magnesium carbonate,530.81,Esophageal reflux,0
29155,magnesium carbonate,536.8,Dyspepsia and other specified disorders of function of stomach,0
29155,magnesium carbonate,787.1,Heartburn,0
29170,magnesium trisilicate,275.2,Disorders of magnesium metabolism,0
29170,magnesium trisilicate,530.81,Esophageal reflux,0
29170,magnesium trisilicate,536.8,Dyspepsia and other specified disorders of function of stomach,0
29170,magnesium trisilicate,787.1,Heartburn,0
29261,manganese chloride,429.9,Heart disease NOS,0
29261,manganese chloride,861.00,Unspecified injury of heart without mention of open wound into thorax,0
29365,calcipotriene,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
29365,calcipotriene,709.9,Unspecified disorder of skin and subcutaneous tissue,1
29418,meclocycline,706.1,Other acne,0
29421,mecobalamin,250.6,Diabetes with neurological manifestations,0
29421,mecobalamin,266.2,Other B-complex deficiencies,0
29421,mecobalamin,281.0,Pernicious anemia,0
29421,mecobalamin,340,Multiple sclerosis,0
29421,mecobalamin,357.5,Alcoholic polyneuropathy,0
29439,medrysone,372.14,Other chronic allergic conjunctivitis,1
29439,medrysone,379.00,Scleritis NOS,1
29439,medrysone,995.27,Other drug allergy,0
29451,Megestrol Acetate,042,Human immunodeficiency virus [HIV] disease,1
29451,Megestrol Acetate,174.9,Malignant neoplasm of breast (female); unspecified,1
29451,Megestrol Acetate,185,Malignant neoplasm of prostate,1
29451,Megestrol Acetate,239.3,Neoplasm of unspecified nature of breast,0
29451,Megestrol Acetate,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
29451,Megestrol Acetate,783.0,Anorexia,1
29451,Megestrol Acetate,783.9,Other symptoms concerning nutrition; metabolism; and development,1
29451,Megestrol Acetate,799.4,Cachexia,1
29491,menadiol,286.3,Congenital deficiency of other clotting factors,0
29561,meropenem,036.0,Meningococcal meningitis,0
29561,meropenem,041.49,Other and unspecified Escherichia coli [E. coli],0
29561,meropenem,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
29561,meropenem,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
29561,meropenem,136.9,Unspecified infectious and parasitic diseases,1
29561,meropenem,288.0,Agranulocytosis,0
29561,meropenem,288.00,Neutropenia NOS,0
29561,meropenem,320.0,Hemophilus meningitis,0
29561,meropenem,320.1,Pneumococcal meningitis,0
29561,meropenem,322,Meningitis of unspecified cause,1
29561,meropenem,322.9,Meningitis NOS,1
29561,meropenem,486,Pneumonia; organism unspecified,1
29561,meropenem,519.8,Other diseases of respiratory system; not elsewhere classified,1
29561,meropenem,540-543.99,,1
29561,meropenem,541,Appendicitis unqualified,1
29561,meropenem,567.9,Peritonitis NOS,1
29561,meropenem,599.0,Urinary tract infection; site not specified,1
29561,meropenem,780.60,Fever; unspecified,0
29648,methdilazine,477.9,Allergic rhinitis NOS,0
29648,methdilazine,691.8,Other atopic dermatitis,0
29648,methdilazine,692.9,Contact dermatitis and other eczema; unspecified cause,0
29648,methdilazine,696.3,Pityriasis rosea,0
29648,methdilazine,708,Urticaria,0
29648,methdilazine,708.9,Unspecified urticaria,0
29652,methenamine hippurate,136.9,Unspecified infectious and parasitic diseases,1
29652,methenamine hippurate,595,Cystitis,0
29652,methenamine hippurate,595.9,Cystitis NOS,0
29652,methenamine hippurate,599.0,Urinary tract infection; site not specified,1
29652,methenamine hippurate,791.9,Other nonspecific findings on examination of urine,0
29829,methylbenzethonium,686.8|041.9,,0
29829,methylbenzethonium,691.0,Diaper or napkin rash,0
29829,methylbenzethonium,692.9,Contact dermatitis and other eczema; unspecified cause,0
29899,methylnaltrexone,338-338.99,,0
29899,methylnaltrexone,564.0,Constipation,1
29899,methylnaltrexone,564.00,Constipation NOS,1
29899,methylnaltrexone,780.96,Generalized pain,0
29899,methylnaltrexone,799.89,Other ill-defined conditions,1
29950,metocurine,037,Tetanus,0
29950,metocurine,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
30003,Milnacipran hydrochloride,338-338.99,,0
30003,Milnacipran hydrochloride,729.0,Rheumatism; unspecified and fibrositis,0
30003,Milnacipran hydrochloride,729.1,Myalgia and myositis unspecified,0
30003,Milnacipran hydrochloride,780.96,Generalized pain,0
30009,miglitol,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
30125,modafinil,298.8,Other and unspecified reactive psychosis,1
30125,modafinil,314,Hyperkinetic syndrome of childhood,1
30125,modafinil,314.01,Attention deficit disorder of childhood with hyperactivity,1
30125,modafinil,314.9,Unspecified hyperkinetic syndrome of childhood,1
30125,modafinil,327.23,Obstructive sleep apnea,1
30125,modafinil,347.0,Narcolepsy,1
30125,modafinil,347.00,Narcolepsy; without cataplexy,1
30125,modafinil,695.1,Erythema multiforme,1
30125,modafinil,695.10,Erythema multiforme; unspecified,1
30125,modafinil,780.09,Other alteration of consciousness,1
30125,modafinil,780.50,Unspecified sleep disturbance,1
30125,modafinil,780.54,Hypersomnia; unspecified,1
30125,modafinil,780.57,Unspecified sleep apnea,1
30125,modafinil,780.79,Other malaise and fatigue,1
30125,modafinil,782.1,Rash and other nonspecific skin eruption,1
30125,modafinil,786.09,Other dyspnea and respiratory abnormality,1
30125,modafinil,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
30129,Fluphenazine enanthate,290-299.99,,0
30129,Fluphenazine enanthate,295,Schizophrenic disorders,0
30129,Fluphenazine enanthate,295.9,Unspecified schizophrenia,0
30129,Fluphenazine enanthate,295.90,Unspecified schizophrenia; unspecified state,0
30129,Fluphenazine enanthate,298.9,Unspecified psychosis,0
30131,moexipril,250.4,Diabetes with renal manifestations,0
30131,moexipril,401-405.99,,1
30131,moexipril,401.9,Hypertension NOS,1
30131,moexipril,428.0,Congestive heart failure (CHF) NOS,0
30131,moexipril,429.3,Cardiomegaly,0
30131,moexipril,997.91,Hypertension,1
30145,mometasone furoate,477.9,Allergic rhinitis NOS,0
30145,mometasone furoate,493,Asthma,1
30145,mometasone furoate,493.9,Asthma; unspecified,1
30145,mometasone furoate,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
30145,mometasone furoate,519.11,Acute bronchospasm,1
30145,mometasone furoate,692.9,Contact dermatitis and other eczema; unspecified cause,1
30145,mometasone furoate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
30145,mometasone furoate,698.9,Unspecified pruritic disorder,0
30236,Morphine Sulfate,338-338.99,,1
30236,Morphine Sulfate,338.2,Chronic pain,1
30236,Morphine Sulfate,338.29,Other chronic pain,1
30236,Morphine Sulfate,780.96,Generalized pain,1
30236,Morphine Sulfate,786.05,Shortness of breath,0
30236,Morphine Sulfate,786.09,Other dyspnea and respiratory abnormality,0
31435,valrubicin,188,Malignant neoplasm of bladder,0
31435,valrubicin,188.9,Malignant neoplasm of bladder; part unspecified,0
31435,valrubicin,230-234.99,,1
31435,valrubicin,234.9,Carcinoma in situ; site unspecified,1
31435,valrubicin,239.4,Neoplasm of unspecified nature of bladder,0
31447,nabilone,787.02,Nausea alone,1
31447,nabilone,787.03,Vomiting alone,1
31448,nabumetone,338-338.99,,0
31448,nabumetone,714.0,Rheumatoid arthritis,1
31448,nabumetone,715.00,Osteoarthrosis; generalized; involving unspecified site,1
31448,nabumetone,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
31448,nabumetone,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
31448,nabumetone,716.90,Arthropathy; unspecified; site unspecified,1
31448,nabumetone,780.96,Generalized pain,0
31476,naftifine,110.3,Dermatophytosis of groin and perianal area,1
31476,naftifine,110.4,Dermatophytosis of foot,1
31476,naftifine,110.5,Dermatophytosis of the body,1
31479,nalmefene,292.89,Other specified drug-induced mental disorders,0
31479,nalmefene,460-519.99,,0
31479,nalmefene,519.9,Unspecified disease of respiratory system,0
31479,nalmefene,786.00,Respiratory abnormality; unspecified,1
31479,nalmefene,977.9,Poisoning by unspecified drug or medicinal substance,0
31479,nalmefene,V12.60,Unspecified disease of respiratory system,0
31555,nebivolol,401-405.99,,1
31555,nebivolol,401.9,Hypertension NOS,1
31555,nebivolol,458,Hypotension,1
31555,nebivolol,458.9,Hypotension NOS,1
31555,nebivolol,997.91,Hypertension,1
31563,Nedocromil,372.14,Other chronic allergic conjunctivitis,1
31563,Nedocromil,493,Asthma,1
31563,Nedocromil,493.9,Asthma; unspecified,1
31563,Nedocromil,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
31563,Nedocromil,698.9,Unspecified pruritic disorder,1
31563,Nedocromil,786.05,Shortness of breath,0
31563,Nedocromil,786.09,Other dyspnea and respiratory abnormality,0
31563,Nedocromil,995.3,Allergy unspecified not elsewhere classified,0
31565,nefazodone,308.9,Unspecified acute reaction to stress,0
31565,nefazodone,309.81,Posttraumatic stress disorder,0
31565,nefazodone,311,Depressive disorder NEC,1
31565,nefazodone,780.79,Other malaise and fatigue,1
31805,nilutamide,185,Malignant neoplasm of prostate,1
31805,nilutamide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
31819,nitazoxanide,007.1,Giardiasis,1
31819,nitazoxanide,007.4,Cryptosporidiosis,0
31819,nitazoxanide,787.7,Abnormal feces,1
31819,nitazoxanide,787.91,Diarrhea,1
31914,tiagabine,296.80,Bipolar disorder NOS,0
31914,tiagabine,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
31914,tiagabine,780.39,Other convulsions,1
31983,norethindrone acetate,253.4,Other anterior pituitary disorders,0
31983,norethindrone acetate,617,Endometriosis,1
31983,norethindrone acetate,617.9,Endometriosis; site unspecified,1
31983,norethindrone acetate,621.3,Endometrial hyperplasia,0
31983,norethindrone acetate,621.30,Endometrial hyperplasia; unspecified,0
31983,norethindrone acetate,626.2,Excessive or frequent menstruation,0
31983,norethindrone acetate,706.1,Other acne,0
31983,norethindrone acetate,733.0,Osteoporosis,0
31983,norethindrone acetate,733.00,Osteoporosis NOS,0
31983,norethindrone acetate,V22.2,Pregnant state; incidental,0
31994,norgestimate,621.4,Hematometra,0
31994,norgestimate,626.0,Absence of menstruation,0
31994,norgestimate,628,Infertility; female,0
31994,norgestimate,628.9,Female infertility NOS,0
31994,norgestimate,780-789.99,,0
31994,norgestimate,V22.2,Pregnant state; incidental,0
32385,olsalazine,556,Ulcerative colitis,1
32385,olsalazine,556.8,Other ulcerative colitis,1
32385,olsalazine,556.9,Ulcerative colitis; unspecified,1
32592,oxaliplatin,140-239.99,,1
32592,oxaliplatin,153.9,Malignant neoplasm of colon; unspecified,1
32592,oxaliplatin,239,Neoplasms of unspecified nature,1
32592,oxaliplatin,239-239.99,,1
32592,oxaliplatin,239.0,Neoplasm of unspecified nature of digestive system,0
32613,oxaprozin,714.0,Rheumatoid arthritis,1
32613,oxaprozin,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
32613,oxaprozin,715.00,Osteoarthrosis; generalized; involving unspecified site,1
32613,oxaprozin,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
32613,oxaprozin,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
32613,oxaprozin,716.90,Arthropathy; unspecified; site unspecified,1
32613,oxaprozin,719.50,Stiffness of joint; not elsewhere classified; involving unspecified site,0
32624,oxcarbazepine,296.80,Bipolar disorder NOS,0
32624,oxcarbazepine,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
32624,oxcarbazepine,345.9,Epilepsy; unspecified,1
32624,oxcarbazepine,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
32624,oxcarbazepine,780.39,Other convulsions,1
32638,oxiconazole,110.3,Dermatophytosis of groin and perianal area,1
32638,oxiconazole,110.4,Dermatophytosis of foot,1
32638,oxiconazole,112.3,Candidiasis of skin and nails,0
32638,oxiconazole,686.9,Unspecified local infection of skin and subcutaneous tissue,0
32675,oxybutynin,596.51,Hypertonicity of bladder,1
32675,oxybutynin,596.54,Neurogenic bladder NOS,1
32675,oxybutynin,596.59,Other functional disorder of bladder,1
32675,oxybutynin,728.85,Spasm of muscle,0
32675,oxybutynin,741,Spina bifida,1
32675,oxybutynin,741.90,Spina bifida unspecified region without hydrocephalus,1
32675,oxybutynin,781.0,Abnormal involuntary movements,0
32675,oxybutynin,788.1,Dysuria,1
32675,oxybutynin,788.3,Urinary incontinence,1
32675,oxybutynin,788.30,Urinary incontinence NOS,1
32675,oxybutynin,788.31,Urge incontinence,1
32675,oxybutynin,788.41,Urinary frequency,0
32675,oxybutynin,788.63,Urgency of urination,0
32675,oxybutynin,788.69,Other abnormality of urination,0
32915,Teriparatide,733.0,Osteoporosis,1
32915,Teriparatide,733.00,Osteoporosis NOS,1
32915,Teriparatide,733.01,Senile osteoporosis,0
32915,Teriparatide,800-829.99,,0
32915,Teriparatide,829,Fracture of unspecified bones,0
32915,Teriparatide,829.0,Fracture of unspecified bone closed,0
32915,Teriparatide,E887,FRACTURE; CAUSE NOS,0
32926,paregoric,338-338.99,,0
32926,paregoric,555.9,Regional enteritis of unspecified site,0
32926,paregoric,780.96,Generalized pain,0
32926,paregoric,786.05,Shortness of breath,0
32926,paregoric,786.09,Other dyspnea and respiratory abnormality,0
32926,paregoric,787.7,Abnormal feces,0
32926,paregoric,787.91,Diarrhea,0
32937,Paroxetine,296.20,Major depressive disorder; single episode; unspecified degree,1
32937,Paroxetine,296.80,Bipolar disorder NOS,1
32937,Paroxetine,296.99,Other specified episodic mood disorder,1
32937,Paroxetine,300.01,Panic disorder without agoraphobia,1
32937,Paroxetine,300.02,Generalized anxiety disorder,1
32937,Paroxetine,300.2,Phobic disorders,1
32937,Paroxetine,300.20,Phobia unspecified,1
32937,Paroxetine,300.23,Social phobia,1
32937,Paroxetine,300.3,Obsessive-compulsive disorders,1
32937,Paroxetine,307.50,Eating disorder NOS,0
32937,Paroxetine,308.9,Unspecified acute reaction to stress,1
32937,Paroxetine,309.81,Posttraumatic stress disorder,1
32937,Paroxetine,311,Depressive disorder NEC,1
32937,Paroxetine,625.4,Premenstrual tension syndromes,1
32937,Paroxetine,627.2,Symptomatic menopausal or female climacteric states,1
32937,Paroxetine,780.97,Altered mental status,1
32937,Paroxetine,782.62,Flushing,1
32937,Paroxetine,783.9,Other symptoms concerning nutrition; metabolism; and development,1
32937,Paroxetine,797,Senility without mention of psychosis,1
32937,Paroxetine,799.89,Other ill-defined conditions,1
32968,clopidogrel,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
32968,clopidogrel,411.1,Intermediate coronary syndrome,1
32968,clopidogrel,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
32968,clopidogrel,440,Atherosclerosis,1
33055,pentaerythritol,413,Angina pectoris,0
33055,pentaerythritol,413.9,Other and unspecified angina pectoris,0
33055,pentaerythritol,786.50,Unspecified chest pain,0
33199,Permethrin,132.0,Pediculus capitis [head louse],1
33199,Permethrin,132.9,Pediculosis NOS,0
33199,Permethrin,133.0,Scabies,1
33253,phenacemide,345.40,Partial epilepsy without intractable epilepsy,0
33272,phendimetrazine,278.00,Obesity NOS,1
33283,phenindamine,477.9,Allergic rhinitis NOS,0
33283,phenindamine,708,Urticaria,0
33283,phenindamine,708.9,Unspecified urticaria,0
33290,phenol,338-338.99,,1
33290,phenol,462,Acute pharyngitis,1
33290,phenol,698.9,Unspecified pruritic disorder,0
33290,phenol,780.96,Generalized pain,1
33290,phenol,784.1,Throat pain,1
33309,phensuximide,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,0
33309,phensuximide,780.39,Other convulsions,0
33408,phenyltoloxamine,477.9,Allergic rhinitis NOS,0
33408,phenyltoloxamine,708,Urticaria,0
33408,phenyltoloxamine,708.9,Unspecified urticaria,0
33408,phenyltoloxamine,724.1,Pain in thoracic spine,0
33408,phenyltoloxamine,724.5,Backache unspecified,0
33408,phenyltoloxamine,786.2,Cough,0
33562,Foscarnet,054.1,Genital herpes,0
33562,Foscarnet,054.10,Genital herpes NOS,0
33562,Foscarnet,078.5,Cytomegaloviral disease,1
33562,Foscarnet,136.9,Unspecified infectious and parasitic diseases,1
33562,Foscarnet,363.20|078.5,,1
33656,physostigmine salicylate,365,Glaucoma,0
33656,physostigmine salicylate,365.9,Glaucoma NOS,0
33656,physostigmine salicylate,977.9,Poisoning by unspecified drug or medicinal substance,0
33738,pioglitazone,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
33738,pioglitazone,250.1,Diabetes with ketoacidosis,1
33738,pioglitazone,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
33738,pioglitazone,251.2,Hypoglycemia NOS,1
33738,pioglitazone,790.99,Other nonspecific findings on examination of blood,1
33747,estropipate,253.4,Other anterior pituitary disorders,1
33747,estropipate,256.31,Premature menopause,0
33747,estropipate,256.39,Other ovarian failure,1
33747,estropipate,626.2,Excessive or frequent menstruation,0
33747,estropipate,627.2,Symptomatic menopausal or female climacteric states,1
33747,estropipate,733.0,Osteoporosis,1
33747,estropipate,733.00,Osteoporosis NOS,1
33747,estropipate,733.01,Senile osteoporosis,1
33747,estropipate,782.62,Flushing,0
33767,pirbuterol,493,Asthma,1
33767,pirbuterol,493.9,Asthma; unspecified,1
33767,pirbuterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
33767,pirbuterol,519.11,Acute bronchospasm,1
33835,plasma protein fraction,785.50,Shock NOS,0
33910,Isradipine,401-405.99,,0
33910,Isradipine,401.9,Hypertension NOS,0
33910,Isradipine,413.1,Prinzmetal angina,0
33910,Isradipine,997.91,Hypertension,0
34132,pegaspargase,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
34132,pegaspargase,204.0,Lymphoid leukemia; acute,1
34132,pegaspargase,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
34132,pegaspargase,204.1,Lymphoid leukemia; chronic,0
34132,pegaspargase,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
34132,pegaspargase,205.10,Chronic myeloid leukemia without mention of having achieved remission,0
34296,potassium bicarbonate,276.8,Hypopotassemia,0
34322,potassium phosphate,275.3,Disorders of phosphorus metabolism,0
34322,potassium phosphate,276.8,Hypopotassemia,0
34345,pralidoxime,786.00,Respiratory abnormality; unspecified,1
34345,pralidoxime,977.9,Poisoning by unspecified drug or medicinal substance,0
34347,pramoxine,338-338.99,,0
34347,pramoxine,455,Hemorrhoids,0
34347,pramoxine,455.6,Hemorrhoids NOS,0
34347,pramoxine,565.0,Anal fissure,0
34347,pramoxine,569.41,Ulcer of anus and rectum,0
34347,pramoxine,692.9,Contact dermatitis and other eczema; unspecified cause,0
34347,pramoxine,698.9,Unspecified pruritic disorder,1
34347,pramoxine,780.96,Generalized pain,0
34347,pramoxine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
34347,pramoxine,782.1,Rash and other nonspecific skin eruption,0
34347,pramoxine,919.4,Insect bite; nonvenomous; of other; multiple; and unspecified sites; without mention of infection,0
34347,pramoxine,940-949.99,,0
34347,pramoxine,949.0,Burn of unspecified site; unspecified degree,0
34347,pramoxine,989.5,Toxic effect of venom,0
34369,prednicarbate,698.9,Unspecified pruritic disorder,0
34369,prednicarbate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
34372,prednisolone acetate,140-239.99,,0
34372,prednisolone acetate,239,Neoplasms of unspecified nature,0
34372,prednisolone acetate,239-239.99,,0
34372,prednisolone acetate,255.41,Glucocorticoid deficiency,0
34372,prednisolone acetate,280-289.99,,0
34372,prednisolone acetate,289.9,Blood disease NOS,0
34372,prednisolone acetate,372.30,Conjunctivitis NOS,0
34372,prednisolone acetate,569.9,Unspecified disorder of intestine,0
34372,prednisolone acetate,709.9,Unspecified disorder of skin and subcutaneous tissue,0
34372,prednisolone acetate,710.9,Unspecified diffuse connective tissue disease,0
34372,prednisolone acetate,729.0,Rheumatism; unspecified and fibrositis,0
34372,prednisolone acetate,782.3,Edema,0
34372,prednisolone acetate,995.3,Allergy unspecified not elsewhere classified,0
34482,Cilastatin / Imipenem,136.9,Unspecified infectious and parasitic diseases,1
34905,proparacaine,338-338.99,,0
34905,proparacaine,780.96,Generalized pain,0
35185,quazepam,307.42,Persistent disorder of initiating or maintaining sleep,0
35208,quinapril,250.4,Diabetes with renal manifestations,0
35208,quinapril,401-405.99,,1
35208,quinapril,401.9,Hypertension NOS,1
35208,quinapril,428,Heart failure,1
35208,quinapril,428.0,Congestive heart failure (CHF) NOS,1
35208,quinapril,428.9,Heart failure unspecified,1
35208,quinapril,429.3,Cardiomegaly,0
35208,quinapril,997.91,Hypertension,1
35220,quinidine gluconate,084.0,Falciparum malaria [malignant tertian],0
35220,quinidine gluconate,427,Cardiac dysrhythmias,0
35220,quinidine gluconate,427.1,Paroxysmal ventricular tachycardia,0
35220,quinidine gluconate,427.31,Atrial fibrillation,0
35220,quinidine gluconate,427.32,Atrial flutter,0
35220,quinidine gluconate,427.89,Other specified cardiac dysrhythmias,0
35220,quinidine gluconate,427.9,Cardiac dysrhythmia NOS,0
35255,Cisapride,530.81,Esophageal reflux,0
35255,Cisapride,536.3,Gastroparesis,0
35255,Cisapride,536.8,Dyspepsia and other specified disorders of function of stomach,0
35255,Cisapride,564.0,Constipation,0
35255,Cisapride,564.00,Constipation NOS,0
35296,Ramipril,250.4,Diabetes with renal manifestations,0
35296,Ramipril,401-405.99,,1
35296,Ramipril,401.9,Hypertension NOS,1
35296,Ramipril,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
35296,Ramipril,428,Heart failure,1
35296,Ramipril,428.0,Congestive heart failure (CHF) NOS,1
35296,Ramipril,428.9,Heart failure unspecified,1
35296,Ramipril,429.3,Cardiomegaly,0
35296,Ramipril,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
35296,Ramipril,791.0,Proteinuria,1
35296,Ramipril,997.91,Hypertension,1
35302,Sirolimus,279.5,Graft-versus-host disease,0
35302,Sirolimus,279.50,Graft-versus-host disease; unspecified,0
35382,resorcinol,695.3,Rosacea,0
35382,resorcinol,706.1,Other acne,0
35400,retinol acetate,264,Vitamin A deficiency,0
35400,retinol acetate,264.9,Vitamin A deficiency NOS,0
35400,retinol acetate,368.6,Night blindness,0
35400,retinol acetate,368.60,Night blindness NOS,0
35400,retinol acetate,372.53,Conjunctival xerosis,0
35400,retinol acetate,579,Intestinal malabsorption,0
35400,retinol acetate,579.9,Unspecified intestinal malabsorption,0
35400,retinol acetate,692.70,Unspecified dermatitis due to sun,0
35400,retinol acetate,692.9,Contact dermatitis and other eczema; unspecified cause,0
35406,retinyl palmitate,264,Vitamin A deficiency,0
35406,retinyl palmitate,264.9,Vitamin A deficiency NOS,0
35406,retinyl palmitate,368.6,Night blindness,0
35406,retinyl palmitate,368.60,Night blindness NOS,0
35406,retinyl palmitate,372.53,Conjunctival xerosis,0
35406,retinyl palmitate,579,Intestinal malabsorption,0
35406,retinyl palmitate,579.9,Unspecified intestinal malabsorption,0
35406,retinyl palmitate,692.70,Unspecified dermatitis due to sun,0
35406,retinyl palmitate,692.9,Contact dermatitis and other eczema; unspecified cause,0
35465,Rho(D) Immune Globulin,287.31,Immune thrombocytopenic purpura,1
35465,Rho(D) Immune Globulin,646.9,Unspecified complication of pregnancy,0
35465,Rho(D) Immune Globulin,646.90,Unspecified complication of pregnancy; unspecified as to episode of care,0
35465,Rho(D) Immune Globulin,656.10,Rhesus isoimmunization; unspecified as to episode of care in pregnancy,1
35465,Rho(D) Immune Globulin,773,Hemolytic disease of fetus or newborn; due to isoimmunization,1
35465,Rho(D) Immune Globulin,773.2,Hemolytic disease due to other and unspecified isoimmunization of fetus or newborn,1
35465,Rho(D) Immune Globulin,V22.2,Pregnant state; incidental,1
35617,rifapentine,011,Pulmonary tuberculosis,1
35617,rifapentine,011.9,Unspecified pulmonary tuberculosis,1
35617,rifapentine,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
35619,rifaximin,009.2,Infectious diarrhea,0
35619,rifaximin,572.2,Hepatic encephalopathy,1
35619,rifaximin,573.9,Unspecified disorder of liver,1
35619,rifaximin,780.60,Fever; unspecified,1
35623,Riluzole,335.20,Amyotrophic lateral sclerosis,1
35636,Risperidone,290,Dementias,1
35636,Risperidone,294.2,,1
35636,Risperidone,294.20,Dementia; unspecified; without behavioral disturbance,1
35636,Risperidone,295,Schizophrenic disorders,1
35636,Risperidone,295.9,Unspecified schizophrenia,1
35636,Risperidone,295.90,Unspecified schizophrenia; unspecified state,1
35636,Risperidone,296.00,Manic disorder; single episode; unspecified degree,1
35636,Risperidone,296.80,Bipolar disorder NOS,1
35636,Risperidone,299.0,Autistic disorder,1
35636,Risperidone,299.00,Infantile autism; current or active state,1
35636,Risperidone,307.23,Tourette's disorder,0
35636,Risperidone,311,Depressive disorder NEC,0
35636,Risperidone,312.9,Unspecified disturbance of conduct,0
35636,Risperidone,780-789.99,,0
35636,Risperidone,799.22,Irritability (ADDED),1
35636,Risperidone,799.24,Emotional lability (ADDED),1
35636,Risperidone,799.89,Other ill-defined conditions,1
35780,ropivacaine,338-338.99,,1
35780,ropivacaine,338.18,Other acute postoperative pain,0
35780,ropivacaine,780.96,Generalized pain,1
35825,ganirelix,256.1,Other ovarian hyperfunction,1
35827,Ketorolac,338-338.99,,1
35827,Ketorolac,368.13,Visual discomfort,1
35827,Ketorolac,372.14,Other chronic allergic conjunctivitis,1
35827,Ketorolac,379.91,Pain in or around eye,1
35827,Ketorolac,379.99,Other ill-defined disorders of eye,1
35827,Ketorolac,698.9,Unspecified pruritic disorder,1
35827,Ketorolac,780.96,Generalized pain,1
35829,ranolazine,413,Angina pectoris,1
35829,ranolazine,413.9,Other and unspecified angina pectoris,1
35829,ranolazine,786.50,Unspecified chest pain,1
36108,Salsalate,338-338.99,,0
36108,Salsalate,714.0,Rheumatoid arthritis,1
36108,Salsalate,715.00,Osteoarthrosis; generalized; involving unspecified site,1
36108,Salsalate,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
36108,Salsalate,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
36108,Salsalate,716.90,Arthropathy; unspecified; site unspecified,1
36108,Salsalate,780.60,Fever; unspecified,0
36108,Salsalate,780.96,Generalized pain,0
36117,salmeterol,491,Chronic bronchitis,1
36117,salmeterol,491.9,Chronic bronchitis NOS,1
36117,salmeterol,493,Asthma,1
36117,salmeterol,493.81,Exercise induced bronchospasm,0
36117,salmeterol,493.9,Asthma; unspecified,1
36117,salmeterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
36117,salmeterol,496,Chronic airway obstruction; not elsewhere classified,1
36117,salmeterol,518.89,Other diseases of lung; not elsewhere classified,1
36117,salmeterol,519.11,Acute bronchospasm,1
36117,salmeterol,786.05,Shortness of breath,1
36117,salmeterol,786.09,Other dyspnea and respiratory abnormality,1
36117,salmeterol,796.4,Other abnormal clinical findings,1
36118,salmon calcitonin,275.42,Hypercalcemia,0
36118,salmon calcitonin,731.0,Osteitis deformans without mention of bone tumor,0
36118,salmon calcitonin,733.0,Osteoporosis,1
36118,salmon calcitonin,733.00,Osteoporosis NOS,1
36118,salmon calcitonin,733.01,Senile osteoporosis,1
36118,salmon calcitonin,756.51,Osteogenesis imperfecta,0
36122,phenyl salicylate,338-338.99,,0
36122,phenyl salicylate,780.96,Generalized pain,0
36345,selenium sulfide,111,Dermatomycosis; other and unspecified,0
36345,selenium sulfide,111.0,Pityriasis versicolor,0
36345,selenium sulfide,111.9,Dermatomycosis NOS,0
36345,selenium sulfide,690.1,Seborrheic dermatitis,0
36345,selenium sulfide,690.10,Seborheic dermatitis; unspecified,0
36345,selenium sulfide,690.18,Other seborrheic dermatitis,0
36345,selenium sulfide,695.89,Other specified erythematous conditions,0
36345,selenium sulfide,698.9,Unspecified pruritic disorder,0
36345,selenium sulfide,706.3,Seborrhea,0
36345,selenium sulfide,709.9,Unspecified disorder of skin and subcutaneous tissue,0
36387,sennosides  USP,564.0,Constipation,1
36387,sennosides  USP,564.00,Constipation NOS,1
36435,sertaconazole,110.4,Dermatophytosis of foot,1
36437,Sertraline,296.20,Major depressive disorder; single episode; unspecified degree,1
36437,Sertraline,296.99,Other specified episodic mood disorder,1
36437,Sertraline,300.00,Anxiety state unspecified,1
36437,Sertraline,300.01,Panic disorder without agoraphobia,1
36437,Sertraline,300.23,Social phobia,1
36437,Sertraline,300.29,Other isolated or specific phobias,1
36437,Sertraline,300.3,Obsessive-compulsive disorders,1
36437,Sertraline,300.9,Unspecified nonpsychotic mental disorder,1
36437,Sertraline,301.4,Obsessive-compulsive personality disorder,1
36437,Sertraline,307.50,Eating disorder NOS,0
36437,Sertraline,308.9,Unspecified acute reaction to stress,1
36437,Sertraline,309.81,Posttraumatic stress disorder,1
36437,Sertraline,309.89,Other specified adjustment reactions,1
36437,Sertraline,311,Depressive disorder NEC,1
36437,Sertraline,611.79,Other signs and symptoms in breast,1
36437,Sertraline,625.4,Premenstrual tension syndromes,1
36437,Sertraline,780-789.99,,0
36437,Sertraline,780.4,Dizziness and giddiness,1
36437,Sertraline,780.79,Other malaise and fatigue,1
36437,Sertraline,780.97,Altered mental status,1
36437,Sertraline,781.0,Abnormal involuntary movements,1
36437,Sertraline,784.0,Headache,1
36437,Sertraline,785.1,Palpitations,1
36437,Sertraline,799.22,Irritability (ADDED),1
36437,Sertraline,799.89,Other ill-defined conditions,1
36437,Sertraline,799.9,Other unknown and unspecified cause of morbidity or mortality,1
36514,sibutramine,278.00,Obesity NOS,1
36514,sibutramine,783.21,Loss of weight,1
36514,sibutramine,783.9,Other symptoms concerning nutrition; metabolism; and development,1
36567,Simvastatin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
36567,Simvastatin,272.0,Pure hypercholesterolemia,1
36567,Simvastatin,272.1,Pure hyperglyceridemia,1
36567,Simvastatin,272.4,Other and unspecified hyperlipidemia,1
36567,Simvastatin,272.8,Other disorders of lipoid metabolism,1
36567,Simvastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
36567,Simvastatin,429.2,Cardiovascular disease [ASCVD],1
36567,Simvastatin,429.9,Heart disease NOS,1
36567,Simvastatin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
36567,Simvastatin,440,Atherosclerosis,1
36567,Simvastatin,447.9,Unspecified disorders of arteries and arterioles,1
36567,Simvastatin,459.9,Unspecified circulatory system disorder,1
36567,Simvastatin,783.21,Loss of weight,0
36567,Simvastatin,783.9,Other symptoms concerning nutrition; metabolism; and development,0
36567,Simvastatin,799.9,Other unknown and unspecified cause of morbidity or mortality,1
36676,Sodium Bicarbonate,276.2,Acidosis,1
36676,Sodium Bicarbonate,276.51,Dehydration,1
36676,Sodium Bicarbonate,276.7,Hyperpotassemia,0
36676,Sodium Bicarbonate,427.5,Cardiac arrest,1
36676,Sodium Bicarbonate,530.81,Esophageal reflux,0
36676,Sodium Bicarbonate,536.8,Dyspepsia and other specified disorders of function of stomach,0
36676,Sodium Bicarbonate,588.89,Other specified disorders resulting from impaired renal function,0
36676,Sodium Bicarbonate,698.9,Unspecified pruritic disorder,0
36676,Sodium Bicarbonate,787.1,Heartburn,0
36676,Sodium Bicarbonate,787.7,Abnormal feces,1
36676,Sodium Bicarbonate,787.91,Diarrhea,1
36676,Sodium Bicarbonate,977.9,Poisoning by unspecified drug or medicinal substance,0
36676,Sodium Bicarbonate,V62.81,Interpersonal problems; not elsewhere classified,0
36709,sodium phosphate,275.3,Disorders of phosphorus metabolism,0
36709,sodium phosphate,45.23,Colonoscopy,0
36726,sodium thiosulfate,111.0,Pityriasis versicolor,0
36726,sodium thiosulfate,977.9,Poisoning by unspecified drug or medicinal substance,0
36726,sodium thiosulfate,985.1,Toxic effect of arsenic and its compounds,0
37075,Ethinyl Estradiol / Norgestrel,706.1,Other acne,0
37075,Ethinyl Estradiol / Norgestrel,V22.2,Pregnant state; incidental,1
37319,sulconazole,110.3,Dermatophytosis of groin and perianal area,1
37319,sulconazole,110.4,Dermatophytosis of foot,1
37319,sulconazole,111.0,Pityriasis versicolor,1
37319,sulconazole,112.3,Candidiasis of skin and nails,0
37319,sulconazole,686.9,Unspecified local infection of skin and subcutaneous tissue,0
37320,sulfabenzamide,616.10,Vaginitis and vulvovaginitis NOS,0
37418,Sumatriptan,339.00,Cluster headache syndrome; unspecified,1
37418,Sumatriptan,339.02,Chronic cluster headache,1
37418,Sumatriptan,346,Migraine,1
37418,Sumatriptan,346.9,Migraine; unspecified,1
37418,Sumatriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
37418,Sumatriptan,784.0,Headache,1
37776,temozolomide,140-239.99,,1
37776,temozolomide,172.9,Melanoma of skin; site unspecified,1
37776,temozolomide,191.9,Malignant neoplasm of brain; unspecified,1
37776,temozolomide,239,Neoplasms of unspecified nature,1
37776,temozolomide,239-239.99,,1
37776,temozolomide,239.6,Neoplasm of unspecified nature of brain,0
37798,Terazosin,401-405.99,,1
37798,Terazosin,401.9,Hypertension NOS,1
37798,Terazosin,600,Hyperplasia of prostate,1
37798,Terazosin,600.0,Hypertrophy (benign) of prostate,0
37798,Terazosin,600.9,Hyperplasia of prostate; unspecified,1
37798,Terazosin,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),1
37798,Terazosin,780-789.99,,0
37798,Terazosin,788.2,Retention of urine,0
37798,Terazosin,788.20,Retention of urine NOS,0
37798,Terazosin,997.91,Hypertension,1
37801,terbinafine,110.0,Dermatophytosis of scalp and beard,1
37801,terbinafine,110.1,Dermatophytosis of nail,1
37801,terbinafine,110.3,Dermatophytosis of groin and perianal area,1
37801,terbinafine,110.4,Dermatophytosis of foot,1
37801,terbinafine,110.5,Dermatophytosis of the body,1
37801,terbinafine,111.0,Pityriasis versicolor,1
37801,terbinafine,112.3,Candidiasis of skin and nails,0
37801,terbinafine,686.9,Unspecified local infection of skin and subcutaneous tissue,1
37806,terconazole,110-118.99,,0
37806,terconazole,112.1,Candidiasis of vulva and vagina,1
37806,terconazole,117.9,Other and unspecified mycoses,0
37806,terconazole,616.10,Vaginitis and vulvovaginitis NOS,1
37859,testosterone enanthate,174.9,Malignant neoplasm of breast (female); unspecified,1
37859,testosterone enanthate,239.3,Neoplasm of unspecified nature of breast,0
37859,testosterone enanthate,253.4,Other anterior pituitary disorders,1
37859,testosterone enanthate,257.2,Other testicular hypofunction,1
37859,testosterone enanthate,259.0,Delay in sexual development and puberty NEC,1
37859,testosterone enanthate,797,Senility without mention of psychosis,1
37859,testosterone enanthate,V21.1,Puberty,1
37925,orlistat,250,Diabetes mellitus,1
37925,orlistat,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
37925,orlistat,278.00,Obesity NOS,1
37925,orlistat,401-405.99,,1
37925,orlistat,401.9,Hypertension NOS,1
37925,orlistat,783.21,Loss of weight,1
37925,orlistat,783.9,Other symptoms concerning nutrition; metabolism; and development,1
37925,orlistat,997.91,Hypertension,1
37935,tetrahydrozoline,461.9,Acute sinusitis NOS,0
37935,tetrahydrozoline,477.9,Allergic rhinitis NOS,0
37935,tetrahydrozoline,695.9,Unspecified erythematous condition,0
38298,tioconazole,110.4,Dermatophytosis of foot,0
38298,tioconazole,112.1,Candidiasis of vulva and vagina,0
38400,atomoxetine,300.9,Unspecified nonpsychotic mental disorder,1
38400,atomoxetine,314,Hyperkinetic syndrome of childhood,1
38400,atomoxetine,314.01,Attention deficit disorder of childhood with hyperactivity,1
38400,atomoxetine,314.9,Unspecified hyperkinetic syndrome of childhood,1
38404,topiramate,296.80,Bipolar disorder NOS,0
38404,topiramate,303,Alcohol dependence syndrome,0
38404,topiramate,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
38404,topiramate,305.01,Alcohol abuse; continuous drinking behavior,0
38404,topiramate,315.9,Unspecified delay in development,0
38404,topiramate,338-338.99,,0
38404,topiramate,339.00,Cluster headache syndrome; unspecified,1
38404,topiramate,339.02,Chronic cluster headache,1
38404,topiramate,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
38404,topiramate,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
38404,topiramate,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
38404,topiramate,345.6,Infantile spasms,0
38404,topiramate,345.60,Infantile spasms; without mention of intractable epilepsy,0
38404,topiramate,345.9,Epilepsy; unspecified,1
38404,topiramate,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
38404,topiramate,346,Migraine,1
38404,topiramate,346.9,Migraine; unspecified,1
38404,topiramate,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
38404,topiramate,780.39,Other convulsions,1
38404,topiramate,780.96,Generalized pain,0
38409,Toremifene,174.9,Malignant neoplasm of breast (female); unspecified,1
38409,Toremifene,239.3,Neoplasm of unspecified nature of breast,0
38413,torsemide,401-405.99,,1
38413,torsemide,401.9,Hypertension NOS,1
38413,torsemide,428.0,Congestive heart failure (CHF) NOS,1
38413,torsemide,514,Pulmonary congestion and hypostasis,0
38413,torsemide,571.5,Cirrhosis of liver without mention of alcohol,0
38413,torsemide,573.9,Unspecified disorder of liver,1
38413,torsemide,581,Nephrotic syndrome,0
38413,torsemide,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
38413,torsemide,584,Acute renal failure,0
38413,torsemide,584.9,Acute renal failure NOS,0
38413,torsemide,585.6,End stage renal disease,1
38413,torsemide,585.9,Chronic kidney disease; unspecified,1
38413,torsemide,586,Renal failure unspecified,1
38413,torsemide,782.3,Edema,1
38413,torsemide,789.5,Ascites,0
38413,torsemide,789.59,Other ascites,0
38413,torsemide,997.91,Hypertension,1
38454,trandolapril,250.4,Diabetes with renal manifestations,0
38454,trandolapril,401-405.99,,1
38454,trandolapril,401.9,Hypertension NOS,1
38454,trandolapril,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
38454,trandolapril,428,Heart failure,1
38454,trandolapril,428.0,Congestive heart failure (CHF) NOS,1
38454,trandolapril,428.9,Heart failure unspecified,1
38454,trandolapril,429.3,Cardiomegaly,0
38454,trandolapril,997.91,Hypertension,1
38546,triamcinolone hexacetonide,255.41,Glucocorticoid deficiency,0
38546,triamcinolone hexacetonide,477.9,Allergic rhinitis NOS,0
38546,triamcinolone hexacetonide,493,Asthma,0
38546,triamcinolone hexacetonide,493.9,Asthma; unspecified,0
38546,triamcinolone hexacetonide,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
38546,triamcinolone hexacetonide,519.11,Acute bronchospasm,0
38546,triamcinolone hexacetonide,709.9,Unspecified disorder of skin and subcutaneous tissue,0
38546,triamcinolone hexacetonide,710.0,Systemic lupus erythematosus,0
38546,triamcinolone hexacetonide,716.90,Arthropathy; unspecified; site unspecified,1
38546,triamcinolone hexacetonide,729.0,Rheumatism; unspecified and fibrositis,0
38574,trichloroacetaldehyde,291.81,Alcohol withdrawal,1
38574,trichloroacetaldehyde,300.00,Anxiety state unspecified,1
38574,trichloroacetaldehyde,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
38574,trichloroacetaldehyde,308.2,Predominant psychomotor disturbance,0
38574,trichloroacetaldehyde,780.52,Insomnia; unspecified,1
38574,trichloroacetaldehyde,799.21,Nervousness (ADDED),0
38578,trichlorofluoromethane,338-338.99,,0
38578,trichlorofluoromethane,780.96,Generalized pain,0
38685,trimethobenzamide,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
38685,trimethobenzamide,787.02,Nausea alone,1
38685,trimethobenzamide,787.03,Vomiting alone,1
38782,Triptorelin,185,Malignant neoplasm of prostate,1
38866,trolamine salicylate,338-338.99,,0
38866,trolamine salicylate,780.96,Generalized pain,0
38891,trospium chloride,596.51,Hypertonicity of bladder,1
38891,trospium chloride,788.41,Urinary frequency,1
38891,trospium chloride,788.69,Other abnormality of urination,1
39171,Brimonidine tartrate,365,Glaucoma,1
39171,Brimonidine tartrate,365.04,Ocular hypertension,1
39171,Brimonidine tartrate,365.1,Open-angle glaucoma,0
39171,Brimonidine tartrate,365.10,Open-angle glaucoma NOS,0
39171,Brimonidine tartrate,365.13,Pigmentary glaucoma,0
39171,Brimonidine tartrate,365.9,Glaucoma NOS,1
39541,vinorelbine,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
39541,vinorelbine,174.9,Malignant neoplasm of breast (female); unspecified,1
39541,vinorelbine,201,Hodgkin's disease,0
39541,vinorelbine,201.0,Hodgkin's paragranuloma,0
39541,vinorelbine,201.1,Hodgkin's granuloma,0
39541,vinorelbine,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
39541,vinorelbine,201.2,Hodgkin's sarcoma,0
39541,vinorelbine,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
39541,vinorelbine,201.9,Hodgkin's disease; unspecified type,0
39541,vinorelbine,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
39541,vinorelbine,239.3,Neoplasm of unspecified nature of breast,0
39541,vinorelbine,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
39625,Tocopherol Acetate,269.1,Deficiency of other vitamins,0
39625,Tocopherol Acetate,283.9,Acquired hemolytic anemia; unspecified,0
39625,Tocopherol Acetate,331.0,Alzheimer's disease,0
39625,Tocopherol Acetate,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
39625,Tocopherol Acetate,770.7,Chronic respiratory disease arising in the perinatal period,0
39684,epinastine,372.14,Other chronic allergic conjunctivitis,1
39786,venlafaxine,296.20,Major depressive disorder; single episode; unspecified degree,1
39786,venlafaxine,299.0,Autistic disorder,0
39786,venlafaxine,299.00,Infantile autism; current or active state,0
39786,venlafaxine,300.00,Anxiety state unspecified,1
39786,venlafaxine,300.01,Panic disorder without agoraphobia,1
39786,venlafaxine,300.02,Generalized anxiety disorder,1
39786,venlafaxine,300.23,Social phobia,1
39786,venlafaxine,300.3,Obsessive-compulsive disorders,0
39786,venlafaxine,311,Depressive disorder NEC,1
39786,venlafaxine,314,Hyperkinetic syndrome of childhood,0
39786,venlafaxine,314.01,Attention deficit disorder of childhood with hyperactivity,0
39786,venlafaxine,314.9,Unspecified hyperkinetic syndrome of childhood,0
39786,venlafaxine,338-338.99,,1
39786,venlafaxine,627.2,Symptomatic menopausal or female climacteric states,1
39786,venlafaxine,780.50,Unspecified sleep disturbance,1
39786,venlafaxine,780.71,Chronic fatigue syndrome,0
39786,venlafaxine,780.79,Other malaise and fatigue,1
39786,venlafaxine,780.8,Generalized hyperhidrosis,1
39786,venlafaxine,780.96,Generalized pain,1
39786,venlafaxine,782.62,Flushing,1
39937,zinc chloride,460,Acute nasopharyngitis (common cold),0
39937,zinc chloride,707.9,Chronic ulcer of unspecified site,0
39937,zinc chloride,709.8,Other specified disorders of skin,0
39952,zinc pyrithione,690.1,Seborrheic dermatitis,0
39952,zinc pyrithione,690.10,Seborheic dermatitis; unspecified,1
39952,zinc pyrithione,706.3,Seborrhea,0
39952,zinc pyrithione,709.9,Unspecified disorder of skin and subcutaneous tissue,0
39954,Zinc Sulfate,460,Acute nasopharyngitis (common cold),0
39954,Zinc Sulfate,707.9,Chronic ulcer of unspecified site,0
39954,Zinc Sulfate,709.8,Other specified disorders of skin,0
39954,Zinc Sulfate,743,Congenital anomalies of eye,0
39954,Zinc Sulfate,743.9,Unspecified anomaly of eye; congenital,0
39993,zolpidem,780.50,Unspecified sleep disturbance,0
39993,zolpidem,780.52,Insomnia; unspecified,1
39998,zonisamide,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
39998,zonisamide,780.39,Other convulsions,1
40001,zopiclone,780.52,Insomnia; unspecified,1
40028,Anistreplase,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
40028,Anistreplase,415.19,Other pulmonary embolism and infarction,0
40048,Carboplatin,140-239.99,,1
40048,Carboplatin,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
40048,Carboplatin,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
40048,Carboplatin,186,Malignant neoplasm of testis,1
40048,Carboplatin,186.9,Malignant neoplasm of other and unspecified testis,1
40048,Carboplatin,188,Malignant neoplasm of bladder,1
40048,Carboplatin,188.9,Malignant neoplasm of bladder; part unspecified,1
40048,Carboplatin,190.5,Malignant neoplasm of retina,1
40048,Carboplatin,195.0,Malignant neoplasm of head; face; and neck,1
40048,Carboplatin,239,Neoplasms of unspecified nature,1
40048,Carboplatin,239-239.99,,1
40048,Carboplatin,239.0,Neoplasm of unspecified nature of digestive system,0
40048,Carboplatin,239.1,Neoplasm of unspecified nature of respiratory system,0
40048,Carboplatin,239.3,Neoplasm of unspecified nature of breast,0
40048,Carboplatin,239.4,Neoplasm of unspecified nature of bladder,0
40048,Carboplatin,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
40048,Carboplatin,239.6,Neoplasm of unspecified nature of brain,1
40048,Carboplatin,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
40048,Carboplatin,289.9,Blood disease NOS,0
40114,Guanfacine,314,Hyperkinetic syndrome of childhood,1
40114,Guanfacine,314.01,Attention deficit disorder of childhood with hyperactivity,1
40114,Guanfacine,314.9,Unspecified hyperkinetic syndrome of childhood,1
40114,Guanfacine,401-405.99,,1
40114,Guanfacine,401.9,Hypertension NOS,1
40114,Guanfacine,780-789.99,,0
40114,Guanfacine,997.91,Hypertension,1
40138,Iloprost,401-405.99,,1
40138,Iloprost,401.9,Hypertension NOS,1
40138,Iloprost,416.0,Primary pulmonary hypertension,1
40138,Iloprost,997.91,Hypertension,1
40144,Levothyroxine Sodium,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
40144,Levothyroxine Sodium,240-246.99,,1
40144,Levothyroxine Sodium,240.9,Goiter NOS,1
40144,Levothyroxine Sodium,242,Thyrotoxicosis with or without goiter,0
40144,Levothyroxine Sodium,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
40144,Levothyroxine Sodium,243,Congenital hypothyroidism,1
40144,Levothyroxine Sodium,244.9,Hypothyroidism NOS,1
40144,Levothyroxine Sodium,245.2,Chronic lymphocytic thyroiditis,1
40144,Levothyroxine Sodium,246.9,Unspecified disorder of thyroid,1
40169,Moricizine,427,Cardiac dysrhythmias,1
40169,Moricizine,427.1,Paroxysmal ventricular tachycardia,1
40169,Moricizine,427.41,Ventricular fibrillation,0
40169,Moricizine,427.69,Other premature beats,1
40169,Moricizine,427.9,Cardiac dysrhythmia NOS,1
40254,Valproate,296.00,Manic disorder; single episode; unspecified degree,1
40254,Valproate,296.80,Bipolar disorder NOS,1
40254,Valproate,331.0,Alzheimer's disease,0
40254,Valproate,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
40254,Valproate,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
40254,Valproate,345.40,Partial epilepsy without intractable epilepsy,0
40254,Valproate,345.9,Epilepsy; unspecified,1
40254,Valproate,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
40254,Valproate,346,Migraine,1
40254,Valproate,346.9,Migraine; unspecified,1
40254,Valproate,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
40254,Valproate,780.39,Other convulsions,1
40254,Valproate,799.24,Emotional lability (ADDED),1
40254,Valproate,799.89,Other ill-defined conditions,1
40254,Valproate,799.9,Other unknown and unspecified cause of morbidity or mortality,0
40575,zileuton,493,Asthma,1
40575,zileuton,493.9,Asthma; unspecified,1
40575,zileuton,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
40790,pantoprazole,251.5,Abnormality of secretion of gastrin,0
40790,pantoprazole,530.1,Esophagitis,1
40790,pantoprazole,530.10,Esophagitis; unspecified,1
40790,pantoprazole,530.81,Esophageal reflux,1
40790,pantoprazole,787.1,Heartburn,1
40968,diclofenac epolamine,338-338.99,,0
40968,diclofenac epolamine,780.96,Generalized pain,0
41126,fluticasone,471,Nasal polyps,0
41126,fluticasone,471.0,Polyp of nasal cavity,0
41126,fluticasone,471.9,Nasal polyp NOS,0
41126,fluticasone,477.9,Allergic rhinitis NOS,0
41126,fluticasone,493,Asthma,1
41126,fluticasone,493.9,Asthma; unspecified,1
41126,fluticasone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
41126,fluticasone,692.9,Contact dermatitis and other eczema; unspecified cause,1
41126,fluticasone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
41127,fluvastatin,272.1,Pure hyperglyceridemia,0
41127,fluvastatin,272.4,Other and unspecified hyperlipidemia,1
41127,fluvastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
41127,fluvastatin,429.2,Cardiovascular disease [ASCVD],1
41127,fluvastatin,429.9,Heart disease NOS,1
41127,fluvastatin,440,Atherosclerosis,1
41127,fluvastatin,447.9,Unspecified disorders of arteries and arterioles,1
41208,halobetasol,698.9,Unspecified pruritic disorder,0
41208,halobetasol,709.9,Unspecified disorder of skin and subcutaneous tissue,1
41289,ibutilide,427,Cardiac dysrhythmias,1
41289,ibutilide,427.31,Atrial fibrillation,1
41289,ibutilide,427.32,Atrial flutter,1
41289,ibutilide,427.9,Cardiac dysrhythmia NOS,1
41493,meloxicam,714.0,Rheumatoid arthritis,1
41493,meloxicam,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
41493,meloxicam,715.00,Osteoarthrosis; generalized; involving unspecified site,1
41493,meloxicam,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
41493,meloxicam,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
41493,meloxicam,716.90,Arthropathy; unspecified; site unspecified,1
41493,meloxicam,780.60,Fever; unspecified,0
41875,quinidine polygalacturonate,084.0,Falciparum malaria [malignant tertian],0
41875,quinidine polygalacturonate,427,Cardiac dysrhythmias,0
41875,quinidine polygalacturonate,427.1,Paroxysmal ventricular tachycardia,0
41875,quinidine polygalacturonate,427.31,Atrial fibrillation,0
41875,quinidine polygalacturonate,427.32,Atrial flutter,0
41875,quinidine polygalacturonate,427.89,Other specified cardiac dysrhythmias,0
41875,quinidine polygalacturonate,427.9,Cardiac dysrhythmia NOS,0
42316,Tacrolimus,279.5,Graft-versus-host disease,0
42316,Tacrolimus,279.50,Graft-versus-host disease; unspecified,0
42316,Tacrolimus,691.8,Other atopic dermatitis,1
42316,Tacrolimus,692.9,Contact dermatitis and other eczema; unspecified cause,1
42319,Nizatidine,251.5,Abnormality of secretion of gastrin,0
42319,Nizatidine,530.11,Reflux esophagitis,0
42319,Nizatidine,530.81,Esophageal reflux,1
42319,Nizatidine,531,Gastric ulcer,1
42319,Nizatidine,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
42319,Nizatidine,532,Duodenal ulcer,1
42319,Nizatidine,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
42319,Nizatidine,536.8,Dyspepsia and other specified disorders of function of stomach,1
42319,Nizatidine,578,Gastrointestinal hemorrhage,0
42319,Nizatidine,578.9,Hemorrhage of gastrointestinal tract NOS,0
42319,Nizatidine,708,Urticaria,0
42319,Nizatidine,708.9,Unspecified urticaria,0
42319,Nizatidine,787.1,Heartburn,1
42328,Astemizole,372.14,Other chronic allergic conjunctivitis,0
42328,Astemizole,477.9,Allergic rhinitis NOS,0
42328,Astemizole,708,Urticaria,0
42328,Astemizole,708.9,Unspecified urticaria,0
42331,Misoprostol,338-338.99,,1
42331,Misoprostol,531,Gastric ulcer,1
42331,Misoprostol,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
42331,Misoprostol,707.9,Chronic ulcer of unspecified site,1
42331,Misoprostol,780.96,Generalized pain,1
42333,Trimetrexate,136.3,Pneumocystosis,1
42347,Bupropion,296.20,Major depressive disorder; single episode; unspecified degree,1
42347,Bupropion,296.99,Other specified episodic mood disorder,1
42347,Bupropion,305.1,Tobacco use disorder,0
42347,Bupropion,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
42347,Bupropion,308.2,Predominant psychomotor disturbance,1
42347,Bupropion,311,Depressive disorder NEC,1
42347,Bupropion,314,Hyperkinetic syndrome of childhood,0
42347,Bupropion,314.01,Attention deficit disorder of childhood with hyperactivity,0
42347,Bupropion,314.9,Unspecified hyperkinetic syndrome of childhood,0
42347,Bupropion,780.39,Other convulsions,1
42347,Bupropion,780.54,Hypersomnia; unspecified,1
42347,Bupropion,780.79,Other malaise and fatigue,1
42347,Bupropion,780.97,Altered mental status,1
42347,Bupropion,799.21,Nervousness (ADDED),1
42351,Lithium Carbonate,296.00,Manic disorder; single episode; unspecified degree,1
42351,Lithium Carbonate,296.80,Bipolar disorder NOS,0
42351,Lithium Carbonate,300.9,Unspecified nonpsychotic mental disorder,0
42351,Lithium Carbonate,308.9,Unspecified acute reaction to stress,0
42351,Lithium Carbonate,309.81,Posttraumatic stress disorder,0
42351,Lithium Carbonate,311,Depressive disorder NEC,1
42351,Lithium Carbonate,312.9,Unspecified disturbance of conduct,0
42351,Lithium Carbonate,799.89,Other ill-defined conditions,1
42351,Lithium Carbonate,799.9,Other unknown and unspecified cause of morbidity or mortality,0
42355,Fluvoxamine,300.01,Panic disorder without agoraphobia,0
42355,Fluvoxamine,300.23,Social phobia,0
42355,Fluvoxamine,300.3,Obsessive-compulsive disorders,1
42355,Fluvoxamine,311,Depressive disorder NEC,0
42359,Tocainide,350.1,Trigeminal neuralgia,0
42359,Tocainide,427,Cardiac dysrhythmias,0
42359,Tocainide,427.9,Cardiac dysrhythmia NOS,0
42368,Encainide,427,Cardiac dysrhythmias,0
42368,Encainide,427.9,Cardiac dysrhythmia NOS,0
42372,Mupirocin,684,Impetigo,1
42375,Leuprolide,185,Malignant neoplasm of prostate,1
42375,Leuprolide,218,Uterine leiomyoma,1
42375,Leuprolide,218.9,Uterine leiomyoma NOS,1
42375,Leuprolide,239.3,Neoplasm of unspecified nature of breast,0
42375,Leuprolide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
42375,Leuprolide,259.1,Precocious sexual development and puberty NEC,1
42375,Leuprolide,285.9,Anemia unspecified,1
42375,Leuprolide,338-338.99,,1
42375,Leuprolide,600,Hyperplasia of prostate,0
42375,Leuprolide,600.9,Hyperplasia of prostate; unspecified,0
42375,Leuprolide,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),0
42375,Leuprolide,617,Endometriosis,1
42375,Leuprolide,617.9,Endometriosis; site unspecified,1
42375,Leuprolide,780.96,Generalized pain,1
42375,Leuprolide,V21.1,Puberty,1
42386,Immunoglobulins  Intravenous,038.9,Septicemia NOS,1
42386,Immunoglobulins  Intravenous,042,Human immunodeficiency virus [HIV] disease,1
42386,Immunoglobulins  Intravenous,042-042.99,,1
42386,Immunoglobulins  Intravenous,078.5,Cytomegaloviral disease,0
42386,Immunoglobulins  Intravenous,079.6,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0
42386,Immunoglobulins  Intravenous,136.9,Unspecified infectious and parasitic diseases,1
42386,Immunoglobulins  Intravenous,204.1,Lymphoid leukemia; chronic,0
42386,Immunoglobulins  Intravenous,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
42386,Immunoglobulins  Intravenous,279.00,Hypogammaglobulinemia unspecified,1
42386,Immunoglobulins  Intravenous,279.04,Congenital hypogammaglobulinemia,1
42386,Immunoglobulins  Intravenous,279.06,Common variable immunodeficiency,1
42386,Immunoglobulins  Intravenous,279.3,Unspecified immunity deficiency,1
42386,Immunoglobulins  Intravenous,283.0,Autoimmune hemolytic anemias,0
42386,Immunoglobulins  Intravenous,287.2,Other nonthrombocytopenic purpuras,1
42386,Immunoglobulins  Intravenous,287.31,Immune thrombocytopenic purpura,1
42386,Immunoglobulins  Intravenous,288.0,Agranulocytosis,0
42386,Immunoglobulins  Intravenous,288.00,Neutropenia NOS,0
42386,Immunoglobulins  Intravenous,356.9,Unspecified idiopathic peripheral neuropathy,1
42386,Immunoglobulins  Intravenous,357.0,Acute infective polyneuritis,0
42386,Immunoglobulins  Intravenous,357.89,Other inflammatory and toxic neuropathy,1
42386,Immunoglobulins  Intravenous,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
42386,Immunoglobulins  Intravenous,614-616.99,,1
42386,Immunoglobulins  Intravenous,614.9,Unspecified inflammatory disease of female pelvic organs and tissues,1
42386,Immunoglobulins  Intravenous,710.3,Dermatomyositis,0
42386,Immunoglobulins  Intravenous,782.7,Spontaneous ecchymoses,1
42386,Immunoglobulins  Intravenous,995.91,Sepsis,0
42405,Muromonab-CD3,279.5,Graft-versus-host disease,0
42405,Muromonab-CD3,279.50,Graft-versus-host disease; unspecified,0
42463,Pravastatin,272.1,Pure hyperglyceridemia,1
42463,Pravastatin,272.4,Other and unspecified hyperlipidemia,1
42463,Pravastatin,272.8,Other disorders of lipoid metabolism,1
42463,Pravastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
42463,Pravastatin,429.2,Cardiovascular disease [ASCVD],1
42463,Pravastatin,429.9,Heart disease NOS,1
42463,Pravastatin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
42463,Pravastatin,440,Atherosclerosis,1
42463,Pravastatin,447.9,Unspecified disorders of arteries and arterioles,1
42463,Pravastatin,783.21,Loss of weight,0
42463,Pravastatin,783.9,Other symptoms concerning nutrition; metabolism; and development,0
42547,Aurothiomalate,714.0,Rheumatoid arthritis,0
42612,Cromolyn,372.30,Conjunctivitis NOS,1
42612,Cromolyn,477.9,Allergic rhinitis NOS,0
42612,Cromolyn,493,Asthma,1
42612,Cromolyn,493.81,Exercise induced bronchospasm,1
42612,Cromolyn,493.9,Asthma; unspecified,1
42612,Cromolyn,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
42612,Cromolyn,519.11,Acute bronchospasm,1
42612,Cromolyn,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
42612,Cromolyn,708.9,Unspecified urticaria,1
42612,Cromolyn,757.33,Congenital pigmentary anomalies of skin,1
42612,Cromolyn,995.3,Allergy unspecified not elsewhere classified,0
42618,Cryptenamine,401-405.99,,0
42618,Cryptenamine,401.9,Hypertension NOS,0
42618,Cryptenamine,997.91,Hypertension,0
42634,Desmopressin Acetate,250,Diabetes mellitus,1
42634,Desmopressin Acetate,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
42634,Desmopressin Acetate,253.5,Diabetes insipidus,1
42634,Desmopressin Acetate,286.0,Congenital factor VIII disorder,1
42634,Desmopressin Acetate,286.4,Von willebrand's disease,1
42634,Desmopressin Acetate,286.7,Acquired coagulation factor deficiency,1
42634,Desmopressin Acetate,287.5,Thrombocytopenia NOS,0
42634,Desmopressin Acetate,307.6,Enuresis,1
42634,Desmopressin Acetate,459.0,Hemorrhage NOS,1
42634,Desmopressin Acetate,588.1,Nephrogenic diabetes insipidus,1
42634,Desmopressin Acetate,783.5,Polydipsia,1
42634,Desmopressin Acetate,788.36,Nocturnal enuresis,1
42634,Desmopressin Acetate,788.43,Nocturia,1
42634,Desmopressin Acetate,790.99,Other nonspecific findings on examination of blood,0
42635,Dextran,415.19,Other pulmonary embolism and infarction,0
42635,Dextran,453.9,Embolism and thrombosis of unspecified site,0
42635,Dextran,785.50,Shock NOS,0
42676,Ergotamine Tartrate,346,Migraine,0
42676,Ergotamine Tartrate,346.9,Migraine; unspecified,0
42676,Ergotamine Tartrate,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
42676,Ergotamine Tartrate,413.1,Prinzmetal angina,0
42676,Ergotamine Tartrate,666,Postpartum hemorrhage,0
42676,Ergotamine Tartrate,666.14,Other immediate postpartum hemorrhage; postpartum,0
42682,Etidronate,275.42,Hypercalcemia,0
42682,Etidronate,731.0,Osteitis deformans without mention of bone tumor,0
42682,Etidronate,733.0,Osteoporosis,0
42682,Etidronate,733.00,Osteoporosis NOS,0
42682,Etidronate,733.99,Other disorders of bone and cartilage,0
42686,Flecainide Acetate,427,Cardiac dysrhythmias,1
42686,Flecainide Acetate,427.0,Paroxysmal supraventricular tachycardia,1
42686,Flecainide Acetate,427.1,Paroxysmal ventricular tachycardia,1
42686,Flecainide Acetate,427.31,Atrial fibrillation,1
42686,Flecainide Acetate,427.32,Atrial flutter,1
42686,Flecainide Acetate,427.89,Other specified cardiac dysrhythmias,1
42686,Flecainide Acetate,427.9,Cardiac dysrhythmia NOS,1
42686,Flecainide Acetate,785.0,Tachycardia NOS,1
42686,Flecainide Acetate,799.9,Other unknown and unspecified cause of morbidity or mortality,1
42736,Dexrazoxane,174.9,Malignant neoplasm of breast (female); unspecified,1
42736,Dexrazoxane,239.3,Neoplasm of unspecified nature of breast,0
42790,Miconazole Nitrate,110.3,Dermatophytosis of groin and perianal area,1
42790,Miconazole Nitrate,110.4,Dermatophytosis of foot,1
42790,Miconazole Nitrate,112.1,Candidiasis of vulva and vagina,1
42790,Miconazole Nitrate,112.3,Candidiasis of skin and nails,1
42790,Miconazole Nitrate,117.3,Aspergillosis,0
42790,Miconazole Nitrate,698.9,Unspecified pruritic disorder,1
42836,Oxyquinoline Sulfate,686.9,Unspecified local infection of skin and subcutaneous tissue,0
42837,p-Aminohippurate,593.9,Unspecified disorder of kidney and ureter,0
42892,Sodium Hyaluronate,338-338.99,,0
42892,Sodium Hyaluronate,780.96,Generalized pain,0
42954,Vitamin B6,266.1,Vitamin B6 deficiency,0
42954,Vitamin B6,269.9,Unspecified nutritional deficiency,0
42954,Vitamin B6,780.39,Other convulsions,0
42954,Vitamin B6,977.9,Poisoning by unspecified drug or medicinal substance,0
42955,Levocarnitine,260-269.99,,0
42955,Levocarnitine,269.9,Unspecified nutritional deficiency,0
42955,Levocarnitine,593.9,Unspecified disorder of kidney and ureter,1
42955,Levocarnitine,994.2,Effects of hunger,0
43611,latanoprost,365,Glaucoma,1
43611,latanoprost,365.04,Ocular hypertension,1
43611,latanoprost,365.1,Open-angle glaucoma,0
43611,latanoprost,365.10,Open-angle glaucoma NOS,0
43611,latanoprost,365.13,Pigmentary glaucoma,0
43611,latanoprost,365.9,Glaucoma NOS,1
44151,clofarabine,204.0,Lymphoid leukemia; acute,1
44151,clofarabine,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
44157,Cladribine,202.4,Leukemic reticuloendotheliosis,1
44157,Cladribine,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,1
44157,Cladribine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
44157,Cladribine,204.1,Lymphoid leukemia; chronic,0
44157,Cladribine,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
44157,Cladribine,340,Multiple sclerosis,0
44281,cevimeline,527.7,Disturbance of salivary secretion,1
45318,halobetasol propionate,698.9,Unspecified pruritic disorder,0
45318,halobetasol propionate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
46043,Alfuzosin hydrochloride,600.0,Hypertrophy (benign) of prostate,0
46049,alglucerase,289.50,Spleen disease NOS,0
46049,alglucerase,573.9,Unspecified disorder of liver,0
46049,alglucerase,799.9,Other unknown and unspecified cause of morbidity or mortality,0
46241,aluminum chloride,521.0,Dental caries,0
46241,aluminum chloride,521.00,Dental caries NOS,0
46307,amlexanox,528.2,Oral aphthae,0
46307,amlexanox,707.9,Chronic ulcer of unspecified site,0
46967,beractant,765.10,Other preterm infants; unspecified [weight],0
46967,beractant,769,Respiratory distress syndrome in newborn,0
47088,Bethanechol Chloride,530.81,Esophageal reflux,0
47088,Bethanechol Chloride,596.54,Neurogenic bladder NOS,0
47088,Bethanechol Chloride,596.59,Other functional disorder of bladder,0
47088,Bethanechol Chloride,788.2,Retention of urine,0
47088,Bethanechol Chloride,788.20,Retention of urine NOS,0
47181,bismuth subcitrate,004.9,Shigellosis NOS,0
47181,bismuth subcitrate,041.49,Other and unspecified Escherichia coli [E. coli],0
47181,bismuth subcitrate,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,0
47461,butenafine,110.3,Dermatophytosis of groin and perianal area,1
47461,butenafine,110.4,Dermatophytosis of foot,1
47461,butenafine,110.5,Dermatophytosis of the body,1
47461,butenafine,111.0,Pityriasis versicolor,0
47461,butenafine,136.9,Unspecified infectious and parasitic diseases,1
47461,butenafine,696.5,Other and unspecified pityriasis,1
47464,Butoconazole nitrate,112.1,Candidiasis of vulva and vagina,1
47579,cabergoline,227.3,Benign neoplasm of pituitary gland and craniopharyngeal duct (pouch),1
47579,cabergoline,229.9,Benign neoplasm NOS,1
47579,cabergoline,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
47579,cabergoline,253.1,Other and unspecified anterior pituitary hyperfunction,1
47579,cabergoline,332,Parkinson's disease,0
47579,cabergoline,332.0,Paralysis agitans,0
47613,Calcium Citrate,275.41,Hypocalcemia,0
47613,Calcium Citrate,733.0,Osteoporosis,0
47613,Calcium Citrate,733.00,Osteoporosis NOS,0
47613,Calcium Citrate,733.01,Senile osteoporosis,0
47622,calcium lactate,275.41,Hypocalcemia,0
47622,calcium lactate,733.0,Osteoporosis,0
47622,calcium lactate,733.00,Osteoporosis NOS,0
47622,calcium lactate,733.01,Senile osteoporosis,0
47627,Calcium phosphate dibasic,275.41,Hypocalcemia,0
47627,Calcium phosphate dibasic,733.0,Osteoporosis,0
47627,Calcium phosphate dibasic,733.00,Osteoporosis NOS,0
47627,Calcium phosphate dibasic,733.01,Senile osteoporosis,0
47686,carbamide peroxide,388.9,Unspecified disorder of ear,0
47686,carbamide peroxide,389.9,Unspecified hearing loss,0
47686,carbamide peroxide,523.10,Chronic gingivitis; plaque induced,0
47686,carbamide peroxide,528.00,Stomatitis and mucositis; unspecified,0
47686,carbamide peroxide,757.1,Ichthyosis congenita,0
47686,carbamide peroxide,781.99,Other symptoms involving nervous and musculoskeletal systems,0
47686,carbamide peroxide,V41.2,Problems with hearing,0
47858,methsuximide,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
47858,methsuximide,780.39,Other convulsions,1
48212,Clidinium bromide,533,Peptic ulcer; site unspecified,0
48212,Clidinium bromide,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
48212,Clidinium bromide,536.8,Dyspepsia and other specified disorders of function of stomach,0
48212,Clidinium bromide,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
48212,Clidinium bromide,564.1,Irritable bowel syndrome,0
48274,Acetaminophen / Propoxyphene,338-338.99,,1
48274,Acetaminophen / Propoxyphene,780.96,Generalized pain,1
48933,Dexamethasone sodium phosphate,140-239.99,,0
48933,Dexamethasone sodium phosphate,239,Neoplasms of unspecified nature,0
48933,Dexamethasone sodium phosphate,239-239.99,,0
48933,Dexamethasone sodium phosphate,255.0,Cushing's syndrome,0
48933,Dexamethasone sodium phosphate,255.41,Glucocorticoid deficiency,0
48933,Dexamethasone sodium phosphate,280-289.99,,0
48933,Dexamethasone sodium phosphate,289.9,Blood disease NOS,0
48933,Dexamethasone sodium phosphate,311,Depressive disorder NEC,0
48933,Dexamethasone sodium phosphate,348.5,Cerebral edema,0
48933,Dexamethasone sodium phosphate,471,Nasal polyps,0
48933,Dexamethasone sodium phosphate,471.0,Polyp of nasal cavity,0
48933,Dexamethasone sodium phosphate,471.9,Nasal polyp NOS,0
48933,Dexamethasone sodium phosphate,477.9,Allergic rhinitis NOS,0
48933,Dexamethasone sodium phosphate,493,Asthma,0
48933,Dexamethasone sodium phosphate,493.9,Asthma; unspecified,0
48933,Dexamethasone sodium phosphate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
48933,Dexamethasone sodium phosphate,784.2,Swelling; mass; or lump in head and neck,0
48933,Dexamethasone sodium phosphate,785.52,Septic shock,0
48933,Dexamethasone sodium phosphate,787.02,Nausea alone,0
48933,Dexamethasone sodium phosphate,787.03,Vomiting alone,0
48936,Dexbrompheniramine maleate,461.9,Acute sinusitis NOS,0
48936,Dexbrompheniramine maleate,477.9,Allergic rhinitis NOS,0
48937,Dexmedetomidine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
48937,Dexmedetomidine,308.2,Predominant psychomotor disturbance,0
48937,Dexmedetomidine,338-338.99,,0
48937,Dexmedetomidine,780.96,Generalized pain,0
48937,Dexmedetomidine,799.21,Nervousness (ADDED),0
49247,dofetilide,427,Cardiac dysrhythmias,1
49247,dofetilide,427.31,Atrial fibrillation,1
49247,dofetilide,427.32,Atrial flutter,1
49247,dofetilide,427.9,Cardiac dysrhythmia NOS,1
49276,Doxazosin,401-405.99,,1
49276,Doxazosin,401.9,Hypertension NOS,1
49276,Doxazosin,600,Hyperplasia of prostate,1
49276,Doxazosin,600.0,Hypertrophy (benign) of prostate,0
49276,Doxazosin,600.9,Hyperplasia of prostate; unspecified,1
49276,Doxazosin,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),1
49276,Doxazosin,788.2,Retention of urine,0
49276,Doxazosin,788.20,Retention of urine NOS,0
49276,Doxazosin,997.91,Hypertension,1
49737,esmolol,401-405.99,,1
49737,esmolol,401.9,Hypertension NOS,1
49737,esmolol,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
49737,esmolol,413,Angina pectoris,0
49737,esmolol,413.9,Other and unspecified angina pectoris,0
49737,esmolol,427.1,Paroxysmal ventricular tachycardia,0
49737,esmolol,427.41,Ventricular fibrillation,0
49737,esmolol,427.89,Other specified cardiac dysrhythmias,1
49737,esmolol,428.0,Congestive heart failure (CHF) NOS,0
49737,esmolol,785.0,Tachycardia NOS,1
49737,esmolol,786.50,Unspecified chest pain,0
49737,esmolol,997.91,Hypertension,1
50121,Fluticasone propionate,471,Nasal polyps,0
50121,Fluticasone propionate,471.0,Polyp of nasal cavity,0
50121,Fluticasone propionate,471.9,Nasal polyp NOS,0
50121,Fluticasone propionate,477.0,Allergic rhinitis due to pollen,1
50121,Fluticasone propionate,477.9,Allergic rhinitis NOS,1
50121,Fluticasone propionate,493,Asthma,1
50121,Fluticasone propionate,493.9,Asthma; unspecified,1
50121,Fluticasone propionate,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
50166,Fosinopril,250.4,Diabetes with renal manifestations,0
50166,Fosinopril,401-405.99,,1
50166,Fosinopril,401.9,Hypertension NOS,1
50166,Fosinopril,428,Heart failure,1
50166,Fosinopril,428.0,Congestive heart failure (CHF) NOS,0
50166,Fosinopril,428.9,Heart failure unspecified,1
50166,Fosinopril,429.3,Cardiomegaly,0
50166,Fosinopril,593.9,Unspecified disorder of kidney and ureter,1
50166,Fosinopril,997.91,Hypertension,1
50610,Goserelin,174.9,Malignant neoplasm of breast (female); unspecified,1
50610,Goserelin,185,Malignant neoplasm of prostate,1
50610,Goserelin,239.3,Neoplasm of unspecified nature of breast,0
50610,Goserelin,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
50610,Goserelin,338-338.99,,1
50610,Goserelin,617,Endometriosis,1
50610,Goserelin,617.9,Endometriosis; site unspecified,1
50610,Goserelin,780.96,Generalized pain,1
50749,halofantrine,084.0,Falciparum malaria [malignant tertian],0
50749,halofantrine,084.1,Vivax malaria [benign tertian],1
50975,histrelin,185,Malignant neoplasm of prostate,1
50975,histrelin,259.1,Precocious sexual development and puberty NEC,1
50975,histrelin,V21.1,Puberty,1
51256,ibutilide fumarate,427,Cardiac dysrhythmias,1
51256,ibutilide fumarate,427.1,Paroxysmal ventricular tachycardia,1
51256,ibutilide fumarate,427.31,Atrial fibrillation,1
51256,ibutilide fumarate,427.32,Atrial flutter,1
51256,ibutilide fumarate,427.9,Cardiac dysrhythmia NOS,1
51272,quetiapine,290,Dementias,1
51272,quetiapine,290-299.99,,0
51272,quetiapine,294.2,,1
51272,quetiapine,294.20,Dementia; unspecified; without behavioral disturbance,1
51272,quetiapine,295,Schizophrenic disorders,1
51272,quetiapine,295.9,Unspecified schizophrenia,1
51272,quetiapine,295.90,Unspecified schizophrenia; unspecified state,1
51272,quetiapine,296.00,Manic disorder; single episode; unspecified degree,1
51272,quetiapine,296.7,Bipolar I disorder; most recent episode (or current) unspecified,1
51272,quetiapine,296.80,Bipolar disorder NOS,1
51272,quetiapine,298.9,Unspecified psychosis,0
51272,quetiapine,299.0,Autistic disorder,0
51272,quetiapine,299.00,Infantile autism; current or active state,0
51272,quetiapine,300.9,Unspecified nonpsychotic mental disorder,1
51272,quetiapine,311,Depressive disorder NEC,1
51428,Insulin  Aspart  Human,250,Diabetes mellitus,1
51428,Insulin  Aspart  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
51428,Insulin  Aspart  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
51428,Insulin  Aspart  Human,790.6,Other abnormal blood chemistry,1
51499,irinotecan,153.9,Malignant neoplasm of colon; unspecified,1
51499,irinotecan,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
51499,irinotecan,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
51499,irinotecan,208,Leukemia of unspecified cell type,0
51499,irinotecan,208.9,Unspecified leukemia,0
51499,irinotecan,208.90,Unspecified leukemia without mention of having achieved remission,0
51499,irinotecan,239.0,Neoplasm of unspecified nature of digestive system,0
51499,irinotecan,239.3,Neoplasm of unspecified nature of breast,0
52101,Cyclobenzaprine hydrochloride,037,Tetanus,0
52101,Cyclobenzaprine hydrochloride,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
52101,Cyclobenzaprine hydrochloride,338-338.99,,1
52101,Cyclobenzaprine hydrochloride,728.85,Spasm of muscle,1
52101,Cyclobenzaprine hydrochloride,728.9,Unspecified disorder of muscle; ligament; and fascia,0
52101,Cyclobenzaprine hydrochloride,729.1,Myalgia and myositis unspecified,0
52101,Cyclobenzaprine hydrochloride,729.82,Cramp of limb,0
52101,Cyclobenzaprine hydrochloride,780.96,Generalized pain,1
52101,Cyclobenzaprine hydrochloride,781.0,Abnormal involuntary movements,1
52101,Cyclobenzaprine hydrochloride,781.99,Other symptoms involving nervous and musculoskeletal systems,0
52101,Cyclobenzaprine hydrochloride,959.9,Other and unspecified injury to unspecified site,0
52105,lithium citrate,296.00,Manic disorder; single episode; unspecified degree,0
52105,lithium citrate,296.80,Bipolar disorder NOS,0
52105,lithium citrate,308.9,Unspecified acute reaction to stress,0
52105,lithium citrate,309.81,Posttraumatic stress disorder,0
52105,lithium citrate,311,Depressive disorder NEC,0
52105,lithium citrate,312.9,Unspecified disturbance of conduct,0
52151,Lodoxamide,370.40,Keratoconjunctivitis NOS,1
52175,Losartan,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
52175,Losartan,250.4,Diabetes with renal manifestations,1
52175,Losartan,401-405.99,,1
52175,Losartan,401.9,Hypertension NOS,1
52175,Losartan,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
52175,Losartan,428.0,Congestive heart failure (CHF) NOS,0
52175,Losartan,429.3,Cardiomegaly,1
52175,Losartan,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
52175,Losartan,593.9,Unspecified disorder of kidney and ureter,1
52175,Losartan,791.0,Proteinuria,1
52175,Losartan,799.9,Other unknown and unspecified cause of morbidity or mortality,1
52175,Losartan,997.91,Hypertension,1
52177,loteprednol etabonate,077.99,Unspecified diseases of conjunctiva due to viruses,0
52177,loteprednol etabonate,364.3,Iridocyclitis NOS,0
52177,loteprednol etabonate,370,Keratitis,0
52177,loteprednol etabonate,370.9,Keratitis NOS,0
52177,loteprednol etabonate,372.03,Other mucopurulent conjunctivitis,0
52177,loteprednol etabonate,372.14,Other chronic allergic conjunctivitis,1
52177,loteprednol etabonate,372.30,Conjunctivitis NOS,1
52177,loteprednol etabonate,695.3,Rosacea,0
52177,loteprednol etabonate,782.3,Edema,0
52356,magnesium citrate,275.2,Disorders of magnesium metabolism,0
52356,magnesium citrate,977.9,Poisoning by unspecified drug or medicinal substance,0
52358,MAGNESIUM GLUCONATE,275.2,Disorders of magnesium metabolism,0
52364,Magnesium Salicylate,338-338.99,,0
52364,Magnesium Salicylate,716.90,Arthropathy; unspecified; site unspecified,0
52364,Magnesium Salicylate,724.1,Pain in thoracic spine,0
52364,Magnesium Salicylate,724.5,Backache unspecified,0
52364,Magnesium Salicylate,780.60,Fever; unspecified,0
52364,Magnesium Salicylate,780.96,Generalized pain,0
52364,Magnesium Salicylate,784.0,Headache,0
52582,mesalamine,338-338.99,,1
52582,mesalamine,556,Ulcerative colitis,1
52582,mesalamine,556.8,Other ulcerative colitis,1
52582,mesalamine,556.9,Ulcerative colitis; unspecified,1
52582,mesalamine,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
52582,mesalamine,569.49,Other specified disorders of rectum and anus,1
52582,mesalamine,707.9,Chronic ulcer of unspecified site,1
52582,mesalamine,780.96,Generalized pain,1
52769,Milrinone,428,Heart failure,1
52769,Milrinone,428.0,Congestive heart failure (CHF) NOS,1
52769,Milrinone,428.9,Heart failure unspecified,1
52769,Milrinone,977.9,Poisoning by unspecified drug or medicinal substance,0
52885,monofluorophosphate,521.0,Dental caries,0
52885,monofluorophosphate,521.00,Dental caries NOS,0
53616,Chloroprocaine hydrochloride,338-338.99,,0
53616,Chloroprocaine hydrochloride,780.96,Generalized pain,0
53654,Nevirapine,042,Human immunodeficiency virus [HIV] disease,1
53654,Nevirapine,042-042.99,,1
53654,Nevirapine,136.9,Unspecified infectious and parasitic diseases,1
53750,Nonoxynol-9,V22.2,Pregnant state; incidental,0
54034,Octoxynol-9,V22.2,Pregnant state; incidental,0
54214,OspA protein,088.81,Lyme disease,0
54251,Oxybutynin chloride,596.51,Hypertonicity of bladder,1
54251,Oxybutynin chloride,596.54,Neurogenic bladder NOS,1
54251,Oxybutynin chloride,596.59,Other functional disorder of bladder,1
54251,Oxybutynin chloride,728.85,Spasm of muscle,0
54251,Oxybutynin chloride,741,Spina bifida,1
54251,Oxybutynin chloride,741.90,Spina bifida unspecified region without hydrocephalus,1
54251,Oxybutynin chloride,781.0,Abnormal involuntary movements,0
54251,Oxybutynin chloride,788.1,Dysuria,1
54251,Oxybutynin chloride,788.3,Urinary incontinence,1
54251,Oxybutynin chloride,788.30,Urinary incontinence NOS,1
54251,Oxybutynin chloride,788.31,Urge incontinence,1
54251,Oxybutynin chloride,788.41,Urinary frequency,1
54251,Oxybutynin chloride,788.69,Other abnormality of urination,1
54365,pamabrom,625.4,Premenstrual tension syndromes,0
54365,pamabrom,724.1,Pain in thoracic spine,0
54365,pamabrom,724.5,Backache unspecified,0
54552,Perindopril,250.4,Diabetes with renal manifestations,0
54552,Perindopril,401,Essential hypertension,1
54552,Perindopril,401-405.99,,1
54552,Perindopril,401.9,Hypertension NOS,1
54552,Perindopril,428.0,Congestive heart failure (CHF) NOS,0
54552,Perindopril,429.3,Cardiomegaly,0
54552,Perindopril,429.9,Heart disease NOS,0
54552,Perindopril,997.91,Hypertension,1
54828,Dexchlorpheniramine maleate,477.0,Allergic rhinitis due to pollen,1
54828,Dexchlorpheniramine maleate,477.9,Allergic rhinitis NOS,1
54828,Dexchlorpheniramine maleate,708,Urticaria,1
54828,Dexchlorpheniramine maleate,708.9,Unspecified urticaria,1
54828,Dexchlorpheniramine maleate,995.3,Allergy unspecified not elsewhere classified,1
54987,Potassium Acetate,276.8,Hypopotassemia,0
54993,potassium citrate,276.2,Acidosis,0
54993,potassium citrate,276.8,Hypopotassemia,0
54993,potassium citrate,592.0,Calculus of kidney,0
55018,Dibasic potassium phosphate,275.3,Disorders of phosphorus metabolism,0
55018,Dibasic potassium phosphate,276.8,Hypopotassemia,0
55019,Monobasic potassium phosphate,275.3,Disorders of phosphorus metabolism,0
55019,Monobasic potassium phosphate,276.8,Hypopotassemia,0
55062,Prednisolone sodium phosphate,140-239.99,,0
55062,Prednisolone sodium phosphate,239,Neoplasms of unspecified nature,0
55062,Prednisolone sodium phosphate,239-239.99,,0
55062,Prednisolone sodium phosphate,255.41,Glucocorticoid deficiency,0
55062,Prednisolone sodium phosphate,280-289.99,,0
55062,Prednisolone sodium phosphate,289.9,Blood disease NOS,0
55062,Prednisolone sodium phosphate,372.30,Conjunctivitis NOS,0
55062,Prednisolone sodium phosphate,569.9,Unspecified disorder of intestine,0
55062,Prednisolone sodium phosphate,709.9,Unspecified disorder of skin and subcutaneous tissue,0
55062,Prednisolone sodium phosphate,710.9,Unspecified diffuse connective tissue disease,0
55062,Prednisolone sodium phosphate,729.0,Rheumatism; unspecified and fibrositis,0
55062,Prednisolone sodium phosphate,782.3,Edema,0
55062,Prednisolone sodium phosphate,995.3,Allergy unspecified not elsewhere classified,0
55672,Rifabutin,011,Pulmonary tuberculosis,0
55672,Rifabutin,011.9,Unspecified pulmonary tuberculosis,0
55672,Rifabutin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
55672,Rifabutin,031.8,Other specified mycobacterial diseases,1
55672,Rifabutin,031.9,Unspecified diseases due to mycobacteria,0
55672,Rifabutin,042,Human immunodeficiency virus [HIV] disease,1
55672,Rifabutin,042-042.99,,1
55672,Rifabutin,136.9,Unspecified infectious and parasitic diseases,1
55681,rimexolone,364.3,Iridocyclitis NOS,1
56188,Sermorelin,253.3,Pituitary dwarfism,0
56188,Sermorelin,261,Nutritional marasmus,0
56443,Sodium Acetate,276.1,Hyposmolality and/or hyponatremia,0
56443,Sodium Acetate,276.2,Acidosis,0
56455,Sodium Benzoate,784.0,Headache,0
56466,sodium citrate,592.9,Urinary calculus NOS,0
56489,Sodium Lactate,276.2,Acidosis,0
56501,Sodium monofluorophosphate,521.0,Dental caries,0
56501,Sodium monofluorophosphate,521.00,Dental caries NOS,0
56512,Sodium polystyrene sulfonate,276.7,Hyperpotassemia,0
56570,somatrem,253.3,Pituitary dwarfism,0
56570,somatrem,259.4,Dwarfism; not elsewhere classified,0
56570,somatrem,428.0,Congestive heart failure (CHF) NOS,0
56570,somatrem,759.81,Prader-Willi syndrome,0
56570,somatrem,783.43,Short stature,0
56570,somatrem,799.4,Cachexia,0
56795,Sufentanil,338-338.99,,1
56795,Sufentanil,780.96,Generalized pain,1
56946,Paclitaxel,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
56946,Paclitaxel,174.9,Malignant neoplasm of breast (female); unspecified,1
56946,Paclitaxel,176,Kaposi's sarcoma,0
56946,Paclitaxel,176.9,Kaposi's sarcoma NOS,0
56946,Paclitaxel,195.0,Malignant neoplasm of head; face; and neck,0
56946,Paclitaxel,239.1,Neoplasm of unspecified nature of respiratory system,0
56946,Paclitaxel,239.3,Neoplasm of unspecified nature of breast,0
56946,Paclitaxel,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
57227,Trimethobenzamide hydrochloride,558.9,Other and unspecified noninfectious gastroenteritis and colitis,0
57227,Trimethobenzamide hydrochloride,787.02,Nausea alone,0
57227,Trimethobenzamide hydrochloride,787.03,Vomiting alone,0
57258,tizanidine,340,Multiple sclerosis,0
57258,tizanidine,350.1,Trigeminal neuralgia,0
57258,tizanidine,724.2,Lumbago,0
57258,tizanidine,728.85,Spasm of muscle,0
57258,tizanidine,728.9,Unspecified disorder of muscle; ligament; and fascia,0
57258,tizanidine,729.1,Myalgia and myositis unspecified,0
57258,tizanidine,729.82,Cramp of limb,0
57258,tizanidine,781.0,Abnormal involuntary movements,1
57308,Topotecan,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
57308,Topotecan,180.9,Malignant neoplasm of cervix uteri; unspecified,1
57308,Topotecan,209.20,Malignant carcinoid tumor of unknown primary site,1
57308,Topotecan,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
57529,foscarnet sodium,078.5,Cytomegaloviral disease,0
57529,foscarnet sodium,363.20|078.5,,0
57555,Pramoxine hydrochloride,338-338.99,,0
57555,Pramoxine hydrochloride,455,Hemorrhoids,0
57555,Pramoxine hydrochloride,455.6,Hemorrhoids NOS,0
57555,Pramoxine hydrochloride,565.0,Anal fissure,0
57555,Pramoxine hydrochloride,569.41,Ulcer of anus and rectum,0
57555,Pramoxine hydrochloride,692.9,Contact dermatitis and other eczema; unspecified cause,0
57555,Pramoxine hydrochloride,698.9,Unspecified pruritic disorder,0
57555,Pramoxine hydrochloride,780.96,Generalized pain,0
57555,Pramoxine hydrochloride,919.4,Insect bite; nonvenomous; of other; multiple; and unspecified sites; without mention of infection,0
57555,Pramoxine hydrochloride,940-949.99,,0
57555,Pramoxine hydrochloride,949.0,Burn of unspecified site; unspecified degree,0
57789,fluorescein sodium,362.10,Background retinopathy; unspecified,1
57789,fluorescein sodium,362.9,Retinal disorder NOS,1
57789,fluorescein sodium,371.9,Unspecified corneal disorder,0
57983,Tetrahydrozoline hydrochloride,461.9,Acute sinusitis NOS,0
57983,Tetrahydrozoline hydrochloride,477.9,Allergic rhinitis NOS,0
57983,Tetrahydrozoline hydrochloride,695.9,Unspecified erythematous condition,0
58157,phendimetrazine tartrate,278.00,Obesity NOS,0
58295,Zinc Acetate,460,Acute nasopharyngitis (common cold),0
58295,Zinc Acetate,707.9,Chronic ulcer of unspecified site,0
58295,Zinc Acetate,709.8,Other specified disorders of skin,0
58300,Zinc Gluconate,460,Acute nasopharyngitis (common cold),0
58300,Zinc Gluconate,707.9,Chronic ulcer of unspecified site,0
58300,Zinc Gluconate,709.8,Other specified disorders of skin,0
58939,COLLAGENASE,707.9,Chronic ulcer of unspecified site,1
58939,COLLAGENASE,709.8,Other specified disorders of skin,0
58939,COLLAGENASE,940-949.99,,0
58939,COLLAGENASE,949.0,Burn of unspecified site; unspecified degree,0
59078,metaxalone,338-338.99,,0
59078,metaxalone,728.85,Spasm of muscle,0
59078,metaxalone,728.9,Unspecified disorder of muscle; ligament; and fascia,0
59078,metaxalone,729.1,Myalgia and myositis unspecified,0
59078,metaxalone,729.82,Cramp of limb,0
59078,metaxalone,729.9,Other and unspecified disorders of soft tissue,0
59078,metaxalone,780.96,Generalized pain,0
59078,metaxalone,781.0,Abnormal involuntary movements,0
59078,metaxalone,781.99,Other symptoms involving nervous and musculoskeletal systems,1
59087,Eucalyptus oil,338-338.99,,0
59087,Eucalyptus oil,780.96,Generalized pain,0
59308,CHROMIUM PICOLINATE,250,Diabetes mellitus,0
59308,CHROMIUM PICOLINATE,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
59636,buclizine,780.4,Dizziness and giddiness,0
59636,buclizine,787.02,Nausea alone,0
59636,buclizine,787.03,Vomiting alone,0
59636,buclizine,994.6,Motion sickness,0
59743,quinethazone,401-405.99,,0
59743,quinethazone,401.9,Hypertension NOS,0
59743,quinethazone,428.0,Congestive heart failure (CHF) NOS,0
59743,quinethazone,581,Nephrotic syndrome,0
59743,quinethazone,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
59743,quinethazone,782.3,Edema,0
59743,quinethazone,997.91,Hypertension,0
59744,interferon alfacon-1,070.31,Viral hepatitis B without mention of hepatic coma; acute or unspecified; with hepatitis delta,0
59744,interferon alfacon-1,070.54,Chronic hepatitis C without mention of hepatic coma,1
59744,interferon alfacon-1,070.7,Unspecified viral hepatitis C,1
59744,interferon alfacon-1,070.70,Unspecified viral hepatitis C without hepatic coma,1
59744,interferon alfacon-1,070.9,Unspecified viral hepatitis without mention of hepatic coma,1
59744,interferon alfacon-1,078.1,Viral warts,0
59744,interferon alfacon-1,078.10,Viral warts; unspecified,0
59744,interferon alfacon-1,136.9,Unspecified infectious and parasitic diseases,1
59744,interferon alfacon-1,155.0,Malignant neoplasm of liver; primary,0
59744,interferon alfacon-1,172.9,Melanoma of skin; site unspecified,0
59744,interferon alfacon-1,176,Kaposi's sarcoma,0
59744,interferon alfacon-1,176.9,Kaposi's sarcoma NOS,0
59744,interferon alfacon-1,189.0,Malignant neoplasm of kidney; except pelvis,0
59744,interferon alfacon-1,202.1,Mycosis fungoides,0
59744,interferon alfacon-1,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
59744,interferon alfacon-1,202.2,Sezary's disease,0
59744,interferon alfacon-1,202.20,Sezary's disease; unspecified site; extranodal and solid organ sites,0
59744,interferon alfacon-1,202.4,Leukemic reticuloendotheliosis,0
59744,interferon alfacon-1,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,0
59744,interferon alfacon-1,203.0,Multiple myeloma,0
59744,interferon alfacon-1,203.00,Multiple myeloma without mention of having achieved remission,0
59744,interferon alfacon-1,228.0,Hemangioma; any site,0
59744,interferon alfacon-1,228.00,Hemangioma NOS,0
59744,interferon alfacon-1,238.71,Essential thrombocythemia,0
59744,interferon alfacon-1,239.0,Neoplasm of unspecified nature of digestive system,0
59744,interferon alfacon-1,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
59744,interferon alfacon-1,239.6,Neoplasm of unspecified nature of brain,0
59744,interferon alfacon-1,273.2,Other paraproteinemias,0
59744,interferon alfacon-1,287.5,Thrombocytopenia NOS,0
59744,interferon alfacon-1,362.50,Macular degeneration (senile) of retina NOS,0
59744,interferon alfacon-1,707.9,Chronic ulcer of unspecified site,0
59744,interferon alfacon-1,709.8,Other specified disorders of skin,0
59744,interferon alfacon-1,790.99,Other nonspecific findings on examination of blood,0
59763,Stavudine,042,Human immunodeficiency virus [HIV] disease,1
59763,Stavudine,042-042.99,,1
59768,pegademase bovine,279.2,Combined immunity deficiency,1
59839,penciclovir,054.9,Herpes simplex without mention of complication,1
59839,penciclovir,075,Infectious mononucleosis,0
59839,penciclovir,338-338.99,,0
59839,penciclovir,780.96,Generalized pain,0
59943,imiquimod,078.0,Molluscum contagiosum,1
59943,imiquimod,078.1,Viral warts,1
59943,imiquimod,078.10,Viral warts; unspecified,1
59943,imiquimod,078.11,Condyloma acuminatum,1
59943,imiquimod,140-239.99,,1
59943,imiquimod,173.91,Basal cell carcinoma of skin; site unspecified,1
59943,imiquimod,173.99,Other specified malignant neoplasm of skin; site unspecified,0
59943,imiquimod,239,Neoplasms of unspecified nature,1
59943,imiquimod,239-239.99,,1
59943,imiquimod,702.0,Actinic keratosis,1
60207,dorzolamide,365,Glaucoma,1
60207,dorzolamide,365.04,Ocular hypertension,1
60207,dorzolamide,365.1,Open-angle glaucoma,0
60207,dorzolamide,365.10,Open-angle glaucoma NOS,0
60207,dorzolamide,365.13,Pigmentary glaucoma,0
60207,dorzolamide,365.9,Glaucoma NOS,1
60212,Atovaquone,130.0,Meningoencephalitis due to toxoplasmosis,0
60212,Atovaquone,136.3,Pneumocystosis,1
60212,Atovaquone,486,Pneumonia; organism unspecified,1
60223,adapalene,706.1,Other acne,1
60307,entacapone,332,Parkinson's disease,0
60307,entacapone,332.0,Paralysis agitans,0
60334,risedronate sodium,731.0,Osteitis deformans without mention of bone tumor,1
60334,risedronate sodium,733.0,Osteoporosis,1
60334,risedronate sodium,733.00,Osteoporosis NOS,1
60334,risedronate sodium,733.01,Senile osteoporosis,1
60548,exenatide,250,Diabetes mellitus,1
60548,exenatide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
60548,exenatide,783.9,Other symptoms concerning nutrition; metabolism; and development,0
60819,bivalirudin,289.84,Heparin-induced thrombocytopenia (HIT),1
60819,bivalirudin,410-414.99,,0
60819,bivalirudin,411.1,Intermediate coronary syndrome,1
60819,bivalirudin,413.9,Other and unspecified angina pectoris,1
60819,bivalirudin,414.8,Other specified forms of chronic ischemic heart disease,0
60819,bivalirudin,414.9,Chronic ischemic heart disease; unspecified,0
60819,bivalirudin,453.9,Embolism and thrombosis of unspecified site,1
60819,bivalirudin,459.9,Unspecified circulatory system disorder,0
61148,Somatropin,140-239.99,,1
61148,Somatropin,239,Neoplasms of unspecified nature,1
61148,Somatropin,239-239.99,,1
61148,Somatropin,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
61148,Somatropin,253.3,Pituitary dwarfism,1
61148,Somatropin,253.4,Other anterior pituitary disorders,1
61148,Somatropin,259.4,Dwarfism; not elsewhere classified,0
61148,Somatropin,428.0,Congestive heart failure (CHF) NOS,0
61148,Somatropin,579.3,Other and unspecified postsurgical nonabsorption,1
61148,Somatropin,585.6,End stage renal disease,1
61148,Somatropin,585.9,Chronic kidney disease; unspecified,1
61148,Somatropin,586,Renal failure unspecified,1
61148,Somatropin,740-759.99,,1
61148,Somatropin,758.6,Gonadal dysgenesis,1
61148,Somatropin,759.81,Prader-Willi syndrome,1
61148,Somatropin,759.9,Congenital anomaly unspecified,1
61148,Somatropin,783.21,Loss of weight,1
61148,Somatropin,783.43,Short stature,1
61148,Somatropin,783.9,Other symptoms concerning nutrition; metabolism; and development,1
61148,Somatropin,799.4,Cachexia,1
61148,Somatropin,799.89,Other ill-defined conditions,1
61381,olanzapine,290-299.99,,1
61381,olanzapine,295,Schizophrenic disorders,1
61381,olanzapine,295.9,Unspecified schizophrenia,1
61381,olanzapine,295.90,Unspecified schizophrenia; unspecified state,1
61381,olanzapine,296.00,Manic disorder; single episode; unspecified degree,1
61381,olanzapine,296.7,Bipolar I disorder; most recent episode (or current) unspecified,1
61381,olanzapine,296.80,Bipolar disorder NOS,1
61381,olanzapine,298.9,Unspecified psychosis,1
61381,olanzapine,300.01,Panic disorder without agoraphobia,0
61381,olanzapine,300.9,Unspecified nonpsychotic mental disorder,1
61381,olanzapine,307.23,Tourette's disorder,0
61381,olanzapine,307.50,Eating disorder NOS,0
61381,olanzapine,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
61381,olanzapine,308.2,Predominant psychomotor disturbance,1
61381,olanzapine,308.9,Unspecified acute reaction to stress,0
61381,olanzapine,309.81,Posttraumatic stress disorder,0
61381,olanzapine,311,Depressive disorder NEC,1
61381,olanzapine,625.4,Premenstrual tension syndromes,1
61381,olanzapine,783.9,Other symptoms concerning nutrition; metabolism; and development,1
61381,olanzapine,799.21,Nervousness (ADDED),1
61805,nitisinone,270.2,Other disturbances of aromatic amino-acid metabolism,1
62174,deserpidine,295,Schizophrenic disorders,0
62174,deserpidine,295.9,Unspecified schizophrenia,0
62174,deserpidine,295.90,Unspecified schizophrenia; unspecified state,0
62174,deserpidine,401-405.99,,0
62174,deserpidine,401.9,Hypertension NOS,0
62174,deserpidine,781.3,Lack of coordination,0
62174,deserpidine,997.91,Hypertension,0
62349,Ethacrynate,401-405.99,,0
62349,Ethacrynate,401.9,Hypertension NOS,0
62349,Ethacrynate,428.0,Congestive heart failure (CHF) NOS,0
62349,Ethacrynate,514,Pulmonary congestion and hypostasis,1
62349,Ethacrynate,571.5,Cirrhosis of liver without mention of alcohol,0
62349,Ethacrynate,581,Nephrotic syndrome,0
62349,Ethacrynate,581.9,Nephrotic syndrome with unspecified pathological lesion in kidney,0
62349,Ethacrynate,584,Acute renal failure,0
62349,Ethacrynate,584.9,Acute renal failure NOS,0
62349,Ethacrynate,585.6,End stage renal disease,0
62349,Ethacrynate,585.9,Chronic kidney disease; unspecified,0
62349,Ethacrynate,586,Renal failure unspecified,0
62349,Ethacrynate,782.3,Edema,1
62349,Ethacrynate,789.5,Ascites,0
62349,Ethacrynate,789.59,Other ascites,0
62349,Ethacrynate,997.91,Hypertension,0
62372,hyaluronate,338-338.99,,0
62372,hyaluronate,780.96,Generalized pain,0
62400,pantothenate,266,Deficiency of B-complex components,0
62400,pantothenate,266.9,Vitamin B deficiency NOS,0
62427,Ursodeoxycholate,571.5,Cirrhosis of liver without mention of alcohol,1
62427,Ursodeoxycholate,571.6,Biliary cirrhosis,1
62427,Ursodeoxycholate,574,Cholelithiasis,0
62427,Ursodeoxycholate,574.20,Calculus of gallbladder without mention of cholecystitis; without mention of obstruction,0
66870,Casanthranol,564.0,Constipation,0
66870,Casanthranol,564.00,Constipation NOS,0
66887,Racepinephrine,493,Asthma,0
66887,Racepinephrine,493.9,Asthma; unspecified,0
66887,Racepinephrine,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
66887,Racepinephrine,780.2,Syncope and collapse,0
66887,Racepinephrine,995.3,Allergy unspecified not elsewhere classified,0
67108,Enoxaparin,410-414.99,,0
67108,Enoxaparin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
67108,Enoxaparin,411.1,Intermediate coronary syndrome,1
67108,Enoxaparin,413,Angina pectoris,1
67108,Enoxaparin,413.9,Other and unspecified angina pectoris,1
67108,Enoxaparin,414.8,Other specified forms of chronic ischemic heart disease,0
67108,Enoxaparin,414.9,Chronic ischemic heart disease; unspecified,0
67108,Enoxaparin,415.19,Other pulmonary embolism and infarction,1
67108,Enoxaparin,451.9,Phlebitis and thrombophlebitis of unspecified site,1
67108,Enoxaparin,453.9,Embolism and thrombosis of unspecified site,1
67108,Enoxaparin,459.9,Unspecified circulatory system disorder,0
67108,Enoxaparin,786.50,Unspecified chest pain,1
67108,Enoxaparin,81.54,TOTAL KNEE REPLACEMENT,0
67108,Enoxaparin,998.9,Unspecified complication of procedure; not elsewhere classified,0
67109,Dalteparin,199,Malignant neoplasm without specification of site,1
67109,Dalteparin,199.1,Other malignant neoplasm of unspecified site,1
67109,Dalteparin,410-414.99,,0
67109,Dalteparin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
67109,Dalteparin,411.1,Intermediate coronary syndrome,1
67109,Dalteparin,414.8,Other specified forms of chronic ischemic heart disease,0
67109,Dalteparin,414.9,Chronic ischemic heart disease; unspecified,0
67109,Dalteparin,415.19,Other pulmonary embolism and infarction,1
67109,Dalteparin,444.9,Embolism and thrombosis of unspecified artery,1
67109,Dalteparin,451.9,Phlebitis and thrombophlebitis of unspecified site,1
67109,Dalteparin,453.9,Embolism and thrombosis of unspecified site,1
67109,Dalteparin,459.9,Unspecified circulatory system disorder,1
67109,Dalteparin,998.9,Unspecified complication of procedure; not elsewhere classified,0
68091,Dolasetron,787.02,Nausea alone,1
68091,Dolasetron,787.03,Vomiting alone,1
68092,lanreotide,140-239.99,,1
68092,lanreotide,239,Neoplasms of unspecified nature,1
68092,lanreotide,239-239.99,,1
68092,lanreotide,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
68092,lanreotide,253.0,Acromegaly and gigantism,1
68099,famciclovir,053,Herpes zoster,1
68099,famciclovir,053.9,Herpes zoster without mention of complication,1
68099,famciclovir,054,Herpes simplex,1
68099,famciclovir,054.1,Genital herpes,1
68099,famciclovir,054.10,Genital herpes NOS,1
68099,famciclovir,054.9,Herpes simplex without mention of complication,1
68099,famciclovir,338-338.99,,1
68099,famciclovir,698.9,Unspecified pruritic disorder,1
68099,famciclovir,780.96,Generalized pain,1
68099,famciclovir,782.1,Rash and other nonspecific skin eruption,1
68149,mycophenolate mofetil,279.5,Graft-versus-host disease,0
68149,mycophenolate mofetil,279.50,Graft-versus-host disease; unspecified,0
68149,mycophenolate mofetil,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
68244,Lamivudine,042,Human immunodeficiency virus [HIV] disease,1
68244,Lamivudine,042-042.99,,1
68244,Lamivudine,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
68244,Lamivudine,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
68244,Lamivudine,136.9,Unspecified infectious and parasitic diseases,1
68442,Filgrastim,042,Human immunodeficiency virus [HIV] disease,1
68442,Filgrastim,042-042.99,,1
68442,Filgrastim,136.9,Unspecified infectious and parasitic diseases,1
68442,Filgrastim,288.0,Agranulocytosis,1
68442,Filgrastim,288.00,Neutropenia NOS,1
68442,Filgrastim,41.00,Bone marrow transplant; not otherwise specified,0
68442,Filgrastim,99.72,Therapeutic leukopheresis,0
68446,pemetrexed,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
68446,pemetrexed,163.9,Malignant neoplasm of pleura; unspecified,1
68503,ziconotide,338.2,Chronic pain,1
68503,ziconotide,338.29,Other chronic pain,1
68503,ziconotide,780.96,Generalized pain,1
69036,rufinamide,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
69036,rufinamide,345.9,Epilepsy; unspecified,1
69036,rufinamide,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
69036,rufinamide,780.39,Other convulsions,1
69120,tiotropium,491,Chronic bronchitis,1
69120,tiotropium,491.9,Chronic bronchitis NOS,1
69120,tiotropium,493,Asthma,0
69120,tiotropium,493.9,Asthma; unspecified,0
69120,tiotropium,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
69120,tiotropium,496,Chronic airway obstruction; not elsewhere classified,1
69120,tiotropium,786.05,Shortness of breath,1
69120,tiotropium,786.09,Other dyspnea and respiratory abnormality,1
69120,tiotropium,796.4,Other abnormal clinical findings,1
69634,sargramostim,136.9,Unspecified infectious and parasitic diseases,1
69634,sargramostim,201,Hodgkin's disease,0
69634,sargramostim,201.0,Hodgkin's paragranuloma,0
69634,sargramostim,201.1,Hodgkin's granuloma,0
69634,sargramostim,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
69634,sargramostim,201.2,Hodgkin's sarcoma,0
69634,sargramostim,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
69634,sargramostim,201.9,Hodgkin's disease; unspecified type,0
69634,sargramostim,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
69634,sargramostim,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
69634,sargramostim,205.0,Myeloid leukemia; acute,1
69634,sargramostim,205.00,Acute myeloid leukemia without mention of having achieved remission,1
69634,sargramostim,239.3,Neoplasm of unspecified nature of breast,0
69634,sargramostim,288.0,Agranulocytosis,1
69634,sargramostim,288.00,Neutropenia NOS,1
69646,tinzaparin,415.19,Other pulmonary embolism and infarction,1
69646,tinzaparin,451.9,Phlebitis and thrombophlebitis of unspecified site,1
69646,tinzaparin,453.9,Embolism and thrombosis of unspecified site,1
69646,tinzaparin,459.9,Unspecified circulatory system disorder,0
69722,Zanamivir,136.9,Unspecified infectious and parasitic diseases,0
69722,Zanamivir,462,Acute pharyngitis,1
69722,Zanamivir,487,Influenza,1
69722,Zanamivir,487.1,Influenza with other respiratory manifestations,1
69722,Zanamivir,729.1,Myalgia and myositis unspecified,1
69722,Zanamivir,780.60,Fever; unspecified,1
69722,Zanamivir,780.99,Other general symptoms,1
69722,Zanamivir,784.0,Headache,1
69722,Zanamivir,784.1,Throat pain,1
69722,Zanamivir,786.2,Cough,1
69722,Zanamivir,799.89,Other ill-defined conditions,1
69749,valsartan,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
69749,valsartan,250.4,Diabetes with renal manifestations,0
69749,valsartan,401-405.99,,1
69749,valsartan,401.9,Hypertension NOS,1
69749,valsartan,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
69749,valsartan,428.0,Congestive heart failure (CHF) NOS,0
69749,valsartan,997.91,Hypertension,1
70223,Aldesleukin,042,Human immunodeficiency virus [HIV] disease,0
70223,Aldesleukin,042-042.99,,0
70223,Aldesleukin,172.9,Melanoma of skin; site unspecified,1
70223,Aldesleukin,189.0,Malignant neoplasm of kidney; except pelvis,1
70223,Aldesleukin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
70223,Aldesleukin,203.0,Multiple myeloma,0
70223,Aldesleukin,203.00,Multiple myeloma without mention of having achieved remission,0
70223,Aldesleukin,239.0,Neoplasm of unspecified nature of digestive system,0
70223,Aldesleukin,279.49,Autoimmune disease; not elsewhere classified (ADDED),1
70223,Aldesleukin,698.9,Unspecified pruritic disorder,1
70223,Aldesleukin,799.89,Other ill-defined conditions,1
70223,Aldesleukin,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
70561,palonosetron,787.02,Nausea alone,1
70561,palonosetron,787.03,Vomiting alone,1
71227,Phenytoin sodium,345.10,Generalized convulsive epilepsy; without mention of intractable epilepsy,1
71227,Phenytoin sodium,345.40,Partial epilepsy without intractable epilepsy,0
71227,Phenytoin sodium,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,0
71227,Phenytoin sodium,757.39,Other specified congenital anomalies of skin,0
71227,Phenytoin sodium,780.39,Other convulsions,1
71512,Phenoxybenzamine Hydrochloride,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
71512,Phenoxybenzamine Hydrochloride,239.9,Neoplasm of unspecified nature; site unspecified,0
71512,Phenoxybenzamine Hydrochloride,401.0,Malignant essential hypertension,0
71512,Phenoxybenzamine Hydrochloride,596.0,Bladder neck obstruction,0
71512,Phenoxybenzamine Hydrochloride,788.3,Urinary incontinence,0
71512,Phenoxybenzamine Hydrochloride,788.30,Urinary incontinence NOS,0
71517,Propoxyphene Hydrochloride,338-338.99,,0
71517,Propoxyphene Hydrochloride,780.96,Generalized pain,0
71534,Triprolidine Hydrochloride,372.14,Other chronic allergic conjunctivitis,0
71534,Triprolidine Hydrochloride,691.8,Other atopic dermatitis,0
71722,Docusate Sodium,455,Hemorrhoids,0
71722,Docusate Sodium,455.6,Hemorrhoids NOS,0
71722,Docusate Sodium,564.0,Constipation,0
71722,Docusate Sodium,564.00,Constipation NOS,0
72143,Raloxifene,174.9,Malignant neoplasm of breast (female); unspecified,1
72143,Raloxifene,233.0,Carcinoma in situ of breast,1
72143,Raloxifene,733.0,Osteoporosis,1
72143,Raloxifene,733.00,Osteoporosis NOS,1
72143,Raloxifene,733.01,Senile osteoporosis,1
72236,fosphenytoin,345.3,Grand mal status; epileptic,1
72236,fosphenytoin,780.39,Other convulsions,1
72257,interferon beta-1b,340,Multiple sclerosis,1
72260,Perindopril Erbumine,250.4,Diabetes with renal manifestations,0
72260,Perindopril Erbumine,401,Essential hypertension,1
72260,Perindopril Erbumine,401-405.99,,1
72260,Perindopril Erbumine,401.9,Hypertension NOS,1
72260,Perindopril Erbumine,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,1
72260,Perindopril Erbumine,428,Heart failure,1
72260,Perindopril Erbumine,428.0,Congestive heart failure (CHF) NOS,1
72260,Perindopril Erbumine,428.9,Heart failure unspecified,1
72260,Perindopril Erbumine,429.3,Cardiomegaly,0
72260,Perindopril Erbumine,997.91,Hypertension,1
72302,ropinirole,332,Parkinson's disease,0
72302,ropinirole,332.0,Paralysis agitans,0
72302,ropinirole,333.94,Restless legs syndrome (RLS),1
72302,ropinirole,781.99,Other symptoms involving nervous and musculoskeletal systems,0
72435,anakinra,714.0,Rheumatoid arthritis,1
72610,troglitazone,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
72611,cefditoren pivoxil,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
72611,cefditoren pivoxil,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
72611,cefditoren pivoxil,136.9,Unspecified infectious and parasitic diseases,1
72611,cefditoren pivoxil,462,Acute pharyngitis,1
72611,cefditoren pivoxil,463,Acute tonsillitis,1
72611,cefditoren pivoxil,482.9,Bacterial pneumonia NOS,0
72611,cefditoren pivoxil,486,Pneumonia; organism unspecified,1
72611,cefditoren pivoxil,490,Bronchitis NOS,1
72611,cefditoren pivoxil,491,Chronic bronchitis,1
72611,cefditoren pivoxil,491.9,Chronic bronchitis NOS,1
72611,cefditoren pivoxil,686.9,Unspecified local infection of skin and subcutaneous tissue,0
72625,duloxetine,250.6,Diabetes with neurological manifestations,0
72625,duloxetine,296.20,Major depressive disorder; single episode; unspecified degree,1
72625,duloxetine,300.00,Anxiety state unspecified,1
72625,duloxetine,300.02,Generalized anxiety disorder,1
72625,duloxetine,300.9,Unspecified nonpsychotic mental disorder,1
72625,duloxetine,338-338.99,,1
72625,duloxetine,355.9,Mononeuritis NOS,1
72625,duloxetine,715.00,Osteoarthrosis; generalized; involving unspecified site,1
72625,duloxetine,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
72625,duloxetine,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
72625,duloxetine,724.2,Lumbago,1
72625,duloxetine,729.0,Rheumatism; unspecified and fibrositis,1
72625,duloxetine,729.1,Myalgia and myositis unspecified,1
72625,duloxetine,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
72625,duloxetine,780.79,Other malaise and fatigue,1
72625,duloxetine,780.96,Generalized pain,1
72625,duloxetine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
72625,duloxetine,788.39,Other urinary incontinence,0
72901,ferumoxides,239.0,Neoplasm of unspecified nature of digestive system,0
72937,tolcapone,332,Parkinson's disease,0
72937,tolcapone,332.0,Paralysis agitans,0
72962,docetaxel,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
72962,docetaxel,172.9,Melanoma of skin; site unspecified,0
72962,docetaxel,185,Malignant neoplasm of prostate,1
72962,docetaxel,239.0,Neoplasm of unspecified nature of digestive system,0
72962,docetaxel,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
72962,docetaxel,239.3,Neoplasm of unspecified nature of breast,0
72962,docetaxel,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
72962,docetaxel,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),0
72965,letrozole,174.9,Malignant neoplasm of breast (female); unspecified,1
72965,letrozole,239.3,Neoplasm of unspecified nature of breast,0
73032,remifentanil,338-338.99,,0
73032,remifentanil,780.96,Generalized pain,0
73044,repaglinide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
73056,Risedronate,731.0,Osteitis deformans without mention of bone tumor,1
73056,Risedronate,733.0,Osteoporosis,1
73056,Risedronate,733.00,Osteoporosis NOS,1
73056,Risedronate,733.01,Senile osteoporosis,1
73137,tirofiban,410-414.99,,0
73137,tirofiban,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
73137,tirofiban,411.1,Intermediate coronary syndrome,1
73137,tirofiban,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,0
73137,tirofiban,414.8,Other specified forms of chronic ischemic heart disease,0
73137,tirofiban,414.9,Chronic ischemic heart disease; unspecified,0
73178,iloperidone,295,Schizophrenic disorders,1
73178,iloperidone,295.9,Unspecified schizophrenia,1
73178,iloperidone,295.90,Unspecified schizophrenia; unspecified state,1
73494,telmisartan,250,Diabetes mellitus,1
73494,telmisartan,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
73494,telmisartan,250.4,Diabetes with renal manifestations,0
73494,telmisartan,401,Essential hypertension,1
73494,telmisartan,401-405.99,,1
73494,telmisartan,401.9,Hypertension NOS,1
73494,telmisartan,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
73494,telmisartan,428.0,Congestive heart failure (CHF) NOS,0
73494,telmisartan,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
73494,telmisartan,997.91,Hypertension,1
73645,valacyclovir,053,Herpes zoster,1
73645,valacyclovir,053.9,Herpes zoster without mention of complication,1
73645,valacyclovir,054,Herpes simplex,1
73645,valacyclovir,054.1,Genital herpes,1
73645,valacyclovir,054.10,Genital herpes NOS,1
73645,valacyclovir,054.9,Herpes simplex without mention of complication,1
73645,valacyclovir,709.9,Unspecified disorder of skin and subcutaneous tissue,1
73645,valacyclovir,780.96,Generalized pain,1
73689,febuxostat,274,Gout,1
73689,febuxostat,274.9,Gout NOS,1
73689,febuxostat,790.6,Other abnormal blood chemistry,1
73710,paricalcitol,252.0,Hyperparathyroidism,1
73710,paricalcitol,252.00,Hyperparathyroidism NOS,1
73710,paricalcitol,585.6,End stage renal disease,1
73710,paricalcitol,585.9,Chronic kidney disease; unspecified,1
73710,paricalcitol,586,Renal failure unspecified,1
73710,paricalcitol,588.81,Secondary hyperparathyroidism (of renal origin),1
74169,Piperacillin / tazobactam,136.9,Unspecified infectious and parasitic diseases,1
74169,Piperacillin / tazobactam,486,Pneumonia; organism unspecified,1
74169,Piperacillin / tazobactam,567.9,Peritonitis NOS,1
74169,Piperacillin / tazobactam,686.9,Unspecified local infection of skin and subcutaneous tissue,1
74667,zaleplon,307.42,Persistent disorder of initiating or maintaining sleep,0
74667,zaleplon,780.52,Insomnia; unspecified,1
74670,corticorelin ovine triflutate,253.9,Unspecified disorder of the pituitary gland and its hypothalamic control,0
74671,corticorelin ovine,253.9,Unspecified disorder of the pituitary gland and its hypothalamic control,0
74671,corticorelin ovine,255.0,Cushing's syndrome,1
75207,bosentan,401-405.99,,1
75207,bosentan,401.9,Hypertension NOS,1
75207,bosentan,416.0,Primary pulmonary hypertension,1
75207,bosentan,997.91,Hypertension,1
75635,eptifibatide,410-414.99,,0
75635,eptifibatide,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
75635,eptifibatide,411.1,Intermediate coronary syndrome,1
75635,eptifibatide,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,0
75635,eptifibatide,414.8,Other specified forms of chronic ischemic heart disease,0
75635,eptifibatide,414.9,Chronic ischemic heart disease; unspecified,0
75917,Interferon beta-1a,340,Multiple sclerosis,1
75917,Interferon beta-1a,780-789.99,,0
76469,BCG  Live  Connaught Strain,010-018.99,,0
76469,BCG  Live  Connaught Strain,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
76469,BCG  Live  Connaught Strain,239.4,Neoplasm of unspecified nature of bladder,0
76895,Reteplase,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
76895,Reteplase,428.0,Congestive heart failure (CHF) NOS,1
77492,tamsulosin,600,Hyperplasia of prostate,1
77492,tamsulosin,600.0,Hypertrophy (benign) of prostate,0
77492,tamsulosin,600.9,Hyperplasia of prostate; unspecified,1
77492,tamsulosin,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),1
77655,zoledronic acid,174.9,Malignant neoplasm of breast (female); unspecified,1
77655,zoledronic acid,185,Malignant neoplasm of prostate,1
77655,zoledronic acid,198.5,Secondary malignant neoplasm of bone and bone marrow,1
77655,zoledronic acid,199,Malignant neoplasm without specification of site,1
77655,zoledronic acid,199.1,Other malignant neoplasm of unspecified site,1
77655,zoledronic acid,203.0,Multiple myeloma,1
77655,zoledronic acid,203.00,Multiple myeloma without mention of having achieved remission,1
77655,zoledronic acid,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
77655,zoledronic acid,275.42,Hypercalcemia,1
77655,zoledronic acid,731.0,Osteitis deformans without mention of bone tumor,0
77655,zoledronic acid,733.0,Osteoporosis,1
77655,zoledronic acid,733.00,Osteoporosis NOS,1
77655,zoledronic acid,733.01,Senile osteoporosis,1
77655,zoledronic acid,733.90,Disorder of bone and cartilage; unspecified,1
77655,zoledronic acid,780.96,Generalized pain,0
78484,danaparoid,287.5,Thrombocytopenia NOS,0
78484,danaparoid,415.19,Other pulmonary embolism and infarction,0
78484,danaparoid,453.9,Embolism and thrombosis of unspecified site,0
78484,danaparoid,459.9,Unspecified circulatory system disorder,0
78484,danaparoid,790.99,Other nonspecific findings on examination of blood,0
78484,danaparoid,998.9,Unspecified complication of procedure; not elsewhere classified,0
78678,Rauwolfia preparation,401-405.99,,0
78678,Rauwolfia preparation,401.9,Hypertension NOS,0
78678,Rauwolfia preparation,997.91,Hypertension,0
78903,Capreomycin,010-018.99,,1
78903,Capreomycin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
81647,phenylbutyrate,238.79,Other lymphatic and hematopoietic tissues,0
81647,phenylbutyrate,277.0,Cystic fibrosis,0
81647,phenylbutyrate,277.00,Cystic fibrosis without mention of meconium ileus,0
81647,phenylbutyrate,282.44,Beta thalassemia,0
81647,phenylbutyrate,282.5,Sickle-cell trait,0
81647,phenylbutyrate,282.6,Sickle-cell disease,0
81647,phenylbutyrate,282.60,Sickle cell disease NOS,0
81647,phenylbutyrate,282.61,Hb-SS disease without crisis,0
81864,alitretinoin,176,Kaposi's sarcoma,0
81864,alitretinoin,176.9,Kaposi's sarcoma NOS,0
81864,alitretinoin,709.9,Unspecified disorder of skin and subcutaneous tissue,0
81952,Amphetamine Sulfate,314,Hyperkinetic syndrome of childhood,0
81952,Amphetamine Sulfate,314.01,Attention deficit disorder of childhood with hyperactivity,0
81952,Amphetamine Sulfate,314.9,Unspecified hyperkinetic syndrome of childhood,0
81952,Amphetamine Sulfate,347.0,Narcolepsy,0
81952,Amphetamine Sulfate,347.00,Narcolepsy; without cataplexy,0
81963,Benzydamine Hydrochloride,462,Acute pharyngitis,1
81963,Benzydamine Hydrochloride,782.9,Other symptoms involving skin and integumentary tissues,1
81965,Betaine Hydrochloride,270.4,Disturbances of sulphur-bearing amino-acid metabolism,1
81984,Clomipramine Hydrochloride,300.01,Panic disorder without agoraphobia,0
81984,Clomipramine Hydrochloride,300.3,Obsessive-compulsive disorders,1
81984,Clomipramine Hydrochloride,311,Depressive disorder NEC,0
81984,Clomipramine Hydrochloride,338-338.99,,0
81984,Clomipramine Hydrochloride,780.96,Generalized pain,0
81993,Demeclocycline Hydrochloride,033.0,Whooping cough due to bordetella pertussis (b. pertussis),0
81993,Demeclocycline Hydrochloride,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
81993,Demeclocycline Hydrochloride,088.81,Lyme disease,1
81993,Demeclocycline Hydrochloride,098,Gonococcal infections,1
81993,Demeclocycline Hydrochloride,098.89,Gonococcal infection of other specified sites,1
81993,Demeclocycline Hydrochloride,136.9,Unspecified infectious and parasitic diseases,1
81993,Demeclocycline Hydrochloride,253.6,Other disorders of neurohypophysis,0
81993,Demeclocycline Hydrochloride,486,Pneumonia; organism unspecified,1
81993,Demeclocycline Hydrochloride,519.8,Other diseases of respiratory system; not elsewhere classified,1
81993,Demeclocycline Hydrochloride,599.0,Urinary tract infection; site not specified,1
81993,Demeclocycline Hydrochloride,706.1,Other acne,1
81997,Diclofenac Potassium,338-338.99,,1
81997,Diclofenac Potassium,368.13,Visual discomfort,0
81997,Diclofenac Potassium,379.99,Other ill-defined disorders of eye,0
81997,Diclofenac Potassium,625.3,Dysmenorrhea,1
81997,Diclofenac Potassium,701.1,Keratoderma; acquired,0
81997,Diclofenac Potassium,714.0,Rheumatoid arthritis,1
81997,Diclofenac Potassium,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,0
81997,Diclofenac Potassium,715.00,Osteoarthrosis; generalized; involving unspecified site,1
81997,Diclofenac Potassium,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
81997,Diclofenac Potassium,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
81997,Diclofenac Potassium,716.90,Arthropathy; unspecified; site unspecified,1
81997,Diclofenac Potassium,720.0,Ankylosing spondylitis,0
81997,Diclofenac Potassium,780.60,Fever; unspecified,0
81997,Diclofenac Potassium,780.96,Generalized pain,1
81998,Diethylpropion Hydrochloride,278.00,Obesity NOS,1
81998,Diethylpropion Hydrochloride,783.9,Other symptoms concerning nutrition; metabolism; and development,1
82001,Docusate Calcium,455,Hemorrhoids,0
82001,Docusate Calcium,455.6,Hemorrhoids NOS,0
82001,Docusate Calcium,564.0,Constipation,0
82001,Docusate Calcium,564.00,Constipation NOS,0
82002,docusate potassium,455,Hemorrhoids,0
82002,docusate potassium,455.6,Hemorrhoids NOS,0
82002,docusate potassium,564.0,Constipation,0
82002,docusate potassium,564.00,Constipation NOS,0
82003,Docusate,455,Hemorrhoids,0
82003,Docusate,455.6,Hemorrhoids NOS,0
82003,Docusate,564.0,Constipation,1
82003,Docusate,564.00,Constipation NOS,1
82004,Diphenhydramine Citrate,300.00,Anxiety state unspecified,0
82004,Diphenhydramine Citrate,307.42,Persistent disorder of initiating or maintaining sleep,0
82004,Diphenhydramine Citrate,375.2,Epiphora,0
82004,Diphenhydramine Citrate,375.20,Epiphora NOS,0
82004,Diphenhydramine Citrate,379.99,Other ill-defined disorders of eye,0
82004,Diphenhydramine Citrate,460,Acute nasopharyngitis (common cold),0
82004,Diphenhydramine Citrate,477.0,Allergic rhinitis due to pollen,0
82004,Diphenhydramine Citrate,477.9,Allergic rhinitis NOS,0
82004,Diphenhydramine Citrate,698.9,Unspecified pruritic disorder,0
82004,Diphenhydramine Citrate,708,Urticaria,0
82004,Diphenhydramine Citrate,708.9,Unspecified urticaria,0
82004,Diphenhydramine Citrate,780-789.99,,0
82004,Diphenhydramine Citrate,786.2,Cough,0
82004,Diphenhydramine Citrate,787.02,Nausea alone,0
82004,Diphenhydramine Citrate,994.6,Motion sickness,0
82005,Diphenoxylate Hydrochloride,787.7,Abnormal feces,0
82005,Diphenoxylate Hydrochloride,787.91,Diarrhea,0
82010,Dopamine Hydrochloride,426.9,Conduction disorder NOS,0
82010,Dopamine Hydrochloride,427.89,Other specified cardiac dysrhythmias,0
82010,Dopamine Hydrochloride,593.9,Unspecified disorder of kidney and ureter,0
82010,Dopamine Hydrochloride,785.50,Shock NOS,0
82010,Dopamine Hydrochloride,785.9,Other symptoms involving cardiovascular system,0
82011,Doxapram Hydrochloride,786.00,Respiratory abnormality; unspecified,1
82011,Doxapram Hydrochloride,786.09,Other dyspnea and respiratory abnormality,1
82027,Hydralazine Hydrochloride,276.69,Other fluid overload,0
82027,Hydralazine Hydrochloride,401-405.99,,0
82027,Hydralazine Hydrochloride,401.0,Malignant essential hypertension,0
82027,Hydralazine Hydrochloride,401.9,Hypertension NOS,0
82027,Hydralazine Hydrochloride,416.0,Primary pulmonary hypertension,0
82027,Hydralazine Hydrochloride,428.0,Congestive heart failure (CHF) NOS,0
82027,Hydralazine Hydrochloride,997.91,Hypertension,0
82038,Loperamide Hydrochloride,004.9,Shigellosis NOS,0
82038,Loperamide Hydrochloride,558.9,Other and unspecified noninfectious gastroenteritis and colitis,1
82038,Loperamide Hydrochloride,780-789.99,,0
82038,Loperamide Hydrochloride,787.7,Abnormal feces,1
82038,Loperamide Hydrochloride,787.91,Diarrhea,1
82041,Meclizine Hydrochloride,780-789.99,,0
82041,Meclizine Hydrochloride,780.4,Dizziness and giddiness,0
82041,Meclizine Hydrochloride,787.02,Nausea alone,0
82041,Meclizine Hydrochloride,787.03,Vomiting alone,0
82041,Meclizine Hydrochloride,994.6,Motion sickness,0
82044,Methamphetamine Hydrochloride,278.00,Obesity NOS,1
82044,Methamphetamine Hydrochloride,296.99,Other specified episodic mood disorder,1
82044,Methamphetamine Hydrochloride,314,Hyperkinetic syndrome of childhood,1
82044,Methamphetamine Hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,1
82044,Methamphetamine Hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,1
82044,Methamphetamine Hydrochloride,347.0,Narcolepsy,0
82044,Methamphetamine Hydrochloride,347.00,Narcolepsy; without cataplexy,0
82054,Naphazoline Hydrochloride,461.9,Acute sinusitis NOS,0
82054,Naphazoline Hydrochloride,472.0,Chronic rhinitis,0
82054,Naphazoline Hydrochloride,695.9,Unspecified erythematous condition,0
82063,Oxycodone Hydrochloride,338-338.99,,1
82063,Oxycodone Hydrochloride,338.18,Other acute postoperative pain,1
82063,Oxycodone Hydrochloride,780.96,Generalized pain,1
82064,Oxymorphone Hydrochloride,300.00,Anxiety state unspecified,1
82064,Oxymorphone Hydrochloride,338-338.99,,1
82064,Oxymorphone Hydrochloride,514,Pulmonary congestion and hypostasis,1
82064,Oxymorphone Hydrochloride,780.96,Generalized pain,1
82064,Oxymorphone Hydrochloride,786.00,Respiratory abnormality; unspecified,1
82064,Oxymorphone Hydrochloride,786.05,Shortness of breath,1
82070,Penbutolol Sulfate,401-405.99,,0
82070,Penbutolol Sulfate,401.9,Hypertension NOS,0
82070,Penbutolol Sulfate,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
82070,Penbutolol Sulfate,413,Angina pectoris,0
82070,Penbutolol Sulfate,413.9,Other and unspecified angina pectoris,0
82070,Penbutolol Sulfate,427.89,Other specified cardiac dysrhythmias,0
82070,Penbutolol Sulfate,458,Hypotension,0
82070,Penbutolol Sulfate,458.9,Hypotension NOS,0
82070,Penbutolol Sulfate,786.50,Unspecified chest pain,0
82070,Penbutolol Sulfate,997.91,Hypertension,0
82078,Phentermine Hydrochloride,278.00,Obesity NOS,0
82084,Propranolol Hydrochloride,140-239.99,,1
82084,Propranolol Hydrochloride,239,Neoplasms of unspecified nature,1
82084,Propranolol Hydrochloride,239-239.99,,1
82084,Propranolol Hydrochloride,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
82084,Propranolol Hydrochloride,239.9,Neoplasm of unspecified nature; site unspecified,1
82084,Propranolol Hydrochloride,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,1
82084,Propranolol Hydrochloride,300.01,Panic disorder without agoraphobia,0
82084,Propranolol Hydrochloride,333.1,Essential and other specified forms of tremor,1
82084,Propranolol Hydrochloride,346,Migraine,1
82084,Propranolol Hydrochloride,346.9,Migraine; unspecified,1
82084,Propranolol Hydrochloride,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
82084,Propranolol Hydrochloride,401-405.99,,1
82084,Propranolol Hydrochloride,401.9,Hypertension NOS,1
82084,Propranolol Hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
82084,Propranolol Hydrochloride,413,Angina pectoris,1
82084,Propranolol Hydrochloride,413.9,Other and unspecified angina pectoris,1
82084,Propranolol Hydrochloride,427,Cardiac dysrhythmias,1
82084,Propranolol Hydrochloride,427.1,Paroxysmal ventricular tachycardia,1
82084,Propranolol Hydrochloride,427.41,Ventricular fibrillation,0
82084,Propranolol Hydrochloride,427.89,Other specified cardiac dysrhythmias,1
82084,Propranolol Hydrochloride,427.9,Cardiac dysrhythmia NOS,1
82084,Propranolol Hydrochloride,428.0,Congestive heart failure (CHF) NOS,0
82084,Propranolol Hydrochloride,429.9,Heart disease NOS,1
82084,Propranolol Hydrochloride,781.0,Abnormal involuntary movements,1
82084,Propranolol Hydrochloride,784.0,Headache,1
82084,Propranolol Hydrochloride,785.0,Tachycardia NOS,1
82084,Propranolol Hydrochloride,786.50,Unspecified chest pain,1
82084,Propranolol Hydrochloride,997.91,Hypertension,1
82091,Pyrilamine Maleate,372.14,Other chronic allergic conjunctivitis,0
82091,Pyrilamine Maleate,460,Acute nasopharyngitis (common cold),0
82091,Pyrilamine Maleate,477.9,Allergic rhinitis NOS,0
82091,Pyrilamine Maleate,780-789.99,,0
82093,Rimantadine Hydrochloride,136.9,Unspecified infectious and parasitic diseases,0
82093,Rimantadine Hydrochloride,487,Influenza,0
82093,Rimantadine Hydrochloride,487.1,Influenza with other respiratory manifestations,0
82101,Sulfacetamide Sodium,076,Trachoma,0
82101,Sulfacetamide Sodium,076.9,Trachoma NOS,0
82101,Sulfacetamide Sodium,370.0,Corneal ulcer,0
82101,Sulfacetamide Sodium,370.00,Corneal ulcer NOS,0
82101,Sulfacetamide Sodium,388.9,Unspecified disorder of ear,0
82101,Sulfacetamide Sodium,686.8|041.9,,0
82101,Sulfacetamide Sodium,690.1,Seborrheic dermatitis,0
82101,Sulfacetamide Sodium,690.10,Seborheic dermatitis; unspecified,0
82101,Sulfacetamide Sodium,706.1,Other acne,1
82101,Sulfacetamide Sodium,706.3,Seborrhea,0
82110,tramadol hydrochloride,338-338.99,,1
82110,tramadol hydrochloride,780.96,Generalized pain,1
82112,Trazodone Hydrochloride,295,Schizophrenic disorders,0
82112,Trazodone Hydrochloride,295.9,Unspecified schizophrenia,0
82112,Trazodone Hydrochloride,295.90,Unspecified schizophrenia; unspecified state,0
82112,Trazodone Hydrochloride,300.00,Anxiety state unspecified,0
82112,Trazodone Hydrochloride,300.9,Unspecified nonpsychotic mental disorder,0
82112,Trazodone Hydrochloride,307.42,Persistent disorder of initiating or maintaining sleep,0
82112,Trazodone Hydrochloride,311,Depressive disorder NEC,1
82122,Levofloxacin,003.9,Salmonella infection NOS,0
82122,Levofloxacin,011,Pulmonary tuberculosis,0
82122,Levofloxacin,011.9,Unspecified pulmonary tuberculosis,0
82122,Levofloxacin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
82122,Levofloxacin,022,Anthrax,1
82122,Levofloxacin,022.1,Pulmonary anthrax,1
82122,Levofloxacin,022.9,Anthrax NOS,1
82122,Levofloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
82122,Levofloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,1
82122,Levofloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,041.89,Other specified bacterial infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
82122,Levofloxacin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
82122,Levofloxacin,136.9,Unspecified infectious and parasitic diseases,1
82122,Levofloxacin,379.99|041.9,,0
82122,Levofloxacin,424.90,Endocarditis valve unspecified cause,0
82122,Levofloxacin,461.0,Acute maxillary sinusitis,1
82122,Levofloxacin,482.84,Legionnaires' disease,0
82122,Levofloxacin,482.9,Bacterial pneumonia NOS,0
82122,Levofloxacin,484.5,Pneumonia in anthrax,1
82122,Levofloxacin,486,Pneumonia; organism unspecified,1
82122,Levofloxacin,490,Bronchitis NOS,1
82122,Levofloxacin,491,Chronic bronchitis,1
82122,Levofloxacin,491.9,Chronic bronchitis NOS,1
82122,Levofloxacin,590.1,Acute pyelonephritis,1
82122,Levofloxacin,590.10,Acute pyelonephritis without lesion of renal medullary necrosis,1
82122,Levofloxacin,590.80,Pyelonephritis NOS,1
82122,Levofloxacin,599.0,Urinary tract infection; site not specified,1
82122,Levofloxacin,601,Inflammatory diseases of prostate,1
82122,Levofloxacin,601.9,Prostatitis NOS,1
82122,Levofloxacin,682.9,Cellulitis and abscess NOS,1
82122,Levofloxacin,686.8|041.9,,0
82122,Levofloxacin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
82124,Idarubicin Hydrochloride,205.0,Myeloid leukemia; acute,1
82124,Idarubicin Hydrochloride,205.00,Acute myeloid leukemia without mention of having achieved remission,1
82124,Idarubicin Hydrochloride,205.1,Myeloid leukemia; chronic,0
82124,Idarubicin Hydrochloride,205.10,Chronic myeloid leukemia without mention of having achieved remission,0
82124,Idarubicin Hydrochloride,208,Leukemia of unspecified cell type,1
82124,Idarubicin Hydrochloride,208.9,Unspecified leukemia,1
82124,Idarubicin Hydrochloride,208.90,Unspecified leukemia without mention of having achieved remission,1
82124,Idarubicin Hydrochloride,239.3,Neoplasm of unspecified nature of breast,0
82130,Mefloquine Hydrochloride,084,Malaria,0
82130,Mefloquine Hydrochloride,084.0,Falciparum malaria [malignant tertian],0
82130,Mefloquine Hydrochloride,084.1,Vivax malaria [benign tertian],1
82130,Mefloquine Hydrochloride,084.2,Quartan malaria,0
82130,Mefloquine Hydrochloride,084.6,Malaria NOS,0
82130,Mefloquine Hydrochloride,136.9,Unspecified infectious and parasitic diseases,1
82137,Dalteparin Sodium,199,Malignant neoplasm without specification of site,1
82137,Dalteparin Sodium,199.1,Other malignant neoplasm of unspecified site,1
82137,Dalteparin Sodium,410-414.99,,0
82137,Dalteparin Sodium,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
82137,Dalteparin Sodium,411.1,Intermediate coronary syndrome,1
82137,Dalteparin Sodium,414.8,Other specified forms of chronic ischemic heart disease,0
82137,Dalteparin Sodium,414.9,Chronic ischemic heart disease; unspecified,0
82137,Dalteparin Sodium,415.19,Other pulmonary embolism and infarction,1
82137,Dalteparin Sodium,444.9,Embolism and thrombosis of unspecified artery,1
82137,Dalteparin Sodium,451.9,Phlebitis and thrombophlebitis of unspecified site,1
82137,Dalteparin Sodium,453.9,Embolism and thrombosis of unspecified site,1
82137,Dalteparin Sodium,459.9,Unspecified circulatory system disorder,1
82137,Dalteparin Sodium,998.9,Unspecified complication of procedure; not elsewhere classified,0
82242,chlorophyllin copper complex,338-338.99,,0
82242,chlorophyllin copper complex,780.96,Generalized pain,0
82806,Fosphenytoin sodium,345.3,Grand mal status; epileptic,1
82806,Fosphenytoin sodium,345.9,Epilepsy; unspecified,1
82806,Fosphenytoin sodium,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
82806,Fosphenytoin sodium,780.39,Other convulsions,1
82819,acamprosate,303,Alcohol dependence syndrome,1
82819,acamprosate,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,1
82819,acamprosate,305.00,Alcohol abuse; unspecified drinking behavior,0
82819,acamprosate,305.01,Alcohol abuse; continuous drinking behavior,1
83008,bicalutamide,185,Malignant neoplasm of prostate,1
83008,bicalutamide,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
83171,Cidofovir,363.20|078.5,,0
83213,Mibefradil,401-405.99,,0
83213,Mibefradil,401.9,Hypertension NOS,0
83213,Mibefradil,413,Angina pectoris,0
83213,Mibefradil,413.9,Other and unspecified angina pectoris,0
83213,Mibefradil,786.50,Unspecified chest pain,0
83213,Mibefradil,997.91,Hypertension,0
83367,atorvastatin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
83367,atorvastatin,272.0,Pure hypercholesterolemia,1
83367,atorvastatin,272.1,Pure hyperglyceridemia,1
83367,atorvastatin,272.2,Mixed hyperlipidemia,1
83367,atorvastatin,272.4,Other and unspecified hyperlipidemia,1
83367,atorvastatin,272.8,Other disorders of lipoid metabolism,1
83367,atorvastatin,401-405.99,,1
83367,atorvastatin,401.9,Hypertension NOS,1
83367,atorvastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
83367,atorvastatin,413,Angina pectoris,1
83367,atorvastatin,413.9,Other and unspecified angina pectoris,1
83367,atorvastatin,414.00,Coronary atherosclerosis of unspecified type of vessel; native or graft,1
83367,atorvastatin,429.2,Cardiovascular disease [ASCVD],1
83367,atorvastatin,429.9,Heart disease NOS,1
83367,atorvastatin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
83367,atorvastatin,447.9,Unspecified disorders of arteries and arterioles,1
83367,atorvastatin,783.21,Loss of weight,1
83367,atorvastatin,783.9,Other symptoms concerning nutrition; metabolism; and development,1
83367,atorvastatin,786.50,Unspecified chest pain,1
83367,atorvastatin,997.91,Hypertension,1
83395,Saquinavir,042,Human immunodeficiency virus [HIV] disease,1
83395,Saquinavir,042-042.99,,1
83395,Saquinavir,136.9,Unspecified infectious and parasitic diseases,1
83515,eprosartan,250.4,Diabetes with renal manifestations,0
83515,eprosartan,401-405.99,,1
83515,eprosartan,401.9,Hypertension NOS,1
83515,eprosartan,428.0,Congestive heart failure (CHF) NOS,0
83515,eprosartan,997.91,Hypertension,1
83682,cefditoren,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
83682,cefditoren,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
83682,cefditoren,136.9,Unspecified infectious and parasitic diseases,1
83682,cefditoren,462,Acute pharyngitis,1
83682,cefditoren,463,Acute tonsillitis,1
83682,cefditoren,482.9,Bacterial pneumonia NOS,0
83682,cefditoren,486,Pneumonia; organism unspecified,1
83682,cefditoren,490,Bronchitis NOS,1
83682,cefditoren,491,Chronic bronchitis,1
83682,cefditoren,491.9,Chronic bronchitis NOS,1
83682,cefditoren,686.9,Unspecified local infection of skin and subcutaneous tissue,0
83816,Delavirdine,042,Human immunodeficiency virus [HIV] disease,0
83816,Delavirdine,042-042.99,,0
83818,irbesartan,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
83818,irbesartan,250.4,Diabetes with renal manifestations,1
83818,irbesartan,401-405.99,,1
83818,irbesartan,401.9,Hypertension NOS,1
83818,irbesartan,593.9,Unspecified disorder of kidney and ureter,1
83818,irbesartan,791.0,Proteinuria,1
83818,irbesartan,997.91,Hypertension,1
83929,abciximab,410-414.99,,0
83929,abciximab,411.1,Intermediate coronary syndrome,1
83929,abciximab,414.8,Other specified forms of chronic ischemic heart disease,0
83929,abciximab,414.9,Chronic ischemic heart disease; unspecified,0
83947,tazarotene,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
83947,tazarotene,706.1,Other acne,1
84108,rosiglitazone,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
84108,rosiglitazone,250.1,Diabetes with ketoacidosis,1
84108,rosiglitazone,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
84108,rosiglitazone,790.99,Other nonspecific findings on examination of blood,1
84158,Methylergonovine Maleate,634,Spontaneous abortion,0
84158,Methylergonovine Maleate,634.90,Spontaneous abortion; unspecified; without mention of complication,0
84158,Methylergonovine Maleate,666,Postpartum hemorrhage,0
84158,Methylergonovine Maleate,666.14,Other immediate postpartum hemorrhage; postpartum,0
84375,glatiramer acetate,340,Multiple sclerosis,1
84857,anastrozole,174.9,Malignant neoplasm of breast (female); unspecified,1
84857,anastrozole,239.3,Neoplasm of unspecified nature of breast,0
84959,imiglucerase,289.50,Spleen disease NOS,0
84959,imiglucerase,573.9,Unspecified disorder of liver,0
84959,imiglucerase,799.9,Other unknown and unspecified cause of morbidity or mortality,0
85248,alosetron,338-338.99,,1
85248,alosetron,564.1,Irritable bowel syndrome,1
85248,alosetron,780.96,Generalized pain,1
85248,alosetron,787.7,Abnormal feces,1
85248,alosetron,787.91,Diarrhea,1
85248,alosetron,789.0,Abdominal pain,1
85248,alosetron,789.00,Abdominal pain; unspecified site,1
85762,Ritonavir,042,Human immunodeficiency virus [HIV] disease,1
85762,Ritonavir,042-042.99,,1
85763,fomivirsen,363.20|078.5,,0
86009,Insulin Lispro,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
86009,Insulin Lispro,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,1
86009,Insulin Lispro,790.6,Other abnormal blood chemistry,1
87636,fexofenadine,379.99,Other ill-defined disorders of eye,0
87636,fexofenadine,477.0,Allergic rhinitis due to pollen,1
87636,fexofenadine,477.9,Allergic rhinitis NOS,1
87636,fexofenadine,698.9,Unspecified pruritic disorder,1
87636,fexofenadine,708,Urticaria,1
87636,fexofenadine,708.9,Unspecified urticaria,1
87636,fexofenadine,797,Senility without mention of psychosis,0
87865,ardeparin sodium,415.19,Other pulmonary embolism and infarction,0
87865,ardeparin sodium,453.9,Embolism and thrombosis of unspecified site,0
87865,ardeparin sodium,459.9,Unspecified circulatory system disorder,0
87865,ardeparin sodium,998.9,Unspecified complication of procedure; not elsewhere classified,0
87866,ardeparin,415.19,Other pulmonary embolism and infarction,0
87866,ardeparin,453.9,Embolism and thrombosis of unspecified site,0
87866,ardeparin,459.9,Unspecified circulatory system disorder,0
87866,ardeparin,998.9,Unspecified complication of procedure; not elsewhere classified,0
88014,rizatriptan,346,Migraine,1
88014,rizatriptan,346.9,Migraine; unspecified,1
88014,rizatriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
88014,rizatriptan,784.0,Headache,1
88249,montelukast,477.0,Allergic rhinitis due to pollen,1
88249,montelukast,477.9,Allergic rhinitis NOS,1
88249,montelukast,493,Asthma,1
88249,montelukast,493.9,Asthma; unspecified,1
88249,montelukast,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
88249,montelukast,780-789.99,,0
89013,aripiprazole,295,Schizophrenic disorders,1
89013,aripiprazole,295.9,Unspecified schizophrenia,1
89013,aripiprazole,295.90,Unspecified schizophrenia; unspecified state,1
89013,aripiprazole,296.00,Manic disorder; single episode; unspecified degree,1
89013,aripiprazole,296.20,Major depressive disorder; single episode; unspecified degree,1
89013,aripiprazole,296.80,Bipolar disorder NOS,1
89013,aripiprazole,296.99,Other specified episodic mood disorder,0
89013,aripiprazole,299.0,Autistic disorder,1
89013,aripiprazole,299.00,Infantile autism; current or active state,1
89013,aripiprazole,300.9,Unspecified nonpsychotic mental disorder,1
89013,aripiprazole,309.89,Other specified adjustment reactions,0
89013,aripiprazole,311,Depressive disorder NEC,1
89013,aripiprazole,312.10,Undersocialized conduct disorder; unaggressive type; unspecified degree,1
89013,aripiprazole,799.22,Irritability (ADDED),1
89013,aripiprazole,799.24,Emotional lability (ADDED),1
89013,aripiprazole,799.89,Other ill-defined conditions,1
89778,Echothiophate,365.02,Anatomical narrow angle borderline glaucoma,0
89778,Echothiophate,365.1,Open-angle glaucoma,0
89778,Echothiophate,365.10,Open-angle glaucoma NOS,0
89778,Echothiophate,365.13,Pigmentary glaucoma,0
89778,Echothiophate,365.20|365.70,,0
89778,Echothiophate,378.0,Esotropia,1
89778,Echothiophate,378.00,Esotropia NOS,1
89778,Echothiophate,378.35,Accommodative component in esotropia,1
89781,belladonna extract  USP,569.9,Unspecified disorder of intestine,0
89781,belladonna extract  USP,728.85,Spasm of muscle,0
89781,belladonna extract  USP,781.0,Abnormal involuntary movements,0
89781,belladonna extract  USP,784.0,Headache,0
89785,Methscopolamine,478.19,Other diseases of nasal cavity and sinuses,0
89785,Methscopolamine,533,Peptic ulcer; site unspecified,1
89785,Methscopolamine,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
89821,Witch Hazel,455,Hemorrhoids,1
89821,Witch Hazel,455.6,Hemorrhoids NOS,1
89821,Witch Hazel,616.10,Vaginitis and vulvovaginitis NOS,0
89821,Witch Hazel,692.9,Contact dermatitis and other eczema; unspecified cause,0
89821,Witch Hazel,698.0,Pruritus ani,0
89821,Witch Hazel,698.9,Unspecified pruritic disorder,1
89821,Witch Hazel,781.99,Other symptoms involving nervous and musculoskeletal systems,1
89821,Witch Hazel,919.4,Insect bite; nonvenomous; of other; multiple; and unspecified sites; without mention of infection,0
89858,Aluminum carbonate,530.11,Reflux esophagitis,0
89858,Aluminum carbonate,530.81,Esophageal reflux,0
89858,Aluminum carbonate,531,Gastric ulcer,0
89858,Aluminum carbonate,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
89858,Aluminum carbonate,532,Duodenal ulcer,0
89858,Aluminum carbonate,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
89858,Aluminum carbonate,536.8,Dyspepsia and other specified disorders of function of stomach,0
89858,Aluminum carbonate,578,Gastrointestinal hemorrhage,0
89858,Aluminum carbonate,578.9,Hemorrhage of gastrointestinal tract NOS,0
89858,Aluminum carbonate,585.6,End stage renal disease,0
89858,Aluminum carbonate,585.9,Chronic kidney disease; unspecified,0
89858,Aluminum carbonate,586,Renal failure unspecified,0
89858,Aluminum carbonate,787.1,Heartburn,0
89887,Latrodectus mactans antivenin,989.5|E905.1,,0
89903,Potassium gluconate,276.8,Hypopotassemia,0
91063,Tripelennamine Hydrochloride,477.9,Allergic rhinitis NOS,0
91063,Tripelennamine Hydrochloride,708,Urticaria,0
91063,Tripelennamine Hydrochloride,708.9,Unspecified urticaria,0
91066,Carbinoxamine maleate,477.0,Allergic rhinitis due to pollen,0
91066,Carbinoxamine maleate,477.9,Allergic rhinitis NOS,0
91104,Codeine sulfate,338.18,Other acute postoperative pain,0
91104,Codeine sulfate,786.2,Cough,0
91109,Butabarbital sodium,300.00,Anxiety state unspecified,0
91109,Butabarbital sodium,307.42,Persistent disorder of initiating or maintaining sleep,0
91109,Butabarbital sodium,780.52,Insomnia; unspecified,1
91118,Imipramine pamoate,296.20,Major depressive disorder; single episode; unspecified degree,1
91118,Imipramine pamoate,300.01,Panic disorder without agoraphobia,0
91118,Imipramine pamoate,307.6,Enuresis,0
91118,Imipramine pamoate,311,Depressive disorder NEC,1
91118,Imipramine pamoate,314,Hyperkinetic syndrome of childhood,0
91118,Imipramine pamoate,314.01,Attention deficit disorder of childhood with hyperactivity,0
91118,Imipramine pamoate,314.9,Unspecified hyperkinetic syndrome of childhood,0
91118,Imipramine pamoate,338-338.99,,0
91118,Imipramine pamoate,780.96,Generalized pain,0
91154,Biperiden Hydrochloride,332,Parkinson's disease,0
91154,Biperiden Hydrochloride,332.0,Paralysis agitans,0
91154,Biperiden Hydrochloride,977.9,Poisoning by unspecified drug or medicinal substance,0
91165,Ephedrine hydrochloride,458.0,Orthostatic hypotension,0
91165,Ephedrine hydrochloride,472.0,Chronic rhinitis,0
91165,Ephedrine hydrochloride,493,Asthma,0
91165,Ephedrine hydrochloride,493.9,Asthma; unspecified,0
91165,Ephedrine hydrochloride,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
91165,Ephedrine hydrochloride,519.11,Acute bronchospasm,0
91166,Ephedrine sulfate,458.0,Orthostatic hypotension,0
91166,Ephedrine sulfate,472.0,Chronic rhinitis,0
91166,Ephedrine sulfate,493,Asthma,0
91166,Ephedrine sulfate,493.9,Asthma; unspecified,0
91166,Ephedrine sulfate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
91166,Ephedrine sulfate,519.11,Acute bronchospasm,0
91167,Phenylephrine bitartrate,365.1,Open-angle glaucoma,0
91167,Phenylephrine bitartrate,365.10,Open-angle glaucoma NOS,0
91167,Phenylephrine bitartrate,365.13,Pigmentary glaucoma,0
91167,Phenylephrine bitartrate,427.89,Other specified cardiac dysrhythmias,0
91167,Phenylephrine bitartrate,455,Hemorrhoids,0
91167,Phenylephrine bitartrate,455.6,Hemorrhoids NOS,0
91167,Phenylephrine bitartrate,458,Hypotension,0
91167,Phenylephrine bitartrate,458.9,Hypotension NOS,0
91167,Phenylephrine bitartrate,477.9,Allergic rhinitis NOS,0
91167,Phenylephrine bitartrate,565.0,Anal fissure,0
91167,Phenylephrine bitartrate,569.41,Ulcer of anus and rectum,0
91167,Phenylephrine bitartrate,698.0,Pruritus ani,0
91167,Phenylephrine bitartrate,785.52,Septic shock,0
91168,Pseudoephedrine Hydrochloride,460,Acute nasopharyngitis (common cold),0
91168,Pseudoephedrine Hydrochloride,461.9,Acute sinusitis NOS,0
91168,Pseudoephedrine Hydrochloride,477.9,Allergic rhinitis NOS,0
91168,Pseudoephedrine Hydrochloride,478.19,Other diseases of nasal cavity and sinuses,0
91168,Pseudoephedrine Hydrochloride,493,Asthma,0
91168,Pseudoephedrine Hydrochloride,493.9,Asthma; unspecified,0
91168,Pseudoephedrine Hydrochloride,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
91168,Pseudoephedrine Hydrochloride,786.2,Cough,0
91168,Pseudoephedrine Hydrochloride,995.3,Allergy unspecified not elsewhere classified,0
91169,Pseudoephedrine sulfate,460,Acute nasopharyngitis (common cold),0
91169,Pseudoephedrine sulfate,461.9,Acute sinusitis NOS,0
91169,Pseudoephedrine sulfate,477.9,Allergic rhinitis NOS,0
91169,Pseudoephedrine sulfate,478.19,Other diseases of nasal cavity and sinuses,0
91169,Pseudoephedrine sulfate,493,Asthma,0
91169,Pseudoephedrine sulfate,493.9,Asthma; unspecified,0
91169,Pseudoephedrine sulfate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
91169,Pseudoephedrine sulfate,995.3,Allergy unspecified not elsewhere classified,0
91188,Dyclonine hydrochloride,338-338.99,,0
91188,Dyclonine hydrochloride,780.96,Generalized pain,0
91188,Dyclonine hydrochloride,784.0,Headache,0
91235,Digitalis preparation,427.31,Atrial fibrillation,0
91235,Digitalis preparation,427.32,Atrial flutter,0
91235,Digitalis preparation,427.89,Other specified cardiac dysrhythmias,0
91235,Digitalis preparation,428.0,Congestive heart failure (CHF) NOS,0
91235,Digitalis preparation,785.51,Cardiogenic shock,0
91235,Digitalis preparation,785.9,Other symptoms involving cardiovascular system,0
91263,Aloe Extract,564.0,Constipation,0
91263,Aloe Extract,564.00,Constipation NOS,0
91264,Malt soup extract,564.0,Constipation,0
91264,Malt soup extract,564.00,Constipation NOS,0
91264,Malt soup extract,787.7,Abnormal feces,0
91264,Malt soup extract,787.91,Diarrhea,0
91293,Naftifine hydrochloride,110.3,Dermatophytosis of groin and perianal area,0
91293,Naftifine hydrochloride,110.4,Dermatophytosis of foot,0
91311,Diflorasone,698.9,Unspecified pruritic disorder,0
91311,Diflorasone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
91351,Flurbiprofen sodium,362.53,Cystoid macular degeneration of retina,0
91351,Flurbiprofen sodium,379.42,Miosis (persistent); not due to miotics,1
91351,Flurbiprofen sodium,714.0,Rheumatoid arthritis,0
91351,Flurbiprofen sodium,715.00,Osteoarthrosis; generalized; involving unspecified site,0
91351,Flurbiprofen sodium,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
91351,Flurbiprofen sodium,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
91603,Tetanus immune globulin  human,037,Tetanus,1
91603,Tetanus immune globulin  human,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,1
102490,Dextromethorphan Hydrobromide,338-338.99,,0
102490,Dextromethorphan Hydrobromide,460,Acute nasopharyngitis (common cold),0
102490,Dextromethorphan Hydrobromide,487,Influenza,0
102490,Dextromethorphan Hydrobromide,487.1,Influenza with other respiratory manifestations,0
102490,Dextromethorphan Hydrobromide,780.96,Generalized pain,0
102490,Dextromethorphan Hydrobromide,786.2,Cough,0
103755,Meperidine Hydrochloride,338-338.99,,1
103755,Meperidine Hydrochloride,780.09,Other alteration of consciousness,0
103755,Meperidine Hydrochloride,780.96,Generalized pain,1
103990,Carbidopa / Levodopa,332,Parkinson's disease,1
103990,Carbidopa / Levodopa,332.0,Paralysis agitans,1
103990,Carbidopa / Levodopa,780-789.99,,0
103990,Carbidopa / Levodopa,787.02,Nausea alone,1
103990,Carbidopa / Levodopa,787.03,Vomiting alone,1
104123,Olsalazine sodium,556,Ulcerative colitis,0
104123,Olsalazine sodium,556.8,Other ulcerative colitis,0
104123,Olsalazine sodium,556.9,Ulcerative colitis; unspecified,0
104466,Tinzaparin sodium,415.19,Other pulmonary embolism and infarction,1
104466,Tinzaparin sodium,451.9,Phlebitis and thrombophlebitis of unspecified site,1
104466,Tinzaparin sodium,453.9,Embolism and thrombosis of unspecified site,1
104466,Tinzaparin sodium,459.9,Unspecified circulatory system disorder,1
104485,Colestipol Hydrochloride,008.45,Intestinal infection due to clostridium difficile,0
104485,Colestipol Hydrochloride,272.1,Pure hyperglyceridemia,1
104485,Colestipol Hydrochloride,272.4,Other and unspecified hyperlipidemia,1
104485,Colestipol Hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
104485,Colestipol Hydrochloride,447.9,Unspecified disorders of arteries and arterioles,1
104485,Colestipol Hydrochloride,787.7,Abnormal feces,0
104485,Colestipol Hydrochloride,787.91,Diarrhea,0
104592,Cyproheptadine hydrochloride,253.7,Iatrogenic pituitary disorders,0
104592,Cyproheptadine hydrochloride,295,Schizophrenic disorders,0
104592,Cyproheptadine hydrochloride,295.9,Unspecified schizophrenia,0
104592,Cyproheptadine hydrochloride,295.90,Unspecified schizophrenia; unspecified state,0
104592,Cyproheptadine hydrochloride,333.81,Blepharospasm,0
104592,Cyproheptadine hydrochloride,339.00,Cluster headache syndrome; unspecified,0
104592,Cyproheptadine hydrochloride,339.02,Chronic cluster headache,0
104592,Cyproheptadine hydrochloride,346,Migraine,0
104592,Cyproheptadine hydrochloride,346.9,Migraine; unspecified,0
104592,Cyproheptadine hydrochloride,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
104592,Cyproheptadine hydrochloride,477.0,Allergic rhinitis due to pollen,0
104592,Cyproheptadine hydrochloride,477.9,Allergic rhinitis NOS,0
104592,Cyproheptadine hydrochloride,698.9,Unspecified pruritic disorder,0
104592,Cyproheptadine hydrochloride,708,Urticaria,0
104592,Cyproheptadine hydrochloride,708.9,Unspecified urticaria,0
104592,Cyproheptadine hydrochloride,728.9,Unspecified disorder of muscle; ligament; and fascia,0
104592,Cyproheptadine hydrochloride,781.3,Lack of coordination,0
104728,Chlorpromazine hydrochloride,037,Tetanus,0
104728,Chlorpromazine hydrochloride,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
104728,Chlorpromazine hydrochloride,136.9,Unspecified infectious and parasitic diseases,0
104728,Chlorpromazine hydrochloride,277.1,Disorders of porphyrin metabolism,0
104728,Chlorpromazine hydrochloride,290-299.99,,0
104728,Chlorpromazine hydrochloride,295,Schizophrenic disorders,0
104728,Chlorpromazine hydrochloride,295.9,Unspecified schizophrenia,0
104728,Chlorpromazine hydrochloride,295.90,Unspecified schizophrenia; unspecified state,0
104728,Chlorpromazine hydrochloride,298.9,Unspecified psychosis,0
104728,Chlorpromazine hydrochloride,300.00,Anxiety state unspecified,0
104728,Chlorpromazine hydrochloride,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
104728,Chlorpromazine hydrochloride,308.2,Predominant psychomotor disturbance,0
104728,Chlorpromazine hydrochloride,780-789.99,,0
104728,Chlorpromazine hydrochloride,786.8,Hiccough,0
104728,Chlorpromazine hydrochloride,787.02,Nausea alone,0
104728,Chlorpromazine hydrochloride,787.03,Vomiting alone,0
104728,Chlorpromazine hydrochloride,799.21,Nervousness (ADDED),0
104966,dihydrocodeine bitartrate,338-338.99,,0
104966,dihydrocodeine bitartrate,338.18,Other acute postoperative pain,0
104966,dihydrocodeine bitartrate,514,Pulmonary congestion and hypostasis,0
104966,dihydrocodeine bitartrate,780.96,Generalized pain,0
104966,dihydrocodeine bitartrate,786.2,Cough,0
105069,Naltrexone hydrochloride,292.89,Other specified drug-induced mental disorders,0
105069,Naltrexone hydrochloride,303,Alcohol dependence syndrome,0
105069,Naltrexone hydrochloride,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
105069,Naltrexone hydrochloride,305.01,Alcohol abuse; continuous drinking behavior,0
105443,Pamidronate Disodium,174.9,Malignant neoplasm of breast (female); unspecified,1
105443,Pamidronate Disodium,199,Malignant neoplasm without specification of site,1
105443,Pamidronate Disodium,199.1,Other malignant neoplasm of unspecified site,1
105443,Pamidronate Disodium,203.0,Multiple myeloma,1
105443,Pamidronate Disodium,203.00,Multiple myeloma without mention of having achieved remission,1
105443,Pamidronate Disodium,275.42,Hypercalcemia,1
105443,Pamidronate Disodium,338-338.99,,1
105443,Pamidronate Disodium,731.0,Osteitis deformans without mention of bone tumor,1
105443,Pamidronate Disodium,733.01,Senile osteoporosis,0
105443,Pamidronate Disodium,733.90,Disorder of bone and cartilage; unspecified,1
105443,Pamidronate Disodium,733.99,Other disorders of bone and cartilage,1
105443,Pamidronate Disodium,780.96,Generalized pain,1
105669,Polysaccharide iron complex,280,Iron deficiency anemias,0
105669,Polysaccharide iron complex,280.9,Iron deficiency anemia; unspecified,0
105694,Epoetin Alfa,285.9,Anemia unspecified,1
105694,Epoetin Alfa,585.6,End stage renal disease,1
105694,Epoetin Alfa,585.9,Chronic kidney disease; unspecified,1
105694,Epoetin Alfa,586,Renal failure unspecified,1
106101,Oxymetazoline hydrochloride,372.30,Conjunctivitis NOS,0
106101,Oxymetazoline hydrochloride,472.0,Chronic rhinitis,0
106101,Oxymetazoline hydrochloride,478.19,Other diseases of nasal cavity and sinuses,0
106212,Calamine,692.9,Contact dermatitis and other eczema; unspecified cause,0
106876,isoniazid / Rifampin,010-018.99,,1
106876,isoniazid / Rifampin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
106876,isoniazid / Rifampin,036,Meningococcal infection,1
106876,isoniazid / Rifampin,036.9,Meningococcal infection; unspecified,1
106876,isoniazid / Rifampin,136.9,Unspecified infectious and parasitic diseases,1
106928,Betamethasone / Clotrimazole,110.3,Dermatophytosis of groin and perianal area,1
106928,Betamethasone / Clotrimazole,110.4,Dermatophytosis of foot,1
106928,Betamethasone / Clotrimazole,110.5,Dermatophytosis of the body,1
106955,Hydrocortisone / pramoxine,338-338.99,,1
106955,Hydrocortisone / pramoxine,455,Hemorrhoids,1
106955,Hydrocortisone / pramoxine,455.6,Hemorrhoids NOS,1
106955,Hydrocortisone / pramoxine,698.9,Unspecified pruritic disorder,1
106955,Hydrocortisone / pramoxine,780.96,Generalized pain,1
106955,Hydrocortisone / pramoxine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
106964,Hydrocortisone / Lidocaine,455,Hemorrhoids,1
106964,Hydrocortisone / Lidocaine,455.6,Hemorrhoids NOS,1
106964,Hydrocortisone / Lidocaine,692.9,Contact dermatitis and other eczema; unspecified cause,1
106964,Hydrocortisone / Lidocaine,698.9,Unspecified pruritic disorder,1
106964,Hydrocortisone / Lidocaine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
106986,Hydrocortisone / Oxytetracycline,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
106986,Hydrocortisone / Oxytetracycline,379.99|041.9,,1
107771,Demecarium,365.02,Anatomical narrow angle borderline glaucoma,0
107771,Demecarium,365.20|365.70,,0
107771,Demecarium,378.30,Heterotropia NOS,0
107771,Demecarium,378.4,Heterophoria,0
107771,Demecarium,378.40,Heterophoria NOS,0
107771,Demecarium,378.9,Unspecified disorder of eye movements,0
108088,Alclometasone,692.9,Contact dermatitis and other eczema; unspecified cause,0
108088,Alclometasone,709.9,Unspecified disorder of skin and subcutaneous tissue,1
108118,Mometasone,461.9,Acute sinusitis NOS,1
108118,Mometasone,477.0,Allergic rhinitis due to pollen,1
108118,Mometasone,477.9,Allergic rhinitis NOS,1
108118,Mometasone,493,Asthma,1
108118,Mometasone,493.9,Asthma; unspecified,1
108118,Mometasone,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
108118,Mometasone,519.11,Acute bronchospasm,1
108118,Mometasone,698.9,Unspecified pruritic disorder,0
113374,aminosalicylate,010-018.99,,0
113374,aminosalicylate,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
114194,Warfarin Sodium,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
114194,Warfarin Sodium,415.19,Other pulmonary embolism and infarction,1
114194,Warfarin Sodium,427.31,Atrial fibrillation,1
114194,Warfarin Sodium,427.9,Cardiac dysrhythmia NOS,1
114194,Warfarin Sodium,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
114194,Warfarin Sodium,435.9,Unspecified transient cerebral ischemia,0
114194,Warfarin Sodium,444.9,Embolism and thrombosis of unspecified artery,1
114194,Warfarin Sodium,451.9,Phlebitis and thrombophlebitis of unspecified site,0
114194,Warfarin Sodium,453.9,Embolism and thrombosis of unspecified site,1
114194,Warfarin Sodium,459.9,Unspecified circulatory system disorder,0
114194,Warfarin Sodium,799.9,Other unknown and unspecified cause of morbidity or mortality,1
114194,Warfarin Sodium,998.9,Unspecified complication of procedure; not elsewhere classified,0
114202,Lactate,276.2,Acidosis,0
114202,Lactate,692.9,Contact dermatitis and other eczema; unspecified cause,0
114202,Lactate,698.9,Unspecified pruritic disorder,1
114202,Lactate,757.1,Ichthyosis congenita,1
114203,feverfew extract,536.8,Dyspepsia and other specified disorders of function of stomach,0
114203,feverfew extract,780.60,Fever; unspecified,0
114289,Indinavir,042,Human immunodeficiency virus [HIV] disease,1
114289,Indinavir,042-042.99,,1
114289,Indinavir,799.89,Other ill-defined conditions,1
114477,Levetiracetam,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
114477,Levetiracetam,345.9,Epilepsy; unspecified,1
114477,Levetiracetam,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
114477,Levetiracetam,780.39,Other convulsions,1
114970,zafirlukast,493,Asthma,1
114970,zafirlukast,493.9,Asthma; unspecified,1
114970,zafirlukast,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
114979,rabeprazole,251.5,Abnormality of secretion of gastrin,0
114979,rabeprazole,530.81,Esophageal reflux,1
114979,rabeprazole,532,Duodenal ulcer,1
114979,rabeprazole,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
114979,rabeprazole,707.9,Chronic ulcer of unspecified site,1
114979,rabeprazole,787.1,Heartburn,1
115238,Becaplermin,136.9,Unspecified infectious and parasitic diseases,1
115238,Becaplermin,707.15,Ulcer of other part of foot,0
115238,Becaplermin,707.9,Chronic ulcer of unspecified site,1
115264,Ibandronate,733.0,Osteoporosis,1
115264,Ibandronate,733.00,Osteoporosis NOS,1
115264,Ibandronate,733.01,Senile osteoporosis,1
115265,ibandronic acid,733.0,Osteoporosis,1
115265,ibandronic acid,733.00,Osteoporosis NOS,1
115265,ibandronic acid,733.01,Senile osteoporosis,1
115552,trovafloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
115552,trovafloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
115552,trovafloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
115552,trovafloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
115552,trovafloxacin,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
115552,trovafloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
115552,trovafloxacin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
115552,trovafloxacin,098,Gonococcal infections,0
115552,trovafloxacin,098.89,Gonococcal infection of other specified sites,0
115552,trovafloxacin,461.9,Acute sinusitis NOS,0
115552,trovafloxacin,482.9,Bacterial pneumonia NOS,0
115552,trovafloxacin,490,Bronchitis NOS,0
115698,ziprasidone,295,Schizophrenic disorders,1
115698,ziprasidone,295.9,Unspecified schizophrenia,1
115698,ziprasidone,295.90,Unspecified schizophrenia; unspecified state,1
115698,ziprasidone,296.00,Manic disorder; single episode; unspecified degree,1
115698,ziprasidone,296.80,Bipolar disorder NOS,1
115698,ziprasidone,300.9,Unspecified nonpsychotic mental disorder,1
115698,ziprasidone,307.23,Tourette's disorder,0
115698,ziprasidone,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
115698,ziprasidone,308.2,Predominant psychomotor disturbance,1
115698,ziprasidone,309.89,Other specified adjustment reactions,1
115698,ziprasidone,799.21,Nervousness (ADDED),1
115698,ziprasidone,799.9,Other unknown and unspecified cause of morbidity or mortality,1
117055,alemtuzumab,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
117055,alemtuzumab,204,Lymphoid leukemia,1
117055,alemtuzumab,204.1,Lymphoid leukemia; chronic,1
117055,alemtuzumab,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
117055,alemtuzumab,204.9,Unspecified lymphoid leukemia,1
117055,alemtuzumab,204.90,Unspecified lymphoid leukemia without mention of having achieved remission,1
118463,Olmesartan medoxomil,250.4,Diabetes with renal manifestations,0
118463,Olmesartan medoxomil,401-405.99,,1
118463,Olmesartan medoxomil,401.9,Hypertension NOS,1
118463,Olmesartan medoxomil,428.0,Congestive heart failure (CHF) NOS,0
118463,Olmesartan medoxomil,997.91,Hypertension,1
118886,Verteporfin,115,Histoplasmosis,1
118886,Verteporfin,115.9,Histoplasmosis; unspecified,1
118886,Verteporfin,115.90,Histoplasmosis; unspecified without mention of manifestation,1
118886,Verteporfin,362.50,Macular degeneration (senile) of retina NOS,1
118886,Verteporfin,367.1,Myopia,1
119565,tolterodine,596.51,Hypertonicity of bladder,1
119565,tolterodine,596.89,Other specified disorders of bladder,0
119565,tolterodine,596.9,Unspecified disorder of bladder,0
119565,tolterodine,788.3,Urinary incontinence,1
119565,tolterodine,788.30,Urinary incontinence NOS,1
119565,tolterodine,788.31,Urge incontinence,1
119565,tolterodine,788.41,Urinary frequency,1
119565,tolterodine,788.69,Other abnormality of urination,1
119771,doripenem,136.9,Unspecified infectious and parasitic diseases,1
119771,doripenem,486,Pneumonia; organism unspecified,1
120608,peginterferon alfa-2a,042,Human immunodeficiency virus [HIV] disease,1
120608,peginterferon alfa-2a,042-042.99,,1
120608,peginterferon alfa-2a,070.31,Viral hepatitis B without mention of hepatic coma; acute or unspecified; with hepatitis delta,0
120608,peginterferon alfa-2a,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
120608,peginterferon alfa-2a,070.54,Chronic hepatitis C without mention of hepatic coma,1
120608,peginterferon alfa-2a,070.7,Unspecified viral hepatitis C,1
120608,peginterferon alfa-2a,070.70,Unspecified viral hepatitis C without hepatic coma,1
120608,peginterferon alfa-2a,070.9,Unspecified viral hepatitis without mention of hepatic coma,1
120608,peginterferon alfa-2a,078.1,Viral warts,0
120608,peginterferon alfa-2a,078.10,Viral warts; unspecified,0
120608,peginterferon alfa-2a,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,1
120608,peginterferon alfa-2a,136.9,Unspecified infectious and parasitic diseases,1
120608,peginterferon alfa-2a,155.0,Malignant neoplasm of liver; primary,0
120608,peginterferon alfa-2a,172.9,Melanoma of skin; site unspecified,0
120608,peginterferon alfa-2a,176,Kaposi's sarcoma,0
120608,peginterferon alfa-2a,176.9,Kaposi's sarcoma NOS,0
120608,peginterferon alfa-2a,189.0,Malignant neoplasm of kidney; except pelvis,0
120608,peginterferon alfa-2a,202.1,Mycosis fungoides,0
120608,peginterferon alfa-2a,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
120608,peginterferon alfa-2a,202.2,Sezary's disease,0
120608,peginterferon alfa-2a,202.20,Sezary's disease; unspecified site; extranodal and solid organ sites,0
120608,peginterferon alfa-2a,202.4,Leukemic reticuloendotheliosis,0
120608,peginterferon alfa-2a,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,0
120608,peginterferon alfa-2a,203.0,Multiple myeloma,0
120608,peginterferon alfa-2a,203.00,Multiple myeloma without mention of having achieved remission,0
120608,peginterferon alfa-2a,228.0,Hemangioma; any site,0
120608,peginterferon alfa-2a,228.00,Hemangioma NOS,0
120608,peginterferon alfa-2a,238.71,Essential thrombocythemia,0
120608,peginterferon alfa-2a,239.0,Neoplasm of unspecified nature of digestive system,0
120608,peginterferon alfa-2a,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
120608,peginterferon alfa-2a,239.6,Neoplasm of unspecified nature of brain,0
120608,peginterferon alfa-2a,273.2,Other paraproteinemias,0
120608,peginterferon alfa-2a,287.5,Thrombocytopenia NOS,0
120608,peginterferon alfa-2a,362.50,Macular degeneration (senile) of retina NOS,0
120608,peginterferon alfa-2a,571.5,Cirrhosis of liver without mention of alcohol,1
120608,peginterferon alfa-2a,707.9,Chronic ulcer of unspecified site,0
120608,peginterferon alfa-2a,709.8,Other specified disorders of skin,0
120608,peginterferon alfa-2a,790.99,Other nonspecific findings on examination of blood,0
121191,rituximab,136.9,Unspecified infectious and parasitic diseases,0
121191,rituximab,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
121191,rituximab,714.0,Rheumatoid arthritis,1
121243,voriconazole,110-118.99,,1
121243,voriconazole,112,Candidiasis,1
121243,voriconazole,112.84,Candidal esophagitis,1
121243,voriconazole,112.89,Other candidiasis of other specified sites,1
121243,voriconazole,112.9,Candidiasis of unspecified site,1
121243,voriconazole,117.3,Aspergillosis,1
121243,voriconazole,117.9,Other and unspecified mycoses,1
121243,voriconazole,136.9,Unspecified infectious and parasitic diseases,1
121243,voriconazole,238.75,Myelodysplastic syndrome; unspecified,1
132879,pentetate calcium trisodium,984,Toxic effect of lead and its compounds (including fumes),0
132879,pentetate calcium trisodium,984.9,Toxic effect of unspecified lead compound,0
132879,pentetate calcium trisodium,985.2,Toxic effect of manganese and its compounds,0
132889,Levonordefrin,525.9,Dental disorder NOS,0
132889,Levonordefrin,528.2,Oral aphthae,0
133008,Amoxicillin trihydrate,027.0,Listeriosis,0
133008,Amoxicillin trihydrate,039,Actinomycotic infections,0
133008,Amoxicillin trihydrate,039.9,Actinomycosis NOS,0
133008,Amoxicillin trihydrate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
133008,Amoxicillin trihydrate,041.9|421.0,,0
133008,Amoxicillin trihydrate,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
133008,Amoxicillin trihydrate,088.81,Lyme disease,0
133008,Amoxicillin trihydrate,136.9,Unspecified infectious and parasitic diseases,0
133008,Amoxicillin trihydrate,382.9,Unspecified otitis media,0
133008,Amoxicillin trihydrate,461.9,Acute sinusitis NOS,0
133008,Amoxicillin trihydrate,532,Duodenal ulcer,0
133008,Amoxicillin trihydrate,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
133008,Amoxicillin trihydrate,599.0,Urinary tract infection; site not specified,0
133008,Amoxicillin trihydrate,686.8|041.9,,0
133008,Amoxicillin trihydrate,E928.3,Human bite,0
134404,Urofollitropin,256.4,Polycystic ovaries,0
134404,Urofollitropin,628,Infertility; female,0
134404,Urofollitropin,628.9,Female infertility NOS,0
134527,Nelfinavir,042,Human immunodeficiency virus [HIV] disease,1
134527,Nelfinavir,042-042.99,,1
134547,bendamustine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
134547,bendamustine,204,Lymphoid leukemia,1
134547,bendamustine,204.1,Lymphoid leukemia; chronic,1
134547,bendamustine,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
134547,bendamustine,204.9,Unspecified lymphoid leukemia,1
134547,bendamustine,204.90,Unspecified lymphoid leukemia without mention of having achieved remission,1
134568,bentoquatam,692.9,Contact dermatitis and other eczema; unspecified cause,0
134615,brimonidine,365,Glaucoma,1
134615,brimonidine,365.04,Ocular hypertension,1
134615,brimonidine,365.1,Open-angle glaucoma,0
134615,brimonidine,365.10,Open-angle glaucoma NOS,0
134615,brimonidine,365.13,Pigmentary glaucoma,0
134615,brimonidine,365.9,Glaucoma NOS,1
134748,rasagiline,332,Parkinson's disease,0
134748,rasagiline,332.0,Paralysis agitans,0
135095,Aspirin / Codeine,338-338.99,,0
135095,Aspirin / Codeine,780.96,Generalized pain,0
135313,isopropyl unoprostone,365,Glaucoma,1
135313,isopropyl unoprostone,365.04,Ocular hypertension,1
135313,isopropyl unoprostone,365.1,Open-angle glaucoma,0
135313,isopropyl unoprostone,365.10,Open-angle glaucoma NOS,0
135313,isopropyl unoprostone,365.13,Pigmentary glaucoma,0
135313,isopropyl unoprostone,365.9,Glaucoma NOS,1
135391,olopatadine,372.14,Other chronic allergic conjunctivitis,1
135391,olopatadine,698.9,Unspecified pruritic disorder,1
135447,donepezil,290,Dementias,1
135447,donepezil,294.2,,1
135447,donepezil,294.20,Dementia; unspecified; without behavioral disturbance,1
135447,donepezil,331.0,Alzheimer's disease,0
135481,candesartan cilexetil,250.4,Diabetes with renal manifestations,0
135481,candesartan cilexetil,401-405.99,,1
135481,candesartan cilexetil,401.9,Hypertension NOS,1
135481,candesartan cilexetil,428,Heart failure,1
135481,candesartan cilexetil,428.0,Congestive heart failure (CHF) NOS,0
135481,candesartan cilexetil,428.9,Heart failure unspecified,1
135481,candesartan cilexetil,997.91,Hypertension,1
135775,zolmitriptan,346,Migraine,1
135775,zolmitriptan,346.00,Migraine with aura; without mention of intractable migraine without mention of status migrainosus,1
135775,zolmitriptan,346.9,Migraine; unspecified,1
135775,zolmitriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
135775,zolmitriptan,784.0,Headache,1
136198,darifenacin,596.51,Hypertonicity of bladder,1
136198,darifenacin,788.3,Urinary incontinence,1
136198,darifenacin,788.30,Urinary incontinence NOS,1
136198,darifenacin,788.31,Urge incontinence,1
136411,sildenafil,302.72,Psychosexual dysfunction with inhibited sexual excitement,1
136411,sildenafil,401-405.99,,1
136411,sildenafil,401.9,Hypertension NOS,1
136411,sildenafil,416.0,Primary pulmonary hypertension,1
136411,sildenafil,607.84,Impotence of organic origin,1
136411,sildenafil,997.91,Hypertension,1
138099,gemifloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
138099,gemifloxacin,136.9,Unspecified infectious and parasitic diseases,1
138099,gemifloxacin,481,Pneumococcal pneumonia [streptococcus pneumoniae pneumonia],0
138099,gemifloxacin,482.3,Pneumonia due to Streptococcus,0
138099,gemifloxacin,482.30,Pneumonia due to Streptococcus; unspecified,0
138099,gemifloxacin,486,Pneumonia; organism unspecified,1
138099,gemifloxacin,490,Bronchitis NOS,1
138099,gemifloxacin,491,Chronic bronchitis,1
138099,gemifloxacin,491.9,Chronic bronchitis NOS,1
138099,gemifloxacin,599.0,Urinary tract infection; site not specified,0
139462,moxifloxacin,003.9,Salmonella infection NOS,0
139462,moxifloxacin,010-018.99,,0
139462,moxifloxacin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
139462,moxifloxacin,022,Anthrax,0
139462,moxifloxacin,022.9,Anthrax NOS,0
139462,moxifloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
139462,moxifloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
139462,moxifloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
139462,moxifloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
139462,moxifloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
139462,moxifloxacin,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
139462,moxifloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
139462,moxifloxacin,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,1
139462,moxifloxacin,098,Gonococcal infections,0
139462,moxifloxacin,098.89,Gonococcal infection of other specified sites,0
139462,moxifloxacin,136.9,Unspecified infectious and parasitic diseases,1
139462,moxifloxacin,372.03,Other mucopurulent conjunctivitis,1
139462,moxifloxacin,372.30,Conjunctivitis NOS,1
139462,moxifloxacin,424.90,Endocarditis valve unspecified cause,0
139462,moxifloxacin,461.9,Acute sinusitis NOS,1
139462,moxifloxacin,482.9,Bacterial pneumonia NOS,0
139462,moxifloxacin,486,Pneumonia; organism unspecified,1
139462,moxifloxacin,490,Bronchitis NOS,1
139462,moxifloxacin,519.8,Other diseases of respiratory system; not elsewhere classified,1
139462,moxifloxacin,590.80,Pyelonephritis NOS,0
139462,moxifloxacin,595,Cystitis,0
139462,moxifloxacin,595.9,Cystitis NOS,0
139462,moxifloxacin,599.0,Urinary tract infection; site not specified,0
139462,moxifloxacin,682.9,Cellulitis and abscess NOS,1
139778,tegaserod,564.0,Constipation,1
139778,tegaserod,564.00,Constipation NOS,1
139778,tegaserod,564.1,Irritable bowel syndrome,1
139778,tegaserod,789.00,Abdominal pain; unspecified site,0
139825,insulin detemir,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
139825,insulin detemir,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,1
139825,insulin detemir,790.6,Other abnormal blood chemistry,1
139896,enfuvirtide,042,Human immunodeficiency virus [HIV] disease,0
139896,enfuvirtide,042-042.99,,0
139896,enfuvirtide,136.9,Unspecified infectious and parasitic diseases,1
139953,Pramlintide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
139953,Pramlintide,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,1
139953,Pramlintide,783.21,Loss of weight,0
139953,Pramlintide,783.9,Other symptoms concerning nutrition; metabolism; and development,0
139994,Oprelvekin,199,Malignant neoplasm without specification of site,1
139994,Oprelvekin,199.1,Other malignant neoplasm of unspecified site,1
139994,Oprelvekin,287.5,Thrombocytopenia NOS,1
139994,Oprelvekin,790.99,Other nonspecific findings on examination of blood,1
140108,Caspofungin,110-118.99,,1
140108,Caspofungin,112,Candidiasis,1
140108,Caspofungin,112.89,Other candidiasis of other specified sites,1
140108,Caspofungin,112.9,Candidiasis of unspecified site,1
140108,Caspofungin,117.3,Aspergillosis,1
140108,Caspofungin,117.9,Other and unspecified mycoses,1
140108,Caspofungin,136.9,Unspecified infectious and parasitic diseases,1
140108,Caspofungin,567.9,Peritonitis NOS,1
140108,Caspofungin,682.2,Cellulitis and abscess of trunk,1
140480,icodextrin,782.3,Edema,0
140480,icodextrin,789.5,Ascites,0
140480,icodextrin,789.59,Other ascites,0
140587,celecoxib,211.3,Benign neoplasm of colon,1
140587,celecoxib,338-338.99,,1
140587,celecoxib,338.1,Acute pain,1
140587,celecoxib,625.3,Dysmenorrhea,1
140587,celecoxib,714.0,Rheumatoid arthritis,1
140587,celecoxib,715.00,Osteoarthrosis; generalized; involving unspecified site,1
140587,celecoxib,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
140587,celecoxib,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
140587,celecoxib,716.90,Arthropathy; unspecified; site unspecified,1
140587,celecoxib,720.0,Ankylosing spondylitis,1
140587,celecoxib,780.96,Generalized pain,1
140587,celecoxib,780.99,Other general symptoms,1
141366,naratriptan,296.99,Other specified episodic mood disorder,0
141366,naratriptan,346,Migraine,1
141366,naratriptan,346.9,Migraine; unspecified,1
141366,naratriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
141366,naratriptan,780-789.99,,0
141366,naratriptan,784.0,Headache,1
141366,naratriptan,787.02,Nausea alone,0
141400,adefovir dipivoxil,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
141400,adefovir dipivoxil,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
141400,adefovir dipivoxil,799.9,Other unknown and unspecified cause of morbidity or mortality,0
141440,alatrofloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
141440,alatrofloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
141440,alatrofloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
141440,alatrofloxacin,041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
141440,alatrofloxacin,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
141440,alatrofloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
141440,alatrofloxacin,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
141440,alatrofloxacin,098,Gonococcal infections,0
141440,alatrofloxacin,098.89,Gonococcal infection of other specified sites,0
141440,alatrofloxacin,461.9,Acute sinusitis NOS,0
141440,alatrofloxacin,482.9,Bacterial pneumonia NOS,0
141440,alatrofloxacin,490,Bronchitis NOS,0
141625,Colesevelam hydrochloride,008.45,Intestinal infection due to clostridium difficile,0
141625,Colesevelam hydrochloride,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
141625,Colesevelam hydrochloride,272.1,Pure hyperglyceridemia,0
141625,Colesevelam hydrochloride,272.4,Other and unspecified hyperlipidemia,1
141625,Colesevelam hydrochloride,440,Atherosclerosis,1
141625,Colesevelam hydrochloride,447.9,Unspecified disorders of arteries and arterioles,0
141625,Colesevelam hydrochloride,787.7,Abnormal feces,0
141625,Colesevelam hydrochloride,787.91,Diarrhea,0
141626,colesevelam,008.45,Intestinal infection due to clostridium difficile,0
141626,colesevelam,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
141626,colesevelam,272.1,Pure hyperglyceridemia,0
141626,colesevelam,272.4,Other and unspecified hyperlipidemia,1
141626,colesevelam,429.9,Heart disease NOS,1
141626,colesevelam,440,Atherosclerosis,1
141626,colesevelam,447.9,Unspecified disorders of arteries and arterioles,0
141626,colesevelam,787.7,Abnormal feces,0
141626,colesevelam,787.91,Diarrhea,0
141704,everolimus,189.0,Malignant neoplasm of kidney; except pelvis,0
141704,everolimus,55.6,Transplant of kidney,0
142130,Acebutolol Hydrochloride,401-405.99,,1
142130,Acebutolol Hydrochloride,401.9,Hypertension NOS,1
142130,Acebutolol Hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
142130,Acebutolol Hydrochloride,413,Angina pectoris,1
142130,Acebutolol Hydrochloride,413.9,Other and unspecified angina pectoris,1
142130,Acebutolol Hydrochloride,427,Cardiac dysrhythmias,1
142130,Acebutolol Hydrochloride,427.1,Paroxysmal ventricular tachycardia,0
142130,Acebutolol Hydrochloride,427.41,Ventricular fibrillation,0
142130,Acebutolol Hydrochloride,427.89,Other specified cardiac dysrhythmias,1
142130,Acebutolol Hydrochloride,427.9,Cardiac dysrhythmia NOS,1
142130,Acebutolol Hydrochloride,786.50,Unspecified chest pain,1
142130,Acebutolol Hydrochloride,997.91,Hypertension,1
142131,Magnesium Aspartate,275.2,Disorders of magnesium metabolism,0
142132,Carteolol Hydrochloride,365.1,Open-angle glaucoma,0
142132,Carteolol Hydrochloride,365.10,Open-angle glaucoma NOS,0
142132,Carteolol Hydrochloride,365.13,Pigmentary glaucoma,0
142132,Carteolol Hydrochloride,401-405.99,,0
142132,Carteolol Hydrochloride,401.9,Hypertension NOS,0
142132,Carteolol Hydrochloride,997.91,Hypertension,0
142146,Bisoprolol Fumarate,401-405.99,,1
142146,Bisoprolol Fumarate,401.9,Hypertension NOS,1
142146,Bisoprolol Fumarate,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
142146,Bisoprolol Fumarate,413,Angina pectoris,0
142146,Bisoprolol Fumarate,413.9,Other and unspecified angina pectoris,0
142146,Bisoprolol Fumarate,427.89,Other specified cardiac dysrhythmias,0
142146,Bisoprolol Fumarate,428.0,Congestive heart failure (CHF) NOS,0
142146,Bisoprolol Fumarate,786.50,Unspecified chest pain,0
142146,Bisoprolol Fumarate,997.91,Hypertension,1
142152,Delavirdine Mesylate,042,Human immunodeficiency virus [HIV] disease,1
142152,Delavirdine Mesylate,042-042.99,,1
142424,Amiloride Hydrochloride,276.2,Acidosis,1
142424,Amiloride Hydrochloride,276.7,Hyperpotassemia,1
142424,Amiloride Hydrochloride,276.8,Hypopotassemia,1
142424,Amiloride Hydrochloride,277.0,Cystic fibrosis,0
142424,Amiloride Hydrochloride,277.00,Cystic fibrosis without mention of meconium ileus,0
142424,Amiloride Hydrochloride,401-405.99,,1
142424,Amiloride Hydrochloride,401.9,Hypertension NOS,1
142424,Amiloride Hydrochloride,428.0,Congestive heart failure (CHF) NOS,1
142424,Amiloride Hydrochloride,782.3,Edema,1
142424,Amiloride Hydrochloride,788.42,Polyuria,1
142424,Amiloride Hydrochloride,789.5,Ascites,1
142424,Amiloride Hydrochloride,789.59,Other ascites,1
142424,Amiloride Hydrochloride,997.91,Hypertension,1
142425,Benzphetamine hydrochloride,278.00,Obesity NOS,0
142427,Brompheniramine Maleate,375.2,Epiphora,0
142427,Brompheniramine Maleate,375.20,Epiphora NOS,0
142427,Brompheniramine Maleate,379.99,Other ill-defined disorders of eye,0
142427,Brompheniramine Maleate,460,Acute nasopharyngitis (common cold),0
142427,Brompheniramine Maleate,477.9,Allergic rhinitis NOS,0
142429,Chlorpheniramine Maleate,460,Acute nasopharyngitis (common cold),0
142429,Chlorpheniramine Maleate,477.9,Allergic rhinitis NOS,0
142429,Chlorpheniramine Maleate,708,Urticaria,0
142429,Chlorpheniramine Maleate,708.9,Unspecified urticaria,0
142429,Chlorpheniramine Maleate,786.2,Cough,0
142429,Chlorpheniramine Maleate,995.3,Allergy unspecified not elsewhere classified,0
142430,Clemastine Fumarate,477.9,Allergic rhinitis NOS,0
142430,Clemastine Fumarate,698.9,Unspecified pruritic disorder,0
142430,Clemastine Fumarate,708,Urticaria,0
142430,Clemastine Fumarate,708.9,Unspecified urticaria,0
142430,Clemastine Fumarate,780.60,Fever; unspecified,0
142430,Clemastine Fumarate,995.3,Allergy unspecified not elsewhere classified,0
142431,Clomiphene Citrate,256.1,Other ovarian hyperfunction,1
142431,Clomiphene Citrate,256.4,Polycystic ovaries,1
142431,Clomiphene Citrate,606,Infertility; male,1
142431,Clomiphene Citrate,606.9,Male infertility NOS,1
142431,Clomiphene Citrate,628,Infertility; female,0
142431,Clomiphene Citrate,628.9,Female infertility NOS,0
142432,Clonidine Hydrochloride,292.89,Other specified drug-induced mental disorders,0
142432,Clonidine Hydrochloride,307.23,Tourette's disorder,0
142432,Clonidine Hydrochloride,314,Hyperkinetic syndrome of childhood,0
142432,Clonidine Hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,0
142432,Clonidine Hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,0
142432,Clonidine Hydrochloride,365,Glaucoma,0
142432,Clonidine Hydrochloride,365.9,Glaucoma NOS,0
142432,Clonidine Hydrochloride,401-405.99,,1
142432,Clonidine Hydrochloride,401.9,Hypertension NOS,1
142432,Clonidine Hydrochloride,527.7,Disturbance of salivary secretion,0
142432,Clonidine Hydrochloride,625.3,Dysmenorrhea,0
142432,Clonidine Hydrochloride,627.2,Symptomatic menopausal or female climacteric states,0
142432,Clonidine Hydrochloride,780.96,Generalized pain,0
142432,Clonidine Hydrochloride,781.0,Abnormal involuntary movements,0
142432,Clonidine Hydrochloride,782.62,Flushing,1
142432,Clonidine Hydrochloride,785.0,Tachycardia NOS,0
142432,Clonidine Hydrochloride,787.7,Abnormal feces,0
142432,Clonidine Hydrochloride,787.91,Diarrhea,0
142432,Clonidine Hydrochloride,997.91,Hypertension,1
142433,Doxorubicin Hydrochloride,042,Human immunodeficiency virus [HIV] disease,1
142433,Doxorubicin Hydrochloride,042-042.99,,1
142433,Doxorubicin Hydrochloride,136.9,Unspecified infectious and parasitic diseases,1
142433,Doxorubicin Hydrochloride,140-239.99,,1
142433,Doxorubicin Hydrochloride,170.9,Malignant neoplasm of bone and articular cartilage; site unspecified,1
142433,Doxorubicin Hydrochloride,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
142433,Doxorubicin Hydrochloride,176,Kaposi's sarcoma,0
142433,Doxorubicin Hydrochloride,176.9,Kaposi's sarcoma NOS,0
142433,Doxorubicin Hydrochloride,188.9,Malignant neoplasm of bladder; part unspecified,1
142433,Doxorubicin Hydrochloride,199,Malignant neoplasm without specification of site,1
142433,Doxorubicin Hydrochloride,199.1,Other malignant neoplasm of unspecified site,1
142433,Doxorubicin Hydrochloride,201,Hodgkin's disease,0
142433,Doxorubicin Hydrochloride,201.0,Hodgkin's paragranuloma,0
142433,Doxorubicin Hydrochloride,201.1,Hodgkin's granuloma,0
142433,Doxorubicin Hydrochloride,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
142433,Doxorubicin Hydrochloride,201.2,Hodgkin's sarcoma,0
142433,Doxorubicin Hydrochloride,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
142433,Doxorubicin Hydrochloride,201.9,Hodgkin's disease; unspecified type,0
142433,Doxorubicin Hydrochloride,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
142433,Doxorubicin Hydrochloride,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
142433,Doxorubicin Hydrochloride,203.0,Multiple myeloma,0
142433,Doxorubicin Hydrochloride,203.00,Multiple myeloma without mention of having achieved remission,0
142433,Doxorubicin Hydrochloride,204.0,Lymphoid leukemia; acute,1
142433,Doxorubicin Hydrochloride,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
142433,Doxorubicin Hydrochloride,205.0,Myeloid leukemia; acute,1
142433,Doxorubicin Hydrochloride,205.00,Acute myeloid leukemia without mention of having achieved remission,1
142433,Doxorubicin Hydrochloride,208,Leukemia of unspecified cell type,1
142433,Doxorubicin Hydrochloride,208.9,Unspecified leukemia,1
142433,Doxorubicin Hydrochloride,208.90,Unspecified leukemia without mention of having achieved remission,1
142433,Doxorubicin Hydrochloride,209.20,Malignant carcinoid tumor of unknown primary site,1
142433,Doxorubicin Hydrochloride,239,Neoplasms of unspecified nature,1
142433,Doxorubicin Hydrochloride,239-239.99,,1
142433,Doxorubicin Hydrochloride,239.0,Neoplasm of unspecified nature of digestive system,0
142433,Doxorubicin Hydrochloride,239.1,Neoplasm of unspecified nature of respiratory system,0
142433,Doxorubicin Hydrochloride,239.3,Neoplasm of unspecified nature of breast,0
142433,Doxorubicin Hydrochloride,239.4,Neoplasm of unspecified nature of bladder,1
142433,Doxorubicin Hydrochloride,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
142433,Doxorubicin Hydrochloride,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
142433,Doxorubicin Hydrochloride,338-338.99,,1
142433,Doxorubicin Hydrochloride,780.96,Generalized pain,1
142433,Doxorubicin Hydrochloride,799.9,Other unknown and unspecified cause of morbidity or mortality,1
142434,Econazole Nitrate,110.3,Dermatophytosis of groin and perianal area,0
142434,Econazole Nitrate,110.4,Dermatophytosis of foot,0
142434,Econazole Nitrate,111.0,Pityriasis versicolor,0
142434,Econazole Nitrate,112.3,Candidiasis of skin and nails,0
142434,Econazole Nitrate,686.9,Unspecified local infection of skin and subcutaneous tissue,0
142435,Ethambutol Hydrochloride,010-018.99,,0
142435,Ethambutol Hydrochloride,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
142435,Ethambutol Hydrochloride,031.9,Unspecified diseases due to mycobacteria,0
142437,Flavoxate Hydrochloride,788.3,Urinary incontinence,0
142437,Flavoxate Hydrochloride,788.30,Urinary incontinence NOS,0
142438,Gentamicin Sulfate (USP),038,Septicemia,0
142438,Gentamicin Sulfate (USP),038.9,Septicemia NOS,0
142438,Gentamicin Sulfate (USP),041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
142438,Gentamicin Sulfate (USP),041.7,Pseudomonas infection in conditions classified elsewhere and of unspecified site,0
142438,Gentamicin Sulfate (USP),041.9|421.0,,0
142438,Gentamicin Sulfate (USP),136.9,Unspecified infectious and parasitic diseases,0
142438,Gentamicin Sulfate (USP),379.99|041.9,,0
142438,Gentamicin Sulfate (USP),424.90,Endocarditis valve unspecified cause,0
142438,Gentamicin Sulfate (USP),519.8,Other diseases of respiratory system; not elsewhere classified,0
142438,Gentamicin Sulfate (USP),599.0,Urinary tract infection; site not specified,0
142438,Gentamicin Sulfate (USP),686.8|041.9,,0
142439,Hydrocodone Bitartrate,338-338.99,,0
142439,Hydrocodone Bitartrate,338.18,Other acute postoperative pain,0
142439,Hydrocodone Bitartrate,780.96,Generalized pain,0
142439,Hydrocodone Bitartrate,786.2,Cough,0
142439,Hydrocodone Bitartrate,V22.2,Pregnant state; incidental,0
142440,Lidocaine Hydrochloride,338-338.99,,1
142440,Lidocaine Hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
142440,Lidocaine Hydrochloride,427.1,Paroxysmal ventricular tachycardia,1
142440,Lidocaine Hydrochloride,427.2,Paroxysmal tachycardia; unspecified,0
142440,Lidocaine Hydrochloride,427.41,Ventricular fibrillation,0
142440,Lidocaine Hydrochloride,427.69,Other premature beats,1
142440,Lidocaine Hydrochloride,528.9,Other and unspecified diseases of the oral soft tissues,0
142440,Lidocaine Hydrochloride,530,Diseases of esophagus,0
142440,Lidocaine Hydrochloride,530.9,Unspecified disorder of esophagus,0
142440,Lidocaine Hydrochloride,780.96,Generalized pain,1
142440,Lidocaine Hydrochloride,940-949.99,,0
142440,Lidocaine Hydrochloride,949.0,Burn of unspecified site; unspecified degree,0
142440,Lidocaine Hydrochloride,977.9,Poisoning by unspecified drug or medicinal substance,0
142442,Naproxen sodium,274,Gout,1
142442,Naproxen sodium,274.9,Gout NOS,1
142442,Naproxen sodium,338-338.99,,1
142442,Naproxen sodium,625.3,Dysmenorrhea,1
142442,Naproxen sodium,714.0,Rheumatoid arthritis,1
142442,Naproxen sodium,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
142442,Naproxen sodium,715.00,Osteoarthrosis; generalized; involving unspecified site,1
142442,Naproxen sodium,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
142442,Naproxen sodium,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
142442,Naproxen sodium,716.90,Arthropathy; unspecified; site unspecified,1
142442,Naproxen sodium,719.50,Stiffness of joint; not elsewhere classified; involving unspecified site,0
142442,Naproxen sodium,720.0,Ankylosing spondylitis,1
142442,Naproxen sodium,726.90,Enthesopathy of specified site,1
142442,Naproxen sodium,727.3,Other bursitis disorders,1
142442,Naproxen sodium,780.60,Fever; unspecified,0
142442,Naproxen sodium,780.96,Generalized pain,1
142442,Naproxen sodium,797,Senility without mention of psychosis,1
142445,Promethazine Hydrochloride,338-338.99,,1
142445,Promethazine Hydrochloride,372.14,Other chronic allergic conjunctivitis,1
142445,Promethazine Hydrochloride,460,Acute nasopharyngitis (common cold),1
142445,Promethazine Hydrochloride,477.0,Allergic rhinitis due to pollen,1
142445,Promethazine Hydrochloride,477.9,Allergic rhinitis NOS,1
142445,Promethazine Hydrochloride,780.96,Generalized pain,1
142445,Promethazine Hydrochloride,786.2,Cough,1
142445,Promethazine Hydrochloride,787.02,Nausea alone,1
142445,Promethazine Hydrochloride,787.03,Vomiting alone,1
142445,Promethazine Hydrochloride,799.89,Other ill-defined conditions,1
142445,Promethazine Hydrochloride,994.6,Motion sickness,1
142445,Promethazine Hydrochloride,995.0,Other anaphylactic reaction,1
142445,Promethazine Hydrochloride,995.3,Allergy unspecified not elsewhere classified,1
142445,Promethazine Hydrochloride,998.9,Unspecified complication of procedure; not elsewhere classified,0
142446,tetracycline hydrochloride,041.81,Mycoplasma infection in conditions classified elsewhere and of unspecified site,0
142446,tetracycline hydrochloride,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
142446,tetracycline hydrochloride,079.98,Unspecified chlamydial infection in conditions classified elsewhere and of unspecified site,0
142446,tetracycline hydrochloride,083.9,Rickettsiosis NOS,0
142446,tetracycline hydrochloride,088.81,Lyme disease,0
142446,tetracycline hydrochloride,097.9,Syphilis NOS,0
142446,tetracycline hydrochloride,098,Gonococcal infections,0
142446,tetracycline hydrochloride,098.89,Gonococcal infection of other specified sites,0
142446,tetracycline hydrochloride,136.9,Unspecified infectious and parasitic diseases,0
142446,tetracycline hydrochloride,379.99|041.9,,0
142446,tetracycline hydrochloride,490,Bronchitis NOS,0
142446,tetracycline hydrochloride,706.1,Other acne,0
142448,liothyronine sodium,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
142448,liothyronine sodium,240-246.99,,0
142448,liothyronine sodium,240.9,Goiter NOS,0
142448,liothyronine sodium,242,Thyrotoxicosis with or without goiter,0
142448,liothyronine sodium,242.90,Thyrotoxicosis without mention of goiter or other cause; and without mention of thyrotoxic crisis or storm,0
142448,liothyronine sodium,244.9,Hypothyroidism NOS,0
142448,liothyronine sodium,245.2,Chronic lymphocytic thyroiditis,0
142448,liothyronine sodium,246.9,Unspecified disorder of thyroid,0
150816,Imipramine Hydrochloride,300.01,Panic disorder without agoraphobia,0
150816,Imipramine Hydrochloride,307.6,Enuresis,0
150816,Imipramine Hydrochloride,311,Depressive disorder NEC,0
150816,Imipramine Hydrochloride,314,Hyperkinetic syndrome of childhood,0
150816,Imipramine Hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,0
150816,Imipramine Hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,0
150816,Imipramine Hydrochloride,338-338.99,,0
150816,Imipramine Hydrochloride,780.96,Generalized pain,0
151195,Atenolol / Chlorthalidone,401-405.99,,1
151195,Atenolol / Chlorthalidone,401.9,Hypertension NOS,1
151195,Atenolol / Chlorthalidone,997.91,Hypertension,1
152021,Dicyclomine Hydrochloride,564.1,Irritable bowel syndrome,1
152021,Dicyclomine Hydrochloride,569.9,Unspecified disorder of intestine,0
152021,Dicyclomine Hydrochloride,728.85,Spasm of muscle,0
152021,Dicyclomine Hydrochloride,780-789.99,,0
152021,Dicyclomine Hydrochloride,781.0,Abnormal involuntary movements,0
152761,Acamprosate calcium,303,Alcohol dependence syndrome,1
152761,Acamprosate calcium,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,1
152761,Acamprosate calcium,305.01,Alcohol abuse; continuous drinking behavior,1
153329,Irinotecan hydrochloride,153.9,Malignant neoplasm of colon; unspecified,1
153329,Irinotecan hydrochloride,162.9,Malignant neoplasm of bronchus and lung; unspecified,0
153329,Irinotecan hydrochloride,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
153329,Irinotecan hydrochloride,208,Leukemia of unspecified cell type,0
153329,Irinotecan hydrochloride,208.9,Unspecified leukemia,0
153329,Irinotecan hydrochloride,208.90,Unspecified leukemia without mention of having achieved remission,0
153329,Irinotecan hydrochloride,239.0,Neoplasm of unspecified nature of digestive system,0
153329,Irinotecan hydrochloride,239.3,Neoplasm of unspecified nature of breast,0
153718,Balsalazide disodium,556,Ulcerative colitis,0
153718,Balsalazide disodium,556.8,Other ulcerative colitis,0
153718,Balsalazide disodium,556.9,Ulcerative colitis; unspecified,0
153970,Hyoscyamine,332,Parkinson's disease,0
153970,Hyoscyamine,332.0,Paralysis agitans,1
153970,Hyoscyamine,472.0,Chronic rhinitis,1
153970,Hyoscyamine,527.7,Disturbance of salivary secretion,1
153970,Hyoscyamine,533,Peptic ulcer; site unspecified,1
153970,Hyoscyamine,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
153970,Hyoscyamine,564.1,Irritable bowel syndrome,1
153970,Hyoscyamine,569.9,Unspecified disorder of intestine,1
153970,Hyoscyamine,577.0,Acute pancreatitis,1
153970,Hyoscyamine,595,Cystitis,1
153970,Hyoscyamine,595.9,Cystitis NOS,1
153970,Hyoscyamine,596.54,Neurogenic bladder NOS,1
153970,Hyoscyamine,596.59,Other functional disorder of bladder,1
153970,Hyoscyamine,705.21,Primary focal hyperhidrosis,1
153970,Hyoscyamine,707.9,Chronic ulcer of unspecified site,1
153970,Hyoscyamine,728.85,Spasm of muscle,1
153970,Hyoscyamine,780-789.99,,0
153970,Hyoscyamine,780.96,Generalized pain,1
153970,Hyoscyamine,781.0,Abnormal involuntary movements,1
153970,Hyoscyamine,789.00,Abdominal pain; unspecified site,1
153970,Hyoscyamine,789.7,Colic (ADDED),1
153971,Atropine Sulfate,338-338.99,,0
153971,Atropine Sulfate,364.3,Iridocyclitis NOS,0
153971,Atropine Sulfate,426.6,Other heart block,0
153971,Atropine Sulfate,427.5,Cardiac arrest,0
153971,Atropine Sulfate,427.89,Other specified cardiac dysrhythmias,0
153971,Atropine Sulfate,531,Gastric ulcer,0
153971,Atropine Sulfate,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
153971,Atropine Sulfate,780.96,Generalized pain,0
153971,Atropine Sulfate,787.7,Abnormal feces,0
153971,Atropine Sulfate,787.91,Diarrhea,0
153971,Atropine Sulfate,95.09,EYE EXAMINATION NOS,0
153971,Atropine Sulfate,977.9,Poisoning by unspecified drug or medicinal substance,0
153972,Hydroxychloroquine Sulfate,084,Malaria,0
153972,Hydroxychloroquine Sulfate,084.2,Quartan malaria,0
153972,Hydroxychloroquine Sulfate,084.6,Malaria NOS,0
153972,Hydroxychloroquine Sulfate,277.1,Disorders of porphyrin metabolism,0
153972,Hydroxychloroquine Sulfate,692.70,Unspecified dermatitis due to sun,0
153972,Hydroxychloroquine Sulfate,695.4,Lupus erythematosus,1
153972,Hydroxychloroquine Sulfate,710.0,Systemic lupus erythematosus,0
153972,Hydroxychloroquine Sulfate,714.0,Rheumatoid arthritis,1
153972,Hydroxychloroquine Sulfate,716.90,Arthropathy; unspecified; site unspecified,1
154985,Nalbuphine Hydrochloride,338-338.99,,1
154985,Nalbuphine Hydrochloride,338.18,Other acute postoperative pain,0
154985,Nalbuphine Hydrochloride,780.96,Generalized pain,1
154987,Hydroxyzine Hydrochloride,300.00,Anxiety state unspecified,0
154987,Hydroxyzine Hydrochloride,698.9,Unspecified pruritic disorder,0
154987,Hydroxyzine Hydrochloride,787.02,Nausea alone,0
154987,Hydroxyzine Hydrochloride,787.03,Vomiting alone,0
154987,Hydroxyzine Hydrochloride,995.3,Allergy unspecified not elsewhere classified,0
155002,Aminolevulinate,702.0,Actinic keratosis,1
155017,Cyclizine Hydrochloride,787.02,Nausea alone,0
155017,Cyclizine Hydrochloride,787.03,Vomiting alone,0
155017,Cyclizine Hydrochloride,994.6,Motion sickness,0
155036,Mechlorethamine hydrochloride,200.1,Lymphosarcoma,1
155036,Mechlorethamine hydrochloride,200.10,Lymphosarcoma; unspecified site; extranodal and solid organ sites,1
155036,Mechlorethamine hydrochloride,201,Hodgkin's disease,0
155036,Mechlorethamine hydrochloride,201.0,Hodgkin's paragranuloma,0
155036,Mechlorethamine hydrochloride,201.1,Hodgkin's granuloma,0
155036,Mechlorethamine hydrochloride,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,0
155036,Mechlorethamine hydrochloride,201.2,Hodgkin's sarcoma,0
155036,Mechlorethamine hydrochloride,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,0
155036,Mechlorethamine hydrochloride,201.9,Hodgkin's disease; unspecified type,0
155036,Mechlorethamine hydrochloride,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,0
155036,Mechlorethamine hydrochloride,202.1,Mycosis fungoides,1
155036,Mechlorethamine hydrochloride,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,1
155036,Mechlorethamine hydrochloride,204.1,Lymphoid leukemia; chronic,1
155036,Mechlorethamine hydrochloride,204.10,Chronic lymphoid leukemia without mention of having achieved remission,1
155036,Mechlorethamine hydrochloride,208,Leukemia of unspecified cell type,1
155036,Mechlorethamine hydrochloride,208.9,Unspecified leukemia,1
155036,Mechlorethamine hydrochloride,208.90,Unspecified leukemia without mention of having achieved remission,1
155036,Mechlorethamine hydrochloride,238.4,Polycythemia vera,1
155036,Mechlorethamine hydrochloride,511.81,Malignant pleural effusion,0
155046,Pentosan Polysulfate,338-338.99,,1
155046,Pentosan Polysulfate,595.9,Cystitis NOS,1
155046,Pentosan Polysulfate,780.96,Generalized pain,1
155046,Pentosan Polysulfate,781.99,Other symptoms involving nervous and musculoskeletal systems,1
155046,Pentosan Polysulfate,788.99,Other symptoms involving urinary system,1
155046,Pentosan Polysulfate,789.00,Abdominal pain; unspecified site,0
155056,Procainamide Hydrochloride,427,Cardiac dysrhythmias,1
155056,Procainamide Hydrochloride,427.1,Paroxysmal ventricular tachycardia,1
155056,Procainamide Hydrochloride,427.31,Atrial fibrillation,1
155056,Procainamide Hydrochloride,427.32,Atrial flutter,0
155056,Procainamide Hydrochloride,427.69,Other premature beats,0
155056,Procainamide Hydrochloride,427.89,Other specified cardiac dysrhythmias,1
155056,Procainamide Hydrochloride,427.9,Cardiac dysrhythmia NOS,1
155080,Methacholine,493,Asthma,1
155080,Methacholine,493.9,Asthma; unspecified,1
155080,Methacholine,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
155122,Phenolphthalein,564.0,Constipation,0
155122,Phenolphthalein,564.00,Constipation NOS,0
155323,methylprednisolone acetate,140-239.99,,0
155323,methylprednisolone acetate,239,Neoplasms of unspecified nature,0
155323,methylprednisolone acetate,239-239.99,,0
155323,methylprednisolone acetate,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
155323,methylprednisolone acetate,279.5,Graft-versus-host disease,0
155323,methylprednisolone acetate,279.50,Graft-versus-host disease; unspecified,0
155323,methylprednisolone acetate,280-289.99,,0
155323,methylprednisolone acetate,289.9,Blood disease NOS,0
155323,methylprednisolone acetate,514,Pulmonary congestion and hypostasis,0
155323,methylprednisolone acetate,518.52,Other pulmonary insufficiency; not elsewhere classified; following trauma and surgery,0
155323,methylprednisolone acetate,995.3,Allergy unspecified not elsewhere classified,0
159821,oxycodone terephthalate,338-338.99,,0
159821,oxycodone terephthalate,338.18,Other acute postoperative pain,0
159821,oxycodone terephthalate,780.96,Generalized pain,0
161623,methenamine mandelate,136.9,Unspecified infectious and parasitic diseases,1
161623,methenamine mandelate,595,Cystitis,1
161623,methenamine mandelate,595.9,Cystitis NOS,1
161623,methenamine mandelate,599.0,Urinary tract infection; site not specified,1
161623,methenamine mandelate,791.9,Other nonspecific findings on examination of urine,1
166283,Lidocaine / Prilocaine,707.10,Ulcer of lower limb; unspecified,1
166283,Lidocaine / Prilocaine,782.0,Disturbance of skin sensation,1
183379,rivastigmine,290,Dementias,1
183379,rivastigmine,294.2,,1
183379,rivastigmine,294.20,Dementia; unspecified; without behavioral disturbance,1
183379,rivastigmine,331.0,Alzheimer's disease,0
183379,rivastigmine,332,Parkinson's disease,0
183379,rivastigmine,332.0,Paralysis agitans,0
183830,iocetamic acid,576.9,Unspecified disorder of biliary tract,0
187832,pregabalin,053.19,Herpes zoster with other nervous system complications,1
187832,pregabalin,338-338.99,,1
187832,pregabalin,345.9,Epilepsy; unspecified,0
187832,pregabalin,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,0
187832,pregabalin,729.0,Rheumatism; unspecified and fibrositis,1
187832,pregabalin,729.1,Myalgia and myositis unspecified,1
187832,pregabalin,729.2,Neuralgia; neuritis; and radiculitis; unspecified,1
187832,pregabalin,780.39,Other convulsions,1
187832,pregabalin,780.96,Generalized pain,1
190353,Daclizumab,279.5,Graft-versus-host disease,0
190353,Daclizumab,279.50,Graft-versus-host disease; unspecified,0
190376,linezolid,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
190376,linezolid,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
190376,linezolid,136.9,Unspecified infectious and parasitic diseases,1
190376,linezolid,482.9,Bacterial pneumonia NOS,0
190376,linezolid,486,Pneumonia; organism unspecified,1
190376,linezolid,686.8|041.9,,0
190376,linezolid,686.9,Unspecified local infection of skin and subcutaneous tissue,1
190376,linezolid,730.2,Unspecified osteomyelitis,1
190376,linezolid,730.20,Unspecified osteomyelitis; site unspecified,1
190521,abacavir,042,Human immunodeficiency virus [HIV] disease,1
190521,abacavir,042-042.99,,1
190521,abacavir,136.9,Unspecified infectious and parasitic diseases,1
190548,tipranavir,042,Human immunodeficiency virus [HIV] disease,0
190548,tipranavir,042-042.99,,0
190548,tipranavir,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
191831,infliximab,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
191831,infliximab,555.9,Regional enteritis of unspecified site,0
191831,infliximab,556,Ulcerative colitis,1
191831,infliximab,556.8,Other ulcerative colitis,1
191831,infliximab,556.9,Ulcerative colitis; unspecified,1
191831,infliximab,696.0,Psoriatic arthropathy,1
191831,infliximab,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
191831,infliximab,707.9,Chronic ulcer of unspecified site,1
191831,infliximab,714.0,Rheumatoid arthritis,1
191831,infliximab,716.90,Arthropathy; unspecified; site unspecified,1
191831,infliximab,720.0,Ankylosing spondylitis,1
191831,infliximab,797,Senility without mention of psychosis,1
191831,infliximab,799.89,Other ill-defined conditions,1
194000,capecitabine,140-239.99,,1
194000,capecitabine,151.9,Malignant neoplasm of stomach; unspecified,0
194000,capecitabine,153.9,Malignant neoplasm of colon; unspecified,1
194000,capecitabine,174.9,Malignant neoplasm of breast (female); unspecified,1
194000,capecitabine,239,Neoplasms of unspecified nature,1
194000,capecitabine,239-239.99,,1
194000,capecitabine,239.0,Neoplasm of unspecified nature of digestive system,0
194000,capecitabine,239.3,Neoplasm of unspecified nature of breast,0
194279,palivizumab,079.6,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0
194337,Vorinostat,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
194337,Vorinostat,799.9,Other unknown and unspecified cause of morbidity or mortality,0
194881,brinzolamide,365,Glaucoma,1
194881,brinzolamide,365.04,Ocular hypertension,1
194881,brinzolamide,365.1,Open-angle glaucoma,0
194881,brinzolamide,365.10,Open-angle glaucoma NOS,0
194881,brinzolamide,365.13,Pigmentary glaucoma,0
194881,brinzolamide,365.9,Glaucoma NOS,1
195085,efavirenz,042,Human immunodeficiency virus [HIV] disease,0
195085,efavirenz,042-042.99,,0
195085,efavirenz,136.9,Unspecified infectious and parasitic diseases,1
195088,lopinavir,042,Human immunodeficiency virus [HIV] disease,0
196102,basiliximab,279.5,Graft-versus-host disease,0
196102,basiliximab,279.50,Graft-versus-host disease; unspecified,0
196319,Palifermin,199,Malignant neoplasm without specification of site,1
196319,Palifermin,199.1,Other malignant neoplasm of unspecified site,1
196319,Palifermin,782.9,Other symptoms involving skin and integumentary tissues,1
202693,Labetalol hydrochloride,401-405.99,,1
202693,Labetalol hydrochloride,401.0,Malignant essential hypertension,0
202693,Labetalol hydrochloride,401.9,Hypertension NOS,1
202693,Labetalol hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
202693,Labetalol hydrochloride,413,Angina pectoris,0
202693,Labetalol hydrochloride,413.9,Other and unspecified angina pectoris,0
202693,Labetalol hydrochloride,428.0,Congestive heart failure (CHF) NOS,0
202693,Labetalol hydrochloride,786.50,Unspecified chest pain,0
202693,Labetalol hydrochloride,997.91,Hypertension,1
202723,Orphenadrine Hydrochloride,037,Tetanus,0
202723,Orphenadrine Hydrochloride,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
202723,Orphenadrine Hydrochloride,338-338.99,,0
202723,Orphenadrine Hydrochloride,728.85,Spasm of muscle,0
202723,Orphenadrine Hydrochloride,728.9,Unspecified disorder of muscle; ligament; and fascia,0
202723,Orphenadrine Hydrochloride,729.1,Myalgia and myositis unspecified,0
202723,Orphenadrine Hydrochloride,729.82,Cramp of limb,0
202723,Orphenadrine Hydrochloride,780.96,Generalized pain,0
202723,Orphenadrine Hydrochloride,781.0,Abnormal involuntary movements,0
203114,Amiodarone hydrochloride,427,Cardiac dysrhythmias,1
203114,Amiodarone hydrochloride,427.1,Paroxysmal ventricular tachycardia,1
203114,Amiodarone hydrochloride,427.41,Ventricular fibrillation,1
203114,Amiodarone hydrochloride,427.89,Other specified cardiac dysrhythmias,0
203114,Amiodarone hydrochloride,427.9,Cardiac dysrhythmia NOS,1
203116,buspirone hydrochloride,300.00,Anxiety state unspecified,1
203116,buspirone hydrochloride,300.02,Generalized anxiety disorder,1
203116,buspirone hydrochloride,311,Depressive disorder NEC,1
203116,buspirone hydrochloride,315.9,Unspecified delay in development,0
203116,buspirone hydrochloride,317-319.99,,0
203116,buspirone hydrochloride,319,Unspecified mental retardation,0
203123,Enalapril Maleate,250.4,Diabetes with renal manifestations,0
203123,Enalapril Maleate,255.13,Bartter's syndrome,0
203123,Enalapril Maleate,401-405.99,,1
203123,Enalapril Maleate,401.0,Malignant essential hypertension,0
203123,Enalapril Maleate,401.9,Hypertension NOS,1
203123,Enalapril Maleate,428,Heart failure,0
203123,Enalapril Maleate,428.0,Congestive heart failure (CHF) NOS,0
203123,Enalapril Maleate,428.9,Heart failure unspecified,0
203123,Enalapril Maleate,429.3,Cardiomegaly,0
203123,Enalapril Maleate,593.9,Unspecified disorder of kidney and ureter,0
203123,Enalapril Maleate,714.0,Rheumatoid arthritis,0
203123,Enalapril Maleate,782.3,Edema,0
203123,Enalapril Maleate,997.91,Hypertension,1
203133,Penicillin G Potassium,032,Diphtheria,1
203133,Penicillin G Potassium,032.9,Diphtheria NOS,1
203133,Penicillin G Potassium,036,Meningococcal infection,0
203133,Penicillin G Potassium,036.9,Meningococcal infection; unspecified,0
203133,Penicillin G Potassium,038,Septicemia,1
203133,Penicillin G Potassium,038.9,Septicemia NOS,1
203133,Penicillin G Potassium,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
203133,Penicillin G Potassium,097.9,Syphilis NOS,1
203133,Penicillin G Potassium,098,Gonococcal infections,1
203133,Penicillin G Potassium,098.89,Gonococcal infection of other specified sites,1
203133,Penicillin G Potassium,136.9,Unspecified infectious and parasitic diseases,1
203133,Penicillin G Potassium,322,Meningitis of unspecified cause,1
203133,Penicillin G Potassium,322.9,Meningitis NOS,1
203133,Penicillin G Potassium,486,Pneumonia; organism unspecified,1
203133,Penicillin G Potassium,785.4,Gangrene,1
203135,Propafenone Hydrochloride,427,Cardiac dysrhythmias,1
203135,Propafenone Hydrochloride,427.31,Atrial fibrillation,1
203135,Propafenone Hydrochloride,427.89,Other specified cardiac dysrhythmias,0
203135,Propafenone Hydrochloride,427.9,Cardiac dysrhythmia NOS,1
203135,Propafenone Hydrochloride,429.9,Heart disease NOS,1
203135,Propafenone Hydrochloride,785.0,Tachycardia NOS,1
203137,selegiline hydrochloride,295,Schizophrenic disorders,0
203137,selegiline hydrochloride,295.9,Unspecified schizophrenia,0
203137,selegiline hydrochloride,295.90,Unspecified schizophrenia; unspecified state,0
203137,selegiline hydrochloride,311,Depressive disorder NEC,0
203137,selegiline hydrochloride,314,Hyperkinetic syndrome of childhood,0
203137,selegiline hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,0
203137,selegiline hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,0
203137,selegiline hydrochloride,331.0,Alzheimer's disease,0
203137,selegiline hydrochloride,332,Parkinson's disease,0
203137,selegiline hydrochloride,332.0,Paralysis agitans,0
203137,selegiline hydrochloride,780-789.99,,0
203138,Verapamil hydrochloride,401-405.99,,1
203138,Verapamil hydrochloride,401.9,Hypertension NOS,1
203138,Verapamil hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
203138,Verapamil hydrochloride,413,Angina pectoris,1
203138,Verapamil hydrochloride,413.1,Prinzmetal angina,0
203138,Verapamil hydrochloride,413.9,Other and unspecified angina pectoris,1
203138,Verapamil hydrochloride,427.31,Atrial fibrillation,1
203138,Verapamil hydrochloride,427.32,Atrial flutter,1
203138,Verapamil hydrochloride,427.89,Other specified cardiac dysrhythmias,1
203138,Verapamil hydrochloride,427.9,Cardiac dysrhythmia NOS,1
203138,Verapamil hydrochloride,785.0,Tachycardia NOS,1
203138,Verapamil hydrochloride,786.50,Unspecified chest pain,1
203138,Verapamil hydrochloride,997.91,Hypertension,1
203143,Fluvoxamine Maleate,296.20,Major depressive disorder; single episode; unspecified degree,1
203143,Fluvoxamine Maleate,300.00,Anxiety state unspecified,1
203143,Fluvoxamine Maleate,300.01,Panic disorder without agoraphobia,1
203143,Fluvoxamine Maleate,300.23,Social phobia,1
203143,Fluvoxamine Maleate,300.3,Obsessive-compulsive disorders,1
203143,Fluvoxamine Maleate,311,Depressive disorder NEC,1
203144,Pravastatin Sodium,272.1,Pure hyperglyceridemia,0
203144,Pravastatin Sodium,272.4,Other and unspecified hyperlipidemia,1
203144,Pravastatin Sodium,272.8,Other disorders of lipoid metabolism,1
203144,Pravastatin Sodium,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
203144,Pravastatin Sodium,413,Angina pectoris,1
203144,Pravastatin Sodium,413.9,Other and unspecified angina pectoris,1
203144,Pravastatin Sodium,429.2,Cardiovascular disease [ASCVD],1
203144,Pravastatin Sodium,429.9,Heart disease NOS,1
203144,Pravastatin Sodium,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
203144,Pravastatin Sodium,440,Atherosclerosis,1
203144,Pravastatin Sodium,447.9,Unspecified disorders of arteries and arterioles,1
203144,Pravastatin Sodium,783.21,Loss of weight,0
203144,Pravastatin Sodium,783.9,Other symptoms concerning nutrition; metabolism; and development,0
203144,Pravastatin Sodium,786.50,Unspecified chest pain,1
203150,cetirizine hydrochloride,379.99,Other ill-defined disorders of eye,1
203150,cetirizine hydrochloride,477.0,Allergic rhinitis due to pollen,1
203150,cetirizine hydrochloride,477.9,Allergic rhinitis NOS,1
203150,cetirizine hydrochloride,478.19,Other diseases of nasal cavity and sinuses,1
203150,cetirizine hydrochloride,698.9,Unspecified pruritic disorder,1
203150,cetirizine hydrochloride,708,Urticaria,1
203150,cetirizine hydrochloride,708.9,Unspecified urticaria,1
203150,cetirizine hydrochloride,780-789.99,,0
203156,Dipivefrin hydrochloride,365,Glaucoma,0
203156,Dipivefrin hydrochloride,365.1,Open-angle glaucoma,0
203156,Dipivefrin hydrochloride,365.10,Open-angle glaucoma NOS,0
203156,Dipivefrin hydrochloride,365.13,Pigmentary glaucoma,0
203156,Dipivefrin hydrochloride,365.9,Glaucoma NOS,0
203160,Losartan Potassium,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
203160,Losartan Potassium,250.4,Diabetes with renal manifestations,1
203160,Losartan Potassium,401-405.99,,1
203160,Losartan Potassium,401.9,Hypertension NOS,1
203160,Losartan Potassium,428.0,Congestive heart failure (CHF) NOS,0
203160,Losartan Potassium,429.3,Cardiomegaly,1
203160,Losartan Potassium,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
203160,Losartan Potassium,593.9,Unspecified disorder of kidney and ureter,1
203160,Losartan Potassium,791.0,Proteinuria,1
203160,Losartan Potassium,997.91,Hypertension,1
203164,Pyridoxine Hydrochloride,780.39,Other convulsions,0
203164,Pyridoxine Hydrochloride,977.9,Poisoning by unspecified drug or medicinal substance,0
203168,Amitriptyline Hydrochloride,053.19,Herpes zoster with other nervous system complications,0
203168,Amitriptyline Hydrochloride,300.00,Anxiety state unspecified,0
203168,Amitriptyline Hydrochloride,307.50,Eating disorder NOS,0
203168,Amitriptyline Hydrochloride,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,0
203168,Amitriptyline Hydrochloride,311,Depressive disorder NEC,0
203168,Amitriptyline Hydrochloride,338-338.99,,0
203168,Amitriptyline Hydrochloride,346,Migraine,0
203168,Amitriptyline Hydrochloride,346.9,Migraine; unspecified,0
203168,Amitriptyline Hydrochloride,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
203168,Amitriptyline Hydrochloride,564.1,Irritable bowel syndrome,0
203168,Amitriptyline Hydrochloride,780.96,Generalized pain,0
203170,Butorphanol Tartrate,338-338.99,,1
203170,Butorphanol Tartrate,780.96,Generalized pain,1
203173,Chlordiazepoxide Hydrochloride,300.00,Anxiety state unspecified,0
203173,Chlordiazepoxide Hydrochloride,303,Alcohol dependence syndrome,0
203173,Chlordiazepoxide Hydrochloride,303.90,Other and unspecified alcohol dependence; unspecified drinking behavior,0
203173,Chlordiazepoxide Hydrochloride,305.01,Alcohol abuse; continuous drinking behavior,0
203173,Chlordiazepoxide Hydrochloride,707.9,Chronic ulcer of unspecified site,0
203174,Desipramine Hydrochloride,311,Depressive disorder NEC,1
203174,Desipramine Hydrochloride,314,Hyperkinetic syndrome of childhood,0
203174,Desipramine Hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,0
203174,Desipramine Hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,0
203174,Desipramine Hydrochloride,338-338.99,,0
203174,Desipramine Hydrochloride,780.96,Generalized pain,0
203176,Dihydroergotamine Mesylate,346,Migraine,1
203176,Dihydroergotamine Mesylate,346.9,Migraine; unspecified,1
203176,Dihydroergotamine Mesylate,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
203176,Dihydroergotamine Mesylate,413.1,Prinzmetal angina,0
203176,Dihydroergotamine Mesylate,666,Postpartum hemorrhage,0
203176,Dihydroergotamine Mesylate,666.14,Other immediate postpartum hemorrhage; postpartum,0
203177,Hydromorphone Hydrochloride,338-338.99,,1
203177,Hydromorphone Hydrochloride,338.18,Other acute postoperative pain,0
203177,Hydromorphone Hydrochloride,780.96,Generalized pain,1
203177,Hydromorphone Hydrochloride,786.2,Cough,0
203177,Hydromorphone Hydrochloride,799.89,Other ill-defined conditions,1
203179,Doxepin Hydrochloride,300.00,Anxiety state unspecified,0
203179,Doxepin Hydrochloride,311,Depressive disorder NEC,0
203179,Doxepin Hydrochloride,338-338.99,,0
203179,Doxepin Hydrochloride,691.8,Other atopic dermatitis,0
203179,Doxepin Hydrochloride,698.9,Unspecified pruritic disorder,0
203179,Doxepin Hydrochloride,780.96,Generalized pain,0
203185,Mepivacaine Hydrochloride,338-338.99,,0
203185,Mepivacaine Hydrochloride,780.96,Generalized pain,0
203188,Methylphenidate Hydrochloride,311,Depressive disorder NEC,0
203188,Methylphenidate Hydrochloride,314,Hyperkinetic syndrome of childhood,1
203188,Methylphenidate Hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,1
203188,Methylphenidate Hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,1
203188,Methylphenidate Hydrochloride,347.0,Narcolepsy,1
203188,Methylphenidate Hydrochloride,347.00,Narcolepsy; without cataplexy,1
203188,Methylphenidate Hydrochloride,780-789.99,,0
203188,Methylphenidate Hydrochloride,780.50,Unspecified sleep disturbance,0
203191,Metoprolol Tartrate,346,Migraine,0
203191,Metoprolol Tartrate,346.9,Migraine; unspecified,0
203191,Metoprolol Tartrate,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
203191,Metoprolol Tartrate,401-405.99,,1
203191,Metoprolol Tartrate,401.9,Hypertension NOS,1
203191,Metoprolol Tartrate,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
203191,Metoprolol Tartrate,413,Angina pectoris,1
203191,Metoprolol Tartrate,413.9,Other and unspecified angina pectoris,1
203191,Metoprolol Tartrate,427.1,Paroxysmal ventricular tachycardia,0
203191,Metoprolol Tartrate,427.31,Atrial fibrillation,0
203191,Metoprolol Tartrate,427.32,Atrial flutter,0
203191,Metoprolol Tartrate,427.41,Ventricular fibrillation,0
203191,Metoprolol Tartrate,427.89,Other specified cardiac dysrhythmias,0
203191,Metoprolol Tartrate,428,Heart failure,0
203191,Metoprolol Tartrate,428.0,Congestive heart failure (CHF) NOS,0
203191,Metoprolol Tartrate,428.9,Heart failure unspecified,0
203191,Metoprolol Tartrate,429.9,Heart disease NOS,1
203191,Metoprolol Tartrate,786.50,Unspecified chest pain,1
203191,Metoprolol Tartrate,997.91,Hypertension,1
203192,Naloxone Hydrochloride,292.89,Other specified drug-induced mental disorders,0
203192,Naloxone Hydrochloride,460-519.99,,0
203192,Naloxone Hydrochloride,519.9,Unspecified disease of respiratory system,0
203192,Naloxone Hydrochloride,785.52,Septic shock,0
203192,Naloxone Hydrochloride,V12.60,Unspecified disease of respiratory system,0
203195,Penicillin V Potassium,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
203195,Penicillin V Potassium,104.9,Spirochetal infection; unspecified,0
203195,Penicillin V Potassium,136.9,Unspecified infectious and parasitic diseases,0
203195,Penicillin V Potassium,382.9,Unspecified otitis media,0
203195,Penicillin V Potassium,390,Rheumatic fever without mention of heart involvement,0
203195,Penicillin V Potassium,390-392.99,,0
203195,Penicillin V Potassium,461.9,Acute sinusitis NOS,0
203195,Penicillin V Potassium,462,Acute pharyngitis,0
203195,Penicillin V Potassium,599.0,Urinary tract infection; site not specified,0
203195,Penicillin V Potassium,686.9,Unspecified local infection of skin and subcutaneous tissue,0
203197,Phenazopyridine hydrochloride,338-338.99,,0
203197,Phenazopyridine hydrochloride,595.9,Cystitis NOS,0
203197,Phenazopyridine hydrochloride,599.0,Urinary tract infection; site not specified,0
203197,Phenazopyridine hydrochloride,780.96,Generalized pain,0
203197,Phenazopyridine hydrochloride,781.99,Other symptoms involving nervous and musculoskeletal systems,0
203199,Protriptyline Hydrochloride,311,Depressive disorder NEC,0
203204,Bupropion Hydrochloride,296.20,Major depressive disorder; single episode; unspecified degree,1
203204,Bupropion Hydrochloride,296.99,Other specified episodic mood disorder,1
203204,Bupropion Hydrochloride,305.1,Tobacco use disorder,0
203204,Bupropion Hydrochloride,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
203204,Bupropion Hydrochloride,308.2,Predominant psychomotor disturbance,1
203204,Bupropion Hydrochloride,311,Depressive disorder NEC,1
203204,Bupropion Hydrochloride,314,Hyperkinetic syndrome of childhood,0
203204,Bupropion Hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,0
203204,Bupropion Hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,0
203204,Bupropion Hydrochloride,780.39,Other convulsions,1
203204,Bupropion Hydrochloride,780.54,Hypersomnia; unspecified,1
203204,Bupropion Hydrochloride,780.79,Other malaise and fatigue,1
203204,Bupropion Hydrochloride,780.97,Altered mental status,1
203204,Bupropion Hydrochloride,799.21,Nervousness (ADDED),1
203207,Fluphenazine Hydrochloride,290-299.99,,0
203207,Fluphenazine Hydrochloride,295,Schizophrenic disorders,0
203207,Fluphenazine Hydrochloride,295.9,Unspecified schizophrenia,0
203207,Fluphenazine Hydrochloride,295.90,Unspecified schizophrenia; unspecified state,0
203207,Fluphenazine Hydrochloride,298.9,Unspecified psychosis,0
203211,Diltiazem Hydrochloride,401-405.99,,1
203211,Diltiazem Hydrochloride,401.9,Hypertension NOS,1
203211,Diltiazem Hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
203211,Diltiazem Hydrochloride,413,Angina pectoris,1
203211,Diltiazem Hydrochloride,413.1,Prinzmetal angina,1
203211,Diltiazem Hydrochloride,413.9,Other and unspecified angina pectoris,1
203211,Diltiazem Hydrochloride,427.31,Atrial fibrillation,0
203211,Diltiazem Hydrochloride,427.32,Atrial flutter,0
203211,Diltiazem Hydrochloride,427.89,Other specified cardiac dysrhythmias,0
203211,Diltiazem Hydrochloride,443.9,Peripheral vascular disease; unspecified,1
203211,Diltiazem Hydrochloride,786.50,Unspecified chest pain,1
203211,Diltiazem Hydrochloride,997.91,Hypertension,1
203212,Ipratropium Bromide,477.9,Allergic rhinitis NOS,1
203212,Ipratropium Bromide,490,Bronchitis NOS,1
203212,Ipratropium Bromide,491,Chronic bronchitis,1
203212,Ipratropium Bromide,491.9,Chronic bronchitis NOS,1
203212,Ipratropium Bromide,492,Emphysema,1
203212,Ipratropium Bromide,492.8,Other emphysema,1
203212,Ipratropium Bromide,493,Asthma,1
203212,Ipratropium Bromide,493.9,Asthma; unspecified,1
203212,Ipratropium Bromide,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
203212,Ipratropium Bromide,496,Chronic airway obstruction; not elsewhere classified,1
203212,Ipratropium Bromide,519.11,Acute bronchospasm,1
203212,Ipratropium Bromide,796.4,Other abnormal clinical findings,1
203213,Epirubicin Hydrochloride,140-239.99,,1
203213,Epirubicin Hydrochloride,151.9,Malignant neoplasm of stomach; unspecified,1
203213,Epirubicin Hydrochloride,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
203213,Epirubicin Hydrochloride,174.9,Malignant neoplasm of breast (female); unspecified,1
203213,Epirubicin Hydrochloride,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
203213,Epirubicin Hydrochloride,239,Neoplasms of unspecified nature,1
203213,Epirubicin Hydrochloride,239-239.99,,1
203213,Epirubicin Hydrochloride,239.3,Neoplasm of unspecified nature of breast,0
203214,Diclofenac Sodium,338-338.99,,1
203214,Diclofenac Sodium,368.13,Visual discomfort,1
203214,Diclofenac Sodium,379.99,Other ill-defined disorders of eye,1
203214,Diclofenac Sodium,625.3,Dysmenorrhea,0
203214,Diclofenac Sodium,701.1,Keratoderma; acquired,1
203214,Diclofenac Sodium,702.0,Actinic keratosis,1
203214,Diclofenac Sodium,714.0,Rheumatoid arthritis,1
203214,Diclofenac Sodium,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,0
203214,Diclofenac Sodium,715.00,Osteoarthrosis; generalized; involving unspecified site,1
203214,Diclofenac Sodium,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
203214,Diclofenac Sodium,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
203214,Diclofenac Sodium,716.90,Arthropathy; unspecified; site unspecified,1
203214,Diclofenac Sodium,720.0,Ankylosing spondylitis,1
203214,Diclofenac Sodium,780.60,Fever; unspecified,0
203214,Diclofenac Sodium,780.96,Generalized pain,1
203217,Leuprolide Acetate,185,Malignant neoplasm of prostate,1
203217,Leuprolide Acetate,218,Uterine leiomyoma,1
203217,Leuprolide Acetate,218.9,Uterine leiomyoma NOS,1
203217,Leuprolide Acetate,239.3,Neoplasm of unspecified nature of breast,0
203217,Leuprolide Acetate,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
203217,Leuprolide Acetate,259.1,Precocious sexual development and puberty NEC,1
203217,Leuprolide Acetate,285.9,Anemia unspecified,1
203217,Leuprolide Acetate,338-338.99,,1
203217,Leuprolide Acetate,600,Hyperplasia of prostate,0
203217,Leuprolide Acetate,600.9,Hyperplasia of prostate; unspecified,0
203217,Leuprolide Acetate,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),0
203217,Leuprolide Acetate,617,Endometriosis,1
203217,Leuprolide Acetate,617.9,Endometriosis; site unspecified,1
203217,Leuprolide Acetate,780.96,Generalized pain,1
203217,Leuprolide Acetate,V21.1,Puberty,1
203222,Esmolol hydrochloride,401-405.99,,1
203222,Esmolol hydrochloride,401.9,Hypertension NOS,1
203222,Esmolol hydrochloride,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
203222,Esmolol hydrochloride,413,Angina pectoris,0
203222,Esmolol hydrochloride,413.9,Other and unspecified angina pectoris,0
203222,Esmolol hydrochloride,427.1,Paroxysmal ventricular tachycardia,0
203222,Esmolol hydrochloride,427.41,Ventricular fibrillation,0
203222,Esmolol hydrochloride,427.89,Other specified cardiac dysrhythmias,1
203222,Esmolol hydrochloride,428.0,Congestive heart failure (CHF) NOS,0
203222,Esmolol hydrochloride,785.0,Tachycardia NOS,1
203222,Esmolol hydrochloride,786.50,Unspecified chest pain,0
203222,Esmolol hydrochloride,997.91,Hypertension,1
203223,digoxin antibodies Fab fragments,977.9,Poisoning by unspecified drug or medicinal substance,0
214177,Lyme Disease Vaccine,088.81,Lyme disease,0
214178,Acetaminophen / butalbital,784.0,Headache,1
214180,Acetaminophen / Dextromethorphan,338-338.99,,1
214180,Acetaminophen / Dextromethorphan,780.60,Fever; unspecified,1
214180,Acetaminophen / Dextromethorphan,780.96,Generalized pain,1
214180,Acetaminophen / Dextromethorphan,784.0,Headache,1
214180,Acetaminophen / Dextromethorphan,786.2,Cough,1
214182,Acetaminophen / Hydrocodone,338-338.99,,1
214182,Acetaminophen / Hydrocodone,716.90,Arthropathy; unspecified; site unspecified,1
214182,Acetaminophen / Hydrocodone,780.96,Generalized pain,1
214183,Acetaminophen / Oxycodone,338-338.99,,1
214183,Acetaminophen / Oxycodone,780.96,Generalized pain,1
214185,Acetaminophen / Pentazocine,338-338.99,,1
214185,Acetaminophen / Pentazocine,780.96,Generalized pain,1
214196,acrivastine / Pseudoephedrine,460,Acute nasopharyngitis (common cold),1
214196,acrivastine / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
214196,acrivastine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
214196,acrivastine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214199,Albuterol / Ipratropium,496,Chronic airway obstruction; not elsewhere classified,1
214199,Albuterol / Ipratropium,796.4,Other abnormal clinical findings,1
214212,Amiloride / Hydrochlorothiazide,276.8,Hypopotassemia,1
214212,Amiloride / Hydrochlorothiazide,401-405.99,,1
214212,Amiloride / Hydrochlorothiazide,401.9,Hypertension NOS,1
214212,Amiloride / Hydrochlorothiazide,428.0,Congestive heart failure (CHF) NOS,1
214212,Amiloride / Hydrochlorothiazide,997.91,Hypertension,1
214220,Amitriptyline / Chlordiazepoxide,300.00,Anxiety state unspecified,1
214220,Amitriptyline / Chlordiazepoxide,307.9,Other and unspecified special symptoms or syndromes; not elsewhere classified,1
214220,Amitriptyline / Chlordiazepoxide,308.2,Predominant psychomotor disturbance,1
214220,Amitriptyline / Chlordiazepoxide,799.21,Nervousness (ADDED),1
214223,Amlodipine / benazepril,401-405.99,,1
214223,Amlodipine / benazepril,401.9,Hypertension NOS,1
214223,Amlodipine / benazepril,997.91,Hypertension,1
214250,Aspirin / Caffeine,338-338.99,,1
214250,Aspirin / Caffeine,525.9,Dental disorder NOS,1
214250,Aspirin / Caffeine,716.90,Arthropathy; unspecified; site unspecified,1
214250,Aspirin / Caffeine,729.1,Myalgia and myositis unspecified,1
214250,Aspirin / Caffeine,780.96,Generalized pain,1
214250,Aspirin / Caffeine,784.0,Headache,1
214251,Aspirin / Carisoprodol,338-338.99,,1
214251,Aspirin / Carisoprodol,780.96,Generalized pain,1
214251,Aspirin / Carisoprodol,781.99,Other symptoms involving nervous and musculoskeletal systems,1
214254,Aspirin / Meprobamate,300.00,Anxiety state unspecified,1
214254,Aspirin / Meprobamate,338-338.99,,1
214254,Aspirin / Meprobamate,780.96,Generalized pain,1
214256,Aspirin / Oxycodone,338-338.99,,1
214256,Aspirin / Oxycodone,780.96,Generalized pain,1
214287,benazepril / Hydrochlorothiazide,401-405.99,,1
214287,benazepril / Hydrochlorothiazide,401.9,Hypertension NOS,1
214287,benazepril / Hydrochlorothiazide,997.91,Hypertension,1
214317,Bisoprolol / Hydrochlorothiazide,401-405.99,,1
214317,Bisoprolol / Hydrochlorothiazide,401.9,Hypertension NOS,1
214317,Bisoprolol / Hydrochlorothiazide,997.91,Hypertension,1
214326,Brompheniramine / Pseudoephedrine,375.2,Epiphora,1
214326,Brompheniramine / Pseudoephedrine,375.20,Epiphora NOS,1
214326,Brompheniramine / Pseudoephedrine,379.99,Other ill-defined disorders of eye,1
214326,Brompheniramine / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
214326,Brompheniramine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
214326,Brompheniramine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214326,Brompheniramine / Pseudoephedrine,698.9,Unspecified pruritic disorder,1
214326,Brompheniramine / Pseudoephedrine,995.3,Allergy unspecified not elsewhere classified,1
214336,Caffeine / Ergotamine,346,Migraine,1
214336,Caffeine / Ergotamine,346.9,Migraine; unspecified,1
214336,Caffeine / Ergotamine,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
214336,Caffeine / Ergotamine,784.0,Headache,1
214342,calcium acetate,275.3,Disorders of phosphorus metabolism,1
214342,calcium acetate,275.41,Hypocalcemia,0
214342,calcium acetate,585.6,End stage renal disease,1
214342,calcium acetate,585.9,Chronic kidney disease; unspecified,1
214342,calcium acetate,586,Renal failure unspecified,1
214342,calcium acetate,733.0,Osteoporosis,0
214342,calcium acetate,733.00,Osteoporosis NOS,0
214342,calcium acetate,733.01,Senile osteoporosis,0
214354,candesartan,250.4,Diabetes with renal manifestations,0
214354,candesartan,401-405.99,,1
214354,candesartan,401.9,Hypertension NOS,1
214354,candesartan,428,Heart failure,1
214354,candesartan,428.0,Congestive heart failure (CHF) NOS,0
214354,candesartan,428.9,Heart failure unspecified,1
214354,candesartan,997.91,Hypertension,1
214357,Captopril / Hydrochlorothiazide,401-405.99,,1
214357,Captopril / Hydrochlorothiazide,401.9,Hypertension NOS,1
214357,Captopril / Hydrochlorothiazide,997.91,Hypertension,1
214390,Chlorpheniramine / Dextromethorphan,375.2,Epiphora,1
214390,Chlorpheniramine / Dextromethorphan,375.20,Epiphora NOS,1
214390,Chlorpheniramine / Dextromethorphan,379.99,Other ill-defined disorders of eye,1
214390,Chlorpheniramine / Dextromethorphan,477.0,Allergic rhinitis due to pollen,1
214390,Chlorpheniramine / Dextromethorphan,477.9,Allergic rhinitis NOS,1
214390,Chlorpheniramine / Dextromethorphan,698.9,Unspecified pruritic disorder,1
214390,Chlorpheniramine / Dextromethorphan,786.2,Cough,1
214390,Chlorpheniramine / Dextromethorphan,995.3,Allergy unspecified not elsewhere classified,1
214392,Chlorpheniramine / Hydrocodone,786.2,Cough,1
214392,Chlorpheniramine / Hydrocodone,995.3,Allergy unspecified not elsewhere classified,1
214393,Chlorpheniramine / Phenylephrine,375.2,Epiphora,1
214393,Chlorpheniramine / Phenylephrine,375.20,Epiphora NOS,1
214393,Chlorpheniramine / Phenylephrine,379.99,Other ill-defined disorders of eye,1
214393,Chlorpheniramine / Phenylephrine,460,Acute nasopharyngitis (common cold),1
214393,Chlorpheniramine / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
214393,Chlorpheniramine / Phenylephrine,477.9,Allergic rhinitis NOS,1
214393,Chlorpheniramine / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
214393,Chlorpheniramine / Phenylephrine,698.9,Unspecified pruritic disorder,1
214393,Chlorpheniramine / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
214416,Chlorpheniramine / Phenylephrine / Pyrilamine,477.9,Allergic rhinitis NOS,1
214418,Chlorthalidone / Clonidine,401-405.99,,1
214418,Chlorthalidone / Clonidine,401.9,Hypertension NOS,1
214418,Chlorthalidone / Clonidine,997.91,Hypertension,1
214442,Codeine / Guaifenesin,786.2,Cough,1
214444,Codeine / Promethazine,460,Acute nasopharyngitis (common cold),1
214444,Codeine / Promethazine,786.2,Cough,1
214444,Codeine / Promethazine,995.3,Allergy unspecified not elsewhere classified,1
214449,Codeine / Phenylephrine / Promethazine,460,Acute nasopharyngitis (common cold),1
214449,Codeine / Phenylephrine / Promethazine,478.19,Other diseases of nasal cavity and sinuses,1
214449,Codeine / Phenylephrine / Promethazine,786.2,Cough,1
214449,Codeine / Phenylephrine / Promethazine,995.3,Allergy unspecified not elsewhere classified,1
214450,Codeine / Phenylephrine / Pyrilamine,786.2,Cough,1
214468,Daunorubicin Liposomal,176,Kaposi's sarcoma,0
214468,Daunorubicin Liposomal,176.9,Kaposi's sarcoma NOS,0
214468,Daunorubicin Liposomal,205.0,Myeloid leukemia; acute,0
214468,Daunorubicin Liposomal,205.00,Acute myeloid leukemia without mention of having achieved remission,0
214470,denileukin diftitox,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
214472,deserpidine / Methyclothiazide,401-405.99,,1
214472,deserpidine / Methyclothiazide,401.9,Hypertension NOS,1
214472,deserpidine / Methyclothiazide,997.91,Hypertension,1
214485,Dextran 1,415.19,Other pulmonary embolism and infarction,0
214485,Dextran 1,453.9,Embolism and thrombosis of unspecified site,0
214485,Dextran 1,785.50,Shock NOS,0
214485,Dextran 1,995.0,Other anaphylactic reaction,0
214488,Dextromethorphan / Guaifenesin,460,Acute nasopharyngitis (common cold),1
214488,Dextromethorphan / Guaifenesin,786.2,Cough,1
214491,Dextromethorphan / Promethazine,460,Acute nasopharyngitis (common cold),1
214491,Dextromethorphan / Promethazine,786.2,Cough,1
214491,Dextromethorphan / Promethazine,995.3,Allergy unspecified not elsewhere classified,1
214494,Dextromethorphan / Guaifenesin / Phenylephrine,460,Acute nasopharyngitis (common cold),1
214494,Dextromethorphan / Guaifenesin / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
214494,Dextromethorphan / Guaifenesin / Phenylephrine,477.9,Allergic rhinitis NOS,1
214494,Dextromethorphan / Guaifenesin / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
214494,Dextromethorphan / Guaifenesin / Phenylephrine,786.2,Cough,1
214494,Dextromethorphan / Guaifenesin / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
214495,Dextromethorphan / Guaifenesin / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214495,Dextromethorphan / Guaifenesin / Pseudoephedrine,786.2,Cough,1
214496,Dextromethorphan / Phenylephrine / Pyrilamine,460,Acute nasopharyngitis (common cold),1
214496,Dextromethorphan / Phenylephrine / Pyrilamine,477.9,Allergic rhinitis NOS,1
214496,Dextromethorphan / Phenylephrine / Pyrilamine,478.19,Other diseases of nasal cavity and sinuses,1
214496,Dextromethorphan / Phenylephrine / Pyrilamine,786.2,Cough,1
214502,Diclofenac / Misoprostol,459.0,Hemorrhage NOS,1
214502,Diclofenac / Misoprostol,707.9,Chronic ulcer of unspecified site,1
214502,Diclofenac / Misoprostol,714.0,Rheumatoid arthritis,1
214502,Diclofenac / Misoprostol,715.00,Osteoarthrosis; generalized; involving unspecified site,1
214502,Diclofenac / Misoprostol,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
214502,Diclofenac / Misoprostol,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
214502,Diclofenac / Misoprostol,716.90,Arthropathy; unspecified; site unspecified,1
214512,Diphenhydramine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
214512,Diphenhydramine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214525,doxorubicin liposomal,042,Human immunodeficiency virus [HIV] disease,1
214525,doxorubicin liposomal,042-042.99,,1
214525,doxorubicin liposomal,136.9,Unspecified infectious and parasitic diseases,1
214525,doxorubicin liposomal,140-239.99,,1
214525,doxorubicin liposomal,171.9,Malignant neoplasm of connective and other soft tissue; site unspecified,1
214525,doxorubicin liposomal,176,Kaposi's sarcoma,0
214525,doxorubicin liposomal,176.9,Kaposi's sarcoma NOS,0
214525,doxorubicin liposomal,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
214525,doxorubicin liposomal,203.0,Multiple myeloma,0
214525,doxorubicin liposomal,203.00,Multiple myeloma without mention of having achieved remission,0
214525,doxorubicin liposomal,239,Neoplasms of unspecified nature,1
214525,doxorubicin liposomal,239-239.99,,1
214525,doxorubicin liposomal,239.3,Neoplasm of unspecified nature of breast,0
214525,doxorubicin liposomal,239.4,Neoplasm of unspecified nature of bladder,0
214525,doxorubicin liposomal,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
214525,doxorubicin liposomal,338-338.99,,1
214525,doxorubicin liposomal,780.96,Generalized pain,1
214525,doxorubicin liposomal,799.9,Other unknown and unspecified cause of morbidity or mortality,1
214536,Enalapril / Hydrochlorothiazide,401-405.99,,1
214536,Enalapril / Hydrochlorothiazide,401.9,Hypertension NOS,1
214536,Enalapril / Hydrochlorothiazide,997.91,Hypertension,1
214549,Estrogens  Esterified (USP),174.9,Malignant neoplasm of breast (female); unspecified,1
214549,Estrogens  Esterified (USP),185,Malignant neoplasm of prostate,1
214549,Estrogens  Esterified (USP),239.3,Neoplasm of unspecified nature of breast,0
214549,Estrogens  Esterified (USP),239.5,Neoplasm of unspecified nature of other genitourinary organs,0
214549,Estrogens  Esterified (USP),253.4,Other anterior pituitary disorders,1
214549,Estrogens  Esterified (USP),256.31,Premature menopause,0
214549,Estrogens  Esterified (USP),256.39,Other ovarian failure,1
214549,Estrogens  Esterified (USP),626.2,Excessive or frequent menstruation,0
214549,Estrogens  Esterified (USP),627.2,Symptomatic menopausal or female climacteric states,1
214549,Estrogens  Esterified (USP),733.0,Osteoporosis,0
214549,Estrogens  Esterified (USP),733.00,Osteoporosis NOS,0
214549,Estrogens  Esterified (USP),733.01,Senile osteoporosis,0
214549,Estrogens  Esterified (USP),780-789.99,,0
214549,Estrogens  Esterified (USP),782.62,Flushing,0
214555,Etanercept,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
214555,Etanercept,696.0,Psoriatic arthropathy,1
214555,Etanercept,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
214555,Etanercept,714.0,Rheumatoid arthritis,1
214555,Etanercept,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
214555,Etanercept,716.90,Arthropathy; unspecified; site unspecified,1
214555,Etanercept,720.0,Ankylosing spondylitis,1
214558,Ethinyl Estradiol / Levonorgestrel,V22.2,Pregnant state; incidental,1
214565,fexofenadine / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
214565,fexofenadine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
214565,fexofenadine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214565,fexofenadine / Pseudoephedrine,698.9,Unspecified pruritic disorder,1
214582,Glatiramer,340,Multiple sclerosis,1
214597,Guaifenesin / Phenylephrine,460,Acute nasopharyngitis (common cold),1
214597,Guaifenesin / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
214597,Guaifenesin / Phenylephrine,477.9,Allergic rhinitis NOS,1
214597,Guaifenesin / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
214597,Guaifenesin / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
214599,Guaifenesin / Pseudoephedrine,460,Acute nasopharyngitis (common cold),1
214599,Guaifenesin / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
214599,Guaifenesin / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
214599,Guaifenesin / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214599,Guaifenesin / Pseudoephedrine,995.3,Allergy unspecified not elsewhere classified,1
214614,homatropine / Hydrocodone,786.2,Cough,1
214616,Hydralazine / Hydrochlorothiazide / Reserpine,401-405.99,,1
214616,Hydralazine / Hydrochlorothiazide / Reserpine,401.9,Hypertension NOS,1
214616,Hydralazine / Hydrochlorothiazide / Reserpine,997.91,Hypertension,1
214618,Hydrochlorothiazide / Lisinopril,401-405.99,,1
214618,Hydrochlorothiazide / Lisinopril,401.9,Hypertension NOS,1
214618,Hydrochlorothiazide / Lisinopril,997.91,Hypertension,1
214619,Hydrochlorothiazide / Losartan,401-405.99,,1
214619,Hydrochlorothiazide / Losartan,401.9,Hypertension NOS,1
214619,Hydrochlorothiazide / Losartan,997.91,Hypertension,1
214620,Hydrochlorothiazide / Methyldopa,401-405.99,,1
214620,Hydrochlorothiazide / Methyldopa,401.9,Hypertension NOS,1
214620,Hydrochlorothiazide / Methyldopa,997.91,Hypertension,1
214621,Hydrochlorothiazide / Metoprolol,401-405.99,,1
214621,Hydrochlorothiazide / Metoprolol,401.9,Hypertension NOS,1
214621,Hydrochlorothiazide / Metoprolol,997.91,Hypertension,1
214622,Hydrochlorothiazide / moexipril,401-405.99,,1
214622,Hydrochlorothiazide / moexipril,401.9,Hypertension NOS,1
214622,Hydrochlorothiazide / moexipril,997.91,Hypertension,1
214623,Hydrochlorothiazide / Propranolol,401-405.99,,1
214623,Hydrochlorothiazide / Propranolol,401.9,Hypertension NOS,1
214623,Hydrochlorothiazide / Propranolol,997.91,Hypertension,1
214627,Hydrocodone / Ibuprofen,338-338.99,,1
214627,Hydrocodone / Ibuprofen,714.0,Rheumatoid arthritis,1
214627,Hydrocodone / Ibuprofen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
214627,Hydrocodone / Ibuprofen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
214627,Hydrocodone / Ibuprofen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
214627,Hydrocodone / Ibuprofen,716.90,Arthropathy; unspecified; site unspecified,1
214627,Hydrocodone / Ibuprofen,780.96,Generalized pain,1
214627,Hydrocodone / Ibuprofen,780.99,Other general symptoms,1
214652,Ibuprofen / Pseudoephedrine,338-338.99,,1
214652,Ibuprofen / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
214652,Ibuprofen / Pseudoephedrine,780.60,Fever; unspecified,1
214652,Ibuprofen / Pseudoephedrine,780.96,Generalized pain,1
214652,Ibuprofen / Pseudoephedrine,784.0,Headache,1
214662,isoniazid / Pyrazinamide / Rifampin,010-018.99,,1
214662,isoniazid / Pyrazinamide / Rifampin,011.90,Unspecified pulmonary tuberculosis; unspecified examination,1
214671,Lamivudine / Zidovudine,042,Human immunodeficiency virus [HIV] disease,1
214671,Lamivudine / Zidovudine,042-042.99,,1
214681,Loperamide / Simethicone,787.7,Abnormal feces,0
214681,Loperamide / Simethicone,787.91,Diarrhea,0
214682,Loratadine / Pseudoephedrine,460,Acute nasopharyngitis (common cold),0
214682,Loratadine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,0
214682,Loratadine / Pseudoephedrine,698.9,Unspecified pruritic disorder,0
214721,Naloxone / Pentazocine,338-338.99,,1
214721,Naloxone / Pentazocine,780.96,Generalized pain,1
214769,Phenylephrine / Promethazine,460,Acute nasopharyngitis (common cold),1
214769,Phenylephrine / Promethazine,478.19,Other diseases of nasal cavity and sinuses,1
214769,Phenylephrine / Promethazine,995.3,Allergy unspecified not elsewhere classified,1
214787,Polythiazide / Prazosin,401-405.99,,1
214787,Polythiazide / Prazosin,401.9,Hypertension NOS,1
214787,Polythiazide / Prazosin,997.91,Hypertension,1
214817,Sacrosidase,520-579.99,,0
214817,Sacrosidase,569.9,Unspecified disorder of intestine,0
214824,sevelamer,275.3,Disorders of phosphorus metabolism,1
214824,sevelamer,585.6,End stage renal disease,1
214824,sevelamer,585.9,Chronic kidney disease; unspecified,1
214824,sevelamer,586,Renal failure unspecified,1
214824,sevelamer,593.9,Unspecified disorder of kidney and ureter,1
214837,Sodium phenylbutyrate,238.79,Other lymphatic and hematopoietic tissues,0
214837,Sodium phenylbutyrate,277.0,Cystic fibrosis,0
214837,Sodium phenylbutyrate,277.00,Cystic fibrosis without mention of meconium ileus,0
214837,Sodium phenylbutyrate,282.44,Beta thalassemia,0
214837,Sodium phenylbutyrate,282.5,Sickle-cell trait,0
214837,Sodium phenylbutyrate,282.6,Sickle-cell disease,0
214837,Sodium phenylbutyrate,282.60,Sickle cell disease NOS,0
214837,Sodium phenylbutyrate,282.61,Hb-SS disease without crisis,0
214866,trandolapril / Verapamil,401-405.99,,1
214866,trandolapril / Verapamil,401.9,Hypertension NOS,1
214866,trandolapril / Verapamil,997.91,Hypertension,1
215247,ammonium lactate,757.1,Ichthyosis congenita,1
216525,Dexamethasone / Neomycin / Polymyxin B,136.9,Unspecified infectious and parasitic diseases,1
216535,DEXTRAN HM,415.19,Other pulmonary embolism and infarction,0
216535,DEXTRAN HM,453.9,Embolism and thrombosis of unspecified site,0
216535,DEXTRAN HM,785.50,Shock NOS,0
218337,Methadone Hydrochloride,292.89,Other specified drug-induced mental disorders,0
218337,Methadone Hydrochloride,304.0,Opioid type dependence,1
218337,Methadone Hydrochloride,304.00,Opioid type dependence unspecified use,1
218337,Methadone Hydrochloride,304.90,Unspecified drug dependence; unspecified use,1
218337,Methadone Hydrochloride,305.90,Other; mixed; or unspecified drug abuse; unspecified use,1
218337,Methadone Hydrochloride,309.83,Adjustment reaction with withdrawal,0
218337,Methadone Hydrochloride,338-338.99,,1
218337,Methadone Hydrochloride,780.96,Generalized pain,1
219228,Acetaminophen / phenyltoloxamine,338-338.99,,1
219228,Acetaminophen / phenyltoloxamine,716.90,Arthropathy; unspecified; site unspecified,1
219228,Acetaminophen / phenyltoloxamine,724.1,Pain in thoracic spine,1
219228,Acetaminophen / phenyltoloxamine,724.5,Backache unspecified,1
219228,Acetaminophen / phenyltoloxamine,780.60,Fever; unspecified,1
219228,Acetaminophen / phenyltoloxamine,780.96,Generalized pain,1
219228,Acetaminophen / phenyltoloxamine,784.0,Headache,1
220982,yohimbine,302.72,Psychosexual dysfunction with inhibited sexual excitement,0
220982,yohimbine,607.84,Impotence of organic origin,0
221050,BCG  Live  Tice Strain,010-018.99,,0
221050,BCG  Live  Tice Strain,011.90,Unspecified pulmonary tuberculosis; unspecified examination,0
221050,BCG  Live  Tice Strain,239.4,Neoplasm of unspecified nature of bladder,0
221057,Amphetamine aspartate,314,Hyperkinetic syndrome of childhood,0
221057,Amphetamine aspartate,314.01,Attention deficit disorder of childhood with hyperactivity,0
221057,Amphetamine aspartate,314.9,Unspecified hyperkinetic syndrome of childhood,0
221057,Amphetamine aspartate,347.0,Narcolepsy,0
221057,Amphetamine aspartate,347.00,Narcolepsy; without cataplexy,0
221070,CARBETAPENTANE TANNATE,460,Acute nasopharyngitis (common cold),0
221070,CARBETAPENTANE TANNATE,786.2,Cough,0
221072,Cerivastatin sodium,272.1,Pure hyperglyceridemia,1
221072,Cerivastatin sodium,272.4,Other and unspecified hyperlipidemia,1
221072,Cerivastatin sodium,447.9,Unspecified disorders of arteries and arterioles,1
221074,CHLORPHENIRAMINE POLISTIREX,477.9,Allergic rhinitis NOS,0
221074,CHLORPHENIRAMINE POLISTIREX,708,Urticaria,0
221074,CHLORPHENIRAMINE POLISTIREX,708.9,Unspecified urticaria,0
221075,Chlorpheniramine Tannate,477.9,Allergic rhinitis NOS,0
221075,Chlorpheniramine Tannate,708,Urticaria,0
221075,Chlorpheniramine Tannate,708.9,Unspecified urticaria,0
221082,Colloidal oatmeal,692.9,Contact dermatitis and other eczema; unspecified cause,0
221082,Colloidal oatmeal,698.9,Unspecified pruritic disorder,0
221083,SULFUR COLLOIDAL,690.1,Seborrheic dermatitis,0
221083,SULFUR COLLOIDAL,690.10,Seborheic dermatitis; unspecified,0
221083,SULFUR COLLOIDAL,695.3,Rosacea,0
221083,SULFUR COLLOIDAL,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
221083,SULFUR COLLOIDAL,706.1,Other acne,0
221083,SULFUR COLLOIDAL,706.3,Seborrhea,0
221088,Dextroamphetamine saccharate,314,Hyperkinetic syndrome of childhood,0
221088,Dextroamphetamine saccharate,314.01,Attention deficit disorder of childhood with hyperactivity,0
221088,Dextroamphetamine saccharate,314.9,Unspecified hyperkinetic syndrome of childhood,0
221088,Dextroamphetamine saccharate,347.0,Narcolepsy,0
221088,Dextroamphetamine saccharate,347.00,Narcolepsy; without cataplexy,0
221095,Enoxaparin sodium,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
221095,Enoxaparin sodium,411.1,Intermediate coronary syndrome,1
221095,Enoxaparin sodium,413,Angina pectoris,1
221095,Enoxaparin sodium,413.9,Other and unspecified angina pectoris,1
221095,Enoxaparin sodium,451.9,Phlebitis and thrombophlebitis of unspecified site,1
221095,Enoxaparin sodium,786.50,Unspecified chest pain,1
221095,Enoxaparin sodium,81.54,TOTAL KNEE REPLACEMENT,0
221096,EPHEDRINE TANNATE,458.0,Orthostatic hypotension,0
221096,EPHEDRINE TANNATE,472.0,Chronic rhinitis,0
221096,EPHEDRINE TANNATE,493,Asthma,0
221096,EPHEDRINE TANNATE,493.9,Asthma; unspecified,0
221096,EPHEDRINE TANNATE,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
221096,EPHEDRINE TANNATE,519.11,Acute bronchospasm,0
221107,HYDROCODONE POLISTIREX,338.18,Other acute postoperative pain,0
221107,HYDROCODONE POLISTIREX,786.2,Cough,0
221110,Ultralente Insulin  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
221110,Ultralente Insulin  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
221110,Ultralente Insulin  Human,790.6,Other abnormal blood chemistry,0
221125,SODIUM PHOSPHATE MONOBASIC MONOHYDRATE,275.3,Disorders of phosphorus metabolism,0
221138,PHENTERMINE RESIN,278.00,Obesity NOS,0
221139,Phenylephrine Tannate,365.1,Open-angle glaucoma,0
221139,Phenylephrine Tannate,365.10,Open-angle glaucoma NOS,0
221139,Phenylephrine Tannate,365.13,Pigmentary glaucoma,0
221139,Phenylephrine Tannate,427.89,Other specified cardiac dysrhythmias,0
221139,Phenylephrine Tannate,455,Hemorrhoids,0
221139,Phenylephrine Tannate,455.6,Hemorrhoids NOS,0
221139,Phenylephrine Tannate,458,Hypotension,0
221139,Phenylephrine Tannate,458.9,Hypotension NOS,0
221139,Phenylephrine Tannate,477.9,Allergic rhinitis NOS,0
221139,Phenylephrine Tannate,565.0,Anal fissure,0
221139,Phenylephrine Tannate,569.41,Ulcer of anus and rectum,0
221139,Phenylephrine Tannate,698.0,Pruritus ani,0
221139,Phenylephrine Tannate,785.52,Septic shock,0
221141,Phenyltoloxamine citrate,477.9,Allergic rhinitis NOS,0
221141,Phenyltoloxamine citrate,708,Urticaria,0
221141,Phenyltoloxamine citrate,708.9,Unspecified urticaria,0
221142,Pirbuterol acetate,493,Asthma,0
221142,Pirbuterol acetate,493.9,Asthma; unspecified,0
221142,Pirbuterol acetate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
221142,Pirbuterol acetate,519.11,Acute bronchospasm,0
221147,POLYETHYLENE GLYCOL 3350,564.0,Constipation,1
221147,POLYETHYLENE GLYCOL 3350,564.00,Constipation NOS,1
221152,PYRILAMINE TANNATE,372.14,Other chronic allergic conjunctivitis,0
221152,PYRILAMINE TANNATE,477.9,Allergic rhinitis NOS,0
221174,tolterodine tartrate,596.51,Hypertonicity of bladder,1
221174,tolterodine tartrate,596.89,Other specified disorders of bladder,0
221174,tolterodine tartrate,596.9,Unspecified disorder of bladder,0
221174,tolterodine tartrate,788.3,Urinary incontinence,1
221174,tolterodine tartrate,788.30,Urinary incontinence NOS,1
221174,tolterodine tartrate,788.31,Urge incontinence,1
221174,tolterodine tartrate,788.41,Urinary frequency,1
221174,tolterodine tartrate,788.69,Other abnormality of urination,1
221183,Zolpidem tartrate,780.50,Unspecified sleep disturbance,0
221183,Zolpidem tartrate,780.52,Insomnia; unspecified,1
223779,Potassium bitartrate,276.8,Hypopotassemia,0
224905,trastuzumab,174.9,Malignant neoplasm of breast (female); unspecified,0
224905,trastuzumab,239.3,Neoplasm of unspecified nature of breast,0
226868,Rabeprazole sodium,530.81,Esophageal reflux,1
226868,Rabeprazole sodium,707.9,Chronic ulcer of unspecified site,1
226868,Rabeprazole sodium,787.1,Heartburn,1
227212,Levobunolol Hydrochloride,365,Glaucoma,0
227212,Levobunolol Hydrochloride,365.1,Open-angle glaucoma,0
227212,Levobunolol Hydrochloride,365.10,Open-angle glaucoma NOS,0
227212,Levobunolol Hydrochloride,365.13,Pigmentary glaucoma,0
227212,Levobunolol Hydrochloride,365.9,Glaucoma NOS,0
227221,Etidocaine hydrochloride,338.18,Other acute postoperative pain,0
227239,Masoprocol,701.1,Keratoderma; acquired,0
227278,Fosinopril Sodium,250.4,Diabetes with renal manifestations,0
227278,Fosinopril Sodium,401-405.99,,1
227278,Fosinopril Sodium,401.9,Hypertension NOS,1
227278,Fosinopril Sodium,428,Heart failure,1
227278,Fosinopril Sodium,428.0,Congestive heart failure (CHF) NOS,1
227278,Fosinopril Sodium,428.9,Heart failure unspecified,1
227278,Fosinopril Sodium,429.3,Cardiomegaly,0
227278,Fosinopril Sodium,593.9,Unspecified disorder of kidney and ureter,1
227278,Fosinopril Sodium,997.91,Hypertension,1
227518,Follicle Stimulating Hormone,253.4,Other anterior pituitary disorders,1
227518,Follicle Stimulating Hormone,256.39,Other ovarian failure,1
227518,Follicle Stimulating Hormone,257.2,Other testicular hypofunction,1
227778,Proparacaine hydrochloride,338-338.99,,0
227778,Proparacaine hydrochloride,780.96,Generalized pain,0
227897,Betamethasone valerate,690.1,Seborrheic dermatitis,0
227897,Betamethasone valerate,690.10,Seborheic dermatitis; unspecified,0
227897,Betamethasone valerate,691.8,Other atopic dermatitis,0
227897,Betamethasone valerate,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
227897,Betamethasone valerate,698.0,Pruritus ani,0
227897,Betamethasone valerate,698.9,Unspecified pruritic disorder,0
227897,Betamethasone valerate,706.3,Seborrhea,0
227897,Betamethasone valerate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
228041,Echinacea Preparation,460,Acute nasopharyngitis (common cold),0
228476,gatifloxacin,003.9,Salmonella infection NOS,0
228476,gatifloxacin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
228476,gatifloxacin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
228476,gatifloxacin,041.49,Other and unspecified Escherichia coli [E. coli],0
228476,gatifloxacin,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
228476,gatifloxacin,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
228476,gatifloxacin,098,Gonococcal infections,1
228476,gatifloxacin,098.89,Gonococcal infection of other specified sites,1
228476,gatifloxacin,136.9,Unspecified infectious and parasitic diseases,1
228476,gatifloxacin,372.03,Other mucopurulent conjunctivitis,1
228476,gatifloxacin,372.30,Conjunctivitis NOS,1
228476,gatifloxacin,461.9,Acute sinusitis NOS,1
228476,gatifloxacin,482.9,Bacterial pneumonia NOS,0
228476,gatifloxacin,490,Bronchitis NOS,1
228476,gatifloxacin,590.80,Pyelonephritis NOS,1
228476,gatifloxacin,595,Cystitis,1
228476,gatifloxacin,595.9,Cystitis NOS,1
228476,gatifloxacin,599.0,Urinary tract infection; site not specified,1
228656,Amprenavir,042,Human immunodeficiency virus [HIV] disease,0
228656,Amprenavir,042-042.99,,0
228783,frovatriptan,346,Migraine,1
228783,frovatriptan,346.9,Migraine; unspecified,1
228783,frovatriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
228783,frovatriptan,784.0,Headache,1
228790,Dutasteride,600,Hyperplasia of prostate,1
228790,Dutasteride,600.0,Hypertrophy (benign) of prostate,0
228790,Dutasteride,600.9,Hyperplasia of prostate; unspecified,1
228790,Dutasteride,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),1
228790,Dutasteride,788.20,Retention of urine NOS,1
229367,quinupristin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
229367,quinupristin,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
229369,dalfopristin,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
229369,dalfopristin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
231049,eletriptan,296.99,Other specified episodic mood disorder,0
231049,eletriptan,338-338.99,,0
231049,eletriptan,346,Migraine,1
231049,eletriptan,346.00,Migraine with aura; without mention of intractable migraine without mention of status migrainosus,1
231049,eletriptan,346.9,Migraine; unspecified,1
231049,eletriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
231049,eletriptan,780.96,Generalized pain,0
231049,eletriptan,784.0,Headache,1
231049,eletriptan,787.02,Nausea alone,0
232158,rofecoxib,338-338.99,,1
232158,rofecoxib,338.1,Acute pain,1
232158,rofecoxib,625.3,Dysmenorrhea,1
232158,rofecoxib,715.00,Osteoarthrosis; generalized; involving unspecified site,1
232158,rofecoxib,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
232158,rofecoxib,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
232158,rofecoxib,716.90,Arthropathy; unspecified; site unspecified,1
232158,rofecoxib,780.96,Generalized pain,1
232158,rofecoxib,780.99,Other general symptoms,1
233272,bexarotene,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
233272,bexarotene,799.9,Other unknown and unspecified cause of morbidity or mortality,0
233698,dronedarone,427,Cardiac dysrhythmias,0
233698,dronedarone,427.31,Atrial fibrillation,1
233698,dronedarone,427.32,Atrial flutter,0
233698,dronedarone,427.9,Cardiac dysrhythmia NOS,1
234416,lanthanum carbonate,585.6,End stage renal disease,1
234416,lanthanum carbonate,585.9,Chronic kidney disease; unspecified,1
234416,lanthanum carbonate,586,Renal failure unspecified,1
234416,lanthanum carbonate,593.9,Unspecified disorder of kidney and ureter,1
235230,Nicardipine hydrochloride,401-405.99,,0
235230,Nicardipine hydrochloride,401.9,Hypertension NOS,0
235230,Nicardipine hydrochloride,413,Angina pectoris,0
235230,Nicardipine hydrochloride,413.1,Prinzmetal angina,0
235230,Nicardipine hydrochloride,413.9,Other and unspecified angina pectoris,0
235230,Nicardipine hydrochloride,428.0,Congestive heart failure (CHF) NOS,0
235230,Nicardipine hydrochloride,786.50,Unspecified chest pain,0
235230,Nicardipine hydrochloride,997.91,Hypertension,0
235355,Thiamine hydrochloride,265.0,Beriberi,0
235355,Thiamine hydrochloride,265.1,Other and unspecified manifestations of thiamine deficiency,0
235355,Thiamine hydrochloride,265.2,Pellagra,0
235355,Thiamine hydrochloride,357.5,Alcoholic polyneuropathy,0
235373,Difenoxin hydrochloride,787.7,Abnormal feces,0
235373,Difenoxin hydrochloride,787.91,Diarrhea,0
235426,Pilocarpine Hydrochloride,239.89,Neoplasms of unspecified nature; other specified sites (ADDED),0
235426,Pilocarpine Hydrochloride,365,Glaucoma,0
235426,Pilocarpine Hydrochloride,365.02,Anatomical narrow angle borderline glaucoma,0
235426,Pilocarpine Hydrochloride,365.20|365.70,,0
235426,Pilocarpine Hydrochloride,365.9,Glaucoma NOS,0
235426,Pilocarpine Hydrochloride,379.43,Mydriasis (persistent); not due to mydriatics,0
235426,Pilocarpine Hydrochloride,527.7,Disturbance of salivary secretion,0
235486,Dexamethasone phosphate,140-239.99,,0
235486,Dexamethasone phosphate,239,Neoplasms of unspecified nature,0
235486,Dexamethasone phosphate,239-239.99,,0
235486,Dexamethasone phosphate,255.0,Cushing's syndrome,0
235486,Dexamethasone phosphate,255.41,Glucocorticoid deficiency,0
235486,Dexamethasone phosphate,280-289.99,,0
235486,Dexamethasone phosphate,289.9,Blood disease NOS,0
235486,Dexamethasone phosphate,311,Depressive disorder NEC,0
235486,Dexamethasone phosphate,348.5,Cerebral edema,0
235486,Dexamethasone phosphate,471,Nasal polyps,0
235486,Dexamethasone phosphate,471.0,Polyp of nasal cavity,0
235486,Dexamethasone phosphate,471.9,Nasal polyp NOS,0
235486,Dexamethasone phosphate,477.9,Allergic rhinitis NOS,0
235486,Dexamethasone phosphate,493,Asthma,0
235486,Dexamethasone phosphate,493.9,Asthma; unspecified,0
235486,Dexamethasone phosphate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
235486,Dexamethasone phosphate,784.2,Swelling; mass; or lump in head and neck,0
235486,Dexamethasone phosphate,785.52,Septic shock,0
235486,Dexamethasone phosphate,787.02,Nausea alone,0
235486,Dexamethasone phosphate,787.03,Vomiting alone,0
235496,Sodium Phosphate  Monobasic,275.3,Disorders of phosphorus metabolism,0
235496,Sodium Phosphate  Monobasic,564.0,Constipation,0
235496,Sodium Phosphate  Monobasic,564.00,Constipation NOS,0
235725,Chlorcyclizine hydrochloride,477.9,Allergic rhinitis NOS,0
235725,Chlorcyclizine hydrochloride,698.9,Unspecified pruritic disorder,0
235725,Chlorcyclizine hydrochloride,787.03,Vomiting alone,0
235725,Chlorcyclizine hydrochloride,994.6,Motion sickness,0
235743,Metformin hydrochloride,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
235743,Metformin hydrochloride,250.1,Diabetes with ketoacidosis,1
235743,Metformin hydrochloride,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
235743,Metformin hydrochloride,790.6,Other abnormal blood chemistry,1
235758,Benazepril hydrochloride,250.4,Diabetes with renal manifestations,0
235758,Benazepril hydrochloride,401-405.99,,1
235758,Benazepril hydrochloride,401.9,Hypertension NOS,1
235758,Benazepril hydrochloride,428.0,Congestive heart failure (CHF) NOS,1
235758,Benazepril hydrochloride,429.3,Cardiomegaly,0
235758,Benazepril hydrochloride,997.91,Hypertension,1
235824,Azelastine hydrochloride,372.14,Other chronic allergic conjunctivitis,1
235824,Azelastine hydrochloride,472.0,Chronic rhinitis,1
235824,Azelastine hydrochloride,477.0,Allergic rhinitis due to pollen,1
235824,Azelastine hydrochloride,477.9,Allergic rhinitis NOS,1
235824,Azelastine hydrochloride,478.19,Other diseases of nasal cavity and sinuses,1
235824,Azelastine hydrochloride,698.9,Unspecified pruritic disorder,1
235824,Azelastine hydrochloride,784.91,Postnasal drip,1
235824,Azelastine hydrochloride,784.99,Other symptoms involving head and neck,1
235838,Terbinafine hydrochloride,110.0,Dermatophytosis of scalp and beard,1
235838,Terbinafine hydrochloride,110.1,Dermatophytosis of nail,1
235838,Terbinafine hydrochloride,110.3,Dermatophytosis of groin and perianal area,1
235838,Terbinafine hydrochloride,110.4,Dermatophytosis of foot,1
235838,Terbinafine hydrochloride,110.5,Dermatophytosis of the body,1
235838,Terbinafine hydrochloride,111.0,Pityriasis versicolor,1
235838,Terbinafine hydrochloride,112.3,Candidiasis of skin and nails,0
235838,Terbinafine hydrochloride,686.9,Unspecified local infection of skin and subcutaneous tissue,1
235996,Erwinia asparaginase,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
236082,Nefazodone hydrochloride,311,Depressive disorder NEC,1
236082,Nefazodone hydrochloride,780.79,Other malaise and fatigue,1
236083,Alendronic acid,338-338.99,,1
236083,Alendronic acid,731.0,Osteitis deformans without mention of bone tumor,0
236083,Alendronic acid,733.0,Osteoporosis,1
236083,Alendronic acid,733.00,Osteoporosis NOS,1
236083,Alendronic acid,733.01,Senile osteoporosis,1
236083,Alendronic acid,733.90,Disorder of bone and cartilage; unspecified,1
236083,Alendronic acid,780.96,Generalized pain,1
236083,Alendronic acid,829.0,Fracture of unspecified bone closed,1
236216,formoterol fumarate,491,Chronic bronchitis,1
236216,formoterol fumarate,491.9,Chronic bronchitis NOS,1
236216,formoterol fumarate,493,Asthma,1
236216,formoterol fumarate,493.81,Exercise induced bronchospasm,0
236216,formoterol fumarate,493.9,Asthma; unspecified,1
236216,formoterol fumarate,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
236216,formoterol fumarate,496,Chronic airway obstruction; not elsewhere classified,1
236216,formoterol fumarate,518.89,Other diseases of lung; not elsewhere classified,1
236216,formoterol fumarate,519.11,Acute bronchospasm,1
236216,formoterol fumarate,796.4,Other abnormal clinical findings,1
236279,Devil's claw preparation,536.8,Dyspepsia and other specified disorders of function of stomach,0
236279,Devil's claw preparation,716.90,Arthropathy; unspecified; site unspecified,0
236279,Devil's claw preparation,783.0,Anorexia,0
236344,Saw palmetto extract,600,Hyperplasia of prostate,0
236344,Saw palmetto extract,600.9,Hyperplasia of prostate; unspecified,0
236344,Saw palmetto extract,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),0
236381,Poractant alfa,518.0,Pulmonary collapse,0
236381,Poractant alfa,769,Respiratory distress syndrome in newborn,0
236474,Fexofenadine hydrochloride,379.99,Other ill-defined disorders of eye,0
236474,Fexofenadine hydrochloride,477.0,Allergic rhinitis due to pollen,1
236474,Fexofenadine hydrochloride,477.9,Allergic rhinitis NOS,1
236474,Fexofenadine hydrochloride,698.9,Unspecified pruritic disorder,1
236474,Fexofenadine hydrochloride,708,Urticaria,1
236474,Fexofenadine hydrochloride,708.9,Unspecified urticaria,1
236474,Fexofenadine hydrochloride,797,Senility without mention of psychosis,0
236495,Tamsulosin hydrochloride,600,Hyperplasia of prostate,1
236495,Tamsulosin hydrochloride,600.0,Hypertrophy (benign) of prostate,0
236495,Tamsulosin hydrochloride,600.9,Hyperplasia of prostate; unspecified,1
236495,Tamsulosin hydrochloride,600.90,Hyperplasia of prostate; unspecified; without urinary obstruction and other lower urinary symptoms (LUTS),1
236539,Ropivacaine hydrochloride,338-338.99,,1
236539,Ropivacaine hydrochloride,338.18,Other acute postoperative pain,0
236539,Ropivacaine hydrochloride,780.96,Generalized pain,1
236559,Donepezil hydrochloride,290,Dementias,1
236559,Donepezil hydrochloride,294.2,,1
236559,Donepezil hydrochloride,294.20,Dementia; unspecified; without behavioral disturbance,1
236559,Donepezil hydrochloride,331.0,Alzheimer's disease,0
236594,amphotericin B liposomal,085.0,Visceral leishmaniasis,1
236594,amphotericin B liposomal,110-118.99,,1
236594,amphotericin B liposomal,112,Candidiasis,1
236594,amphotericin B liposomal,112.3,Candidiasis of skin and nails,0
236594,amphotericin B liposomal,112.9,Candidiasis of unspecified site,1
236594,amphotericin B liposomal,114,Coccidioidomycosis,0
236594,amphotericin B liposomal,114.9,Coccidioidomycosis NOS,0
236594,amphotericin B liposomal,115,Histoplasmosis,0
236594,amphotericin B liposomal,115.9,Histoplasmosis; unspecified,0
236594,amphotericin B liposomal,115.90,Histoplasmosis; unspecified without mention of manifestation,0
236594,amphotericin B liposomal,116,Blastomycotic infection,0
236594,amphotericin B liposomal,116.0,Blastomycosis,0
236594,amphotericin B liposomal,116.1,Paracoccidioidomycosis,0
236594,amphotericin B liposomal,117.1,Sporotrichosis,0
236594,amphotericin B liposomal,117.3,Aspergillosis,1
236594,amphotericin B liposomal,117.7,Zygomycosis,0
236594,amphotericin B liposomal,117.9,Other and unspecified mycoses,1
236594,amphotericin B liposomal,136.9,Unspecified infectious and parasitic diseases,1
236594,amphotericin B liposomal,288.0,Agranulocytosis,0
236594,amphotericin B liposomal,288.00,Neutropenia NOS,0
236594,amphotericin B liposomal,321.0,Cryptococcal meningitis,1
236594,amphotericin B liposomal,567.9,Peritonitis NOS,0
236594,amphotericin B liposomal,595,Cystitis,0
236594,amphotericin B liposomal,595.9,Cystitis NOS,0
236594,amphotericin B liposomal,599.0,Urinary tract infection; site not specified,0
236665,Black Cohosh Extract,253.4,Other anterior pituitary disorders,0
236665,Black Cohosh Extract,256.31,Premature menopause,0
236665,Black Cohosh Extract,536.8,Dyspepsia and other specified disorders of function of stomach,0
236665,Black Cohosh Extract,625.3,Dysmenorrhea,0
236665,Black Cohosh Extract,627.2,Symptomatic menopausal or female climacteric states,0
236665,Black Cohosh Extract,782.62,Flushing,0
236685,Memantine hydrochloride,331.0,Alzheimer's disease,0
236719,Sodium Phosphate  Dibasic,275.3,Disorders of phosphorus metabolism,0
236747,Pramipexole dihydrochloride,311,Depressive disorder NEC,0
236747,Pramipexole dihydrochloride,332,Parkinson's disease,0
236747,Pramipexole dihydrochloride,332.0,Paralysis agitans,0
236747,Pramipexole dihydrochloride,333.94,Restless legs syndrome (RLS),1
236778,Trospium,596.51,Hypertonicity of bladder,1
236778,Trospium,788.41,Urinary frequency,1
236778,Trospium,788.69,Other abnormality of urination,1
236961,epinastine hydrochloride,372.14,Other chronic allergic conjunctivitis,1
237005,Levomethadyl,292.89,Other specified drug-induced mental disorders,0
237005,Levomethadyl,338-338.99,,0
237005,Levomethadyl,780.96,Generalized pain,0
237057,lepirudin,287.5,Thrombocytopenia NOS,1
237057,lepirudin,410-414.99,,0
237057,lepirudin,411.1,Intermediate coronary syndrome,1
237057,lepirudin,414.8,Other specified forms of chronic ischemic heart disease,0
237057,lepirudin,414.9,Chronic ischemic heart disease; unspecified,0
237057,lepirudin,453.9,Embolism and thrombosis of unspecified site,1
237057,lepirudin,459.9,Unspecified circulatory system disorder,1
237057,lepirudin,790.99,Other nonspecific findings on examination of blood,1
237125,Sevelamer hydrochloride,275.3,Disorders of phosphorus metabolism,1
237125,Sevelamer hydrochloride,585.6,End stage renal disease,1
237125,Sevelamer hydrochloride,585.9,Chronic kidney disease; unspecified,1
237125,Sevelamer hydrochloride,586,Renal failure unspecified,1
237125,Sevelamer hydrochloride,593.9,Unspecified disorder of kidney and ureter,1
237148,BISMUTH-FORMIC-IODIDE,004.9,Shigellosis NOS,0
237148,BISMUTH-FORMIC-IODIDE,041.49,Other and unspecified Escherichia coli [E. coli],0
237148,BISMUTH-FORMIC-IODIDE,079.99,Unspecified viral infection in conditions classified elsewhere and of unspecified site,0
237148,BISMUTH-FORMIC-IODIDE,686.8|041.9,,0
237148,BISMUTH-FORMIC-IODIDE,958.3,Posttraumatic wound infection not elsewhere classified,0
237159,Levalbuterol,493,Asthma,0
237159,Levalbuterol,493.9,Asthma; unspecified,0
237159,Levalbuterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
237159,Levalbuterol,496,Chronic airway obstruction; not elsewhere classified,0
237159,Levalbuterol,519.11,Acute bronchospasm,1
237159,Levalbuterol,796.4,Other abnormal clinical findings,0
253166,estrogens  conjugated synthetic A,239.3,Neoplasm of unspecified nature of breast,0
253166,estrogens  conjugated synthetic A,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
253166,estrogens  conjugated synthetic A,253.4,Other anterior pituitary disorders,0
253166,estrogens  conjugated synthetic A,256.31,Premature menopause,0
253166,estrogens  conjugated synthetic A,256.39,Other ovarian failure,0
253166,estrogens  conjugated synthetic A,626.2,Excessive or frequent menstruation,0
253166,estrogens  conjugated synthetic A,627.2,Symptomatic menopausal or female climacteric states,0
253166,estrogens  conjugated synthetic A,733.01,Senile osteoporosis,0
253166,estrogens  conjugated synthetic A,782.62,Flushing,0
253174,Hepatitis A Vaccine  Inactivated,070.1,Viral hepatitis A without mention of hepatic coma,1
253174,Hepatitis A Vaccine  Inactivated,070.9,Unspecified viral hepatitis without mention of hepatic coma,1
253174,Hepatitis A Vaccine  Inactivated,136.9,Unspecified infectious and parasitic diseases,1
253174,Hepatitis A Vaccine  Inactivated,573.3,Hepatitis NOS,1
253174,Hepatitis A Vaccine  Inactivated,573.9,Unspecified disorder of liver,1
253181,NPH Insulin  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
253181,NPH Insulin  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
253181,NPH Insulin  Human,790.6,Other abnormal blood chemistry,0
253182,Regular Insulin  Human,250,Diabetes mellitus,1
253182,Regular Insulin  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
253182,Regular Insulin  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,1
253182,Regular Insulin  Human,250.1,Diabetes with ketoacidosis,0
253182,Regular Insulin  Human,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,0
253182,Regular Insulin  Human,276.7,Hyperpotassemia,0
253182,Regular Insulin  Human,790.6,Other abnormal blood chemistry,1
253337,bevacizumab,140-239.99,,0
253337,bevacizumab,153.9,Malignant neoplasm of colon; unspecified,1
253337,bevacizumab,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
253337,bevacizumab,174.9,Malignant neoplasm of breast (female); unspecified,1
253337,bevacizumab,189.0,Malignant neoplasm of kidney; except pelvis,1
253337,bevacizumab,199,Malignant neoplasm without specification of site,1
253337,bevacizumab,199.1,Other malignant neoplasm of unspecified site,1
253337,bevacizumab,239,Neoplasms of unspecified nature,0
253337,bevacizumab,239-239.99,,0
253337,bevacizumab,239.6,Neoplasm of unspecified nature of brain,0
253337,bevacizumab,362.50,Macular degeneration (senile) of retina NOS,0
253337,bevacizumab,799.9,Other unknown and unspecified cause of morbidity or mortality,0
253453,peginterferon alfa-2b,070.31,Viral hepatitis B without mention of hepatic coma; acute or unspecified; with hepatitis delta,0
253453,peginterferon alfa-2b,070.54,Chronic hepatitis C without mention of hepatic coma,0
253453,peginterferon alfa-2b,078.1,Viral warts,0
253453,peginterferon alfa-2b,078.10,Viral warts; unspecified,0
253453,peginterferon alfa-2b,155.0,Malignant neoplasm of liver; primary,0
253453,peginterferon alfa-2b,172.9,Melanoma of skin; site unspecified,0
253453,peginterferon alfa-2b,176,Kaposi's sarcoma,0
253453,peginterferon alfa-2b,176.9,Kaposi's sarcoma NOS,0
253453,peginterferon alfa-2b,189.0,Malignant neoplasm of kidney; except pelvis,0
253453,peginterferon alfa-2b,202.1,Mycosis fungoides,0
253453,peginterferon alfa-2b,202.10,Mycosis fungoides; unspecified site; extranodal and solid organ sites,0
253453,peginterferon alfa-2b,202.2,Sezary's disease,0
253453,peginterferon alfa-2b,202.20,Sezary's disease; unspecified site; extranodal and solid organ sites,0
253453,peginterferon alfa-2b,202.4,Leukemic reticuloendotheliosis,0
253453,peginterferon alfa-2b,202.40,Leukemic reticuloendotheliosis; unspecified site; extranodal and solid organ sites,0
253453,peginterferon alfa-2b,203.0,Multiple myeloma,0
253453,peginterferon alfa-2b,203.00,Multiple myeloma without mention of having achieved remission,0
253453,peginterferon alfa-2b,228.0,Hemangioma; any site,0
253453,peginterferon alfa-2b,228.00,Hemangioma NOS,0
253453,peginterferon alfa-2b,238.71,Essential thrombocythemia,0
253453,peginterferon alfa-2b,239.0,Neoplasm of unspecified nature of digestive system,0
253453,peginterferon alfa-2b,239.2,Neoplasm of unspecified nature of bone; soft tissue; and skin,0
253453,peginterferon alfa-2b,239.6,Neoplasm of unspecified nature of brain,0
253453,peginterferon alfa-2b,273.2,Other paraproteinemias,0
253453,peginterferon alfa-2b,287.5,Thrombocytopenia NOS,0
253453,peginterferon alfa-2b,362.50,Macular degeneration (senile) of retina NOS,0
253453,peginterferon alfa-2b,707.9,Chronic ulcer of unspecified site,0
253453,peginterferon alfa-2b,709.8,Other specified disorders of skin,0
253453,peginterferon alfa-2b,790.99,Other nonspecific findings on examination of blood,0
257844,Mefenamate,338-338.99,,1
257844,Mefenamate,625.3,Dysmenorrhea,1
257844,Mefenamate,625.4,Premenstrual tension syndromes,0
257844,Mefenamate,626.2,Excessive or frequent menstruation,0
257844,Mefenamate,780.60,Fever; unspecified,0
257844,Mefenamate,780.96,Generalized pain,1
258337,Hydrochlorothiazide / Triamterene,276.6,Fluid overload,1
258337,Hydrochlorothiazide / Triamterene,276.69,Other fluid overload,1
258337,Hydrochlorothiazide / Triamterene,401-405.99,,1
258337,Hydrochlorothiazide / Triamterene,401.9,Hypertension NOS,1
258337,Hydrochlorothiazide / Triamterene,782.3,Edema,1
258337,Hydrochlorothiazide / Triamterene,997.91,Hypertension,1
258439,Heavy mineral oil,560.9,Unspecified intestinal obstruction,0
258439,Heavy mineral oil,564.0,Constipation,0
258439,Heavy mineral oil,564.00,Constipation NOS,0
258494,exemestane,174.9,Malignant neoplasm of breast (female); unspecified,1
258494,exemestane,239.3,Neoplasm of unspecified nature of breast,0
259264,Ganirelix acetate,256.1,Other ovarian hyperfunction,1
259277,POTASSIUM CHELATED,276.8,Hypopotassemia,0
259280,Tenecteplase,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
259318,Pemirolast potassium,372.14,Other chronic allergic conjunctivitis,0
259453,Levobupivacaine,338-338.99,,0
259453,Levobupivacaine,780.96,Generalized pain,0
259454,Levobupivacaine hydrochloride,338-338.99,,0
259454,Levobupivacaine hydrochloride,780.96,Generalized pain,0
260101,Oseltamivir,136.9,Unspecified infectious and parasitic diseases,1
260101,Oseltamivir,462,Acute pharyngitis,1
260101,Oseltamivir,478.19,Other diseases of nasal cavity and sinuses,1
260101,Oseltamivir,487,Influenza,1
260101,Oseltamivir,487.1,Influenza with other respiratory manifestations,1
260101,Oseltamivir,488.01,Influenza due to identified avian influenza virus with pneumonia,0
260101,Oseltamivir,780.60,Fever; unspecified,1
260101,Oseltamivir,780.79,Other malaise and fatigue,1
260101,Oseltamivir,780.99,Other general symptoms,1
260101,Oseltamivir,784.0,Headache,1
260101,Oseltamivir,784.1,Throat pain,1
260101,Oseltamivir,786.2,Cough,1
260101,Oseltamivir,797,Senility without mention of psychosis,1
260101,Oseltamivir,799.89,Other ill-defined conditions,1
261415,Fosinopril / Hydrochlorothiazide,401-405.99,,1
261415,Fosinopril / Hydrochlorothiazide,401.9,Hypertension NOS,1
261415,Fosinopril / Hydrochlorothiazide,997.91,Hypertension,1
261417,Hydrochlorothiazide / quinapril,401-405.99,,1
261417,Hydrochlorothiazide / quinapril,401.9,Hypertension NOS,1
261417,Hydrochlorothiazide / quinapril,997.91,Hypertension,1
261432,Phenylephrine / Pyrilamine,460,Acute nasopharyngitis (common cold),1
261432,Phenylephrine / Pyrilamine,477.9,Allergic rhinitis NOS,1
261432,Phenylephrine / Pyrilamine,478.19,Other diseases of nasal cavity and sinuses,1
261435,Sodium ferric gluconate complex,280,Iron deficiency anemias,1
261435,Sodium ferric gluconate complex,280.9,Iron deficiency anemia; unspecified,1
262150,Iron Carbonyl,280,Iron deficiency anemias,0
262150,Iron Carbonyl,280.9,Iron deficiency anemia; unspecified,0
263010,tositumomab,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
266604,Metyrosine,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
266604,Metyrosine,239.9,Neoplasm of unspecified nature; site unspecified,1
266604,Metyrosine,401,Essential hypertension,1
266604,Metyrosine,401-405.99,,1
266604,Metyrosine,401.9,Hypertension NOS,1
266604,Metyrosine,997.91,Hypertension,1
266663,Nedocromil Sodium,372.14,Other chronic allergic conjunctivitis,1
266663,Nedocromil Sodium,493,Asthma,0
266663,Nedocromil Sodium,493.9,Asthma; unspecified,0
266663,Nedocromil Sodium,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
266663,Nedocromil Sodium,698.9,Unspecified pruritic disorder,1
266663,Nedocromil Sodium,786.05,Shortness of breath,0
266663,Nedocromil Sodium,786.09,Other dyspnea and respiratory abnormality,0
266856,Divalproex Sodium,296.00,Manic disorder; single episode; unspecified degree,1
266856,Divalproex Sodium,296.20,Major depressive disorder; single episode; unspecified degree,1
266856,Divalproex Sodium,296.80,Bipolar disorder NOS,1
266856,Divalproex Sodium,331.0,Alzheimer's disease,0
266856,Divalproex Sodium,345.00,Generalized nonconvulsive epilepsy; without mention of intractable epilepsy,1
266856,Divalproex Sodium,345.40,Partial epilepsy without intractable epilepsy,0
266856,Divalproex Sodium,345.9,Epilepsy; unspecified,1
266856,Divalproex Sodium,345.90,Epilepsy; unspecified; without mention of intractable epilepsy,1
266856,Divalproex Sodium,346,Migraine,1
266856,Divalproex Sodium,346.9,Migraine; unspecified,1
266856,Divalproex Sodium,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
266856,Divalproex Sodium,780.39,Other convulsions,1
266856,Divalproex Sodium,799.24,Emotional lability (ADDED),1
266959,Pheniramine Maleate,477.9,Allergic rhinitis NOS,0
266959,Pheniramine Maleate,708,Urticaria,0
266959,Pheniramine Maleate,708.9,Unspecified urticaria,0
267073,Methicillin Sodium,136.9,Unspecified infectious and parasitic diseases,0
267073,Methicillin Sodium,482.9,Bacterial pneumonia NOS,0
267073,Methicillin Sodium,686.9,Unspecified local infection of skin and subcutaneous tissue,0
267073,Methicillin Sodium,730.2,Unspecified osteomyelitis,0
267073,Methicillin Sodium,730.20,Unspecified osteomyelitis; site unspecified,0
267342,spectinomycin hydrochloride,098,Gonococcal infections,1
267342,spectinomycin hydrochloride,098.89,Gonococcal infection of other specified sites,1
267366,Sodium Ascorbate,267,Ascorbic acid deficiency,0
267366,Sodium Ascorbate,270.2,Other disturbances of aromatic amino-acid metabolism,0
267366,Sodium Ascorbate,285.9,Anemia unspecified,0
267366,Sodium Ascorbate,289.7,Methemoglobinemia,0
267366,Sodium Ascorbate,460,Acute nasopharyngitis (common cold),0
267366,Sodium Ascorbate,879.8,Open wound(s) (multiple) of unspecified site(s); without mention of complication,0
267396,Bupivacaine Hydrochloride,338-338.99,,1
267396,Bupivacaine Hydrochloride,780.96,Generalized pain,1
274332,nateglinide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
274403,mecasermin,260-269.99,,1
274403,mecasermin,269.9,Unspecified nutritional deficiency,1
274403,mecasermin,994.2,Effects of hunger,1
274771,nelarabine,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
274771,nelarabine,208,Leukemia of unspecified cell type,1
274771,nelarabine,208.9,Unspecified leukemia,1
274771,nelarabine,208.90,Unspecified leukemia without mention of having achieved remission,1
274783,Insulin Glargine,250,Diabetes mellitus,1
274783,Insulin Glargine,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
274783,Insulin Glargine,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,1
274783,Insulin Glargine,790.6,Other abnormal blood chemistry,1
274786,telithromycin,136.9,Unspecified infectious and parasitic diseases,1
274786,telithromycin,486,Pneumonia; organism unspecified,1
274964,ciclesonide,477.0,Allergic rhinitis due to pollen,1
274964,ciclesonide,477.9,Allergic rhinitis NOS,1
274964,ciclesonide,493,Asthma,1
274964,ciclesonide,493.9,Asthma; unspecified,1
274964,ciclesonide,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
275635,desloratadine,477.0,Allergic rhinitis due to pollen,1
275635,desloratadine,477.9,Allergic rhinitis NOS,1
275635,desloratadine,478.19,Other diseases of nasal cavity and sinuses,1
275635,desloratadine,698.9,Unspecified pruritic disorder,1
275635,desloratadine,708,Urticaria,1
275635,desloratadine,708.9,Unspecified urticaria,1
275635,desloratadine,995.3,Allergy unspecified not elsewhere classified,0
275891,valganciclovir,042,Human immunodeficiency virus [HIV] disease,1
275891,valganciclovir,078.5,Cytomegaloviral disease,0
275891,valganciclovir,363.20|078.5,,1
276237,emtricitabine,042,Human immunodeficiency virus [HIV] disease,1
276237,emtricitabine,042-042.99,,1
276237,emtricitabine,136.9,Unspecified infectious and parasitic diseases,1
278567,valdecoxib,625.3,Dysmenorrhea,1
278567,valdecoxib,714.0,Rheumatoid arthritis,1
278567,valdecoxib,715.00,Osteoarthrosis; generalized; involving unspecified site,1
278567,valdecoxib,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
278567,valdecoxib,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
278567,valdecoxib,716.90,Arthropathy; unspecified; site unspecified,1
278739,pegvisomant,253.0,Acromegaly and gigantism,1
279645,almotriptan,300.29,Other isolated or specific phobias,1
279645,almotriptan,338-338.99,,1
279645,almotriptan,346,Migraine,1
279645,almotriptan,346.9,Migraine; unspecified,1
279645,almotriptan,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
279645,almotriptan,368.13,Visual discomfort,1
279645,almotriptan,379.99,Other ill-defined disorders of eye,1
279645,almotriptan,780.96,Generalized pain,1
279645,almotriptan,784.0,Headache,1
279645,almotriptan,787.02,Nausea alone,1
282357,fulvestrant,174.9,Malignant neoplasm of breast (female); unspecified,1
282357,fulvestrant,239.3,Neoplasm of unspecified nature of breast,0
282388,imatinib,140-239.99,,1
282388,imatinib,173.99,Other specified malignant neoplasm of skin; site unspecified,1
282388,imatinib,204.0,Lymphoid leukemia; acute,1
282388,imatinib,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
282388,imatinib,205.1,Myeloid leukemia; chronic,1
282388,imatinib,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
282388,imatinib,208,Leukemia of unspecified cell type,1
282388,imatinib,208.9,Unspecified leukemia,1
282388,imatinib,208.90,Unspecified leukemia without mention of having achieved remission,1
282388,imatinib,239,Neoplasms of unspecified nature,1
282388,imatinib,239-239.99,,1
282388,imatinib,239.0,Neoplasm of unspecified nature of digestive system,1
282388,imatinib,733.29,Other bone cyst,1
282388,imatinib,757.33,Congenital pigmentary anomalies of skin,1
282415,Amantadine Hydrochloride,136.9,Unspecified infectious and parasitic diseases,1
282415,Amantadine Hydrochloride,332,Parkinson's disease,1
282415,Amantadine Hydrochloride,332.0,Paralysis agitans,1
282415,Amantadine Hydrochloride,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
282415,Amantadine Hydrochloride,487,Influenza,1
282415,Amantadine Hydrochloride,487.1,Influenza with other respiratory manifestations,1
282415,Amantadine Hydrochloride,519.8,Other diseases of respiratory system; not elsewhere classified,1
282446,posaconazole,110-118.99,,1
282446,posaconazole,112,Candidiasis,1
282446,posaconazole,112.9,Candidiasis of unspecified site,1
282446,posaconazole,117.9,Other and unspecified mycoses,1
282446,posaconazole,136.9,Unspecified infectious and parasitic diseases,1
282448,artemether / lumefantrine,084,Malaria,0
282448,artemether / lumefantrine,084.2,Quartan malaria,0
282448,artemether / lumefantrine,084.6,Malaria NOS,0
283547,CARBETAPENTANE CITRATE,786.2,Cough,0
283579,Milk thistle extract,571.4,Chronic hepatitis,0
283579,Milk thistle extract,571.40,Chronic hepatitis NOS,0
283579,Milk thistle extract,571.5,Cirrhosis of liver without mention of alcohol,0
283742,Esomeprazole,530.1,Esophagitis,1
283742,Esomeprazole,530.10,Esophagitis; unspecified,1
283742,Esomeprazole,530.81,Esophageal reflux,1
283742,Esomeprazole,531,Gastric ulcer,1
283742,Esomeprazole,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
283742,Esomeprazole,532,Duodenal ulcer,1
283742,Esomeprazole,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,1
283742,Esomeprazole,707.9,Chronic ulcer of unspecified site,1
283742,Esomeprazole,787.1,Heartburn,1
283809,travoprost,365,Glaucoma,1
283809,travoprost,365.04,Ocular hypertension,1
283809,travoprost,365.1,Open-angle glaucoma,0
283809,travoprost,365.10,Open-angle glaucoma NOS,0
283809,travoprost,365.13,Pigmentary glaucoma,0
283809,travoprost,365.9,Glaucoma NOS,1
283810,bimatoprost,365,Glaucoma,1
283810,bimatoprost,365.04,Ocular hypertension,1
283810,bimatoprost,365.1,Open-angle glaucoma,1
283810,bimatoprost,365.10,Open-angle glaucoma NOS,1
283810,bimatoprost,365.13,Pigmentary glaucoma,1
283810,bimatoprost,365.9,Glaucoma NOS,1
283810,bimatoprost,704.09,Other alopecia,1
283821,Rasburicase,140-239.99,,1
283821,Rasburicase,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
283821,Rasburicase,208,Leukemia of unspecified cell type,1
283821,Rasburicase,208.9,Unspecified leukemia,1
283821,Rasburicase,208.90,Unspecified leukemia without mention of having achieved remission,1
283821,Rasburicase,239,Neoplasms of unspecified nature,1
283821,Rasburicase,239-239.99,,1
283821,Rasburicase,277.88,Tumor lysis syndrome,0
283821,Rasburicase,277.89,Other specified disorders of metabolism,0
283821,Rasburicase,790.6,Other abnormal blood chemistry,1
283838,darbepoetin alfa,285.9,Anemia unspecified,1
283838,darbepoetin alfa,585.6,End stage renal disease,1
283838,darbepoetin alfa,585.9,Chronic kidney disease; unspecified,1
283838,darbepoetin alfa,586,Renal failure unspecified,1
284620,abacavir / Lamivudine / Zidovudine,042,Human immunodeficiency virus [HIV] disease,0
284620,abacavir / Lamivudine / Zidovudine,042-042.99,,0
284635,fluticasone / salmeterol,496,Chronic airway obstruction; not elsewhere classified,0
284635,fluticasone / salmeterol,786.05,Shortness of breath,0
284635,fluticasone / salmeterol,786.09,Other dyspnea and respiratory abnormality,0
284635,fluticasone / salmeterol,796.4,Other abnormal clinical findings,0
284637,HYLAN G-F 20,715.00,Osteoarthrosis; generalized; involving unspecified site,0
284637,HYLAN G-F 20,715.9,Osteoarthrosis; unspecified whether generalized or localized,0
284637,HYLAN G-F 20,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,0
284640,lopinavir / Ritonavir,042,Human immunodeficiency virus [HIV] disease,1
284640,lopinavir / Ritonavir,042-042.99,,1
285155,Kelp preparation,244.9,Hypothyroidism NOS,0
285223,Cat's Claw preparation,531,Gastric ulcer,0
285223,Cat's Claw preparation,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
285223,Cat's Claw preparation,535.50,Unspecified gastritis and gastroduodenitis; without mention of hemorrhage,0
285228,Kava preparation,300.00,Anxiety state unspecified,0
285228,Kava preparation,311,Depressive disorder NEC,0
288262,cinoxate,692.70,Unspecified dermatitis due to sun,0
288262,cinoxate,692.71,Sunburn,0
298665,nepafenac,338-338.99,,1
298665,nepafenac,780.96,Generalized pain,1
298869,eplerenone,401-405.99,,1
298869,eplerenone,401.9,Hypertension NOS,1
298869,eplerenone,410,Acute myocardial infarction,1
298869,eplerenone,410.9,Acute myocardial infarction; unspecified site,1
298869,eplerenone,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
298869,eplerenone,428,Heart failure,1
298869,eplerenone,428.9,Heart failure unspecified,1
298869,eplerenone,997.91,Hypertension,1
299081,spinosad,132.0,Pediculus capitis [head louse],1
299635,alefacept,523.6,Accretions on teeth,1
299635,alefacept,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
300195,tenofovir disoproxil,042,Human immunodeficiency virus [HIV] disease,1
300195,tenofovir disoproxil,042-042.99,,1
300195,tenofovir disoproxil,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
300195,tenofovir disoproxil,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
300195,tenofovir disoproxil,136.9,Unspecified infectious and parasitic diseases,1
301542,rosuvastatin,250,Diabetes mellitus,1
301542,rosuvastatin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
301542,rosuvastatin,272.1,Pure hyperglyceridemia,1
301542,rosuvastatin,272.4,Other and unspecified hyperlipidemia,1
301542,rosuvastatin,272.8,Other disorders of lipoid metabolism,1
301542,rosuvastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
301542,rosuvastatin,429.2,Cardiovascular disease [ASCVD],1
301542,rosuvastatin,429.9,Heart disease NOS,1
301542,rosuvastatin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
301542,rosuvastatin,440,Atherosclerosis,1
301542,rosuvastatin,783.21,Loss of weight,0
301542,rosuvastatin,783.9,Other symptoms concerning nutrition; metabolism; and development,0
301739,abarelix,185,Malignant neoplasm of prostate,1
302285,conivaptan,253.6,Other disorders of neurohypophysis,1
302285,conivaptan,276.1,Hyposmolality and/or hyponatremia,1
302285,conivaptan,428,Heart failure,1
302285,conivaptan,428.9,Heart failure unspecified,1
302379,omalizumab,493,Asthma,1
302379,omalizumab,493.0,Extrinsic asthma,0
302379,omalizumab,493.9,Asthma; unspecified,1
302379,omalizumab,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
304962,arformoterol,491,Chronic bronchitis,1
304962,arformoterol,491.9,Chronic bronchitis NOS,1
304962,arformoterol,493,Asthma,1
304962,arformoterol,493.9,Asthma; unspecified,1
304962,arformoterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
304962,arformoterol,496,Chronic airway obstruction; not elsewhere classified,1
304962,arformoterol,518.89,Other diseases of lung; not elsewhere classified,1
304962,arformoterol,796.4,Other abnormal clinical findings,1
306266,entecavir,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
306266,entecavir,070.32,Viral hepatitis B without mention of hepatic coma; chronic; without mention of hepatitis delta,1
306266,entecavir,573.9,Unspecified disorder of liver,1
306674,vardenafil,302.72,Psychosexual dysfunction with inhibited sexual excitement,1
306674,vardenafil,607.84,Impotence of organic origin,1
314583,D-BIOTIN,266,Deficiency of B-complex components,0
314583,D-BIOTIN,266.9,Vitamin B deficiency NOS,0
314583,D-BIOTIN,277.9,Unspecified disorder of metabolism,0
314583,D-BIOTIN,704.0,Alopecia,0
314583,D-BIOTIN,704.00,Alopecia NOS,0
314683,Insulin  Zinc  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
314683,Insulin  Zinc  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
314683,Insulin  Zinc  Human,790.6,Other abnormal blood chemistry,0
314684,Insulin  Protamine Lispro  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
314684,Insulin  Protamine Lispro  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
314684,Insulin  Protamine Lispro  Human,790.6,Other abnormal blood chemistry,0
314726,Menthol / phenol,698.9,Unspecified pruritic disorder,0
314837,SODIUM PHOSPHATE DIHYDRATE,275.3,Disorders of phosphorus metabolism,0
314881,Undecylenate,110.3,Dermatophytosis of groin and perianal area,0
314881,Undecylenate,110.4,Dermatophytosis of foot,0
314881,Undecylenate,686.9,Unspecified local infection of skin and subcutaneous tissue,0
317201,ammonia spirit  aromatic,780.09,Other alteration of consciousness,0
317841,dl-alpha tocopheryl acetate,269.1,Deficiency of other vitamins,0
317841,dl-alpha tocopheryl acetate,283.9,Acquired hemolytic anemia; unspecified,0
317841,dl-alpha tocopheryl acetate,331.0,Alzheimer's disease,0
317841,dl-alpha tocopheryl acetate,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
317841,dl-alpha tocopheryl acetate,770.7,Chronic respiratory disease arising in the perinatal period,0
318340,Aloe vera preparation,564.0,Constipation,0
318340,Aloe vera preparation,564.00,Constipation NOS,0
318340,Aloe vera preparation,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,0
318340,Aloe vera preparation,698.9,Unspecified pruritic disorder,0
318340,Aloe vera preparation,940-949.99,,0
318340,Aloe vera preparation,949.0,Burn of unspecified site; unspecified degree,0
318340,Aloe vera preparation,991.3,Frostbite of other and unspecified sites,0
318341,cetuximab,140-239.99,,1
318341,cetuximab,153.9,Malignant neoplasm of colon; unspecified,0
318341,cetuximab,232.9,Carcinoma in situ of skin; site unspecified,1
318341,cetuximab,239,Neoplasms of unspecified nature,1
318341,cetuximab,239-239.99,,1
319780,Capsicum extract,053,Herpes zoster,0
319780,Capsicum extract,053.9,Herpes zoster without mention of complication,0
319780,Capsicum extract,250.6,Diabetes with neurological manifestations,0
319780,Capsicum extract,338-338.99,,0
319780,Capsicum extract,729.2,Neuralgia; neuritis; and radiculitis; unspecified,0
319780,Capsicum extract,780.96,Generalized pain,0
319837,Gotu Kola Extract,459.81,Venous (peripheral) insufficiency NOS,0
319837,Gotu Kola Extract,709.9,Unspecified disorder of skin and subcutaneous tissue,0
319837,Gotu Kola Extract,780.79,Other malaise and fatigue,0
321064,olmesartan,250.4,Diabetes with renal manifestations,0
321064,olmesartan,401-405.99,,1
321064,olmesartan,401.9,Hypertension NOS,1
321064,olmesartan,428.0,Congestive heart failure (CHF) NOS,0
321064,olmesartan,997.91,Hypertension,1
321208,fondaparinux,415.19,Other pulmonary embolism and infarction,1
321208,fondaparinux,451.9,Phlebitis and thrombophlebitis of unspecified site,1
321208,fondaparinux,453.9,Embolism and thrombosis of unspecified site,1
321208,fondaparinux,459.0,Hemorrhage NOS,1
321208,fondaparinux,459.9,Unspecified circulatory system disorder,0
321208,fondaparinux,998.9,Unspecified complication of procedure; not elsewhere classified,0
321952,Pimecrolimus,691.8,Other atopic dermatitis,1
321952,Pimecrolimus,692.9,Contact dermatitis and other eczema; unspecified cause,1
321952,Pimecrolimus,709.9,Unspecified disorder of skin and subcutaneous tissue,0
321988,Escitalopram,296.20,Major depressive disorder; single episode; unspecified degree,1
321988,Escitalopram,300.00,Anxiety state unspecified,1
321988,Escitalopram,300.02,Generalized anxiety disorder,1
321988,Escitalopram,300.9,Unspecified nonpsychotic mental disorder,1
321988,Escitalopram,311,Depressive disorder NEC,1
322154,Fondaparinux sodium,415.19,Other pulmonary embolism and infarction,1
322154,Fondaparinux sodium,451.9,Phlebitis and thrombophlebitis of unspecified site,1
322154,Fondaparinux sodium,459.0,Hemorrhage NOS,1
322167,Solifenacin,596.51,Hypertonicity of bladder,1
322167,Solifenacin,788.3,Urinary incontinence,1
322167,Solifenacin,788.30,Urinary incontinence NOS,1
322167,Solifenacin,788.41,Urinary frequency,1
322167,Solifenacin,788.63,Urgency of urination,1
322167,Solifenacin,788.69,Other abnormality of urination,1
322248,Tenofovir disoproxil fumarate,042,Human immunodeficiency virus [HIV] disease,1
322248,Tenofovir disoproxil fumarate,042-042.99,,1
322248,Tenofovir disoproxil fumarate,136.9,Unspecified infectious and parasitic diseases,1
323828,Rosuvastatin calcium,250,Diabetes mellitus,1
323828,Rosuvastatin calcium,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
323828,Rosuvastatin calcium,272.1,Pure hyperglyceridemia,1
323828,Rosuvastatin calcium,272.4,Other and unspecified hyperlipidemia,1
323828,Rosuvastatin calcium,272.8,Other disorders of lipoid metabolism,1
323828,Rosuvastatin calcium,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
323828,Rosuvastatin calcium,429.2,Cardiovascular disease [ASCVD],1
323828,Rosuvastatin calcium,429.9,Heart disease NOS,1
323828,Rosuvastatin calcium,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
323828,Rosuvastatin calcium,440,Atherosclerosis,1
323828,Rosuvastatin calcium,783.21,Loss of weight,0
323828,Rosuvastatin calcium,783.9,Other symptoms concerning nutrition; metabolism; and development,0
324042,Hydrochlorothiazide / Spironolactone,276.69,Other fluid overload,1
324042,Hydrochlorothiazide / Spironolactone,401-405.99,,1
324042,Hydrochlorothiazide / Spironolactone,401.9,Hypertension NOS,1
324042,Hydrochlorothiazide / Spironolactone,997.91,Hypertension,1
325526,Ginseng Preparation,302.72,Psychosexual dysfunction with inhibited sexual excitement,0
325526,Ginseng Preparation,607.84,Impotence of organic origin,0
325526,Ginseng Preparation,780.79,Other malaise and fatigue,0
325642,ertapenem,038,Septicemia,0
325642,ertapenem,038.9,Septicemia NOS,0
325642,ertapenem,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
325642,ertapenem,041.49,Other and unspecified Escherichia coli [E. coli],0
325642,ertapenem,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
325642,ertapenem,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
325642,ertapenem,136.9,Unspecified infectious and parasitic diseases,1
325642,ertapenem,519.8,Other diseases of respiratory system; not elsewhere classified,0
325642,ertapenem,590.80,Pyelonephritis NOS,1
325642,ertapenem,682.2,Cellulitis and abscess of trunk,0
325642,ertapenem,686.9,Unspecified local infection of skin and subcutaneous tissue,1
325646,aliskiren,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
325646,aliskiren,401,Essential hypertension,1
325646,aliskiren,401-405.99,,1
325646,aliskiren,401.9,Hypertension NOS,1
325646,aliskiren,593.9,Unspecified disorder of kidney and ureter,1
325646,aliskiren,997.91,Hypertension,1
325887,micafungin,112,Candidiasis,1
325887,micafungin,112.5,Disseminated candidiasis,1
325887,micafungin,112.84,Candidal esophagitis,1
325887,micafungin,112.89,Other candidiasis of other specified sites,1
325887,micafungin,112.9,Candidiasis of unspecified site,1
325887,micafungin,567.9,Peritonitis NOS,1
326374,norelgestromin,621.4,Hematometra,0
326374,norelgestromin,626.0,Absence of menstruation,0
327361,adalimumab,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
327361,adalimumab,555.9,Regional enteritis of unspecified site,0
327361,adalimumab,696.0,Psoriatic arthropathy,1
327361,adalimumab,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
327361,adalimumab,714.0,Rheumatoid arthritis,1
327361,adalimumab,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
327361,adalimumab,720.0,Ankylosing spondylitis,1
327361,adalimumab,780-789.99,,0
328134,gefitinib,140-239.99,,1
328134,gefitinib,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
328134,gefitinib,199.1,Other malignant neoplasm of unspecified site,1
328134,gefitinib,239,Neoplasms of unspecified nature,1
328134,gefitinib,239-239.99,,1
328134,gefitinib,239.1,Neoplasm of unspecified nature of respiratory system,0
328141,Angelica sinensis preparation,256.31,Premature menopause,0
328141,Angelica sinensis preparation,401-405.99,,0
328141,Angelica sinensis preparation,401.9,Hypertension NOS,0
328141,Angelica sinensis preparation,564.0,Constipation,0
328141,Angelica sinensis preparation,564.00,Constipation NOS,0
328141,Angelica sinensis preparation,625.3,Dysmenorrhea,0
328141,Angelica sinensis preparation,729.0,Rheumatism; unspecified and fibrositis,0
328141,Angelica sinensis preparation,997.91,Hypertension,0
337523,ixabepilone,174.9,Malignant neoplasm of breast (female); unspecified,1
337525,erlotinib,157.9,Malignant neoplasm of pancreas; part unspecified,1
337525,erlotinib,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
337525,erlotinib,197.8,Secondary malignant neoplasm of other digestive organs and spleen,1
337525,erlotinib,199.1,Other malignant neoplasm of unspecified site,1
337623,Dornase Alfa,277.0,Cystic fibrosis,1
337623,Dornase Alfa,277.00,Cystic fibrosis without mention of meconium ileus,1
337623,Dornase Alfa,490,Bronchitis NOS,0
338036,pegfilgrastim,136.9,Unspecified infectious and parasitic diseases,1
338036,pegfilgrastim,288.0,Agranulocytosis,1
338036,pegfilgrastim,288.00,Neutropenia NOS,1
338817,agalsidase beta,272.7,Lipidoses,1
338817,agalsidase beta,277.6,Other deficiencies of circulating enzymes,1
341018,anidulafungin,112,Candidiasis,1
341018,anidulafungin,112.84,Candidal esophagitis,1
341018,anidulafungin,112.9,Candidiasis of unspecified site,1
341248,ezetimibe,272.0,Pure hypercholesterolemia,1
341248,ezetimibe,272.2,Mixed hyperlipidemia,1
341248,ezetimibe,272.4,Other and unspecified hyperlipidemia,1
341248,ezetimibe,272.5,Lipoprotein deficiencies,1
341248,ezetimibe,440,Atherosclerosis,1
341248,ezetimibe,459.9,Unspecified circulatory system disorder,1
341248,ezetimibe,783.21,Loss of weight,1
341248,ezetimibe,783.9,Other symptoms concerning nutrition; metabolism; and development,1
342369,lenalidomide,203.0,Multiple myeloma,1
342369,lenalidomide,203.00,Multiple myeloma without mention of having achieved remission,1
342369,lenalidomide,238.75,Myelodysplastic syndrome; unspecified,1
343047,Atazanavir,042,Human immunodeficiency virus [HIV] disease,0
343047,Atazanavir,042-042.99,,0
343047,Atazanavir,136.9,Unspecified infectious and parasitic diseases,1
343047,Atazanavir,995.20,Unspecified adverse effect of unspecified drug; medicinal and biological substance,1
343048,Treprostinil,136.9,Unspecified infectious and parasitic diseases,1
343048,Treprostinil,416.0,Primary pulmonary hypertension,1
352362,Acetaminophen / Tramadol,338-338.99,,1
352362,Acetaminophen / Tramadol,780.96,Generalized pain,1
352364,Buprenorphine / Naloxone,304.0,Opioid type dependence,1
352364,Buprenorphine / Naloxone,304.00,Opioid type dependence unspecified use,1
352364,Buprenorphine / Naloxone,304.90,Unspecified drug dependence; unspecified use,1
352367,Cetirizine / Pseudoephedrine,375.2,Epiphora,1
352367,Cetirizine / Pseudoephedrine,375.20,Epiphora NOS,1
352367,Cetirizine / Pseudoephedrine,379.99,Other ill-defined disorders of eye,1
352367,Cetirizine / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
352367,Cetirizine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
352367,Cetirizine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
352367,Cetirizine / Pseudoephedrine,698.9,Unspecified pruritic disorder,1
352367,Cetirizine / Pseudoephedrine,995.3,Allergy unspecified not elsewhere classified,1
352372,dexmethylphenidate,300.9,Unspecified nonpsychotic mental disorder,1
352372,dexmethylphenidate,314,Hyperkinetic syndrome of childhood,1
352372,dexmethylphenidate,314.01,Attention deficit disorder of childhood with hyperactivity,1
352372,dexmethylphenidate,314.9,Unspecified hyperkinetic syndrome of childhood,1
352372,dexmethylphenidate,780-789.99,,0
352374,drotrecogin alfa,038.9,Septicemia NOS,1
352374,drotrecogin alfa,785.52,Septic shock,0
352374,drotrecogin alfa,995.91,Sepsis,1
352377,Ethinyl Estradiol / norelgestromin,V22.2,Pregnant state; incidental,1
352381,Glipizide / Metformin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
352381,Glipizide / Metformin,790.6,Other abnormal blood chemistry,1
352385,Insulin  Aspart Protamine  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
352385,Insulin  Aspart Protamine  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
352385,Insulin  Aspart Protamine  Human,276.7,Hyperpotassemia,0
352385,Insulin  Aspart Protamine  Human,790.6,Other abnormal blood chemistry,0
352387,Lovastatin / Niacin,272.8,Other disorders of lipoid metabolism,1
352387,Lovastatin / Niacin,440,Atherosclerosis,1
352387,Lovastatin / Niacin,786.50,Unspecified chest pain,1
352767,Methscopolamine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
353105,dexmethylphenidate hydrochloride,300.9,Unspecified nonpsychotic mental disorder,1
353105,dexmethylphenidate hydrochloride,314,Hyperkinetic syndrome of childhood,1
353105,dexmethylphenidate hydrochloride,314.01,Attention deficit disorder of childhood with hyperactivity,1
353105,dexmethylphenidate hydrochloride,314.9,Unspecified hyperkinetic syndrome of childhood,1
353105,dexmethylphenidate hydrochloride,780-789.99,,0
354770,natalizumab,046.3,Progressive multifocal leukoencephalopathy,1
354770,natalizumab,340,Multiple sclerosis,1
354770,natalizumab,555.9,Regional enteritis of unspecified site,0
354770,natalizumab,780-789.99,,0
354770,natalizumab,799.9,Other unknown and unspecified cause of morbidity or mortality,1
356773,pramlintide acetate,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
356773,pramlintide acetate,783.21,Loss of weight,0
356773,pramlintide acetate,783.9,Other symptoms concerning nutrition; metabolism; and development,0
356887,levocetirizine,477.0,Allergic rhinitis due to pollen,1
356887,levocetirizine,477.9,Allergic rhinitis NOS,1
356887,levocetirizine,708,Urticaria,1
356887,levocetirizine,708.9,Unspecified urticaria,1
356988,efalizumab,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
357977,sunitinib,140-239.99,,1
357977,sunitinib,189.0,Malignant neoplasm of kidney; except pelvis,1
357977,sunitinib,209,Neuroendocrine tumors,1
357977,sunitinib,209-209.99,,1
357977,sunitinib,239,Neoplasms of unspecified nature,1
357977,sunitinib,239-239.99,,1
357977,sunitinib,239.0,Neoplasm of unspecified nature of digestive system,1
357977,sunitinib,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,1
357977,sunitinib,239.9,Neoplasm of unspecified nature; site unspecified,1
358255,aprepitant,787.02,Nausea alone,1
358255,aprepitant,787.03,Vomiting alone,1
358257,tolvaptan,253.6,Other disorders of neurohypophysis,1
358257,tolvaptan,276.1,Hyposmolality and/or hyponatremia,1
358257,tolvaptan,428,Heart failure,1
358257,tolvaptan,428.9,Heart failure unspecified,1
358257,tolvaptan,571.5,Cirrhosis of liver without mention of alcohol,1
358258,bortezomib,200.4,Mantle cell lymphoma,1
358258,bortezomib,203.0,Multiple myeloma,1
358258,bortezomib,203.00,Multiple myeloma without mention of having achieved remission,1
358263,tadalafil,302.72,Psychosexual dysfunction with inhibited sexual excitement,1
358263,tadalafil,401-405.99,,1
358263,tadalafil,401.9,Hypertension NOS,1
358263,tadalafil,416.0,Primary pulmonary hypertension,1
358263,tadalafil,600.0,Hypertrophy (benign) of prostate,0
358263,tadalafil,607.84,Impotence of organic origin,1
358263,tadalafil,780-789.99,,0
358263,tadalafil,782.3,Edema,0
358263,tadalafil,785.9,Other symptoms involving cardiovascular system,0
358263,tadalafil,788.41,Urinary frequency,0
358263,tadalafil,788.62,Slowing of urinary stream,0
358263,tadalafil,788.69,Other abnormality of urination,0
358263,tadalafil,997.91,Hypertension,1
358274,ambrisentan,416.0,Primary pulmonary hypertension,1
360375,Fenugreek seed preparation,490,Bronchitis NOS,0
360375,Fenugreek seed preparation,751.9,Unspecified congenital anomaly of digestive system,0
360375,Fenugreek seed preparation,786.2,Cough,0
360375,Fenugreek seed preparation,787.3,Flatulence; eructation; and gas pain,0
384410,Ethinyl Estradiol / Norethindrone,706.1,Other acne,1
384410,Ethinyl Estradiol / Norethindrone,V22.2,Pregnant state; incidental,1
384455,tigecycline,136.9,Unspecified infectious and parasitic diseases,1
386938,Follitropin Alfa,253.4,Other anterior pituitary disorders,1
386938,Follitropin Alfa,256.39,Other ovarian failure,1
386938,Follitropin Alfa,257.2,Other testicular hypofunction,1
389132,Budesonide / formoterol,491,Chronic bronchitis,1
389132,Budesonide / formoterol,491.9,Chronic bronchitis NOS,1
389132,Budesonide / formoterol,492.8,Other emphysema,1
389132,Budesonide / formoterol,493,Asthma,1
389132,Budesonide / formoterol,493.9,Asthma; unspecified,1
389132,Budesonide / formoterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,1
389132,Budesonide / formoterol,496,Chronic airway obstruction; not elsewhere classified,1
389132,Budesonide / formoterol,518.89,Other diseases of lung; not elsewhere classified,1
389132,Budesonide / formoterol,519.11,Acute bronchospasm,1
389132,Budesonide / formoterol,796.4,Other abnormal clinical findings,1
392509,Laronidase,277.5,Mucopolysaccharidosis,1
392509,Laronidase,756.9,Other and unspecified congenital anomalies of musculoskeletal system,1
392556,Benzoyl Peroxide / Erythromycin,706.1,Other acne,1
400008,Insulin  Glulisine  Human,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
400008,Insulin  Glulisine  Human,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
400008,Insulin  Glulisine  Human,790.6,Other abnormal blood chemistry,1
401713,Carglumic acid,270.6,Disorders of urea cycle metabolism,1
402316,Miglustat,272.7,Lipidoses,1
402899,TOCOPHEROL DL-ALPHA,269.1,Deficiency of other vitamins,0
402899,TOCOPHEROL DL-ALPHA,283.9,Acquired hemolytic anemia; unspecified,0
402899,TOCOPHEROL DL-ALPHA,331.0,Alzheimer's disease,0
402899,TOCOPHEROL DL-ALPHA,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
402899,TOCOPHEROL DL-ALPHA,770.7,Chronic respiratory disease arising in the perinatal period,0
404773,Amlodipine / atorvastatin,272.4,Other and unspecified hyperlipidemia,1
404773,Amlodipine / atorvastatin,401-405.99,,1
404773,Amlodipine / atorvastatin,401.9,Hypertension NOS,1
404773,Amlodipine / atorvastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
404773,Amlodipine / atorvastatin,413,Angina pectoris,1
404773,Amlodipine / atorvastatin,413.9,Other and unspecified angina pectoris,1
404773,Amlodipine / atorvastatin,429.9,Heart disease NOS,1
404773,Amlodipine / atorvastatin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
404773,Amlodipine / atorvastatin,786.50,Unspecified chest pain,1
404773,Amlodipine / atorvastatin,997.91,Hypertension,1
407884,L-METHYLFOLATE,266.2,Other B-complex deficiencies,0
407884,L-METHYLFOLATE,281.9,Deficiency anemia NOS,0
407884,L-METHYLFOLATE,742.8,Other specified congenital anomalies of nervous system,0
407990,cinacalcet,194.1,Malignant neoplasm of parathyroid gland,0
407990,cinacalcet,275.42,Hypercalcemia,1
407990,cinacalcet,585.6,End stage renal disease,1
407990,cinacalcet,585.9,Chronic kidney disease; unspecified,1
407990,cinacalcet,586,Renal failure unspecified,1
407990,cinacalcet,588.81,Secondary hyperparathyroidism (of renal origin),1
451796,Chloroquine hydrochloride,006,Amebiasis,1
451796,Chloroquine hydrochloride,006.9,Amebiasis NOS,1
451796,Chloroquine hydrochloride,084,Malaria,0
451796,Chloroquine hydrochloride,084.0,Falciparum malaria [malignant tertian],1
451796,Chloroquine hydrochloride,084.2,Quartan malaria,1
451796,Chloroquine hydrochloride,084.6,Malaria NOS,0
451796,Chloroquine hydrochloride,136.8,Other specified infectious and parasitic diseases,1
451796,Chloroquine hydrochloride,694.4,Pemphigus,0
451796,Chloroquine hydrochloride,695.4,Lupus erythematosus,0
451796,Chloroquine hydrochloride,710.1,Systemic sclerosis,0
451796,Chloroquine hydrochloride,714.0,Rheumatoid arthritis,0
460132,darunavir,042,Human immunodeficiency virus [HIV] disease,1
460132,darunavir,042-042.99,,1
460132,darunavir,797,Senility without mention of psychosis,1
461016,Eszopiclone,307.42,Persistent disorder of initiating or maintaining sleep,0
461016,Eszopiclone,780.52,Insomnia; unspecified,1
465397,Ciprofloxacin / Dexamethasone,136.9,Unspecified infectious and parasitic diseases,1
465397,Ciprofloxacin / Dexamethasone,380.10,Infective otitis externa; unspecified,1
465397,Ciprofloxacin / Dexamethasone,382.9,Unspecified otitis media,1
465711,Ciprofloxacin / Hydrocortisone,380.10,Infective otitis externa; unspecified,1
466423,Antipyrine / Benzocaine,338-338.99,,1
466423,Antipyrine / Benzocaine,382.9,Unspecified otitis media,1
466423,Antipyrine / Benzocaine,780.96,Generalized pain,1
466431,Chlorpheniramine / Dextromethorphan / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
466431,Chlorpheniramine / Dextromethorphan / Pseudoephedrine,786.2,Cough,1
466489,Codeine / Guaifenesin / Pseudoephedrine,460,Acute nasopharyngitis (common cold),1
466489,Codeine / Guaifenesin / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
466489,Codeine / Guaifenesin / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
466489,Codeine / Guaifenesin / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
466489,Codeine / Guaifenesin / Pseudoephedrine,786.2,Cough,1
466489,Codeine / Guaifenesin / Pseudoephedrine,995.3,Allergy unspecified not elsewhere classified,1
466523,doxorubicin hydrochloride liposome,042,Human immunodeficiency virus [HIV] disease,0
466523,doxorubicin hydrochloride liposome,176,Kaposi's sarcoma,0
466523,doxorubicin hydrochloride liposome,176.9,Kaposi's sarcoma NOS,0
466523,doxorubicin hydrochloride liposome,203.0,Multiple myeloma,0
466523,doxorubicin hydrochloride liposome,203.00,Multiple myeloma without mention of having achieved remission,0
466523,doxorubicin hydrochloride liposome,239.3,Neoplasm of unspecified nature of breast,0
466523,doxorubicin hydrochloride liposome,239.4,Neoplasm of unspecified nature of bladder,0
466523,doxorubicin hydrochloride liposome,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
466549,Aspirin / Caffeine / Orphenadrine,338-338.99,,1
466549,Aspirin / Caffeine / Orphenadrine,780.96,Generalized pain,1
466549,Aspirin / Caffeine / Orphenadrine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
466584,Acetaminophen / Aspirin / Caffeine,338-338.99,,1
466584,Acetaminophen / Aspirin / Caffeine,525.9,Dental disorder NOS,1
466584,Acetaminophen / Aspirin / Caffeine,716.90,Arthropathy; unspecified; site unspecified,1
466584,Acetaminophen / Aspirin / Caffeine,729.1,Myalgia and myositis unspecified,1
466584,Acetaminophen / Aspirin / Caffeine,780.96,Generalized pain,1
466584,Acetaminophen / Aspirin / Caffeine,784.0,Headache,1
473387,ferumoxytol,285.9,Anemia unspecified,1
473387,ferumoxytol,585.6,End stage renal disease,1
473387,ferumoxytol,585.9,Chronic kidney disease; unspecified,1
473387,ferumoxytol,586,Renal failure unspecified,1
473837,telavancin,136.9,Unspecified infectious and parasitic diseases,1
473837,telavancin,686.9,Unspecified local infection of skin and subcutaneous tissue,0
474128,telbivudine,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
475230,degarelix,185,Malignant neoplasm of prostate,1
475342,dasatinib,204.0,Lymphoid leukemia; acute,1
475342,dasatinib,204.00,Acute lymphoid leukemia without mention of having achieved remission,1
475342,dasatinib,205.1,Myeloid leukemia; chronic,1
475342,dasatinib,205.10,Chronic myeloid leukemia without mention of having achieved remission,1
475342,dasatinib,208,Leukemia of unspecified cell type,1
475342,dasatinib,208.9,Unspecified leukemia,1
475342,dasatinib,208.90,Unspecified leukemia without mention of having achieved remission,1
475968,liraglutide,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
475968,liraglutide,783.21,Loss of weight,0
475968,liraglutide,783.9,Other symptoms concerning nutrition; metabolism; and development,0
475968,liraglutide,790.6,Other abnormal blood chemistry,0
475969,etravirine,042,Human immunodeficiency virus [HIV] disease,1
475969,etravirine,042-042.99,,1
475969,etravirine,136.9,Unspecified infectious and parasitic diseases,1
476588,solifenacin succinate,596.51,Hypertonicity of bladder,1
476588,solifenacin succinate,788.3,Urinary incontinence,1
476588,solifenacin succinate,788.30,Urinary incontinence NOS,1
476588,solifenacin succinate,788.41,Urinary frequency,1
476588,solifenacin succinate,788.63,Urgency of urination,1
476588,solifenacin succinate,788.69,Other abnormality of urination,1
477468,Morphine Liposomal,786.05,Shortness of breath,0
477468,Morphine Liposomal,786.09,Other dyspnea and respiratory abnormality,0
477631,butabarbital,300.00,Anxiety state unspecified,0
477631,butabarbital,307.42,Persistent disorder of initiating or maintaining sleep,0
477631,butabarbital,780.52,Insomnia; unspecified,1
480167,lapatinib,174.9,Malignant neoplasm of breast (female); unspecified,0
484211,ezetimibe / Simvastatin,272.0,Pure hypercholesterolemia,1
484211,ezetimibe / Simvastatin,272.8,Other disorders of lipoid metabolism,1
484211,ezetimibe / Simvastatin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,0
484211,ezetimibe / Simvastatin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,0
484211,ezetimibe / Simvastatin,440,Atherosclerosis,1
484211,ezetimibe / Simvastatin,459.9,Unspecified circulatory system disorder,1
484211,ezetimibe / Simvastatin,783.21,Loss of weight,1
484211,ezetimibe / Simvastatin,783.9,Other symptoms concerning nutrition; metabolism; and development,1
484259,Ibuprofen / Oxycodone,338-338.99,,1
484259,Ibuprofen / Oxycodone,780.96,Generalized pain,1
484348,Omega-3 Acid Ethyl Esters (USP),272.1,Pure hyperglyceridemia,1
484348,Omega-3 Acid Ethyl Esters (USP),427,Cardiac dysrhythmias,0
484348,Omega-3 Acid Ethyl Esters (USP),427.9,Cardiac dysrhythmia NOS,0
484348,Omega-3 Acid Ethyl Esters (USP),783.21,Loss of weight,1
484348,Omega-3 Acid Ethyl Esters (USP),783.9,Other symptoms concerning nutrition; metabolism; and development,1
486895,magnesium amino acid chelate,275.2,Disorders of magnesium metabolism,0
495881,sorafenib,155.0,Malignant neoplasm of liver; primary,0
495881,sorafenib,155.2,Malignant neoplasm of liver; not specified as primary or secondary,0
495881,sorafenib,189.0,Malignant neoplasm of kidney; except pelvis,1
498509,pegaptanib,362.50,Macular degeneration (senile) of retina NOS,1
577312,Mineral Oil  Light,560.9,Unspecified intestinal obstruction,0
577312,Mineral Oil  Light,564.0,Constipation,0
577312,Mineral Oil  Light,564.00,Constipation NOS,0
578033,galsulfase,277.5,Mucopolysaccharidosis,1
587318,glycolic acid,692.9,Contact dermatitis and other eczema; unspecified cause,0
588003,Meclofenamate,625.3,Dysmenorrhea,0
588003,Meclofenamate,716.90,Arthropathy; unspecified; site unspecified,0
588250,milnacipran,338-338.99,,0
588250,milnacipran,729.0,Rheumatism; unspecified and fibrositis,1
588250,milnacipran,729.1,Myalgia and myositis unspecified,1
588250,milnacipran,780.96,Generalized pain,0
591781,eculizumab,283.11,Hemolytic-uremic syndrome,1
591781,eculizumab,283.2,Hemoglobinuria due to hemolysis from external causes,1
592464,Articaine,338-338.99,,0
592464,Articaine,780.96,Generalized pain,0
593411,sitagliptin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
594040,Atropine / Diphenoxylate,787.7,Abnormal feces,1
594040,Atropine / Diphenoxylate,787.91,Diarrhea,1
594680,docosanol,054.9,Herpes simplex without mention of complication,1
595060,ranibizumab,362.50,Macular degeneration (senile) of retina NOS,1
596205,ramelteon,780.52,Insomnia; unspecified,1
596724,anagrelide,238.4,Polycythemia vera,0
596724,anagrelide,238.71,Essential thrombocythemia,0
596724,anagrelide,238.79,Other lymphatic and hematopoietic tissues,1
596724,anagrelide,287.5,Thrombocytopenia NOS,0
596724,anagrelide,453.9,Embolism and thrombosis of unspecified site,1
596724,anagrelide,459.0,Hemorrhage NOS,0
596724,anagrelide,790.99,Other nonspecific findings on examination of blood,1
597142,brimonidine / Timolol,365,Glaucoma,1
597142,brimonidine / Timolol,365.04,Ocular hypertension,1
597142,brimonidine / Timolol,365.9,Glaucoma NOS,1
597501,desloratadine / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
597501,desloratadine / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
597501,desloratadine / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
605496,carbetapentane / Guaifenesin,460,Acute nasopharyngitis (common cold),1
605998,Chlorpheniramine / Codeine,375.2,Epiphora,1
605998,Chlorpheniramine / Codeine,375.20,Epiphora NOS,1
605998,Chlorpheniramine / Codeine,379.99,Other ill-defined disorders of eye,1
605998,Chlorpheniramine / Codeine,460,Acute nasopharyngitis (common cold),1
605998,Chlorpheniramine / Codeine,477.0,Allergic rhinitis due to pollen,1
605998,Chlorpheniramine / Codeine,477.9,Allergic rhinitis NOS,1
605998,Chlorpheniramine / Codeine,698.9,Unspecified pruritic disorder,1
605998,Chlorpheniramine / Codeine,786.2,Cough,1
605998,Chlorpheniramine / Codeine,995.3,Allergy unspecified not elsewhere classified,1
605999,Chlorpheniramine / Methscopolamine,477.0,Allergic rhinitis due to pollen,1
605999,Chlorpheniramine / Methscopolamine,477.9,Allergic rhinitis NOS,1
605999,Chlorpheniramine / Methscopolamine,698.9,Unspecified pruritic disorder,1
605999,Chlorpheniramine / Methscopolamine,995.3,Allergy unspecified not elsewhere classified,1
606396,Human Secretin,573.9,Unspecified disorder of liver,0
606396,Human Secretin,577,Diseases of pancreas,1
606396,Human Secretin,577.9,Pancreatic disease NOS,1
607999,Metformin / pioglitazone,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
611247,Fluoxetine / olanzapine,300.3,Obsessive-compulsive disorders,0
611247,Fluoxetine / olanzapine,307.50,Eating disorder NOS,0
611247,Fluoxetine / olanzapine,308.9,Unspecified acute reaction to stress,0
611247,Fluoxetine / olanzapine,309.81,Posttraumatic stress disorder,0
611247,Fluoxetine / olanzapine,311,Depressive disorder NEC,0
611854,Chlordiazepoxide / clidinium,564.1,Irritable bowel syndrome,1
611854,Chlordiazepoxide / clidinium,707.9,Chronic ulcer of unspecified site,1
612865,tocilizumab,714.0,Rheumatoid arthritis,1
612865,tocilizumab,714.30,Polyarticular juvenile rheumatoid arthritis; chronic or unspecified,1
612937,Interferon Alfa-n3,078.11,Condyloma acuminatum,0
613391,prasugrel,315.00,Reading disorder NOS,0
613391,prasugrel,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
613391,prasugrel,411.1,Intermediate coronary syndrome,1
613391,prasugrel,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
613391,prasugrel,453.9,Embolism and thrombosis of unspecified site,1
613391,prasugrel,459.0,Hemorrhage NOS,1
613391,prasugrel,786.50,Unspecified chest pain,1
614373,deferasirox,275.09,Other disorders of iron metabolism,1
614391,abatacept,714.0,Rheumatoid arthritis,1
614391,abatacept,716.90,Arthropathy; unspecified; site unspecified,1
614534,abacavir / Lamivudine,042,Human immunodeficiency virus [HIV] disease,0
614534,abacavir / Lamivudine,042-042.99,,0
616739,Rotigotine,332,Parkinson's disease,0
616739,Rotigotine,332.0,Paralysis agitans,0
617615,Immune Globulin Subcutaneous (Human),279.3,Unspecified immunity deficiency,0
617615,Immune Globulin Subcutaneous (Human),287.31,Immune thrombocytopenic purpura,0
617777,Omeprazole / Sodium Bicarbonate,530.81,Esophageal reflux,1
617777,Omeprazole / Sodium Bicarbonate,707.9,Chronic ulcer of unspecified site,1
617777,Omeprazole / Sodium Bicarbonate,787.1,Heartburn,1
618278,Azelate,695.3,Rosacea,1
618278,Azelate,706.1,Other acne,1
618278,Azelate,709.9,Unspecified disorder of skin and subcutaneous tissue,1
618365,estrogens  conjugated synthetic B,239.3,Neoplasm of unspecified nature of breast,0
618365,estrogens  conjugated synthetic B,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
618365,estrogens  conjugated synthetic B,253.4,Other anterior pituitary disorders,0
618365,estrogens  conjugated synthetic B,256.31,Premature menopause,0
618365,estrogens  conjugated synthetic B,256.39,Other ovarian failure,0
618365,estrogens  conjugated synthetic B,625.8,Other specified symptoms associated with female genital organs,1
618365,estrogens  conjugated synthetic B,626.2,Excessive or frequent menstruation,0
618365,estrogens  conjugated synthetic B,627.2,Symptomatic menopausal or female climacteric states,0
618365,estrogens  conjugated synthetic B,733.01,Senile osteoporosis,0
618365,estrogens  conjugated synthetic B,782.62,Flushing,0
618425,Nalidixate,003.9,Salmonella infection NOS,0
618425,Nalidixate,041.49,Other and unspecified Escherichia coli [E. coli],0
618425,Nalidixate,041.6,Proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site,0
618425,Nalidixate,136.9,Unspecified infectious and parasitic diseases,1
618425,Nalidixate,599.0,Urinary tract infection; site not specified,1
618974,4-Aminobenzoate,694.4,Pemphigus,0
618974,4-Aminobenzoate,710.1,Systemic sclerosis,0
618974,4-Aminobenzoate,710.3,Dermatomyositis,0
620216,maraviroc,042,Human immunodeficiency virus [HIV] disease,0
620216,maraviroc,042-042.99,,0
623033,lubiprostone,564.0,Constipation,1
623033,lubiprostone,564.00,Constipation NOS,1
623033,lubiprostone,564.1,Irritable bowel syndrome,1
623400,lacosamide,780.39,Other convulsions,1
629565,alglucosidase alfa,271.0,Glycogenosis,1
629565,alglucosidase alfa,277.6,Other deficiencies of circulating enzymes,1
631657,insulin human  rDNA origin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,0
631657,insulin human  rDNA origin,250.01,type I diabetes mellitus [insulin dependent type] [IDDM] [juvenile type]; not stated as uncontrolled; without mention of complication,0
631657,insulin human  rDNA origin,790.6,Other abnormal blood chemistry,0
641465,armodafinil,327.23,Obstructive sleep apnea,1
641465,armodafinil,347.0,Narcolepsy,1
641465,armodafinil,347.00,Narcolepsy; without cataplexy,1
641465,armodafinil,780.09,Other alteration of consciousness,1
641465,armodafinil,780.50,Unspecified sleep disturbance,1
641465,armodafinil,780.54,Hypersomnia; unspecified,1
641465,armodafinil,780.57,Unspecified sleep apnea,1
641465,armodafinil,786.09,Other dyspnea and respiratory abnormality,1
642274,retapamulin,684,Impetigo,1
644101,idursulfase,277.5,Mucopolysaccharidosis,1
646781,Benzoyl Peroxide / Clindamycin,706.1,Other acne,1
647235,glimepiride / pioglitazone,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
657797,temsirolimus,189.0,Malignant neoplasm of kidney; except pelvis,1
658708,ecallantide,277.6,Other deficiencies of circulating enzymes,1
660890,sevelamer carbonate,275.3,Disorders of phosphorus metabolism,0
662019,Pralatrexate,202.7,Peripheral T-cell lymphoma,1
662019,Pralatrexate,202.70,Peripheral T-cell lymphoma; unspecified site; extranodal and solid organ sites,1
662263,dorzolamide / Timolol,365,Glaucoma,1
662263,dorzolamide / Timolol,365.04,Ocular hypertension,1
662263,dorzolamide / Timolol,365.9,Glaucoma NOS,1
662263,dorzolamide / Timolol,V62.81,Interpersonal problems; not elsewhere classified,0
668310,carvedilol phosphate,401-405.99,,1
668310,carvedilol phosphate,401.9,Hypertension NOS,1
668310,carvedilol phosphate,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
668310,carvedilol phosphate,413,Angina pectoris,0
668310,carvedilol phosphate,413.9,Other and unspecified angina pectoris,0
668310,carvedilol phosphate,428,Heart failure,1
668310,carvedilol phosphate,428.0,Congestive heart failure (CHF) NOS,0
668310,carvedilol phosphate,428.9,Heart failure unspecified,1
668310,carvedilol phosphate,786.50,Unspecified chest pain,0
668310,carvedilol phosphate,997.91,Hypertension,1
673579,lisdexamfetamine dimesylate,314,Hyperkinetic syndrome of childhood,1
673579,lisdexamfetamine dimesylate,314.01,Attention deficit disorder of childhood with hyperactivity,1
673579,lisdexamfetamine dimesylate,314.9,Unspecified hyperkinetic syndrome of childhood,1
673579,lisdexamfetamine dimesylate,780-789.99,,0
679314,paliperidone,295,Schizophrenic disorders,1
679314,paliperidone,295.7,Schizoaffective disorder,1
679314,paliperidone,295.70,Schizo-affective type schizophrenia; unspecified state,1
679314,paliperidone,295.9,Unspecified schizophrenia,1
679314,paliperidone,295.90,Unspecified schizophrenia; unspecified state,1
684879,pyridoxine,266.1,Vitamin B6 deficiency,0
684879,pyridoxine,269.9,Unspecified nutritional deficiency,0
684879,pyridoxine,285.9,Anemia unspecified,1
684879,pyridoxine,780.39,Other convulsions,0
684879,pyridoxine,977.9,Poisoning by unspecified drug or medicinal substance,0
689304,Fluorometholone / Sulfacetamide,379.99,Other ill-defined disorders of eye,1
689374,chloroxylenol / pramoxine,698.9,Unspecified pruritic disorder,1
689380,Chlorpheniramine / Codeine / Phenylephrine,375.2,Epiphora,1
689380,Chlorpheniramine / Codeine / Phenylephrine,375.20,Epiphora NOS,1
689380,Chlorpheniramine / Codeine / Phenylephrine,379.99,Other ill-defined disorders of eye,1
689380,Chlorpheniramine / Codeine / Phenylephrine,460,Acute nasopharyngitis (common cold),1
689380,Chlorpheniramine / Codeine / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
689380,Chlorpheniramine / Codeine / Phenylephrine,477.9,Allergic rhinitis NOS,1
689380,Chlorpheniramine / Codeine / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
689380,Chlorpheniramine / Codeine / Phenylephrine,698.9,Unspecified pruritic disorder,1
689380,Chlorpheniramine / Codeine / Phenylephrine,786.2,Cough,1
689380,Chlorpheniramine / Codeine / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,375.2,Epiphora,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,375.20,Epiphora NOS,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,379.99,Other ill-defined disorders of eye,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,460,Acute nasopharyngitis (common cold),1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,477.9,Allergic rhinitis NOS,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,698.9,Unspecified pruritic disorder,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,786.2,Cough,1
689389,Chlorpheniramine / Dextromethorphan / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
689512,Aspirin / Caffeine / dihydrocodeine,338-338.99,,1
689512,Aspirin / Caffeine / dihydrocodeine,780.96,Generalized pain,1
689522,Aspirin / Carisoprodol / Codeine,338-338.99,,1
689522,Aspirin / Carisoprodol / Codeine,780.96,Generalized pain,1
689522,Aspirin / Carisoprodol / Codeine,781.99,Other symptoms involving nervous and musculoskeletal systems,1
689569,Acetaminophen / Caffeine / dihydrocodeine,338-338.99,,1
689569,Acetaminophen / Caffeine / dihydrocodeine,780.96,Generalized pain,1
689572,Acetaminophen / Caffeine / isometheptene,346,Migraine,1
689572,Acetaminophen / Caffeine / isometheptene,346.9,Migraine; unspecified,1
689572,Acetaminophen / Caffeine / isometheptene,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,1
689572,Acetaminophen / Caffeine / isometheptene,784.0,Headache,1
689583,Acetaminophen / Chlorpheniramine / Phenylephrine,338-338.99,,1
689583,Acetaminophen / Chlorpheniramine / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
689583,Acetaminophen / Chlorpheniramine / Phenylephrine,780.60,Fever; unspecified,1
689583,Acetaminophen / Chlorpheniramine / Phenylephrine,780.96,Generalized pain,1
689583,Acetaminophen / Chlorpheniramine / Phenylephrine,784.0,Headache,1
689606,Atropine / Hyoscyamine / Phenobarbital / Scopolamine,564.1,Irritable bowel syndrome,1
689606,Atropine / Hyoscyamine / Phenobarbital / Scopolamine,707.9,Chronic ulcer of unspecified site,1
689632,Chlorpheniramine / Methscopolamine / Pseudoephedrine,375.2,Epiphora,1
689632,Chlorpheniramine / Methscopolamine / Pseudoephedrine,375.20,Epiphora NOS,1
689632,Chlorpheniramine / Methscopolamine / Pseudoephedrine,379.99,Other ill-defined disorders of eye,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,338-338.99,,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,487,Influenza,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,487.1,Influenza with other respiratory manifestations,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,780.60,Fever; unspecified,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,780.96,Generalized pain,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,784.0,Headache,1
689776,Acetaminophen / Dextromethorphan / Guaifenesin / Phenylephrine,786.2,Cough,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,338-338.99,,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,375.2,Epiphora,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,375.20,Epiphora NOS,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,379.99,Other ill-defined disorders of eye,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,698.9,Unspecified pruritic disorder,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,780.60,Fever; unspecified,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,780.96,Generalized pain,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,784.0,Headache,1
689785,Acetaminophen / Diphenhydramine / Phenylephrine,786.2,Cough,1
689799,Acetaminophen / phenyltoloxamine / salicylamide,338-338.99,,1
689799,Acetaminophen / phenyltoloxamine / salicylamide,716.90,Arthropathy; unspecified; site unspecified,1
689799,Acetaminophen / phenyltoloxamine / salicylamide,780.96,Generalized pain,1
689799,Acetaminophen / phenyltoloxamine / salicylamide,784.0,Headache,1
690161,prednisolone / Sulfacetamide,136.9,Unspecified infectious and parasitic diseases,1
690161,prednisolone / Sulfacetamide,379.99,Other ill-defined disorders of eye,1
690419,Betamethasone / calcipotriene,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
690647,Brompheniramine / Codeine / Phenylephrine,375.2,Epiphora,1
690647,Brompheniramine / Codeine / Phenylephrine,375.20,Epiphora NOS,1
690647,Brompheniramine / Codeine / Phenylephrine,379.99,Other ill-defined disorders of eye,1
690647,Brompheniramine / Codeine / Phenylephrine,460,Acute nasopharyngitis (common cold),1
690647,Brompheniramine / Codeine / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
690647,Brompheniramine / Codeine / Phenylephrine,477.9,Allergic rhinitis NOS,1
690647,Brompheniramine / Codeine / Phenylephrine,698.9,Unspecified pruritic disorder,1
690647,Brompheniramine / Codeine / Phenylephrine,786.2,Cough,1
690647,Brompheniramine / Codeine / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
690693,Diphenhydramine / Phenylephrine,375.2,Epiphora,1
690693,Diphenhydramine / Phenylephrine,375.20,Epiphora NOS,1
690693,Diphenhydramine / Phenylephrine,379.99,Other ill-defined disorders of eye,1
690693,Diphenhydramine / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
690693,Diphenhydramine / Phenylephrine,477.9,Allergic rhinitis NOS,1
690693,Diphenhydramine / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
690693,Diphenhydramine / Phenylephrine,698.9,Unspecified pruritic disorder,1
690693,Diphenhydramine / Phenylephrine,786.2,Cough,1
690693,Diphenhydramine / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
690740,Sulfacetamide / Sulfur,706.1,Other acne,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,375.2,Epiphora,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,375.20,Epiphora NOS,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,379.99,Other ill-defined disorders of eye,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,460,Acute nasopharyngitis (common cold),1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,477.0,Allergic rhinitis due to pollen,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,477.9,Allergic rhinitis NOS,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,478.19,Other diseases of nasal cavity and sinuses,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,698.9,Unspecified pruritic disorder,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,786.2,Cough,1
690808,Brompheniramine / Dextromethorphan / Pseudoephedrine,995.3,Allergy unspecified not elsewhere classified,1
693010,Neomycin / Polymyxin B / prednisolone,136.9,Unspecified infectious and parasitic diseases,1
700810,Lisdexamfetamine,314,Hyperkinetic syndrome of childhood,1
700810,Lisdexamfetamine,314.01,Attention deficit disorder of childhood with hyperactivity,1
700810,Lisdexamfetamine,314.9,Unspecified hyperkinetic syndrome of childhood,1
700810,Lisdexamfetamine,780-789.99,,0
705022,fluticasone furoate,471,Nasal polyps,0
705022,fluticasone furoate,471.0,Polyp of nasal cavity,0
705022,fluticasone furoate,471.9,Nasal polyp NOS,0
705022,fluticasone furoate,477.9,Allergic rhinitis NOS,1
705022,fluticasone furoate,493,Asthma,0
705022,fluticasone furoate,493.9,Asthma; unspecified,0
705022,fluticasone furoate,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
705258,Acetaminophen / Dextromethorphan / Doxylamine,338-338.99,,1
705258,Acetaminophen / Dextromethorphan / Doxylamine,460,Acute nasopharyngitis (common cold),1
705258,Acetaminophen / Dextromethorphan / Doxylamine,487,Influenza,1
705258,Acetaminophen / Dextromethorphan / Doxylamine,487.1,Influenza with other respiratory manifestations,1
705258,Acetaminophen / Dextromethorphan / Doxylamine,780.60,Fever; unspecified,1
705258,Acetaminophen / Dextromethorphan / Doxylamine,780.96,Generalized pain,1
705258,Acetaminophen / Dextromethorphan / Doxylamine,784.0,Headache,1
705258,Acetaminophen / Dextromethorphan / Doxylamine,786.2,Cough,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,338-338.99,,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,460,Acute nasopharyngitis (common cold),1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,478.19,Other diseases of nasal cavity and sinuses,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,487,Influenza,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,487.1,Influenza with other respiratory manifestations,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,780.60,Fever; unspecified,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,780.96,Generalized pain,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,784.0,Headache,1
705259,Acetaminophen / Dextromethorphan / Phenylephrine,786.2,Cough,1
709271,certolizumab pegol,555.9,Regional enteritis of unspecified site,0
709271,certolizumab pegol,714.0,Rheumatoid arthritis,1
711942,eltrombopag,287.31,Immune thrombocytopenic purpura,0
712566,ofatumumab,204.1,Lymphoid leukemia; chronic,0
712566,ofatumumab,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
714438,pazopanib,189.0,Malignant neoplasm of kidney; except pelvis,0
719872,Raltegravir,042,Human immunodeficiency virus [HIV] disease,1
719872,Raltegravir,042-042.99,,1
719872,Raltegravir,136.9,Unspecified infectious and parasitic diseases,1
720825,silodosin,600.0,Hypertrophy (benign) of prostate,0
733003,Plerixafor,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
733003,Plerixafor,203.0,Multiple myeloma,1
733003,Plerixafor,203.00,Multiple myeloma without mention of having achieved remission,1
734064,Desvenlafaxine,296.20,Major depressive disorder; single episode; unspecified degree,1
746070,Lithium Aspartate,296.80,Bipolar disorder NOS,0
746070,Lithium Aspartate,308.9,Unspecified acute reaction to stress,0
746070,Lithium Aspartate,309.81,Posttraumatic stress disorder,0
746070,Lithium Aspartate,311,Depressive disorder NEC,0
746070,Lithium Aspartate,312.9,Unspecified disturbance of conduct,0
746741,Pramipexole,311,Depressive disorder NEC,0
746741,Pramipexole,332,Parkinson's disease,0
746741,Pramipexole,332.0,Paralysis agitans,0
746741,Pramipexole,333.94,Restless legs syndrome (RLS),1
753340,Sapropterin,270.1,Phenylketonuria [PKU],1
753341,Sapropterin dihydrochloride,270.1,Phenylketonuria [PKU],0
762595,Typhoid Vaccine Live Ty21a,002.0,Typhoid fever,1
762817,Rubella Virus Vaccine Live (Wistar RA 27-3 Strain),056,Rubella,0
762817,Rubella Virus Vaccine Live (Wistar RA 27-3 Strain),056.9,Rubella without mention of complication,0
763450,rilonacept,708.2,Urticaria due to cold and heat,1
784649,Asenapine,295,Schizophrenic disorders,1
784649,Asenapine,295.9,Unspecified schizophrenia,1
784649,Asenapine,295.90,Unspecified schizophrenia; unspecified state,1
784649,Asenapine,296.00,Manic disorder; single episode; unspecified degree,1
784649,Asenapine,296.7,Bipolar I disorder; most recent episode (or current) unspecified,1
784649,Asenapine,296.80,Bipolar disorder NOS,1
787390,tapentadol,338-338.99,,1
787390,tapentadol,338.1,Acute pain,1
787390,tapentadol,338.18,Other acute postoperative pain,1
787390,tapentadol,338.2,Chronic pain,1
787390,tapentadol,338.29,Other chronic pain,1
787390,tapentadol,780.96,Generalized pain,1
787390,tapentadol,780.99,Other general symptoms,1
797195,fesoterodine,596.51,Hypertonicity of bladder,1
797196,Fesoterodine Fumarate,596.51,Hypertonicity of bladder,1
797272,clindamycin phosphate,041.00,Unspecified Streptococcus infection in conditions classified elsewhere and of unspecified site,0
797272,clindamycin phosphate,041.10,Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site,0
797272,clindamycin phosphate,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
797272,clindamycin phosphate,041.9|421.0,,0
797272,clindamycin phosphate,130,Toxoplasmosis,0
797272,clindamycin phosphate,130.9,Toxoplasmosis NOS,0
797272,clindamycin phosphate,136.3,Pneumocystosis,0
797272,clindamycin phosphate,136.9,Unspecified infectious and parasitic diseases,1
797272,clindamycin phosphate,486,Pneumonia; organism unspecified,1
797272,clindamycin phosphate,519.8,Other diseases of respiratory system; not elsewhere classified,1
797272,clindamycin phosphate,567.9,Peritonitis NOS,1
797272,clindamycin phosphate,616.10|041.9,,1
797272,clindamycin phosphate,706.1,Other acne,1
797272,clindamycin phosphate,730.2,Unspecified osteomyelitis,1
797272,clindamycin phosphate,730.20,Unspecified osteomyelitis; site unspecified,1
797272,clindamycin phosphate,995.3,Allergy unspecified not elsewhere classified,1
797550,Immune Globulin (Human),042,Human immunodeficiency virus [HIV] disease,1
797550,Immune Globulin (Human),042-042.99,,1
797550,Immune Globulin (Human),045,Acute poliomyelitis,0
797550,Immune Globulin (Human),045.9,Acute poliomyelitis; unspecified,0
797550,Immune Globulin (Human),045.90,Acute poliomyelitis; unspecified; poliovirus; unspecified type,0
797550,Immune Globulin (Human),052,Chickenpox,1
797550,Immune Globulin (Human),052.9,Varicella uncomplicated,1
797550,Immune Globulin (Human),055,Measles,1
797550,Immune Globulin (Human),055.9,Measles without mention of complication,1
797550,Immune Globulin (Human),056,Rubella,1
797550,Immune Globulin (Human),056.9,Rubella without mention of complication,1
797550,Immune Globulin (Human),070.1,Viral hepatitis A without mention of hepatic coma,1
797550,Immune Globulin (Human),070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,0
797550,Immune Globulin (Human),279.3,Unspecified immunity deficiency,1
797550,Immune Globulin (Human),287.31,Immune thrombocytopenic purpura,1
797752,Hepatitis B Surface Antigen Vaccine,070.30,Viral hepatitis B without mention of hepatic coma; acute or unspecified; without mention of hepatitis delta,1
798279,Haemophilus influenzae b  capsular polysaccharide inactivated tetanus toxoid conjugate vaccine,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
798304,Diphtheria Toxoid Vaccine,032,Diphtheria,0
798304,Diphtheria Toxoid Vaccine,032.9,Diphtheria NOS,0
798306,Tetanus Toxoid Vaccine,037,Tetanus,0
798306,Tetanus Toxoid Vaccine,041.84,Other anaerobe infection in conditions classified elsewhere and of unspecified site,0
798361,Hepatitis A Vaccine (Inactivated) Strain HM175,070.1,Viral hepatitis A without mention of hepatic coma,0
798372,Mumps Virus Vaccine Live  Jeryl Lynn Strain,072,Mumps,0
798372,Mumps Virus Vaccine Live  Jeryl Lynn Strain,072.9,Mumps uncomplicated,0
798444,Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine,041.85,Other gram-negative organism infection in conditions classified elsewhere and of unspecified site,0
803516,Niacin / Simvastatin,272.8,Other disorders of lipoid metabolism,1
803516,Niacin / Simvastatin,459.9,Unspecified circulatory system disorder,1
804187,Yellow-Fever Virus Vaccine  17D-204 strain,060,Yellow fever,0
804187,Yellow-Fever Virus Vaccine  17D-204 strain,060.9,Yellow fever NOS,0
805452,romiplostim,287.31,Immune thrombocytopenic purpura,0
805452,romiplostim,459.0,Hemorrhage NOS,1
807219,Typhoid Vi Polysaccharide Vaccine  S typhi Ty2 strain,002.0,Typhoid fever,1
809864,C1 inhibitor (Human),277.6,Other deficiencies of circulating enzymes,1
809864,C1 inhibitor (Human),995.1,Angioneurotic edema not elsewhere classified,1
816346,dexlansoprazole,530.19,Other esophagitis,1
816346,dexlansoprazole,530.81,Esophageal reflux,1
816346,dexlansoprazole,787.1,Heartburn,1
817579,Acetaminophen / Codeine,338-338.99,,1
817579,Acetaminophen / Codeine,780.96,Generalized pain,1
819300,golimumab,696.0,Psoriatic arthropathy,1
819300,golimumab,714.0,Rheumatoid arthritis,1
819300,golimumab,720.0,Ankylosing spondylitis,1
826070,factor VIII (Human),286.0,Congenital factor VIII disorder,1
826070,factor VIII (Human),286.7,Acquired coagulation factor deficiency,1
826070,factor VIII (Human),459.0,Hemorrhage NOS,1
828529,Albumin Human  USP,041.9,Bacterial infection; unspecified; in conditions classified elsewhere and of unspecified site,0
828529,Albumin Human  USP,273.8,Other disorders of plasma protein metabolism,1
828529,Albumin Human  USP,276.51,Dehydration,1
828529,Albumin Human  USP,514,Pulmonary congestion and hypostasis,1
828529,Albumin Human  USP,518.52,Other pulmonary insufficiency; not elsewhere classified; following trauma and surgery,1
828529,Albumin Human  USP,567.9,Peritonitis NOS,1
828529,Albumin Human  USP,571.5,Cirrhosis of liver without mention of alcohol,1
828529,Albumin Human  USP,593.9,Unspecified disorder of kidney and ureter,1
828529,Albumin Human  USP,769,Respiratory distress syndrome in newborn,0
828529,Albumin Human  USP,785.50,Shock NOS,1
828529,Albumin Human  USP,785.9,Other symptoms involving cardiovascular system,0
828529,Albumin Human  USP,789.5,Ascites,1
828529,Albumin Human  USP,789.59,Other ascites,1
828529,Albumin Human  USP,796.4,Other abnormal clinical findings,1
828529,Albumin Human  USP,799.89,Other ill-defined conditions,1
828529,Albumin Human  USP,940-949.99,,0
828529,Albumin Human  USP,949.0,Burn of unspecified site; unspecified degree,0
830457,rabies virus vaccine flury-lep strain,071,Rabies,1
830464,rabies virus vaccine wistar strain PM-1503-3M (Human),071,Rabies,0
830471,rabies immune globulin  (human) vaccine,071,Rabies,0
835827,testosterone cypionate,239.3,Neoplasm of unspecified nature of breast,0
835827,testosterone cypionate,253.4,Other anterior pituitary disorders,1
835827,testosterone cypionate,257.2,Other testicular hypofunction,1
835827,testosterone cypionate,259.0,Delay in sexual development and puberty NEC,0
835827,testosterone cypionate,797,Senility without mention of psychosis,1
840781,drospirenone / Ethinyl Estradiol,338-338.99,,1
840781,drospirenone / Ethinyl Estradiol,625.4,Premenstrual tension syndromes,1
840781,drospirenone / Ethinyl Estradiol,706.1,Other acne,1
840781,drospirenone / Ethinyl Estradiol,780.96,Generalized pain,1
840781,drospirenone / Ethinyl Estradiol,V22.2,Pregnant state; incidental,1
845525,Japanese encephalitis virus vaccine  inactivated,062.0,Japanese encephalitis,0
847083,ustekinumab,696.1,Other psoriasis and similar disorders excluding psoriatic arthropathy,1
857649,methscopolamine nitrate,478.19,Other diseases of nasal cavity and sinuses,0
857974,saxagliptin,250,Diabetes mellitus,1
857974,saxagliptin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
857974,saxagliptin,250.1,Diabetes with ketoacidosis,1
857974,saxagliptin,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
858045,paliperidone palmitate,295,Schizophrenic disorders,0
858045,paliperidone palmitate,295.9,Unspecified schizophrenia,0
858045,paliperidone palmitate,295.90,Unspecified schizophrenia; unspecified state,0
859393,adapalene / Benzoyl Peroxide,706.1,Other acne,1
859857,saquinavir mesylate,042,Human immunodeficiency virus [HIV] disease,1
859857,saquinavir mesylate,042-042.99,,1
859857,saquinavir mesylate,136.9,Unspecified infectious and parasitic diseases,1
860168,abobotulinumtoxinA,333.83,Spasmodic torticollis,0
860168,abobotulinumtoxinA,701.8,Other specified hypertrophic and atrophic conditions of skin,0
860168,abobotulinumtoxinA,728.9,Unspecified disorder of muscle; ligament; and fascia,0
860168,abobotulinumtoxinA,780-789.99,,0
860168,abobotulinumtoxinA,780.8,Generalized hyperhidrosis,0
860168,abobotulinumtoxinA,781.0,Abnormal involuntary movements,0
860168,abobotulinumtoxinA,784.0,Headache,0
860178,rimabotulinumtoxinB,333.81,Blepharospasm,0
860178,rimabotulinumtoxinB,333.83,Spasmodic torticollis,0
860178,rimabotulinumtoxinB,333.90,Unspecified extrapyramidal disease and abnormal movement disorder,1
860178,rimabotulinumtoxinB,343.9,Infantile cerebral palsy NOS,0
860178,rimabotulinumtoxinB,346,Migraine,0
860178,rimabotulinumtoxinB,346.9,Migraine; unspecified,0
860178,rimabotulinumtoxinB,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
860178,rimabotulinumtoxinB,378.30,Heterotropia NOS,0
860178,rimabotulinumtoxinB,378.4,Heterophoria,0
860178,rimabotulinumtoxinB,378.40,Heterophoria NOS,0
860178,rimabotulinumtoxinB,378.9,Unspecified disorder of eye movements,0
860178,rimabotulinumtoxinB,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,0
860178,rimabotulinumtoxinB,565.0,Anal fissure,0
860178,rimabotulinumtoxinB,569.41,Ulcer of anus and rectum,0
860178,rimabotulinumtoxinB,701.8,Other specified hypertrophic and atrophic conditions of skin,0
860178,rimabotulinumtoxinB,723.1,Cervicalgia,1
860178,rimabotulinumtoxinB,728.85,Spasm of muscle,0
860178,rimabotulinumtoxinB,728.9,Unspecified disorder of muscle; ligament; and fascia,0
860178,rimabotulinumtoxinB,757.9,Unspecified congenital anomaly of the integument,0
860178,rimabotulinumtoxinB,780-789.99,,0
860178,rimabotulinumtoxinB,780.8,Generalized hyperhidrosis,0
860178,rimabotulinumtoxinB,780.96,Generalized pain,1
860178,rimabotulinumtoxinB,781.0,Abnormal involuntary movements,0
860189,onabotulinumtoxinA,136.9,Unspecified infectious and parasitic diseases,1
860189,onabotulinumtoxinA,333.81,Blepharospasm,1
860189,onabotulinumtoxinA,333.83,Spasmodic torticollis,0
860189,onabotulinumtoxinA,333.90,Unspecified extrapyramidal disease and abnormal movement disorder,1
860189,onabotulinumtoxinA,343.9,Infantile cerebral palsy NOS,0
860189,onabotulinumtoxinA,346,Migraine,0
860189,onabotulinumtoxinA,346.9,Migraine; unspecified,0
860189,onabotulinumtoxinA,346.90,Migraine; unspecified; without mention of intractable migraine without mention of status migrainosus,0
860189,onabotulinumtoxinA,378.30,Heterotropia NOS,1
860189,onabotulinumtoxinA,378.4,Heterophoria,1
860189,onabotulinumtoxinA,378.40,Heterophoria NOS,1
860189,onabotulinumtoxinA,378.9,Unspecified disorder of eye movements,1
860189,onabotulinumtoxinA,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,0
860189,onabotulinumtoxinA,565.0,Anal fissure,0
860189,onabotulinumtoxinA,569.41,Ulcer of anus and rectum,0
860189,onabotulinumtoxinA,701.8,Other specified hypertrophic and atrophic conditions of skin,1
860189,onabotulinumtoxinA,705.21,Primary focal hyperhidrosis,1
860189,onabotulinumtoxinA,723.1,Cervicalgia,1
860189,onabotulinumtoxinA,728.85,Spasm of muscle,1
860189,onabotulinumtoxinA,728.9,Unspecified disorder of muscle; ligament; and fascia,0
860189,onabotulinumtoxinA,757.9,Unspecified congenital anomaly of the integument,0
860189,onabotulinumtoxinA,780-789.99,,0
860189,onabotulinumtoxinA,780.8,Generalized hyperhidrosis,0
860189,onabotulinumtoxinA,780.96,Generalized pain,1
860189,onabotulinumtoxinA,781.0,Abnormal involuntary movements,0
860189,onabotulinumtoxinA,784.0,Headache,0
860693,galantamine hydrobromide,331.0,Alzheimer's disease,0
860693,galantamine hydrobromide,780-789.99,,0
861634,pitavastatin,272.4,Other and unspecified hyperlipidemia,1
863035,bepotastine,372.14,Other chronic allergic conjunctivitis,1
866331,Morphine / Naltrexone,338-338.99,,1
866331,Morphine / Naltrexone,780.96,Generalized pain,1
877015,levoleucovorin,963.1,Poisoning by antineoplastic and immunosuppressive drugs,0
877510,romidepsin,202.7,Peripheral T-cell lymphoma,1
877510,romidepsin,202.70,Peripheral T-cell lymphoma; unspecified site; extranodal and solid organ sites,1
877510,romidepsin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
883815,Dexamethasone / Tobramycin,136.9,Unspecified infectious and parasitic diseases,1
883815,Dexamethasone / Tobramycin,379.99,Other ill-defined disorders of eye,1
883815,Dexamethasone / Tobramycin,379.99|041.9,,1
897018,dalfampridine,340,Multiple sclerosis,1
897018,dalfampridine,780-789.99,,0
897018,dalfampridine,799.9,Other unknown and unspecified cause of morbidity or mortality,0
898492,collagenase Clostridium histolyticum,707.9,Chronic ulcer of unspecified site,0
898492,collagenase Clostridium histolyticum,709.8,Other specified disorders of skin,0
898492,collagenase Clostridium histolyticum,728.85,Spasm of muscle,1
898492,collagenase Clostridium histolyticum,940-949.99,,0
898492,collagenase Clostridium histolyticum,949.0,Burn of unspecified site; unspecified degree,0
901212,Amlodipine / telmisartan,401-405.99,,1
901212,Amlodipine / telmisartan,401.9,Hypertension NOS,1
901212,Amlodipine / telmisartan,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
901212,Amlodipine / telmisartan,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
901212,Amlodipine / telmisartan,997.91,Hypertension,1
901805,velaglucerase alfa,272.7,Lipidoses,1
901845,Alternaria alternata allergenic extract,995.3,Allergy unspecified not elsewhere classified,0
968170,polidocanol,454.9,Asymptomatic varicose veins,1
968804,Cytarabine liposome,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
968804,Cytarabine liposome,208,Leukemia of unspecified cell type,0
968804,Cytarabine liposome,208.9,Unspecified leukemia,0
968804,Cytarabine liposome,208.90,Unspecified leukemia without mention of having achieved remission,0
968804,Cytarabine liposome,239.7,Neoplasm of unspecified nature of endocrine glands and other parts of nervous system,0
979111,Methylnaltrexone bromide,338-338.99,,0
979111,Methylnaltrexone bromide,564.0,Constipation,1
979111,Methylnaltrexone bromide,564.00,Constipation NOS,1
979111,Methylnaltrexone bromide,780.96,Generalized pain,0
979111,Methylnaltrexone bromide,799.89,Other ill-defined conditions,1
979384,North American coral snake antivenin,344.9,Paralysis NOS,0
979384,North American coral snake antivenin,989.5,Toxic effect of venom,0
991743,alpha 1-proteinase inhibitor  human,273.4,Alpha-1-antitrypsin deficiency,0
991743,alpha 1-proteinase inhibitor  human,492,Emphysema,1
991743,alpha 1-proteinase inhibitor  human,492.8,Other emphysema,1
993449,denosumab,185,Malignant neoplasm of prostate,1
993449,denosumab,733.0,Osteoporosis,1
993449,denosumab,733.00,Osteoporosis NOS,1
993449,denosumab,733.90,Disorder of bone and cartilage; unspecified,1
993449,denosumab,800-829.99,,0
993449,denosumab,829,Fracture of unspecified bones,0
993449,denosumab,829.0,Fracture of unspecified bone closed,0
993449,denosumab,E887,FRACTURE; CAUSE NOS,0
993491,midodrine hydrochloride,458,Hypotension,1
993491,midodrine hydrochloride,458.0,Orthostatic hypotension,1
993491,midodrine hydrochloride,458.9,Hypotension NOS,1
993491,midodrine hydrochloride,788.3,Urinary incontinence,0
993491,midodrine hydrochloride,788.30,Urinary incontinence NOS,0
993491,midodrine hydrochloride,796.2,Elevated blood pressure reading without diagnosis of hypertension,1
993548,Bupropion hydrobromide,305.1,Tobacco use disorder,0
993548,Bupropion hydrobromide,311,Depressive disorder NEC,0
993548,Bupropion hydrobromide,314,Hyperkinetic syndrome of childhood,0
993548,Bupropion hydrobromide,314.01,Attention deficit disorder of childhood with hyperactivity,0
993548,Bupropion hydrobromide,314.9,Unspecified hyperkinetic syndrome of childhood,0
994202,Esomeprazole / Naproxen,338-338.99,,1
994202,Esomeprazole / Naproxen,531,Gastric ulcer,1
994202,Esomeprazole / Naproxen,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,1
994202,Esomeprazole / Naproxen,707.9,Chronic ulcer of unspecified site,1
994202,Esomeprazole / Naproxen,714.0,Rheumatoid arthritis,1
994202,Esomeprazole / Naproxen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
994202,Esomeprazole / Naproxen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
994202,Esomeprazole / Naproxen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
994202,Esomeprazole / Naproxen,716.90,Arthropathy; unspecified; site unspecified,1
994202,Esomeprazole / Naproxen,720.0,Ankylosing spondylitis,1
994202,Esomeprazole / Naproxen,780.96,Generalized pain,1
996051,cabazitaxel,185,Malignant neoplasm of prostate,1
997261,sipuleucel-T,185,Malignant neoplasm of prostate,0
1000082,alcaftadine,372.14,Other chronic allergic conjunctivitis,1
1000082,alcaftadine,698.9,Unspecified pruritic disorder,1
1000104,incobotulinumtoxin A,333.81,Blepharospasm,0
1000104,incobotulinumtoxin A,333.83,Spasmodic torticollis,0
1000104,incobotulinumtoxin A,701.8,Other specified hypertrophic and atrophic conditions of skin,0
1000104,incobotulinumtoxin A,780-789.99,,0
1000104,incobotulinumtoxin A,780.8,Generalized hyperhidrosis,0
1000104,incobotulinumtoxin A,781.0,Abnormal involuntary movements,0
1000104,incobotulinumtoxin A,784.0,Headache,0
1000112,medroxyprogesterone acetate,182.0,Malignant neoplasm of corpus uteri; except isthmus,1
1000112,medroxyprogesterone acetate,189.0,Malignant neoplasm of kidney; except pelvis,0
1000112,medroxyprogesterone acetate,199.1,Other malignant neoplasm of unspecified site,1
1000112,medroxyprogesterone acetate,239.3,Neoplasm of unspecified nature of breast,0
1000112,medroxyprogesterone acetate,239.5,Neoplasm of unspecified nature of other genitourinary organs,0
1000112,medroxyprogesterone acetate,338-338.99,,1
1000112,medroxyprogesterone acetate,617,Endometriosis,1
1000112,medroxyprogesterone acetate,617.9,Endometriosis; site unspecified,1
1000112,medroxyprogesterone acetate,621.3,Endometrial hyperplasia,1
1000112,medroxyprogesterone acetate,621.30,Endometrial hyperplasia; unspecified,1
1000112,medroxyprogesterone acetate,621.4,Hematometra,1
1000112,medroxyprogesterone acetate,625.3,Dysmenorrhea,1
1000112,medroxyprogesterone acetate,626.0,Absence of menstruation,1
1000112,medroxyprogesterone acetate,626.4,Irregular menstrual cycle,0
1000112,medroxyprogesterone acetate,626.9,Unspecified disorders of menstruation and other abnormal bleeding from female genital tract,1
1000112,medroxyprogesterone acetate,780.96,Generalized pain,1
1000112,medroxyprogesterone acetate,786.09,Other dyspnea and respiratory abnormality,0
1000112,medroxyprogesterone acetate,V22.2,Pregnant state; incidental,1
1005920,ulipristal acetate,V22.2,Pregnant state; incidental,0
1005921,ulipristal,V22.2,Pregnant state; incidental,0
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,250,Diabetes mellitus,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,250.4,Diabetes with renal manifestations,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,401-405.99,,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,401.9,Hypertension NOS,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,413,Angina pectoris,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,413.9,Other and unspecified angina pectoris,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,593.9,Unspecified disorder of kidney and ureter,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,786.50,Unspecified chest pain,1
1008801,Amlodipine / Hydrochlorothiazide / olmesartan,997.91,Hypertension,1
1009015,Amlodipine / olmesartan,250,Diabetes mellitus,1
1009015,Amlodipine / olmesartan,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
1009015,Amlodipine / olmesartan,250.4,Diabetes with renal manifestations,1
1009015,Amlodipine / olmesartan,401-405.99,,1
1009015,Amlodipine / olmesartan,401.9,Hypertension NOS,1
1009015,Amlodipine / olmesartan,413,Angina pectoris,1
1009015,Amlodipine / olmesartan,413.9,Other and unspecified angina pectoris,1
1009015,Amlodipine / olmesartan,593.9,Unspecified disorder of kidney and ureter,1
1009015,Amlodipine / olmesartan,786.50,Unspecified chest pain,1
1009015,Amlodipine / olmesartan,997.91,Hypertension,1
1009149,Aluminum Hydroxide / Magnesium Hydroxide,530.11,Reflux esophagitis,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,530.81,Esophageal reflux,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,531,Gastric ulcer,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,531.90,Gastric ulcer; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,532,Duodenal ulcer,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,532.90,Duodenal ulcer; unspecified as acute or chronic; without hemorrhage or perforation; without mention of obstruction,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,536.8,Dyspepsia and other specified disorders of function of stomach,1
1009149,Aluminum Hydroxide / Magnesium Hydroxide,578,Gastrointestinal hemorrhage,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,578.9,Hemorrhage of gastrointestinal tract NOS,0
1009149,Aluminum Hydroxide / Magnesium Hydroxide,787.1,Heartburn,1
1009156,Chlorpheniramine / Methscopolamine / Phenylephrine,375.2,Epiphora,1
1009156,Chlorpheniramine / Methscopolamine / Phenylephrine,375.20,Epiphora NOS,1
1009156,Chlorpheniramine / Methscopolamine / Phenylephrine,379.99,Other ill-defined disorders of eye,1
1009156,Chlorpheniramine / Methscopolamine / Phenylephrine,477.0,Allergic rhinitis due to pollen,1
1009156,Chlorpheniramine / Methscopolamine / Phenylephrine,477.9,Allergic rhinitis NOS,1
1009156,Chlorpheniramine / Methscopolamine / Phenylephrine,995.3,Allergy unspecified not elsewhere classified,1
1011650,Pegloticase,274,Gout,1
1011650,Pegloticase,274.9,Gout NOS,1
1012892,fingolimod,340,Multiple sclerosis,0
1025342,Levomefolic Acid,V22.2,Pregnant state; incidental,0
1037042,dabigatran etexilate,427.31,Atrial fibrillation,1
1037042,dabigatran etexilate,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
1040004,ceftaroline fosamil,136.9,Unspecified infectious and parasitic diseases,1
1040004,ceftaroline fosamil,482.9,Bacterial pneumonia NOS,1
1040004,ceftaroline fosamil,486,Pneumonia; organism unspecified,1
1040004,ceftaroline fosamil,686.9,Unspecified local infection of skin and subcutaneous tissue,0
1040005,ceftaroline,486,Pneumonia; organism unspecified,0
1040005,ceftaroline,686.9,Unspecified local infection of skin and subcutaneous tissue,0
1040027,Lurasidone Hydrochloride,295,Schizophrenic disorders,0
1040027,Lurasidone Hydrochloride,295.9,Unspecified schizophrenia,0
1040027,Lurasidone Hydrochloride,295.90,Unspecified schizophrenia; unspecified state,0
1040028,lurasidone,295,Schizophrenic disorders,1
1040028,lurasidone,295.9,Unspecified schizophrenia,1
1040028,lurasidone,295.90,Unspecified schizophrenia; unspecified state,1
1040053,Dextromethorphan / Quinidine,335.20,Amyotrophic lateral sclerosis,1
1040053,Dextromethorphan / Quinidine,340,Multiple sclerosis,1
1043562,Metformin / saxagliptin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
1043562,Metformin / saxagliptin,250.1,Diabetes with ketoacidosis,1
1043562,Metformin / saxagliptin,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
1044584,tesamorelin,272.6,Lipodystrophy,1
1045453,eribulin,174.9,Malignant neoplasm of breast (female); unspecified,1
1046243,alpha-Tocopherol Acetate,269.1,Deficiency of other vitamins,0
1046243,alpha-Tocopherol Acetate,283.9,Acquired hemolytic anemia; unspecified,0
1046243,alpha-Tocopherol Acetate,331.0,Alzheimer's disease,0
1046243,alpha-Tocopherol Acetate,333.99,Other extrapyramidal diseases and abnormal movement disorders,0
1046243,alpha-Tocopherol Acetate,770.7,Chronic respiratory disease arising in the perinatal period,0
1047802,Hyoscyamine hydrobromide,472.0,Chronic rhinitis,0
1047802,Hyoscyamine hydrobromide,527.7,Disturbance of salivary secretion,0
1047802,Hyoscyamine hydrobromide,533,Peptic ulcer; site unspecified,0
1047802,Hyoscyamine hydrobromide,533.90,Peptic ulcer of unspecified site; unspecified as acute or chronic; without mention of hemorrhage or perforation; without mention of obstruction,0
1047802,Hyoscyamine hydrobromide,564.1,Irritable bowel syndrome,0
1047802,Hyoscyamine hydrobromide,596.54,Neurogenic bladder NOS,0
1047802,Hyoscyamine hydrobromide,596.59,Other functional disorder of bladder,0
1047802,Hyoscyamine hydrobromide,705.21,Primary focal hyperhidrosis,0
1047802,Hyoscyamine hydrobromide,728.85,Spasm of muscle,0
1047802,Hyoscyamine hydrobromide,780.96,Generalized pain,0
1047802,Hyoscyamine hydrobromide,781.0,Abnormal involuntary movements,0
1047802,Hyoscyamine hydrobromide,789.00,Abdominal pain; unspecified site,0
1047802,Hyoscyamine hydrobromide,789.7,Colic (ADDED),0
1086769,vilazodone,296.20,Major depressive disorder; single episode; unspecified degree,1
1091642,azilsartan medoxomil,401-405.99,,0
1091642,azilsartan medoxomil,401.9,Hypertension NOS,0
1091642,azilsartan medoxomil,997.91,Hypertension,0
1091643,azilsartan,401-405.99,,1
1091643,azilsartan,401.9,Hypertension NOS,1
1091643,azilsartan,997.91,Hypertension,1
1091836,Roflumilast,491,Chronic bronchitis,1
1091836,Roflumilast,491.9,Chronic bronchitis NOS,1
1091836,Roflumilast,496,Chronic airway obstruction; not elsewhere classified,1
1091836,Roflumilast,796.4,Other abnormal clinical findings,1
1092437,belimumab,279.49,Autoimmune disease; not elsewhere classified (ADDED),0
1092437,belimumab,710.0,Systemic lupus erythematosus,0
1094833,ipilimumab,172.9,Melanoma of skin; site unspecified,1
1094833,ipilimumab,173.99,Other specified malignant neoplasm of skin; site unspecified,0
1098413,Vandetanib,193,Malignant neoplasm of thyroid gland,1
1100065,Famotidine / Ibuprofen,707.9,Chronic ulcer of unspecified site,1
1100065,Famotidine / Ibuprofen,714.0,Rheumatoid arthritis,1
1100065,Famotidine / Ibuprofen,715.00,Osteoarthrosis; generalized; involving unspecified site,1
1100065,Famotidine / Ibuprofen,715.9,Osteoarthrosis; unspecified whether generalized or localized,1
1100065,Famotidine / Ibuprofen,715.90,Osteoarthrosis; unspecified whether generalized or localized; involving unspecified site,1
1100065,Famotidine / Ibuprofen,716.90,Arthropathy; unspecified; site unspecified,1
1100071,abiraterone acetate,185,Malignant neoplasm of prostate,0
1100072,abiraterone,185,Malignant neoplasm of prostate,1
1100699,Linagliptin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
1100699,Linagliptin,250.1,Diabetes with ketoacidosis,1
1100699,Linagliptin,250.10,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; with ketoacidosis,1
1101333,gabapentin enacarbil,296.80,Bipolar disorder NOS,0
1101333,gabapentin enacarbil,300.2,Phobic disorders,0
1101333,gabapentin enacarbil,300.20,Phobia unspecified,0
1101333,gabapentin enacarbil,338-338.99,,0
1101333,gabapentin enacarbil,345.50,Partial epilepsy without impairment of consciousness without intractable epilepsy,0
1101333,gabapentin enacarbil,780.96,Generalized pain,0
1102129,boceprevir,070.54,Chronic hepatitis C without mention of hepatic coma,1
1102129,boceprevir,070.7,Unspecified viral hepatitis C,1
1102129,boceprevir,070.70,Unspecified viral hepatitis C without hepatic coma,1
1102129,boceprevir,070.9,Unspecified viral hepatitis without mention of hepatic coma,1
1102129,boceprevir,571.5,Cirrhosis of liver without mention of alcohol,1
1102261,telaprevir,070.54,Chronic hepatitis C without mention of hepatic coma,1
1102261,telaprevir,070.7,Unspecified viral hepatitis C,1
1102261,telaprevir,070.70,Unspecified viral hepatitis C without hepatic coma,1
1102261,telaprevir,070.9,Unspecified viral hepatitis without mention of hepatic coma,1
1102261,telaprevir,571.5,Cirrhosis of liver without mention of alcohol,1
1102270,Rilpivirine,042,Human immunodeficiency virus [HIV] disease,1
1102270,Rilpivirine,042-042.99,,1
1111103,fidaxomicin,136.9,Unspecified infectious and parasitic diseases,1
1111103,fidaxomicin,787.7,Abnormal feces,1
1111103,fidaxomicin,787.91,Diarrhea,1
1114195,rivaroxaban,415.19,Other pulmonary embolism and infarction,1
1114195,rivaroxaban,427.31,Atrial fibrillation,1
1114195,rivaroxaban,451.9,Phlebitis and thrombophlebitis of unspecified site,1
1114195,rivaroxaban,453.40,Venous embolism and thrombosis of unspecified deep vessels of lower extremity,0
1114195,rivaroxaban,453.9,Embolism and thrombosis of unspecified site,1
1114195,rivaroxaban,81.54,TOTAL KNEE REPLACEMENT,0
1114326,indacaterol,493,Asthma,0
1114326,indacaterol,493.9,Asthma; unspecified,0
1114326,indacaterol,493.90,Asthma; unspecified type; without mention of status asthmaticus,0
1114693,Bendamustine hydrochloride,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,0
1114693,Bendamustine hydrochloride,204.1,Lymphoid leukemia; chronic,0
1114693,Bendamustine hydrochloride,204.10,Chronic lymphoid leukemia without mention of having achieved remission,0
1116632,Ticagrelor,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
1116632,Ticagrelor,411.1,Intermediate coronary syndrome,1
1116632,Ticagrelor,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
1116632,Ticagrelor,786.50,Unspecified chest pain,1
1116632,Ticagrelor,794.31,Nonspecific abnormal electrocardiogram [ECG] [EKG],1
1147220,Vemurafenib,172.9,Melanoma of skin; site unspecified,1
1147220,Vemurafenib,173.99,Other specified malignant neoplasm of skin; site unspecified,0
1147320,brentuximab vedotin,201,Hodgkin's disease,1
1147320,brentuximab vedotin,201.0,Hodgkin's paragranuloma,1
1147320,brentuximab vedotin,201.1,Hodgkin's granuloma,1
1147320,brentuximab vedotin,201.10,Hodgkin's granuloma; unspecified site; extranodal and solid organ sites,1
1147320,brentuximab vedotin,201.2,Hodgkin's sarcoma,1
1147320,brentuximab vedotin,201.20,Hodgkin's sarcoma; unspecified site; extranodal and solid organ sites,1
1147320,brentuximab vedotin,201.9,Hodgkin's disease; unspecified type,1
1147320,brentuximab vedotin,201.90,Hodgkin's disease; unspecified type; unspecified site; extranodal and solid organ sites,1
1147320,brentuximab vedotin,202.80,Other malignant lymphomas; unspecified site; extranodal and solid organ sites,1
1148138,icatibant,277.6,Other deficiencies of circulating enzymes,1
1148495,crizotinib,162.9,Malignant neoplasm of bronchus and lung; unspecified,1
1148495,crizotinib,199,Malignant neoplasm without specification of site,1
1148495,crizotinib,199.1,Other malignant neoplasm of unspecified site,1
1189803,Simvastatin / sitagliptin,250.00,type II diabetes mellitus [non-insulin dependent type] [NIDDM type] [adult-onset type] or unspecified type; not stated as uncontrolled; without mention of complication,1
1189803,Simvastatin / sitagliptin,272.0,Pure hypercholesterolemia,1
1189803,Simvastatin / sitagliptin,272.4,Other and unspecified hyperlipidemia,1
1189803,Simvastatin / sitagliptin,410.90,Acute myocardial infarction; unspecified site; episode of care unspecified,1
1189803,Simvastatin / sitagliptin,434.91,Cerebral artery occlusion; unspecified; with cerebral infarction,1
1189803,Simvastatin / sitagliptin,459.9,Unspecified circulatory system disorder,1
1193326,ruxolitinib,238.4,Polycythemia vera,1
1193326,ruxolitinib,289.83,Myelofibrosis,1
1193326,ruxolitinib,289.89,Other specified diseases of blood and blood-forming organs,1
1232150,aflibercept,362.50,Macular degeneration (senile) of retina NOS,1
1242987,vismodegib,173.91,Basal cell carcinoma of skin; site unspecified,0
1243041,ivacaftor,277.0,Cystic fibrosis,0
1243041,ivacaftor,277.00,Cystic fibrosis without mention of meconium ileus,0
1292422,Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain,052,Chickenpox,0
1292422,Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain,052.9,Varicella uncomplicated,0
1294535,SIBUTRAMINE HYDROCHLORIDE,278.00,Obesity NOS,1
1294535,SIBUTRAMINE HYDROCHLORIDE,783.21,Loss of weight,1
1294535,SIBUTRAMINE HYDROCHLORIDE,783.9,Other symptoms concerning nutrition; metabolism; and development,1
1294548,Conivaptan hydrochloride,253.6,Other disorders of neurohypophysis,1
1294548,Conivaptan hydrochloride,276.1,Hyposmolality and/or hyponatremia,1
1294548,Conivaptan hydrochloride,428,Heart failure,1
1294548,Conivaptan hydrochloride,428.9,Heart failure unspecified,1
1294580,Gemtuzumab ozogamicin,205.0,Myeloid leukemia; acute,1
1294580,Gemtuzumab ozogamicin,205.00,Acute myeloid leukemia without mention of having achieved remission,1
1294580,Gemtuzumab ozogamicin,208,Leukemia of unspecified cell type,1
1294580,Gemtuzumab ozogamicin,208.9,Unspecified leukemia,1
1294580,Gemtuzumab ozogamicin,208.90,Unspecified leukemia without mention of having achieved remission,1
1294622,Histrelin acetate,185,Malignant neoplasm of prostate,1
1294622,Histrelin acetate,259.1,Precocious sexual development and puberty NEC,0

